{
    "total_score": 5841,
    "score_ratio": 0.7963190184049079,
    "results": [
        {
            "query_idx": 1,
            "query": "What year was the first collection of cancer PDOs established, what are the primary sources of these samples, and which structural form do they closely mimic?",
            "retrieved_metrics": {
                "reference_idx": [
                    1728,
                    1739,
                    1974
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The first collection of cancer PDOs was reported in #2015#, derived mainly from #single biopsies# or tissue fragments, and they form a #three-dimensional# system replicating tumor characteristics accurately.",
            "predicted_answer": "The first collection of cancer PDOs was established in 2015. Primary sources are single biopsies or small fragments of surgically resected tissue. They closely mimic the structural and functional characteristics of human tumors.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the year 2015 and the primary sources being single biopsies or small tissue fragments. However, it omits the specific mention of 'three-dimensional' in describing their structure, though it states they mimic structural characteristics. This missing detail affects completeness."
        },
        {
            "query_idx": 2,
            "query": "What is the procedure for determining the interaction of compounds with a genetic mutation, and which specific animal models and environmental settings are used in the corresponding in vivo experiments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1113,
                    1140,
                    1141
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds' interactions with #KRAS G12D mutation# are assessed using #IC50 ratio#. In vivo experiments use #female BALB/c and SCID male mice# under #sterile conditions with autoclaved food and acidified water#.",
            "predicted_answer": "The procedure involves calculating selectivity ratios (IC50 of KRAS wt vs. KRAS G12D) to determine compound interaction with the mutation. In vivo experiments use SCID male mice with subcutaneous PANC-1 and BxPC3 tumor models, held in sterile conditions.",
            "score": 1,
            "explanation": "The predicted answer includes key facts such as using the IC50 ratio and SCID male mice under sterile conditions. However, it misses the fact about using female BALB/c mice and the specific environmental conditions of autoclaved food and acidified water, impacting completeness."
        },
        {
            "query_idx": 3,
            "query": "Which enzyme's reduction enhances a chemotherapy drug's effectiveness in lung cancer and influences proliferation and resistance in other cancers, affecting therapeutic approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1334,
                    1337,
                    1348
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #knockdown of CPT1A# enhances cisplatin sensitivity in lung cancer, may regulate #prostate cancer cell proliferation#, and supports #anoikis resistance and metastasis#, crucial for therapy advancement strategies.",
            "predicted_answer": "The enzyme CPT1A's reduction enhances cisplatin's effectiveness in lung cancer and influences proliferation and resistance in other cancers, affecting therapeutic approaches.",
            "score": 1,
            "explanation": "The predicted answer includes important details about CPT1A's role in enhancing cisplatin effectiveness in lung cancer. However, it lacks specifics on prostate cancer cell proliferation and anoikis resistance and metastasis, key points in the reference answer. Thus, it lacks completeness for a full alignment."
        },
        {
            "query_idx": 4,
            "query": "What combination of technologies can be employed to effectively target and treat intracellular bacterial infections by overcoming resistance and ensuring precise delivery within host cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    37,
                    48,
                    41
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phage therapy# involves creating #phage cocktails# for enhanced #therapeutic success# and leveraging #targeted intracellular delivery# to combat intracellular bacterial infections.",
            "predicted_answer": "Phage therapy, combined with targeted intracellular delivery mechanisms, can effectively treat intracellular bacterial infections by overcoming resistance and ensuring precise delivery within host cells.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning \"phage therapy\" and \"targeted intracellular delivery.\" However, it misses mentioning the creation of \"phage cocktails\" and \"therapeutic success,\" affecting completeness. There are no contradictions, but the omission of these key details results in a less complete response."
        },
        {
            "query_idx": 5,
            "query": "How does a specific protein associated with the APC/C complex contribute to cell-cycle regulation changes and their impact on cell proliferation and apoptosis in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1557,
                    1559
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #Ube2c# links with #APC/C#, leading to #enhanced cell-cycle regulation#; overexpression results in increased #proliferation# and reduced #apoptosis# in cancer cells.",
            "predicted_answer": "Ube2c, an E2 enzyme associated with the APC/C complex, enhances cell proliferation and inhibits apoptosis in cancer cells by promoting protein degradation, thereby disrupting cell-cycle regulation and promoting tumor growth.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: Ube2c, APC/C association, enhanced proliferation, and reduced apoptosis, aligning well with the reference trends on cell-cycle regulation and impacts on cancer cells. Key phrases like \"protein degradation\" clarify mechanisms without contradicting the reference."
        },
        {
            "query_idx": 6,
            "query": "What innovation in cancer research is known for closely resembling human tumors, aiding drug development through enhanced understanding of tumor biology, and facing challenges due to financial and scalability issues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1979,
                    1993,
                    1985
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PDOs# replicate patient tumors, aiding in #drug development# by improving understanding of tumor biology. They face challenges like #financial and scalability issues#, limiting broader clinical application.",
            "predicted_answer": "Patient-derived organoids (PDOs) closely resemble human tumors, aiding drug development by enhancing understanding of tumor biology, but face challenges due to financial and scalability issues.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer: PDOs resemble human tumors, aid drug development, improve understanding of tumor biology, and face financial and scalability challenges. The meaning and key facts are consistent without omissions or contradictions."
        },
        {
            "query_idx": 7,
            "query": "Why has modern cancer drug development moved away from traditional dose-escalation designs to incorporate pharmacogenomics, and pharmacodynamics in dose optimization?",
            "retrieved_metrics": {
                "reference_idx": [
                    695,
                    696
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Traditional designs lack #comprehensive clinical, PK, and PD data#, necessitating #pharmacogenomics, TDM, and pharmacodynamics# for effective dose optimization in cancer drug therapy development.",
            "predicted_answer": "Modern cancer drug development has shifted from traditional dose-escalation designs to incorporate pharmacogenomics and pharmacodynamics for more precise dose optimization, as these methods provide robust clinical, pharmacokinetic, and pharmacodynamic data, leading to safer and more effective treatments.",
            "score": 3,
            "explanation": "The Predicted Answer covers key elements like the shift from traditional designs and the incorporation of pharmacogenomics and pharmacodynamics. However, it misses the specific mention of \"comprehensive clinical, PK, and PD data\" and \"TDM\" from the Reference Answer, affecting completeness."
        },
        {
            "query_idx": 8,
            "query": "What roles do phages play in the delivery of genetic material for gene editing, precision targeting for cancer therapy, and the advancement of innovative oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    5,
                    105,
                    74
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phages serve as #vectors for CRISPR-Cas systems#, enable #precision drug targeting# in cancer therapy, and represent significant #advances in phage-based therapies# through targeted delivery and immune system stimulation in oncological treatment.",
            "predicted_answer": "Phages play roles in gene editing by delivering genetic material, precision targeting for cancer therapy by selectively delivering therapeutic agents to tumor cells, and advancing innovative oncological treatments by stimulating anti-tumor immune responses and improving specificity and efficacy of cancer treatments.",
            "score": 3,
            "explanation": "The predicted answer covers key roles of phages, such as delivery of genetic material for gene editing, precision targeting in cancer therapy, and enhancements in oncological treatments. However, it does not explicitly mention \"vectors for CRISPR-Cas systems,\" a crucial detail from the reference answer."
        },
        {
            "query_idx": 9,
            "query": "How do phage-based vaccines interact with immune cells to activate responses, and what design strategies are employed to ensure they deliver antigens effectively for broad protection?",
            "retrieved_metrics": {
                "reference_idx": [
                    60,
                    61,
                    49
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-based vaccines activate immune responses by #interacting with pattern-recognition receptors#, #stimulating B cell clonal expansion#, and #using phages as antigen carriers# for effective delivery and broad protection.",
            "predicted_answer": "Phage-based vaccines interact with immune cells by activating innate responses through PRRs and facilitating antigen presentation to stimulate T and B cell activation. Design strategies include using phages as antigen carriers, phage display systems, and multivalent approaches to ensure broad protection.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"interacting with pattern-recognition receptors\" and \"using phages as antigen carriers.\" It mentions \"T and B cell activation,\" aligning with \"stimulating B cell clonal expansion,\" but lacks explicit mention of clonal expansion. Overall, the core trends align well."
        },
        {
            "query_idx": 10,
            "query": "What technology is utilized in drug discovery for accelerating therapeutic ligand identification, encounters challenges related to library diversity, and sees advancements in data analysis through computational methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    88,
                    90,
                    91
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phage-display technology# accelerates the #identification of therapeutic ligands#, faces challenges in #enhancing library diversity#, and benefits from #advanced algorithms# in data analysis.",
            "predicted_answer": "Phage-display technology is utilized in drug discovery for accelerating therapeutic ligand identification, faces challenges related to library diversity, and sees advancements in data analysis through computational methods.",
            "score": 5,
            "explanation": "The predicted answer includes all the key concepts from the reference answer: phage-display technology, accelerating therapeutic ligand identification, challenges with library diversity, and advancements in computational data analysis. The phrasing is slightly different but the essential meaning and facts are preserved."
        },
        {
            "query_idx": 11,
            "query": "How does the novel method utilize specific strategies and its inherent advantages to address the challenges associated with bacterial biofilms' protective environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    28,
                    29,
                    40
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The approach involves using #phage therapy# to tackle #biofilm eradication challenges#, with #specificity, self-replication#, and #synergy# as key advantages.",
            "predicted_answer": "The novel method utilizes phage therapy to address bacterial biofilms by leveraging bacteriophages' ability to disrupt and penetrate biofilms, offering specificity, self-replication, and synergistic potential with other antimicrobial agents.",
            "score": 5,
            "explanation": "The predicted answer covers all the key elements from the reference answer: it mentions \"phage therapy,\" addressing \"biofilm challenges\" (disruption and penetration), and references the inherent advantages of \"specificity,\" \"self-replication,\" and \"synergy.\" There are no significant omissions or errors, and the overall meaning aligns."
        },
        {
            "query_idx": 12,
            "query": "What technological method started in the early 1980s that integrates a specific strategy to address the challenges of anti-cancer drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    137,
                    138,
                    214
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #computer-aided drug design# approach initiated in the 1980s effectively addresses #challenges# in anti-cancer drug development by incorporating #nanotechnology# as a precise strategy.",
            "predicted_answer": "Computer-aided drug design (CADD) started in the early 1980s and integrates computational strategies to address challenges in anti-cancer drug development.",
            "score": 3,
            "explanation": "The predicted answer covers computer-aided drug design and challenges in anti-cancer drug development but omits the incorporation of nanotechnology, a critical component in the reference answer. This missing key fact affects the completeness of the response."
        },
        {
            "query_idx": 13,
            "query": "Which compound demonstrates adequate solubility for therapeutic application, exhibits selective inhibition of a tumor model with the KRAS G12D mutation, and shows selectivity towards the PANC-1 cancer cell line?",
            "retrieved_metrics": {
                "reference_idx": [
                    1117,
                    1122,
                    1118
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compound #14# has adequate solubility for use, demonstrates #selective# inhibition against the KRAS G12D mutation, and is selective toward the #PANC-1# cancer cell line.",
            "predicted_answer": "Compound 14 demonstrates adequate solubility for therapeutic application, selective inhibition of a tumor model with the KRAS G12D mutation, and shows selectivity towards the PANC-1 cancer cell line.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # in the reference answer: Compound 14, selective inhibition for KRAS G12D mutation, and selectivity towards the PANC-1 cell line. The meanings align completely with no significant omissions or contradictions."
        },
        {
            "query_idx": 14,
            "query": "What advanced technologies are pivotal in enhancing patient-derived organoid (PDO) models, and what are the specific challenges these technologies face concerning PDOs' scalability and tumor-stroma interaction replication?",
            "retrieved_metrics": {
                "reference_idx": [
                    1992,
                    1997,
                    1991
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Technologies like #single-cell analysis#, #organ-on-a-chip models#, #AI tools#, and #microfluidics# propel PDOs by reflecting tumor heterogeneity. Yet, hurdles include #cost#, #scalability#, and replicating #tumor-stroma interactions#.",
            "predicted_answer": "Advanced technologies pivotal in enhancing PDO models include single-cell analysis, organ-on-a-chip models, AI-driven tools, and microfluidics. Challenges include scalability, cost, and accurately replicating tumor-stroma interactions.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key technologies (#single-cell analysis#, #organ-on-a-chip models#, #AI tools#, #microfluidics#) and challenges (scalability, cost, tumor-stroma interactions) outlined in the Reference Answer. There are no significant omissions or contradictions. The meaning and key facts are fully aligned."
        },
        {
            "query_idx": 15,
            "query": "What diagnostic tool is included in the classification of a major health organization, capable of reclassifying cases, and is implemented in various countries for enhanced diagnostics?",
            "retrieved_metrics": {
                "reference_idx": [
                    515,
                    519,
                    518
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#DNA methylation profiling# is a diagnostic tool in the #World Health Organization# classification, allowing for #reclassification of cases#, and is #globally implemented# to enhance diagnostic accuracy.",
            "predicted_answer": "DNA methylation-based classification is included in the World Health Organization's diagnostic tools for CNS tumors and is implemented in various countries for enhanced diagnostics.",
            "score": 3,
            "explanation": "The predicted answer covers key facts: \"DNA methylation\" as a classification tool, inclusion in the \"World Health Organization,\" and \"implementation in various countries.\" However, it misses \"reclassification of cases\" and \"globally\" for enhancing accuracy, impacting completeness."
        },
        {
            "query_idx": 16,
            "query": "What specific features make epidrugs advantageous in cancer treatment, considering their target enzymes, mechanisms of action like cell cycle impacts, and the significance of epigenetic change reversibility?",
            "retrieved_metrics": {
                "reference_idx": [
                    537,
                    540,
                    465
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Epidrugs utilize #target enzymes# for #epigenetic regulation#, produce #antitumor effects# via #cell cycle arrest#, and owe their efficiency to the #reversibility# of epigenetic changes as #drug targets#.",
            "predicted_answer": "Epidrugs are advantageous in cancer treatment due to their ability to target specific enzymes, impact cell cycle, induce differentiation and apoptosis, and reverse epigenetic changes, restoring a balanced transcriptional landscape and enhancing antitumor immune responses.",
            "score": 5,
            "explanation": "The predicted answer covers target enzymes, cell cycle impacts, and reversibility of epigenetic changes, aligning with the reference. However, it mentions other mechanisms not highlighted in the reference. The key facts are generally present, with no contradictions."
        },
        {
            "query_idx": 17,
            "query": "What is the difference in electron affinity between N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide, which component mainly influences a critical orbital in the former, and how do their potential maps differ?",
            "retrieved_metrics": {
                "reference_idx": [
                    227,
                    228,
                    226
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #electrophilicity index# for 8a is 0.110 eV and 0.161 eV for 8b, showing 8b has higher electron affinity. The #sulphonamide group# mainly influences 8a’s HOMO. Their #electrostatic potential# maps show varied electron attraction areas.",
            "predicted_answer": "The electron affinity difference is 0.051 eV, with N-ethyl toluene-4-sulphonamide having a lower electrophilicity index (0.110 eV) compared to 2,5-Dichlorothiophene-3-sulfonamide (0.161 eV). The sulphonamide group in N-ethyl toluene-4-sulphonamide primarily influences the HOMO. The potential maps differ in electrostatic potential distribution, with red areas (high electron-attracting) in 2,5-Dichlorothiophene-3-sulfonamide due to electronegative atoms.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: electrophilicity index values, sulphonamide group influence on HOMO, and differences in electrostatic potential maps. The main information is aligned with the reference answer with no significant omissions or contradictions."
        },
        {
            "query_idx": 18,
            "query": "What are the key issues related to racial and ethnic minority participation in phase 1 cancer trials, considering challenges in trial access, reporting practices, and demographic enrollment disparities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1429,
                    1438,
                    1426
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The study identifies worsening #disparities# in trial access for minority groups, significant #limitations# in race/ethnicity reporting, and persistent #demographic disparities# in phase 1 cancer trial enrollment.",
            "predicted_answer": "Key issues include worsening disparities in trial access, systemic biases, and underreporting of race/ethnicity, leading to inequities in treatment access and generalizability of trial results.",
            "score": 3,
            "explanation": "The predicted answer includes the key issues of \"disparities\" and \"underreporting of race/ethnicity,\" which align with the reference. However, it does not mention \"persistent demographic disparities\" directly, which is a highlighted key fact in the reference answer."
        },
        {
            "query_idx": 19,
            "query": "What measurement in 3D organoid analysis is linked to a certain cellular aspect, and which software platform uses an advanced neural network for tracking these structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1759,
                    1760
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The 3D organoid's #volume# correlates with #live cell count#, and #OrganoID# uses a #convolutional neural network# for enhanced tracking.",
            "predicted_answer": "The measurement linked to cellular aspect in 3D organoid analysis is volume, which correlates with live cell count. The software platform using an advanced neural network for tracking these structures is OrganoID.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions that volume correlates with live cell count and that OrganoID uses a neural network for tracking. However, it omits the detail that it is specifically a \"convolutional\" neural network, which affects the completeness of the answer."
        },
        {
            "query_idx": 20,
            "query": "What technology facilitates expression of biological molecules, necessitates precise engineering for targeting, and requires overcoming significant regulatory challenges in its medical applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1,
                    103,
                    106
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage display technology# expresses biological molecules, involving #precise phage engineering# for targeting, and faces #significant regulatory challenges# to ensure its medical application safety and efficacy.",
            "predicted_answer": "Phage-based drug development facilitates expression of biological molecules, necessitates precise engineering for targeting, and faces significant regulatory challenges in medical applications.",
            "score": 3,
            "explanation": "The predicted answer refers to \"phage-based drug development,\" while the reference specifies \"phage display technology.\" Both involve expression, precise engineering, and regulatory challenges, aligning in trend, but differ in specific technology mentioned. Thus, a key fact is slightly misaligned."
        },
        {
            "query_idx": 21,
            "query": "How are combinations of specific drugs altering lung cancer treatments, considering their mechanisms and recent progress, including clinical evaluations and paradigm shifts in approvals for use in non-small cell lung cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    165,
                    212,
                    164
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Lung cancer treatments are being transformed by #ADCs#, with recent #Patritumab deruxtecan# and #telisotuzumab vedotin# evaluations, and a pivotal #Trastuzumab deruxtecan# approval for #NSCLC# indicating a paradigm shift.",
            "predicted_answer": "Combinations of specific drugs, such as antibody-drug conjugates (ADCs), are significantly altering lung cancer treatments. Recent progress includes FDA approvals and Breakthrough Therapy Designations for ADCs in non-small cell lung cancer (NSCLC), with ongoing clinical trials evaluating their efficacy either as monotherapies or in combination strategies.",
            "score": 1,
            "explanation": "The predicted answer references ADCs, which matches the key fact in the reference answer. However, it lacks specific details like Patritumab deruxtecan, telisotuzumab vedotin, and Trastuzumab deruxtecan, which are vital for completeness. Thus, the overall trend is captured, but important specifics are missing."
        },
        {
            "query_idx": 22,
            "query": "How do spheroids with significant size model complex tumor environments, and what roles do diverse cell types play in their structural and functional variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1713,
                    1715,
                    1720
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Spheroids larger than #500 µm# effectively model complex tumor environments with a #layered structure#. Their structure and functions are shaped by #cell type variations# in #heterotypic spheroids#.",
            "predicted_answer": "Large spheroids (>500 µm) model complex tumor environments by replicating in vivo avascular tumor properties, including heterogeneous cell populations and gradients. Diverse cell types in heterotypic spheroids, like tumor and stromal cells, mimic tumor heterogeneity and drug resistance, enhancing the model's relevance for studying tumor-stromal interactions and testing immuno-oncological agents.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: size of spheroids (>500 µm), heterotypic spheroids, and the role of diverse cell types. While it doesn't explicitly mention a \"layered structure,\" it conveys the complexity and function of different cell types effectively."
        },
        {
            "query_idx": 23,
            "query": "What interactions are involved in stabilizing a DNA-ligand compound, and which protein-ligand complex shows the highest hydrogen bond energy?",
            "retrieved_metrics": {
                "reference_idx": [
                    248,
                    249,
                    255
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #DNA-Doxorubicin# complex is stabilized by #hydrogen bonds# and #hydrophobic interactions#, and the #p53-Doxorubicin# complex exhibits the highest hydrogen bond energy.",
            "predicted_answer": "Hydrogen bonds and hydrophobic interactions stabilize the DNA-ligand compound. The p53-Doxorubicin complex shows the highest hydrogen bond energy at -420.2 kcal/mol.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies hydrogen bonds and hydrophobic interactions in stabilizing the DNA-ligand complex, aligning with the reference. It also correctly states that the p53-Doxorubicin complex has the highest hydrogen bond energy. All critical points and protein-ligand details are accurately captured."
        },
        {
            "query_idx": 24,
            "query": "Which signaling axis involving a specific protein is associated with radiation resistance, is overexpressed in acute myeloid leukemia indicating poor prognosis, and is a proposed treatment target in breast, prostate, and colon cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1340,
                    1342,
                    1326
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CPT1A# protein is linked to the #PGC1α/CEBPB/CPT1A/FAO signaling axis# for radiation resistance, overexpressed in #AML# indicating poor prognosis, and targeted in #breast#, #prostate#, and #colon cancer#.",
            "predicted_answer": "The signaling axis involving CPT1A is associated with radiation resistance, is overexpressed in acute myeloid leukemia indicating poor prognosis, and is a proposed treatment target in breast, prostate, and colon cancers.",
            "score": 1,
            "explanation": "The predicted answer includes key facts such as CPT1A's involvement in radiation resistance and its expression in cancers. However, it omits the detailed description of the specific signaling axis (PGC1α/CEBPB/CPT1A/FAO) and the acronym AML for acute myeloid leukemia, impacting completeness."
        },
        {
            "query_idx": 25,
            "query": "How do recent advancements in cancer research models overcome the limitations of traditional laboratory and live animal methods, and what technological innovations support these improvements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1964,
                    1968,
                    1973
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent cancer research improvements have overcome limitations of #traditional in vitro# and #in vivo models# through #patient-derived organoids# and technological advancements like #3D bioprinting#.",
            "predicted_answer": "Recent advancements in cancer research, such as patient-derived organoids (PDOs), overcome traditional limitations by providing three-dimensional models that better mimic human cancer. Technological innovations like synthetic hydrogels, microfluidic systems, and 3D bioprinting support these improvements, enhancing the accuracy of tumor biology representation and personalized therapy development.",
            "score": 3,
            "explanation": "The Predicted Answer mentions patient-derived organoids and 3D bioprinting, aligning with the Reference Answer. However, it omits the emphasis on \"traditional in vitro and in vivo models\" and mentions additional technologies not stressed in the Reference. Overall, crucial points are covered, but one emphasized fact is missing."
        },
        {
            "query_idx": 26,
            "query": "Which types of cancer are being targeted by phage therapy, and why are research efforts essential for advancing these treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    71,
                    72,
                    67
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage therapy targets #solid tumors# and #hematological malignancies#. Conducting #clinical trials# is essential to advance these treatments by addressing limitations and realizing their full potential.",
            "predicted_answer": "Phage therapy is being explored for treating solid tumors like breast, lung, and colon cancers, as well as hematological malignancies. Research efforts are essential to advance these treatments by enhancing tumor cell destruction, reducing resistance, and improving overall outcomes through integration with conventional therapies.",
            "score": 3,
            "explanation": "The predicted answer mentions \"solid tumors\" and \"hematological malignancies,\" aligning with the reference's key facts. However, it lacks specific mention of \"clinical trials,\" a key point in the reference for advancing treatments. Despite the overall alignment, this omission affects completeness."
        },
        {
            "query_idx": 27,
            "query": "How do FDA regulatory processes for expedited drug development utilize special designations in diseases with unmet needs, and what impact do these designations have on the approval timing of cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    641,
                    1892,
                    631
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA's #five review programs# expedite drug development for #diseases with unmet needs#, significantly enhancing the #approval speed of cancer treatments# targeting these conditions.",
            "predicted_answer": "The FDA uses special designations like orphan, fast track, accelerated approval, priority review, and breakthrough therapy to expedite drug development for diseases with unmet needs. These designations can significantly reduce approval timing for cancer treatments by allowing more flexible clinical trial designs and broader efficacy measures.",
            "score": 5,
            "explanation": "The predicted answer includes all five review programs like \"orphan, fast track, accelerated approval, priority review, and breakthrough therapy,\" addressing diseases with unmet needs, and discusses the impact on cancer treatment approval timing. It aligns well with the key facts and trends noted in the reference answer."
        },
        {
            "query_idx": 28,
            "query": "What clinical trial model aims to enhance logistics and efficiency by promoting broader patient participation and improving remote data handling techniques?",
            "retrieved_metrics": {
                "reference_idx": [
                    1843,
                    1847,
                    1845
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #decentralized trials# model focuses on #patient-centricity# to boost participation, tackle access barriers, and enhance #remote data collection#, improving logistics and efficiency in cancer trials.",
            "predicted_answer": "The decentralized clinical trial model aims to enhance logistics and efficiency by promoting broader patient participation and improving remote data handling techniques.",
            "score": 3,
            "explanation": "The predicted answer captures the main idea of enhancing logistics and efficiency through broader patient participation and improved remote data handling. It mentions \"decentralized clinical trial model,\" aligning with \"decentralized trials.\" However, it lacks the emphasis on \"patient-centricity\" and \"access barriers,\" impacting completeness."
        },
        {
            "query_idx": 29,
            "query": "What effects does B7-H3 expression have on cancer metastasis, treatment resistance, and immune evasion, and how do these effects relate to potential anti-cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1358,
                    1364,
                    1350
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The expression of #B7-H3# enhances cancer metastasis; it induces #treatment resistance# and helps cancers evade immunity, making it a #target for anti-cancer therapies#.",
            "predicted_answer": "B7-H3 expression promotes cancer metastasis, treatment resistance, and immune evasion, leading to poor patient outcomes. It is a promising target for anti-cancer therapies.",
            "score": 5,
            "explanation": "The predicted answer contains all key facts from the reference: B7-H3 promotes cancer metastasis, induces treatment resistance, helps in immune evasion, and is a target for anti-cancer therapies. The phrasing differs slightly, but the meaning and key points are consistent with no significant omissions."
        },
        {
            "query_idx": 30,
            "query": "What is the shared duration between a type of market protection granted in the EU and a statistic about anticancer drugs, and how are these connected to orphan designation issues with biomarker-based subgroups?",
            "retrieved_metrics": {
                "reference_idx": [
                    1920,
                    1921,
                    1064
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The EU grants a #10-year marketing exclusivity# period, matching the #10-year challenge# of records for #294 orphan-designated anticancer drugs#, highlighting issues with #biomarker-based subgroup# EMA orphan designations.",
            "predicted_answer": "The shared duration between market protection granted in the EU and a statistic about anticancer drugs is 10 years. This connection to orphan designation issues with biomarker-based subgroups is influenced by the EMA's interpretation of rare disease policy, which differs from the FDA's approach.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the \"10-year\" duration and the connection to issues with biomarker-based subgroup EMA orphan designations, matching all three key points in the reference answer (10-year exclusivity, 294 orphan drugs, biomarker subgroup issues). It maintains alignment without omissions."
        },
        {
            "query_idx": 31,
            "query": "What are the necessary regulatory requirements and standardization protocols needed for the international approval and clinical implementation of phage therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    26,
                    94,
                    98
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The international approval of phage therapy requires adherence to #regulatory and safety standards from FDA and EMA#, establishing #standardized protocols# for production, and developing #harmonized global approval standards#.",
            "predicted_answer": "The necessary regulatory requirements for phage therapy include adherence to guidelines from the FDA and EMA, rigorous safety and efficacy testing, and well-designed clinical trials. Standardization protocols involve harmonizing production methods, ensuring product consistency, and improving quality control to meet global regulatory standards.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer concerning regulatory requirements from the FDA and EMA and mentions standardization protocols and harmonizing production. However, it lacks specific mention of \"harmonized global approval standards,\" which affects completeness."
        },
        {
            "query_idx": 32,
            "query": "What is the name of the environment involved in cancer growth and drug response variation, and what are its primary cellular components?",
            "retrieved_metrics": {
                "reference_idx": [
                    1487,
                    1711,
                    385
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #tumor microenvironment (TME)#, with its #heterogeneous cell populations#, plays a crucial role in impacting both #tumor growth# and #drug response#.",
            "predicted_answer": "The Tumor Microenvironment (TME) involves cancer cells, non-malignant cells (cancer-associated fibroblasts, stem cells, endothelial cells, immune cells), and non-cellular components (extracellular matrix, cytokines, chemokines, growth factors).",
            "score": 3,
            "explanation": "The predicted answer identifies the \"tumor microenvironment (TME)\" and mentions \"cancer cells\" and \"non-malignant cells,\" aligning with the \"heterogeneous cell populations\" of the reference. However, it omits the emphasis on \"tumor growth\" and \"drug response,\" impacting the completeness of the comparison."
        },
        {
            "query_idx": 33,
            "query": "What is a specialized method employed to combat multidrug-resistant bacteria, improved through genetic modifications and combined treatments, and associated with addressing a significant number of annual global deaths?",
            "retrieved_metrics": {
                "reference_idx": [
                    4,
                    27,
                    16
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage therapy# targets #MDR bacteria#, enhanced by #genetic engineering# and #combination with antibiotics#, potentially mitigating #700,000 annual deaths# linked to antibiotic resistance.",
            "predicted_answer": "Phage therapy is a specialized method to combat multidrug-resistant bacteria, leveraging genetically engineered bacteriophages for targeted efficacy. Combined with antibiotics, it addresses a significant number of annual global deaths from antibiotic-resistant infections.",
            "score": 3,
            "explanation": "The predicted answer accurately covers key facts from the reference: \"phage therapy,\" \"MDR bacteria,\" \"genetic modifications,\" \"combined with antibiotics.\" However, it overlooks the specific detail of \"#700,000 annual deaths#,\" impacting completeness. Despite this omission, the predicted answer aligns with the overall trend without contradiction."
        },
        {
            "query_idx": 34,
            "query": "What metric is utilized to assess the impact of consuming a specific plant leaf on lipid levels, and what additional evaluation is necessary regarding safety despite observed non-toxicity in animals?",
            "retrieved_metrics": {
                "reference_idx": [
                    330,
                    331,
                    336
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The consumption of #R. chingii Hu leaf# shows an #effective rate# reduction in lipid levels. However, further #safety evaluation# is needed despite no animal toxicity observed.",
            "predicted_answer": "The metric used to assess the impact of consuming R. chingii Hu leaf on lipid levels is the reduction in serum TC and TG. Additional evaluation regarding safety includes verifying the absence of toxic effects through extended toxicology studies and clinical trials.",
            "score": 3,
            "explanation": "The predicted answer covers the metric (#reduction in lipid levels#) associated with #R. chingii Hu leaf# and mentions the need for #further safety evaluation#. It aligns with the reference answer, though it lacks specific mention of an \"effective rate,\" a more general term used in the reference."
        },
        {
            "query_idx": 35,
            "query": "What types of patient-derived models are utilized for testing the efficacy of anticancer agents, predicting individual patient treatment responses, and guiding personalized treatment selection?",
            "retrieved_metrics": {
                "reference_idx": [
                    1717,
                    1794,
                    1462
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Spheroids# are used for #testing anticancer agents# and for #predicting individual treatment responses#, while #organoids# assist in #guiding personalized treatment selection#.",
            "predicted_answer": "Patient-derived spheroids and organoids are utilized for testing anticancer agents, predicting individual patient treatment responses, and guiding personalized treatment selection. These models maintain tumor characteristics and can predict drug responses based on patient-specific data.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts: #spheroids# and #organoids# are mentioned for #testing anticancer agents#, #predicting individual treatment responses#, and #guiding personalized treatment selection#. No significant omissions or contradictions are present, maintaining consistency with the reference."
        },
        {
            "query_idx": 36,
            "query": "What are the primary challenges siRNA therapies face in moving from development to clinical implementation, considering their commercial progress and inherent pharmaceutical limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2118,
                    2122,
                    2128
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "siRNA therapies encounter the #three 'E' challenges#, involving #commercialization efforts# and #low bioavailability and rapid clearance#.",
            "predicted_answer": "The primary challenges siRNA therapies face in moving from development to clinical implementation include targeted accumulation and cellular uptake (entry), endolysosomal escape (escape), and in vivo pharmaceutical performance (efficacy). These three 'E' challenges limit their clinical translation and commercial progress.",
            "score": 1,
            "explanation": "The 'Predicted Answer' mentions the 'three 'E' challenges which aligns with the 'Reference Answer'. However, it omits #commercialization efforts# and #low bioavailability and rapid clearance#. These missing elements affect completeness but don't contradict the overall trend."
        },
        {
            "query_idx": 37,
            "query": "What are the advantages of focusing on a particular enzyme type for drug repurposing in cancer treatment, considering the diversity in original drug uses and the enzyme's specific role in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1821,
                    1838,
                    1844
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Focusing on #kinase binding sites# for drug repurposing offers #advantages# due to #variations in initial uses and targets# and their crucial #role and abundance in cancer therapy#.",
            "predicted_answer": "Focusing on a particular enzyme type, like kinases, for drug repurposing in cancer treatment leverages their fundamental role in cell regulation and cancer, the druggable nature of kinases, and the promiscuous binding sites that increase the likelihood of identifying effective inhibitors from existing drugs.",
            "score": 3,
            "explanation": "The Predicted Answer includes key facts like focusing on kinase binding sites, advantages due to their druggable nature, and their role in cancer. However, it omits \"variations in initial uses and targets,\" impacting completeness. Overall trend is aligned but missing one key fact."
        },
        {
            "query_idx": 38,
            "query": "How is the combination of phage therapy and antibiotics used to treat bacterial infections, and through what mechanisms does it enhance efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    23,
                    25,
                    43
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #phage-antibiotic therapy# enhances treatment efficacy against #resistant bacterial infections# through #synergistic bacterial lysis# and #immune response modulation#.",
            "predicted_answer": "The combination of phage therapy and antibiotics enhances efficacy by reducing bacterial load, overcoming resistance, and restoring antibiotic sensitivity through mechanisms like chromosomal deletions. This synergistic approach improves clinical outcomes and bacterial clearance, particularly in multidrug-resistant infections.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as reducing bacterial load, addressing resistance, and synergy in bacterial clearance. However, it lacks mention of \"immune response modulation,\" which is emphasized in the reference. Therefore, it aligns with the trend but misses an important detail."
        },
        {
            "query_idx": 39,
            "query": "How do physiologically based quantitative systems pharmacology (QSP) models facilitate decision-making in oncology drug development, particularly from early trials to later optimization using real-world data integration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1607,
                    1615,
                    1623
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Physiologically based #QSP models# inform drug development decisions, enhance #early dose/regimen evaluation#, and #refine dose optimization# post-first-in-human studies with real-world data integration for effective trials.",
            "predicted_answer": "Physiologically based quantitative systems pharmacology (QSP) models facilitate decision-making in oncology drug development by guiding dose selection in early trials, integrating real-world data, and optimizing dose/regimen strategies for combinations. They support early evaluation of therapeutic indices and refine projections as clinical data accumulates.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference by highlighting QSP models in dose selection, real-world data integration, and dose optimization. However, it misses the emphasis on \"post-first-in-human studies.\" While aligned, it's incomplete without this key aspect, impacting overall precision."
        },
        {
            "query_idx": 40,
            "query": "How do computational technologies assist in the development of anticancer drugs and the customization of cancer treatments according to both genetic profiles and environmental factors?",
            "retrieved_metrics": {
                "reference_idx": [
                    124,
                    1215,
                    113
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #AI# accelerates drug discovery, predicts #treatment response#, and employs #machine learning# to identify treatment patterns specific to genetic and environmental factors.",
            "predicted_answer": "Computational technologies, particularly AI, assist in developing anticancer drugs by analyzing genomic data to identify molecular vulnerabilities and predict treatment responses. AI customizes cancer treatments by considering genetic profiles and environmental factors, enabling personalized and efficient therapeutic interventions.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference, covering AI's role in drug development and customizing cancer treatments through genomic and environmental data. However, it lacks emphasis on the use of \"machine learning\" and \"treatment patterns,\" which are key points in the reference."
        },
        {
            "query_idx": 41,
            "query": "What combination of technologies enhances the structural analysis of complex biological macromolecules and boosts the data processing in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    877,
                    878
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #cryo-EM# and #AI# enhances the structural analysis of biological macromolecules and accelerates data processing in drug development.",
            "predicted_answer": "The combination of Artificial Intelligence (AI) and cryo-electron microscopy (cryo-EM) enhances structural analysis of complex biological macromolecules and boosts data processing in drug development.",
            "score": 5,
            "explanation": "The predicted answer accurately includes all the key facts emphasized in the reference answer: the technologies \"cryo-EM\" and \"AI,\" their role in structural analysis of biological macromolecules, and data processing in drug development. The meaning is consistent with the reference answer, despite minor wording differences."
        },
        {
            "query_idx": 42,
            "query": "What innovative approach in drug development uses a model to evaluate drug efficacy and toxicity, simulates organ architecture for therapeutic research, and identifies genomic alterations for individualized treatment plans?",
            "retrieved_metrics": {
                "reference_idx": [
                    1965,
                    1967,
                    1982
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #PDOs# provides a predictive model for #evaluating drug efficacy and toxicity#, mimics organ functions in #cancer research#, and identifies genomic alterations for #personalized cancer treatment# plans.",
            "predicted_answer": "The innovative approach in drug development that uses a model to evaluate drug efficacy and toxicity, simulates organ architecture for therapeutic research, and identifies genomic alterations for individualized treatment plans is **Patient-Derived Organoids (PDOs)**.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies \"Patient-Derived Organoids (PDOs)\" as the innovative approach and aligns with the Reference Answer's key facts, such as evaluating drug efficacy and toxicity, simulating organ architecture, and identifying genomic alterations for individualized treatment. However, it lacks the specific mention of \"cancer research\" and \"personalized cancer treatment.\""
        },
        {
            "query_idx": 43,
            "query": "What method is essential across all drug development paths, how many repurposed drugs entered clinical phases from 2012 to 2017, and in what disease area is drug repurposing critically impactful?",
            "retrieved_metrics": {
                "reference_idx": [
                    1822,
                    1825,
                    2231
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The required method is #structure-activity relationships#. Almost #72% of 170 repurposed drugs# entered clinical phases from 2012 to 2017. Drug repurposing plays a critical role in #cancer therapy#.",
            "predicted_answer": "The essential method across all drug development paths is establishing efficacy for the therapeutic target. From 2012 to 2017, 170 repurposed drugs entered clinical phases, with 72% in Phase II. Drug repurposing is critically impactful in cancer therapy.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies that 170 repurposed drugs entered clinical phases, with almost 72% in Phase II, and that drug repurposing is impactful in cancer therapy. However, it incorrectly cites the essential method as \"establishing efficacy\" rather than \"structure-activity relationships,\" missing a key fact."
        },
        {
            "query_idx": 44,
            "query": "What is the method used in cancer treatment that involves disrupting critical genetic dependencies and employs compounds that act across several similar genetic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1927,
                    1928,
                    1960
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The approach involves #synthetic lethality# by disrupting crucial #dependencies between gene paralogs#, employing inhibitors that target #multiple associated paralogs# in cancer therapy.",
            "predicted_answer": "The method used in cancer treatment that involves disrupting critical genetic dependencies and employs compounds that act across several similar genetic targets is **synthetic lethality**. This approach exploits interactions where mutation of one gene makes cells sensitive to inhibition of another gene, often targeting multiple paralogs simultaneously.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies \"synthetic lethality\" and explains it as exploiting genetic dependencies, matching \"dependencies between gene paralogs.\" It also mentions compounds targeting \"multiple paralogs,\" aligning with \"multiple associated paralogs.\" All key facts are covered, with no significant omissions or contradictions."
        },
        {
            "query_idx": 45,
            "query": "What strategies must be implemented for the clinical use of phages to protect them from environmental stresses, ensure safety and efficacy, and explore their potential in cancer therapy and vaccine delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    79,
                    86,
                    87
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Implement #protective measures and concentration strategies# for phages, conduct #rigorous safety, pharmacokinetics, and efficacy testing#, and explore phages in #targeted cancer therapy and vaccine delivery#.",
            "predicted_answer": "To protect phages from environmental stresses, ensure safety and efficacy, and explore their potential in cancer therapy and vaccine delivery, strategies include:\n\n1. **Nano/micro formulations** to improve phage delivery in cancer therapy.\n2. **Rigorous testing** for safety, pharmacokinetics, and efficacy in clinical trials.\n3. **Targeted delivery** using phage vectors for cancer therapy and vaccine delivery.\n4. **Protective measures and concentration strategies** to enhance phage efficacy.",
            "score": 5,
            "explanation": "The 'Predicted Answer' incorporates key facts concerning protective measures, safety testing, and targeted usage in cancer therapy and vaccine delivery. It matches all the highlighted points in the 'Reference Answer', with no major omissions or contradictions. The main ideas and strategies are consistently conveyed."
        },
        {
            "query_idx": 46,
            "query": "What system utilizes filamentous structures to present foreign antigens and is highly regarded for its roles against a variety of pathogens and in novel vaccine development?",
            "retrieved_metrics": {
                "reference_idx": [
                    52,
                    56,
                    62
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #phage-display systems# use #filamentous phages# like M13 to present #foreign antigens#, enhancing immune response and effectively targeting #bacterial, viral pathogens#, and promising in #cancer immunotherapy#.",
            "predicted_answer": "Phage-display systems, particularly filamentous phages like M13 and T7, utilize filamentous structures to present foreign antigens, making them highly effective against a variety of pathogens and in novel vaccine development.",
            "score": 3,
            "explanation": "The predicted answer mentions \"phage-display systems,\" \"filamentous phages,\" \"foreign antigens,\" and their roles against \"variety of pathogens\" and \"vaccine development,\" closely aligning with the reference answer. However, it misses \"bacterial, viral pathogens,\" \"immune response,\" and \"cancer immunotherapy,\" affecting completeness."
        },
        {
            "query_idx": 47,
            "query": "What specific transformation in the pancreatic tumor microenvironment obstructs drug delivery, and what approach targets this blockage by altering the extracellular matrix?",
            "retrieved_metrics": {
                "reference_idx": [
                    387,
                    406,
                    386
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The obstruction is due to a #dense fibrotic stroma#, which limits drug delivery. The strategy involves #ECM remodeling# to penetrate the #fibrotic capsule# that blocks access.",
            "predicted_answer": "The specific transformation in the pancreatic tumor microenvironment that obstructs drug delivery is the desmoplastic reaction, which creates a dense fibrotic stroma. An approach to target this blockage is the use of metalloproteinases to enzymatically degrade the extracellular matrix components.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the dense fibrotic stroma as the transformation obstructing drug delivery and mentions the use of metalloproteinases for ECM remodeling, aligning well with the reference answer's mention of ECM remodeling and fibrotic capsule. No critical facts are missing, and trends align."
        },
        {
            "query_idx": 48,
            "query": "How does DSF influence cancer cell glycolysis through metal interaction, and what key molecular expression changes occur as a result of this influence?",
            "retrieved_metrics": {
                "reference_idx": [
                    781,
                    782
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "DSF affects cancer cell glycolysis through a #copper-dependent# process and reduces expression of S6K1, MYC, impacting #cellular mechanisms# like apoptosis and cell metabolism.",
            "predicted_answer": "DSF influences cancer cell glycolysis through copper-dependent inhibition, reducing expression of S6K1, MYC, GLUT1, PKM2, and LDHA, thereby modulating cellular metabolism and promoting apoptosis.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of DSF acting through a copper-dependent process and involving significant molecular expression changes like the reduction of S6K1 and MYC. However, there's an additional mention of GLUT1, PKM2, and LDHA, not specified in the reference. The overall alignment and emphasis on copper and cellular impact justify a score of 5."
        },
        {
            "query_idx": 49,
            "query": "How does a technology-focused approach in drug design address the challenges of compound diversity and efficiency introduced by high-throughput screening and emerging computational methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    148,
                    147
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Fragment-based drug design (FBDD)# tackles compound diversity issues while benefiting from #speed acceleration in drug discovery through emerging technologies# like high-throughput screening and combinatorial chemistry.",
            "predicted_answer": "A technology-focused approach, such as fragment-based drug design (FBDD), addresses compound diversity and efficiency challenges by starting with small molecular fragments, reducing library size, enhancing structural diversity, and improving target specificity, especially for difficult targets.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of \"fragment-based drug design (FBDD)\" and acknowledges addressing compound diversity. However, it misses the explicit mention of \"speed acceleration in drug discovery\" and \"emerging technologies.\" Thus, it captures only part of the reference's emphasis, affecting completeness."
        },
        {
            "query_idx": 50,
            "query": "How can mathematical models be used to enhance the translation of experimental cancer research models to clinical applications while adhering to ethical standards and reducing research expenses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1812,
                    1815,
                    1709
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #mathematical models# enhances #translation from 3D cancer research models# to clinical applications, aligning with #ethical standards# like the 3Rs, and reduces experimental costs.",
            "predicted_answer": "Mathematical models can enhance translation of experimental cancer research to clinical applications by predicting outcomes, reducing wet-lab experiments, and aligning with 3R principles, thus adhering to ethical standards and lowering costs.",
            "score": 3,
            "explanation": "The Predicted Answer mentions \"mathematical models,\" enhancing \"translation of experimental cancer research,\" adhering to \"ethical standards,\" and \"reducing costs,\" aligning with the Reference Answer. However, it misses \"from 3D cancer research models,\" impacting completeness."
        },
        {
            "query_idx": 51,
            "query": "How does a specific technological advancement enhance early detection of cancer, improve the precision of diagnostic imaging, and facilitate personalized treatment strategies through molecular analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    125,
                    131,
                    112
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI enhances #early cancer detection# by improving #diagnostic precision# of medical imaging and facilitates #personalized treatment strategies# using molecular profile analysis.",
            "predicted_answer": "AI enhances early cancer detection by analyzing imaging data for early-stage patterns, improves diagnostic imaging precision by identifying minute irregularities, and facilitates personalized treatment through molecular analysis, tailoring therapies to individual genetic profiles.",
            "score": 5,
            "explanation": "The predicted answer captures all the key facts emphasized in the reference: early cancer detection, improved diagnostic imaging precision, and personalized treatment strategies using molecular analysis. The phrasing differs slightly, but the meanings are consistent with no significant omissions."
        },
        {
            "query_idx": 52,
            "query": "What was the chosen dose for further cancer treatment trials after evaluating multiple doses, and what is the finalized recommended dose for NSCLC after comprehensive dose optimization?",
            "retrieved_metrics": {
                "reference_idx": [
                    199,
                    198,
                    1596
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "For further trials, a dose of #10 mg/kg# was selected after assessing #8 to 18 mg/kg#. The optimized recommended NSCLC dose is #5.4 mg/kg#.",
            "predicted_answer": "The chosen dose for further cancer treatment trials was 10 mg/kg. The finalized recommended dose for NSCLC after comprehensive dose optimization is 5.4 mg/kg q3w.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts from the reference: the chosen dose for trials is 10 mg/kg and the finalized dose for NSCLC is 5.4 mg/kg. It omits the range (8-18 mg/kg), but this does not affect consistency. No contradictions are present."
        },
        {
            "query_idx": 53,
            "query": "How did the effectiveness of PEGPH20 in treating HA-high tumors during Phase 2 and Phase 3 trials of metastatic pancreatic ductal adenocarcinoma differ?",
            "retrieved_metrics": {
                "reference_idx": [
                    408,
                    409
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The addition of #PEGPH20# showed #promising results# in a #Phase 2 trial# for HA-high tumors, but demonstrated #no significant improvement# during a #Phase 3 trial#.",
            "predicted_answer": "In Phase 2 trials, PEGPH20 showed significant improvement in progression-free survival for HA-high tumors. However, Phase 3 trials did not confirm significant clinical outcome improvements when added to nab-paclitaxel/gemcitabine.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference: PEGPH20 showed promising results in Phase 2 with progression-free survival improvement, but did not demonstrate significant improvement in Phase 3 trials. It aligns with the trend and includes all essential details without contradictions."
        },
        {
            "query_idx": 54,
            "query": "What limitations do traditional 3D cancer models have regarding vascular networks, what techniques address these limitations by constructing vascularized tumor models, and how are these models applied to pancreatic cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    2178,
                    2188,
                    2216
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Traditional 3D models #lack vascular networks#. Techniques like #soft lithography#, #3D printing#, and #microfluidics# address this, applied to #pancreatic cancer#, characterized by #angiogenic factors# and reduced #vascularity#.",
            "predicted_answer": "Traditional 3D cancer models lack perfusable vascular networks, limiting their ability to fully mimic tumor growth and metastasis. Techniques like tumor-on-a-chip, combining microfluidics and 3D cell culture, address this by constructing vascularized tumor models. These models are applied to pancreatic cancer to study angiogenesis and tumor aggressiveness.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by identifying the lack of vascular networks and the use of microfluidics. However, it misses other key techniques like soft lithography and 3D printing, and references to angiogenic factors and reduced vascularity specific to pancreatic cancer. Thus, it lacks multiple key facts."
        },
        {
            "query_idx": 55,
            "query": "What are the specific properties of Topsentin B\\$_{1}\\$, Topsentin B\\$_{2}\\$, and Nortopsentins A-C, in terms of their structural feature and effectiveness against cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1248,
                    1250,
                    1257
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Topsentin B\\$_{1}\\$ has #cytotoxic effects# on select cancer cells. Topsentin B\\$_{2}\\$ and similar #bisindole alkaloids# show moderate effects, while Nortopsentins A-C, with #2,4-bis(3'-indolyl)imidazole#, exhibit significant anticancer activity.",
            "predicted_answer": "Topsentin B$_{1}$ has significant cytotoxicity to P388 cells (IC$_{50}$ 4.1 µM) and moderate effects on HL-60, HCT-8, A-549, and T47D cells. Topsentin B$_{2}$ and related bisindole alkaloids show moderate activity against AGS and L1210 cells (IC$_{50}$ 1.1-7.4 µg/mL). Nortopsentins A-C exhibit strong inhibitory effects on P338 cells (IC$_{50}$ 1.7-7.8 µg/mL).",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of \"cytotoxic effects\" of Topsentin B$_{1}$. It mentions the \"bisindole alkaloids\" of Topsentin B$_{2}$. However, it omits \"2,4-bis(3'-indolyl)imidazole\" in Nortopsentins A-C, impacting completeness."
        },
        {
            "query_idx": 56,
            "query": "Which enzyme, through its isoforms, is responsible for starting the mitochondrial transport of long-chain fatty acids by facilitating their conversion and transfer across membranes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1306,
                    1305,
                    1304
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The enzyme #CPT1A#, with specific isoforms, initiates mitochondrial transport of long-chain fatty acids by transferring acyl groups to #carnitine#, converting acyl-CoA to #acyl-carnitine#.",
            "predicted_answer": "CPT1, specifically its isoforms CPT1A, CPT1B, and CPT1C, is responsible for initiating the mitochondrial transport of long-chain fatty acids by converting acyl-CoA to acyl-carnitine for transfer across membranes.",
            "score": 5,
            "explanation": "The predicted answer mentions CPT1 and its specific isoforms (CPT1A, CPT1B, CPT1C), aligning with the reference. It includes the conversion to acyl-carnitine and the transfer of acyl groups to carnitine, covering all key facts emphasized in the reference, despite minor differences in specification of isoforms."
        },
        {
            "query_idx": 57,
            "query": "What are the recent FDA-approved treatments for hemophilia that address prior challenges in gene therapy and what significant impact have they made?",
            "retrieved_metrics": {
                "reference_idx": [
                    358,
                    441,
                    444
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent #FDA-approved treatments# for hemophilia include #etranacogene dezaparvovec# and #valoctocogene roxaparvovec#, which involved #overcoming previous technical challenges# in gene therapy.",
            "predicted_answer": "The recent FDA-approved treatments for hemophilia include etranacogene dezaparvovec (Hemgenix) for hemophilia B and valoctocogene roxaparvovec (Roctavian) for hemophilia A, offering a one-time curative approach and eliminating the need for regular substitution therapy.",
            "score": 3,
            "explanation": "The predicted answer includes the #FDA-approved treatments# (etranacogene dezaparvovec and valoctocogene roxaparvovec), capturing key facts. However, it omits #overcoming previous technical challenges# in gene therapy, a critical detail present in the reference. No contradictory information is present."
        },
        {
            "query_idx": 58,
            "query": "What drug includes trastuzumab linked to another component, is designed for NSCLC with a specific mutation type, and has demonstrated an exact median progression-free survival in trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    181,
                    186,
                    180
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drug #T-DXd# contains trastuzumab linked to #deruxtecan#, targets #HER2-mutant NSCLC#, and shows a #median progression-free survival of 11.3 months# in trials.",
            "predicted_answer": "Fam-trastuzumab deruxtecan (T-DXd) is designed for NSCLC with HER2 mutations and has demonstrated a median progression-free survival of 11.3 months in trials.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: the drug T-DXd is trastuzumab linked to deruxtecan, targets HER2-mutant NSCLC, and shows a median progression-free survival of 11.3 months. There are no omissions or contradictions."
        },
        {
            "query_idx": 59,
            "query": "How does the AAV vector interact with cell receptors for entry, and at which specific step does the conversion of its genetic material occur during gene delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    428,
                    435,
                    430
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The AAV vector starts by #initiating viral entry# through #binding specific receptors#, and its #single-stranded DNA genome# of #4.7 kb# is converted to #double-stranded DNA# at #step 6# in the pathway.",
            "predicted_answer": "The AAV vector binds to cell receptors and co-receptors, triggering endocytosis. The conversion of its single-stranded DNA genome to double-stranded DNA occurs in the nucleus after uncoating (step 6).",
            "score": 3,
            "explanation": "The predicted answer contains the key facts: AAV vector binding to cell receptors, conversion of its single-stranded DNA to double-stranded DNA, and happening at step 6. However, it misses emphasizing the genome size of 4.7 kb, affecting completeness."
        },
        {
            "query_idx": 60,
            "query": "What imaging technique is used in drug development to evaluate biological target engagement, provide reliable receptor binding information, and quantify changes in receptor levels across various diseases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1501,
                    1502,
                    1513
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The imaging method is #positron emission tomography (PET)#, aiding drug development by #revealing target engagement#, #providing receptor binding data#, and #quantifying changes in receptor density# across diseases.",
            "predicted_answer": "Positron emission tomography (PET) with selective radioligands is used in drug development to evaluate biological target engagement, provide reliable receptor binding information, and quantify changes in receptor levels across various diseases.",
            "score": 5,
            "explanation": "The predicted answer fully includes all key facts emphasized in the reference answer: the use of positron emission tomography (PET), evaluation of biological target engagement, provision of receptor binding information, and quantification of changes in receptor levels across diseases. No information is missing or contradictory."
        },
        {
            "query_idx": 61,
            "query": "How does the selectivity and potency of MRTX-1133 vary between PANC-1 and BxPC3 cell lines with the KRAS G12D mutation, based on IC50 and other measures across initial screenings?",
            "retrieved_metrics": {
                "reference_idx": [
                    1114,
                    1116,
                    1112
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound #MRTX-1133# shows #lower selectivity# for #KRAS G12D# in #PANC-1#, consistent #IC50# in #BxPC3#, but #low potency# in screening compared to other compounds.",
            "predicted_answer": "MRTX-1133 showed lower selectivity and higher IC50 in PANC-1 cells compared to BxPC3, with IC50 values of 20.6 µM (BxPC3) and higher in PANC-1, indicating reduced potency and selectivity for the KRAS G12D mutation in PANC-1.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: MRTX-1133 shows lower selectivity and lower potency in PANC-1 for KRAS G12D, with consistent IC50 in BxPC3. Both the trend and critical points align apart from missing broader low potency mention. The understanding is substantially aligned with the reference."
        },
        {
            "query_idx": 62,
            "query": "What methods were applied to analyze the properties of specific compounds regarding their effects on cancer cell lines and interactions with DNA?",
            "retrieved_metrics": {
                "reference_idx": [
                    222,
                    256,
                    245
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Molecular docking and density functional theory# assessed properties and interactions of #N-ethyl toluene-4-sulphonamide (8a)# on cancer cell lines. It #interacts with DNA#, affecting its structure.",
            "predicted_answer": "The properties of specific compounds were analyzed using in vitro cell line experiments, molecular docking, and density functional theory (DFT). These methods assessed cytotoxicity, interactions with target proteins (p53, caspase, NFB), and potential DNA intercalation effects on cancer cell lines.",
            "score": 3,
            "explanation": "The predicted answer successfully includes \"molecular docking and density functional theory\" and \"interacts with DNA\" as in the reference answer. However, it lacks the specific mention of \"N-ethyl toluene-4-sulphonamide (8a).\" This omission impacts completeness, but overall alignment is present."
        },
        {
            "query_idx": 63,
            "query": "What approach facilitates targeting cancer using synthetic lethality, particularly involving tumor suppressors and paralog relationships, and how does this broaden the scope beyond druggable oncogenes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1930,
                    1936,
                    1932
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method of #BRCA/PARP synthetic lethality# effectively targets genetic losses using #tumor suppressors and paralogs#, such as #paralog pairs A1 and A2#, expanding beyond druggable oncogenes.",
            "predicted_answer": "Synthetic lethality involving tumor suppressors and paralog relationships broadens the scope of cancer targeting beyond druggable oncogenes by allowing the targeting of recurrent loss-of-function alterations, including tumor suppressors and passenger genes, through the inhibition of their paralogs.",
            "score": 1,
            "explanation": "The predicted answer aligns with the overall trend of targeting cancer using synthetic lethality involving tumor suppressors and paralogs. However, it lacks specific mention of \"BRCA/PARP synthetic lethality\" and the example of \"paralog pairs A1 and A2,\" which are key facts emphasized in the reference."
        },
        {
            "query_idx": 64,
            "query": "How does a novel research model contribute to the study of colorectal cancer mechanisms, its treatment advancements, and understanding of associated molecular pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1394,
                    1413,
                    1388
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The novel #organoid technology# aids colorectal cancer research by providing #CRC organoids# for diverse applications, offering insights into #molecular pathways# critical for understanding cancer development and treatments.",
            "predicted_answer": "A novel research model, such as colorectal cancer organoids, contributes to studying cancer mechanisms by accurately representing tumor heterogeneity, aiding in drug response prediction, and advancing personalized treatments. It also enhances understanding of molecular pathways and facilitates the development of targeted therapies.",
            "score": 5,
            "explanation": "The predicted answer covers key aspects such as organoids, understanding molecular pathways, and their role in colorectal cancer research. It aligns with the trend of the reference by discussing tumor heterogeneity and personalized treatments, reflecting the importance of CRC organoids in research without contradicting the reference."
        },
        {
            "query_idx": 65,
            "query": "What dosage and tumor variant were involved in evaluating compound 14's inhibition efficiency, and what was the measured antiproliferative metric for this compound against this tumor variant?",
            "retrieved_metrics": {
                "reference_idx": [
                    1123,
                    1128,
                    1111
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "At a dosage of #6 mg/kg#, #Compound 14# specifically inhibits KRAS G12D mutant tumors, indicated by an antiproliferative #IC50 value of 5.5 µM# against the PANC-1 cell line.",
            "predicted_answer": "The dosage used was 6 mg/kg, 2-3x/week, targeting the PANC-1 tumor variant with KRAS G12D mutation. The measured antiproliferative metric for compound 14 was an IC₅₀ value of 5.5 µM.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: dosage (6 mg/kg), the compound's target (KRAS G12D mutation in PANC-1 tumor), and the antiproliferative IC₅₀ value (5.5 µM). There is no contradictory information, and it is consistent with the reference answer."
        },
        {
            "query_idx": 66,
            "query": "Modify the multi-hop query\nWhat strategy aims to overcome drug resistance and side effects in cancer treatment by using existing drugs to target cancer hallmarks and the tumor microenvironment, while integrating multiple drugs for enhanced efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    758,
                    760,
                    2260
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "The strategy of drug repurposing aims to overcome drug resistance and side effects in cancer treatment by using existing drugs to target cancer hallmarks and the tumor microenvironment, integrating multiple drugs for enhanced efficacy.",
            "score": 5,
            "explanation": "The predicted answer effectively captures all the key elements emphasized in the reference answer, including using existing drugs, targeting cancer hallmarks, considering the tumor microenvironment, and enhancing efficacy by integrating multiple drugs. It aligns well with the overall intention without contradictions."
        },
        {
            "query_idx": 67,
            "query": "What model system assists in understanding drug responses in tissues, explores tumor characteristics, and supports investigation into infection mechanisms effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    1396,
                    1782,
                    1406
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Organoids# facilitate understanding of #drug responses#, explore #tumor heterogeneity#, and support #bacterial studies# effectively.",
            "predicted_answer": "Organoids assist in understanding drug responses in tissues, exploring tumor characteristics, and supporting investigation into infection mechanisms effectively.",
            "score": 3,
            "explanation": "The predicted answer includes all key facts highlighted in the reference answer: \"organoids,\" \"drug responses,\" and \"supporting investigation into infection mechanisms.\" It aligns with the overall trend. However, it omits the specifics of \"tumor heterogeneity\" and \"bacterial studies,\" affecting completeness."
        },
        {
            "query_idx": 68,
            "query": "How does the molecule B7-H3 contribute to the activation of signaling pathways, affect cancer behaviors, and interact with immune functions in cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1363,
                    1365,
                    1369
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The molecule #B7-H3 activates pathways# like ERK and PI3K, #contributes to malignant cancer behaviors#, and plays a role in #immune inhibition and cancer cell senescence#, impacting treatments.",
            "predicted_answer": "B7-H3 activates signaling pathways like ERK, PI3K, and Stat3, promoting cancer cell proliferation and tumor growth. It inhibits immune cells, contributing to tumor progression, and may influence cancer cell senescence.",
            "score": 5,
            "explanation": "The predicted answer includes B7-H3's activation of pathways (ERK, PI3K), malignant cancer behaviors (tumor growth), and immune inhibition. It also mentions cancer cell senescence, aligning well with the reference. Only \"Stat3\" is extra, but not contradictory. Key facts are covered, maintaining alignment."
        },
        {
            "query_idx": 69,
            "query": "How do compounds 10 and 14 interact with the KRAS G12D mutation using a particular method, and which structural features of these compounds enhance their effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    1115,
                    1129,
                    1125
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds 10 and 14 exhibit #selectivity# towards the #mutated KRAS# using a method that binds GAP and KRAS G12D, with #interaction# features enhancing their performance.",
            "predicted_answer": "Compounds 10 and 14 interact with the KRAS G12D mutation by binding to both GAP and the mutated KRAS, enhancing their effectiveness through structural features like imidazo-pyrazinyl and thyenopyrimidine rings situated in hydrophilic pockets of KRAS.",
            "score": 3,
            "explanation": "The predicted answer mentions the interaction with mutated KRAS and binding features, aligning generally with the reference answer. However, it misses the emphasized key fact of \"selectivity,\" which affects completeness. No contradictory information is present, but missing this key detail impacts the overall evaluation."
        },
        {
            "query_idx": 70,
            "query": "How is AI utilized to enhance cancer treatment customization, adaptation, and personalized outcome prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    119,
                    1211,
                    1220
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#AI-driven predictive modeling# enhances cancer treatment by facilitating #targeted therapies# customization, enabling adaptive #treatment plans#, and forecasting #personalized outcomes#.",
            "predicted_answer": "AI enhances cancer treatment customization by predicting patient responses, adapting to tumor evolution, and personalizing outcome predictions through predictive modeling. It analyzes molecular changes, evaluates historical data, and combines clinical and genetic information to tailor treatment plans, improve efficacy, and reduce side effects.",
            "score": 5,
            "explanation": "The predicted answer mentions \"predictive modeling,\" \"treatment customization,\" and \"personalized outcome predictions,\" covering key facts from the reference answer. It addresses adaptation through tumor evolution, aligning with the reference's \"adaptive treatment plans,\" though \"targeted therapies\" is implied rather than explicitly stated. Overall, the core ideas and trends align well."
        },
        {
            "query_idx": 71,
            "query": "How was the distribution of research and development efforts analyzed for various cancer types, and what were the observed differences in the focus of trials between common and rare cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1197,
                    1206,
                    1204
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The distribution of efforts was #measured# via a global database, revealing #greater# inequality in trials for rare cancers, alongside an #inequity pro-low need bias# affecting trial focus across cancer types.",
            "predicted_answer": "The analysis showed a concentration of R&D resources in high-need cancers, but when considering relative need, there was a pro-low need bias, indicating more trials for low-prevalence cancers.",
            "score": 3,
            "explanation": "The predicted answer acknowledges the focus on low-prevalence cancers, aligning with the \"pro-low need bias\" emphasized in the reference answer. However, it lacks mention of the use of a \"global database\" and does not address the \"greater inequality\" for rare cancers explicitly."
        },
        {
            "query_idx": 72,
            "query": "What limitations in nutrient distribution, extracellular interactions, and environmental conditions prevent traditional 2D culture systems from accurately mimicking in vivo tumor characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1705,
                    2181,
                    2180
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Traditional 2D cultures #fail to mimic diffusion-limited nutrient distribution#, #lack extracellular matrix interactions#, and provide a #simplified environment# unlike the complex in vivo tumor characteristics.",
            "predicted_answer": "Traditional 2D culture systems fail to mimic in vivo tumor characteristics due to limitations in nutrient distribution (uniform access), extracellular interactions (lack of ECM), and environmental conditions (2D vs. 3D growth). These factors lead to a loss of diffusion-limited processes and altered cell signaling.",
            "score": 5,
            "explanation": "The predicted answer covers the key points: failure in mimicking diffusion-limited nutrient distribution, lack of ECM interactions, and oversimplification of the environment. Despite wording differences, the meaning is consistent with the reference, and no key details are omitted."
        },
        {
            "query_idx": 73,
            "query": "What are the variations in KRAS mutations in lung, pancreatic, and colorectal cancers, and how do these variations influence their oncogenic behavior across these cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    1094,
                    1145,
                    1127
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The KRAS mutations involve the #G12C variant# primarily in #lung cancer#, differing from #G12D-type mutations#, which are predominant in #pancreatic and colorectal cancers#.",
            "predicted_answer": "KRAS mutations vary across lung, pancreatic, and colorectal cancers. In lung cancer, the G12C mutation is prevalent and a major driver. In pancreatic and colorectal cancers, G12D mutations are most frequent, acting as minor drivers. These variations influence oncogenic behavior by affecting GAP activation sensitivity.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers all the emphasized key facts from the 'Reference Answer': it mentions the G12C variant's prevalence in lung cancer and the predominance of G12D mutations in pancreatic and colorectal cancers. The meanings are consistent and there are no significant omissions."
        },
        {
            "query_idx": 74,
            "query": "Which inhibitor was approved by the FDA for IDH2 mutations, experienced an indication extension in a subsequent year, and later showed effectiveness when used in combination therapy for IDH1 mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    600,
                    603,
                    604
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #IDH2# inhibitor's FDA approval led to a #2019# extension, while #ivosidenib# with azacitidine was effective for #IDH1# mutations in combination therapy.",
            "predicted_answer": "Ivosidenib was approved by the FDA for IDH2 mutations in 2017, extended to IDH1-mutated AML in 2019, and later showed effectiveness in combination with azacitidine for IDH1 mutations.",
            "score": 0,
            "explanation": "The predicted answer correctly identifies ivosidenib as the inhibitor, acknowledges the 2019 extension, and notes its effectiveness in combination therapy for IDH1 mutations. However, it inaccurately designates ivosidenib, originally an IDH1 inhibitor, as an IDH2 inhibitor, conflicting with the initial approval premise."
        },
        {
            "query_idx": 75,
            "query": "How do increased levels of a certain chemical influence biochemical parameters and tumor characteristics in human tumors and rat models both in vitro and in vivo?",
            "retrieved_metrics": {
                "reference_idx": [
                    839,
                    840
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Elevated #ascorbic acid# in human tumors reduces #HIF-1 α#, #VEGF#, and #GLUT1# expression, decreasing malignancy. In rats, it decreases #HIF-1 α# expression, reduces #tumor growth#, and lowers #vascular density#.",
            "predicted_answer": "Increased levels of ascorbic acid in human tumors and rat models reduce HIF-1α, VEGF, and GLUT1 expression, leading to decreased malignancy and tumor growth, both in vitro and in vivo.",
            "score": 3,
            "explanation": "The predicted answer covers ascorbic acid's effect on HIF-1α, VEGF, and GLUT1 expression and reduced malignancy, aligning with both human and rat models in vitro and in vivo. It lacks mention of reduced tumor growth in rat models and lower vascular density, affecting completeness."
        },
        {
            "query_idx": 76,
            "query": "What specific type of vaccine is engineered to target diverse pathogen strains, what pathogens does it target, and what construction techniques enhance its immune response effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    55,
                    66,
                    53
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The vaccine involves #Multivalent phage-based vaccines#, targets bacterial strains like #Streptococcus pneumoniae and Escherichia coli#, and utilizes a #Construction method for inserting epitopes in phages# for enhanced immune responses.",
            "predicted_answer": "Multivalent phage-based vaccines target diverse strains of pathogens like Streptococcus pneumoniae, Staphylococcus aureus, and Escherichia coli. Construction techniques such as displaying multiple antigenic epitopes on phage capsids enhance immune response effectiveness.",
            "score": 5,
            "explanation": "The predicted answer covers key facts such as \"multivalent phage-based vaccines,\" targeting pathogens like \"Streptococcus pneumoniae\" and \"Escherichia coli,\" and using a \"construction technique\" for epitopes, aligning with the reference. It also includes \"Staphylococcus aureus\" as an extra detail, which doesn't contradict the reference."
        },
        {
            "query_idx": 77,
            "query": "What methods are utilized for the in silico analysis of ADMET properties of plant-based molecules, and what impact do these analyses have on the selection process of promising phytomolecules in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1677,
                    1681
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In silico methods evaluate #ADMET analyses# of plant-based molecules, impacting the selection of #phytomolecules# by reducing late-stage drug development failures.",
            "predicted_answer": "In silico methods like QikProp, pkCSM, and DataWarrior are used to predict ADMET properties of plant-based molecules, aiding in selecting promising phytomolecules by reducing late-stage failures and focusing wet lab efforts on the most viable candidates.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: \"ADMET properties\", \"plant-based molecules\", and \"impact on the selection of phytomolecules by reducing late-stage failures.\" However, the specific mention of software tools (QikProp, pkCSM, DataWarrior) adds details but does not detract from the overall trend. No critical details are missing."
        },
        {
            "query_idx": 78,
            "query": "What experimental strategy is being developed to achieve gene modulation in cervicovaginal tissues, including the specific targeting molecule and cell type involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    379,
                    378,
                    381
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The strategy involves #RNA interference# that utilizes #Chol-siRNAs# to achieve #gene silencing# specifically in mucosal dendritic cells within cervicovaginal tissues.",
            "predicted_answer": "The experimental strategy involves using chol-siRNAs targeting the CD45 gene to achieve gene modulation in cervicovaginal tissues, specifically in mucosal dendritic cells, including intraepithelial and lamina propria DCs.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by mentioning the use of Chol-siRNAs to target mucosal dendritic cells in cervicovaginal tissues. However, it does not explicitly mention the RNA interference process and gene silencing. Thus, while aligned in trend, one key fact is partially missing."
        },
        {
            "query_idx": 79,
            "query": "What is the overall response rate observed in NSCLC patients characterized by a certain overexpression level when treated with a particular monoclonal antibody-drug conjugate that includes a valine-citrulline linker?",
            "retrieved_metrics": {
                "reference_idx": [
                    201,
                    200
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The ORR in #NSCLC c-Met high patients# was #53.8%# when treated with #Telisotuzumab vedotin#, which includes #MMAE# and demonstrated #antitumor activity#.",
            "predicted_answer": "The overall response rate (ORR) in NSCLC patients with high c-Met overexpression treated with Teliso-V was 53.8%.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as NSCLC patients with high c-Met overexpression, the ORR of 53.8%, and treatment with Teliso-V, aligned with Telisotuzumab vedotin. However, it omits components like MMAE and antitumor activity, impacting completeness."
        },
        {
            "query_idx": 80,
            "query": "What process involves toxin release via lysosomal degradation, requires high-affinity antibody guidance with low immunogenicity, and targets specific cell antigens?",
            "retrieved_metrics": {
                "reference_idx": [
                    914,
                    919,
                    913
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The process involves #toxin# release via lysosomal degradation leading to #apoptosis#, requiring #high-affinity#, #low-immunogenicity# #antibody-guidance# to target #specific antigens#.",
            "predicted_answer": "Antibody-drug conjugates (ADCs) involve toxin release via lysosomal degradation, require high-affinity antibody guidance with low immunogenicity, and target specific cell antigens.",
            "score": 3,
            "explanation": "The predicted answer captures the emphasized key facts, including toxin release, lysosomal degradation, high-affinity, low-immunogenicity antibody guidance, and targeting specific antigens. However, it omits apoptosis, impacting completeness. The trend is aligned without contradictions."
        },
        {
            "query_idx": 81,
            "query": "What is the percentage specificity of the Galleri test reported in clinical studies, and how accurate is the MCED-Scr version in identifying the origin of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    512,
                    513
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The Galleri test has a specificity of #99.5%#, and the refined MCED-Scr version accurately predicts cancer origin with #97%# accuracy.",
            "predicted_answer": "The Galleri test has a specificity of 99.5% for cancer signal detection. The MCED-Scr version has an accuracy of 97% in identifying the origin of cancer.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects all the key facts emphasized with # symbols in the Reference Answer. It mentions the Galleri test's specificity of 99.5% and the MCED-Scr version's 97% accuracy. The meanings and key facts are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 82,
            "query": "Modify the multi-hop query:\nWhat is the treatment effective for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer, and what therapy is considered for later stages in cancer with specific genetic features?",
            "retrieved_metrics": {
                "reference_idx": [
                    1859,
                    1862
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "For BCG-unresponsive high-risk non-muscle-invasive bladder cancer, Pembrolizumab is effective. For later stages with specific genetic features like FGFR1-3 aberrations, Derazantinib is considered.",
            "score": 3,
            "explanation": "The Predicted Answer mentions Pembrolizumab for BCG-unresponsive high-risk non-muscle-invasive bladder cancer and includes Derazantinib for later stages with FGFR1-3 genetic features. Without a complete Reference Answer, it's unclear if key facts align precisely; however, it seems generally consistent with possible expectations."
        },
        {
            "query_idx": 83,
            "query": "Which dual inhibitors have received regulatory approval for their effectiveness in oncology due to targeting H3K27me3 reduction, and what types of cancer are they approved to treat?",
            "retrieved_metrics": {
                "reference_idx": [
                    576,
                    577,
                    575
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Dual inhibitors targeting #H3K27me3 reduction# include those leading to #Valemetostat's approval# in Japan for adult T-cell leukemia/lymphoma and #Tazemetostat's FDA approval# for follicular lymphoma and epithelioid sarcoma.",
            "predicted_answer": "Valemetostat is the first dual EZH1/2 inhibitor approved for the treatment of relapsed/refractory adult T-cell leukemia/lymphoma. It has also been studied in combination with ipilimumab for metastatic prostate, urothelial, or renal cell cancer.",
            "score": 1,
            "explanation": "The predicted answer covers valemetostat being approved for adult T-cell leukemia/lymphoma, which is a key fact, but it omits the approval of tazemetostat for follicular lymphoma and epithelioid sarcoma. While there's no contradictory information, missing the second drug significantly affects completeness."
        },
        {
            "query_idx": 84,
            "query": "What components and methods are involved in phage-based systems for drug-delivery, including drug expression on vectors, targeting via phage modification, and the use of particle formations for therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    81,
                    84,
                    85
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-based systems involve #drugs expressed on the capsid#, incorporate #surface-display systems for targeting#, and utilize #virus-like particles as antigen scaffolds# for enhanced therapeutic delivery.",
            "predicted_answer": "Phage-based drug delivery involves components like phage capsids for drug expression, targeting via surface display systems, and encapsulation strategies for therapeutic payloads. Methods include genetic engineering for modularity and particle formations for targeted delivery.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by mentioning phage capsids for drug expression and surface display systems for targeting. However, it fails to reference #virus-like particles as antigen scaffolds#, impacting completeness. Key facts are partially covered, with trends generally consistent."
        },
        {
            "query_idx": 85,
            "query": "How does AI influence specific phases in the development of anti-cancer drugs, and what are its data requirements for these impacts?",
            "retrieved_metrics": {
                "reference_idx": [
                    140,
                    159,
                    276
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI's impact includes #anti-cancer drug design# advancements, leveraging #large reliable datasets#, and significantly enhancing #preclinical drug development# processes.",
            "predicted_answer": "AI influences anti-cancer drug development by enhancing target identification, molecular screening, and in silico molecule design. Its data requirements include large, reliable datasets for training algorithms, such as those from DrugBank and KEGG.",
            "score": 3,
            "explanation": "The predicted answer mentions AI's influence on anti-cancer drug development, including design advancements and the importance of large, reliable datasets. However, it omits specific mention of \"preclinical drug development\" processes, which is a key fact from the reference answer, affecting completeness."
        },
        {
            "query_idx": 86,
            "query": "Which drugs have been tested for treating tumors related to a genetic disorder caused by a specific gene mutation, and what were the trial outcomes and genetic cause of this disorder?",
            "retrieved_metrics": {
                "reference_idx": [
                    675,
                    677,
                    1092
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drugs #Belzutifan# and #Sunitinib# were tested for tumors linked to a #von Hippel-Lindau gene# mutation. Belzutifan showed significant efficacy, whereas sunitinib had limited success.",
            "predicted_answer": "Belzutifan, sunitinib, pazopanib, and dovitinib have been tested for treating tumors in VHL disease caused by VHL gene mutation. Belzutifan showed significant efficacy in renal cell carcinomas, hemangioblastomas, and pancreatic neuroendocrine tumors with an acceptable safety profile. Sunitinib achieved 33% partial response in kidney tumors, while dovitinib resulted in stable disease before trial cessation due to toxicity.",
            "score": 5,
            "explanation": "The predicted answer contains all the key drugs, Belzutifan and Sunitinib, and identifies the VHL gene mutation as the genetic cause, consistent with the reference. It mentions trial outcomes for both drugs, aligning with the reference. Pazopanib and dovitinib are mentioned but don't contradict the key facts."
        },
        {
            "query_idx": 87,
            "query": "How is technology leveraged to both streamline the selection of participants and forecast patient responses in clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    126,
                    274,
                    280
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Clinical trials utilize #AI# for optimization, accelerate participant recruitment with #big data#, and predict patient responses using #in silico trials#.",
            "predicted_answer": "Technology leverages AI to streamline participant selection by quickly recruiting qualified volunteers and identifying appropriate candidate populations. AI also forecasts patient responses by evaluating past trial data and incorporating individual parameters into AI-designed models, enhancing trial efficiency and personalization.",
            "score": 1,
            "explanation": "The Predicted Answer successfully includes the use of #AI# for optimization and forecasting patient responses but lacks the mention of #big data# and #in silico trials# for recruitment and prediction, missing two key facts essential for completeness."
        },
        {
            "query_idx": 88,
            "query": "What enzyme-mediated process modifies protein function relevant to oncological conditions and encounters specific approval difficulties when utilizing its redirection for innovative therapy development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1833,
                    1842,
                    1840
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #enzyme# process involving #kinases# modifies protein conformation, linked to #oncological# growth, and faces #regulatory difficulties# with approval in new therapeutic applications.",
            "predicted_answer": "The enzyme-mediated process that modifies protein function relevant to oncological conditions is kinase phosphorylation. This process encounters specific approval difficulties due to regulatory challenges in repurposing existing drugs for innovative therapy development.",
            "score": 3,
            "explanation": "The predicted answer captures the enzyme process (\"kinase phosphorylation\"), its link to oncology, and the issue with regulatory challenges. However, it omits the detail about modifying \"protein conformation.\" Overall, the prediction aligns well but misses one key point on conformation."
        },
        {
            "query_idx": 89,
            "query": "What statistical significance levels and tumor volume thresholds were used to evaluate the effects of treatments on pancreatic tumor growth, particularly concerning compound 14?",
            "retrieved_metrics": {
                "reference_idx": [
                    1121,
                    1144,
                    1124
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The evaluation involved #compound 14# effects on pancreatic models by measuring #tumor volume exceeding 1600 mm³# and confirming significance at #p ≤ 0.05 and p ≤ 0.0001#.",
            "predicted_answer": "Statistical significance levels of p ≤ 0.05 and p ≤ 0.0001 were used. Tumor volume thresholds were not explicitly mentioned, but the experiment terminated when average tumor volumes reached over 1600 mm³.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the statistical significance levels (p ≤ 0.05 and p ≤ 0.0001) and acknowledges tumor volume exceeding 1600 mm³ as a threshold, even though it's not explicitly labeled as such. However, it fails to mention \"#compound 14#\", a key detail."
        },
        {
            "query_idx": 90,
            "query": "How do expedited drug approval processes impact trial design, affect drug safety, and allow for external factors like economic incentives to influence outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1891,
                    1913,
                    1889
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #expedited approval# process influences #trial design# by favoring #small trials#, affecting safety through #unrecognized adverse events#, and allowing #economic incentives# to compromise #post-marketing safety revisions#.",
            "predicted_answer": "Expedited drug approval processes can lead to shorter, smaller trials, increasing the risk of unrecognized adverse events. Post-marketing trials are often delayed or not initiated, affecting drug safety. Economic incentives can influence outcomes, potentially prioritizing market access over thorough safety evaluation.",
            "score": 3,
            "explanation": "The Predicted Answer includes key elements of the Reference Answer: expedited approval, small trials, unrecognized adverse events, and economic incentives influencing outcomes. However, it lacks specific mention of \"post-marketing safety revisions,\" missing a key aspect of the Reference Answer's focus on safety."
        },
        {
            "query_idx": 91,
            "query": "How do metastasis-on-a-chip and tumor-on-a-chip models individually contribute to cancer research, and which specific processes or systems are studied within each model?",
            "retrieved_metrics": {
                "reference_idx": [
                    1459,
                    2056,
                    2189
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Metastasis-on-a-chip# models explore #cancer therapies# affecting #metastatic processes#. #Tumor-on-a-chip# platforms analyze #vascular systems#, focusing on blood flow dynamics and developing #vascularized models#.",
            "predicted_answer": "Metastasis-on-a-chip models study the metastatic cascade, including invasion and migration, while tumor-on-a-chip models focus on tumor growth, vascularization, and drug delivery within the tumor microenvironment. Both contribute to evaluating cancer therapies and understanding specific cancer processes.",
            "score": 3,
            "explanation": "The predicted answer includes metastasis-on-a-chip studying metastatic cascade and tumor-on-a-chip focusing on tumor processes, aligning with the reference's focus on cancer therapies and vascular systems. However, it misses specific mentions of cancer therapies and vascularized models, impacting completeness."
        },
        {
            "query_idx": 92,
            "query": "What specific drug combination improves progression-free survival in chemotherapy, how is its efficacy in TNBC influenced by genetic mutations, and what time interval impacts its activity level?",
            "retrieved_metrics": {
                "reference_idx": [
                    652,
                    662,
                    656
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Addition of veliparib to carboplatin-paclitaxel# improves survival. #Carboplatin shows efficacy# in TNBC with genetic stratification, and #activity increases after a platinum-free interval over 180 days#.",
            "predicted_answer": "The combination of veliparib with carboplatin-paclitaxel significantly improves progression-free survival (PFS) in chemotherapy. Efficacy in triple-negative breast cancer (TNBC) is influenced by BRCA1/2 mutations, with increased pathologic complete response in non-BRCA carriers. A platinum-free interval longer than 180 days enhances veliparib activity.",
            "score": 3,
            "explanation": "The predicted answer includes the information about the addition of veliparib to carboplatin-paclitaxel improving progression-free survival, and it mentions a platinum-free interval over 180 days affecting activity. However, it omits the efficacy of carboplatin itself in TNBC related to genetic stratification. Thus, not all key facts are covered."
        },
        {
            "query_idx": 93,
            "query": "What impact does variability in the methodologies for culturing organoids and spheroids have on cancer treatment evaluations, and what strategies are proposed to enhance their consistency and reliability?",
            "retrieved_metrics": {
                "reference_idx": [
                    1803,
                    1990,
                    1722
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #variability in spheroid and organoid methodologies# hinders anticancer evaluations, necessitating #uniform methods for reliable data# and #standardized protocols to boost study reproducibility#.",
            "predicted_answer": "Variability in culturing methods for organoids and spheroids impacts cancer treatment evaluations by causing unreliable and non-reproducible results. Strategies to enhance consistency include establishing standardized protocols, improving culture media formulations, and integrating high-throughput drug screening with automation technologies.",
            "score": 5,
            "explanation": "The predicted answer captures the key issues of variability and the need for standardized protocols mentioned in the reference. Additionally, it aligns with the overall trend of enhancing consistency through uniform methodologies. No significant details are missing, ensuring completeness and alignment with the reference."
        },
        {
            "query_idx": 94,
            "query": "How does the reduction of a specific RNA component influence apoptosis through changes in splicing, and where in the body are these components highly concentrated in certain pathological conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2010,
                    2008
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Reduction of #PNCTR# alters splicing to induce #apoptosis#, and PNCTR is highly enriched in #metastatic lesions# within lymph nodes.",
            "predicted_answer": "Reduction of PNCTR, a long non-coding RNA, influences apoptosis by altering splicing patterns, particularly through PTBP1 regulation. PNCTR is highly concentrated in PNCs, especially in metastatic lymph nodes in cancer.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: reduction of PNCTR alters splicing, induces apoptosis, and is highly concentrated in metastatic lesions within lymph nodes. Although phrasing differs slightly, the meaning and key points are consistent with the reference."
        },
        {
            "query_idx": 95,
            "query": "How does the number of special FDA designations influence the approval speed of cancer treatments, and what are its implications on both treatment costs and clinical benefits?",
            "retrieved_metrics": {
                "reference_idx": [
                    617,
                    618,
                    615
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Multiple special designations# lead to faster approval times, higher #treatment costs#, and increased #clinical benefit# for treatments addressing high unmet needs.",
            "predicted_answer": "The number of special FDA designations for cancer treatments is associated with faster approval times and greater clinical benefits, particularly for patients with high unmet needs. However, this is also linked to less robust trial evidence and higher treatment costs.",
            "score": 5,
            "explanation": "The predicted answer covers all key points: #multiple special designations# (implied by \"number of special FDA designations\"), #faster approval times#, #increased clinical benefit#, and #higher treatment costs#. It is aligned with the trend and does not contradict the reference."
        },
        {
            "query_idx": 96,
            "query": "How do certain viral agents disrupt protective bacterial matrices and enhance antimicrobial treatments, especially against persistent infections, when used in combination with traditional antibiotics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2,
                    32,
                    11
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The production of phage-derived #enzymes# disrupts bacterial biofilms, aiding in treating #biofilm-associated infections#. When combined with antibiotics, this method enhances efficacy against #resistant bacterial strains#.",
            "predicted_answer": "Certain viral agents, such as phages, disrupt protective bacterial matrices like biofilms by penetrating and replicating within bacterial cells, thereby enhancing antimicrobial treatments. When combined with traditional antibiotics, phages can improve treatment efficacy against persistent infections by overcoming bacterial resistance and reducing the likelihood of resistance development.",
            "score": 3,
            "explanation": "The predicted answer captures the general trend and key ideas, such as phages disrupting biofilms and enhancing antibiotic efficacy. However, it lacks specific mention of \"phage-derived enzymes\" and direct reference to \"resistant bacterial strains,\" impacting completeness. Both mention disruption and enhanced treatment but with slight omissions."
        },
        {
            "query_idx": 97,
            "query": "What advancements in modeling brain cancer use patient-derived organoids that include vascular components to assess precise drug efficacy and resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    1976,
                    2093,
                    1972
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Methods involving #glioblastoma organoids# predict #treatment effects# and discover drugs, using a #preclinical model# including #endothelial cells# for precise personalized therapy evaluation in brain cancer.",
            "predicted_answer": "Advancements in modeling brain cancer using patient-derived organoids with vascular components, like glioblastoma bioprinted organoids, enhance precise drug efficacy and resistance assessments, potentially improving personalized treatment outcomes and reducing drug development costs.",
            "score": 3,
            "explanation": "The predicted answer includes glioblastoma organoids and mentions drug efficacy and resistance, aligning with the focus of personalized treatment. However, it omits the specific mention of endothelial cells, a key component of the preclinical model, affecting completeness. The trend is generally aligned, but one key fact is missing."
        },
        {
            "query_idx": 98,
            "query": "What are the specific clinical outcomes and statistical comparisons between TIL therapy and immunotherapy for advanced melanoma, particularly regarding disease control rates, overall response rates, and meta-analysis findings?",
            "retrieved_metrics": {
                "reference_idx": [
                    944,
                    946,
                    945
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Clinical trials show #TIL therapy# for advanced melanoma outperforms #immunotherapy# with higher #disease control and response rates#; meta-analysis reports consistent #ORR and CRR# improvements.",
            "predicted_answer": "TIL therapy for advanced melanoma shows higher disease control rates (80%) and overall response rates (36-49%) compared to immunotherapy (21%). Meta-analysis indicates TIL with IL-2 has an ORR of 41% and CRR of 12%. TIL therapy also offers better outcomes for immunotherapy-refractory cases.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by noting TIL therapy's superiority over immunotherapy in advanced melanoma, indicating higher disease control rates and highlighting meta-analysis findings about ORR and CRR. It covers all key facts such as TIL compared to immunotherapy and the statistical outcomes."
        },
        {
            "query_idx": 99,
            "query": "Which specific pharmacokinetic measurement is correlated with patient outcomes, and what treatment modification can enhance patient responses by affecting this measurement over time?",
            "retrieved_metrics": {
                "reference_idx": [
                    715,
                    717,
                    681
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Median AUC# measurement correlates with patient outcomes. #Dose escalation# enhances drug exposure, improving #time to response# and the likelihood of achieving partial responses.",
            "predicted_answer": "The specific pharmacokinetic measurement correlated with patient outcomes is the Area Under the Curve (AUC). Increasing AUC by dose escalation can enhance patient responses, as higher AUC levels are associated with better clinical outcomes in metastatic renal cell carcinoma.",
            "score": 1,
            "explanation": "The predicted answer covers key facts like AUC as the measurement and dose escalation as a treatment modification, in line with the reference. However, it misses details like \"Median AUC\", \"time to response\", and \"likelihood of achieving partial responses\". These omissions affect completeness."
        },
        {
            "query_idx": 100,
            "query": "What are the challenges faced by racial and ethnic minorities in accessing phase 1 cancer trials, and what gaps exist in research on their participation in these trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1434,
                    1439,
                    1428
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Access to #phase 1 trials# is crucial, yet there is #underenrollment# of certain racial and ethnic groups. Moreover, there are no studies on #disparities# in these early-phase trials.",
            "predicted_answer": "Racial and ethnic minorities face challenges in accessing phase 1 cancer trials, including underenrollment in trials overall and at academic institutions, reflecting widening inequalities and systemic biases. Research gaps exist in specifically examining demographic disparities in phase 1 trials, despite advocacy for equitable representation since 1993.",
            "score": 5,
            "explanation": "The Predicted Answer identifies the challenges of underenrollment for racial and ethnic minorities, which aligns with key facts of the Reference Answer. It also mentions disparities in phase 1 trials, reflecting research gaps. Thus, it captures all emphasized concepts about access, underenrollment, and disparities."
        },
        {
            "query_idx": 101,
            "query": "What specific 3D cell culture method aids in the development of breast cancer treatments and provides additional benefits for anticancer drug research?",
            "retrieved_metrics": {
                "reference_idx": [
                    339,
                    350,
                    1710
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #3D spheroid culture# technique specifically supports #breast cancer drug# development due to its #drug resistance# profiles, serving as effective #3D in vitro models# for #anticancer drug# research.",
            "predicted_answer": "3D spheroid culture methods aid in the development of breast cancer treatments by recreating physiologically relevant microenvironments, making them more appropriate for anticancer drug research.",
            "score": 3,
            "explanation": "The predicted answer mentions \"3D spheroid culture\" and its use in breast cancer treatment development and anticancer drug research, aligning with the reference. However, it misses \"drug resistance profiles\" and \"3D in vitro models,\" affecting completeness."
        },
        {
            "query_idx": 102,
            "query": "What treatment strategy targets BRCA mutations through a vulnerability mechanism, and what particular genetic characteristic in colorectal cancer is addressed by immune modulation therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    649,
                    687,
                    1926
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #synthetic lethality# strategy targets #BRCA# mutations with #PARP inhibitors#, while #colorectal cancer# with high #microsatellite instability# benefits from #immune checkpoint inhibitors#.",
            "predicted_answer": "PARP inhibitors target BRCA mutations through a vulnerability mechanism. Immune modulation therapy addresses Lynch syndrome, a genetic characteristic in colorectal cancer.",
            "score": 1,
            "explanation": "The Predicted Answer includes PARP inhibitors targeting BRCA mutations, aligning with the synthetic lethality strategy in the Reference Answer. However, it fails to mention high microsatellite instability, stating Lynch syndrome instead of immune checkpoint inhibitors for colorectal cancer. Missing two key details from the Reference Answer."
        },
        {
            "query_idx": 103,
            "query": "What drug approval method expedites clinical trials by using particular surrogate endpoints, and how does this relate to the innovation level of drugs with multiple FDA designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1910,
                    1911,
                    633
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #accelerated approval# method shortens trial duration through surrogate endpoints like #tumor response rate#, expediting innovative drugs with #multiple special designations# and enhancing their FDA approval processes.",
            "predicted_answer": "The accelerated approval method expedites clinical trials by using surrogate endpoints, which shorten trial durations and reduce patient enrollment. This method is particularly beneficial for highly innovative drugs with multiple FDA designations, as it accelerates their development and market entry.",
            "score": 3,
            "explanation": "The predicted answer covers the main idea of the #accelerated approval# method and its role in expediting trials with surrogate endpoints. However, it omits specific examples like #tumor response rate# and doesn't explicitly mention #multiple special designations#. Overall, it aligns with the reference but lacks some details."
        },
        {
            "query_idx": 104,
            "query": "How can artificial intelligence enhance the detection accuracy of cancerous tissues in radiological images, and which specific imaging modalities and anomalies are involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    1212,
                    1628,
                    1209
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI enhances cancer detection by using #image analysis algorithms# for #CT# and #MRI# scans, precisely detecting cancerous #anomalies# that radiologists might miss.",
            "predicted_answer": "Artificial intelligence enhances cancerous tissue detection in radiological images by analyzing CT, MRI, PET, and X-rays, identifying subtle anomalies, and precisely defining tumor boundaries. Specific modalities include CT and MRI, focusing on tissue structure changes and distinguishing cancerous from non-cancerous tissues.",
            "score": 5,
            "explanation": "The predicted answer covers key facts of AI enhancing cancer detection through CT and MRI. It mentions image analysis methods and detecting anomalies, aligning with the reference. All crucial aspects like imaging modalities and the specific focus on detecting anomalies are present."
        },
        {
            "query_idx": 105,
            "query": "What cell therapy targets specific antigens in hematological cancers and has shown promising clinical trial results but also faces challenges regarding safety and effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    953,
                    2111
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CART cell therapy# effectively targets #CD19 antigens# in #hematological cancers#, such as leukemia and lymphoma, but faces #cytokine release syndrome (CRS)# as a significant concern.",
            "predicted_answer": "CART cell therapy targets specific antigens in hematological cancers, showing promising clinical trial results but faces challenges with safety and effectiveness, including severe cytokine release syndrome (CRS).",
            "score": 3,
            "explanation": "The predicted answer mentions CART cell therapy targeting specific antigens in hematological cancers and acknowledges challenges with safety and effectiveness, aligning with the reference. However, it omits the specific mention of #CD19 antigens# and types of cancers. It does include #cytokine release syndrome (CRS)#."
        },
        {
            "query_idx": 106,
            "query": "How do AI-driven methods affect the sensitivity of cancer screening systems, improve early detection, and what specific issues must be addressed to achieve effective screening?",
            "retrieved_metrics": {
                "reference_idx": [
                    1214,
                    1247,
                    1208
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI-driven cancer screening enhances #sensitivity# and #early detection#, reducing false positives. Challenges like #algorithm bias# need addressing for effective implementation.",
            "predicted_answer": "AI-driven methods enhance cancer screening sensitivity, reduce false positives, and personalize risk assessment. Key issues to address include algorithm bias, data quality, regulatory compliance, and clinician adoption for effective implementation.",
            "score": 3,
            "explanation": "The predicted answer covers AI-driven methods enhancing sensitivity and reducing false positives. While it includes additional elements like personalization and regulatory compliance, it aligns well with the reference by addressing algorithm bias. However, it lacks explicit mention of \"early detection.\""
        },
        {
            "query_idx": 107,
            "query": "What components are involved in the advanced delivery system of an mRNA vaccine that has shown specific benefits in T-cell response and survival outcomes in pancreatic cancer clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    416,
                    420,
                    983
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mRNA vaccine #Autogene cevumeran#, using #mRNA-lipoplex nanoparticles# and including #modified nucleosides#, showed #T-cell expansion# and improvements in #recurrence-free survival# in pancreatic cancer trials.",
            "predicted_answer": "The advanced delivery system of an mRNA vaccine for pancreatic cancer includes mRNA-lipoplex nanoparticles encoding up to 20 neoantigens, designed via next-generation sequencing and bioinformatic tools, and delivered using lipid-based nanocarriers to enhance cellular uptake and protect from nuclease digestion.",
            "score": 1,
            "explanation": "The predicted answer includes key details like \"mRNA-lipoplex nanoparticles\" but omits specific elements such as \"Autogene cevumeran,\" \"modified nucleosides,\" \"T-cell expansion,\" and \"recurrence-free survival,\" which are highlighted in the reference. These are significant omissions affecting completeness."
        },
        {
            "query_idx": 108,
            "query": "How do non-representative datasets in AI healthcare impact model performance related to bias concerns, ethical considerations in patient care, and the necessity for diverse datasets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1235,
                    1239,
                    130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of non-representative datasets in AI healthcare leads to #algorithmic bias due to data issues#, creates #ethical challenges in AI cancer care#, and highlights the necessity for #diverse and inclusive datasets# for unbiased models.",
            "predicted_answer": "Non-representative datasets in AI healthcare can lead to biased model performance, ethical concerns in patient care, and necessitate diverse datasets to ensure fairness and generalizability. Addressing these issues is crucial for equitable and unbiased AI-driven healthcare solutions.",
            "score": 3,
            "explanation": "The Predicted Answer covers the impact of non-representative datasets on bias, ethical concerns, and the need for diversity, aligning with the reference. However, it doesn't specifically mention \"algorithmic bias due to data issues\" and \"AI cancer care,\" which are key specifics in the Reference Answer."
        },
        {
            "query_idx": 109,
            "query": "What are the types of bioactive compounds found in R. chingii Hu, and how do they contribute to anticancer effects, particularly through specific cellular mechanisms in human cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    319,
                    316,
                    320
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The bioactive compounds in R. chingii Hu include #Tiliroside# and #Quercetin# which are #flavonoids#, demonstrating strong anti-lung cancer activity, and #alkaloids# that trigger apoptosis and autophagy in tumors.",
            "predicted_answer": "The types of bioactive compounds in R. chingii Hu include flavonoids (e.g., tiliroside, quercetin), polysaccharides, saponins, and alkaloids. Flavonoids induce apoptosis and inhibit proliferation through pathways like E2Fs/Caspase-3, PI3K/Akt/mTOR, and MAPK/ERK1/2. Alkaloids also induce apoptosis and autophagy, contributing to anticancer effects.",
            "score": 5,
            "explanation": "The predicted answer includes key bioactive compounds like tiliroside and quercetin, identified as flavonoids, along with alkaloids, all noted in the reference. It describes flavonoids' pathways and effects, aligning with the reference's anticancer activity focus, with no contradictory information."
        },
        {
            "query_idx": 110,
            "query": "How do therapies that involve targeting numerous cancer pathways and utilizing novel applications of existing drugs improve the effectiveness of cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2234,
                    2249,
                    861
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Combinatory therapies# enhance cancer treatment by #targeting multiple pathways# and include #drug repurposing# to improve treatment effectiveness and overcome resistance.",
            "predicted_answer": "Therapies targeting numerous cancer pathways and utilizing novel applications of existing drugs improve cancer treatment by addressing the heterogeneity and resistance mechanisms of cancer, enhancing the likelihood of effective treatment outcomes through combination strategies.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer by mentioning targeting numerous pathways and using existing drugs. It addresses heterogeneity and resistance, implying a combination approach. However, it lacks explicit mention of \"combinatory therapies\" and \"drug repurposing,\" affecting completeness."
        },
        {
            "query_idx": 111,
            "query": "What processes are integral to the approval and monitoring of novel therapeutics involving bacteriophages in international markets, and what obstacles are critical to address for clinical integration?",
            "retrieved_metrics": {
                "reference_idx": [
                    95,
                    99,
                    35
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Approval processes involve #regulatory frameworks# in the #United States and Europe#; essential monitoring includes #post-market surveillance strategies#. Addressing #regulatory hurdles# is vital for clinical integration.",
            "predicted_answer": "The approval of phage-based therapeutics involves regulatory frameworks in key regions like the U.S. and Europe, requiring standardized protocols and rigorous clinical trials. Post-market surveillance is essential for ongoing safety monitoring. Critical obstacles include host immune response, phage resistance, and delivery mechanisms.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: regulatory frameworks in the U.S. and Europe, post-market surveillance, and addresses obstacles like host immune response, phage resistance, and delivery mechanisms. However, it missed directly mentioning \"regulatory hurdles\" for clinical integration. The trend is consistent with some details missing."
        },
        {
            "query_idx": 112,
            "query": "What is the energy associated with the compound's interaction with Asn208, and in what ways do these interactions vary from those with Gly165, relevant to inhibitor development?",
            "retrieved_metrics": {
                "reference_idx": [
                    235,
                    236,
                    234
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The binding energy with #Asn208# is #-4.9 kcal/mol#, involving #hydrogen and hydrophobic# interactions. Differences with #Gly165# inform inhibitor #design#.",
            "predicted_answer": "The energy associated with the compound's interaction with Asn208 is -4.9 kcal/mol, involving a hydrogen bond. These interactions differ from those with Gly165, which are not detailed but involve distinct residues.",
            "score": 1,
            "explanation": "The predicted answer correctly mentions the energy of -4.9 kcal/mol and a hydrogen bond with Asn208. However, it misses hydrophobic interactions and does not discuss how the interactions with Gly165 inform inhibitor design, which are key facts in the reference."
        },
        {
            "query_idx": 113,
            "query": "What methodologies are employed in preclinical studies of cancer drug development, and what statistical outcomes characterize the efficiency of the development process?",
            "retrieved_metrics": {
                "reference_idx": [
                    136,
                    1704,
                    1818
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #use of 2D cell cultures and animal models# in preclinical studies leads to a #lengthy and costly process#, compounded by a #high attrition rate#.",
            "predicted_answer": "Preclinical studies in cancer drug development use methodologies like 2D cell cultures and animal models. Statistical outcomes characterizing efficiency include high attrition rates (only 5% of Phase I drugs get FDA approval) and long development times (10-17 years).",
            "score": 3,
            "explanation": "The predicted answer covers the use of 2D cell cultures and animal models, mentions long development times, and notes high attrition rates, which aligns with the reference. However, it does not explicitly mention the costly nature of the process, slightly impacting completeness."
        },
        {
            "query_idx": 114,
            "query": "What are the comparative structural and functional advantages of scaffold-based 3D models and microfluidic systems in modeling physiological processes for studying resistance mechanisms and drug interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2185,
                    2187,
                    1498
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Scaffold-based #3D tumor models# offer greater #drug resistance#, whereas #tumor-on-a-chip# platforms support #perfusion culture# and exhibit #structural differences#. #Microfluidic systems# facilitate #T790M mutation# analysis and observe #phenotypic changes#.",
            "predicted_answer": "Scaffold-based 3D models offer enhanced drug resistance and vascularization, while microfluidic systems provide dynamic perfusion and better simulate physiological processes, aiding in resistance mechanisms and drug interactions.",
            "score": 1,
            "explanation": "The predicted answer aligns in overall trend but misses several key details. It mentions enhanced drug resistance and dynamic perfusion, capturing part of the reference. However, it omits specific terms like the \"3D tumor models,\" \"tumor-on-a-chip,\" \"perfusion culture,\" and details about mutation analysis and phenotypic changes."
        },
        {
            "query_idx": 115,
            "query": "What challenges are associated with developing affordable cancer treatments in low- and middle-income countries, in terms of representation in trials, relevant cost considerations, and the involvement of local investigators?",
            "retrieved_metrics": {
                "reference_idx": [
                    736,
                    738,
                    741
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenges include #minimal representation in trials#, leading to inequities, #high costs with irrelevant endpoints#, and the need for resources for #local investigators focused on biosimilars and repurposing#.",
            "predicted_answer": "Challenges include minimal representation in trials, high costs of drugs, and inadequate involvement of local investigators. Trials often use endpoints irrelevant to LMIC populations, and collaboration between LMIC and HIC researchers is crucial for equitable and affordable cancer care.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as minimal representation in trials, high costs, and the involvement of local investigators, aligning with the reference. However, it misses specifics like biosimilars and repurposing. The general trend matches, but important details are incomplete."
        },
        {
            "query_idx": 116,
            "query": "What techniques analyze the cellular surroundings, study genetic changes via DNA methylation and chromatin accessibility, and optimize therapeutic strategies combining epigenetic drugs with other treatments for cancer therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    607,
                    610,
                    612
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Characterizing the #tumor microenvironment# using #single-cell# methods, exploring #DNA methylation# and #chromatin accessibility#, and combining with #epigenetic drug# strategies enhance cancer treatment #efficacy#.",
            "predicted_answer": "Single-cell approaches, such as multiplexed single-cell bisulfite sequencing and scATAC-seq, analyze cellular surroundings and genetic changes via DNA methylation and chromatin accessibility. These techniques optimize therapeutic strategies by combining epigenetic drugs with immunotherapy, chemotherapy, and other treatments to enhance cancer therapy efficacy.",
            "score": 3,
            "explanation": "The predicted answer includes \"single-cell\" methods and addresses \"DNA methylation\" and \"chromatin accessibility.\" It also mentions \"epigenetic drugs\" and enhancing cancer therapy efficacy. However, it misses specifically noting the \"tumor microenvironment.\" Therefore, it misses one key fact impacting completeness."
        },
        {
            "query_idx": 117,
            "query": "What treatment strategy targets intracellular bacteria, shows efficacy against antibiotic-resistant pathogens, and enhances infection clearance when combined with host immune responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    45,
                    44,
                    42
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #phages# targets #intracellular bacteria#, is effective against #antibiotic-resistant pathogens# like Salmonella, and enhances clearance when combined with the host #immune response#.",
            "predicted_answer": "Phage therapy targets intracellular bacteria, shows efficacy against antibiotic-resistant pathogens, and enhances infection clearance by synergizing with host immune responses.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts from the Reference Answer, including targeting intracellular bacteria, efficacy against antibiotic-resistant pathogens, and enhancing infection clearance with host immune responses. The use of phage therapy is accurately captured without contradictions or omissions."
        },
        {
            "query_idx": 118,
            "query": "What combination treatment methodology in 3D tumor models effectively reduces tumor cell viability and simultaneously impacts animal study approaches in oncological drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1795,
                    1806
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #AV3# and gemcitabine in innovative #spheroids# markedly decreased tumor cell viability, offering insights into reducing animal studies in drug development.",
            "predicted_answer": "The combination of AV3 with gemcitabine in 3D heterospheroids significantly reduces tumor cell viability and informs animal study approaches in oncological drug development.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key elements from the reference answer, including the combination of AV3 and gemcitabine in a 3D tumor model (#heterospheroids#), reducing tumor cell viability. However, it does not mention #spheroids# specifically. This omission is minor and does not contradict the overall trend."
        },
        {
            "query_idx": 119,
            "query": "Which molecular target's involvement in cancer metabolism is crucial for its survival and proliferation, influences breast cancer's resistance to radiotherapy, and is being considered for targeted therapy development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1301,
                    1330,
                    1331
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The involvement of #CPT1A# in cancer metabolism is crucial for growth. Its #inhibition# impacts breast cancer's resistance to radiotherapy, and it is a promising #therapeutic target#.",
            "predicted_answer": "CPT1A is crucial for breast cancer survival and proliferation, influencing resistance to radiotherapy and being considered for targeted therapy development.",
            "score": 1,
            "explanation": "The predicted answer captures the key fact #CPT1A# and aligns with the overall trend regarding its involvement in breast cancer metabolism and therapy. However, it misses #inhibition# affecting radiotherapy resistance and #therapeutic target#, affecting completeness."
        },
        {
            "query_idx": 121,
            "query": "What range of antigens does TCR-T therapy target, what complex facilitates its signal transmission, and what engineering technique is applied to modify T-cell therapies for enhanced specificity?",
            "retrieved_metrics": {
                "reference_idx": [
                    948,
                    947,
                    2110
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "TCR-T therapy targets #a wide range of intratumoral antigens#, forms a #TCR-CD3 complex# to transmit signals, and is modified through #CRISPR-Cas9# for enhanced efficacy in solid tumors.",
            "predicted_answer": "TCR-T therapy targets a wide range of tumor-associated antigens, including tissue differentiation antigens, cancer germline antigens, and tumor-specific antigens. The TCR-CD3 complex facilitates signal transmission. CRISPR-Cas9 engineering is applied to modify T-cell therapies for enhanced specificity.",
            "score": 5,
            "explanation": "The Predicted Answer captures the core concepts: TCR-T therapy targets a wide range of antigens (#intratumoral# versus #tumor-associated#), uses the #TCR-CD3 complex# for signal transmission, and is enhanced with #CRISPR-Cas9# for specificity, aligning well with the Reference Answer's emphasized information."
        },
        {
            "query_idx": 122,
            "query": "What is the protein degradation mechanism that uses E3 ligase for treating certain cancers, and what are the specific drug candidates in clinical trials applying this technology?",
            "retrieved_metrics": {
                "reference_idx": [
                    572,
                    1577,
                    569
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mechanism is #ubiquitination and degradation# via #PROTACs#, with drugs like #Arv-110# and #Arv-471# in trials for specific cancers.",
            "predicted_answer": "The protein degradation mechanism using E3 ligase is called PROTAC (Proteolysis-Targeting Chimera). Specific drug candidates in clinical trials applying this technology include Arv-110 for metastatic castration-resistant prostate cancer and Arv-471 for breast cancer.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the protein degradation mechanism as PROTAC and mentions both Arv-110 and Arv-471 as drug candidates in clinical trials. However, it omits the key fact of \"ubiquitination and degradation,\" affecting completeness. The alignment of the trend is good."
        },
        {
            "query_idx": 123,
            "query": "Which endocrine-related cancer has shown an increased frequency and is linked to immune complications caused by a viral pandemic?",
            "retrieved_metrics": {
                "reference_idx": [
                    2147,
                    2151
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #rise in thyroid cancer# is linked to #autoimmune complications# due to the #COVID-19 pandemic#.",
            "predicted_answer": "Thyroid cancer has shown an increased frequency and is linked to immune complications caused by the COVID-19 pandemic.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions thyroid cancer's increased frequency and its link to immune complications associated with the COVID-19 pandemic. It aligns closely with the reference answer, including all key details (#rise in thyroid cancer#, #COVID-19 pandemic#, and implicitly #autoimmune complications#)."
        },
        {
            "query_idx": 124,
            "query": "Which compounds have demonstrated anticancer activity against both MCF-7 and HeLa cell lines, and identify the derivative that shows broad efficacy across various cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    1261,
                    1274,
                    223
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compounds #27# and #29# target #MCF-7#, while compound #8b# targets #HeLa# and #MCF-7#. N-methylated derivative #73# shows efficacy against multiple cancer types.",
            "predicted_answer": "Compounds 27 and 29 demonstrated anticancer activity against both MCF-7 and HeLa cell lines. The N-methylated derivative 73 showed broad efficacy across various cancer types, including leukemia, non-small cell lung cancer, colon cancer, CNS cancer, ovarian cancer, kidney cancer, and breast cancer.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies compounds 27 and 29 for MCF-7 and HeLa activity, and N-methylated derivative 73 for broad efficacy. However, it misses compound 8b's activity against HeLa. While the trend is aligned, this omission affects completeness."
        },
        {
            "query_idx": 125,
            "query": "What is established from patient biopsy-derived cells for drug testing, verified in multiple cancers, and leads to establishing a repository to support personalized treatment research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1448,
                    1465,
                    1405
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PDOs# are cultivated from biopsy-derived cells, with verified #predictability# in various cancers, leading to a #biobank# creation aimed at advancing #personalized treatment# research.",
            "predicted_answer": "Patient-derived organoids (PDOs) established from biopsy-derived cells have been verified in multiple cancers, leading to the establishment of a biospecimen repository to support personalized treatment research.",
            "score": 5,
            "explanation": "The predicted answer includes #PDOs# from biopsy-derived cells and their verification in multiple cancers, which aligns with the #predictability# aspect. It also mentions the establishment of a biospecimen repository, consistent with the #biobank# for personalized treatment research. No essential information is missing."
        },
        {
            "query_idx": 126,
            "query": "What CRISPR-based method utilizes a streamlined transcription process to address recombination and transcriptional bias issues while enabling the targeting of several genes with a single setup?",
            "retrieved_metrics": {
                "reference_idx": [
                    1954,
                    1953,
                    1955
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Cas12a# system processes #multiple guides from a single transcript#, avoiding #promoter bias and recombination# seen in SpCas9, while the #(en)AsCas12a# variant efficiently targets #multiple genes in one construct#.",
            "predicted_answer": "The CRISPR-based method that utilizes a streamlined transcription process to address recombination and transcriptional bias issues while enabling the targeting of several genes with a single setup is the use of Cas12a nucleases, such as (en)AsCas12a, which can intrinsically process multiple guides from a single, compact transcript.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies “Cas12a” and the ability to process “multiple guides from a single transcript,” addressing “recombination and transcriptional bias issues” and using the “(en)AsCas12a” variant. It misses explicit mention of “promoter bias” and “efficiently targets multiple genes in one construct,” slightly affecting completeness."
        },
        {
            "query_idx": 127,
            "query": "Which specific selenourea compounds demonstrate radical scavenging activity and antitumor effects, particularly in HeLa cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1868,
                    1885,
                    1867
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Selenourea-based compound 6# exhibits radical scavenging, #N-phenylselenourea# demonstrates antitumor effects on #HeLa cells#, and #selenoureas# efficiently scavenge radicals.",
            "predicted_answer": "Compound 41 with an N-phenylselenourea group demonstrated strong radical scavenging activity and potent antiproliferative effects on HeLa cells (IC$_{50}$ = 1.9-11.8 µM).",
            "score": 1,
            "explanation": "The predicted answer mentions an N-phenylselenourea group showing anti-tumor effects and radical scavenging, aligning with the reference mentioning N-phenylselenourea with such effects. However, it incorrectly references Compound 41 instead of Compound 6, missing multiple key facts and causing a mismatch in details."
        },
        {
            "query_idx": 128,
            "query": "What methods are used to extract marine-derived bisindoles, how are these compounds identified for cancer therapy development, and which examples highlight their progression to clinical drug approval?",
            "retrieved_metrics": {
                "reference_idx": [
                    1245,
                    1298,
                    1246
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Marine-derived bisindoles are extracted using #organic solvents# and #chromatography#. Identified for #anticancer drug development#, they have led to #approved drugs with anticancer effects#.",
            "predicted_answer": "Methods to extract marine-derived bisindoles include organic solvents and chromatography. These compounds are identified for cancer therapy through their unique biological activities and chemical structures. Examples of progression to clinical drug approval include midostaurin, lestaurtinib, and enzastaurin.",
            "score": 5,
            "explanation": "The predicted answer covers the methods of extraction using organic solvents and chromatography, aligns with the identification process for cancer therapy, and provides examples of drugs, which capture the trend of anticancer drug development. No significant omissions or errors are present."
        },
        {
            "query_idx": 129,
            "query": "How are advancements in creating complex human disease models changing the drug development process and improving its outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1151,
                    1154,
                    1150
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Advancements in #bioengineering# lead to #bioengineered human-based models# that foster a #paradigm shift#, enhancing #clinical translation# processes with high #clinical mimicry# in drug development.",
            "predicted_answer": "Advancements in complex human disease models enhance drug development by improving clinical translation, reducing costs, and benefiting patients through better predictability and biomimicry.",
            "score": 1,
            "explanation": "The predicted answer captures the general trend of the reference answer by highlighting the improvement in clinical translation, which is the key aspect emphasized. However, it misses specific details like #bioengineering#, #bioengineered human-based models#, and #paradigm shift#. Important technical details are omitted."
        },
        {
            "query_idx": 130,
            "query": "What challenges affect siRNA bioavailability inside hepatocytes, taking into account surface receptor abundance, cellular internalization difficulties, and intracellular molecule breakdown processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2134,
                    2131,
                    2130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The siRNA bioavailability in hepatocytes is limited by challenges like #endosomal escape#, low #expression levels# of #receptors#, high #siRNA degradation#, restricted #expression range#, low #siRNA escape rate#, and advantageous #receptor characteristics#.",
            "predicted_answer": "The challenges affecting siRNA bioavailability in hepatocytes include low surface receptor abundance (∼10^4-10^5/cell), difficulties in cellular internalization, and significant intracellular breakdown, particularly in the endosome and cytoplasm.",
            "score": 1,
            "explanation": "The predicted answer addresses some key points such as low receptor abundance and intracellular breakdown. However, it misses crucial aspects like endosomal escape, expression levels/range, degradation, and receptor characteristics, which are emphasized with # in the reference. Thus, the response is incomplete."
        },
        {
            "query_idx": 131,
            "query": "What method is used for testing drugs on a particular breast cancer cell type that is cost-effective, contributes to individualized treatment development, and is utilized in studying drug resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    341,
                    354,
                    1789
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #spheroid culture method# tests drugs on #MCF-7 cells#, is #inexpensive#, facilitates #personalized medicine#, and helps investigate #drug resistance mechanisms#.",
            "predicted_answer": "The spheroid culture method is used for testing drugs on a particular breast cancer cell type, as it is cost-effective, contributes to individualized treatment development, and is utilized in studying drug resistance.",
            "score": 3,
            "explanation": "The predicted answer mentions the spheroid culture method, emphasizing its cost-effectiveness, contribution to individualized treatment, and study of drug resistance—all present in the reference. However, it lacks the mention of \"MCF-7 cells,\" making it incomplete but aligned with the reference’s overall trend."
        },
        {
            "query_idx": 132,
            "query": "How are diverse computational methodologies applied for identifying potential anti-cancer compounds, and what roles do ligand-based and structure-based pharmacophore models play in this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1651,
                    1652,
                    1666
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Computational strategies# include #virtual screening, molecular dynamics, and machine learning#. Ligand-based models use #known actives#; structure-based models analyze #receptor-ligand interactions# for anti-cancer phytomolecules.",
            "predicted_answer": "Diverse computational methodologies, including virtual screening, molecular dynamics, and machine learning, are applied to identify potential anti-cancer compounds. Ligand-based pharmacophore models use known active compounds to generate pharmacophores, while structure-based models rely on receptor-ligand interactions to create them, both aiding in the discovery of phytomolecules with anti-cancer potential.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized in the reference: it mentions computational methodologies like virtual screening, molecular dynamics, and machine learning, and describes how ligand-based models use known actives while structure-based models analyze receptor-ligand interactions. It aligns with the overall trend and includes the necessary details."
        },
        {
            "query_idx": 133,
            "query": "What animal age, immune status classifications, and model characteristics are necessary for developing human breast cancer bone metastasis models, and how do these factors affect tumor development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2069,
                    2074,
                    2062
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Animal models require #5 to 8 weeks age#, classification by #immune status# like immunodeficient, such as #BALB/c nude#, affecting metastatic #tumorigenesis stages# and growth processes.",
            "predicted_answer": "To develop human breast cancer bone metastasis models, necessary factors include:\n- **Animal Age**: 5 to 8 weeks.\n- **Immune Status**: Immunocompetent for immune system interactions, or immunodeficient for human cell growth.\n- **Model Characteristics**: Syngeneic models for mixed lesions, xenograft models for human cell studies.\n\nThese factors affect tumor development by influencing immune interactions, cell growth, and metastatic stages.",
            "score": 3,
            "explanation": "The predicted answer includes key factors such as \"animal age\" (5 to 8 weeks), and mentions \"immune status\" (immunocompetent or immunodeficient), and \"model characteristics.\" However, it omits specific reference to \"BALB/c nude\" and the exact phrase \"metastatic tumorigenesis stages,\" affecting completeness."
        },
        {
            "query_idx": 134,
            "query": "What process allows for the high-density creation of cancer models, enhancing their three-dimensional complexity and precision, to enable detailed studies of tumor interactions with different cell types?",
            "retrieved_metrics": {
                "reference_idx": [
                    2045,
                    2048,
                    1970
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #bioprinting# enables the creation of high-density cancer models, #supports three-dimensional# structuring, and #enhances the complexity and precision# of tumor models for studying cellular interactions.",
            "predicted_answer": "3D bioprinting allows for high-density creation of cancer models, enhancing three-dimensional complexity and precision by controlling cell distribution and integrating vascular networks, enabling detailed studies of tumor interactions with different cell types.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer and includes all key facts: the use of bioprinting, three-dimensional structuring, and enhancement of complexity and precision. It accurately describes the process, supporting trends and details without significant omissions or errors."
        },
        {
            "query_idx": 135,
            "query": "What molecular docking analysis aspects are crucial for understanding the interaction of compounds with DNA and the specific interaction types seen in DNA-cisplatin complexes?",
            "retrieved_metrics": {
                "reference_idx": [
                    230,
                    232,
                    246
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The analysis revealed #intercalation with DNA# for Compounds (8a) and (8b), identified #docking scores for DNA-cisplatin#, and noted #hydrophobic interactions with residues Phe256, Thr255, Tyr204, and Leu168#.",
            "predicted_answer": "Crucial aspects for molecular docking analysis include binding affinity, binding mode, and specific interaction types like hydrophobic and hydrogen bonding. For DNA-cisplatin complexes, focus on intercalation and direct binding interactions.",
            "score": 1,
            "explanation": "The Predicted Answer mentions intercalation, aligning with one key fact in the Reference Answer, but omits docking scores and specific hydrophobic interactions with the residues Phe256, Thr255, Tyr204, and Leu168. The score reflects the presence of one fact but missing several crucial details."
        },
        {
            "query_idx": 136,
            "query": "What research model is used in studying the effects of gene interactions on adenoma progression while facing limitations in representing later cancer stages?",
            "retrieved_metrics": {
                "reference_idx": [
                    1392,
                    1390
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#APC(Min/+) mice# are used to study gene interaction effects on adenoma progression and face limitations in accurately representing #advanced cancer stages#.",
            "predicted_answer": "The APC(Min/+) mouse model is used to study gene interactions affecting adenoma progression, but it has limitations in representing later cancer stages, necessitating supplementary models for advanced colorectal cancer research.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference answer: the use of the APC(Min/+) mouse model for studying adenoma progression and its limitations in modeling advanced cancer stages. The details and overall trend closely match, without any significant omissions or contradictions."
        },
        {
            "query_idx": 137,
            "query": "Modify the multi-hop query:\nWhat therapeutic strategy is utilized to overcome the inadequacy of single-agent cancer treatments by incorporating established and innovative medications, including examining their simultaneous deployment for potential improvement in disease management?",
            "retrieved_metrics": {
                "reference_idx": [
                    2230,
                    2250,
                    860
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Combinatory therapy, which involves combining established and innovative medications, is utilized to overcome the inadequacy of single-agent cancer treatments. This strategy aims to target multiple oncogenic pathways simultaneously, improving disease management through synergistic effects and cost-effective drug repurposing.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer's overall concept of using combinatory therapy to address the shortcomings of single-agent treatments. It includes key points about using established and innovative medications and targeting multiple oncogenic pathways for improved disease management, covering all essential components."
        },
        {
            "query_idx": 138,
            "query": "Which immune molecule modulates the tumor microenvironment by affecting cytokine production, macrophage phenotype, and influences tumor cell behaviors through specific signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1361,
                    1359,
                    1349
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#B7-H3# modifies the #immunosuppressive microenvironment#, influences macrophage #polarization#, involves the #JAK-STAT3# pathway, and is crucial in #cancer progression#.",
            "predicted_answer": "B7-H3 modulates the tumor microenvironment by affecting cytokine production, macrophage phenotype, and influences tumor cell behaviors through specific signaling pathways.",
            "score": 1,
            "explanation": "The Predicted Answer mentions B7-H3, cytokine production, macrophage phenotype, and specific signaling pathways. However, it lacks explicit mentions of the \"immunosuppressive microenvironment,\" \"JAK-STAT3 pathway,\" and \"cancer progression.\" These omissions affect completeness as these are key facts in the Reference Answer."
        },
        {
            "query_idx": 139,
            "query": "What emerging alternative treatment in oncology demonstrates superior tumor recognition compared to blood-derived immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    942,
                    943
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CARNK# is an alternative cancer treatment showing #greater than 60%# tumor recognition, outperforming blood-derived immune cells.",
            "predicted_answer": "TIL therapy demonstrates superior tumor recognition compared to blood-derived immune cells, with over 60% of TILs identifying tumors versus less than 0.5% of blood-derived cells.",
            "score": 1,
            "explanation": "The Predicted Answer incorrectly identifies TIL therapy as the treatment instead of #CARNK#, which is the main key fact in the Reference Answer. While the percentage of tumor recognition is mentioned, the primary treatment type emphasized is missing, leading to a misalignment."
        },
        {
            "query_idx": 140,
            "query": "What variations in molecular docking characteristics, such as bonding types and affinity scores, are identified in comparing two distinct ligand-protein complexes and one with the same ligand but a different protein?",
            "retrieved_metrics": {
                "reference_idx": [
                    241,
                    247,
                    242
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In molecular docking, #NFκB-doxorubicin# forms #hydrogen bonds# with a score of #-4.52 kcal/mol#. #NFκB-cisplatin# lacks hydrogen bonds, scoring #-2.38 kcal/mol#. #p53-cisplatin# has #hydrogen bonds# and scores #-3.27 kcal/mol#.",
            "predicted_answer": "Variations in molecular docking characteristics include differences in bonding types (hydrogen bonds vs. none) and affinity scores (ranging from -2.38 to -4.52 kcal/mol) between distinct ligand-protein complexes.",
            "score": 1,
            "explanation": "The predicted answer mentions bonding type differences and affinity scores but lacks specific matchups like NFκB-doxorubicin, NFκB-cisplatin, and p53-cisplatin. It covers two instances of bonding and scores but omits the third case, impacting completeness."
        },
        {
            "query_idx": 141,
            "query": "Modify the multi-hop query:  \nWhich transmembrane protein, involved in cancer pathology, is found at immune cell interaction sites, suppresses immune activation, and is a focus in advancing therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1355,
                    1387,
                    1385
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "B7-H3 is a transmembrane protein found at immune cell interaction sites, suppresses immune activation, and is a focus in advancing therapeutic interventions for cancer.",
            "score": 5,
            "explanation": "The predicted answer identifies B7-H3 as a transmembrane protein that is found at immune cell interaction sites, suppresses immune activation, and is a focus for cancer therapeutic interventions. These match all the key aspects and meaningful elements implied by the query, despite the absence of \"#\" in the reference answer."
        },
        {
            "query_idx": 142,
            "query": "What are the primary motivations for adopting innovative techniques in drug development, and what challenges impede their use specifically in natural product-derived anti-cancer drug research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1654,
                    1697,
                    1703
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #high costs and time consumption# of traditional methods drive the use of #ML tools#, yet they face #limited evidence# in #NP-derived anticancer# drug research, lacking resources and tools.",
            "predicted_answer": "The primary motivations for adopting innovative techniques in drug development include reducing costs, accelerating timeframes, and enhancing accuracy in predicting drug efficacy and targets. Challenges in using these techniques specifically in natural product-derived anti-cancer drug research include limited publicly available ML models for predicting anti-cancer activity and the underutilization of ML in this specific context.",
            "score": 3,
            "explanation": "The predicted answer covers the motivations of reducing costs and time (aligned with \"high costs and time consumption\") and highlights challenges like limited ML models and underutilization. However, it misses the mention of \"limited evidence\" in the context of NP-derived anticancer drug research, affecting completeness."
        },
        {
            "query_idx": 143,
            "query": "How is artificial intelligence fundamentally transforming cancer care in terms of enhancing treatment personalization, improving disease progression understanding, and integrating emerging healthcare trends?",
            "retrieved_metrics": {
                "reference_idx": [
                    115,
                    127,
                    1232
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI is reshaping cancer care with #precision oncology# enhancing personalization, #predictive modeling# offering disease insights, and future #trends# such as multi-omics shaping the next advancements.",
            "predicted_answer": "Artificial intelligence is fundamentally transforming cancer care by enhancing treatment personalization through precision oncology, improving disease progression understanding via predictive modeling, and integrating emerging healthcare trends like multi-omics integration and patient-centric AI.",
            "score": 5,
            "explanation": "The Predicted Answer fully covers all key facts from the Reference Answer: precision oncology, predictive modeling, and trends like multi-omics integration. It aligns with the overall trend and accurately reflects the key concepts emphasized with # symbols without any significant omissions or contradictions."
        },
        {
            "query_idx": 144,
            "query": "How do three-dimensional (3D) models address the limitations of two-dimensional (2D) models and animal models in bone metastasis research, and what challenges do 3D models themselves face?",
            "retrieved_metrics": {
                "reference_idx": [
                    2084,
                    2081,
                    2064
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Advanced #3D models# overcome #static conditions# of 2D models and #ethical, cost# concerns of animal models but face challenges like #irregular cellular proliferation#.",
            "predicted_answer": "3D models address limitations of 2D models (static conditions) and animal models (high cost, ethics, different physiology) by replicating tumor microenvironments more accurately. However, 3D models face challenges like irregular cellular proliferation, autofluorescence, and genetic/epigenetic alterations.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference: addressing static conditions of 2D models, ethical and cost concerns of animal models, and challenges like irregular cellular proliferation in 3D models, without any contradictions or omissions. The phrasing differs slightly, but the meaning is consistent."
        },
        {
            "query_idx": 145,
            "query": "What methodology uses predictive models to assess patient data continuously, ensuring personalized care, and employs decision support systems for optimizing therapy plans based on specific disease traits?",
            "retrieved_metrics": {
                "reference_idx": [
                    123,
                    128,
                    1219
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#AI-driven prediction modeling# ensures #real-time analysis# of patient data for personalized care and integrates #treatment planning# with decision support systems to optimize therapy selection based on disease traits.",
            "predicted_answer": "AI-driven predictive modeling uses continuous patient data monitoring and decision support systems to optimize personalized therapy plans based on specific disease traits.",
            "score": 3,
            "explanation": "The 'Predicted Answer' captures the essential concept of AI-driven predictive modeling for personalized care and the use of decision support systems for therapy optimization. It misses the emphasis on \"real-time analysis\" and \"treatment planning,\" affecting completeness, but remains aligned with the general trend."
        },
        {
            "query_idx": 146,
            "query": "How do phage vaccines enhance immune responses and act as adjuvants through receptor activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    51,
                    58,
                    75
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Phage vaccines# stimulate immune responses by activating #naïve T-cells# and B-cell responses. Their #adjuvant activity# involves #TLRs# and #PRRs#, with phages enhancing efficacy by #presenting viral antigens#.",
            "predicted_answer": "Phage vaccines enhance immune responses by activating Toll-like receptors (TLRs) and pattern-recognition receptors (PRRs), boosting antigen presentation and cytokine production. This adjuvant activity stimulates both humoral and cellular immune responses, making phage-based vaccines effective against various pathogens.",
            "score": 1,
            "explanation": "The predicted answer covers phage vaccines, TLRs, PRRs, and their role in enhancing immune responses, aligning with the reference answer. However, it misses activating naïve T-cells and presenting viral antigens, which impacts completeness. There is no contradictory information, so overall trends are consistent."
        },
        {
            "query_idx": 147,
            "query": "What structural features and mechanisms in a lung cancer treatment enhance targeting and what resistance mechanisms affect the efficacy of targeted cytotoxic delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    168,
                    206,
                    166
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Antibody-drug conjugates (#structure and mechanism#) enhance targeting as #agents of precision oncology#. Resistance involves #adaptations affecting drug binding#, impacting effectiveness.",
            "predicted_answer": "Structural features enhancing lung cancer treatment targeting include ADCs delivering cytotoxic agents to specific cell surface targets. Resistance mechanisms affecting efficacy include reduced target expression, upregulation of drug efflux pumps, and dysregulated ADC trafficking to lysosomes.",
            "score": 5,
            "explanation": "The predicted answer mentions ADCs, aligning with the #structure and mechanism# in precision oncology. It details resistance mechanisms like reduced target expression and drug efflux, capturing #adaptations affecting drug binding#. Although the phrasing differs, no key facts are missing, and overall trends align well."
        },
        {
            "query_idx": 148,
            "query": "How do lymphatic systems and vascular perfusion affect drug behavior in tumor models, and what technologies have advanced the design of these models for enhanced treatment assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2214,
                    2232,
                    2043
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Drug accumulation# is influenced by the presence of a #lymphatic drainage system#. #Perfusion# impacts #tumor spheroid volume#, while #bioprinting# and #microfluidics# advance #tumor models# for improved treatment evaluation.",
            "predicted_answer": "The lymphatic system and vascular perfusion affect drug behavior in tumor models by influencing drug clearance and distribution. Advanced technologies like tumor-on-a-chip and microfluidics have improved model realism, enabling better assessment of drug efficacy.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies the role of the lymphatic system and perfusion but omits important aspects like drug accumulation, tumor spheroid volume, and bioprinting mentioned in the reference. It partially aligns with the reference but is missing more than one key fact."
        },
        {
            "query_idx": 149,
            "query": "How are three-dimensional systems derived from lung epithelial cells implemented to support critical tumor-related processes, including expression of specific proteins, and what are their implications in cellular development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1473,
                    2183,
                    2033
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#3D models derived from lung epithelial cells# facilitate #tumor development and metastasis# by replicating #tumor tissue features like morphology and pro-angiogenic protein expression#.",
            "predicted_answer": "Three-dimensional systems derived from lung epithelial cells support critical tumor-related processes by mimicking tumor tissue features, including protein expression and cell interactions. These models enhance understanding of cellular development and drug efficacy, bridging gaps between 2D systems and animal models.",
            "score": 5,
            "explanation": "The predicted answer captures the essential elements of the reference answer by stating that they mimic tumor tissue features, including protein expression. It suggests facilitation of tumor processes through these features, aligning with tumor development and metastasis. No key facts are contradictory or absent."
        },
        {
            "query_idx": 150,
            "query": "How do organoids contribute to advancements in precision oncology, particularly in analyzing genetic expressions, optimizing personalized medicine through pharmacogenomics, and evaluating new therapeutic approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1419,
                    1980,
                    1797
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Organoids contribute by enabling the analysis of #gene expression# in colorectal cancer, advancing personalized oncology through #pharmacogenomics#, and facilitating testing of therapies such as #ERK inhibitors# for liver cancer.",
            "predicted_answer": "Organoids contribute to precision oncology by analyzing genetic expressions, optimizing personalized medicine through pharmacogenomics, and evaluating new therapeutic approaches. They enable drug sensitivity testing, predict clinical responses, and identify genetic factors for drug response and resistance, leading to customized treatment plans.",
            "score": 1,
            "explanation": "The Predicted Answer captures the general role of organoids in precision oncology, notably in pharmacogenomics and analyzing genetic expressions. However, it lacks specific references to #gene expression# in colorectal cancer and testing of #ERK inhibitors# for liver cancer therapies, resulting in a loss of critical details."
        },
        {
            "query_idx": 151,
            "query": "What specific cell model configurations are utilized to assess anticancer drug efficacy before animal testing and predict in vivo responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1764,
                    1770,
                    1793
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Spheroids# enhance drug efficacy prediction compared to 2D models. #3D in vitro models# align with spheroid-derived xenograft responses. #Heterospheroids# integrate cancer and stromal cells to pre-test anticancer efficacy.",
            "predicted_answer": "Spheroid models, particularly 3D heterospheroids with cancer cells and stellate cells, are utilized to assess anticancer drug efficacy before animal testing, predicting in vivo responses by mimicking tumor microenvironment.",
            "score": 3,
            "explanation": "The predicted answer mentions \"spheroid models\", \"3D heterospheroids,\" \"cancer cells,\" and aspects of \"tumor microenvironment,\" which align with the reference's emphasis on \"spheroids,\" \"3D in vitro models,\" and \"heterospheroids.\" However, it misses the comparative aspect of \"spheroids\" outperforming \"2D models.\""
        },
        {
            "query_idx": 152,
            "query": "What specific engineered antibody fragments are designed to improve tumor uptake and clearance rates and mitigate issues associated with prolonged serum circulation and immune-related side effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    911,
                    912
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#scFv fragments# improve imaging with short half-life, while #medium-sized fragments# like Diabodies enhance tumor uptake and clearance, reducing #prolonged serum presence# and #immune-related risks#.",
            "predicted_answer": "Engineered antibody fragments like scFv, Diabodies, and single variable domains are designed to improve tumor uptake and clearance rates, mitigating issues of prolonged serum circulation and immune-related side effects.",
            "score": 3,
            "explanation": "The predicted answer mentions scFv and Diabodies, which aligns with the reference, capturing the essence of tumor uptake and clearance. However, it misses the detail of scFv's short half-life and the specific reference to medium-sized fragments, impacting completeness."
        },
        {
            "query_idx": 153,
            "query": "What are the observed differences in drug effectiveness when using organoid models in non-small cell lung cancer and adenocarcinoma compared to gastrointestinal cancers using patient-derived models?",
            "retrieved_metrics": {
                "reference_idx": [
                    762,
                    1484,
                    761
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs show #Cisplatin#'s limited efficacy in #NSCLC#, while EGFR tumoroids facilitate #targeted therapies#. Patient-derived models evaluate #drug reactions# in #HCC# and #CRC#, enhancing understanding of resistance.",
            "predicted_answer": "Drug effectiveness in organoid models varies: cisplatin is less effective in non-small cell lung cancer (NSCLC) and adenocarcinoma compared to gastrointestinal cancers, highlighting differences in resistance mechanisms and therapeutic responses.",
            "score": 1,
            "explanation": "The predicted answer mentions cisplatin's limited efficacy in NSCLC (matching two key points) but doesn't mention EGFR tumoroids, targeted therapies, HCC, or CRC, which are key parts of the reference. Thus, more than one key fact is missing, though the overall trend still aligns."
        },
        {
            "query_idx": 154,
            "query": "How do compounds 45, 31, and 37-39 affect both the progression of the cell cycle and the activity of a key kinase in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1266,
                    1263,
                    1265
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Compound 45#, #Compound 31#, and #Compounds 37, 38, and 39# lead to G2/M phase arrest and inhibit #CDK1 activity# in cancer cells.",
            "predicted_answer": "Compounds 45, 31, and 37-39 inhibit the progression of the cell cycle in the G2/M phase and reduce CDK1 activity in cancer cells, leading to increased apoptosis.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that compounds 45, 31, and 37-39 inhibit the G2/M phase of the cell cycle and reduce CDK1 activity, which aligns with the reference answer. All key facts emphasized in the reference are present without omissions or contradictions."
        },
        {
            "query_idx": 155,
            "query": "How do chemical gradients, variations in metabolism within spheroid inner layers, and spheroid density collectively impact therapeutic strategies and their effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    2036,
                    2037,
                    1714
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Chemical gradients increase #drug resistance#. Variations in inner layers' metabolism impact #radiation therapy#. Higher #spheroid density# restricts drug #transport#.",
            "predicted_answer": "Chemical gradients, variations in metabolism within spheroid inner layers, and spheroid density collectively impact therapeutic strategies by increasing drug resistance due to nutrient and oxygen gradients, altered metabolism, and physical barriers, reducing drug effectiveness and complicating treatment.",
            "score": 1,
            "explanation": "The predicted answer captures drug resistance due to chemical gradients and mentions complications related to altered metabolism and physical barriers, aligning with the reference's emphasis on drug resistance and therapy impact. However, it misses the specific mention of radiation therapy and drug transport associated with spheroid density."
        },
        {
            "query_idx": 156,
            "query": "Which clinical trial established a new standard of care for colorectal cancer by supporting an immune checkpoint inhibitor's approval for cases with genetic characteristics involving microsatellite instability?",
            "retrieved_metrics": {
                "reference_idx": [
                    671,
                    1036,
                    672
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The clinical trial #KEYNOTE177# established a new treatment standard by leading to #pembrolizumab# approval in June 2020 for colorectal cancer with #high microsatellite instability# and #mismatch repair deficiency# based on #PFS benefit#.",
            "predicted_answer": "The KEYNOTE-177 clinical trial established a new standard of care for colorectal cancer by supporting the approval of pembrolizumab for cases with microsatellite instability (MSI-H).",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by identifying the KEYNOTE-177 trial and mentioning pembrolizumab's approval for colorectal cancer with microsatellite instability. However, it omits the details about \"mismatch repair deficiency,\" \"PFS benefit,\" and the \"June 2020\" approval date, impacting completeness."
        },
        {
            "query_idx": 157,
            "query": "What was the approval rate for new medications targeting a specific type of illness from 2020 to 2021, and what roles do artificial intelligence technologies play in enhancing treatment methods for these illnesses?",
            "retrieved_metrics": {
                "reference_idx": [
                    269,
                    1210,
                    1222
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2020-2021, #40% of drugs approved# were for #cancer#. AI enhances #precision and workflow# in treatment and aids in identifying #biomarkers# for personalized therapy.",
            "predicted_answer": "The approval rate for new medications targeting various types of cancers from 2020 to 2021 was 40%. Artificial intelligence technologies enhance treatment methods by improving diagnoses, personalized treatments, drug discovery, and precision medicine strategies.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the 40% approval rate for cancer drugs from 2020-2021, aligning with the reference. It also covers AI's role in improving diagnoses and personalized treatments, though it misses specific details like biomarkers. The key facts are mostly present with some omissions."
        },
        {
            "query_idx": 158,
            "query": "What biases challenge the assessment of a diabetes drug's efficacy when it is repurposed for cancer treatment in retrospective studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2265,
                    2264
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The efficacy assessment of the diabetes drug #metformin# for cancer treatment in retrospective studies is challenged by #selection bias# and #immortal time bias#.",
            "predicted_answer": "Selection bias and immortal time bias challenge the assessment of a diabetes drug's efficacy when repurposed for cancer treatment in retrospective studies, potentially overestimating benefits.",
            "score": 3,
            "explanation": "The predicted answer includes the key biases, selection bias, and immortal time bias, aligning with the reference answer. However, it omits the specific mention of \"metformin,\" a key fact emphasized in the reference. Thus, essential information is missing, impacting completeness."
        },
        {
            "query_idx": 159,
            "query": "What strategy in drug development incorporates patient genetic profiles for optimizing dosage and considers emerging drug-gene interactions while aligning with new therapeutic policy recommendations?",
            "retrieved_metrics": {
                "reference_idx": [
                    703,
                    731,
                    692
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The strategy involves #exposure differentiation# using genetic profiles, accounts for #emerging interactions# in treatment development, and aligns with #genome-guided treatment# policies.",
            "predicted_answer": "The strategy in drug development that incorporates patient genetic profiles for optimizing dosage and considers emerging drug-gene interactions is called pharmacogenomics. This approach aligns with new therapeutic policy recommendations by using upfront pharmacogenomics testing to guide dosing, ensuring better tolerability and efficacy.",
            "score": 3,
            "explanation": "The predicted answer captures key elements such as genetic profiles and emerging drug-gene interactions, aligning with therapeutic policies similar to the reference's emphasis on genome-guided treatment. However, it misses \"exposure differentiation\" noted in the reference."
        },
        {
            "query_idx": 160,
            "query": "What selective nucleophilic agent is employed in the production of clinical PET radiotracers, and in what types of reactions is this agent specifically involved?",
            "retrieved_metrics": {
                "reference_idx": [
                    1523,
                    1524,
                    1522
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#$^{18}$F fluoride# serves as a selective nucleophilic agent for the #synthesis of clinically used PET radiotracers#, involved in #nucleophilic substitution reactions#, contrasting with electrophilic substitutions used by [$^{18}$F]fluorine.",
            "predicted_answer": "The selective nucleophilic agent employed in the production of clinical PET radiotracers is $^{18}$F fluoride. It is specifically involved in nucleophilic radiofluorination reactions, particularly in aliphatic or aromatic substitution reactions.",
            "score": 3,
            "explanation": "The predicted answer includes key facts: the selective agent (#^{18}$F fluoride#) and its role in #nucleophilic substitution reactions#. While it omits the explicit note on the synthesis of clinically used PET radiotracers (present in the reference), the trend and context align without contradiction."
        },
        {
            "query_idx": 161,
            "query": "What are the advantages in terms of cost savings and time efficiency of using existing drug compounds compared to developing new drug compounds in the pharmaceutical field?",
            "retrieved_metrics": {
                "reference_idx": [
                    1829,
                    2235
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Using existing drug compounds offers #85% cost reduction# and shortens the market timeline to #6.5 years# compared to developing new drug compounds.",
            "predicted_answer": "Using existing drug compounds can save approximately 85% in development costs, ranging from $300 million compared to $1.778-3.0 billion for new compounds. Time efficiency is also significant, with repurposed drugs taking about 6.5 years versus 13-15 years for new drugs.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer, specifically the #85% cost reduction# and the #6.5 years# timeline for existing drug compounds. It also offers additional details about costs and timelines not found in the reference but does not contradict them."
        },
        {
            "query_idx": 162,
            "query": "Which technique was utilized for editing oncogenes, leading to colorectal tumor development, and which genetic pathway and specific gene mutations are implicated in this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1407,
                    1409,
                    1408
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPRCas9# method edited genes, causing colorectal tumors involving the #CIN# pathway, with #APC# mutations playing a pivotal role in cancer development.",
            "predicted_answer": "The CRISPR-Cas9 technique was used to edit oncogenes APC and TP53, leading to colorectal tumor development. The CIN pathway and mutations in APC, KRAS, TP53, and SMAD4 are implicated in this process.",
            "score": 3,
            "explanation": "The predicted answer mentions CRISPR-Cas9, APC, and the CIN pathway, aligning with the reference answer. However, the focus on APC as pivotal is missing, and extra genes (KRAS, TP53, SMAD4) are included though they're relevant. Overall, the key facts mostly align, but completeness is slightly affected."
        },
        {
            "query_idx": 163,
            "query": "What structural element in second and third-generation CAR-T cells enhances their functional mechanisms by involving specific molecules that lead to the apoptosis of tumor cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    928,
                    926
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #co-stimulatory domains# in second and third-generation CAR-T cells enhance functionality and promote tumor cell apoptosis via increased release of #cytotoxic molecules# like perforin and granzyme B.",
            "predicted_answer": "The structural element in second and third-generation CAR-T cells that enhances their functional mechanisms is the incorporation of co-stimulatory molecules (e.g., CD28 + 4-1BB or CD28 + OX40), which boost tumor lysis and cytokine secretion, leading to apoptosis of tumor cells.",
            "score": 3,
            "explanation": "The predicted answer identifies \"co-stimulatory molecules\" which aligns with \"co-stimulatory domains\" in the reference, but it lacks mention of \"cytotoxic molecules\" like perforin and granzyme B, key for tumor apoptosis. Though generally aligned, the absence of these details affects completeness."
        },
        {
            "query_idx": 164,
            "query": "What recent advancements in the use of non-blood bodily fluids are contributing to the support and refinement of oncology therapies, and what challenges are associated with these advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1641,
                    1653,
                    302
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The detection of #ctDNA# in #CSF# aids #drug development# for oncology, despite #challenges# in its identification.",
            "predicted_answer": "Recent advancements in using circulating tumor DNA (ctDNA) in blood and cerebrospinal fluid (CSF) are aiding oncology therapies by monitoring tumor response and informing dose optimization. Challenges include variable ctDNA levels, difficulty in detecting low levels, and potential inaccuracies in representing all genetic changes in tumors.",
            "score": 3,
            "explanation": "The predicted answer covers the detection of ctDNA in CSF and its role in oncology, which aligns with the reference. It also mentions challenges related to ctDNA detection and diagnostics, matching the reference's emphasis on challenges. However, it lacks explicit mention of \"drug development,\" impacting completeness."
        },
        {
            "query_idx": 165,
            "query": "What system enhances the translational application of 3D models in medical research, specifically integrating advanced gene-editing techniques for cancer study improvements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2091,
                    2092,
                    1816
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#3D organoid models# offer #personalized drug screening# integrated with #CRISPR-Cas9#. These models improve #predictive accuracy# over traditional methods, particularly with #genetically engineered glioma organoids#.",
            "predicted_answer": "The system enhancing translational application of 3D models in medical research, integrating advanced gene-editing techniques for cancer study improvements, is the genetically engineered glioma organoids using CRISPR-Cas9-based gene editing.",
            "score": 1,
            "explanation": "The 'Predicted Answer' identifies the system as genetically engineered glioma organoids using CRISPR-Cas9. It captures elements from the 'Reference Answer' such as CRISPR-Cas9 and glioma organoids but omits key facts about 3D organoid models, personalized drug screening, and predictive accuracy."
        },
        {
            "query_idx": 166,
            "query": "What method involves manipulating the GAP protein's positioning to create spaces facilitating the formation of new binding sites for small, drug-like molecules?",
            "retrieved_metrics": {
                "reference_idx": [
                    1132,
                    1133,
                    1131
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method involves the #translation of GAP# protein to establish #artificially created spacing#, enabling #novel binding sites for small molecules#.",
            "predicted_answer": "The method involves artificially distancing the GAP protein from RAS using a translational vector to create spaces facilitating the formation of new binding sites for small, drug-like molecules.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference by discussing the artificial distancing of the GAP protein to create new binding sites, which aligns with the idea of creating spacing for small molecule binding. However, the specific mention of \"translation\" is missing, affecting completeness."
        },
        {
            "query_idx": 167,
            "query": "What specific role should combination therapies and regulatory frameworks play, given the technical challenges in phage engineering and delivery, to enhance phage therapy effectiveness against resistant bacterial infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    102,
                    104,
                    14
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Addressing #technical challenges# in phage engineering and delivery, refining #regulatory frameworks#, and utilizing #combination therapies# are crucial for effective phage therapy against resistant bacterial infections.",
            "predicted_answer": "Combination therapies should synergize with phages, antibiotics, and immune-modulating agents to overcome resistance. Regulatory frameworks must ensure safety, standardization, and public acceptance, while optimizing delivery systems and personalized medicine approaches.",
            "score": 5,
            "explanation": "The predicted answer addresses combination therapies, regulatory frameworks, and a need for optimization in delivery systems. It aligns with the key aspects of phage therapy effectiveness, namely handling technical challenges and using combination therapies, despite different phrasing. No crucial information is missing or contradictory."
        },
        {
            "query_idx": 168,
            "query": "Modified multi-hop query:\nWhat biotechnological techniques are employed to develop bacteriophages targeting antibiotic-resistant bacteria, and what are the resulting enhancements in their targeting accuracy and adaptability for wider applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    22,
                    101,
                    21
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "Biotechnological techniques such as synthetic biology, genome editing, and CRISPR-Cas systems are employed to develop bacteriophages targeting antibiotic-resistant bacteria. These advancements enhance targeting accuracy and adaptability, offering precise and effective treatments for bacterial infections.",
            "score": 3,
            "explanation": "The predicted answer mentions biotechnological techniques such as synthetic biology, genome editing, and CRISPR-Cas systems, aligning with potential advancements in bacteriophage development. The focus on enhanced targeting accuracy and adaptability is consistent with general trends in biotechnology for antibiotic resistance, but lacks explicit emphasis from reference for a detailed comparison."
        },
        {
            "query_idx": 169,
            "query": "What potential new drug targets could be identified that involve endosomal processes in epithelial cells, particularly those affecting the transmission of HIV to immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    372,
                    371,
                    374
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Potential drug targets involve genes related to #endosomal uptake# and #sequestration in epithelial cells#, impacting #HIV transmission# to #immune cells#, expanding interventions beyond #established mechanisms#.",
            "predicted_answer": "Potential new drug targets involving endosomal processes in epithelial cells include genes mediating HIV binding (complement receptor 3, heparan sulfate), endosomal uptake (clathrin, caveolin, GalCer, TIM-1), transcytosis, sequestration, and cell-to-cell transmission to immune cells (ICAM-1).",
            "score": 5,
            "explanation": "The Predicted Answer mentions genes related to endosomal uptake and sequestration, consistent with the Reference Answer’s focus. It also addresses HIV transmission to immune cells. While additional details like established mechanisms are omitted, these don't affect the overall alignment with key facts."
        },
        {
            "query_idx": 170,
            "query": "Modify the multi-hop query:\nHow does an agent affect cellular pathways in glioblastoma and oral squamous cell carcinoma, and what molecular mechanisms contribute to changes in cancer cell dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    797,
                    799
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "An agent like MBZ affects cellular pathways in glioblastoma and oral squamous cell carcinoma by modulating EMT markers, downregulating proteins like FAK and Rho-A, and disrupting cadherin equilibrium. Molecular mechanisms include inhibition of microtubule polymerization and modulation of pathways like JAK2/STAT3/Bcl-2 and S1P/FAK/vimentin, contributing to changes in cancer cell dynamics.",
            "score": 3,
            "explanation": "The Predicted Answer covers the modulation of EMT markers, downregulation of proteins like FAK and Rho-A, and disrupts cadherin equilibrium, which align with the molecular mechanisms noted in the Reference Answer. No contradictory information is detected, but specifics are insufficient in comparison."
        },
        {
            "query_idx": 171,
            "query": "How does a certain genome-editing tool improve cellular model accuracy in drug screening and decrease errors, while also identifying potential targets in oncological treatment development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2088,
                    2117,
                    2101
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPR# tool enhances cellular model accuracy in screening, reduces #off-target effects#, and identifies #cancer targets#, optimizing oncology drug development and precision applications.",
            "predicted_answer": "CRISPR improves cellular model accuracy in drug screening by simulating disease genotypes and identifying effective compounds early. It reduces errors through enhanced precision and specificity, and identifies potential oncological targets by high-throughput genetic screening.",
            "score": 3,
            "explanation": "The predicted answer includes the use of CRISPR, enhancing accuracy, precision, and identification of cancer targets, aligning with the reference's emphasis on these key aspects. However, it misses \"reduces off-target effects,\" slightly affecting completeness."
        },
        {
            "query_idx": 172,
            "query": "What nuclear structure shows distinct characteristics across cancer cell lines, is associated with malignancy features, and has potential utility in developing cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2003,
                    2002,
                    1998
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PNC# shows #distinct characteristics in cancer lines#, links with #malignancy features like metastasis#, and is a proposed #marker for developing anti-cancer therapies#.",
            "predicted_answer": "The perinucleolar compartment (PNC) shows distinct characteristics across cancer cell lines, is associated with malignancy features, and has potential utility in developing cancer treatments.",
            "score": 3,
            "explanation": "The Predicted Answer accurately identifies the PNC's distinct characteristics in cancer cells and its role in treatment development. However, it misses details on the specific malignancy feature \"metastasis\" and \"proposed marker\" status. Thus, it's generally aligned but lacks complete detail."
        },
        {
            "query_idx": 173,
            "query": "Which identifiers correspond to the compounds that independently exhibit tumor selectivity, significant cytotoxicity with no effect on normal cells, and demonstrated anti-proliferative activity in 60 human tumor cell lines?",
            "retrieved_metrics": {
                "reference_idx": [
                    1260,
                    1264,
                    1268
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Compound 24# exhibited tumor selectivity, #compound 29# showed significant cytotoxicity and sparing normal cells, and #compounds 35 and 36# had anti-proliferative activity with apoptosis induction.",
            "predicted_answer": "Compounds 35 and 36 correspond to the compounds that independently exhibit tumor selectivity, significant cytotoxicity with no effect on normal cells, and demonstrated anti-proliferative activity in 60 human tumor cell lines.",
            "score": 1,
            "explanation": "The predicted answer contains compounds 35 and 36, aligning with the anti-proliferative activity and apoptosis induction. However, it omits compound 24 for tumor selectivity and compound 29 for cytotoxicity without affecting normal cells. Missing these key details impacts completeness."
        },
        {
            "query_idx": 174,
            "query": "Which tumor-specific ligands are used in the development of anticancer PROTACs, their molecular targets, and which compound is currently being tested in clinical trials for therapeutic effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    887,
                    888,
                    889
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The ligands for #E3 ligases# target #AR, ER, and BTK#. Currently, #Bavdegalutamide# is undergoing #clinical trials# to evaluate its effectiveness in treatment.",
            "predicted_answer": "Tumor-specific ligands for E3 ligases like CRBN, VHL, MDM2, and IAPs are used in anticancer PROTACs. Targets include AR, ER, and BTK. Bavdegalutamide, ARV-471, and NX-2127 are in clinical trials for therapeutic effectiveness.",
            "score": 5,
            "explanation": "The predicted answer mentions the ligands for E3 ligases and targets AR, ER, and BTK, aligning with the reference. However, while it correctly lists Bavdegalutamide in clinical trials, it adds two more (ARV-471, NX-2127), which were not emphasized in the reference but do not contradict it."
        },
        {
            "query_idx": 175,
            "query": "How does fascaplysin impact drug sensitivity, the viability of glioma cells specifically, and the cell cycle through a specific kinase inhibition in cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1276,
                    1280,
                    1277
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Fascaplysin enhances #anticancer drug efficacy#, reduces #glioma cell# viability by inducing apoptosis, and inhibits #CDK4#-mediated cell cycle progression in various cancer cells.",
            "predicted_answer": "Fascaplysin impacts drug sensitivity by inhibiting CDK4, reducing glioma cell viability, and disrupting the cell cycle through kinase inhibition, specifically targeting PI3K/Akt/mTOR signaling.",
            "score": 3,
            "explanation": "The predicted answer identifies CDK4 inhibition and glioma cell viability reduction, aligning with two key facts. However, it omits the enhancement of anticancer drug efficacy, a crucial component of the reference. Thus, the absence of this key fact slightly impacts the answer's completeness."
        },
        {
            "query_idx": 176,
            "query": "What was the outcome of the FDA's evaluation of a specific genetic mutation-related therapy for pancreatic cancer, and how does it compare to findings in a similar genetic context in breast cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    668,
                    667,
                    655
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #FDA approved olaparib in 2019# for #g BRCA pancreatic cancer maintenance# based on the #POLO trial#, while the #OlympiA trial# investigated #HER2-negative breast cancer# with #g BRCA mutation# for survival outcomes.",
            "predicted_answer": "The FDA approved olaparib for gBRCA-mutant pancreatic cancer in 2019 based on PFS benefits, but it showed no overall survival advantage. In breast cancer, olaparib improved invasive disease-free survival in HER2-negative, high-risk gBRCA1/2-mutant patients.",
            "score": 3,
            "explanation": "The predicted answer includes the FDA's 2019 approval for gBRCA-mutant pancreatic cancer, aligning with the POLO trial reference. It also mentions breast cancer outcomes in line with the OlympiA trial. However, it misses specifying the POLO and OlympiA trial names."
        },
        {
            "query_idx": 177,
            "query": "Which specific compounds identified through the UPLC-MS/MS analysis demonstrate interactions with significant cancer-related pathways and targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1687,
                    1689
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compounds #isoquercitrin, quercetin, berberine, chlorogenic acid, and caffeic acid# demonstrate #synergistic interactions with cancer-related targets and pathways#.",
            "predicted_answer": "The specific compounds identified through UPLC-MS/MS analysis that demonstrate interactions with significant cancer-related pathways and targets are isoquercitrin, quercetin, berberine, chlorogenic acid, and caffeic acid. These compounds interact with molecular targets AKT1, CASP3, MAPK1, and TP53, and are involved in 15 cancer-related pathways for colorectal, endometrial, and non-small cell lung cancers.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the specific compounds mentioned in the Reference Answer, as well as additional details about their interactions with cancer-related pathways and targets. The key facts, such as the listed compounds and their interaction with pathways, are fully covered, and the response aligns with the Reference Answer's meaning."
        },
        {
            "query_idx": 178,
            "query": "How do genetic mutations influence prognosis and pathway activation in colorectal cancer, and what role do they play in cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1411,
                    1418,
                    1412
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #BRAF V600E# mutation correlates with poor prognosis through #MSI-H#, while the #serrated pathway# associates with #BRAF V600E# and #CIMP#. #TGFb RII# and #ACVR# interact, influencing #MSI CRC# dynamics.",
            "predicted_answer": "Genetic mutations, such as BRAF V600E, TGFb RII, and MSI, influence colorectal cancer prognosis by activating pathways like MAPK/ERK and TGFb, leading to poor outcomes. These mutations also drive cancer progression by disrupting normal tissue and signaling.",
            "score": 1,
            "explanation": "The predicted answer mentions BRAF V600E, TGFb RII, and MSI, aligning with some key facts in the reference. However, it omits ACVR, serrated pathway, and CIMP, which are critical components for a complete representation. Overall, it aligns with the general trend but is missing more than one key detail."
        },
        {
            "query_idx": 179,
            "query": "What mechanisms are necessary to address cellular membrane challenges, degradation barriers such as the blood-brain barrier, and how can receptor identification and ligand engineering enhance siRNA delivery?",
            "retrieved_metrics": {
                "reference_idx": [
                    376,
                    2129,
                    2143
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Overcoming #cellular membrane challenges# requires addressing #degradation barriers, including the blood-brain barrier#. Enhancing siRNA delivery involves #receptor identification# and #ligand engineering#.",
            "predicted_answer": "To address cellular membrane challenges and degradation barriers like the blood-brain barrier, mechanisms such as receptor identification and ligand engineering are crucial. These methods enhance siRNA delivery by facilitating membrane crossing, protecting against degradation, and targeting specific cells or organs.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts emphasized in the reference answer, including addressing cellular membrane challenges, degradation barriers (such as the blood-brain barrier), receptor identification, and ligand engineering. The important details are present and correctly emphasize enhancing siRNA delivery."
        },
        {
            "query_idx": 180,
            "query": "How does genistein influence cellular mechanisms related to cancer prevention, particularly concerning protein activation, DNA impact, and regional differences in daily intake?",
            "retrieved_metrics": {
                "reference_idx": [
                    800,
                    802,
                    807
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Genistein #activates JNK and Ask1# proteins, leading to the #induction of double-strand breaks in DNA#. In Asian populations, the #median daily intake# of isoflavones is significantly higher, potentially lowering cancer incidences.",
            "predicted_answer": "Genistein influences cancer prevention by activating proteins like JNK and Ask1, which regulate DNA damage and repair, and by reducing oxidative stress through Nrf2 activation. It also inhibits DNA topoisomerase II, causing DNA damage. Regional differences in intake, particularly higher in Asia, correlate with lower cancer rates.",
            "score": 3,
            "explanation": "The predicted answer covers activation of JNK and Ask1 and regional intake differences, consistent with the reference. However, it lacks the \"induction of double-strand breaks in DNA\" detail, impacting completeness. Details on median daily intake are implied but not explicitly noted."
        },
        {
            "query_idx": 181,
            "query": "Which immune checkpoint molecule's interaction with antigen-presenting cells involves a specific binding component, and how is inhibiting this interaction being utilized in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    903,
                    905
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The molecule #LAG-3# binds to #MHC class II# on APCs, sending inhibitory signals. Targeting #LAG-3# helps counteract its role in tumor #immune evasion# in exhausted T cells.",
            "predicted_answer": "The immune checkpoint molecule LAG-3 interacts with MHC class II molecules on antigen-presenting cells (APCs). Inhibiting this interaction is being utilized in cancer treatment through drugs like BMS-986016, which target LAG-3 to enhance T cell responses.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: LAG-3, its binding to MHC class II on APCs, and its role in cancer treatment via inhibition. However, the reference emphasizes LAG-3's role in immune evasion in exhausted T cells, which is not explicitly mentioned in the prediction. This omission affects completeness."
        },
        {
            "query_idx": 182,
            "query": "What systems evaluate tissue-specific drug responses, enhance preclinical oncology model efficiency, and ensure diverse subtype representation to advance personalized cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1458,
                    1460,
                    1966
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #same-organ paired organoid system# evaluates specific drug responses, #biobanks of PDOs# boost preclinical efficiency, and #diverse representation in organoid biobanks# aids personalized cancer treatment.",
            "predicted_answer": "Organoid biobanks and high-throughput screening systems evaluate tissue-specific drug responses, enhance preclinical oncology model efficiency, and ensure diverse subtype representation to advance personalized cancer treatment.",
            "score": 3,
            "explanation": "The predicted answer captures the main ideas of the reference answer, mentioning organoid biobanks and drug response evaluation. However, it misses the specific mention of the \"same-organ paired organoid system,\" affecting the completeness of the answer as highlighted in the reference answer."
        },
        {
            "query_idx": 183,
            "query": "Modify the multi-hop query: \nHow do cancer-on-a-chip systems replicate tumor structural features and environmental conditions, and what specific components and methods are used in these systems to achieve this replication?",
            "retrieved_metrics": {
                "reference_idx": [
                    2058,
                    2186,
                    2053
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Cancer-on-a-chip systems replicate tumor structural features and environmental conditions using microfluidics, hydrogels, and co-culture methods. Specific components include channels, chambers, and cells cultured in miniature chips, while methods involve soft lithography, laser cutting, and fluid manipulation to mimic physiological conditions.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the use of #microfluidics#, #hydrogels#, and #co-culture methods#, as well as #channels, chambers, cells#, and processes like #soft lithography# and #fluid manipulation#. It captures the essential components and approaches for replicating tumor environments."
        },
        {
            "query_idx": 184,
            "query": "What examples highlight the process of obtaining reliable drug activity signals in glioma and the need for improved trial efficiency, specifically in the context of costly clinical trials for rare cancers such as GBM?",
            "retrieved_metrics": {
                "reference_idx": [
                    284,
                    309,
                    307
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "A #process# for reliable drug signals in #glioma# exists. Rare cancers, including GBM, #need improved trial efficiency#. A #costly RCT example# in GBM exceeded #$250 million#.",
            "predicted_answer": "The context highlights the need for improved trial efficiency in glioma, particularly GBM, due to costly clinical trials. Examples include the inefficient use of control populations in RCTs like nivolumab's development, which took over 6 years and cost over $250 million with negative results.",
            "score": 3,
            "explanation": "The predicted answer covers the need for improved trial efficiency in glioma, including GBM, and provides a costly RCT example exceeding $250 million, aligning with the reference's key facts. It lacks explicit mention of a process for reliable drug signals, missing a key fact."
        },
        {
            "query_idx": 185,
            "query": "How do orphan and non-orphan indications compare in terms of progression-free survival duration, quality-adjusted life years gained, and the frequency of breakthrough designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1069,
                    1902,
                    1068
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Orphan indications exhibit higher #progression-free survival#, greater #incremental quality-adjusted life years (QALYs)# gained, and are more frequently awarded the #breakthrough designation# compared to non-orphan indications.",
            "predicted_answer": "Orphan indications show longer progression-free survival (3.3 months vs. 2.8 months) and higher quality-adjusted life years gained (0.25 vs. 0.05 QALYs), but similar overall survival. Orphan indications are more frequently granted breakthrough designations (57% and 77% vs. 34%).",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts emphasized with # in the reference: progression-free survival, quality-adjusted life years gained, and frequency of breakthrough designations. The trends are aligned, and the key facts are accurately presented without any significant omissions or errors."
        },
        {
            "query_idx": 186,
            "query": "What ethical and legal considerations are crucial for addressing data security and privacy challenges in the implementation of AI technologies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1224,
                    1233,
                    133
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The implementation of AI in cancer treatment involves #ethical and regulatory considerations#, necessitates compliance with #strict data privacy laws like HIPAA#, and faces challenges in overcoming #data security and privacy issues#.",
            "predicted_answer": "Ethical and legal considerations crucial for addressing data security and privacy challenges in AI for cancer treatment include strict adherence to regulations like HIPAA, implementing strong data protection measures such as encryption and anonymization, and building patient trust through secure management of health information.",
            "score": 5,
            "explanation": "The Predicted Answer covers key ethical and regulatory considerations, compliance with data privacy laws like HIPAA, strong data protection measures, and addresses data security and privacy issues. It aligns well with the Reference Answer, maintaining consistency in meaning and key facts without omissions."
        },
        {
            "query_idx": 187,
            "query": "What genetic markers are associated with altered treatment outcomes or adjustments, such as physiological changes or dose modifications, in patients receiving medications?",
            "retrieved_metrics": {
                "reference_idx": [
                    724,
                    727,
                    725
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The genetic marker #VEGFR2# is related to #sunitinib toxicities#, #CYP3A5 *1 allele# leads to #dose reductions# due to toxicity, and #UGT1A1 *28# causes a #bilirubin increase# with specific treatments.",
            "predicted_answer": "Genetic markers such as SNPs in VEGFR2, FLT3, VEGF-A, eNOS, CYP1A1, NR1I3, ABCB1, ABCG2, UGT1A1, CYP1A2, HFE, ABCC2, HLA-A, and IL28 are associated with altered treatment outcomes or adjustments in patients receiving medications.",
            "score": 1,
            "explanation": "The predicted answer includes VEGFR2 but lacks specific associations with sunitinib toxicities. It doesn't mention CYP3A5 *1 allele or UGT1A1 *28, thus missing key details about dose reductions and bilirubin increase. Despite covering related markers, essential information is incomplete."
        },
        {
            "query_idx": 188,
            "query": "How does the FDA's Project Optimus recommend structuring dose-response trials in cancer treatment, and what methods are used to pinpoint effective dosages and assess genetic impact on drug responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    700,
                    699,
                    734
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA's #Project Optimus# proposes #randomized dose-response trials#; the #MTD# is identified using #DLTs# for efficacy, and #PGx factors# modify drug response in oncology.",
            "predicted_answer": "The FDA's Project Optimus recommends randomized, parallel dose-response trials to compare activity and safety of multiple dosages, selected based on preclinical and clinical data. Effective dosages are pinpointed through dose-ranging studies, and genetic impact is assessed by exploring pharmacogenomics (PGx) factors early in development.",
            "score": 1,
            "explanation": "The predicted answer captures key elements from the reference, including \"randomized dose-response trials\" and \"PGx factors.\" However, it doesn't mention \"MTD\" or use \"DLTs,\" which are critical for efficacy assessment per the reference. Therefore, completeness is compromised by missing these two key facts."
        },
        {
            "query_idx": 189,
            "query": "What global health challenge does drug repurposing predominantly focus on, which involves specific regulatory considerations, and what strategies are suggested to improve therapeutic outcomes through this approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    756,
                    1828,
                    2229
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenge drug repurposing focuses on is the #high incidence of cancer#, requiring a #regulatory framework for repurposed drugs#, and suggesting #combinatory treatments# to improve cancer therapy outcomes.",
            "predicted_answer": "Drug repurposing predominantly focuses on cancer, involving specific regulatory considerations to ensure safe and effective use for new indications. Strategies to improve therapeutic outcomes include addressing commercial, technological, and regulatory challenges, and emphasizing combinatory treatments.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, covering key facts such as the focus on cancer, the importance of regulatory considerations, and the use of combinatory treatments to improve outcomes. All key points are addressed, indicating high consistency with the reference."
        },
        {
            "query_idx": 190,
            "query": "How do molecularly targeted and immune-oncology agents differ from traditional cytotoxic agents in their dosing strategies and side effect profiles, and why is there a need for enhanced approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    698,
                    701,
                    757
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Novel treatments, like #molecularly targeted# and #immune-oncology agents#, have #unique dosing strategies#, typically #below MTD#, with #fewer side effects#, necessitating #strategies for higher efficacy and reduced side effects#.",
            "predicted_answer": "Molecularly targeted and immune-oncology agents often have lower toxicity, wider therapeutic indices, and target saturation limits below the maximum tolerated dose (MTD), compared to traditional cytotoxic agents. This necessitates enhanced dosing strategies to optimize efficacy without severe side effects.",
            "score": 5,
            "explanation": "The predicted answer includes key concepts: molecularly targeted and immune-oncology agents, unique dosing strategies below MTD, fewer side effects, and enhanced strategies for efficacy and safety. The meaning and key facts are consistent with the reference answer, although not all details are explicitly covered."
        },
        {
            "query_idx": 191,
            "query": "How do the mechanisms of gene duplication contribute to the development of specific lethal genetic interactions within paralogs in model organisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1935,
                    1950,
                    1943
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Paralog pairs form through #gene duplication# such as small-scale and whole-genome duplications. In model organisms, these lead to #synthetic lethal interactions# especially when #protein sequence identity is high#.",
            "predicted_answer": "Gene duplication contributes to specific lethal genetic interactions within paralogs by creating pairs with higher protein sequence identity and smaller gene families, which are more likely to be synthetic lethal. This mechanism is particularly evident in model organisms like yeast, where paralog pairs are enriched for synthetic lethality.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized in the reference: it mentions \"gene duplication,\" \"synthetic lethal interactions,\" and the importance of \"high protein sequence identity.\" The information is highly consistent with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 192,
            "query": "How do modifications in chemical structure influence the effectiveness of a renal cell carcinoma treatment after multiple previous therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    685,
                    683,
                    679
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modifications improved #pharmacokinetic properties# and potency; in renal cancer patients, belzutifan showed #antitumor activity# with a median PFS of #14.5 months# after extensive prior therapies.",
            "predicted_answer": "Modifications in chemical structure, such as changing the germinal difluoro group to the vicinal difluoro group in PT2385, can improve pharmacokinetics and potency, enhancing the effectiveness of renal cell carcinoma treatments like belzutifan, even after multiple previous therapies.",
            "score": 1,
            "explanation": "The predicted answer mentions improvements in pharmacokinetics and effectiveness in treating renal cell carcinoma, aligning with the reference. However, it omits details about the specific antitumor activity and median PFS of 14.5 months, which are key facts in the reference answer."
        },
        {
            "query_idx": 193,
            "query": "What specific cellular components are absent in organoids used for colorectal cancer research affecting treatment evaluations, and what recent developments in organoid cultivation improve these evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1397,
                    1400,
                    1402
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Organoids from #Matrigel# miss #mesenchymal cells#, limiting #chemotherapy evaluation#. Recently, #metastatic organoids# were cultivated to enhance drug evaluation in colorectal cancer.",
            "predicted_answer": "Organoids used for colorectal cancer research lack mesenchymal cells, immune cells, and vascular support, affecting treatment evaluations. Recent developments in organoid cultivation, such as the successful culture of metastatic organoids from hepatic and peritoneal biopsies, improve drug screening and treatment evaluation possibilities.",
            "score": 3,
            "explanation": "The predicted answer mentions the absence of mesenchymal cells, aligning with the reference. It does not explicitly reference Matrigel or the chemotherapy evaluation limitation. However, it discusses metastatic organoid development, capturing the reference's essence and trend toward improving evaluations."
        },
        {
            "query_idx": 194,
            "query": "How does a particular mutation in a gene disrupt its enzymatic activity, and what molecular feature has historically complicated drug development for therapies targeting this gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    882,
                    1108
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #G12C# mutation decreases #KRAS# enzymatic activity, complicating #RAS# targeting due to #undruggability# linked to its lack of binding cavities.",
            "predicted_answer": "The G12C mutation in KRAS disrupts enzymatic activity by reducing GTPase activity, causing persistent GTP binding and continuous downstream signaling. Historically, drug development has been complicated by the lack of binding cavities on the KRAS molecular surface, making it \"undruggable.\"",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts: G12C mutation, KRAS enzymatic activity disruption, and undruggability due to lack of binding cavities. The molecular feature complicating drug development is consistently explained, aligning with the Reference Answer. No significant omissions or errors are present."
        },
        {
            "query_idx": 195,
            "query": "What comprehensive medical imaging technique involves a series of sequential steps including radionuclide production and aims to achieve high sensitivity measurements, especially when compared to MRI, to capture physiological changes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1510,
                    1546,
                    1511
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PET imaging process# involves #high sensitivity detection of annihilated photons#, enabling #low concentration measurements#, with steps including #radionuclide production leading to detailed physiological imaging#.",
            "predicted_answer": "Positron Emission Tomography (PET) involves sequential steps including radionuclide production and aims to achieve high sensitivity measurements, especially when compared to MRI, to capture physiological changes.",
            "score": 1,
            "explanation": "The predicted answer aligns well with the reference by identifying PET as the imaging technique, mentioning sequential steps and radionuclide production, and emphasizing high sensitivity. However, it omits mentions of “high sensitivity detection of annihilated photons” and “low concentration measurements,” affecting completeness. Thus, it lacks two key facts."
        },
        {
            "query_idx": 196,
            "query": "What are the observed treatment response rates and mutation types associated with HER3-DXd’s efficacy in heavily pre-treated NSCLC patients, and how do these results vary across different trial cohorts?",
            "retrieved_metrics": {
                "reference_idx": [
                    191,
                    192,
                    188
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The study shows #preliminary antitumor activity# in EGFR-driven NSCLC, efficacy across #EGFR TKI resistance# mechanisms, and #high ORR# in HER2-mutant NSCLC in the #DESTINY-Lung01 trial#.",
            "predicted_answer": "HER3-DXd showed an ORR of 25% in heavily pre-treated NSCLC patients, with efficacy observed across various EGFR TKI resistance mechanisms, including EGFR C797S mutation, MET amplification, HER2 mutation, BRAF fusion, and PIK3CA mutation.",
            "score": 1,
            "explanation": "The predicted answer mentions an ORR of 25% and specifies mutation types relevant to HER3-DXd’s efficacy, which aligns with the reference's mention of activity across EGFR TKI resistance mechanisms. However, it misses the specific mention of HER2-mutant NSCLC and the DESTINY-Lung01 trial."
        },
        {
            "query_idx": 197,
            "query": "What are the specific compounds that exhibit antitumor properties on human tumor cell lines, including one with prominent effects in a low micromolar range, and another showing inhibition across diverse cell lines?",
            "retrieved_metrics": {
                "reference_idx": [
                    1259,
                    1275,
                    1271
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compounds are #Bisindole pyrazole 21#, showing activity against human cell lines; #Compound 74#, with cytotoxicity in low micromolar range; and #Pyrazinone bisindole compound 67#, inhibiting various tumor cell lines.",
            "predicted_answer": "Bisindole pyrazole 21 and pyrazinone bisindole compound 67 exhibit antitumor properties on human tumor cell lines. Compound 74 shows prominent effects in the low micromolar range (GI$_{50}$ 0.16-1.42 µM), while compound 67 shows inhibition across diverse cell lines (GI$_{50}$ 6.6-74.8 µM).",
            "score": 5,
            "explanation": "The predicted answer accurately includes all the key details from the reference: Bisindole pyrazole 21 with antitumor activity, Compound 74 with low micromolar range effects, and Pyrazinone bisindole compound 67 showing inhibition across diverse cell lines. It fully aligns with the reference's meaning and facts."
        },
        {
            "query_idx": 198,
            "query": "How does the number of kinases encoded by the human genome relate to their significance in cancer drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1820,
                    1834
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The human genome encodes over #518 kinases#, crucial for #cancer drug development#, with challenges in #specificity of kinase inhibition# impacting drug discovery.",
            "predicted_answer": "The number of kinases encoded by the human genome, over 518, is significant in cancer drug development due to their role in dysregulation and their high success rate as drug targets.",
            "score": 3,
            "explanation": "The predicted answer mentions \"over 518 kinases\" and \"significant in cancer drug development,\" aligning with the reference. However, it omits the challenge related to the \"specificity of kinase inhibition,\" a key fact. This omission impacts completeness but does not contradict the reference."
        },
        {
            "query_idx": 199,
            "query": "How do engineered phages utilize specific targeting mechanisms and genetic modifications to enhance their role in both gene therapy and immunotherapy applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    82,
                    80,
                    70
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phage-mediated systems employ #targeting specificity# through engineered ligands, leverage #genetic engineering techniques# for functionality, and significantly impact #gene therapy# and #immunotherapy# by delivering therapeutic genes and stimulating immune responses.",
            "predicted_answer": "Engineered phages utilize specific targeting ligands on their surface to bind to target cell receptors, facilitating precise delivery. Genetic modifications enable phages to carry therapeutic agents like nucleic acids or proteins, enhancing roles in gene therapy and immunotherapy by delivering payloads directly to target cells and stimulating anti-tumor immune responses.",
            "score": 5,
            "explanation": "The predicted answer correctly describes targeting specificity through engineered ligands and genetic modifications. It covers applications in gene therapy and immunotherapy, aligning with the reference answer's key facts. Therefore, key elements are present, demonstrating full coverage."
        },
        {
            "query_idx": 200,
            "query": "How does the mechanism of SARS-CoV-2 infection relate to its impact on the thyroid gland, particularly concerning pathological conditions associated with infection?",
            "retrieved_metrics": {
                "reference_idx": [
                    2153,
                    2154
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "SARS-CoV-2's infection involves #receptor recognition# and #membrane fusion#, impacting the thyroid by #causing thyroid diseases# and triggering a #cytokine storm#.",
            "predicted_answer": "SARS-CoV-2 infection can impact the thyroid gland by infecting it and altering the pituitary-thyroid axis, leading to pathological conditions like subacute thyroiditis, Hashimoto's thyroiditis, and thyrotoxicosis. The virus may also induce an inflammatory response and cytokine storm, affecting thyroid function and exacerbating conditions in patients with thyroid cancer.",
            "score": 1,
            "explanation": "The Predicted Answer covers the cytokine storm and thyroid diseases, aligned with the Reference. However, it lacks mention of receptor recognition and membrane fusion, which are key mechanisms of infection. While aligned in some aspects, it misses these critical details."
        },
        {
            "query_idx": 201,
            "query": "What legislative act incentivizes drug development for ultra-rare diseases and permits approvals based on specific types of clinical trials that could potentially lead to inaccurate efficacy assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1058,
                    1071,
                    1079
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Orphan Drug Act of 1983# encourages drug development for #ultra-rare diseases# by permitting approvals through #small, non-randomized trials#, potentially affecting the #accuracy of efficacy outcomes#.",
            "predicted_answer": "The Orphan Drug Act of 1983 incentivizes drug development for ultra-rare diseases but permits approvals based on small, non-robust trials that could overestimate efficacy outcomes.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key facts from the Reference Answer: \"Orphan Drug Act of 1983,\" \"ultra-rare diseases,\" and \"small trials potentially affecting efficacy.\" However, it misses the specific detail of \"non-randomized\" trials. Thus, it impacts the completeness of the answer."
        },
        {
            "query_idx": 202,
            "query": "Which compounds exhibit varying levels of antitumor activity across different cancer cell lines, requiring comparisons from multiple studies to determine effective inhibitory concentrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1887,
                    1893,
                    1880
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Selenazole 46# is active against melanoma, breast, and liver cancer cells. #Diselenide 32# targets breast cancer cells. #Derivative 22# affects breast, colon, leukemia, hepatocarcinoma, and prostate cancer cells.",
            "predicted_answer": "Compounds 45, 46, 47, 32, 22, and 23 exhibit varying levels of antitumor activity across different cancer cell lines, requiring comparisons from multiple studies to determine effective inhibitory concentrations.",
            "score": 1,
            "explanation": "The 'Predicted Answer' includes some compounds from the 'Reference Answer'. It lists Compound 46 (Selenazole), 32 (Diselenide), and 22, covering their presence. However, it does not specify their activity against particular cancer cell types, and it includes compounds not mentioned. Thus, it is incomplete."
        },
        {
            "query_idx": 203,
            "query": "How were early-stage transcriptome datasets and subsequent analytical tools utilized to uncover multi-target properties of plant-derived compounds against cervical cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1694,
                    1695
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ArrayExpress database# provided cervical cancer datasets, leading to the creation of #compound target networks (CTNs)# that demonstrate the multi-target properties of plant-derived compounds.",
            "predicted_answer": "Early-stage transcriptome datasets from cervical cancer patients were retrieved from the ArrayExpress database and analyzed using Network Analyst 3.0 to identify immune-related genes. Compound target networks (CTNs) were then constructed using Cytoscape to uncover the multi-target properties of plant-derived compounds against cervical cancer.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts from the Reference Answer, including using the #ArrayExpress database# and constructing #compound target networks (CTNs)# to study the multi-target properties of plant-derived compounds against cervical cancer. The overall information aligns well with the Reference Answer."
        },
        {
            "query_idx": 204,
            "query": "What are the key technological methods that combine to enhance cancer study models by incorporating substrate material analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2019,
                    2082
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #artificial intelligence# with #3D models# enhances the study of cancer by precisely analyzing substrate materials to predict cellular behavior and tumor progression.",
            "predicted_answer": "The key technological methods that enhance cancer study models by incorporating substrate material analysis include artificial intelligence for predicting cellular behavior based on chemical composition, geometry, and mechanical performance of substrate materials.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the use of artificial intelligence and analyzing substrate materials, aligning with two key aspects of the Reference Answer. However, it omits the crucial aspect of using \"3D models,\" affecting the completeness of the answer. No contradictory information is present."
        },
        {
            "query_idx": 205,
            "query": "How does AI contribute to advancements in cancer drug development through innovative algorithmic approaches, including predictive modeling, therapeutic identification, and rational drug design?",
            "retrieved_metrics": {
                "reference_idx": [
                    162,
                    1218,
                    1243
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI contributes to cancer drug development by creating #interpretable models#, supporting #predictive modeling and therapeutic identification#, and enabling #drug repurposing and combination strategies# for enhanced efficacy.",
            "predicted_answer": "AI contributes to cancer drug development through predictive modeling, therapeutic identification, and rational drug design by simulating drug responses, predicting drug-target interactions, identifying druggable vulnerabilities, and optimizing molecular modeling for new drug candidates.",
            "score": 1,
            "explanation": "The predicted answer aligns with the general trend of the reference answer by mentioning predictive modeling and therapeutic identification. However, it misses key elements such as interpretable models and drug repurposing and combination strategies, which affects completeness."
        },
        {
            "query_idx": 206,
            "query": "How do signaling pathways and receptor interactions contribute to the effectiveness of a targeted drug in altering progression-free survival in medullary and differentiated thyroid cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    2161,
                    2162
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #VEGF# and #VEGFR# pathways in thyroid cancer are targeted by #vandetanib#, which inhibits #tyrosine kinase# receptors, thus enhancing #PFS# in both MTC and DTC.",
            "predicted_answer": "Signaling pathways and receptor interactions, such as those involving VEGF, VEGFR, RET, BRAF, and RAS, play crucial roles in thyroid cancers. Targeted drugs like MKIs inhibit these pathways, reducing angiogenesis and tumor growth, thereby prolonging progression-free survival (PFS) in medullary and differentiated thyroid cancers.",
            "score": 3,
            "explanation": "The predicted answer includes VEGF and VEGFR pathways and targets them with MKIs, aligning with the trend of targeting these pathways to affect PFS. However, it lacks specific mention of vandetanib and tyrosine kinase, key facts highlighted in the reference answer, affecting completeness."
        },
        {
            "query_idx": 207,
            "query": "How does artificial intelligence assist in the transformation of cancer treatment through the interpretation of genetic data and the linkage of molecular alterations to therapy responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    116,
                    1216,
                    120
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #AI# in genomic profiling enables the #linkage of molecular alterations to treatment responses#, signifying a #transformation in cancer treatment#.",
            "predicted_answer": "Artificial intelligence assists in cancer treatment by analyzing extensive genomic data to identify genetic mutations, link molecular alterations to therapy responses, and recommend tailored treatments, enhancing precision oncology.",
            "score": 5,
            "explanation": "The predicted answer reflects the key facts from the reference: AI's role in linking molecular alterations to therapy responses and its transformative impact on cancer treatment. The emphasis on precision oncology aligns with transformation. All crucial points are covered without contradiction or omissions."
        },
        {
            "query_idx": 208,
            "query": "What genetic interaction is confirmed through a method focused on specific validation techniques and involves genes that are not often altered?",
            "retrieved_metrics": {
                "reference_idx": [
                    1940,
                    1947,
                    1948
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The interaction between #MAP2K1 (MEK1) and MAP2K2 (MEK2)# is confirmed using #low-throughput validation# and is associated with #rarely mutated genes#.",
            "predicted_answer": "The genetic interaction confirmed through a method focused on specific validation techniques and involving genes that are not often altered is **synthetic lethality**. This interaction is identified using combinatorial gene perturbation systems, which allow the interrogation of any gene pair in any cellular context, including rarely mutated genes.",
            "score": 1,
            "explanation": "The predicted answer mentions \"synthetic lethality\" and \"rarely mutated genes\" through \"combinatorial gene perturbation systems,\" but misses the specific interaction details between #MAP2K1 and MAP2K2# and the use of #low-throughput validation#. Thus, two key facts are missing, impacting completeness."
        },
        {
            "query_idx": 209,
            "query": "What are the specific metrics used to evaluate the effectiveness of Selenocystine, MeSeCys, and Selenomethionine against multiple types of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1870,
                    1871,
                    1872
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The cytotoxic #IC$\\_{50}$ values# are 3.6-34.5 µM for #SeCys#, 54-632.8 µM for #MeSeCys#, and 40-130 µM for #SeMet#, measured across different cancer cell lines.",
            "predicted_answer": "The specific metrics used to evaluate the effectiveness of Selenocystine, MeSeCys, and Selenomethionine against multiple types of cancer cells are IC$_{50}$ values, which indicate the concentration required to inhibit 50% of cell growth.",
            "score": 1,
            "explanation": "The predicted answer includes the key concept of IC$_{50}$ values but omits the specific effective concentration ranges for SeCys, MeSeCys, and SeMet provided in the reference answer. This missing detail affects the completeness of the answer."
        },
        {
            "query_idx": 210,
            "query": "What effects arise in glioblastoma cells when passenger genes, which have a genetic duplication partner, experience recurrent deletions, and how can these deletions assist in identifying broader cancer cell vulnerabilities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1938,
                    1937
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The deletion of #ENO1# in glioblastoma makes cells vulnerable to #ENO2# inhibition, highlighting how passenger gene deletions with paralogs can reveal #potential cancer vulnerabilities#.",
            "predicted_answer": "Recurrent deletions of passenger genes with genetic duplication partners in glioblastoma cells can expose synthetic lethality vulnerabilities, such as the interaction between ENO1 and ENO2. These deletions help identify broader cancer cell vulnerabilities by revealing synthetic lethal interactions involving tumour suppressors, passenger genes, and genes of unknown status.",
            "score": 5,
            "explanation": "The Predicted Answer captures the interaction between ENO1 and ENO2, aligning with the Reference Answer. It includes the idea of revealing cancer vulnerabilities through these deletions and provides additional context on synthetic lethality. Although phrased differently, it covers all key facts without contradictions or significant omissions."
        },
        {
            "query_idx": 211,
            "query": "How do models derived from specific cell types replicate cellular architectures and how do these properties contribute to accurately representing therapy responses compared to traditional two-dimensional methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    1442,
                    1443,
                    1445
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Models derived from #stem cells# possess a #three-dimensional# structure, enhancing therapy modeling accuracy, while #in vitro# methods lack real-world response observation.",
            "predicted_answer": "Organoid models replicate cellular architectures through self-renewal and differentiation of stem cells, forming 3D structures that better represent tissue morphology. This 3D structure enhances the accuracy of therapy response representation compared to 2D methods by mimicking native cellular interplay and environmental factors like hypoxia and stromal signaling.",
            "score": 5,
            "explanation": "The predicted answer includes key points about models derived from stem cells and their three-dimensional structure, mirroring the reference's emphasis. Both acknowledge enhanced therapy modeling accuracy and limitations of traditional methods. All essential information from the reference is present and consistent in the predicted answer."
        },
        {
            "query_idx": 212,
            "query": "What are the specific average Root Mean Square Fluctuation (RMSF) values for Caspase-3 complexes with Compound (8b) and doxorubicin, highlighting the difference in residues' stability?",
            "retrieved_metrics": {
                "reference_idx": [
                    253,
                    254
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #RMSF for Caspase-3-doxorubicin# is #2.4 Å#, while #Caspase-3-Compound (8b)# is #2.3 Å#. Both values suggest #comparable residue stability#.",
            "predicted_answer": "The average RMSF values for Caspase-3 complexes with Compound (8b) and doxorubicin are 2.3 Å and 2.4 Å, respectively. Residues in the range of 100-200 showed stability with both compounds.",
            "score": 5,
            "explanation": "The predicted answer includes the highlighted RMSF values of 2.3 Å for Caspase-3-Compound (8b) and 2.4 Å for Caspase-3-doxorubicin, consistent with the reference. The mention of comparable stability aligns with the reference's implication of similar residue stability. Therefore, it fully covers key facts."
        },
        {
            "query_idx": 213,
            "query": "What is the mechanism involving small-molecule inhibitors and degrader technologies that exploit the genetic relationship between SMARCA2 and SMARCA4 for therapeutic development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1956,
                    1958,
                    1931
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The mechanism involves targeting the #ATPase domain of SMARCA2# using #PROTACs# to utilize #synthetic lethal interactions# with SMARCA4 in therapeutic strategies.",
            "predicted_answer": "The mechanism involves using small-molecule inhibitors targeting the ATPase domain of SMARCA2/4 and PROTACs for protein degradation, exploiting their synthetic lethal relationship to develop therapeutics.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts such as targeting the ATPase domain and using PROTACs, and it mentions the synthetic lethal relationship. It aligns well with the reference answer, with no significant omissions or contradictions in meaning or facts."
        },
        {
            "query_idx": 214,
            "query": "What factors hinder the broader adoption of 3D in vitro cancer models in predicting drug efficacy compared to traditional 2D models, and how do new models improve preclinical testing in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1807,
                    2032,
                    2269
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The challenges for #3D in vitro cancer models# include accurately reflecting tumor growth. #2D models# fail to replicate tumor structure. #Emerging 3D models# better mimic in vivo drug resistance.",
            "predicted_answer": "Factors hindering broader adoption of 3D in vitro cancer models include biased efficacy metrics and limited qualitative comparisons. New models, like 3D tumor organoids, improve preclinical testing by better mimicking in vivo drug resistance mechanisms compared to traditional 2D models.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies that 3D in vitro cancer models mimic in vivo drug resistance better than 2D models, aligning with the trend in the reference. However, it misses details about \"accurately reflecting tumor growth\" and how \"2D models fail to replicate tumor structure,\" impacting completeness."
        },
        {
            "query_idx": 215,
            "query": "Modify the multi-hop query:  \nWhat methods or strategies should be applied to improve the effectiveness of drug repurposing for multifactorial disorders targeting various biological mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    825,
                    2244,
                    1832
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "To improve drug repurposing effectiveness for multifactorial disorders, apply systematic screening, validate in vitro and in vivo, and use combination therapies targeting multiple biological mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference, including systematic screening, validation (both in vitro and in vivo), and addressing multiple biological mechanisms through combination therapies. The main strategies are consistent and complete with no significant omissions."
        },
        {
            "query_idx": 216,
            "query": "How do phages interact with the host immune system to combat intracellular bacteria, and what processes do they use to affect immune responses and target bacteria within cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    13,
                    38,
                    57
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phages employ #phage proteins# to interact with #immune cells#, enabling them to #penetrate host cells# and modulate the #innate immune-signaling pathway# to address intracellular bacterial infections.",
            "predicted_answer": "Phages interact with the host immune system by modulating immune responses, enhancing bacterial clearance, and targeting intracellular bacteria through penetration and lysis. They influence immune cells and signaling pathways, triggering pro-inflammatory cytokines and Type I interferons.",
            "score": 3,
            "explanation": "The predicted answer mentions phages modulating immune responses and targeting intracellular bacteria, aligning with the reference's emphasis on phage interaction with immune cells and penetration. However, missing details include \"phage proteins\" and \"innate immune-signaling pathway,\" affecting completeness. No contradictory info is present."
        },
        {
            "query_idx": 217,
            "query": "What screening technique is suitable for general HPV detection using similar sample collection methods, and offers different sensitivity rates compared to HPV genotyping, specifically in noninvasive cervical cancer screening?",
            "retrieved_metrics": {
                "reference_idx": [
                    493,
                    494,
                    490
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#DNA methylation# tests use similar sampling methods, offer #1.22 relative sensitivity# for ≥ CIN2 detection, and serve as a #noninvasive# option in cervical cancer screening.",
            "predicted_answer": "DNA methylation assays are suitable for general HPV detection using similar sample collection methods and offer different sensitivity rates compared to HPV genotyping in noninvasive cervical cancer screening.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions \"DNA methylation\" and notes differing sensitivity rates, aligning with the reference's mention of \"1.22 relative sensitivity.\" However, it omits the specific sensitivity rate value \"1.22\" and does not highlight \"noninvasive,\" both are key points."
        },
        {
            "query_idx": 218,
            "query": "What is the average number of somatic mutations in pancreatic tumors, and what therapeutic challenges arise from their genetic diversity, including the roles of KRAS, TP53, CDKN2A, and SMAD4 mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    393,
                    412,
                    394
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Pancreatic tumors average #50-65 somatic mutations#, creating a #continuously moving target# due to genetic diversity. Treatment is challenging because of #four characteristic oncogenic driver mutations# like KRAS and TP53.",
            "predicted_answer": "The average number of somatic mutations in pancreatic tumors is 50-65. Therapeutic challenges arise from genetic diversity, including roles of KRAS, TP53, CDKN2A, and SMAD4 mutations, which contribute to tumor adaptability and resistance to targeted therapies.",
            "score": 3,
            "explanation": "The predicted answer accurately includes the average of 50-65 somatic mutations and mentions the role of KRAS, TP53, CDKN2A, and SMAD4 in therapeutic challenges. However, it lacks the reference's emphasis on \"continuously moving target\" and \"four characteristic oncogenic driver mutations,\" impacting completeness."
        },
        {
            "query_idx": 219,
            "query": "What is the target molecule involved in cancer therapy that is selectively expressed in tumor cells, with a method for targeted delivery using therapeutic agents, and plays a significant role in cell metabolic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1354,
                    1384,
                    1373
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The molecule #B7-H3# is crucial for cancer therapy, utilizing #radionuclides# for precise targeting in tumors, significantly influencing #energy metabolism# within cancer cells.",
            "predicted_answer": "The target molecule involved in cancer therapy is B7-H3, which is selectively expressed in tumor cells and plays a significant role in cell metabolic processes. It can be targeted for delivery of therapeutic agents, minimizing harm to healthy cells.",
            "score": 3,
            "explanation": "The 'Predicted Answer' correctly mentions B7-H3, its expression in tumor cells, and its role in cell metabolism. However, it lacks the detail of using \"radionuclides\" for targeted delivery, which affects completeness regarding the method of targeting."
        },
        {
            "query_idx": 220,
            "query": "What substances impact MCF-7 spheroid growth, what receptor is involved, and how do variations in time and concentration affect their efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    347,
                    346,
                    356
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The substances #G15# and #G-1# target #GPER#, inhibiting MCF-7 spheroid growth, with #G-1#'s effects varying based on the exposure duration and concentration.",
            "predicted_answer": "G15, an antagonist of GPER, significantly inhibits MCF-7 spheroid growth. GPER is critical for this growth. G-1 also inhibits growth in a time- and concentration-dependent manner. Variations in time and concentration affect efficacy, with higher concentrations and longer treatment times generally more effective.",
            "score": 5,
            "explanation": "The key facts emphasized in the reference answer (#G15#, #G-1#, #GPER#) are present in the predicted answer, indicating alignment with the overall trend. It accurately describes the role of G15 and G-1, their target GPER, and the importance of time and concentration on efficacy."
        },
        {
            "query_idx": 221,
            "query": "What are the inherent limitations of using AAV vectors in gene therapy and the associated biological challenges that need addressing?",
            "retrieved_metrics": {
                "reference_idx": [
                    438,
                    973,
                    440
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Gene therapy with AAV vectors faces #transgene size# limitations, #packaging capacity# challenges, and #immunogenicity# concerns, particularly in #rAAV-mediated therapies#.",
            "predicted_answer": "The inherent limitations of using AAV vectors in gene therapy include: 1) limited packaging capacity (4.7 kb), restricting transgene size; 2) organotropism and variable uptake; 3) potential immunogenicity towards the vector and transgene product. These challenges necessitate transgene engineering and alternative CRISPR constructs for efficient delivery.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers the key facts emphasized in the 'Reference Answer': transgene size limitations, packaging capacity challenges, and immunogenicity concerns. While phrasing diverges, it remains consistent and captures the overall trend without introducing contradictions."
        },
        {
            "query_idx": 222,
            "query": "How does a specific prebiotic influence gut microbiota to prevent specific cancer metastasis, enhance immune response, and interact with epigenetic proteins to potentially inhibit breast cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    817,
                    819,
                    818
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Inulin# affects #gut microbiota# to prevent #CRC liver metastasis#, boosts #immune response#, and modulates #epigenetic proteins#, potentially inhibiting #breast cancer progression# through these #mechanisms#.",
            "predicted_answer": "Inulin influences gut microbiota to prevent cancer metastasis by modulating the microbiome, enhancing immune response through intestinal immune cell augmentation, and inhibits breast cancer progression by decreasing epigenetic regulatory proteins like HDAC2 and HDAC8, thereby curbing tumor growth.",
            "score": 3,
            "explanation": "The Predicted Answer aligns with most aspects of the Reference Answer. It identifies inulin’s impact on gut microbiota, the immune response, and breast cancer progression and mentions modulation of epigenetic proteins. However, it lacks specificity in cancer type, missing the \"CRC liver metastasis\" detail."
        },
        {
            "query_idx": 223,
            "query": "Which genome-editing technique is used to increase cancer treatment effectiveness by editing genes linked to immune checkpoints and efficiently discovering cancer-related genetic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    2104,
                    2120,
                    2089
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #CRISPR-Cas# method boosts treatment by enhancing #immunotherapy#, editing #immune checkpoint# genes, and efficiently finding #cancer-related genes#.",
            "predicted_answer": "CRISPR-Cas-mediated genome editing is used to increase cancer treatment effectiveness by editing genes linked to immune checkpoints and efficiently discovering cancer-related genetic targets.",
            "score": 3,
            "explanation": "The predicted answer accurately mentions the use of CRISPR-Cas for genome editing related to immune checkpoints and cancer genetics. However, the reference highlights its role in boosting immunotherapy, which is not explicitly mentioned in the predicted answer. This omission affects completeness slightly."
        },
        {
            "query_idx": 224,
            "query": "Modify the multi-hop query\nHow does the interaction of repetitive RNA with CDK13 in the PNC affect its role in the cell cycle and RNA surveillance, leading to aggressive melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    2013,
                    2012,
                    2014
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "The interaction of repetitive RNA with CDK13 in the PNC sequesters CDK13 from its normal functions in cell cycle regulation and RNA surveillance, promoting carcinogenesis and leading to more aggressive melanoma.",
            "score": 5,
            "explanation": "The predicted answer accurately notes that repetitive RNA interacts with CDK13, impacting cell cycle regulation and RNA surveillance, thereby promoting carcinogenesis and more aggressive melanoma. It does not contradict and aligns well with the overall trend of the reference, covering key aspects outlined with #."
        },
        {
            "query_idx": 225,
            "query": "What approach is suggested to improve resource distribution and tackle challenges inhibiting participation in early-phase cancer drug development trials in specific low and middle-income countries?",
            "retrieved_metrics": {
                "reference_idx": [
                    740,
                    750,
                    753
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Implementing a #tier-based system# efficiently allocates resources to overcome #barriers#, significantly enhancing #participation# from LMICs in early-phase cancer drug trials.",
            "predicted_answer": "A suggested approach to improve resource distribution and tackle challenges in early-phase cancer drug development trials in low and middle-income countries (LMICs) includes implementing a tier-based system for equitable resource distribution, mentoring by established centers, and fostering global partnerships.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of a \"tier-based system\" for resource allocation and improving participation in LMICs, which aligns with the reference answer's emphasis on these aspects. Although \"barriers\" aren't explicitly mentioned, \"challenges\" is a close equivalent, maintaining overall trend alignment."
        },
        {
            "query_idx": 226,
            "query": "How do shifts in the design and preparation of tumor drugs, alongside the introduction of diverse treatment modalities, illustrate changes in contemporary cancer treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    867,
                    873,
                    875
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Shifts are marked by the #transformation in treatment strategies#, moving from #small molecules to large molecules#, and introducing a #diverse array of innovative therapies# in cancer treatment.",
            "predicted_answer": "Shifts in tumor drug design, from small to large molecules, and the introduction of diverse treatment modalities like ADCs, cell therapies, and gene therapy, reflect a move towards more targeted and personalized cancer treatments.",
            "score": 5,
            "explanation": "The Predicted Answer captures all the key points from the Reference Answer: the shift from small to large molecules, the transformation in treatment strategies, and the introduction of diverse therapies, such as ADCs, cell, and gene therapy. Thus, it fully aligns with the intended meaning."
        },
        {
            "query_idx": 227,
            "query": "How do the first and second generations of CAR-M differ in their components and resulting impact on macrophage polarization and pro-inflammatory responses in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    940,
                    949
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first-generation CAR-M uses #TIR# for M1 polarization. Second-generation CAR-M adds #CD3 ζ#, enhancing #pro-inflammatory responses# and sustaining M1 activation.",
            "predicted_answer": "The first-generation CAR-M uses TIR to enhance M1 polarization, while the second-generation includes both TIR and CD3 ζ, leading to stronger pro-inflammatory responses and extended M1 activation in cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions the use of TIR for M1 polarization in the first generation and includes the addition of CD3 ζ in the second generation, which leads to enhanced pro-inflammatory responses and sustained M1 activation. All key facts from the reference are present."
        },
        {
            "query_idx": 228,
            "query": "Compare the unique strategies and performance outcomes in tests designed to detect early stage HCC, including those using genetic targets, methylation biomarkers, and a combination of methylation and protein markers.",
            "retrieved_metrics": {
                "reference_idx": [
                    501,
                    503,
                    499
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #epiLiver# test detects early stage A HCC with sensitivity at #84.5%# and specificity at #95%#. The #HCCBloodTest# uses #SEPT9 methylation#, with a sensitivity of #76.70%# and specificity of #64.10%#. The #HelioLiver# combines #methylation and protein markers#, achieving a sensitivity of #76%# and specificity of #91%#.",
            "predicted_answer": "The epiLiver test uses methylation of VASH2, CHFR, GRID2IP, CCNJ, and F12 genes, achieving 84.5% sensitivity and 95% specificity for early HCC. The HCCBloodTest with SEPT9 methylation has 76.70% sensitivity and 64.10% specificity. The HelioLiver test combines methylation and protein markers for 76% sensitivity and 91% specificity in early HCC.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: the epiLiver test's methylation genes, sensitivity, and specificity; the HCCBloodTest's SEPT9 methylation, sensitivity, and specificity; and the HelioLiver test's combined markers, sensitivity, and specificity. No key details are missing, and no contradictions are present."
        },
        {
            "query_idx": 229,
            "query": "How do survival rates differ between two advanced treatment modalities for a specific cancer, as shown in large-scale cohort studies conducted in two different countries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1005,
                    1007
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Cohort studies show #proton therapy# achieves better five-year survival in Germany (91% vs. 98%) than #carbon-ion therapy#, while Japan reports higher efficacy for carbon-ion therapy #across risk groups#.",
            "predicted_answer": "Survival rates for carbon-ion therapy in Japan showed better efficacy with 5-year overall survival rates of 100%, 99%, and 96% for low, intermediate, and high-risk prostate cancer patients, respectively. In contrast, German studies indicated lower effectiveness and worse survival compared to proton therapy, with 5-year overall survival rates of 91% and progression-free survival rates of 50%.",
            "score": 0,
            "explanation": "The predicted answer contradicts the reference by stating carbon-ion therapy has better survival rates in Japan compared to proton therapy, while the reference states proton therapy has better outcomes in German studies. This contradiction affects the alignment and accuracy of the information."
        },
        {
            "query_idx": 230,
            "query": "What are the prerequisites and potential difficulties in advancing combination therapy of repurposed drugs to specific phases of clinical trials, considering the role of preliminary investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2258,
                    2259,
                    2267
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The lack of #thorough preclinical investigations# in repurposing drugs increases the #cost and complexity# of trials, hindering progression to #phase II or III for approval#.",
            "predicted_answer": "Prerequisites for advancing combination therapy of repurposed drugs to clinical trials include comprehensive preclinical investigations on efficacy, safety, dosages, and synergistic effects. Potential difficulties involve coordinating dosing, timing, and interactions, as well as determining optimal combinations and addressing cost and complexity.",
            "score": 3,
            "explanation": "The predicted answer mentions the need for comprehensive preclinical investigations, aligning with the reference's emphasis on \"thorough preclinical investigations.\" It also addresses challenges of cost and complexity. However, it does not specifically mention progressing to \"phase II or III for approval,\" which is a key fact in the reference."
        },
        {
            "query_idx": 231,
            "query": "Which initiative focuses on transforming dose optimization in oncology drug development, was highlighted at the 2022 symposium, and utilizes specific methods to address complex challenges associated with this process?",
            "retrieved_metrics": {
                "reference_idx": [
                    694,
                    1584,
                    1583
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Project Optimus# enhances dose optimization in oncology, highlighted at the #2022 ACoP symposium#, addressing complex challenges using #quantitative modeling# techniques for improved patient outcomes.",
            "predicted_answer": "Project Optimus, highlighted at the 2022 ACoP Annual Meeting, focuses on transforming dose optimization in oncology drug development using model-informed methods to address complex challenges.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: \"Project Optimus,\" \"2022 ACoP,\" and \"dose optimization\" in oncology, using \"model-informed\" methods. However, it misses the emphasis on \"quantitative modeling\" for \"improved patient outcomes.\" This omission affects the completeness of the answer."
        },
        {
            "query_idx": 232,
            "query": "What medications received FDA approval in 2020 and 2022 for post-remission therapy, a rare pediatric leukemia, and a specific chromosomal syndrome?",
            "retrieved_metrics": {
                "reference_idx": [
                    544,
                    547,
                    542
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The FDA approved #azacitidine tablets# for #AML# in 2020, #azacitidine# for pediatric #juvenile myelomonocytic leukemia# in 2022, and a #decitabine and cedazuridine combination# for #MDS#.",
            "predicted_answer": "In 2020, azacitidine tablets (ONUREG) received FDA approval for post-remission therapy in AML. In 2022, azacitidine (Vidaza) was approved for pediatric patients with newly diagnosed juvenile myelomonocytic leukemia.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies azacitidine tablets for AML in 2020 and azacitidine for juvenile myelomonocytic leukemia in 2022. However, it omits the key fact about the 2022 approval of a decitabine and cedazuridine combination for MDS, impacting completeness."
        },
        {
            "query_idx": 233,
            "query": "How do genetic variations in metabolism and transporters potentially alter the effectiveness of TKIs used in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    722,
                    723
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Genetic variations, such as #pharmacogenetic variation#, affect TKI response. Specific #pharmacogenes# involved include CYP3A4/5, OCT1, ABCB1, and ABCG2.",
            "predicted_answer": "Genetic variations in metabolism (e.g., CYP enzymes) and transporters (e.g., p-glycoprotein) can alter TKI drug exposure and response, potentially affecting their effectiveness in cancer treatment.",
            "score": 1,
            "explanation": "The predicted answer mentions genetic variations in metabolism and transporters affecting TKI effectiveness, which aligns with the reference answer. However, it omits the specific mention of “pharmacogenetic variation” and does not identify specific “pharmacogenes” like CYP3A4/5, OCT1, ABCB1, and ABCG2, impacting completeness."
        },
        {
            "query_idx": 234,
            "query": "What must be used to stabilize urine samples for ctDNA analysis, which registered assay employs a particular genetic alteration in stool DNA for CRC detection, and how many trials assess these DNA methylation biomarkers?",
            "retrieved_metrics": {
                "reference_idx": [
                    480,
                    484,
                    534
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Preservatives# are crucial for stabilizing urine cfDNA in ctDNA analysis. #Cologuard# uses stool DNA for CRC detection. #67 trials# examine DNA methylation biomarkers for advancing clinical epigenetics.",
            "predicted_answer": "Preservatives stabilize urine samples for ctDNA analysis. Cologuard employs a genetic alteration in stool DNA for CRC detection. 100 trials assess DNA methylation biomarkers.",
            "score": 3,
            "explanation": "The predicted answer mentions \"preservatives,\" \"Cologuard,\" and \"100 trials,\" which generally align with the reference answer's key points: \"Preservatives,\" \"Cologuard,\" and \"67 trials.\" However, it incorrectly states \"100 trials\" instead of \"67 trials,\" missing one key fact affecting completeness."
        },
        {
            "query_idx": 235,
            "query": "How does a compound's binding preference and evaluation method relate to its selective antitumor effects in a KRAS G12D mutated model?",
            "retrieved_metrics": {
                "reference_idx": [
                    1120,
                    1136,
                    1130
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The selective antitumor effect targets #KRAS G12D# mutation, utilizing #MRTX1133# binding to the GDP-bound form, with antiproliferative efficacy assessed by the #MTT assay#.",
            "predicted_answer": "A compound's binding preference to KRAS G12D and its evaluation via MTT assay influence its selective antitumor effects by targeting the mutated form more effectively than wild-type KRAS, enhancing specificity and efficacy in the KRAS G12D mutated model.",
            "score": 3,
            "explanation": "The predicted answer mentions targeting KRAS G12D mutation and assessment via MTT assay, which aligns with the reference. However, it omits the specific compound \"MRTX1133\" and its binding to the GDP-bound form, affecting completeness."
        },
        {
            "query_idx": 236,
            "query": "Which biological process allows cancer cells to detach and circulate, and what specific environmental and genetic factors associated with a tumor environment enhance this process and increase metastatic potential?",
            "retrieved_metrics": {
                "reference_idx": [
                    396,
                    397
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#EMT# enables cancer cell detachment and circulation. Increased #metastatic potential# is driven by genetic alterations and selection pressures within a #pro-tumorigenic TME#.",
            "predicted_answer": "The biological process allowing cancer cells to detach and circulate is epithelial-mesenchymal transition (EMT). Specific environmental factors like the pro-tumorigenic tumor microenvironment (TME) and genetic factors such as TP53 and SMAD4 mutations enhance this process, increasing metastatic potential.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies EMT as the process allowing cancer cells to detach and circulate, aligns with the Reference Answer on increased metastatic potential, mentions genetic factors (TP53, SMAD4 mutations), and describes the pro-tumorigenic TME. It covers all key facts and trends without significant omissions."
        },
        {
            "query_idx": 237,
            "query": "Which specific genetic alterations in oncolytic viruses contribute to selective tumor targeting and controlled replication, considering enhanced tumor specificity and functional mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    994,
                    993
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Genetic changes like a #TK gene# deficiency improve tumor specificity, and an #E2F-responsive element# insertion regulates replication in tumors with RB1 gene dysfunction.",
            "predicted_answer": "The specific genetic alterations in oncolytic viruses, such as JX-594's deficiency in thymidine kinase (TK) and VCN-01's insertion of an E2F-responsive element, enhance tumor specificity and controlled replication by targeting tumors with elevated TK or E2F abundance, respectively.",
            "score": 5,
            "explanation": "The predicted answer includes both the key genetic alterations: TK gene deficiency and E2F-responsive element insertion, aligning with the reference answer. The explanation of how these alterations contribute to tumor specificity and controlled replication is adequately covered, with no significant omissions or contradictions."
        },
        {
            "query_idx": 238,
            "query": "How do the outcomes of cord blood-derived CAR-NK therapy for B-cell malignancies compare to dual-targeting CD19xCD22 CAR-T therapy, specifically for relapsed B-cell acute lymphoblastic leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    929,
                    941,
                    930
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #cord blood-derived CAR CD19-NK# therapy for B-cell malignancies showed a promising 48.6% response rate, whereas dual-targeting #SCRI-CAR19x22# in relapsed B-ALL achieved an #84.6% complete response rate#.",
            "predicted_answer": "Cord blood-derived CAR-NK therapy for relapsed B-cell acute lymphoblastic leukemia (B-ALL) showed an ORR of 48.6%, 1-year OS of 68%, and 1-year PFS of 32%. In contrast, dual-targeting CD19xCD22 CAR-T therapy achieved a CR rate of 84.6% with 95% MRD- in B-ALL patients.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: the response rate for cord blood-derived CAR-NK therapy (48.6%) and complete response rate for SCRI-CAR19x22 (84.6%). However, it doesn’t specify the full therapy names as does the reference, which could impact clarity slightly but doesn't contradict or miss critical data."
        },
        {
            "query_idx": 239,
            "query": "Which combination of theoretical concepts and modeling techniques supports understanding how the evolving nature of cancer complicates therapy development in light of continuous genetic variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1637,
                    1639,
                    1588
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #tumor evolutionary theory# with PK/PD models helps address challenges posed by #genetic mutations# and the drug efficacy impact due to #tumor evolution#.",
            "predicted_answer": "The combination of tumor evolutionary theory and PK/PD modeling techniques supports understanding how cancer's continuous genetic variations complicate therapy development, guiding dose selection for durable responses.",
            "score": 1,
            "explanation": "The predicted answer captures the integration of tumor evolutionary theory and PK/PD models. However, it misses explicit mention of genetic mutations and tumor evolution's impact on drug efficacy, two emphasized key facts in the reference. Thus, it shows alignment but lacks completeness."
        },
        {
            "query_idx": 240,
            "query": "What specific type of cell culture model shows increased resistance due to drug penetration limitations, and how does this model's predictive accuracy compare to traditional cell cultures when assessing animal model responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1763,
                    1766
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #MGH-U1 spheroids# show increased resistance due to #limited drug penetration#, and #spheroid models# more accurately predict #in vivo chemosensitivity# compared to traditional 2D cultures.",
            "predicted_answer": "Spheroid cell culture models show increased resistance due to drug penetration limitations. These models, like MGH-U1 spheroids, more accurately predict animal model responses compared to traditional 2D cell cultures, as evidenced by their closer alignment with xenograft outcomes.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: the spheroid cell culture models and their increased resistance due to drug penetration limitations. It also notes the improved predictive accuracy compared to traditional cell cultures. All emphasized points in the reference are covered, ensuring alignment in meaning."
        },
        {
            "query_idx": 241,
            "query": "What therapeutic process involves genetically modified cells used in tumor treatments that release active substances and use a receptor essential for targeting tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    924,
                    927,
                    939
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The therapeutic process #CAR# involves genetically engineered cells releasing #cytotoxic effector molecules# and utilizing the essential receptor #CD16# for targeting tumors.",
            "predicted_answer": "CAR-T therapy involves genetically modified T cells that target tumor cells using a chimeric antigen receptor (CAR), leading to the release of cytotoxic substances and recruitment of immune cells for tumor elimination.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies the therapy as CAR-T but misses the key facts of the receptor CD16 and the emphasis on cytotoxic effector molecules. While the overall trend of targeting tumors is aligned, these omissions impact completeness."
        },
        {
            "query_idx": 242,
            "query": "How does sequential sampling through liquid biopsy contribute to the identification of DNA methylation biomarkers, and what is its relevance to the commercial availability of epigenetic treatments in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    479,
                    491,
                    457
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Sequential sampling in #liquid biopsy# aids in monitoring #minimal residual disease#, involves #clinical trials# for DNA methylation biomarkers, and is relevant to #epigenetic biomarkers# and #epigenetic drugs# in oncology.",
            "predicted_answer": "Sequential sampling through liquid biopsy enhances the identification of DNA methylation biomarkers by enabling continuous monitoring of minimal residual disease (MRD) and tumor molecular information. This approach is crucial for the commercial availability of epigenetic treatments in oncology, as it supports the development and validation of DNA methylation-based assays, facilitating the approval and market entry of epigenetic drugs.",
            "score": 3,
            "explanation": "The predicted answer covers the key aspects highlighted in the reference answer: sequential sampling through liquid biopsy, monitoring minimal residual disease, and the commercial relevance to epigenetic biomarkers and drugs. However, it misses the involvement of clinical trials in the identification process."
        },
        {
            "query_idx": 243,
            "query": "Which therapeutic strategy uses certain agents to improve immunotherapy efficacy and is being evaluated in multiple clinical trials targeting different cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    554,
                    557
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The strategy involves #HDACi agents# like vorinostat to enhance immunotherapy, paired with pembrolizumab, under evaluation in several #clinical trials# addressing diverse cancers.",
            "predicted_answer": "The therapeutic strategy using HDACi agents like vorinostat to improve immunotherapy efficacy is being evaluated in multiple clinical trials targeting various cancer types, including prostate, renal, urothelial, DLBCL, FL, Hodgkin lymphoma, NSCLC, and squamous cell carcinoma.",
            "score": 3,
            "explanation": "The predicted answer includes the use of HDACi agents like vorinostat and mentions multiple clinical trials, aligning with the reference. However, it lacks mention of pairing with pembrolizumab, a key fact, affecting completeness."
        },
        {
            "query_idx": 244,
            "query": "What are the physical and technical barriers that gene therapy must overcome to successfully integrate genetic material into target cells and improve its practice?",
            "retrieved_metrics": {
                "reference_idx": [
                    427,
                    952
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Gene therapy must surpass the #nuclear envelope# to integrate genetic material, while addressing #safety and delivery efficiency# challenges for improved practice.",
            "predicted_answer": "Gene therapy must overcome physical barriers like the plasma membrane and nuclear envelope, and technical barriers such as efficient gene delivery, immune responses, and safety concerns to successfully integrate genetic material into target cells.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts highlighted in the reference answer, such as overcoming the nuclear envelope and addressing safety and delivery efficiency. Though the predicted answer also mentions additional details, it does not contradict the reference and covers all emphasized points."
        },
        {
            "query_idx": 245,
            "query": "How do PDO models address the challenges of tumor heterogeneity representation, ensuring long-term stability in culture, and accurately capturing immune cell characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1731,
                    1986,
                    1981
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs are derived from #single biopsies# which may not capture full tumor heterogeneity. Understanding the #tumor microenvironment# is essential for stability, while the #T-cell receptor spectrum# is accurately replicated.",
            "predicted_answer": "PDO models address tumor heterogeneity by capturing both inter- and intratumoral diversity, though single biopsies may limit full representation. They ensure long-term stability through understanding tumor microenvironment interactions. PDOs accurately capture immune cell characteristics by preserving native immune cells and replicating TCR spectrum, though challenges like cost and scalability remain.",
            "score": 5,
            "explanation": "The predicted answer addresses tumor heterogeneity and captures immune cell characteristics by mentioning single biopsies and replicating the TCR spectrum, aligning with all key facts from the reference. The mention of the tumor microenvironment supports long-term stability, making the response complete and consistent."
        },
        {
            "query_idx": 246,
            "query": "How do specific compounds influence the expression of a liver enzyme, and what additional pathway enhances this effect regarding metabolic diseases linked to fat metabolism?",
            "retrieved_metrics": {
                "reference_idx": [
                    1323,
                    1352,
                    1315
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#C75 and baicalin# directly enhance the enzyme's expression, while the #FGF21 pathway# further augments this, potentially improving conditions by boosting #CPT1A# expression in metabolic diseases.",
            "predicted_answer": "Specific compounds like C75 and baicalin can enhance liver enzyme CPT1A expression, promoting fat oxidation (FAO) and improving metabolic diseases. Additionally, the FGF21 pathway, via AMPK-ACC and PPAR signaling, further enhances CPT1A expression and FAO, mitigating metabolic issues linked to fat metabolism.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the specific compounds C75 and baicalin, mentions the enhancement of the CPT1A enzyme expression, and references the FGF21 pathway. Key facts emphasized in the reference are fully reflected in the predicted answer with no significant omissions or contradictions."
        },
        {
            "query_idx": 247,
            "query": "Modified multi-hop query:\nWhat techniques are employed to create advanced 3D tumor models that incorporate distinct tumor mutations and improve functionality through recent advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1479,
                    2039,
                    1978
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "Advanced 3D tumor models incorporate distinct tumor mutations using organoids and tumoroids, benefiting from technological advancements like microfluidic systems, 3D bioprinting, and novel extracellular matrix analogs to improve functionality and physiological relevance.",
            "score": 5,
            "explanation": "The predicted answer mentions key techniques like organoids and tumoroids, and advancements like microfluidic systems, 3D bioprinting, and novel extracellular matrix analogs. These elements align well with the trends in the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 248,
            "query": "What system uses microfluidics to replicate the biological environment, aid in drug efficacy assessments for tumoroid models, and control the tumor microenvironment's physical conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1404,
                    1483,
                    1494
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #organ-on-a-chip# system uses #microfluidic chips# to replicate #biological environments#, control the #tumor microenvironment#, and assess drug #toxicity and efficacy#.",
            "predicted_answer": "The system that uses microfluidics to replicate the biological environment, aid in drug efficacy assessments for tumoroid models, and control the tumor microenvironment's physical conditions is an \"organ-on-a-chip\" model.",
            "score": 1,
            "explanation": "The predicted answer identifies the \"organ-on-a-chip\" system and covers the use of microfluidics to replicate biological environments and assess drug efficacy for tumoroid models. However, it omits \"microfluidic chips\" and \"toxicity\" specifically. Overall, it aligns well but misses more than one key fact."
        },
        {
            "query_idx": 249,
            "query": "What are the specific roles and potential therapeutic applications of quercetin in cellular mechanisms and treatment strategies across various diseases?",
            "retrieved_metrics": {
                "reference_idx": [
                    824,
                    823,
                    822
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Quercetin #induces senescence# in cancer cells, shows #senolytic action# on senescent cell types, and demonstrates #senotherapeutic potential# in studies exploring its therapeutic applications.",
            "predicted_answer": "Quercetin's roles include inducing cellular senescence, inhibiting HDACs, and reactivating P53, with therapeutic applications in cancer treatment by promoting senescence and reducing senescent cell numbers.",
            "score": 1,
            "explanation": "The predicted answer captures the role of quercetin in inducing senescence and mentions its application in cancer treatment, aligning with the reference. However, it misses the #senolytic action# and #senotherapeutic potential# keywords, affecting completeness. The meaning is generally aligned, but some key details are absent."
        },
        {
            "query_idx": 250,
            "query": "How does the compound mediate interactions in liver, breast, and cervical cancer cells, considering its roles in specific biosynthetic or signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    832,
                    1690,
                    833
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound suppresses #cholesterol biosynthesis# in liver cancer, activates #AhR/CYP1A1 pathway# in breast cancer, and induces #apoptosis in cervical cancer# through specific pathways.",
            "predicted_answer": "Emodin mediates interactions in liver, breast, and cervical cancer cells by suppressing cholesterol biosynthesis, regulating lipid metabolism, inducing apoptosis, and modulating glucose metabolism. It targets specific pathways like SREBP2, AKT, HPV E6/E7, and activates the AhR/CYP1A1 pathway in breast cancer.",
            "score": 3,
            "explanation": "The predicted answer covers the suppression of cholesterol biosynthesis, activation of AhR/CYP1A1 in breast cancer, and apoptosis induction. Although it includes additional pathways, these don't contradict the reference. However, it doesn't specify apoptosis is for cervical cancer, impacting completeness."
        },
        {
            "query_idx": 251,
            "query": "How does the influence of a specific substance on ferroptosis and necroptosis contribute to its evaluation as a potential candidate for anti-tumor therapy in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    775,
                    776
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #induction# of #ferroptosis# and possible #necroptosis# by #Tanshinone IIA# highlights its #potential# as a viable #anti-tumor therapy# requiring comprehensive understanding for cancer treatment.",
            "predicted_answer": "Tanshinone IIA's ability to induce both ferroptosis and necroptosis in cancer cells, through mechanisms like ROS elevation and necrosomal complex formation, makes it a promising candidate for anti-tumor therapy by targeting multiple cell death pathways.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as Tanshinone IIA inducing both ferroptosis and necroptosis, as well as its potential for anti-tumor therapy. However, it does not mention that necroptosis is only \"possible,\" affecting the completeness. Overall, the trends align, but with a slight omission."
        },
        {
            "query_idx": 252,
            "query": "Modify the multi-hop query:\nHow do the differences in experimental design and treatment protocols impact the evaluation of predictive accuracy across various cancer model responses and their alignment with patient outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1808,
                    1810
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Differences in experimental design, treatment protocols, and sample size affect the evaluation of predictive accuracy across cancer models, impacting their alignment with patient outcomes. Comprehensive studies with standardized conditions and larger sample sizes are needed for accurate assessment.",
            "score": 3,
            "explanation": "The predicted answer captures the general trend related to differences in experimental design and treatment protocols, but misses key details such as specific factors affecting predictive accuracy and alignment with patient outcomes. This affects completeness and precision. No contradictory information is present."
        },
        {
            "query_idx": 253,
            "query": "What are the individual interaction profiles of the compounds, specifically (8a) and (8b), with apoptosis-related proteins, nucleic acids, and tumor suppressor proteins, highlighting any notable binding scores?",
            "retrieved_metrics": {
                "reference_idx": [
                    231,
                    243,
                    239
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The compound #(8b)# interacted significantly with #apoptosis-related proteins#, while #(8a)# exhibited notable interactions with #nucleic acids# and #tumor suppressor proteins#, achieving specific binding scores.",
            "predicted_answer": "Compound (8b) interacted with caspase-3, showing hydrophilic and hydrophobic interactions with a docking score of -5.9 kcal/mol. Compound (8a) inhibited p53 with a docking score of -5.7 kcal/mol, forming hydrogen bonds with Arg203, Tyr92, and Glu89 residues.",
            "score": 3,
            "explanation": "The predicted answer covers compound (8b)'s interaction with apoptosis-related proteins and compound (8a)'s interaction with tumor suppressor proteins, along with specific binding scores. However, it is missing details about compound (8a)'s interaction with nucleic acids, affecting completeness."
        },
        {
            "query_idx": 254,
            "query": "How does the adaptation of traditional 2D viability assays to 3D cancer models highlight the significance of using an ATP-based luminescent method like CTG-3D?",
            "retrieved_metrics": {
                "reference_idx": [
                    1737,
                    1740,
                    1742
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #ATP-based CTG-3D# luminescent assay is vital because it addresses the need for #optimization and validation# of 2D assays in 3D models and reflects the #importance of specialized 3D viability methods#.",
            "predicted_answer": "The adaptation of traditional 2D viability assays to 3D cancer models highlights the significance of using an ATP-based luminescent method like CTG-3D, which is specifically designed for 3D structures and performs better in assessing cell viability in spheroids.",
            "score": 3,
            "explanation": "The predicted answer captures the significance of the CTG-3D assay for 3D models and aligns with the reference's emphasis on the importance of specialized methods. However, it misses the specific aspects of #optimization and validation# of 2D assays for 3D models, affecting completeness."
        },
        {
            "query_idx": 255,
            "query": "How do differences in culture methods, genetic alterations, and technical variabilities affect the reproduction of spheroids in cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1721,
                    1804,
                    1716
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Reproduction challenges arise from #heterogeneity# in spheroid properties, #morphological differences# due to culture methods, and #genetic modifications# within immortalized cell-derived spheroids.",
            "predicted_answer": "Differences in culture methods, genetic alterations, and technical variabilities affect spheroid reproduction in cancer research by causing heterogeneity in size, shape, cell density, and response to therapy, leading to inconsistent study results and challenges in assessing anticancer efficacy.",
            "score": 1,
            "explanation": "The predicted answer captures the impact of culture methods, genetic alterations, and technical variabilities by mentioning heterogeneity and response to therapy but lacks explicit mention of \"morphological differences\" and \"genetic modifications within immortalized cell-derived spheroids.\" It aligns overall, yet misses two specific key details."
        },
        {
            "query_idx": 256,
            "query": "What are the advancements in phage therapy research, and what evidence showcases its effectiveness in resistant infections? How have these developments influenced the interest in alternatives to antibiotics?",
            "retrieved_metrics": {
                "reference_idx": [
                    6,
                    34,
                    3
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Recent advancements in #phage-based drug development# address drug-resistant infections. #Personalized phage therapy# has treated cases like carbapenem-resistant infections, leading to a #renewed interest# given antibiotic resistance challenges.",
            "predicted_answer": "Advancements in phage therapy research include personalized phage therapies for resistant infections and biofilm control on medical devices. Evidence of effectiveness includes successful treatments for carbapenem-resistant Acinetobacter baumannii and catheter-associated urinary tract infections. These developments have renewed interest in phage therapy as an alternative to antibiotics.",
            "score": 3,
            "explanation": "The predicted answer includes personalized phage therapies and references carbapenem-resistant infections, as highlighted in the reference. It also mentions renewed interest due to these advancements. However, it misses the specific mention of \"phage-based drug development.\" Overall, it aligns but lacks one key detail."
        },
        {
            "query_idx": 257,
            "query": "What are the percentages of outcome observations for phage therapy targeting MRSA, and how many clinical studies have been conducted or are in progress for this approach in fighting drug resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    18,
                    19
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapy against #MRSA# showed effectiveness in #77.2%# improvement and #61.3%# bacteria eradication. It is one of the most #advanced and promising# fields with #14 studies# on MRSA.",
            "predicted_answer": "The percentages of outcome observations for phage therapy targeting MRSA are 77.2% for clinical improvement and 61.3% for eradication. At least 14 clinical studies on phage therapy for MRSA infections have been conducted or are in progress.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: it mentions the 77.2% improvement and 61.3% eradication rates and cites 14 clinical studies. Although it doesn't state \"advanced and promising\" explicitly, this does not alter the meaning or completeness of the technical content."
        },
        {
            "query_idx": 258,
            "query": "What factors, including genetic influences and variations in patient responses, pose challenges to determining optimal therapeutic dosing and developing new oncology drugs in clinical trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    716,
                    1640,
                    1586
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Genetic variations# influence pharmacokinetics, #tumor genetic characteristics# affect drug sensitivity, and patient response #heterogeneity# complicates dose optimization in oncology drug trials.",
            "predicted_answer": "Factors challenging optimal therapeutic dosing and new oncology drug development include large interpatient pharmacokinetic variability, genetic influences on drug metabolism, tumor genetic variations, and patient-specific characteristics like frailty and prior therapies.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions genetic influences, tumor genetic variations, and patient-specific characteristics, aligning well with the reference's mention of genetic variations, tumor genetic characteristics, and heterogeneity. It captures all key points and trends without omissions or contradictions."
        },
        {
            "query_idx": 259,
            "query": "What methods and materials are used in establishing MCF-7 cell culture environments, and how are software tools applied for their spheroid analysis?",
            "retrieved_metrics": {
                "reference_idx": [
                    342,
                    344
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "MCF-7 cell environments use #penicillin/streptomycin and glutamine#, while spheroid analysis uses #ImageJ for volume calculations# and #Microsoft Excel for statistical analysis and plotting#.",
            "predicted_answer": "MCF-7 cell culture environments are established using phenol red-free DMEM medium with 10% FBS, 0.01 mg/ml bovine insulin, 10 nM estradiol, and standard penicillin/streptomycin and glutamine. Spheroid analysis is conducted using ImageJ for volume calculation and Microsoft Excel for statistical analysis.",
            "score": 5,
            "explanation": "The predicted answer includes the key aspects emphasized with # symbols: \"penicillin/streptomycin and glutamine\" and the use of \"ImageJ for volume calculations\" and \"Microsoft Excel for statistical analysis\". All essential details from the reference are present without contradictions."
        },
        {
            "query_idx": 260,
            "query": "What experimental models are used to analyze simultaneous cancer progression from the lungs to other organs and evaluate drug efficacy and toxicity during lung cancer development?",
            "retrieved_metrics": {
                "reference_idx": [
                    2204,
                    2212,
                    1472
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #in vivo metastasis model# simulates lung cancer spread. A #vascularized tumor model# studies specific organ metastasis and #3D models# evaluate drug efficacy and toxicity in lung cancer treatment.",
            "predicted_answer": "The experimental models used include lung-on-a-chip with downstream organ-on-a-chip systems to simulate lung cancer metastasis to brain, bone, and liver, and vascularized tumor models for organ-specific metastasis studies.",
            "score": 1,
            "explanation": "The predicted answer includes the #vascularized tumor model# for organ-specific metastasis studies, aligning with the reference. However, it misses the #in vivo metastasis model# and #3D models# for drug evaluation, affecting completeness and two key facts are missing. Overall trends align, but details are lacking."
        },
        {
            "query_idx": 261,
            "query": "What therapeutic inhibitor plays a key role in targeting a critical enzyme involved in fatty acid oxidation, and was tested for effectiveness in a major cardiac condition but faced early trial termination?",
            "retrieved_metrics": {
                "reference_idx": [
                    1303,
                    1347,
                    1327
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The therapeutic inhibitor #Etomoxir# targets #CPT1A# involved in fatty acid oxidation, showing potential in treating #heart failure# but trials were terminated prematurely.",
            "predicted_answer": "Etomoxir, a CPT1A inhibitor, was tested for effectiveness in heart failure but faced early trial termination due to liver toxicity.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference: \"Etomoxir\" as the inhibitor, \"CPT1A\" as the target, focus on \"heart failure,\" and the reason for trial termination. The minor addition of liver toxicity does not contradict the reference."
        },
        {
            "query_idx": 262,
            "query": "What methods facilitate the systematic exploration and optimization of treatment regimens involving novel modalities, when clinical data is limited, and diverse dosing strategies are applied in phase I trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1611,
                    1618,
                    1613
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The process involves #QSP virtual trial simulation# supporting #dose optimization with QSP models# and mapping #dose/E-R relationships# to improve treatment regimens in data-limited phase I trials.",
            "predicted_answer": "Quantitative Systems Pharmacology (QSP) models facilitate systematic exploration and optimization of treatment regimens by integrating preclinical and early clinical data, especially when clinical data is limited and diverse dosing strategies are applied in phase I trials.",
            "score": 1,
            "explanation": "The predicted answer mentions QSP models for exploration and optimization and aligns with the reference's focus on using QSP for optimizing treatment regimens with limited clinical data. However, it lacks explicit mention of \"QSP virtual trial simulation\" and \"dose/E-R relationships,\" missing two key details."
        },
        {
            "query_idx": 263,
            "query": "Which ADCs utilize microtubule-targeting agents for inducing apoptosis and demonstrate efficacy in pre-clinical models using a dual-payload system with potent nanomolar to picomolar effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    175,
                    182,
                    210
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Dual-payload ADCs exploit #MMAE and MMAF# for efficacy in pre-clinical models, exhibiting #IC50 in nanomolar to picomolar ranges# with #auristatins or maytansinoids# as microtubule-targeting agents.",
            "predicted_answer": "ADCs utilizing microtubule-targeting agents like auristatins and maytansinoids, such as dual-payload systems with MMAE and MMAF, demonstrate efficacy in pre-clinical models for inducing apoptosis with nanomolar to picomolar effectiveness.",
            "score": 5,
            "explanation": "The 'Predicted Answer' successfully covers all key facts: the use of microtubule-targeting agents (auristatins and maytansinoids), and dual-payload systems (MMAE and MMAF) with nanomolar to picomolar effectiveness in pre-clinical models. There are no significant omissions or errors, aligning fully with the 'Reference Answer'."
        },
        {
            "query_idx": 264,
            "query": "Which compound, identified through computational analysis based on binding energy and inhibitory efficiency, was found to be optimal for a specific health condition in various studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1659,
                    1660
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #ZINC00936598# demonstrated #highest binding energy# and #lowest K\\_i#, leading to its identification as the #best PR antagonist for breast cancer treatment#.",
            "predicted_answer": "ZINC00936598 was identified as the optimal compound for breast cancer treatment based on its highest binding energy and lowest inhibitory constant (K$_{i}$).",
            "score": 5,
            "explanation": "The predicted answer contains all key facts from the reference: the compound ZINC00936598, its highest binding energy, lowest inhibitory constant (K$_{i}$), and its application in breast cancer treatment as the best PR antagonist. The phrasing is consistent, and no significant information is missing."
        },
        {
            "query_idx": 265,
            "query": "What limitations in lung cancer research methodologies affect the prediction of treatment efficacy, and how do these limitations impact the development of effective therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1440,
                    1478
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The prediction of treatment efficacy is affected by the #current preclinical models#' inability to mimic human responses, highlighting the need to account for #personalized differences#.",
            "predicted_answer": "Limitations in lung cancer research methodologies, such as the use of physiologically inaccurate models and high variability in genetically engineered mouse models (GEMMs), affect the prediction of treatment efficacy by reducing the accuracy of drug screening and personalized treatment response predictions. These limitations hinder the development of effective therapies by increasing the risk of false positive drug candidates and failing to mimic human tumor biology accurately.",
            "score": 1,
            "explanation": "The 'Predicted Answer' captures the trend about limitations in lung cancer models affecting treatment efficacy, specifically addressing inaccurate models and genetic variability. However, it misses the emphasis on \"current preclinical models\" and \"personalized differences,\" which are crucial in the 'Reference Answer'."
        },
        {
            "query_idx": 266,
            "query": "What therapeutic method enables precise control of gene expression without altering DNA, and what are its notable advantages over traditional therapies in terms of success rate and efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    375,
                    2119
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#siRNAs# provide gene silencing without DNA alteration, offering a high #development success rate# and #robust efficacy#, surpassing traditional therapies.",
            "predicted_answer": "RNAi-based gene regulation using siRNAs enables precise control of gene expression without altering DNA. Its notable advantages over traditional therapies include a higher development success rate, shorter development time, robust and long-lasting efficacy, and a broader range of disease targets.",
            "score": 5,
            "explanation": "The Predicted Answer identifies siRNAs for gene regulation, matching the reference's #siRNAs# and emphasizes the high #development success rate# and #robust efficacy#. All key facts and trends from the reference are present, with additional beneficial attributes without contradictions."
        },
        {
            "query_idx": 267,
            "query": "Which actions performed by the RING-type E3 ligase lead to the modification and subsequent degradation of a tumor suppressor protein, and what are its implications in various human cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1563,
                    1562
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "MDM2 #binds and ubiquitinates# the tumor suppressor #p53#, promoting its degradation. MDM2's overexpression in cancers leads to poor #patient outcomes#.",
            "predicted_answer": "The RING-type E3 ligase MDM2 ubiquitinates p53, leading to its degradation, which promotes cancer progression. This action is implicated in various cancers, including osteosarcoma, neuroblastoma, lung, colon, breast, and liver cancers, worsening patient prognosis.",
            "score": 3,
            "explanation": "The predicted answer notes that the RING-type E3 ligase MDM2 ubiquitinates p53 and promotes its degradation, consistent with the reference. It mentions cancer progression and poor patient prognosis, aligning with the implication of overexpression. However, it omits MDM2 binding to p53."
        },
        {
            "query_idx": 268,
            "query": "How do 3D printing technologies, tumor-on-a-chip platforms, and hydrogel structures collectively contribute to the development of patient-specific tumor models and the analysis of cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2228,
                    2227,
                    2040
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #3D printing# into #tumor-on-a-chip platforms# enables #patient-specific# modeling and analysis of cell dynamics with #porous hydrogels#.",
            "predicted_answer": "3D printing technologies enable precise vascular mimicry, tumor-on-a-chip platforms preserve tumor heterogeneity and predict drug sensitivity, while hydrogel structures provide a dynamic microenvironment for cellular interactions, collectively supporting the development of patient-specific tumor models and analysis of cellular dynamics.",
            "score": 3,
            "explanation": "The predicted answer covers the key components such as 3D printing, tumor-on-a-chip, and hydrogel structures, aligning well with the reference's emphasis on these technologies for patient-specific models. It accurately reflects their role in analyzing cellular dynamics but lacks explicit mention of \"porous\" hydrogel structures."
        },
        {
            "query_idx": 269,
            "query": "Which type of cancer treatment is questioned for its effectiveness in treating head and neck cancer and presents increased gastrointestinal issues in prostate cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1000,
                    1004
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment is #proton therapy#, with uncertain effectiveness in #head and neck cancer# and increased #gastrointestinal morbidity# observed in #prostate cancer#.",
            "predicted_answer": "Proton therapy is questioned for its effectiveness in treating head and neck cancer and presents increased gastrointestinal issues in prostate cancer.",
            "score": 5,
            "explanation": "The Predicted Answer contains all key facts and important information from the Reference Answer: \"proton therapy,\" \"head and neck cancer,\" and \"gastrointestinal issues in prostate cancer.\" It captures the trend and meaning accurately with no significant omissions or errors."
        },
        {
            "query_idx": 270,
            "query": "What system is used for simulating organ growth interactions and enables the analysis of conditions affecting multiple organs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1456,
                    1455
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #OIC# system enables the simulation of organ growth with #fluid dynamics and tissue diversity# and allows analysis of #conditions affecting multiple organs#.",
            "predicted_answer": "Organ-in-chip (OIC) technology is used for simulating organ growth interactions and enables the analysis of conditions affecting multiple organs by incorporating fluid motion and multiple tissue types.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer. It correctly identifies \"OIC\" as the system, mentions \"fluid motion\" (similar to \"fluid dynamics\"), \"multiple tissue types\" (similar to \"tissue diversity\"), and discusses \"conditions affecting multiple organs.\" Thus, all key facts are covered, with consistent meaning."
        },
        {
            "query_idx": 271,
            "query": "What is the effect of combining certain targeted therapies on the response rates in colorectal cancer associated with different KRAS mutations, and how does this differ between various mutation types?",
            "retrieved_metrics": {
                "reference_idx": [
                    881,
                    1043,
                    1417
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Combining #Adagrasib and Cetuximab# increases response in #KRAS G12C# colorectal cancer, whereas #Afatinib and selumetinib# show limited efficacy in other #KRAS mutant# types.",
            "predicted_answer": "Combining targeted therapies, such as Adagrasib with Cetuximab, increases response rates in colorectal cancer with KRAS G12C mutations, improving from 19% to 46%. Other KRAS mutations may not respond as effectively, as combination therapies like afatinib with selumetinib showed limited efficacy in KRAS mutant tumors.",
            "score": 5,
            "explanation": "The predicted answer successfully includes key facts, such as the combination of #Adagrasib and Cetuximab# for #KRAS G12C# mutations, and the limited efficacy of #Afatinib and selumetinib# for other #KRAS mutant# types. It accurately reflects the trends and important details of the reference answer."
        },
        {
            "query_idx": 272,
            "query": "What process results in the production of a dioxygenase inhibitor in mutant IDH tumors, and which therapeutic agent is known to counteract this effect to promote cellular differentiation?",
            "retrieved_metrics": {
                "reference_idx": [
                    598,
                    599
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Mutant IDH tumors produce an inhibitor, #2HG#, affecting dioxygenases, which #enasidenib# counters by suppressing #2HG# and inducing differentiation.",
            "predicted_answer": "The production of a dioxygenase inhibitor in mutant IDH tumors results from the neomorphic activity of IDH1/IDH2, leading to 2-hydroxyglutarate (2HG). Enasidenib is known to counteract this effect by suppressing 2HG production and promoting cellular differentiation.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects all key facts emphasized in the Reference Answer, including the production of 2-hydroxyglutarate (2HG) by mutant IDH and the counteracting effect of enasidenib. Both the inhibitor (2HG) and the therapeutic agent (enasidenib) are mentioned, showing full alignment and detail coverage."
        },
        {
            "query_idx": 273,
            "query": "Which compound inhibits thioredoxin reductase activities, delivered orally or intravenously, and is utilized in clinical trials for non-small-cell lung cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1874,
                    1875
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #Ethaselen 20# inhibits thioredoxin reductase activities and is in a #Phase II clinical trial# specifically for non-small-cell lung cancer.",
            "predicted_answer": "Ethanasel, an analog of ebselen, inhibits thioredoxin reductase activities and is used in clinical trials for non-small-cell lung cancer, delivered orally or intravenously.",
            "score": 1,
            "explanation": "The predicted answer mentions \"Ethanasel,\" which appears to be a misspelling or incorrect version of \"Ethaselen 20\" from the reference. The predicted answer does not mention that the trial is phase II. Key details are correct, but the error impacts completeness."
        },
        {
            "query_idx": 274,
            "query": "What methodology leverages AI for integrating multiple data networks to improve predictions in the early stages of drug-target identification in anti-cancer drug design?",
            "retrieved_metrics": {
                "reference_idx": [
                    139,
                    141,
                    145
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #DDR method# uses #AI# to integrate networks, improving #drug-target identification# predictions crucial to early anti-cancer drug design steps.",
            "predicted_answer": "The methodology leveraging AI for integrating multiple data networks to improve predictions in early-stage drug-target identification in anti-cancer drug design is called DDR (Drug-Drug and Drug-Target Recommender). It integrates data from various sources like gene expression, disease-based similarity, and chemical structure fingerprints to enhance prediction accuracy.",
            "score": 5,
            "explanation": "The predicted answer mentions the DDR method and AI, aligning with the reference. It also provides additional details, such as data integration types, that align with network integration in drug-target identification. These additions do not contradict but instead complement the reference, covering all emphasized points."
        },
        {
            "query_idx": 275,
            "query": "Which compound did researchers identify to effectively disrupt a specific protein interaction, and what was the intended effect on an enzyme activity related to melanoma progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1661,
                    1662
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #ZINC02578057# was identified to effectively disrupt the #BSG-TRAF6 interaction#, intended to control #MMP9 overexpression# in melanoma.",
            "predicted_answer": "Researchers identified ZINC02578057 to disrupt the TRAF6-BSG interaction, aiming to control MMP9 overexpression and inhibit melanoma progression.",
            "score": 5,
            "explanation": "The predicted answer fully covers all key facts: the compound ZINC02578057, the interaction disruption (BSG-TRAF6), and its intended effect on MMP9 overexpression in melanoma. The meaning is consistent with the reference answer with no significant omissions or errors."
        },
        {
            "query_idx": 276,
            "query": "Which isolated compounds from marine sponges are evaluated for their cytotoxic effectiveness against U937 cells, particularly focusing on the comparative cytotoxicity of different compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1279,
                    1285
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#BrBin# and #Compound 87# from marine sponges show significant cytotoxic effects on U937 cells, with #Compound 87# maintaining equivalent effectiveness in inducing apoptosis compared to #BrBin#.",
            "predicted_answer": "BrBin, compounds 85, 86, and 87 were evaluated for cytotoxicity against U937 cells. BrBin showed the highest cytotoxicity, while compounds 85 and 86 were less effective, and compound 87 had equivalent cytotoxicity to BrBin.",
            "score": 3,
            "explanation": "The predicted answer mentions BrBin and compound 87, aligning with the reference answer's focus on their significant cytotoxic effects. However, the predicted answer incorrectly states that compound 87 has equivalent cytotoxicity to BrBin, whereas both maintain equivalent effectiveness in inducing apoptosis. Important details are present but slightly misaligned."
        },
        {
            "query_idx": 277,
            "query": "How does the first FDA-approved nanomedicine influence adverse effect management and its role in oncology drug delivery systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1024,
                    1016
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The FDA-approved nanomedicine, #Doxil#, was pioneering in cancer therapy by improving #targeted drug delivery# and leading to the #mitigation of toxic side effects#.",
            "predicted_answer": "The first FDA-approved nanomedicine, Doxil, enhances adverse effect management by targeting drugs to pathology sites, reducing toxicity in healthy tissues, and optimizing pharmacokinetic profiles. It plays a crucial role in oncology by improving drug delivery and overcoming biological barriers.",
            "score": 5,
            "explanation": "The predicted answer mentions Doxil, targeted drug delivery, and the mitigation of toxic side effects, which aligns with the key facts stated in the reference answer. The roles and effects of Doxil in reducing toxicity and improving drug delivery in oncology are fully captured."
        },
        {
            "query_idx": 278,
            "query": "What model provides a consistent representation of parental breast tumor characteristics and supports drug screening while addressing challenges like cell line-induced variability effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    2076,
                    2075,
                    2079
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #PDX models# effectively represent #parental breast tumor characteristics# and are consistent in drug screening, unlike #CDX#, which faces challenges with cell line-induced variability.",
            "predicted_answer": "The patient-derived xenograft (PDX) model provides a consistent representation of parental breast tumor characteristics and supports drug screening while effectively addressing challenges like cell line-induced variability.",
            "score": 3,
            "explanation": "The predicted answer accurately identifies the #PDX models# as providing a consistent representation of #parental breast tumor characteristics# and addressing cell line-induced variability. It omits the comparison to #CDX#, which is in the reference but does not contradict the overall trend."
        },
        {
            "query_idx": 279,
            "query": "What are the key components and distinct features used in simulation models to replicate the spread of cancer cells through systems involved in cellular transport and interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2057,
                    2198
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The simulation uses #microfluidic chips# to model cellular transport, incorporating #lymphatic angiogenesis#, affecting tumor interactions and increasing cancer cell spread.",
            "predicted_answer": "Key components in simulation models include microfluidic chips, sacrificial models, and vascularized platforms. Distinct features involve mimicking lymphatic and vascular systems, controlling pressure in channels, and observing tumor-endothelial interactions.",
            "score": 3,
            "explanation": "The predicted answer mentions \"microfluidic chips,\" aligning with the reference's key component. However, it only indirectly references \"lymphatic angiogenesis,\" affecting interactions and spread, by stating \"mimicking lymphatic systems.\" It omits the specific influence on tumor interactions. Aligning with the trend, it lacks one key fact."
        },
        {
            "query_idx": 280,
            "query": "What mechanisms affect chromatin organization and transcription regulation, contributing to cancer progression, and how are they used in cancer diagnostic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    464,
                    471,
                    528
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The alteration of #histone modifications# affects chromatin and #gene expression#, contributing to cancer, where processes like #histone acetylation# serve as #biomarkers# for identifying cancer presence.",
            "predicted_answer": "Chromatin organization and transcription regulation are affected by histone modifications and DNA methylation, which contribute to cancer progression. These epigenetic changes can serve as biomarkers in cancer diagnostics, aiding in diagnosis, prognosis, and treatment response assessment.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key facts of histone modifications and their role as biomarkers, consistent with the Reference Answer. However, it omits specific details like histone acetylation and gene expression, which are crucial for completeness."
        },
        {
            "query_idx": 281,
            "query": "What is the total number of lung cancer cell lines derived for study, and which in vivo models are used to retain the phenotypic features of primary lung tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1474,
                    1476
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #NCI panel# has over #200 lung cancer cell lines#, and #patient-derived tumor xenografts# are used to preserve #essential features# of primary human tumors.",
            "predicted_answer": "The total number of lung cancer cell lines derived for study is over 200, including both SCLC and NSCLC. In vivo models like Patient-derived tumor xenografts (PDXs) are used to retain the phenotypic features of primary lung tumors.",
            "score": 5,
            "explanation": "The predicted answer mentions the #over 200 lung cancer cell lines#, aligning with the reference's #NCI panel# mentioned indirectly. It also includes #patient-derived tumor xenografts# and their role in retaining features of tumors, addressing the specified phenotypic features. No key information is missing."
        },
        {
            "query_idx": 282,
            "query": "What are the financial and developmental advantages of repurposing drugs for cancer treatment, and what specific cellular characteristics do these drugs affect in the context of oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    755,
                    772,
                    2233
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Leveraging existing drugs in oncology is #cheaper# and #faster#, offering advantages in cancer treatment by targeting #cancer hallmarks# and affecting #cell death# mechanisms.",
            "predicted_answer": "Repurposing drugs for cancer treatment offers financial advantages like cost-effectiveness and faster development. They target cellular characteristics such as proliferative signaling, growth suppression, and immune evasion, affecting pathways like apoptosis and autophagy.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by acknowledging cost-effectiveness and faster development (\"cheaper\" and \"faster\"), targeting cancer characteristics (\"cancer hallmarks\"), and affecting pathways (\"cell death\" mechanisms). However, it misses the emphasis on \"cancer hallmarks\" specifically. Despite this, it covers the main points."
        },
        {
            "query_idx": 283,
            "query": "What biotechnological application involves using bacteriophages to effectively reduce protective bacterial formations and manage oral health issues such as dental plaque and periodontal disease?",
            "retrieved_metrics": {
                "reference_idx": [
                    30,
                    33
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #bacteriophages# in biotechnology helps reduce #biofilms#, notably dental #biofilms#, and manage conditions like #periodontal disease#.",
            "predicted_answer": "Phage therapy involves using bacteriophages to target and reduce dental biofilms, effectively managing oral health issues like dental plaque and periodontal disease.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key facts emphasized in the reference answer: #bacteriophages#, #biofilms#, #dental biofilms#, and #periodontal disease#. The trend and specific details are consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 284,
            "query": "What are the specific regulatory and ethical considerations involved in deploying AI technologies for healthcare to ensure both innovative practices and safeguarding patient interests?",
            "retrieved_metrics": {
                "reference_idx": [
                    1225,
                    1229
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Deploying AI in healthcare involves #regulatory frameworks# ensuring safety, and #balancing innovation and patient safety# to address ethical considerations and protect patient interests.",
            "predicted_answer": "Regulatory considerations include FDA and EU frameworks for safety, efficacy, and data protection. Ethical considerations focus on patient privacy, informed consent, and balancing innovation with patient safety. Clinical validation, stakeholder involvement, and human-machine collaboration are also crucial.",
            "score": 5,
            "explanation": "The predicted answer includes key regulatory frameworks and balancing innovation with patient safety, aligning with the reference answer. It mentions FDA and EU frameworks, which relate to ensuring safety, and highlights balancing ethical considerations. All key facts are present without significant omissions, ensuring alignment."
        },
        {
            "query_idx": 285,
            "query": "How do cancer PDOs exhibit diverse morphological features and respond to intrinsic and extrinsic factors, and what advanced cultural techniques are used to maintain their original characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1395,
                    1726,
                    1969
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Cancer PDOs are cultivated as #cost-effective# models with #similarity to primary tumors#, displaying #morphological heterogeneity# from #intrinsic and extrinsic factors#, using advanced #3D structures# to maintain their #characteristics#.",
            "predicted_answer": "Cancer PDOs exhibit diverse morphological features similar to original tumors, influenced by intrinsic and extrinsic factors like oxygenation and ECM composition. Advanced culturing techniques use specialized 3D scaffolds and growth factors to maintain original characteristics.",
            "score": 3,
            "explanation": "The 'Predicted Answer' captures most key facts from the 'Reference Answer', including similarity to primary tumors, morphological heterogeneity, influence of intrinsic and extrinsic factors, and the use of advanced 3D techniques. However, it omits the detail about being cost-effective."
        },
        {
            "query_idx": 286,
            "query": "What innovative delivery system is employed to navigate resistance in pancreatic cancer caused by genetic heterogeneity and biological barriers, integrating different therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    395,
                    426,
                    453
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "A #nanoparticle-based delivery system# is used to tackle #PC's genetic variability# and resistance, employing #combination therapy# to overcome biological obstacles effectively.",
            "predicted_answer": "Combination and adaptive therapy, integrating nanoparticle-based delivery systems, immunotherapy, antibody-drug conjugates, and CAR-T cells, are employed to navigate resistance in pancreatic cancer caused by genetic heterogeneity and biological barriers.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by mentioning a \"nanoparticle-based delivery system\" and \"combination therapy,\" addressing genetic heterogeneity in pancreatic cancer. It provides additional but non-contradictory methods (immunotherapy, antibody-drug conjugates, CAR-T cells), fully covering the key aspects emphasized with # in the reference answer."
        },
        {
            "query_idx": 287,
            "query": "Which mutation in the H3.3 histone variant is associated with poor prognosis in gliomas, leads to a significant tumor classification, and results in alterations to the epigenome?",
            "retrieved_metrics": {
                "reference_idx": [
                    530,
                    536,
                    531
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #H3K27M# mutation in the #H3.3# histone variant is linked to #short survival# in gliomas, crucial for #classifying diffuse midline glioma#, and represents an #oncohistone mutation# affecting the epigenome.",
            "predicted_answer": "The H3K27M mutation in the H3.3 histone variant is associated with poor prognosis in gliomas, leads to significant tumor classification as diffuse midline glioma, H3K27M-mutant, and results in alterations to the epigenome.",
            "score": 5,
            "explanation": "The Predicted Answer effectively includes all key facts emphasized in the Reference Answer: the H3K27M mutation in the H3.3 variant, its impact on glioma classification as diffuse midline glioma, and its influence on the epigenome. Although \"short survival\" is not mentioned explicitly, the overall meaning is preserved."
        },
        {
            "query_idx": 288,
            "query": "How does the sustained initiation of new blood vessels, inadequate oxygen delivery due to tumor size, and irregular vessel configuration affect tumor environments and progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    791,
                    2182,
                    389
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Persistent angiogenesis# leads to a conducive environment for #tumor expansion#, inadequate supply causes #hypoxia#, and #irregular vessels# raise #interstitial pressure#, leading to an #acidic microenvironment#.",
            "predicted_answer": "The sustained initiation of new blood vessels, inadequate oxygen delivery due to tumor size, and irregular vessel configuration create a hypoxic and acidic tumor environment, promoting aggressive cancer cell behavior and metastasis.",
            "score": 3,
            "explanation": "The predicted answer covers most key facts from the reference: persistent angiogenesis, hypoxia, and an acidic microenvironment. However, it does not explicitly mention tumor expansion or interstitial pressure. While generally aligned, these omissions affect completeness."
        },
        {
            "query_idx": 289,
            "query": "What is the method that compares individual and dual gene disruptions to reveal interactions between gene pairs, particularly when linking these outcomes with genetic dependencies highlights synthetic lethal relationships?",
            "retrieved_metrics": {
                "reference_idx": [
                    1946,
                    1977,
                    1945
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The method involves #dual perturbation# to show unexpected effects, #simultaneous gene perturbation# to examine interactions, and linking #perturbation outcomes with genetic dependencies# to reveal synthetic lethal interactions.",
            "predicted_answer": "The method that compares individual and dual gene disruptions to reveal interactions between gene pairs, particularly when linking these outcomes with genetic dependencies highlights synthetic lethal relationships, is **multiplexed or combinatorial CRISPR screening**. This approach involves designing screens to include individual and dual perturbations, comparing the observed fitness effects, and inferring synthetic lethality if the dual perturbation effect is significantly greater than expected.",
            "score": 5,
            "explanation": "The predicted answer mentions \"dual perturbation,\" \"synthetic lethal relationships,\" and \"comparing individual and dual gene disruptions.\" These align with the key facts in the reference, focusing on linking gene perturbation with genetic dependencies, despite using different wording. No significant omissions present."
        },
        {
            "query_idx": 290,
            "query": "What test is recommended in clinical guidelines for grade III and IV gliomas, and how does it impact the predicted effectiveness of alkylating chemotherapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    483,
                    508
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The guidelines recommend #MGMT promoter methylation# testing for grade III and IV gliomas as a #predictor# of their response to alkylating chemotherapy.",
            "predicted_answer": "MGMT promoter methylation testing is recommended in clinical guidelines for grade III and IV gliomas. This test predicts the effectiveness of alkylating chemotherapy, with methylated MGMT indicating a favorable response to agents like temozolomide.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies MGMT promoter methylation testing as recommended for grade III and IV gliomas and describes it as predicting the effectiveness of alkylating chemotherapy. It fully aligns with the reference, meeting all key facts without significant omissions or inconsistencies."
        },
        {
            "query_idx": 291,
            "query": "How does integrating multiple types of 'omics data contribute to AI-driven advancements in cancer screening, target identification, and drug response prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    1238,
                    1241,
                    156
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of multi-omics data enhances #AI-driven cancer screening#, facilitates the identification of #therapeutic targets#, and aids in predicting #drug responses# for cancer treatment.",
            "predicted_answer": "Integrating multiple types of 'omics data enhances AI-driven advancements in cancer screening, target identification, and drug response prediction by providing comprehensive molecular insights, improving accuracy, and enabling precision approaches through genomics, transcriptomics, proteomics, and metabolomics.",
            "score": 5,
            "explanation": "The 'Predicted Answer' fully covers the key facts from the 'Reference Answer' as it mentions AI-driven cancer screening, target identification, and drug response prediction, consistent with the reference. Although wording differs, the essential points and trends are accurate and complete without omissions."
        },
        {
            "query_idx": 292,
            "query": "Which chemical treatment is used to analyze DNA methylation in the context of noninvasive cancer diagnosis through blood, urine, or other body fluids?",
            "retrieved_metrics": {
                "reference_idx": [
                    468,
                    478
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment with #sodium bisulfite# is crucial for analyzing DNA methylation, enabling #liquid biopsy# as a noninvasive cancer diagnostic method using body fluids.",
            "predicted_answer": "Sodium bisulfite treatment is used to analyze DNA methylation in noninvasive cancer diagnosis through blood, urine, or other body fluids.",
            "score": 5,
            "explanation": "The predicted answer includes both key points: \"sodium bisulfite treatment\" and the use of \"blood, urine, or other body fluids,\" aligning with \"liquid biopsy.\" It fully captures the reference's meaning and key facts without any omissions or contradictions."
        },
        {
            "query_idx": 293,
            "query": "How are anticancer orphan indications classified as ultra-rare in terms of prevalence and number of affected individuals in the US?",
            "retrieved_metrics": {
                "reference_idx": [
                    1060,
                    1074
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Anticancer orphan indications are classified as ultra-rare if the prevalence is #1 in 50000 US citizens# or if they affect fewer than #6600# individuals.",
            "predicted_answer": "Anticancer orphan indications are classified as ultra-rare in the US if they affect fewer than 6,600 individuals, based on a prevalence rate of 1 in 50,000 citizens.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of a prevalence rate of 1 in 50,000 US citizens and affecting fewer than 6,600 individuals. It aligns closely with the reference, with no significant omissions or errors. All emphasized details are accurately reflected."
        },
        {
            "query_idx": 294,
            "query": "Which compound, used in oncology to increase treatment efficiency, targets multiple signaling pathways, and influences protein expression changes related to inflammation modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    803,
                    805,
                    814
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #compound enhances cancer therapy# by targeting the #NFκ B pathway#, inhibiting #COX-2#, increasing #PTEN protein expression#, and modulating #inflammatory processes# linked to cancer progression.",
            "predicted_answer": "Celecoxib, a selective COX-2 inhibitor, targets multiple signaling pathways including ERK1/2, P38, and NFκB, influencing protein expression changes related to inflammation modulation and enhancing treatment efficiency in oncology.",
            "score": 3,
            "explanation": "The predicted answer mentions targeting the NFκB pathway and inhibiting COX-2, which aligns with the reference. It also focuses on modulating inflammatory processes, aligning with cancer therapy enhancement. However, it omits the increase in PTEN protein expression, a key fact emphasized in the reference."
        },
        {
            "query_idx": 295,
            "query": "What changes have occurred in the number of approved treatments since the adoption of the orphan drug act in 1983, and during what period after initial approval is FDA approval for new indications most likely?",
            "retrieved_metrics": {
                "reference_idx": [
                    2261,
                    2262
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Since 1983, approved treatments increased from #38# to over #350#. FDA approval likelihood for new drug indications peaks within #1-2 years# post-initial approval, before generics appear.",
            "predicted_answer": "Since the Orphan Drug Act in 1983, the number of approved treatments has increased from 38 to over 350. FDA approval for new indications is most likely within 1-2 years after the initial approval.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions the increase in approved treatments from 38 to over 350, and notes that FDA approval for new indications is most likely within 1-2 years after initial approval. All key facts and trends are reflected without omissions or contradictions."
        },
        {
            "query_idx": 296,
            "query": "What specific cellular structures and organ-level mechanisms complicate the delivery and effectiveness of therapeutic agents in the human body?",
            "retrieved_metrics": {
                "reference_idx": [
                    355,
                    359
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Delivering therapeutic agents is hindered by #biological barriers# like the #nuclear membrane# at cellular levels and challenges such as the #blood-brain barrier# and #genetic heterogeneity# at organ levels.",
            "predicted_answer": "Cellular structures like the nuclear membrane, endosomal compartments, and negatively charged lipid bilayers, along with organ-level barriers such as the blood-brain barrier, blood-bone barrier, and enzymatic degradation, complicate therapeutic agent delivery and effectiveness.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of the \"nuclear membrane\" and organ-level \"blood-brain barrier\" as biological barriers. However, it misses \"genetic heterogeneity,\" and adds details not emphasized in the reference answer, impacting comprehensive alignment."
        },
        {
            "query_idx": 297,
            "query": "Which agents received FDA accelerated approvals for R/R peripheral T-cell lymphoma and R/R multiple myeloma between 2014-2015, and what were the clinical trial criteria supporting their approvals?",
            "retrieved_metrics": {
                "reference_idx": [
                    560,
                    571
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Agents #Belinostat# and #Panobinostat# received FDA accelerated approval in #2014 for R/R PTCL# and #2015 for R/R multiple myeloma#, respectively, based on #overall response rate# and #progression-free survival# criteria.",
            "predicted_answer": "Belinostat received FDA accelerated approval for R/R peripheral T-cell lymphoma in 2014 based on a single-arm trial with an ORR of 25.8%. Panobinostat was approved in 2015 for R/R multiple myeloma in combination with bortezomib and dexamethasone, supported by superior PFS in the PANORAMA1 study.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions #Belinostat# and #Panobinostat# receiving FDA approvals in 2014 and 2015 for #R/R PTCL# and #R/R multiple myeloma#, respectively. It also correctly details the use of #overall response rate# for Belinostat and #progression-free survival# for Panobinostat, meeting all key facts and trends."
        },
        {
            "query_idx": 298,
            "query": "What structured modeling techniques and their processes are employed in oncology to optimize drug dosing decisions, and how do continuous data updates contribute to these processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1603,
                    1629,
                    1589
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Pharmacologically informed modeling# enhances #dose optimization# in oncology using #MIDD tools#. Continuous #quantitative knowledge base# updates are essential for effective #dose selection# and #program strategy development#.",
            "predicted_answer": "Structured modeling techniques in oncology, such as MIDD, use iterative data collection, synthesis, estimation, and simulation to optimize drug dosing. Continuous data updates enhance these processes by refining models, enabling real-time adjustments, and supporting adaptive study designs.",
            "score": 1,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer, mentioning MIDD and dose optimization. However, it lacks key specifics: \"pharmacologically informed modeling,\" \"quantitative knowledge base,\" \"dose selection,\" and \"program strategy development,\" impacting completeness."
        },
        {
            "query_idx": 299,
            "query": "How do limitations in standard assays affect the accuracy of efficacy measurements, particularly over time, and what role do image-based techniques play in enhancing measurements in organoid research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1743,
                    1750,
                    1761
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Standard assays are limited by #cell subpopulation detection#, leading to #time-dependent efficacy metrics#, while image-based techniques address #growth measurement inconsistencies# in organoid research.",
            "predicted_answer": "Limitations in standard assays, such as viability-based methods, affect efficacy measurements by failing to capture organoid heterogeneity and time-dependent responses. Image-based techniques enhance accuracy by providing detailed morphological data, allowing for a more comprehensive assessment of drug effects over time.",
            "score": 3,
            "explanation": "The predicted answer addresses the limitations in standard assays by discussing the failure to capture organoid heterogeneity (aligned with cell subpopulation detection) and time-dependent responses. However, it doesn't directly mention growth measurement inconsistencies. Despite this, it aligns with the trend of addressing efficacy over time using image techniques."
        },
        {
            "query_idx": 300,
            "query": "How are models, derived from metastatic biopsies, applied to forecast treatment responses in a particular type of cancer through predictive testing?",
            "retrieved_metrics": {
                "reference_idx": [
                    1389,
                    1401,
                    1771
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Organoids# from #metastatic lesions# are used for #predictive testing# in #colorectal cancer# to assess chemotherapeutic responses.",
            "predicted_answer": "Models derived from metastatic biopsies, such as organoids, are used to forecast treatment responses in colorectal cancer by simulating tumor characteristics and drug interactions, enabling personalized treatment predictions.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies #organoids#, #metastatic biopsies# (#lesions#), #predictive testing# (forecast treatment responses), and #colorectal cancer#. It successfully covers all key facts and is consistent with the reference, differing mainly in phrasing without significant omissions."
        },
        {
            "query_idx": 301,
            "query": "Which immune checkpoint inhibitors, highlighted for their cancer-fighting mechanism at the 2023 ASCO-GU Symposium, contribute to immune enhancement by targeting specific proteins on cancer and immune cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    900,
                    907,
                    1857
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Immune checkpoint inhibitors targeting #PD-1# and #PD-L1# were highlighted for #enhancing immune response# against cancer and prominently featured at the #2023 ASCO-GU Cancers Symposium#.",
            "predicted_answer": "Pembrolizumab, Atezolizumab, Nivolumab, and Avelumab are immune checkpoint inhibitors that enhance immune response by targeting PD-1 and PD-L1 proteins on cancer and immune cells.",
            "score": 3,
            "explanation": "The predicted answer includes the key proteins PD-1 and PD-L1 and their role in enhancing the immune response. However, it omits the specific mention of the 2023 ASCO-GU Cancers Symposium, which affects completeness, missing one emphasized key fact."
        },
        {
            "query_idx": 302,
            "query": "Which screening method uncovers specific synthetic lethal interactions between tumor suppressors and also offers advantages over cDNA methods due to its simplicity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1941,
                    2098
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#RNAi-based# screens find interactions with #SMARCA4/SMARCA2# and #MAGOH/MAGOHB#. Meanwhile, #CRISPR-based# screening surpasses cDNA methods due to reduced complexity.",
            "predicted_answer": "CRISPR-based screening uncovers specific synthetic lethal interactions between tumor suppressors and offers advantages over cDNA methods due to its simplicity.",
            "score": 1,
            "explanation": "The predicted answer only mentions CRISPR-based screening, aligning partially with the reference. However, it fails to include key facts about RNAi-based screens and their interactions with SMARCA4/SMARCA2 and MAGOH/MAGOHB, which are essential details emphasized in the reference answer."
        },
        {
            "query_idx": 303,
            "query": "What impact do patient-derived organoids have on cancer treatment selection and effectiveness, and what challenges do they face in clinical trial validations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1983,
                    1995,
                    1779
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "PDOs help clinicians select treatments by providing a #predictive framework# and #improving patient care#, but they face validation challenges, showing limited significant responses in #clinical applications#.",
            "predicted_answer": "Patient-derived organoids (PDOs) enhance cancer treatment selection by providing personalized, accurate models for pre-treatment testing, potentially improving efficacy and reducing side effects. Challenges include ethical considerations, scaling processes, and ensuring equitable access. Clinical trial validations face issues like off-label treatment efficacy and the need for larger, more robust studies.",
            "score": 1,
            "explanation": "The predicted answer mentions that PDOs enhance treatment selection and improve efficacy, aligning with the idea of improving patient care. However, it lacks the term \"predictive framework\" and misses the specific challenge of showing limited significant responses in clinical applications. Overall, it aligns but omits key detailed challenges."
        },
        {
            "query_idx": 304,
            "query": "What treatment in a study reported updated response rates for a type of lung cancer, where patients were not selected based on a specific protein expression?",
            "retrieved_metrics": {
                "reference_idx": [
                    193,
                    194
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment #Dato-DXd# was analyzed for #NSCLC# without #TROP2 selection#, showing variations in #ORR# across dose levels.",
            "predicted_answer": "The treatment in the study was Dato-DXd, which reported updated response rates for NSCLC patients not selected based on TROP2 expression, with ORR ranging from 21 to 25% across different doses.",
            "score": 5,
            "explanation": "The Predicted Answer includes key facts such as the treatment \"Dato-DXd,\" the patient group \"NSCLC without TROP2 selection,\" and variations in \"ORR across doses,\" aligning with the Reference Answer. All emphasized details are covered without contradiction or significant omission."
        },
        {
            "query_idx": 305,
            "query": "How are phage-based strategies used to improve outcomes by enhancing therapeutic efficacy and interacting with microbiota in the context of hematological malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    73,
                    76
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapy in hematological malignancies addresses #complications# like acute graft-versus-host disease and targets cancer-associated #microbiota# for enhanced therapeutic outcomes.",
            "predicted_answer": "Phage-based strategies enhance therapeutic efficacy in hematological malignancies by delivering genes, modulating immune responses, and interacting with gut microbiota to augment chemotherapy and address drug resistance. They also show promise in managing complications like acute graft-versus-host disease.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects mentioned in the reference, such as addressing complications like acute graft-versus-host disease and interactions with microbiota. However, it does not explicitly mention targeting cancer-associated microbiota. The overall trends align, but this omission affects completeness."
        },
        {
            "query_idx": 306,
            "query": "What was the statistical timeframe and specific method used to evaluate the racial group proportions against CiNA data in clinical trials, and how were representation differences determined?",
            "retrieved_metrics": {
                "reference_idx": [
                    1424,
                    1432,
                    1431
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The assessment conducted from #July 2021 to March 2022# employed #Pearson χ² tests# to evaluate racial group proportions. Differences in representation were calculated by comparing these #proportions# with corresponding data from CiNA for overrepresentation or underrepresentation.",
            "predicted_answer": "The statistical timeframe was from July 12, 2021, to March 15, 2022. The specific method used was a 2-sample test for equality of proportions with continuity correction. Representation differences were determined by comparing trial proportions with CiNA data, with positive differences indicating overrepresentation and negative differences indicating underrepresentation.",
            "score": 3,
            "explanation": "The predicted and reference answers align in general. Both indicate the timeframe from July to March of the respective years and involve comparing trial proportions to CiNA data. However, the predicted answer incorrectly identifies the method as a \"2-sample test\" instead of \"Pearson χ² tests,\" thus missing this key detail."
        },
        {
            "query_idx": 307,
            "query": "Which group of therapeutic drugs is associated with changes in clinical development times due to FDA special designations, and what statistical methods are used to study these changes?",
            "retrieved_metrics": {
                "reference_idx": [
                    621,
                    628,
                    646
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Oncology drugs with #cumulative FDA special designations# show altered #clinical development times#, examined using methods like #Kaplan-Meier curves# and #Cox proportional hazard regression#.",
            "predicted_answer": "Oncology drugs are associated with changes in clinical development times due to FDA special designations. Statistical methods used include Kaplan-Meier curves, Cox proportional hazard regression, Fisher's exact tests, Kruskal-Wallis tests, and random-effect models for meta-analysis.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies oncology drugs as associated with changes in clinical development times due to FDA special designations. It includes the statistical methods Kaplan-Meier curves and Cox proportional hazard regression. However, it misses 'cumulative' regarding FDA designations. Despite this, the overall trend is consistent."
        },
        {
            "query_idx": 308,
            "query": "Which proteins have been identified through experimental techniques as interacting with B7-H3, and why are these interactions significant in scientific research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1381,
                    1382
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The proteins #Angio-associated migratory cell protein (AAMP)# and #Interleukin-20 receptor alpha (IL-20RA)# have been identified as B7-H3 interaction partners through experimental techniques, aiding research into its biological roles.",
            "predicted_answer": "IL-20RA and AAMP have been identified as B7-H3 interaction partners through experimental techniques like BiFC and co-IP. These interactions are significant as they suggest B7-H3's role in immune regulation and potential targets for cancer therapy.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies AAMP and IL-20RA as B7-H3 interaction partners, matching the key facts in the Reference Answer. It also aligns with the significance of these findings related to B7-H3's roles, with no major facts omitted or contradictions present."
        },
        {
            "query_idx": 309,
            "query": "What is the name of the antibody identified using patient-derived organoids for colorectal cancer, which receptors does it bind on cancer stem cells, and what is the outcome on organoid development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1169,
                    1801
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The antibody #MCLA-158# binds to #LGR5# and #EGFR# receptors on cancer stem cells, resulting in #significant blockage of organoid growth#.",
            "predicted_answer": "The antibody identified is MCLA-158, which binds EGFR and LGR5 on cancer stem cells, leading to robust blocking of organoid growth.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts from the 'Reference Answer': the antibody name (MCLA-158), the receptors (EGFR and LGR5), and the outcome (blocking of organoid growth). The meanings align precisely despite different phrasing, with no significant omissions or contradictions."
        },
        {
            "query_idx": 310,
            "query": "What computational strategies and modern techniques are utilized to identify new chemical entities derived from plants in the field of anti-cancer drug discovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    1655,
                    1702,
                    1688
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Computer-aided drug discovery utilizes #structure and ligand-based approaches#, including #molecular docking#, #dynamics#, and #QSAR#, with emerging #ML# and #network pharmacology# to identify #NCEs from plant sources#.",
            "predicted_answer": "Computational strategies for identifying new chemical entities derived from plants in anti-cancer drug discovery include molecular docking, pharmacophore modeling, QSAR, and virtual screening. Modern techniques such as machine learning (ML) and network pharmacology are also utilized.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as molecular docking, QSAR, machine learning, and network pharmacology, aligning with the reference answer. However, it misses \"structure and ligand-based approaches\", \"dynamics\", and specific focus on \"NCEs from plant sources\", affecting completeness."
        },
        {
            "query_idx": 311,
            "query": "What cell line and plate format are used in the newly devised method for studying breast cancer drug effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    340,
                    349
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The evaluation method uses #MCF-7# cells with a novel approach in #ultra-low attachment 6-well# plates and a distinct #method# in #96-well low attachment# plates.",
            "predicted_answer": "The newly devised method uses MCF-7 breast cancer cell line and 96-well low attachment plates for studying breast cancer drug effectiveness.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference answer, mentioning the #MCF-7# cell line and #96-well low attachment# plates. However, it omits the use of #ultra-low attachment 6-well# plates, a key fact. No contradictory information is present, but completeness is slightly impacted."
        },
        {
            "query_idx": 312,
            "query": "Which signalling pathways require targeting in cancer treatment to overcome drug resistance, what role do these pathways play in cancer cell functions, and how can existing drugs address cancer holistically?",
            "retrieved_metrics": {
                "reference_idx": [
                    2252,
                    2255,
                    769
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Renin-Angiotensin System# and its involvement with #CPT1# support cancer proliferation. Targeting these pathways alongside #drug repurposing# approaches addresses cancer’s #14 hallmarks#.",
            "predicted_answer": "Targeting multiple signalling pathways like RAS, Notch, Wnt/β-catenin, and Sonic Hedgehog in cancer treatment can overcome drug resistance by addressing the complex interactions within the tumour microenvironment. Existing drugs can address cancer holistically by inhibiting multiple targets simultaneously, leveraging the known safety profiles of repurposed drugs to target cancer hallmarks.",
            "score": 1,
            "explanation": "The predicted answer does not include any mention of the Renin-Angiotensin System, CPT1, or the 14 hallmarks of cancer, which are key facts emphasized in the reference answer. This affects the completeness and alignment of the answer with the reference."
        },
        {
            "query_idx": 313,
            "query": "How do infectious disease safety protocols impact surgical procedures for rapidly progressing thyroid tumors, and what non-surgical treatments are considered when surgery is not viable?",
            "retrieved_metrics": {
                "reference_idx": [
                    2157,
                    2159,
                    2158
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "During the #COVID-19# pandemic, #surgical procedures are impacted# by restrictions. For rapidly advancing thyroid cancers, if #surgery is not viable#, alternatives like #RAI or pharmacotherapy# are considered.",
            "predicted_answer": "Infectious disease safety protocols during the COVID-19 pandemic may delay or restrict surgical procedures for rapidly progressing thyroid tumors, especially aggressive ones. Non-surgical treatments like radioactive iodine (RAI) or pharmacotherapy are considered when surgery is not viable.",
            "score": 5,
            "explanation": "The predicted answer fully includes all key facts from the reference answer: it mentions the COVID-19 pandemic and its impact on surgical procedures, considers rapidly progressing thyroid tumors, and identifies RAI and pharmacotherapy as alternatives when surgery is not viable. There are no omissions or contradictions."
        },
        {
            "query_idx": 314,
            "query": "How are selenium-based compounds currently being used in pharmaceutical development, and what diseases are targeted by ongoing research and future therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1865,
                    1904
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Selenium compounds are developed for #pharmaceuticals#, targeting #tumor and diabetes# treatment in ongoing research and future therapies.",
            "predicted_answer": "Selenium-based compounds are used in pharmaceutical development for their antioxidant, anticancer, antimicrobial, and neuroprotective properties. Ongoing research targets diseases like cancer, diabetes, Alzheimer's, and infections. Future therapeutic applications focus on expanding their use in nanomedicines.",
            "score": 3,
            "explanation": "The predicted answer includes the use of selenium-based compounds in pharmaceuticals and targets diseases like cancer and diabetes, aligning with the reference answer. However, it adds additional diseases and properties. While consistent, it lacks specific focus on tumors as key terminology from the reference."
        },
        {
            "query_idx": 315,
            "query": "What treatment regimen involving Pembrolizumab is used for advanced cervical cancer, populations with PD-L1 CPS of 1 or greater, and early-stage TNBC, and what are their respective outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1032,
                    1033,
                    660
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Using #Pembrolizumab# with TP and optional #Bevacizumab# improves #OS and PFS# for advanced cervical cancer, reduces #mortality risk# by 40% for PD-L1 CPS ≥1, and boosts #complete response and event-free survival# in TNBC.",
            "predicted_answer": "For advanced cervical cancer with PD-L1 CPS ≥1, Pembrolizumab combined with TP (paclitaxel and cisplatin or carboplatin) plus optional Bevacizumab improves OS and PFS. For early-stage TNBC, Pembrolizumab with neoadjuvant chemotherapy followed by adjuvant Pembrolizumab increases pathologic complete response and event-free survival.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts and trends from the reference answer regarding the use of Pembrolizumab with TP and optional Bevacizumab for advanced cervical cancer, and its benefits in OS and PFS, as well as important outcomes for TNBC. However, it omits the 40% mortality risk reduction."
        },
        {
            "query_idx": 316,
            "query": "What trial phase is currently examining inhibitors in breast cancer with BRCA mutations, focusing on reducing specific side effects, and what foundational evidence supports this approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    651,
                    665,
                    657
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Phase III trials target #g BRCA mutations# in breast cancer, aiming to cut down #hematologic toxicity#, underpinned by #preclinical proof-of-concept# supporting BRCA-associated cancer treatment.",
            "predicted_answer": "The current trial phase examining inhibitors in breast cancer with BRCA mutations is Phase III, focusing on reducing hematologic toxicity with PARP1 inhibitors like AZD5305. Foundational evidence supports this approach through the synthetic lethality concept, where PARPi target tumors with deficient homologous recombination repair, leading to DNA damage and cell death.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: it mentions \"Phase III,\" \"BRCA mutations,\" \"hematologic toxicity,\" and the foundational concept (synthetic lethality aligned with \"preclinical proof-of-concept\"). There are no significant omissions or contradictions."
        },
        {
            "query_idx": 317,
            "query": "What are the effects of different injection sites on the efficiency of bone metastasis in breast cancer models, and which specific cell lines achieve the highest success rates in these models?",
            "retrieved_metrics": {
                "reference_idx": [
                    2065,
                    2071,
                    2068
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Injection sites affect #bone metastasis efficiency#, with success rates for #4T1, E0771, and KEP# cell lines. #MDA MB-231 subtypes# show 95% success via tail injection.",
            "predicted_answer": "Different injection sites affect bone metastasis efficiency: tail vein causes lung metastases, intracardiac causes bone and brain metastases. High success rates are achieved by cell lines like 4T1 (20%), E0771 (60-80%), KEP (50%), and MDA MB-231 subtypes (95% bone metastasis via tail injection).",
            "score": 5,
            "explanation": "The predicted answer captures the critical aspects of bone metastasis efficiency linked to injection sites and mentions the key cell lines (4T1, E0771, KEP, MDA MB-231) associated with varying success rates. It covers the essential #emphasized# information without contradictions, maintaining trend consistency."
        },
        {
            "query_idx": 318,
            "query": "Which compounds impact the acidification process in cancer cells that influences both drug resistance and immune evasion mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    843,
                    844
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#PPIs# impact the #acidification process# modulating #chemoresistance# and influencing #immune evasion mechanisms# in tumor cells.",
            "predicted_answer": "Proton pump inhibitors (PPIs) impact the acidification process in cancer cells by reducing V-ATPase activity, which influences drug resistance and immune evasion mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference: \"PPIs,\" \"acidification process,\" and their influence on \"drug resistance\" and \"immune evasion mechanisms.\" The phrases differ slightly, but all crucial details are present, and the predicted answer is consistent and complete in meaning."
        },
        {
            "query_idx": 319,
            "query": "What is the specific genetic mutation that FDA-approved irreversible inhibitors target, which compound was the first approved to address these mutations, and what structural challenges are associated with this gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    880,
                    1110,
                    883
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "FDA-approved irreversible inhibitors target the #KRAS G12C# mutation. The first approved inhibitor is #Sotorasib#, known as #AMG 510#, with development challenges due to KRAS's smooth surface.",
            "predicted_answer": "The specific genetic mutation targeted by FDA-approved irreversible inhibitors is KRAS G12C. The first approved compound is Sotorasib (AMG 510). Structural challenges include the smooth surface of the KRAS protein lacking obvious pockets and its propensity to bind GTP.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference: the mutation #KRAS G12C#, the first approved compound #Sotorasib# (#AMG 510#), and mentions structural challenges linked to the KRAS protein. Both answers align well in key facts and overall trends."
        },
        {
            "query_idx": 320,
            "query": "What comprehensive methodologies combine detailed molecular characterization and spatial analysis to address the diverse cellular composition in tumors and its implications for treatment resistance in clinical oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    608,
                    1052
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Multi-omics technologies# enable detailed #molecular characterization and spatial analysis#, addressing #intratumoral heterogeneity# challenges crucial for overcoming treatment resistance in clinical oncology.",
            "predicted_answer": "Comprehensive methodologies combining multi-omics technologies with spatial resolution, such as slide-DNA-seq, enable detailed molecular characterization and spatial analysis of tumor microenvironments, addressing cellular heterogeneity and its implications for treatment resistance in clinical oncology.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference, as it correctly mentions \"multi-omics technologies\" and \"molecular characterization and spatial analysis,\" addressing \"cellular heterogeneity\" (equivalent to \"intratumoral heterogeneity\") and its implications for treatment resistance in clinical oncology. All key facts are present with consistent meaning."
        },
        {
            "query_idx": 321,
            "query": "Which gene editing strategies are implemented to address immune rejection challenges in both CAR19-T cells and universal CAR-T cell therapies, and what specific targets do they focus on in each type?",
            "retrieved_metrics": {
                "reference_idx": [
                    935,
                    963,
                    2114
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Gene editing tools# like #TALENs# prevent immune rejection in #CAR19-T cells#, while #CRISPR-Cas9# targets #MHC related genes# in #universal CAR-T cells# to provide immunological advantages.",
            "predicted_answer": "Gene editing strategies for immune rejection in CAR19-T cells and universal CAR-T cells include knocking out TCR and CD52 genes using TALENs, and targeting MHC genes with CRISPR-Cas9. These edits prevent host immune rejection and graft-versus-host disease.",
            "score": 3,
            "explanation": "The predicted answer covers the use of TALENs in CAR19-T cells and CRISPR-Cas9 in universal CAR-T cells, aligning with the reference's emphasis on these tools and their targets. However, the predicted answer omits the specific mention of targeting MHC genes in universal CAR-T cells."
        },
        {
            "query_idx": 322,
            "query": "What therapeutic approach involves inhibiting specific proteins like CDK4 and CDK6 and is associated with discovering new therapeutic opportunities through understanding genetic interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1959,
                    1962
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The therapeutic approach involves inhibiting #paralog members# like #CDK4 and CDK6#, leveraging #synthetic lethality# with #gene pairs#, promising new therapeutic opportunities.",
            "predicted_answer": "The therapeutic approach involves targeting specific proteins like CDK4 and CDK6, exemplified by drugs like palbociclib, and is associated with discovering new therapeutic opportunities through understanding genetic interactions, particularly synthetic lethality between paralog pairs.",
            "score": 3,
            "explanation": "The predicted answer mentions targeting CDK4 and CDK6, aligning with the reference. It includes synthetic lethality but omits explicit mention of \"paralog members\" and \"gene pairs.\" The overall trend is correct, but the absence of \"paralog members\" and \"gene pairs\" affects completeness."
        },
        {
            "query_idx": 323,
            "query": "What are the integrated components and specific resistance indicators analyzed in the newly developed in vitro model for testing immune checkpoint inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1492,
                    1497
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The model integrates an #immune-competent tumor model# with a #tumoroid and artificial lymph node#, analyzing #primary resistance indicators#, including #TILs and PD-L1 expression#.",
            "predicted_answer": "The integrated components in the in vitro model include patient-derived tumoroids connected to artificial lymph nodes with mature antigen-presenting cells. Specific resistance indicators analyzed are tumor-infiltrating lymphocytes (TILs) and PD-L1 expression.",
            "score": 3,
            "explanation": "The predicted answer includes the integrated components \"tumoroid and artificial lymph node\" and specific resistance indicators \"TILs and PD-L1 expression.\" It misses the mention of \"#immune-competent tumor model#\" and \"#primary resistance indicators#,\" affecting completeness but aligns with the overall trend."
        },
        {
            "query_idx": 324,
            "query": "Which PET ligands are used to measure an enzyme associated with Alzheimer's in the human brain and a phosphodiesterase isoform related to CNS disorders?",
            "retrieved_metrics": {
                "reference_idx": [
                    1539,
                    1538
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#[$^{18}$F]LSN3316612# measures an enzyme linked to Alzheimer's, while #PF-06445974# targets a phosphodiesterase isoform related to CNS disorders.",
            "predicted_answer": "The PET ligands used are [$^{18}$F]LSN3316612 for O-GlcNAc hydrolase (OGA) associated with Alzheimer's and PF-06445974 for Phosphodiesterase 4B (PDE4B) related to CNS disorders.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies both key PET ligands: [$^{18}$F]LSN3316612 for Alzheimer's-related enzyme and PF-06445974 for the phosphodiesterase isoform related to CNS disorders. All crucial information highlighted in the reference answer is present and correctly linked, with no contradictions."
        },
        {
            "query_idx": 325,
            "query": "Describe the selenium-based compounds used in cancer treatment, specifying the cancer type each targets and the mechanism of action or measurement value associated with each.",
            "retrieved_metrics": {
                "reference_idx": [
                    1883,
                    1886,
                    1884
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Compound 36 targets breast cancer with an #IC₅₀ value of 1.5 µM#. Selenazoles target melanoma with #antitumor activity#. Selnocoxib-1 targets prostate cancer through #inhibition mechanism# downregulating p-AKT, COX-2, HIF-1a.",
            "predicted_answer": "Selenocyanate compounds, such as benzyl selenocyanate, target breast cancer (MCF-7) by inhibiting tubulin polymerization and Akt phosphorylation, with an IC50 value of 1.5 µM. Selenazoles, like compound 44, exhibit antitumor activity against mouse melanoma. Selnocoxib-1 inhibits prostate cancer (PAIII, PC-3M) with IC50 values of 5 µM, downregulating p-AKT, COX-2, and HIF-1α.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key elements: selenocyanate compounds target breast cancer (IC₅₀ 1.5 µM), selenazoles' antitumor activity against melanoma, and Selnocoxib-1's prostate cancer targets with detailed inhibition mechanisms. The details and trends align well with no significant omissions or errors."
        },
        {
            "query_idx": 326,
            "query": "What technological advancements are used to enhance the accuracy of cancer diagnosis and to tailor personalized cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1213,
                    1627
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Deep learning# enhances cancer diagnosis accuracy, while #machine learning# tailors personalized therapies, improving both precision in diagnostics and treatment approaches.",
            "predicted_answer": "Technological advancements like deep learning algorithms and AI-powered digital pathology platforms enhance cancer diagnosis accuracy by automating image analysis and revealing molecular signatures, improving prognostic assessment and personalized therapies.",
            "score": 3,
            "explanation": "The predicted answer includes \"deep learning\" and touches on enhancing diagnostic accuracy with AI technologies, aligning with the reference. However, it misses \"machine learning,\" which is crucial for tailoring personalized therapies, leading to incomplete coverage of key facts."
        },
        {
            "query_idx": 327,
            "query": "What changes are necessary in both the approach for phage-based vaccination methodologies and the technical systems supporting these vaccines to improve their overall effectiveness in inducing an immune response?",
            "retrieved_metrics": {
                "reference_idx": [
                    64,
                    63
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Improvements are needed in the #targeted phage-based vaccination strategies# and the #optimization of phage display systems# to enhance the effectiveness of the immune response.",
            "predicted_answer": "To improve the effectiveness of phage-based vaccination methodologies, optimize antigen presentation and phage display systems to enhance immunogenicity. Additionally, streamline technical systems, including cold-free supply chains, and navigate regulatory frameworks for broader acceptance.",
            "score": 3,
            "explanation": "The predicted answer addresses optimizing antigen presentation and phage display systems in alignment with the reference's call for optimized phage display systems. However, it doesn't specifically mention \"targeted\" strategies. This omission of a key detail impacts completeness slightly, aligning with a score of 3."
        },
        {
            "query_idx": 328,
            "query": "What cancer model, noted for its ability to reproduce original tumor features, provides enhanced transcriptional accuracy and is applied in NSCLC studies for evaluating drug effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    1481,
                    1489,
                    1482
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The model used is the #lung tumoroids#, which #mimic primary tumor# features, offer #higher transcriptional accuracy#, and are used in #NSCLC tumoroid# studies to evaluate #drug toxicity# and efficacy.",
            "predicted_answer": "The cancer model that provides enhanced transcriptional accuracy and is applied in NSCLC studies for evaluating drug effects is the patient-derived tumoroid model, which reproduces original tumor features and includes relevant healthy cells.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer. It correctly identifies the cancer model as the tumoroid model, mentions its transcriptional accuracy and ability to reproduce original tumor features, and its application in NSCLC studies. However, it does not explicitly mention \"drug toxicity.\""
        },
        {
            "query_idx": 329,
            "query": "How do different proton therapy techniques compare in terms of radiation dose delivery and adverse event rates for treating locally advanced and unresectable NSCLC, relative to photon radiation therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1003,
                    1002
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#IMPT# offers lower radiation doses and fewer adverse events in locally advanced NSCLC, whereas #PSPT# demonstrates a reduced rate of adverse events in unresectable NSCLC compared to photon radiation.",
            "predicted_answer": "Intensity-modulated proton therapy (IMPT) delivers lower radiation doses to surrounding organs and has lower adverse event rates compared to photon radiation therapy for locally advanced and unresectable NSCLC. Passive scattering proton therapy (PSPT) also shows improved safety with fewer adverse events.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts, namely #IMPT# and #PSPT#, concerning lower radiation doses and reduced adverse events compared to photon therapy. It maintains alignment with the Reference Answer, though specifics on the NSCLC type for PSPT are less precise. No contradictions are evident."
        },
        {
            "query_idx": 330,
            "query": "How is the impact of drug exposure on cells within three-dimensional cultures assessed and quantified graphically to evaluate treatment potency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1733,
                    1744
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #proportion of living cells# is assessed through viability assays and quantified in a #concentration-response curve# to gauge the drug's potency in 3D cultures.",
            "predicted_answer": "The impact of drug exposure on cells within three-dimensional cultures is assessed and quantified graphically using concentration-response curves derived from cell viability assays. Key metrics include IC50 (half-maximal inhibitory concentration) and AUC (area under the curve), which measure drug potency by comparing cell viability at different drug concentrations to an untreated control.",
            "score": 3,
            "explanation": "The predicted answer includes the use of concentration-response curves and viability assays both mentioned in the reference, which aligns with the core concept of drug potency assessment. However, it fails to mention #the proportion of living cells#, missing a key fact. No contradictory information is present."
        },
        {
            "query_idx": 331,
            "query": "What biological challenges affect the persistent effectiveness of gene therapy in non-native target cells, potentially leading to decreased expression of the therapy product over time?",
            "retrieved_metrics": {
                "reference_idx": [
                    448,
                    449
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The nature of #non-native transduced target cells# poses biological challenges, affecting the persistent effectiveness of Roctavian, as its #transgene expression decreases# over time.",
            "predicted_answer": "The persistent effectiveness of gene therapy in non-native target cells is challenged by factors such as the inability of hepatocytes to produce complex proteins like FVIII, differences in protein size and co-expression with chaperone proteins, and the fading of transgene expression over time, potentially necessitating redosing.",
            "score": 5,
            "explanation": "The predicted answer mentions the nature of non-native target cells affecting gene therapy effectiveness, aligning with the reference's mention of \"non-native transduced target cells.\" It also notes the decrease in transgene expression. All key facts from the reference are reflected in the predicted answer."
        },
        {
            "query_idx": 332,
            "query": "How is ubiquitin transferred in the ubiquitination process, and what classification is based on the N-terminal sequences of HECT-type E3s?",
            "retrieved_metrics": {
                "reference_idx": [
                    1553,
                    1554
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Ubiquitin transfer involves a #two-step reaction# from E2 to E3, then to substrates. HECT-type E3s are classified into #three groups# based on N-terminal sequences.",
            "predicted_answer": "Ubiquitin is transferred in the ubiquitination process through a two-step reaction involving HECT E3s, forming a HECT-Ub thioester intermediate. HECT-type E3s are classified based on N-terminal sequences into WW domain-containing, HERC/RLD-containing, and WW/RLD-lacking groups.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the \"two-step reaction\" involving ubiquitin transfer in the ubiquitination process and mentions the three groups of HECT-type E3s based on their N-terminal sequences. This aligns with the key facts in the reference answer without any contradictory information."
        },
        {
            "query_idx": 333,
            "query": "What investigational agents are currently being evaluated in clinical trials for their roles in treating SCLC, AML, and NSCLC, and what are their distinct evaluation criteria in these trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    587,
                    583,
                    202
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The agents under investigation include #CC -90011# in #SCLC trials#, showing #safety and efficacy of Iadademstat# in #AML#, and #Enfortumabvedotin# for #targeting Nectin 4 in NSCLC#.",
            "predicted_answer": "Investigational agents being evaluated in clinical trials for SCLC, AML, and NSCLC include CC-90011 plus nivolumab, bomedemstat plus atezolizumab, and iadademstat. Evaluation criteria involve assessing efficacy, safety, and clinical activity, such as complete response (CR) rates.",
            "score": 1,
            "explanation": "The Predicted Answer mentions CC-90011 but does not specify its evaluation in SCLC. It correctly identifies iadademstat but not in the context of AML. Enfortumab vedotin for NSCLC is missing. Overall, the predicted answer omits a key fact and misaligns drug indications."
        },
        {
            "query_idx": 334,
            "query": "What drug used in leukemia treatment incorporates longitudinal data and a tumor growth inhibition model to determine drug effectiveness and toxicity, and uses a specific model linking drug concentration to tumor response?",
            "retrieved_metrics": {
                "reference_idx": [
                    1622,
                    1630,
                    1811
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The drug #Asciminib# for #chronic myeloid leukemia# uses #longitudinal data# and #TGI-survival modeling# to assess #effectiveness# and #toxicity#, with the #Simeoni TGI model# relating concentration to #tumor inhibition#.",
            "predicted_answer": "The drug asciminib, used in chronic myeloid leukemia treatment, incorporates longitudinal data and the Simeoni TGI model to determine drug effectiveness and toxicity by linking drug concentration to tumor response.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the drug as Asciminib for chronic myeloid leukemia, using longitudinal data and the Simeoni TGI model to evaluate effectiveness and toxicity by linking drug concentration to tumor response. It matches all key facts in the reference answer without significant omissions or contradictions."
        },
        {
            "query_idx": 335,
            "query": "What legal pathway introduced by the US Congress in 2012 enhances the drug development process by allowing trial flexibility and approvals relying on non-traditional clinical trial endpoints?",
            "retrieved_metrics": {
                "reference_idx": [
                    1916,
                    1915,
                    644
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2012, the #Breakthrough Therapy designation# was introduced, offering #trial design flexibility# and #approval based on surrogate endpoints# to expedite drug development for serious conditions.",
            "predicted_answer": "The Breakthrough Therapy designation, introduced by the US Congress in 2012, enhances drug development by allowing trial flexibility and approvals based on non-traditional clinical trial endpoints.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer: \"Breakthrough Therapy designation,\" \"trial flexibility,\" and \"approvals based on non-traditional clinical trial endpoints.\" The meaning and overall trend align, with no significant omissions or errors."
        },
        {
            "query_idx": 336,
            "query": "What challenges exist in the treatment development for rare aggressive cancers, and how do inefficiencies in late-stage trials underscore the necessity for a specific pre-clinical study approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    286,
                    304,
                    2270
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The development of therapies for #rare aggressive cancers# is hindered by unclear mechanisms. Inefficiencies in #late-stage trials# emphasize the need for #pre-clinical combination studies# to ensure effective clinical evaluations.",
            "predicted_answer": "Challenges in treating rare aggressive cancers include inadequate target exposure, intrinsic resistance, and poorly defined tumor microenvironment factors. Inefficiencies in late-stage trials, such as high failure rates and insufficient patient accrual, underscore the need for comprehensive pre-clinical studies to identify effective therapeutic combinations and reduce costs.",
            "score": 1,
            "explanation": "The predicted answer addresses challenges in treating rare aggressive cancers and the inefficiencies in late-stage trials. However, it is missing the \"unclear mechanisms\" challenge and the necessity for \"pre-clinical combination studies\". Two critical points reflected by hash tags are missing, impacting completeness."
        },
        {
            "query_idx": 337,
            "query": "What technology is utilized for the early detection of a specific pulmonary complication in lung cancer, and what primary therapy is used for this condition's management once detected?",
            "retrieved_metrics": {
                "reference_idx": [
                    205,
                    215
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#eNose technology# enables early detection of ILD, and #steroid treatment# serves as the primary management for #ILD#.",
            "predicted_answer": "Breath Analysis technology is utilized for early detection of interstitial lung disease (ILD) in lung cancer. Once detected, the primary therapy for ILD management includes corticosteroids, with dosing based on severity.",
            "score": 3,
            "explanation": "The predicted answer mentions \"Breath Analysis technology\" instead of \"eNose technology,\" failing to match the key specific technology in the reference. It aligns by mentioning interstitial lung disease (ILD) and corticosteroids (steroid treatment) for management. Missing the exact technology reduces completeness."
        },
        {
            "query_idx": 338,
            "query": "Which analytical method evaluates clinical trial activity disparities and investment distribution across various cancer types around the globe, and how does it address each type's specific research needs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1198,
                    1200
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The analysis employs a #unique global database# measuring clinical trial disparities for #rare and non-rare cancers#, addressing #inequity in R&D investment based on relative need#.",
            "predicted_answer": "The analytical method that evaluates clinical trial activity disparities and investment distribution across various cancer types globally is based on a unique global database of clinical trial activity and costs. It measures inequalities and inequity in clinical trial activity and R&D investment, considering different R&D stages and time evolution, using proxies like prevalence, incidence, and survival rates to address each cancer type's specific research needs.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of using a unique global database to evaluate clinical trial disparities. It mentions the measurement of inequalities and inequity, aligning with research needs. However, it omits mentioning \"rare and non-rare cancers\" explicitly as emphasized in the reference answer."
        },
        {
            "query_idx": 339,
            "query": "Which type of cancer, often requiring treatment as a second or third option and characterized by severe healthcare needs and fewer available therapies, is frequently recognized through special healthcare designations?",
            "retrieved_metrics": {
                "reference_idx": [
                    636,
                    640
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hematologic cancers# frequently receive #special designations# due to #severe healthcare needs#, lower disease incidence, and being treated in advanced therapy lines with limited options.",
            "predicted_answer": "Hematologic cancers, often treated as second- or third-line options, are frequently recognized through special healthcare designations due to their severe healthcare needs and fewer available therapies.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of #hematologic cancers# and their #special designations# due to #severe healthcare needs#. However, it omits the reference's mention of \"lower disease incidence\" and the detail about advanced therapy lines with limited options, affecting completeness."
        },
        {
            "query_idx": 340,
            "query": "What is the viral agent used in glioma treatment, what therapeutic combination is utilized, and how does this combination impact patient survival?",
            "retrieved_metrics": {
                "reference_idx": [
                    991,
                    992
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agent #DNX-2401# targets #recurrent malignant glioma#, combined with an #immune checkpoint inhibitor#, resulting in a #survival benefit# for patients.",
            "predicted_answer": "The viral agent used in glioma treatment is DNX-2401, an adenovirus-based oncolytic virus. A therapeutic combination with an immune checkpoint inhibitor has shown a survival benefit in select patients, with 3 out of 20 achieving complete responses and progress-free survival of over 3 years.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies DNX-2401 as the viral agent and mentions its combination with an immune checkpoint inhibitor and the survival benefit, covering all key facts indicated by # symbols in the Reference Answer. The responses align in terms of meaning and important information."
        },
        {
            "query_idx": 341,
            "query": "Which compound extracted from R. chingii Hu demonstrates notable cytotoxic effects on tumor cells and is among the plant's key types of bioactive chemical structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    314,
                    317
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Tormentic acid#, extracted from R. chingii Hu, exhibits strong cytotoxic effects against cancer cells. It is classified among the plant’s main #terpenoids# with significant bioactivity.",
            "predicted_answer": "Tormentic acid, a terpenoid isolated from R. chingii Hu, demonstrates notable cytotoxic effects on tumor cells and is among the plant's key bioactive chemical structures.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: the compound \"Tormentic acid,\" its extraction source \"R. chingii Hu,\" its \"cytotoxic effects on tumor cells,\" and its classification as a \"terpenoid\" with \"significant bioactivity.\" There are no omissions or contradictions."
        },
        {
            "query_idx": 342,
            "query": "Which therapy received approval in 2023 for pediatric patients with a low-grade glioma mutation, and what therapy is the standard for melanoma involving a particular mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1025,
                    1040
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The therapy #Tafinlar + Mekinist# received #pediatric approval in 2023# for patients with #low-grade glioma#, while #standard treatment# for #melanoma# involves patients with the #BRAF V600E/K mutation#.",
            "predicted_answer": "In 2023, Tafinlar + Mekinist was approved for pediatric patients with low-grade gliomas carrying the BRAF V600E mutation. For melanoma with BRAF V600E/K mutations, the standard therapy is Dabrafenib + Trametinib.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes all key facts: \"Tafinlar + Mekinist\" for \"pediatric approval in 2023\" with \"low-grade glioma\" and \"standard treatment for melanoma with BRAF V600E/K mutation\". There are no omissions or contradictions against the Reference Answer."
        },
        {
            "query_idx": 343,
            "query": "What are the factors escalating the production expenses of monoclonal antibodies and the implications of increasing production scale for clinical use?",
            "retrieved_metrics": {
                "reference_idx": [
                    908,
                    909
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The production expenses rise due to #high costs# linked with #complex production processes#, requiring #large quantities# of monoclonal antibodies for achieving the desired clinical outcomes.",
            "predicted_answer": "The factors escalating production expenses of monoclonal antibodies include their large size, complex structure, and the need for eukaryotic machinery. Increasing production scale aims to lower costs but also faces challenges like antibody-related side effects.",
            "score": 1,
            "explanation": "The predicted answer discusses complexity and production scale, aligning with the trend of the reference answer. However, it misses explicit mention of \"high costs,\" \"large quantities,\" and \"complex production processes,\" resulting in an incomplete reflection of key facts highlighted in the reference answer."
        },
        {
            "query_idx": 344,
            "query": "How are patient-derived organoids from breast cancer used to predict tumor growth responses, particularly in gemcitabine resistance, and what statistical data supports their derivation and predictive accuracy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1783,
                    1784,
                    1732
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Breast cancer PDxOs have an #85% success rate#, exhibit #TGI# in gemcitabine resistance, and show a predictive power with #accuracy# 86%, #positive value# 75%, and #negative value# 91%.",
            "predicted_answer": "Patient-derived organoids (PDOs) from breast cancer are used to predict tumor growth responses, including gemcitabine resistance, by testing kinase inhibitors on PDOs. Statistical data from Xu et al. indicates that PDOs have good predictive power for in vivo outcomes (accuracy = 86%, positive predictive value = 75%, negative predictive value = 91%).",
            "score": 3,
            "explanation": "The predicted answer captures the key fact about the 86% accuracy, 75% positive predictive value, and 91% negative predictive value, consistent with the reference. However, it misses the \"85% success rate\" fact and the specific mention of TGI in gemcitabine resistance, affecting completeness."
        },
        {
            "query_idx": 345,
            "query": "How are functional cell clusters developed and utilized to represent and investigate diverse tumor variations in cancer research and personalized medicine?",
            "retrieved_metrics": {
                "reference_idx": [
                    1393,
                    1802,
                    2038
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Functional cell clusters are developed into #3D structural models# using #tissue stem cells#, stored as a #biobank of tumor subtypes# to investigate and represent #tumor heterogeneity# for personalized medicine.",
            "predicted_answer": "Functional cell clusters, such as organoids, are developed by inducing tissue stem cells to differentiate into 3D structures that mimic tumor properties. They are utilized in cancer research and personalized medicine to model tumor heterogeneity, assess drug efficacy, and create biobanks for diverse tumor subtypes.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: it mentions #3D structures#, #tissue stem cells#, a #biobank of tumor subtypes#, and #tumor heterogeneity#. The meaning is consistent with no significant omissions or errors, aligning with the overall trend of representing and investigating tumor variations."
        },
        {
            "query_idx": 346,
            "query": "What is the name of the compound used in research that faces a challenge due to poor systemic absorption despite showing effects involving a specific enzyme associated with cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    788,
                    790,
                    789
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Epigallocatechin 3-gallate# (EGCG) targets cancer cells by #telomerase inhibition# but its #limited bioavailability# hinders effectiveness in trials.",
            "predicted_answer": "Epigallocatechin 3-gallate (EGCG) is the compound used in research that faces a challenge due to poor systemic absorption despite showing effects involving the telomerase enzyme associated with cancer cells.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the compound as Epigallocatechin 3-gallate (EGCG) and notes the challenge of poor systemic absorption (limited bioavailability) and its association with telomerase in cancer cells. It covers all key points emphasized with # in the reference answer."
        },
        {
            "query_idx": 347,
            "query": "How does the effectiveness of the Colvera test compare with a common noninvasive biomarker in monitoring plasma elements for disease recurrence, and which specific elements does it analyze?",
            "retrieved_metrics": {
                "reference_idx": [
                    487,
                    489
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Colvera test# shows a higher #odds ratio# compared to carcinoembryonic antigen, measuring the #methylation# of BCAT and IKZF1 in plasma to monitor disease recurrence.",
            "predicted_answer": "The Colvera test is more effective than carcinoembryonic antigen (CEA) in monitoring disease recurrence, with higher sensitivity for both local and distant recurrence. Colvera analyzes the methylation levels of BCAT and IKZF1 in plasma.",
            "score": 3,
            "explanation": "The predicted answer captures key elements, stating that Colvera is more effective than CEA and details the analysis of methylation levels of BCAT and IKZF1. However, it omits the specific mention of a \"higher odds ratio\" compared to the reference. This affects completeness slightly but aligns overall."
        },
        {
            "query_idx": 348,
            "query": "What is the 2020 global estimate for new breast cancer cases, and how does the suppression of a key enzyme affect two different metabolic processes in Myc-driven breast cancer and other cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1328,
                    1329,
                    1338
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In 2020, there were #2.26 million# new breast cancer cases. CPT1A suppression alters #energy metabolism# in Myc-driven breast cancer and enhances #β-catenin# acetylation in other cancer cells.",
            "predicted_answer": "The 2020 global estimate for new breast cancer cases is 2.26 million. Suppressing CPT1A affects two metabolic processes: reducing lymphangiogenesis and inhibiting fatty acid oxidation (FAO) in Myc-driven breast cancer and other cancer cells.",
            "score": 1,
            "explanation": "The predicted answer correctly states the 2020 global estimate for new breast cancer cases as 2.26 million. However, it misses the key detail of \"energy metabolism\" alteration in Myc-driven cancer and \"β-catenin\" acetylation in other cancer cells, instead mentioning different metabolic processes."
        },
        {
            "query_idx": 349,
            "query": "What pharmacokinetic factors influence the clinical impact of a specific TKI used in chronic myeloid leukemia, and how are these factors considered in treatment modifications?",
            "retrieved_metrics": {
                "reference_idx": [
                    712,
                    714
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The TKI #imatinib#'s #pharmacokinetic profile# affects its clinical impact, necessitating #treatment adjustments# in chronic myeloid leukemia based on patient response variability.",
            "predicted_answer": "Pharmacokinetic factors influencing TKI impact in CML include age, BMI, compliance, concomitant drugs, diet, genetics, and organ function. Systemic drug exposure (AUC) relates to efficacy and toxicity, guiding dose modifications to optimize response and reduce toxicities.",
            "score": 1,
            "explanation": "The predicted answer discusses general pharmacokinetic factors affecting TKIs in CML, including feedback aspects like systemic drug exposure, which can lead to treatment adjustments. However, it fails to specifically mention #imatinib# and its #pharmacokinetic profile# as well as #treatment adjustments# based on #patient response variability#, thus missing multiple key facts."
        },
        {
            "query_idx": 350,
            "query": "How does a specific drug targeting lipid metabolism affect the growth of xenografts in prostate cancer, and what is the duration of its effect?",
            "retrieved_metrics": {
                "reference_idx": [
                    1332,
                    1333
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The drug #Etomoxir# targets #CPT1A# in lipid metabolism, reducing prostate cancer #xenograft growth# for #21 days#.",
            "predicted_answer": "Etomoxir, an inhibitor of CPT1A, reduces xenograft growth in prostate cancer for up to 21 days by decreasing mTOR signaling and increasing apoptosis.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts from the reference answer: the drug Etomoxir targeting CPT1A, affecting xenograft growth in prostate cancer for 21 days. Additional details about mTOR signaling and apoptosis do not contradict the reference, strengthening the explanation without any significant omissions."
        },
        {
            "query_idx": 351,
            "query": "What specific dose-related factor influences the risk of severe complications in hemophilia gene therapy using AAV vectors and has led to concerns due to serious incidents?",
            "retrieved_metrics": {
                "reference_idx": [
                    447,
                    975
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #dosage# of AAV vectors impacts the risk of severe complications in hemophilia gene therapy, resulting in #controversy# due to serious incidents at high doses.",
            "predicted_answer": "The specific dose-related factor influencing the risk of severe complications in hemophilia gene therapy using AAV vectors is the vector dose, which has led to concerns due to serious incidents such as liver function abnormalities and acute liver failure.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of \"dose\" related to AAV vectors influencing complications and mentions serious incidents. However, the reference highlights \"controversy\" at \"high doses,\" which the predicted answer does not explicitly address, affecting completeness."
        },
        {
            "query_idx": 352,
            "query": "Which polymer-based nanoparticles are used in oncology for targeted drug delivery and show comparative effectiveness to soluble anti-PD-L1 monoclonal antibodies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    854,
                    1023
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In oncology, #PLGA# nanoparticles are used for #targeted drug delivery# and have shown #effectiveness comparable to anti-PD-L1 monoclonal antibody treatments#, enhancing cancer care.",
            "predicted_answer": "PLGA nanoparticles are used in oncology for targeted drug delivery and show comparative effectiveness to soluble anti-PD-L1 monoclonal antibodies in cancer treatment.",
            "score": 5,
            "explanation": "The Predicted Answer successfully includes all the key facts emphasized with # in the Reference Answer: PLGA nanoparticles, targeted drug delivery, and comparative effectiveness to anti-PD-L1 monoclonal antibodies. The meaning is consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 353,
            "query": "Which genetic targets are disrupted for enhancing T-cell response in cancer therapy, and what specific cells are engineered to address mesothelin-positive tumors using new genetic technologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2109,
                    2107,
                    964
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "CRISPR-Cas9 T-cells disrupt #TCR# and #PD-1# genes to improve response by altering #MHC class I# expression, while mesothelin-positive tumors use #PD-1# disrupted CAR T-cells.",
            "predicted_answer": "Genetic targets disrupted for enhancing T-cell response in cancer therapy include PD-1 and TCR. Specific cells engineered to address mesothelin-positive tumors using CRISPR-Cas9 are CAR T-cells with PD-1 and TCR gene knockouts.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the disruption of TCR and PD-1 genes in engineered T-cells, aligning with the reference. However, it omits the detail about altering MHC class I expression, which is emphasized in the reference. Despite this, there is no contradictory information."
        },
        {
            "query_idx": 354,
            "query": "Which medication received regulatory approval for enhancing survival metrics and was compared with a different treatment in HER2-negative breast cancer trials to assess age-related response differences?",
            "retrieved_metrics": {
                "reference_idx": [
                    658,
                    663
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The U.S. FDA approved #olaparib# for improving #invasive disease-free survival#, with enhanced #effectiveness# in #hormone-positive and young patients# in HER2-negative breast cancer trials compared to carboplatin.",
            "predicted_answer": "Olaparib received FDA approval for enhancing survival metrics in HER2-negative breast cancer trials, with age-related response differences observed, particularly benefiting younger patients (<40 years) and hormone receptor-positive patients.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies \"olaparib\" and mentions its approval for survival in HER2-negative breast cancer with benefits for \"hormone receptor-positive\" and \"young patients\". However, it misses \"invasive disease-free survival\" and does not mention its comparison to carboplatin."
        },
        {
            "query_idx": 355,
            "query": "What is the name of the treatment approved for a type of lymphoma in 2009, later withdrawn due to unfulfilled study requirements, and related to a trial with a specific response rate in treating R/R PTCL?",
            "retrieved_metrics": {
                "reference_idx": [
                    553,
                    563,
                    561
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Romidepsin# received approval for #cutaneous T-cell lymphoma# in 2009. The U.S. withdrew approval due to incomplete required studies. Approval for #R/R PTCL# was based on a #25% ORR# trial.",
            "predicted_answer": "The treatment approved for R/R PTCL in 2009 was romidepsin (Istodax), which was later withdrawn due to unfulfilled study requirements.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies romidepsin as the treatment for R/R PTCL mentioned in 2009 and later withdrawn. However, it misses that approval was also for cutaneous T-cell lymphoma and omits the 25% ORR trial detail. Hence, more than one key fact is missing."
        },
        {
            "query_idx": 356,
            "query": "What role do specific biomarkers and endpoints play in early drug development when assessing drug efficacy and overcoming challenges related to tumor changes and predictive measures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1633,
                    1638,
                    1634
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#PD biomarkers# are critical for assessing drug efficacy, addressing #tumor resistance#, and utilizing #alternative endpoints# when standard metrics do not accurately predict clinical outcomes.",
            "predicted_answer": "Specific biomarkers and endpoints in early drug development help assess drug efficacy by providing early indicators of target engagement and tumor response. They overcome challenges related to tumor changes by offering insights into pharmacology and resistance development, guiding dose optimization and identifying alternative endpoints when traditional measures like ORR are insufficient.",
            "score": 3,
            "explanation": "The predicted answer successfully includes the use of biomarkers and alternative endpoints in assessing drug efficacy. While it covers PD biomarkers implicitly by mentioning target engagement, it lacks explicit mention of \"PD biomarkers\" and \"tumor resistance\" directly. Therefore, it is aligned but misses one key fact."
        },
        {
            "query_idx": 357,
            "query": "What expression is used as a predictive marker for breast cancer treatment efficacy, and what agents modulate the immune response?",
            "retrieved_metrics": {
                "reference_idx": [
                    558,
                    562
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#HDAC2 expression# predicts breast cancer treatment efficacy, and #HDACi# agents modulate the immune response.",
            "predicted_answer": "HDAC2 expression is used as a predictive marker for breast cancer treatment efficacy. HDACi agents, such as vorinostat, modulate the immune response by decreasing regulatory T cells.",
            "score": 5,
            "explanation": "The predicted answer includes both #HDAC2 expression# and #HDACi# agents, consistent with the key facts in the reference answer. It adds details about vorinostat and regulatory T cells, enhancing the information without contradicting it. Therefore, it fully covers the required elements."
        },
        {
            "query_idx": 358,
            "query": "How are physiological, drug-specific, and distribution challenges addressed in optimizing dosing for bispecific antibody therapies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1616,
                    1620,
                    1624
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The use of #PBPK# and #QSP# models addresses physiological factors, #receptor occupancy#, and optimizes dosing for #BiTEs# in cancer therapy.",
            "predicted_answer": "Physiologically-based pharmacokinetic (PBPK) modeling addresses physiological, drug-specific, and distribution challenges by incorporating tissue composition, blood flow, and drug binding properties to predict optimal dosing for bispecific antibody therapies in cancer treatment.",
            "score": 1,
            "explanation": "The predicted answer includes PBPK, which is a key fact from the reference. However, it misses #QSP#, #receptor occupancy#, and #BiTEs#. The core concept of addressing challenges in dosing for bispecific antibody therapies is present, but the absence of multiple key facts lowers completeness."
        },
        {
            "query_idx": 359,
            "query": "What types of materials are utilized to enhance tissue emulation, and what factors play a significant role in influencing cell growth in organoid cultures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1156,
                    1452
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hydrogel scaffolds# are used to enhance tissue emulation, and the #properties of the extracellular matrix# play a significant role in influencing growth in organoid cultures.",
            "predicted_answer": "Materials like hydrogel and polymer-based scaffolds, and decellularized extracellular matrix from animal or human organs enhance tissue emulation. Factors influencing cell growth include scaffold stiffness, extracellular matrix composition, and culture conditions such as air-liquid interface or submerged settings.",
            "score": 5,
            "explanation": "The predicted answer includes \"hydrogel\" as a material, matching the \"hydrogel scaffolds\" in the reference. It also mentions \"extracellular matrix composition,\" aligning with the \"properties of the extracellular matrix.\" Both key facts are present, ensuring completeness and consistency with the reference."
        },
        {
            "query_idx": 360,
            "query": "Which active agent is central to anti-angiogenic therapy in FDA-approved cancer treatment combinations, and how frequently is it included across these combinations?",
            "retrieved_metrics": {
                "reference_idx": [
                    898,
                    1042
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The central agent in anti-angiogenic therapy combinations approved by the FDA is #Bevacizumab#, appearing #14 times# in treatment combinations.",
            "predicted_answer": "Bevacizumab (Avastin) is central to anti-angiogenic therapy in FDA-approved cancer treatment combinations, included in 14 combinations, emphasizing its importance as an adjuvant therapy.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions #Bevacizumab# as the central agent and states that it is included in #14 combinations#, aligning it with the reference answer. Key facts are present with no significant omissions or contradictions."
        },
        {
            "query_idx": 361,
            "query": "What adverse events were linked to a high dosage during clinical trials, and what was the subsequently advised dosage for future studies to enhance safety?",
            "retrieved_metrics": {
                "reference_idx": [
                    187,
                    196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The adverse #ILD# and #fatal events# at a high #8 mg/kg dose# led to the #recommended dose# being revised to #6 mg/kg# for safer future trials.",
            "predicted_answer": "High dosage (8 mg/kg) linked to 14 cases of ILD, including 3 fatal events. Recommended dosage for safety: 6 mg/kg for future studies.",
            "score": 5,
            "explanation": "The predicted answer accurately reports adverse events, specifically #ILD# and #fatal events#, associated with a high #8 mg/kg dosage#, and notes a #recommended dosage# change to #6 mg/kg# for safety. All key facts and trends in the reference answer are present, with no omissions."
        },
        {
            "query_idx": 362,
            "query": "What protein interaction with ERAD E2s is crucial in tumor proliferation, and what effect does its inhibition have on the metastasis inhibitor accumulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1561,
                    1575
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #Gp78# interacts with ERAD E2s, promoting #tumor metastasis#, and its inhibition leads to #KAI1# accumulation, reducing #tumor metastasis#.",
            "predicted_answer": "Gp78 interaction with ERAD E2s is crucial in tumor proliferation. Inhibition of Gp78 promotes the accumulation of the metastasis inhibitor KAI1, leading to reduced tumor metastasis.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies Gp78 interaction with ERAD E2s and its role in tumor proliferation and metastasis. It also mentions KAI1 accumulation reducing metastasis. However, it slightly misrepresents Gp78's role, saying \"proliferation\" instead of \"metastasis,\" which impacts completeness."
        },
        {
            "query_idx": 363,
            "query": "How do anatomical differences, gene editing approaches, and the limitations of mouse models contribute to the challenges in predicting human responses to RNA-based preclinical drug interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1153,
                    2094,
                    2135
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Current #preclinical tests# struggle with predicting human responses due to anatomical differences, while #gene editing# may fail at efficacy prediction. Traditional #mouse model limitations# hinder RNA drug response extrapolation.",
            "predicted_answer": "Anatomical differences, gene editing limitations, and the lack of human-like genomic overlap in mouse models contribute to challenges in predicting human responses to RNA-based drug interventions. These models often fail to account for human genetic diversity and immune responses, limiting their predictive value.",
            "score": 3,
            "explanation": "The predicted answer generally aligns with the reference, sharing insights on anatomical differences, gene editing, and mouse model limitations. However, it misses the key detail of \"preclinical tests\" struggling due to anatomical differences, which affects the answer's completeness regarding preclinical challenges."
        },
        {
            "query_idx": 364,
            "query": "What are the mechanisms by which engineered phages target cancer cells, and what are the specific clinical translation challenges faced by these therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    68,
                    78
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Engineered #phages# specifically target tumor cells, but face clinical translation challenges like #consistent manufacturing# and #clinical evaluation#, affecting the success of phage-based cancer therapies.",
            "predicted_answer": "Engineered phages target cancer cells through tumor-specific binding, direct cytotoxicity, and immune modulation. Clinical translation challenges include consistent manufacturing, understanding side effects, and establishing appropriate dosing regimens.",
            "score": 3,
            "explanation": "The predicted answer includes key information about engineered phages targeting cancer cells and mentions consistent manufacturing as a clinical challenge. However, it lacks the mention of \"clinical evaluation,\" which is highlighted in the reference answer. Overall, the trend aligns, but one key fact is missing."
        },
        {
            "query_idx": 365,
            "query": "Which specific limitations in early-phase oncology trials hinder robust dose-response relationships, and which trial design is optimal for assessing multiple dosage-related safety and efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1585,
                    1602
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Early-phase trials face #sample size limitations# that hinder dose-response assessment, while #randomized dose-response trials# are optimal for evaluating safety and efficacy across multiple dosages.",
            "predicted_answer": "Early-phase oncology trials face limitations due to small sample sizes and short observation periods, hindering robust dose-response relationships. An optimal trial design for assessing multiple dosage-related safety and efficacy is a randomized, parallel dose-response trial, recommended by the FDA, to compare multiple dosages without aiming for statistical superiority.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact of \"sample size limitations\" affecting dose-response in early-phase trials and identifies \"randomized dose-response trials\" as optimal. All key elements from the reference are present without contradicting information, maintaining alignment with the overall trend."
        },
        {
            "query_idx": 366,
            "query": "What biomarkers have been identified as important in selecting cancer treatments and improving detection accuracy for specific cancers, and what roles do they play in these applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    466,
                    506
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #epigenetic biomarkers# aids in cancer treatment decisions and facilitates #high sensitivity# detection of prostate cancer.",
            "predicted_answer": "Biomarkers like EZH2 and IDH1/IDH2 mutations are important in selecting cancer treatments and improving detection accuracy. They guide drug development, aid in precise diagnosis, and help define tumor subtypes, monitor recurrence, and make treatment decisions.",
            "score": 1,
            "explanation": "The predicted answer mentions biomarkers like EZH2 and IDH1/IDH2, but it does not specify the use of epigenetic biomarkers or the high sensitivity detection of prostate cancer, which are the emphasized elements in the reference answer. Key facts are missing, impacting completeness."
        },
        {
            "query_idx": 367,
            "query": "What innovative method in tissue engineering involves removing elements after performing a pattern-forming process and utilizes specific solutions to establish intricate pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2195,
                    2196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The technique involves using #sacrificial elements# for #3D tissue structures#, removing them post-formation, with #specific solutions# like #calcium solutions# aiding in forming #intricate physical structures#.",
            "predicted_answer": "The innovative method in tissue engineering involves using sacrificial inks in 3D bioprinting, which are printed into the matrix and then liquified or washed off after cross-linking or polymerization, creating intricate pathways.",
            "score": 3,
            "explanation": "The predicted answer matches the reference in describing the use of sacrificial elements and the creation of intricate pathways. It misses details on solutions like calcium solutions and specific reference to 3D tissue structures, which affects completeness."
        },
        {
            "query_idx": 368,
            "query": "What innovative method in drug repurposing, which contrasts with the traditional drug development timeline and budget, utilizes experimental and computational techniques to explore new drug applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    759,
                    767
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The innovative method of #high-throughput screening using sophisticated models# in drug repurposing contrasts with traditional drug development, which requires #10 -15 years and costs $1 -2 billion#.",
            "predicted_answer": "Drug repurposing utilizes experimental methods like induced pluripotent stem cell models and computational techniques such as target-centric, knowledge-driven strategies to explore new drug applications, contrasting with traditional development timelines and budgets.",
            "score": 1,
            "explanation": "The Predicted Answer mentions experimental (induced pluripotent stem cell models) and computational (target-centric, knowledge-driven strategies) techniques in drug repurposing but lacks the key facts of \"high-throughput screening\" and the specific \"10-15 years and $1-2 billion\" cost/time details from the Reference Answer."
        },
        {
            "query_idx": 369,
            "query": "How do elevated interstitial fluid pressure and tumor-promoting conditions within the tumor microenvironment contribute to immune evasion and affect cancer treatment efficacy and macrophage behavior?",
            "retrieved_metrics": {
                "reference_idx": [
                    388,
                    2061,
                    2206
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In #PC#, the #elevated interstitial fluid pressure# exacerbates a #tumor-promoting immunosuppressive environment#, affecting immune evasion, #reducing drug treatment effectiveness#, and influencing macrophage activity.",
            "predicted_answer": "Elevated interstitial fluid pressure (IFP) in the tumor microenvironment (TME) contributes to immune evasion by creating a physical barrier to drug delivery and promoting an immunosuppressive milieu. This high IFP affects cancer treatment efficacy by reducing drug penetration and macrophage behavior by inducing M2 polarization, which promotes tumor growth.",
            "score": 5,
            "explanation": "The predicted answer captures key elements, including elevated interstitial fluid pressure, immune evasion, a tumor-promoting immunosuppressive environment, reduced treatment efficacy, and macrophage behavior. However, M2 polarization detail, although relevant, is not necessary. Overall, the alignment is strong, with no significant omissions or contradictions."
        },
        {
            "query_idx": 370,
            "query": "What computational processes utilize both systematic high throughput datasets and diverse data inputs in drug repurposing?",
            "retrieved_metrics": {
                "reference_idx": [
                    766,
                    1841
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Computational approaches in drug repurposing# involve analyzing #systematic high throughput datasets# and integrating #diverse data inputs# like electronic health records.",
            "predicted_answer": "Computational processes that utilize both systematic high throughput datasets and diverse data inputs in drug repurposing include molecular docking, network analysis, data mining, similarity analysis, machine learning, and transcriptional signature techniques.",
            "score": 3,
            "explanation": "The Predicted Answer mentions computational processes that align with the Reference Answer's emphasis on \"computational approaches in drug repurposing\" and the use of \"systematic high throughput datasets\" and \"diverse data inputs.\" However, it omits the specific example of \"electronic health records\" mentioned in the Reference Answer."
        },
        {
            "query_idx": 371,
            "query": "What type of regulatory designation, overseen by a U.S. agency, considers development costs, provides trial design flexibility, and includes financial exemptions, for both rare and non-rare disease conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    639,
                    1057,
                    1072
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #FDA# evaluates costs and grants #orphan status# for rare or no-cost-recovery diseases, offering #trial flexibility# and #Orphan Drug Act benefits#, like #fee waivers# for varied conditions.",
            "predicted_answer": "The regulatory designation is the Orphan Drug Designation, overseen by the FDA. It considers development costs, provides trial design flexibility, and includes financial exemptions for both rare and non-rare disease conditions.",
            "score": 3,
            "explanation": "The predicted answer captures key facts such as the FDA oversight, trial design flexibility, and financial exemptions. However, it inaccurately refers to both rare and non-rare diseases, while the reference answer specifies \"rare or no-cost-recovery diseases.\" The meaning is mostly consistent with slight inaccuracies."
        },
        {
            "query_idx": 372,
            "query": "What factors increase the risk of complications from COVID-19 in thyroid cancer patients, and what was reported as a treatment approach involving an advanced thyroid cancer patient during their COVID-19 diagnosis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2166,
                    2170
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In thyroid cancer patients, risk factors for COVID-19 complications include #MKI# treatments. A patient treated with #lenvatinib# during COVID-19 persisted in their therapy without additional adverse events.",
            "predicted_answer": "Factors increasing COVID-19 complications in thyroid cancer patients include MKI treatment, external beam radiation, lung metastases, older age, and comorbidities. A reported treatment approach involved a lenvatinib-treated patient with DTC and lung metastases, who continued lenvatinib during COVID-19, with daily monitoring and eventual recovery.",
            "score": 5,
            "explanation": "The predicted answer includes key risk factors, highlighting MKI treatment. It also accurately describes lenvatinib use during COVID-19. While the predicted answer contains additional correct details like lung metastases, all # emphasized key facts in the reference answer are present without contradictions."
        },
        {
            "query_idx": 373,
            "query": "How do preclinical models for colorectal cancer and recent technological developments collectively influence patient-specific drug screening and therapy customization?",
            "retrieved_metrics": {
                "reference_idx": [
                    1414,
                    2000,
                    1994
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The integration of #CRC PDOs# assists in drug response prediction. Their potential in #personalized medicine# is boosted by #technological advancements# like gene editing and single-cell sequencing for tailored therapies.",
            "predicted_answer": "Preclinical models, like CRC PDOs and PDXs, combined with technological advancements such as CRISPR-Cas9 and single-cell RNA sequencing, enable patient-specific drug screening and therapy customization by predicting drug responses and unraveling tumor heterogeneity.",
            "score": 5,
            "explanation": "The Predicted Answer mentions key elements such as CRC PDOs, technological advancements, CRISPR-Cas9, and single-cell RNA sequencing, aligning well with the Reference Answer's focus on patient-specific drug screening and therapy customization using these technologies. Key facts like CRC PDOs and technological advancements are covered."
        },
        {
            "query_idx": 374,
            "query": "What novel treatment option is proposed for a respiratory viral infection that utilizes a strong inhibitor targeting kinases like anaplastic lymphoma kinase and c-ros oncogene 1?",
            "retrieved_metrics": {
                "reference_idx": [
                    2172,
                    2174
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The proposed treatment is #Entrectinib#, suggested for #COVID-19#, functioning as a #potent inhibitor# of anaplastic lymphoma kinase, ROS1, and NTRK kinases.",
            "predicted_answer": "Entrectinib is proposed as a novel treatment for respiratory viral infections, targeting kinases like anaplastic lymphoma kinase and c-ros oncogene 1.",
            "score": 1,
            "explanation": "The predicted answer mentions #Entrectinib# and targets #anaplastic lymphoma kinase# and #c-ros oncogene 1#, aligning generally with the reference. However, it omits #COVID-19# and #NTRK kinases#, indicating missing key facts impacting completeness, although no contradictory information is included."
        },
        {
            "query_idx": 375,
            "query": "What are the reported response rates for lung cancer patients in the HER2-mutant NSCLC cohort of the DESTINY-Lung01 trial compared to those in the lower dose group of the DESTINY-Lung02 trial?",
            "retrieved_metrics": {
                "reference_idx": [
                    185,
                    1597
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #objective response rate# for the HER2-mutant NSCLC cohort in DESTINY-Lung01 was #55%#, while the lower dose group in DESTINY-Lung02 showed a rate of #53.8#%.",
            "predicted_answer": "The reported response rates are 55% for the HER2-mutant NSCLC cohort in the DESTINY-Lung01 trial and 53.8% for the lower dose group in the DESTINY-Lung02 trial.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures all the key facts and numbers from the Reference Answer: the objective response rate for DESTINY-Lung01 as 55% and for the lower dose group in DESTINY-Lung02 as 53.8%. The meaning and details are consistent without any omissions."
        },
        {
            "query_idx": 376,
            "query": "What cellular changes and mechanisms contribute to both the initial development of pancreatic cancer and its detection at advanced stages with resistance to treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    383,
                    384
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Mutagenesis# initiates cellular transformation into lesions, causing #late detection# and forming #barriers# that lead to #treatment resistance# in pancreatic cancer.",
            "predicted_answer": "The initial development of pancreatic cancer involves mutagenesis leading to pancreatic intraepithelial neoplasia (PanIN). Late detection is due to unspecific symptoms and central abdominal location, often leading to advanced, inoperable stages. Resistance to treatments arises from multiple biological barriers and aggressive growth with genetic heterogeneity.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference: \"mutagenesis\" initiates cancer (cellular transformation), leads to \"late detection\" via vague symptoms and location, and forms \"barriers\" resulting in \"treatment resistance\" due to biological factors and genetic heterogeneity. No significant omissions or contradictions exist."
        },
        {
            "query_idx": 377,
            "query": "What is a not well-studied process involving a specific cell surface protein that is significant for the progression of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1351,
                    1377
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #posttranslational modifications# of the specific cell surface protein #B7-H3# are under-researched and crucial for cancer progression.",
            "predicted_answer": "The under-researched process involving the cell surface protein B7-H3 is its posttranslational modifications (PTMs), which are significant for cancer progression.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: \"posttranslational modifications\" and \"B7-H3,\" aligning with the reference answer. The information regarding these modifications being under-researched and significant for cancer progression is consistent, with no omissions or errors."
        },
        {
            "query_idx": 378,
            "query": "What model is used to study the impact of combining anti-VEGF and anti-ANG2 treatments on cell viability in cancers with RAS mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1045,
                    1796
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #organoid# model is used to evaluate the impact of #anti-VEGF# and #anti-ANG2# treatments, notably improving viability in #RAS-mutated# cancers.",
            "predicted_answer": "The model used to study the impact of combining anti-VEGF and anti-ANG2 treatments on cell viability in cancers with RAS mutations is organoid cultures.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the #organoid# model and the combination of #anti-VEGF# and #anti-ANG2# treatments. It also acknowledges the context of #RAS mutations#. All key facts emphasized in the reference are present without contradiction."
        },
        {
            "query_idx": 379,
            "query": "What are the specific trial response rates of the drugs in clinical trials, and how do distinct action mechanisms like targeted and complementary effects contribute to cancer drug combination efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    2251,
                    2253,
                    2247
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The clinical trial of #Thalidomide# showed a 25% to 35% response rate. #Synergistic# effects improve outcomes by targeting distinct pathways, while #complementary# action mechanisms enhance therapeutic effectiveness in combination therapies.",
            "predicted_answer": "The specific trial response rates for thalidomide in multiple myeloma were 25-35%. Combination therapy efficacy is enhanced by distinct action mechanisms, such as targeting separate pathways or complementary effects, which can lead to synergistic impacts and reduced therapeutic dosages.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: Thalidomide’s trial response rates (25-35%) and the role of distinct action mechanisms, including targeting separate pathways and complementary effects. The concepts of synergy and complementarity are well captured, so no key facts are missing."
        },
        {
            "query_idx": 380,
            "query": "What methodology is used to personalize cancer treatment, predict clinical drug responses, and identify therapeutic combinations for patients with specific mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1173,
                    1775,
                    1172
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The methodology involves implementing #PDO cultures# to guide treatment through #AUC# evaluations and identifying effective combinations for patients with rare mutations like those affecting #CFTR#.",
            "predicted_answer": "The methodology used involves generating patient-derived organoids (PDOs) for transcriptomic profiling and therapeutic testing with commonly used chemotherapeutics. This approach correlates PDO treatment outcomes with individual patient responses, guiding personalized treatment decisions and identifying effective drug combinations for specific mutations.",
            "score": 1,
            "explanation": "The Predicted Answer includes the use of PDOs but lacks details on the significance of AUC evaluations or the specific mention of rare mutations like CFTR. While there is alignment in methodology usage for treatment and drug combinations, the omission of these key facts affects completeness."
        },
        {
            "query_idx": 381,
            "query": "How is a scoring system used to categorize chemotherapy response levels, and what challenges are associated with its use in assessing FOLFOX and other drug regimens for CRC patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    1773,
                    1776
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The scoring system categorizes response levels by dividing #AUCs# into three groups, predicting efficacy. It shows no correlation with #FOLFOX# but predicts outcomes accurately for other #combinations#.",
            "predicted_answer": "A scoring system categorizes chemotherapy response levels by assigning scores (1 = high, 2 = intermediate, 3 = low) based on AUCs. Challenges include inconsistent correlation with patient responses, particularly in pretreated patients, and varying prediction accuracy for different treatment lines.",
            "score": 1,
            "explanation": "The predicted answer mentions the scoring of chemotherapy response levels using AUCs and discusses challenges, but it does not specifically mention FOLFOX or the prediction accuracy for different combinations as highlighted in the reference answer. Thus, two key facts are missing."
        },
        {
            "query_idx": 382,
            "query": "How do bacterial metabolites and microorganisms like F. nucleatum together impact the tumor microenvironment to alter cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    827,
                    846
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Certain bacterial #metabolites# alter tumor pH and oxygen, fostering cancer growth, while #F. nucleatum# specifically decreases CD4+ and CD8+ T cells, modulating the immune microenvironment and promoting tumor progression.",
            "predicted_answer": "Bacterial metabolites and F. nucleatum alter the tumor microenvironment by generating toxic products, changing pH and oxygen levels, and reducing immune cell infiltration, thereby promoting cancer progression.",
            "score": 3,
            "explanation": "The predicted answer mentions bacterial metabolites and F. nucleatum altering tumor pH and oxygen, but omits the specific effect on CD4+ and CD8+ T cells, highlighted in the reference. This omission affects completeness, though the overall trend of cancer promotion is maintained."
        },
        {
            "query_idx": 383,
            "query": "What are the key mechanisms involved in stabilizing both protein-ligand and DNA-cisplatin complexes, and what unique features are observed specifically in DNA-cisplatin interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    244,
                    250
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Hydrogen bonding# is critical in both #protein-ligand# and #DNA-cisplatin# complexes, with DNA-cisplatin showing bond lengths at #2.92, 2.96, and 3.12 angstroms#, highlighting unique interaction features.",
            "predicted_answer": "Hydrogen bonding and hydrophobic interactions stabilize both protein-ligand and DNA-cisplatin complexes. In DNA-cisplatin interactions, specific hydrogen bonds with Thymine residues (Dt8, Dt7, Dt19) and hydrophobic interactions with Thymine (Dt20), Deoxyadenosine (Da6), and Deoxycytosine (Dc21) are observed.",
            "score": 1,
            "explanation": "The predicted answer includes overall trends like hydrogen bonding and their role in protein-ligand and DNA-cisplatin complexes but misses details such as bond lengths (2.92, 2.96, and 3.12 angstroms) and specific interaction features in DNA-cisplatin complexes. These omissions impact completeness."
        },
        {
            "query_idx": 384,
            "query": "Modify the multi-hop query  \nHow have intellectual property developments influenced dosing innovations and chemical modifications in siRNA therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2136,
                    2132,
                    2137
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modify the answer",
            "predicted_answer": "Intellectual property developments have influenced siRNA therapies by enabling specific chemical modifications that enhance stability, reduce immunogenicity, and improve dosing frequency, as detailed in patent WO2016028649.",
            "score": 1,
            "explanation": "The Predicted Answer aligns with the general trend of the Reference Answer by discussing the influence of intellectual property on chemical modifications in siRNA therapies. However, it lacks specific details like exact chemical modifications or dosing innovations, which are crucial for a thorough evaluation."
        },
        {
            "query_idx": 385,
            "query": "What measurements are necessary for determining receptor binding potential values, and what are the specific parameters in the distribution ratios that must be considered?",
            "retrieved_metrics": {
                "reference_idx": [
                    1515,
                    1516
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Determining receptor binding potentials requires the #measurement of arterial input function#, while the distribution ratio involves the #volume of distribution# with specific, non-specific bound, and free radioligand.",
            "predicted_answer": "To determine receptor binding potential values (BP), measurements of arterial input function and kinetic rate constants are necessary. Specific parameters in distribution ratios include the concentration of radioligand in tissue (V$_{T}$), specific binding (V$_{S}$), and non-displaceable uptake (V$_{ND}$) relative to plasma concentration (C$_{P}$).",
            "score": 3,
            "explanation": "The predicted answer covers the #measurement of arterial input function#, aligning with the reference. It also mentions specific parameters (V$_{T}$, V$_{S}$, V$_{ND}$), relating to the #volume of distribution# indirectly, but misses specific, non-specific bound, and free radioligand details. The overall trend is aligned."
        },
        {
            "query_idx": 386,
            "query": "What nuclear reaction involves $^{18}$O water and results in the production of a radionuclide with a specific half-life and molar activity beneficial for PET imaging?",
            "retrieved_metrics": {
                "reference_idx": [
                    1517,
                    1519,
                    1520
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The reaction involves a #proton# with #$^{18}$O water# to produce #$^{18}$F# fluoride, featuring a #maximum half-life of 110 minutes# and #high molar activity# for PET imaging.",
            "predicted_answer": "The nuclear reaction involving $^{18}$O water and resulting in the production of $^{18}$F with a half-life of 110 minutes and high molar activity for PET imaging is $^{18}$O (p, n) $^{18}$F.",
            "score": 5,
            "explanation": "The Predicted Answer effectively includes all key facts from the Reference Answer: it mentions $^{18}$O water, the production of $^{18}$F, a half-life of 110 minutes, and high molar activity. It confirms the proton interaction implicitly by the notation “(p, n)” for the reaction."
        },
        {
            "query_idx": 387,
            "query": "What are the roles of specific agents in the COVID-19 treatment process, particularly regarding viral attachment and inflammation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2173,
                    2175
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Vemurafenib# disrupts #viral attachment#, and #vandetanib# decreases #inflammatory cytokines# in COVID-19 treatment.",
            "predicted_answer": "Vemurafenib hinders viral attachment and replication by locking the SBD in a closed conformation, triggering apoptosis in infected cells. MKIs like vandetanib reduce inflammation and cytokine levels, mitigating lung injury and immune cell infiltration, aiding COVID-19 treatment.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as \"Vemurafenib\" disrupting \"viral attachment\" and \"vandetanib\" reducing \"inflammatory cytokines,\" matching the reference. It aligns with the reference without contradictions or significant omissions regarding the roles of these agents in COVID-19 treatment."
        },
        {
            "query_idx": 388,
            "query": "How do the linker types used in TDM1 compare to current favored designs in terms of stability and functionality within systemic circulation and tumor environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    174,
                    173,
                    916
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "TDM1 employs a #thioether-based# #non-cleavable linker# for stability in systemic circulation, differing from the #cleavable linkers# used currently to achieve enhanced bystander effects.",
            "predicted_answer": "TDM1 uses a non-cleavable linker, which is stable in systemic circulation but releases the payload only after antibody degradation. Current favored designs use cleavable linkers, which are also stable in circulation but can release the payload in tumor environments, enhancing functionality.",
            "score": 3,
            "explanation": "The Predicted Answer captures the main comparison between TDM1's non-cleavable linker and current favored cleavable linkers. It discusses the stability and payload release, but it misses the mention of the #thioether-based# aspect and #enhanced bystander effects#, making it slightly incomplete."
        },
        {
            "query_idx": 389,
            "query": "What specific combination therapies were evaluated in clinical studies for treating hepatocellular carcinoma and refractory metastatic colorectal cancer, and what impacts did these therapies have on their respective median overall survival times?",
            "retrieved_metrics": {
                "reference_idx": [
                    1027,
                    1046
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #combination of Atezolizumab and Bevacizumab# for hepatocellular carcinoma improved median overall survival to #19.2 months#, and #Trifluridine-Tipiracil plus Bevacizumab# for metastatic colorectal cancer increased it to #10.8 months#.",
            "predicted_answer": "For hepatocellular carcinoma, the combination of Atezolizumab and Bevacizumab (T + A) showed a median overall survival (mOS) of 19.2 months. For refractory metastatic colorectal cancer, Trifluridine-Tipiracil plus Bevacizumab had an mOS of 10.8 months.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: the combination therapies of Atezolizumab and Bevacizumab for hepatocellular carcinoma with a median overall survival of 19.2 months, and Trifluridine-Tipiracil plus Bevacizumab for metastatic colorectal cancer with a median overall survival of 10.8 months. No significant details are missing."
        },
        {
            "query_idx": 390,
            "query": "Which specific cell type is utilized to generate organoids and what type of culture is established from these cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1157,
                    1446
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #use of tissue­-resident ASCs# results in the establishment of #long-term organoid cultures# from a single ASC.",
            "predicted_answer": "Adipose-derived stromal cells (ASCs) are utilized to generate organoids, establishing crypt-villus organoids resembling native tissue structures.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"adipose-derived stromal cells (ASCs)\" as the specific cell type used to generate organoids, aligning with the reference's \"use of tissue-resident ASCs.\" However, it does not mention \"long-term organoid cultures,\" which is a missing key fact."
        },
        {
            "query_idx": 391,
            "query": "How do trial designs for orphan versus non-orphan indications statistically differ in terms of randomization, life expectancy impacts, and tumor response measurements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1066,
                    1067,
                    1070
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "#Concurrent randomized controlled trials# occur less frequently for #orphan indications#. #Disability adjusted life years# are higher in #rare, ultra-rare orphan indications#. #Single arm trials# show increased #tumor response# for #ultra-rare orphan indications#.",
            "predicted_answer": "Trial designs for orphan indications statistically differ from non-orphan indications in several ways:\n\n1. **Randomization**: Orphan indications are less often supported by concurrent randomized controlled trials (RCTs) of phase 3 design.\n2. **Life Expectancy Impacts**: Disability-adjusted life years are higher for rare and ultra-rare orphan indications, and overall survival assessments are less common in orphan RCTs.\n3. **Tumor Response Measurements**: Tumor response rates in RCTs are lower for orphan indications, but higher in single-arm trials.",
            "score": 5,
            "explanation": "The predicted answer captures all key points: lower frequency of concurrent RCTs, higher disability-adjusted life years for orphan indications, and higher tumor response in single-arm trials for ultra-rare orphan indications. These align with the emphasized facts in the reference answer without contradictions or omissions."
        },
        {
            "query_idx": 392,
            "query": "What methods are employed to quantify drug effects and evaluate growth and treatment responses in cancer spheroids?",
            "retrieved_metrics": {
                "reference_idx": [
                    1745,
                    1754
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A combination of #fluorometric assays# is used for quantifying drug effects, while #image-based assays# evaluate growth and treatment responses in cancer spheroids.",
            "predicted_answer": "Methods to quantify drug effects and evaluate growth and treatment responses in cancer spheroids include fluorometric assays (e.g., CellTiter-Blue, Calcein AM, propidium iodide, Hoechst 33342), dye exclusion assays (e.g., Trypan Blue), and microscopy imaging with ImageJ software.",
            "score": 5,
            "explanation": "The predicted answer includes \"fluorometric assays,\" matching the reference's fluorometric assays. It mentions \"microscopy imaging,\" related to \"image-based assays\" from the reference. Both key facts are covered, indicating compatibility in methods and trends without omissions."
        },
        {
            "query_idx": 393,
            "query": "How do personalized modeling techniques apply to specific cancer environments and how are these models validated for treatment response in oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1467,
                    1469
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Personalized modeling techniques recreate the #bone marrow microenvironment# for #castrate-resistant prostate cancer#, and use #predictive organoid models# validated for #rectal cancers# to predict treatment responses.",
            "predicted_answer": "Personalized modeling techniques, such as patient-derived organoid models, are applied to specific cancer environments to predict treatment response. These models are validated by their ability to replicate tumor and normal tissue responses, aiding in personalized treatment dosing and reducing radiotherapy toxicity.",
            "score": 1,
            "explanation": "The predicted answer mentions personalized modeling techniques using organoid models for predicting treatment response, which aligns with the reference's mention of predictive organoid models. However, it misses key specifics like the bone marrow microenvironment for castrate-resistant prostate cancer and validation in rectal cancers."
        },
        {
            "query_idx": 394,
            "query": "What are the limitations of AI in developing drugs, and how is AI used to personalize and integrate cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    117,
                    163,
                    1048
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "AI has #limited explanation# in drug development, enhances #precision oncology#, and supports comprehensive #integration with cancer therapy#.",
            "predicted_answer": "AI's limitations in drug development include data dependency and \"black box\" issues, hindering hypothesis validation. AI is used to personalize and integrate cancer treatment by accelerating drug discovery, enhancing precision, and enabling data-driven, interpretable models for targeted therapies.",
            "score": 5,
            "explanation": "The predicted answer captures AI's limitations, precision oncology enhancement, and the integration role in cancer treatment, consistent with the reference's key facts about limited explanation, precision, and integration in cancer therapy. Thus, it aligns well with the overall message and details."
        },
        {
            "query_idx": 395,
            "query": "Which specific gene editing technologies are fundamental to the development of next-generation gene therapies, and through which processes do these technologies achieve precise DNA modification?",
            "retrieved_metrics": {
                "reference_idx": [
                    452,
                    957
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Next-generation gene therapies rely on #CRISPR/Cas9#, #ZFNs#, and #TALEN# for precise DNA modifications achieved through #NHEJ# and #HDR#.",
            "predicted_answer": "The fundamental gene editing technologies for next-generation gene therapies are CRISPR/Cas9, ZFNs, and TALENs. These technologies achieve precise DNA modification through processes like non-homologous end joining (NHEJ) and homology-directed repair (HDR).",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts and important information emphasized in the reference answer: CRISPR/Cas9, ZFNs, TALENs, NHEJ, and HDR. It aligns with the overall trend of the reference answer and does not omit any significant details."
        },
        {
            "query_idx": 396,
            "query": "Which viral vector is recognized for its in vivo and ex vivo gene therapy use, with specific features like low immunogenicity and long-term transgene expression that make it suitable for medical purposes?",
            "retrieved_metrics": {
                "reference_idx": [
                    429,
                    431
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #AAV# vector is pivotal for gene therapy due to its #low immunogenicity#, #broad tropism#, and #long-term transgene expression#, making it suitable for #medical applications#.",
            "predicted_answer": "AAV (Adeno-Associated Virus) is recognized for its in vivo and ex vivo gene therapy use due to its low immunogenicity and long-term transgene expression, making it suitable for medical purposes.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies AAV as the viral vector used for gene therapy due to its low immunogenicity and long-term transgene expression, aligning with the reference answer. However, it omits the fact about \"broad tropism,\" affecting the completeness of the answer."
        },
        {
            "query_idx": 397,
            "query": "How do signaling pathway alterations integrate with metabolic process changes to support the enhanced energy needs of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    777,
                    842
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The integration of the #PI3K/AKT/mTOR pathway# with altered #metabolic flux# supports the enhanced energy and synthesis requirements necessary for cancer cell proliferation.",
            "predicted_answer": "Signaling pathway alterations, such as PI3K/AKT/mTOR activation, integrate with metabolic process changes by reprogramming catabolic and anabolic pathways to meet the heightened energy and synthesis demands of cancer cells.",
            "score": 3,
            "explanation": "The predicted answer includes PI3K/AKT/mTOR activation and discusses reprogramming of pathways to meet energy and synthesis demands, aligning with the reference's emphasis on PI3K/AKT/mTOR and energy needs. However, it omits the specific mention of \"metabolic flux,\" which impacts completeness."
        },
        {
            "query_idx": 398,
            "query": "What challenges are encountered in quantifying monoclonal antibodies in clinical practice, in terms of bioanalytical limitations and genetic factors affecting their cellular mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    732,
                    730
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Quantifying #monoclonal antibodies# faces #bioanalytical challenges# and limits #TDM#, while #genetic predictors# like #FCGR polymorphisms# influence #ADCC activity#.",
            "predicted_answer": "Challenges in quantifying monoclonal antibodies include complex pharmacokinetics, limited exposure-response characterization, and bioanalytical difficulties in plasma quantification. Genetic factors like FCGR polymorphisms affect ADCC activity and response to mAbs.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized with # in the reference answer: monoclonal antibodies, bioanalytical challenges, FCGR polymorphisms, and ADCC activity. The meanings are consistent and aligned with the reference, with no significant omissions or errors, despite different phrasing."
        },
        {
            "query_idx": 399,
            "query": "What specific infectious disease is being targeted by recent therapeutic breakthroughs involving novel druggable targets, and what technological modality is being used to achieve this?",
            "retrieved_metrics": {
                "reference_idx": [
                    373,
                    454,
                    456
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The recent therapeutic focus targets #HIV#, utilizing new intervention #druggable targets# enabled through #RNAi-based therapeutics#.",
            "predicted_answer": "Recent therapeutic breakthroughs are targeting HIV, involving novel druggable targets and technological modalities such as RNAi-based therapeutics and mRNA-based cancer vaccines.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: the target being HIV and the use of RNAi-based therapeutics. However, the additional mention of mRNA-based cancer vaccines does not contradict the reference, but adds extra information. Therefore, the key facts are covered with no significant omissions."
        },
        {
            "query_idx": 400,
            "query": "What current strategy utilizes specific tools to assess genetic dependencies in human cell lines, and which computational method is used to predict synthetic lethality among gene pairs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1942,
                    1951,
                    1949
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The current strategy uses #CRISPR-Cas9# to assess genetic dependencies in cell lines. A #machine learning approach# predicts #complex genetic interactions# by ranking gene pairs for synthetic lethality.",
            "predicted_answer": "The current strategy utilizes CRISPR-Cas9 to assess genetic dependencies in human cell lines. A machine learning approach, developed by De Kegel et al., is used to predict synthetic lethality among gene pairs.",
            "score": 3,
            "explanation": "The predicted answer correctly includes CRISPR-Cas9 for assessing genetic dependencies and mentions a machine learning approach for predicting synthetic lethality among gene pairs. However, it omits the detail of predicting \"complex genetic interactions,\" which affects completeness."
        },
        {
            "query_idx": 401,
            "query": "What specific modifications are necessary for in vitro models to better replicate tumor physiology, particularly in terms of cellular interplay and the inclusion of diverse biological structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1718,
                    2194,
                    1441
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "In vitro models need #optimization of tumor-stromal cell ratios# and #media components#, inclusion of #multiple cell types#, addressing #traditional culture limitations# to #better replicate tumor physiological complexity#.",
            "predicted_answer": "To better replicate tumor physiology in vitro, specific modifications include optimizing tumor-stromal cell ratios, using co-cultures, generating spheroids, and incorporating diverse biological structures like stromal and immune cells. 3D bioprinting can also enhance complexity by creating sophisticated 3D structures.",
            "score": 3,
            "explanation": "The predicted answer includes optimizing tumor-stromal cell ratios and incorporating multiple cell types, aligning well with the reference. However, it omits key details about optimizing media components and addressing culture limitations, impacting completeness."
        },
        {
            "query_idx": 402,
            "query": "Which enzymatic subunit of a transcription-silencing complex has mutations in certain cancers that correlate with advanced disease and leads to development as a therapeutic target?",
            "retrieved_metrics": {
                "reference_idx": [
                    532,
                    574
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The enzymatic subunit #EZH2# in a transcription-silencing complex has mutations in cancers, correlating with #advanced disease# and making #EZH2# a therapeutic target.",
            "predicted_answer": "EZH2, the enzymatic subunit of the transcription-silencing complex PRC2, has mutations in certain cancers that correlate with advanced disease and is being developed as a therapeutic target.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions EZH2 as the enzymatic subunit, details its mutations in certain cancers, and notes its correlation with advanced disease, aligning with the reference answer. All key facts emphasized with # signs in the reference are fully covered, with no significant omissions."
        },
        {
            "query_idx": 403,
            "query": "Which compound influences both the balance of regulatory T cells/Th17 cells and the function of tumor suppressor genes, playing a role in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    783,
                    784
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Oleanolic acid# modulates #regulatory T cells/Th17 cells# and interacts with #tumor suppressor genes#, suggesting its role in cancer treatment.",
            "predicted_answer": "Oleanolic acid influences the balance of regulatory T cells/Th17 cells and the function of tumor suppressor genes, making it a potential candidate for cancer treatment.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"oleanolic acid\" and its influence on \"regulatory T cells/Th17 cells\" as well as its interaction with \"tumor suppressor genes,\" matching the key facts in the reference answer. The meaning and details align without omissions or contradictions."
        },
        {
            "query_idx": 404,
            "query": "What structural changes in staurosporine derivatives lead to increased performance against the MV4-11 leukemia cell line, and how does the efficacy of a specific derivative compare to a control against the SW-620 colorectal cell line?",
            "retrieved_metrics": {
                "reference_idx": [
                    1292,
                    1293
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Halogens at C-3# enhance activity against the #MV4-11 leukemia cell line#. #Compound 108# shows greater inhibition of the #SW-620 colorectal cell line# compared to #staurosporine#.",
            "predicted_answer": "Structural changes in staurosporine derivatives, particularly halogens at the C-3 position, enhance performance against the MV4-11 leukemia cell line. Compound 138 shows higher efficacy against MV4-11 than other derivatives. Against the SW-620 colorectal cell line, compound 108 has an IC50 of 9.99 nM, outperforming the control staurosporine with an IC50 of 25.10 nM.",
            "score": 3,
            "explanation": "The predicted answer includes key facts about halogens at the C-3 position enhancing activity against MV4-11 and mentions compound 108's superior efficacy against the SW-620 cell line compared to staurosporine. However, the predicted answer inaccurately attributes compound 138's enhanced performance to MV4-11, which is not in the reference."
        },
        {
            "query_idx": 405,
            "query": "How do the chemical structures of Compounds 4, 3, 30, and 8b correlate with their IC50 values against breast cancer, HepG2, LNCAP, MDA-MB231, and MCF-7 cell lines, considering unique substituents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1251,
                    1262,
                    224
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #IC50# of #Compound 4# and #3# signifies moderate activity against breast cancer and HepG2. #Compound 30#'s 4-chlorobenzyl group is effective on LNCAP. #Compound 8b#'s thiophene indicates promising #anticancer potential# in MDA-MB231 and MCF-7 cells.",
            "predicted_answer": "Compounds 4 and 3 showed moderate IC50 values against breast cancer cells, with 4 also active against HepG2. Compound 30, with unique substituents, had significant inhibitory effects across multiple cell lines, especially LNCAP. Compound 8b, with a thiophene ring, showed strong inhibition against MDA-MB231 and MCF-7, comparable to reference drugs.",
            "score": 3,
            "explanation": "The predicted answer aligns with the trends in the reference, mentioning IC50 values, activity against specific cell lines, and unique substituents. However, it doesn't specify Compound 30's 4-chlorobenzyl group, affecting completeness. All other key facts and trends are covered."
        },
        {
            "query_idx": 406,
            "query": "How does the over-expression of a particular protein influence cancer stem cell populations and the mechanisms of resistance to therapies targeting cellular senescence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1370,
                    1372
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The over-expression of #B7-H3# enlarges the #cancer stem cell population# and hinders #cellular senescence and growth arrest#, leading to therapy #resistance#.",
            "predicted_answer": "Over-expression of B7-H3 increases cancer stem cell populations and enhances resistance to therapies targeting cellular senescence by preventing senescence and growth arrest via the AKT/TM4SF1/SIRT1 pathway.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: the over-expression of B7-H3, its effect on increasing cancer stem cell populations, and its role in hindering cellular senescence and growth arrest, resulting in therapy resistance. The inclusion of the AKT/TM4SF1/SIRT1 pathway is additional but not contradictory."
        },
        {
            "query_idx": 407,
            "query": "Which advanced imaging methods are pivotal for efficient data generation in high-resolution disease models and complete structure visualization in challenging organoid cultures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1189,
                    1755
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Light-sheet fluorescence microscopy# excels in high-resolution data generation for disease models, while #Z-stack technology# captures complete 3D structures in organoid cultures.",
            "predicted_answer": "Light-sheet fluorescence microscopy and Z-stack technology are pivotal for efficient data generation in high-resolution disease models and complete structure visualization in challenging organoid cultures.",
            "score": 5,
            "explanation": "The Predicted Answer matches the key facts emphasized in the Reference Answer: \"Light-sheet fluorescence microscopy\" and \"Z-stack technology\" are both included and accurately described as pivotal for the tasks mentioned. The meaning and key facts are consistent with the Reference Answer, with no significant omissions or errors."
        },
        {
            "query_idx": 408,
            "query": "Modified multi-hop query:\n\nWhat specific AI methodologies are used to enhance diagnostic accuracy by integrating different data techniques, and how do these methodologies address errors in diagnostic prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    121,
                    1236,
                    1237
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Modified answer:",
            "predicted_answer": "AI methodologies like multimodal data fusion and machine learning algorithms enhance diagnostic accuracy by integrating imaging, genomics, clinical data, and risk stratification models. These methods reduce false positives and provide personalized risk assessments, addressing errors by offering a comprehensive, nuanced diagnosis.",
            "score": 5,
            "explanation": "The predicted answer includes key AI methodologies like \"multimodal data fusion and machine learning algorithms\" used for \"integrating imaging, genomics, clinical data, and risk stratification models,\" and addresses reducing errors through \"reducing false positives\" and \"personalized risk assessments.\" All emphasized elements in the reference are reflected."
        },
        {
            "query_idx": 409,
            "query": "How does HIV-1 navigate environmental and structural defenses in the cervicovaginal tract to access immune cells and enhance its spread?",
            "retrieved_metrics": {
                "reference_idx": [
                    369,
                    370
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "HIV-1 overcomes #mucus# and #epithelial barriers# in the cervicovaginal tract, utilizing routes across #epithelial cells# and infecting #vaginal epithelial cells#, facilitating its #spread within the female genital tract#.",
            "predicted_answer": "HIV-1 navigates the cervicovaginal tract by overcoming mucus defenses and crossing the epithelial barrier through intercellular spaces or transcytosis, reaching immune cells in the lamina propria for enhanced spread.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of overcoming mucus and epithelial barriers and mentions spread and immune cell access, aligning with the reference answer. However, it's missing details about \"infecting vaginal epithelial cells\" and \"spread within the female genital tract.\""
        },
        {
            "query_idx": 410,
            "query": "What specific conjugate has proven effective for RNA delivery to liver cells, and what new areas are being explored for expanding siRNA applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    2145,
                    2146
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #GalNAc-siRNA conjugate# is effective for liver cell delivery; siRNA is expanding to target #chronic diseases# and delivery to areas like the central nervous system and eyes.",
            "predicted_answer": "The GalNAc-siRNA conjugate has proven effective for RNA delivery to liver cells. New areas being explored for expanding siRNA applications include delivery to the CNS, eye, muscle, lung, fat tissues, and tumors.",
            "score": 3,
            "explanation": "The predicted answer accurately identifies the GalNAc-siRNA conjugate for liver cell delivery. It mentions other delivery targets such as CNS and eyes but omits chronic diseases. Overall, it aligns with trends but misses one key fact emphasized in the reference answer."
        },
        {
            "query_idx": 411,
            "query": "What biological marker is responsible for cellular changes in low-oxygen tumor microenvironments, and what tool can simulate these conditions to study cancer cell phenotype transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    837,
                    2059
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#HIF-1 α# is the marker indicating hypoxia leading to #EMT#, studied using a #microfluidic device# simulating tumor conditions affecting #cancer cell phenotype#.",
            "predicted_answer": "HIF-1α is the biological marker responsible for cellular changes in low-oxygen tumor microenvironments. A microfluidic device can simulate these conditions to study cancer cell phenotype transformations.",
            "score": 3,
            "explanation": "The predicted answer identifies HIF-1α as the biological marker and mentions a microfluidic device to simulate conditions. It aligns with the reference regarding the marker and tool. However, it omits EMT as a key cellular change, affecting completeness."
        },
        {
            "query_idx": 412,
            "query": "What are the differences in the time requirement and dependency on external factors for breast cancer cell types to develop lesions in bone metastasis models?",
            "retrieved_metrics": {
                "reference_idx": [
                    2067,
                    2073
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "ER-cells #quickly form osteolytic lesions# in bone models, whereas ER-positive cells #take over 6 months to metastasize# without estradiol, highlighting different dependencies and time requirements.",
            "predicted_answer": "ER+ cells (like MCF-7) require longer time (over 6 months) and estradiol supplementation for bone metastasis, often forming mixed lesions. ER- cells (like MDA-MB-231) metastasize faster (2-4 weeks) and create osteolytic lesions without external factors.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that ER+ cells take over 6 months and require estradiol supplementation, while ER- cells quickly form osteolytic lesions within 2-4 weeks. The essential facts and trends about time and external factors are accurately captured. No key facts are missing."
        },
        {
            "query_idx": 413,
            "query": "How do co-culture systems with cancer organoids and three-dimensional scaffold models contribute to cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1727,
                    2041
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Co-culture systems contribute by promoting #PDO growth#, while three-dimensional models assist in maintaining #metastasis potential#.",
            "predicted_answer": "Co-culture systems with cancer organoids and three-dimensional scaffold models enhance cancer research by mimicking the tumor microenvironment, promoting organoid growth, and recovering biological pathways absent in conventional cultures, thus providing a more accurate in vitro model of cancer progression and metastasis.",
            "score": 5,
            "explanation": "The predicted answer mentions promoting \"organoid growth\", aligning with the reference's \"PDO growth\". It notes providing a model for \"cancer progression and metastasis,\" addressing the reference's \"metastasis potential\". Both key points are present, with no significant omissions or contradictions."
        },
        {
            "query_idx": 414,
            "query": "How do monoclonal antibodies interact with tumor-associated macrophages to alter their polarization and activity in the treatment of cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    411,
                    904
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Agonistic #CD40# antibodies shift macrophage polarization to #M1#, while anti-#CD24# antibodies increase macrophage activity by blocking anti-phagocytic signals, supporting cancer treatment outcomes.",
            "predicted_answer": "Monoclonal antibodies, such as agonistic CD40, interact with tumor-associated macrophages (TAMs) by shifting their polarization to the M1 phenotype, enhancing tumor cell apoptosis and activating tumor-specific T cells.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of CD40 antibodies and M1 polarization. However, it lacks the mention of anti-CD24 antibodies, a vital detail from the reference answer impacting completeness. Overall, the trend aligns, but an important detail is missing."
        },
        {
            "query_idx": 415,
            "query": "What kind of systematically collected data, when aligned with a regulatory initiative, informs dosage changes in cancer treatment trials involving specific targeted therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1644,
                    1645
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The collection of #fit-for-purpose PRO data# as part of the #FDA Oncology Center of Excellence# indicates that #up to 60% of patients# in trials with EGFR-targeting drugs face dosage changes due to tolerability.",
            "predicted_answer": "Systematically collected fit-for-purpose Patient-Reported Outcome (PRO) data, when aligned with regulatory initiatives, inform dosage changes in cancer treatment trials involving specific targeted therapies by providing insights into patient tolerance and adherence.",
            "score": 1,
            "explanation": "The predicted answer mentions fit-for-purpose PRO data and its relevance to dosage changes in cancer trials, aligning with the trend of the reference answer. However, it lacks reference to the FDA Oncology Center of Excellence and the statistic of \"up to 60% of patients,\" missing two key facts."
        },
        {
            "query_idx": 416,
            "query": "How do M2a and M1 macrophages influence tumor cell behavior, particularly focusing on invasion/metastasis and the suppression of tumor growth and angiogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2203,
                    2207
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The presence of #M2a macrophages# promotes tumor cell infiltration and potential metastasis, while #M1 macrophages# suppress tumor growth and fully inhibit angiogenesis.",
            "predicted_answer": "M2a macrophages promote tumor cell invasion and metastasis by facilitating infiltration and release of tumor cells. M1 macrophages suppress tumor growth and angiogenesis, inhibiting tumor migration and invasion.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions that M2a macrophages promote tumor cell invasion and metastasis and that M1 macrophages suppress tumor growth and angiogenesis. However, it does not fully capture that M1 macrophages \"fully inhibit\" angiogenesis, which is emphasized in the reference."
        },
        {
            "query_idx": 417,
            "query": "How many naturally occurring small molecules were evaluated initially, and how many inhibitors with certain characteristics were ultimately identified for a specific mutated protein target in a cancer study?",
            "retrieved_metrics": {
                "reference_idx": [
                    1664,
                    1667
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "From an initial evaluation of #152056# naturally occurring small molecules, #3 inhibitors# with the lowest binding free energy effectively targeted the double-mutated EGFR protein.",
            "predicted_answer": "Initially, 152,056 naturally occurring small molecules were evaluated. Ultimately, 3 inhibitors with specific characteristics were identified for the mutated EGFR protein in the cancer study.",
            "score": 3,
            "explanation": "The predicted answer correctly states the initial evaluation of 152,056 naturally occurring small molecules and the identification of 3 inhibitors, aligning with the reference answer. However, the detail about \"the lowest binding free energy\" for the inhibitors is missing, impacting completeness."
        },
        {
            "query_idx": 418,
            "query": "What biochemical pathway modifies the activity of CPT1A, and which structural component determines its affinity for malonyl-CoA through various conformational states?",
            "retrieved_metrics": {
                "reference_idx": [
                    1318,
                    1319
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #AMPK-ACC-CPT1A pathway# regulates CPT1A activity, while the #N-terminal state of CPT1A# determines malonyl-CoA affinity through its different conformational states.",
            "predicted_answer": "The biochemical pathway that modifies CPT1A activity is the AMPK-ACC-CPT1A axis. The structural component determining CPT1A's affinity for malonyl-CoA is the N-terminal state (residues 1-42), which can exist in inhibitory (Nα) or non-inhibitory (Nβ) conformational states.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts: the \"AMPK-ACC-CPT1A axis\" (aligning with \"#AMPK-ACC-CPT1A pathway#\") and the \"N-terminal state\" as crucial to determining malonyl-CoA affinity, matching the #N-terminal state of CPT1A# and its conformational states. All details are consistent with the Reference Answer."
        },
        {
            "query_idx": 419,
            "query": "Which compounds exhibit distinct mechanisms against cancer, one inhibiting multiple cancer types and the other specifically targeting prostate cancer via a kinase pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1876,
                    1877
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Methylselenic acid# inhibits multiple cancers by inducing caspase pathways, while #methylimidoseleno carbamates# target prostate cancer via PI3K/Akt/mTOR inhibition.",
            "predicted_answer": "Methylselenic acid inhibits multiple cancer types by triggering caspase pathways and UPR, while methylimidoseleno carbamates specifically target prostate cancer via kinase inhibition.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies both #Methylselenic acid# and #methylimidoseleno carbamates# as related to cancer treatment. However, it inaccurately describes the mechanism for the latter: the predicted answer mentions \"kinase inhibition\" but misses the specifics of \"PI3K/Akt/mTOR inhibition,\" which is crucial."
        },
        {
            "query_idx": 420,
            "query": "What challenges do spheroids and 2D cell cultures present in terms of drug penetration and cell interaction, and how do these challenges impact the predictability of anticancer drug efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1706,
                    1767
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Many anticancer compounds exhibit #reduced efficacy in spheroids# due to poor drug penetration, while #2D cultures poorly predict in vivo outcomes# due to cell interaction discrepancies, limiting drug efficacy evaluation.",
            "predicted_answer": "Spheroids present challenges in drug penetration due to their 3D structure, leading to reduced efficacy of anticancer compounds. 2D cell cultures, on the other hand, show higher drug sensitivity but lack accurate cell-cell interactions, impairing predictability of drug efficacy. Both models impact the reliability of anticancer drug efficacy predictions.",
            "score": 3,
            "explanation": "The Predicted Answer addresses challenges with spheroids and 2D cell cultures related to drug penetration and cell interaction. However, it doesn't fully cover the key details, specifically about #2D cultures poorly predicting in vivo outcomes#, which affects the completeness of the prediction. The overall trend is consistent."
        },
        {
            "query_idx": 421,
            "query": "What critical structural aspect enhances the cytotoxicity of specific compounds, and how does the cytotoxic efficacy of these compounds compare to standard chemotherapy agents like cisplatin?",
            "retrieved_metrics": {
                "reference_idx": [
                    1287,
                    1791
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #bridged sugar units# are vital for increasing cytotoxicity, and these compounds exhibit an #18-fold higher# cytotoxic potency than cisplatin, highlighting their therapeutic potential.",
            "predicted_answer": "The critical structural aspect enhancing cytotoxicity is the presence of bridged sugar units. Compounds with these units, like Compound 108, exhibit cytotoxicity higher than standard chemotherapy agents like cisplatin, as evidenced by IC50 values.",
            "score": 3,
            "explanation": "The predicted answer mentions \"bridged sugar units\" as critical for enhancing cytotoxicity, aligning with the reference. However, it lacks the specific \"#18-fold higher#\" cytotoxicity detail, affecting completeness despite being consistent with the overall trend. No contradictory information is present."
        },
        {
            "query_idx": 422,
            "query": "How does the unique regulatory process in PDAC facilitate tumor access to circulation, and what is the effect of cellular structure loss on cell replacement and programmed cell death in this context?",
            "retrieved_metrics": {
                "reference_idx": [
                    2218,
                    2219
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In PDAC, #angiogenesis# regulation uniquely allows microvessel development for tumor access to circulation and hampers chemotherapy reach; #endothelial# ablation leads to tumor cell linings with selective HUVEC apoptosis.",
            "predicted_answer": "The unique regulatory process in PDAC facilitates tumor access to circulation by promoting angiogenesis early, allowing microvessels to connect tumor cells to the circulation. Cellular structure loss, such as endothelial ablation, leads to cell replacement by tumor cells and selective apoptosis of endothelial cells, enhancing tumor invasion and metastasis.",
            "score": 3,
            "explanation": "The predicted answer includes #angiogenesis# and mentions #endothelial# ablation, aligning with the reference. However, it misses the effect on chemotherapy reach and specific mention of HUVEC apoptosis. Thus, while generally consistent, it lacks some details, affecting completeness."
        },
        {
            "query_idx": 423,
            "query": "How do specific advanced 3D cell culture models contribute to the evaluation of novel metal-based cancer treatments, and what unique benefits do they provide in testing these agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1785,
                    1786
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #spheroids and organoids# serve as advanced testing platforms in which #ruthenium complexes# can be screened. Their design mimics the tumor microenvironment, providing a more relevant assessment.",
            "predicted_answer": "Advanced 3D cell culture models, like cancer spheroids and organoids, contribute to evaluating novel metal-based cancer treatments by providing a more relevant environment than 2D cultures, mimicking tumor ECM and aiding in the selection of promising candidates before animal studies.",
            "score": 3,
            "explanation": "The predicted answer mentions \"spheroids and organoids\" and their role in mimicking the tumor environment, aligned with the reference answer. However, it lacks specific mention of \"ruthenium complexes.\" This missing detail affects the completeness but doesn't contradict the reference."
        },
        {
            "query_idx": 424,
            "query": "Which drugs, originally used for rheumatoid arthritis, psoriatic arthritis, and as anthelmintic agents, have shown potential in cancer therapy due to their effects on specific metabolic enzymes or cellular structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    778,
                    793
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Leflunomide#, used for rheumatoid and psoriatic arthritis, affects a metabolic enzyme, while #Mebendazole#, used as an anthelmintic, targets cellular microtubules, both showing anticancer potential.",
            "predicted_answer": "Leflunomide, originally used for rheumatoid arthritis and psoriatic arthritis, and mebendazole, an anthelmintic agent, have shown potential in cancer therapy due to their effects on metabolic enzymes (DHODH inhibition) and cellular structures (microtubule interaction), respectively.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: Leflunomide and Mebendazole's respective original uses and their roles in cancer therapy through DHODH inhibition and microtubule interaction align with the reference. All emphasized details are present and aligned in meaning."
        },
        {
            "query_idx": 425,
            "query": "Which two medications are associated with cancer treatment mechanisms involving new blood vessel growth inhibition and action against tumor cell gene deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    764,
                    786
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The medications #atorvastatin# and #simvastatin# are notable in cancer treatments for #inhibiting angiogenesis# and targeting #RB-deficient# tumor cells.",
            "predicted_answer": "Atorvastatin and simvastatin are associated with cancer treatment mechanisms involving new blood vessel growth inhibition and action against tumor cell gene deficiencies.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies the medications atorvastatin and simvastatin. However, it lacks the specific mechanisms of action mentioned in the reference: inhibiting angiogenesis and targeting RB-deficient tumor cells. These are key facts significant to the context provided."
        },
        {
            "query_idx": 426,
            "query": "What challenges affect minority group participation in clinical trials, and what statistical issue hinders the assessment of participant diversity in these studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1436,
                    1437
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The participation of minority groups in trials is affected by #social determinants of health#, while #32.2% of trials do not report race and ethnicity#, hindering diversity assessment.",
            "predicted_answer": "Challenges affecting minority group participation in clinical trials include social determinants of health and access to academic medical centers. The statistical issue hindering the assessment of participant diversity is the underreporting of race and ethnicity data, as highlighted by the 32.2% of trials not reporting this information.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"social determinants of health\" as a challenge for minority participation. Additionally, it mentions the underreporting of race and ethnicity, aligning with the reference's \"32.2% of trials do not report race and ethnicity.\" All key facts are present with no significant omissions."
        },
        {
            "query_idx": 427,
            "query": "What method is applied to adjust drug concentration in patients taking oral therapies, and what are the criteria used to determine the need for implementing such a method?",
            "retrieved_metrics": {
                "reference_idx": [
                    718,
                    719
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Pharmacokinetic-guided interventions# are applied to adjust drug concentration based on #suitability criteria for TDM# in patients taking oral therapies.",
            "predicted_answer": "Pharmacokinetic-guided interventions are applied to adjust drug concentration in patients taking oral therapies. Criteria for implementing this method include interpatient variability in pharmacokinetic exposure, narrow therapeutic range, and defined exposure-response relationships.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"Pharmacokinetic-guided interventions\" as the method used to adjust drug concentration, aligning with one key fact in the reference. However, it does not explicitly mention the \"suitability criteria for TDM,\" thus missing a crucial element, affecting completeness."
        },
        {
            "query_idx": 428,
            "query": "Which biological model is used for evaluating drug metabolism, maintaining genetic consistency with original tissues, and predicting treatment responses specifically in prostate cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1450,
                    1449,
                    1466
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "Patient-derived organoids show #CYP3A4# expression near in vivo levels, retain #genetic similarity# to original tissues, and predict treatment responses in #prostate cancer#.",
            "predicted_answer": "Patient-derived organoids (PDOs) are used for evaluating drug metabolism, maintaining genetic consistency with original tissues, and predicting treatment responses specifically in prostate cancer.",
            "score": 3,
            "explanation": "The predicted answer mentions the use of patient-derived organoids for assessing drug metabolism, maintaining genetic consistency with original tissues, and predicting treatment responses in prostate cancer, aligning with the reference. However, it omits the specific detail of \"CYP3A4 expression near in vivo levels.\""
        },
        {
            "query_idx": 429,
            "query": "What are the specific activities exhibited by the phytochemicals of the ethnomedicinal plant used by Indian tribal communities, and what pharmaceutical assessments do they comply with?",
            "retrieved_metrics": {
                "reference_idx": [
                    1683,
                    1685
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The phytochemicals of #Selaginella repanda# have #anti-proliferative effects# on MCF7, HCT116, and A549 cell lines and comply with pharmaceutical standards through #Lipinski's rule of 5#.",
            "predicted_answer": "The phytochemicals of Selaginella repanda exhibit anti-proliferative activity against cancer cell lines and comply with ADMET parameters, including good bioavailability and permeability.",
            "score": 1,
            "explanation": "The predicted answer includes key information about Selaginella repanda's anti-proliferative activity and pharmaceutical assessment, similar to the reference. It covers bioavailability but omits details about specific cell lines (MCF7, HCT116, A549) and Lipinski's rule of 5. Overall, alignment is present, but important specifics are missing."
        },
        {
            "query_idx": 430,
            "query": "What alternative dosing strategy is proposed to achieve effective BTK receptor targeting while minimizing safety risks, differing from the conventional 3+3 dose design?",
            "retrieved_metrics": {
                "reference_idx": [
                    729,
                    735
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #personalized approach# to dosing is advocated to ensure effective #BTK receptor occupancy# and #safety#, differing from traditional methods like the 3 + 3 escalation design.",
            "predicted_answer": "A personalized pharmacology-driven dose optimization strategy is proposed, shifting away from the conventional 3+3 dose design to achieve effective BTK receptor targeting while minimizing safety risks.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by proposing a personalized approach, targeting BTK receptor and aiming at safety. However, it misses mentioning \"BTK receptor occupancy,\" which affects completeness. The overall trend is matched but lacks one critical detail."
        },
        {
            "query_idx": 431,
            "query": "How can organoid technology and cellular integration enhance cancer treatment while addressing tumor microenvironment challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    1423,
                    1989
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The combination of #personalized therapeutic regimens# and organoid technology, integrating #immune and endothelial cells#, aids in overcoming tumor microenvironment challenges in cancer treatment.",
            "predicted_answer": "Organoid technology enhances cancer treatment by mimicking tumor microenvironment (TME) complexities, integrating immune and endothelial cells to improve drug efficacy and immunotherapy outcomes, addressing challenges like hypoxia and immunosuppression.",
            "score": 3,
            "explanation": "The predicted answer includes some key facts like integrating immune and endothelial cells and addressing tumor microenvironment challenges, consistent with the reference. However, it omits the aspect of \"personalized therapeutic regimens,\" important in the reference for completeness."
        },
        {
            "query_idx": 432,
            "query": "What specific investigational treatments are being explored in clinical trials for advanced hematologic conditions associated with IDH1 mutations and IDH2-mutated relapsed/refractory acute myeloid leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    606,
                    601
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The investigational therapies involve #ivosidenib# in trials for #IDH1-mutant conditions# and #enasidenib# in studies targeting #IDH2-mutated R/R AML#.",
            "predicted_answer": "Investigational treatments for IDH1 mutations include ivosidenib with azacitidine and nivolumab. For IDH2-mutated relapsed/refractory acute myeloid leukemia, enasidenib is being explored in monotherapy and combinations with azacitidine, venetoclax, and ruxolitinib.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies #ivosidenib# for #IDH1-mutant conditions# and #enasidenib# for #IDH2-mutated R/R AML#. It aligns well with the reference answer, adding details about combinations but not contradicting key facts. Thus, it covers all important information without omissions."
        },
        {
            "query_idx": 433,
            "query": "What is the ClinicalTrials.gov identifier for TEN-010 trials in solid tumors, and what is the objective response rate for its use with venetoclax and rituximab in a phase 1 DLBCL trial?",
            "retrieved_metrics": {
                "reference_idx": [
                    591,
                    593
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The identifier for solid tumors involving #TEN-010# is #NCT01987362#, and in combination with venetoclax and rituximab, the ORR for DLBCL is #38.5%#.",
            "predicted_answer": "The ClinicalTrials.gov identifier for TEN-010 trials in solid tumors is NCT01987362. In a phase 1 DLBCL trial with venetoclax and rituximab, the objective response rate (ORR) was 38.5%.",
            "score": 5,
            "explanation": "The predicted answer accurately provides the ClinicalTrials.gov identifier for TEN-010 trials in solid tumors as NCT01987362, and reports the objective response rate for DLBCL with venetoclax and rituximab as 38.5%. All key facts emphasized in the reference are present without omissions or contradictions."
        },
        {
            "query_idx": 434,
            "query": "What biological system is involved in clearing foreign particles and contributes to difficulties in the systemic distribution of oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    403,
                    851
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Mononuclear Phagocyte System (MPS)# clears foreign particles, causing #uneven distribution of systemic oncological treatments#, leading to challenges in drug delivery.",
            "predicted_answer": "The mononuclear phagocyte system (MPS) is involved in clearing foreign particles and contributes to difficulties in the systemic distribution of oncological treatments.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the Mononuclear Phagocyte System (MPS) and its role in clearing foreign particles, aligning with the reference. However, it omits the key detail about the \"uneven distribution of systemic oncological treatments,\" affecting the completeness of the answer."
        },
        {
            "query_idx": 435,
            "query": "What recent genetic modification method has advanced cancer research applications, and why is it superior in precision and functionality to existing gene-editing technologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    959,
                    971
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Prime Editing# has advanced cancer research by offering #advantages# like high precision, enabling diverse base substitutions and small indels, surpassing the capabilities of CRISPR-Cas9 and other methods.",
            "predicted_answer": "Prime Editing has advanced cancer research by enabling precise genetic modifications, superior to existing technologies like CRISPR-Cas9 and ZFNs, due to its ability to perform all types of single-base substitutions, multiple-base substitutions, and small indels with high precision.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies Prime Editing and highlights its high precision and ability to perform diverse genetic modifications. It mentions its superiority over CRISPR-Cas9 and ZFNs, aligning well with the Reference Answer's emphasis on advantages, precision, and surpassing other methods. No significant omissions are observed."
        },
        {
            "query_idx": 436,
            "query": "How is the classification of drug indications determined by both the approval timeline and the number of drugs used in the therapeutic approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    625,
                    1062
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The classification involves the #distinction between original and supplemental approvals# and categorizing treatments as either #monotherapy or combination# based on the number of drugs involved.",
            "predicted_answer": "The classification of drug indications is determined by the approval timeline (original vs. supplemental) and the number of drugs used (monotherapy vs. combination). Original approvals are based on initial FDA approval dates, while supplemental approvals follow. Monotherapy involves a single drug, and combination treatments use multiple drugs.",
            "score": 5,
            "explanation": "The predicted answer includes the main aspects of the classification of drug indications: the distinction between original and supplemental approvals, and the categorization of treatments as monotherapy or combination. Both key facts emphasized with # in the reference are present without contradictions."
        },
        {
            "query_idx": 437,
            "query": "What metrics are used to evaluate the influence of cancer cell growth rate, and what specific methodological change was proposed in 2016 for assessing drug efficacy regarding these metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1748,
                    1747
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The metrics #GR50# and #GRAUC# evaluate cancer cell growth rate. In 2016, a change was proposed to use the #growth rate inhibition curve# instead of the viability curve.",
            "predicted_answer": "The metrics used to evaluate cancer cell growth rate influence are GR50, GRAUC, IC50, and AUC. In 2016, Hafner et al. proposed replacing the concentration-viability curve with the concentration-growth rate inhibition curve to assess drug efficacy more accurately.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: metrics GR50 and GRAUC, and the proposed use of the growth rate inhibition curve. The additional metrics (IC50, AUC) do not contradict the reference. The trend and key facts align with no significant omissions."
        },
        {
            "query_idx": 438,
            "query": "What effects are observed in preclinical models of cancer when utilizing DNMTi agents in combination with other antineoplastic therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    551,
                    552
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Combining DNMTi agents with antineoplastic therapies in preclinical models results in #improved anticancer activity# and #complete tumor regression#.",
            "predicted_answer": "In preclinical models of cancer, DNMTi agents in combination with other antineoplastic therapies show enhanced anticancer activity, complete tumor regression, and improved overall survival. This suggests potential for higher efficacy in solid tumors.",
            "score": 5,
            "explanation": "The Predicted Answer captures key facts such as \"enhanced anticancer activity\" and \"complete tumor regression,\" which are emphasized in the Reference Answer. It includes additional information on \"improved overall survival\" and does not contradict the Reference Answer, thus maintaining alignment and completeness."
        },
        {
            "query_idx": 439,
            "query": "Which protein is involved both in promoting new blood vessel formation and altering glucose metabolism in cancer cells through distinct molecular pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1366,
                    1371
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The protein #B7-H3# promotes angiogenesis via increased #VEGF# through the #NF-κB pathway# and modifies glucose metabolism by enhancing #glycolysis# through upregulation of #HIF-1α# targets.",
            "predicted_answer": "B7-H3 is involved in promoting new blood vessel formation and altering glucose metabolism in cancer cells through distinct molecular pathways.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies the protein B7-H3 as involved in both angiogenesis and altering glucose metabolism in cancer cells, aligning with the reference. However, it lacks details on VEGF, NF-κB pathway, glycolysis, and HIF-1α targets, leading to incomplete coverage."
        },
        {
            "query_idx": 440,
            "query": "What delivery system offers promising solutions for overcoming targeting, immune reaction, and stability challenges of genome editing within the body, and what are its key characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    966,
                    978
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CRISPR# delivery faces targeting, immune, and stability challenges. #PNPs# offer solutions with controlled release, biocompatibility, and customization for in vivo genome editing.",
            "predicted_answer": "The delivery system offering promising solutions for overcoming targeting, immune reaction, and stability challenges of genome editing within the body is the lipid nanoparticles (LNPs) and polymer nanoparticles (PNPs). Key characteristics include controlled release, enhanced solubility, targeted delivery, customization, and biocompatibility.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies PNPs as a solution to the challenges in genome editing, which aligns with the reference. However, it does not mention \"CRISPR,\" which is a key aspect in the reference answer. All other characteristics like controlled release and biocompatibility are present."
        },
        {
            "query_idx": 441,
            "query": "What is the role of B7-H3 in modulating immune cell populations and the suppression of T cell-mediated responses in tumor environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1362,
                    1379
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Elevated #B7-H3# expression is linked to #increased immune cell numbers# in tumors and #suppression of CD8+ T cell-dependent anti-tumor immunity#.",
            "predicted_answer": "B7-H3 modulates immune cell populations by promoting the expansion of CD8$^{+}$ T-cells, CD4$^{+}$ T cells, natural killer cells, and plasmacytoid dendritic cells, while suppressing CD8$^{+}$ T cell-mediated anti-tumor immunity in tumor environments.",
            "score": 3,
            "explanation": "The Predicted Answer indicates B7-H3 affects various immune cell populations and mentions the suppression of CD8$^{+}$ T cell-mediated anti-tumor immunity, aligning with the Reference Answer. However, it omits the link between elevated B7-H3 expression and increased immune cell numbers. This missing key fact affects completeness."
        },
        {
            "query_idx": 442,
            "query": "Which investigational therapeutic approach involves combining specific immune checkpoint inhibitors in trials for prostate cancer and also utilizes chemotherapy agents for NMC treatment in clinical studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    592,
                    590
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The investigational #ZEN -3694# is trialed with immune checkpoint inhibitors like #nivolumab#, #pembrolizumab# for prostate cancer, and with chemotherapy drugs #etoposide#, #cisplatin# for NMC treatment.",
            "predicted_answer": "The investigational approach involves combining immune checkpoint inhibitors like ZEN-3694 with pembrolizumab and enzalutamide for prostate cancer, and adding ZEN-3694 to chemotherapy (etoposide and cisplatin) for NMC treatment.",
            "score": 3,
            "explanation": "The predicted answer includes 'pembrolizumab' and 'ZEN-3694' as immune checkpoint inhibitors for prostate cancer and 'etoposide' and 'cisplatin' for NMC, aligning with the reference. However, it wrongly mentions 'enzalutamide' and omits 'nivolumab', affecting completeness."
        },
        {
            "query_idx": 443,
            "query": "What is the name of the molecule currently under clinical investigation for solid tumors, and which overexpressed protein involved in cancer malignancy is it targeting?",
            "retrieved_metrics": {
                "reference_idx": [
                    1565,
                    1578
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Smac mimic inhibitor# is being tested in clinical trials against solid tumors, aiming to inhibit the overexpressed protein #Skp2#, linked to cancer malignancy.",
            "predicted_answer": "The molecule under clinical investigation for solid tumors is Lcl161, targeting the overexpressed protein Skp2 involved in cancer malignancy.",
            "score": 1,
            "explanation": "The predicted answer identified Lcl161, which may not accurately represent the \"Smac mimic inhibitor\" emphasized in the reference answer. However, it correctly targets the protein Skp2. The discrepancy in the molecule's name and alignment affects completeness."
        },
        {
            "query_idx": 444,
            "query": "What is the preclinical screening method used for therapies targeting genetic disorders, and what model is effective for testing immune checkpoint inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    2095,
                    2097
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9-edited zebrafish models# are used for testing therapies for genetic disorders, while #Efficient PDX models# are effective for immune checkpoint inhibitors.",
            "predicted_answer": "The preclinical screening method for therapies targeting genetic disorders is CRISPR-Cas9-edited zebrafish models. An effective model for testing immune checkpoint inhibitors is the PDX model.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts: the use of #CRISPR-Cas9-edited zebrafish models# for genetic disorders and #PDX models# for immune checkpoint inhibitors. It aligns well with the Reference Answer without any significant omissions or contradictions."
        },
        {
            "query_idx": 445,
            "query": "What specific designations and associated pathways have cancer drugs received from the FDA between 2012 and 2022, and what factors are analyzed in their recognition process?",
            "retrieved_metrics": {
                "reference_idx": [
                    616,
                    1925
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Cancer drugs received #multiple special designations# and were analyzed through #special approval pathways# emphasizing aspects like clinical benefit within 2012-2022.",
            "predicted_answer": "Cancer drugs received FDA designations such as orphan, fast track, accelerated approval, priority review, and breakthrough therapy between 2012 and 2022. Factors analyzed in their recognition process include clinical development, benefit, innovativeness, trial evidence, epidemiology, and price.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by noting multiple designations received by cancer drugs and special approval pathways. It details types of designations and evaluation factors, reflecting the meaning of special designations and approvals for clinical benefit. However, it does not explicitly emphasize \"special approval pathways.\""
        },
        {
            "query_idx": 446,
            "query": "What unique structural features in specific compounds correlate to their potency against different cancer cell lines, and what cellular processes do they affect?",
            "retrieved_metrics": {
                "reference_idx": [
                    1878,
                    1881,
                    1258
                ],
                "num_of_contexts": 3
            },
            "groundtruth_answer": "The #Phenylselenide tail# in compound 28 acts against T-lymphoma lines. Compound 27's #benzodiazepine scaffold# disrupts microtubules, while #bisindole thiophene compound 20# targets leukemic cell lines effectively.",
            "predicted_answer": "Selenides, such as compound 27 with a benzodiazepine scaffold, correlate to potency against cancer cell lines by interfering with intracellular microtubule organization, halting the cell cycle at G2/M, and promoting cell death.",
            "score": 1,
            "explanation": "The predicted answer mentions the benzodiazepine scaffold of compound 27 and its disruption of microtubules, aligning with the reference. However, it omits the phenylselenide tail of compound 28 and bisindole thiophene compound 20. These omissions affect completeness, though no contradictions exist."
        },
        {
            "query_idx": 447,
            "query": "Which DNMT inhibitor was first FDA-approved in 2004 for a hematologic condition, what was its efficacy based on response rate, and what is the action mechanism of such inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    541,
                    535
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first DNMT inhibitor approved by the FDA in 2004 was #azacitidine# for #myelodysplastic syndrome#, achieving a #15.7% response rate#. These inhibitors form #irreversible DNA-DNMT adducts#, causing epigenetic and cytotoxic effects.",
            "predicted_answer": "Azacitidine was the first DNMT inhibitor FDA-approved in 2004 for myelodysplastic syndrome, with an overall response rate of 15.7%. DNMT inhibitors like azacitidine and decitabine act by irreversibly binding to DNA-DNMT, causing dual epigenetic and cytotoxic effects.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions azacitidine, the condition (myelodysplastic syndrome), the response rate of 15.7%, and the mechanism of action (irreversible DNA-DNMT binding causing epigenetic and cytotoxic effects). All key facts in the reference are reflected and there are no contradictions."
        },
        {
            "query_idx": 448,
            "query": "Which therapies were approved by the U.S. Food and Drug Administration in the 1990s specifically for different types of cancer impacting bladder and lymphatic systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    868,
                    872
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The U.S. Food and Drug Administration approved #BCG# for superficial #bladder cancer# and #Rituximab# for #B-cell lymphomas# in the 1990s, revolutionizing targeted cancer therapies.",
            "predicted_answer": "The FDA approved BCG for bladder cancer in 1990 and Rituximab for B-cell lymphomas in 1997.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key points emphasized in the reference answer: \"BCG\" for \"bladder cancer\" and \"Rituximab\" for \"B-cell lymphomas.\" Both are accurately attributed to the correct decade, the 1990s. The information is consistent, without any significant omissions or inaccuracies."
        },
        {
            "query_idx": 449,
            "query": "Modify the multi-hop query:  \nWhat experimental antibody-drug conjugate treatment showed specific results in terms of progression-free survival for HER2-mutated advanced NSCLC, and which related treatment received approval for these patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    179,
                    1617
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer based on the suggestions:",
            "predicted_answer": "Trastuzumab deruxtecan showed specific results in terms of progression-free survival for HER2-mutated advanced NSCLC, and it received approval for these patients.",
            "score": 5,
            "explanation": "The predicted answer mentions Trastuzumab deruxtecan as the treatment for HER2-mutated advanced NSCLC with specific results in progression-free survival and its approval. However, without specific highlighted key facts from the reference to compare, I assume all necessary elements are covered in general trend."
        },
        {
            "query_idx": 450,
            "query": "What processes influence the conversion of specific precursor cells into bone cells, and what factors contribute to the activation and movement of bone-degrading cells in the setting of cancer metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2026,
                    2030
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #biochemical or biomechanical stimulus# facilitates precursor cell conversion to bone cells, while #RANKL expression# affects the activation and movement of bone-degrading cells in cancer metastasis.",
            "predicted_answer": "The conversion of mesenchymal stem cells into bone cells (osteoblasts, osteoclasts, and bone-lining cells) is influenced by biochemical and biomechanical stimuli. In cancer metastasis, factors like RANKL, MMP1, IL-11, TNF-α, and interleukins (IL-1, IL-6, IL-8) activate and move bone-degrading cells (osteoclasts) through RANK/RANKL/OPG and JAK1/STAT3 pathways.",
            "score": 5,
            "explanation": "The predicted answer covers both main elements from the reference answer: biochemical and biomechanical stimuli for cell conversion, and RANKL involvement in bone cell activation and movement. It includes additional specifics (like pathways) but aligns with trends and includes key facts, with no contradictions."
        },
        {
            "query_idx": 451,
            "query": "How many compounds were successfully identified after profiling based on adherence to ADMET properties and effectiveness against significant breast cancer targets, supported by documented evidence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1682,
                    1692
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#24 compounds# were identified post-#ADMET# profiling, and #68 phytochemicals# were determined to be effective against critical #breast cancer targets#.",
            "predicted_answer": "24 compounds were successfully identified after profiling based on adherence to ADMET properties and effectiveness against significant breast cancer targets.",
            "score": 3,
            "explanation": "The predicted answer includes the identification of \"24 compounds,\" adherence to \"ADMET\" profiling, and effectiveness against \"breast cancer targets.\" However, it omits the detail of \"#68 phytochemicals#\" from the reference, which is a key fact emphasized in the reference."
        },
        {
            "query_idx": 452,
            "query": "What methodology is used to identify and design novel inhibitors when the receptor's structural information is unavailable, and what process aids in recognizing crucial molecular features?",
            "retrieved_metrics": {
                "reference_idx": [
                    1657,
                    1665
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ligand-based drug design# methodology identifies novel inhibitors when receptor structure is absent. It employs #pharmacophore modelling# to pinpoint essential molecular features necessary for biological activity.",
            "predicted_answer": "Ligand-based drug design (LBDD) using QSAR and pharmacophore modeling is employed when receptor structural information is unavailable. Pharmacophore modeling aids in recognizing crucial molecular features for inhibitor design.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer: the use of ligand-based drug design (LBDD) and pharmacophore modeling. It conveys the same meaning with the same emphasis on essential molecular features for inhibitor design. Both answers accurately reflect the methodology and process involved."
        },
        {
            "query_idx": 453,
            "query": "How does the tumor microenvironment in pancreatic cancer contribute to immune response challenges and therapy resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    392,
                    407
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The tumor microenvironment in pancreatic cancer causes #immune suppression# through signaling molecules and creates a #resistance to immunotherapy# due to poor T cell access and stromal barriers.",
            "predicted_answer": "The tumor microenvironment in pancreatic cancer promotes immune suppression by sustaining chronic inflammation and creating a stromal barrier, which hinders cytotoxic CD8+ T cell infiltration and contributes to therapy resistance.",
            "score": 3,
            "explanation": "The predicted answer captures the #immune suppression# and the creation of #stromal barriers#, aligning closely with the reference. However, it does not explicitly mention #resistance to immunotherapy#, although it implies therapy resistance generally. Therefore, one key fact is missing, affecting completeness."
        },
        {
            "query_idx": 454,
            "query": "How do HECT and RBR type E3 ligases differ from RING-type E3 ligases in their ubiquitination mechanisms, specifically concerning the reaction steps and the involvement of zinc ions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1555,
                    1560
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "HECT and RBR ligases use a #two-step reaction# with a catalytic active site, while RING-type E3s enable #Ub transfer# directly, facilitated by a #zinc-dependent RING domain#.",
            "predicted_answer": "HECT and RBR type E3 ligases use a two-step ubiquitination mechanism, involving a thioester intermediate. RING-type E3 ligases directly transfer Ub from E2 to substrates, facilitated by zinc ions in the RING domain.",
            "score": 5,
            "explanation": "The predicted answer covers the two-step ubiquitination mechanism for HECT and RBR ligases and the direct Ub transfer facilitated by zinc in the RING domain, aligning with the reference. It covers all key facts (#two-step reaction#, #Ub transfer#, and #zinc-dependent RING domain#) without omissions."
        },
        {
            "query_idx": 455,
            "query": "What method is used to determine the origin of cancers of unknown primary and how does this determination affect the outcomes of targeted versus non-targeted treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    510,
                    517
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The method is #DNA methylation-based classification#, identifying primary cancer origin, leading to improved survival with #targeted therapy# compared to non-targeted, or empirical, treatment.",
            "predicted_answer": "DNA methylation-based classifiers, like EPICUP, determine the origin of cancers of unknown primary (CUP). This determination significantly improves outcomes, with targeted therapy leading to better overall survival compared to non-targeted treatment.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of using \"DNA methylation-based classifiers\" to determine cancer origin and emphasizes improved outcomes with \"targeted therapy,\" aligning with the Reference Answer. Both technical method and treatment outcome details match without omissions."
        },
        {
            "query_idx": 456,
            "query": "What host responses over time need examination to ensure the prolonged effectiveness of phage therapies, given potential interactions and antibody development?",
            "retrieved_metrics": {
                "reference_idx": [
                    77,
                    93
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Phage therapies' success over time requires understanding host #immune system# interactions and potential #neutralizing antibodies#, impacting long-term treatment efficacy.",
            "predicted_answer": "Host responses to examine include immune modulation, development of neutralizing antibodies, and potential off-target effects on the microbiome to ensure prolonged phage therapy effectiveness.",
            "score": 5,
            "explanation": "The predicted answer mentions \"immune modulation,\" \"neutralizing antibodies,\" and \"off-target effects on the microbiome.\" The reference focuses on \"immune system interactions\" and \"neutralizing antibodies.\" The predicted answer aligns with the key facts in the reference and adds additional context without contradictions."
        },
        {
            "query_idx": 457,
            "query": "What agents are combined with aromatase inhibitors for breast cancer treatment, where one agent received a significant status in the US, and another received a national approval elsewhere?",
            "retrieved_metrics": {
                "reference_idx": [
                    564,
                    565
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agents are #Entinostat#, given a breakthrough status in the US with exemestane, and #Chidamide#, approved in China combined with an aromatase inhibitor.",
            "predicted_answer": "Entinostat received FDA Breakthrough Therapy Designation in the US for combination with exemestane, and chidamide received approval in China for combination with an aromatase inhibitor.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies and details both #Entinostat# as receiving FDA Breakthrough Therapy Designation in the US and being combined with exemestane, and #Chidamide# as being approved in China for use with an aromatase inhibitor. It fully aligns with the reference answer, without omissions or contradictions."
        },
        {
            "query_idx": 458,
            "query": "What are the advantages of a specific bioreactor model that supports a three-dimensional growth environment and offers variable culture conditions resembling natural settings?",
            "retrieved_metrics": {
                "reference_idx": [
                    2042,
                    2046
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #stirring bioreactors# provide a #three-dimensional growth environment# and feature #adjustable culture parameters#, making them effective in mimicking natural conditions.",
            "predicted_answer": "The specific bioreactor model offers advantages such as adjustable culture parameters, realistic 3D growth, controlled perfusion, and dynamic conditions, closely resembling natural settings while preventing contamination.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning a three-dimensional growth environment and adjustable culture parameters, consistent with mimicking natural conditions. However, it doesn't specify the \"stirring\" aspect, which is important, leading to a missing key fact."
        },
        {
            "query_idx": 459,
            "query": "How is the radiofluorination reaction used to synthesize a compound that crosses a protective barrier in imaging studies, and what receptor demonstrates notable uptake of a similar radiolabeled compound?",
            "retrieved_metrics": {
                "reference_idx": [
                    1532,
                    1542
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Cu mediated radiofluorination# synthesizes $\\text{^{18}F}$-TRACK, allowing it to cross the #blood-brain barrier#. In studies, the #5-HT$_{1B}$# receptor exhibits high uptake of a related compound.",
            "predicted_answer": "The radiofluorination reaction was used to synthesize $^{18}$F-TRACK, a Tropomyosin Receptor Kinase (Trk) inhibitor, which crosses the blood-brain barrier and shows high brain uptake. The 5-HT$_{1B}$ receptor demonstrates notable uptake of a similar radiolabeled compound.",
            "score": 3,
            "explanation": "The predicted answer captures the synthesis of $\\text{^{18}F}$-TRACK, its ability to cross the blood-brain barrier, and the notable uptake by the 5-HT$_{1B}$ receptor. However, it omits the key detail of \"Cu-mediated\" radiofluorination, affecting completeness."
        },
        {
            "query_idx": 460,
            "query": "Which specific genetic variant impacts the metabolism of irinotecan, and what approach is used to assess its effect on the drug's metabolism and associated clinical outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    690,
                    710
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #UGT1A1# *28 allele impacts irinotecan metabolism, and #Modeling and Simulation methods# assess its effect on drug metabolism and clinical outcomes.",
            "predicted_answer": "The specific genetic variant that impacts the metabolism of irinotecan is the UGT1A1*28 allele. This variant is assessed using pharmacokinetic and pharmacodynamic models to evaluate its effect on drug metabolism and associated clinical outcomes, such as irinotecan-induced toxicity.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the UGT1A1*28 allele as the specific genetic variant impacting irinotecan metabolism and mentions the use of pharmacokinetic and pharmacodynamic models, aligning with \"Modeling and Simulation methods\" in the reference answer. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 461,
            "query": "What agents are explored to enhance outcomes in non-small-cell lung cancer and identify response predictors in head and neck squamous cell carcinoma treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    288,
                    290
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The agent #Ipilimumab# aids in improving outcomes in non-small-cell lung cancer, while #Cetuximab# is studied for response predictors in head and neck squamous cell carcinoma.",
            "predicted_answer": "In non-small-cell lung cancer, agents like ipilimumab and nivolumab are explored to enhance outcomes. In head and neck squamous cell carcinoma (HNSCC), PD-1 antibodies and cetuximab are used, with window trials aiming to identify response predictors.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies ipilimumab for non-small-cell lung cancer and cetuximab for head and neck squamous cell carcinoma, covering both key facts from the reference. However, the inclusion of additional agents and trials, while not contradictory, extends beyond the specified facts."
        },
        {
            "query_idx": 462,
            "query": "What are the distinct issues regarding physicians' decision-making roles and the potential for imbalanced treatment outcomes in AI-driven healthcare systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1230,
                    1234
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Physicians should retain #control# in decision-making regarding AI healthcare applications, ensuring that #imbalanced treatment outcomes# from algorithmic biases are addressed to prevent inequities.",
            "predicted_answer": "The distinct issues include physicians' reliance on AI suggestions, potential biases in AI algorithms leading to imbalanced treatment outcomes, and the need for improved interpretability and transparency of AI systems to ensure fair and equitable healthcare.",
            "score": 3,
            "explanation": "The predicted answer covers potential biases in AI algorithms leading to imbalanced treatment outcomes, aligning with the reference's emphasis on addressing algorithmic biases to prevent inequities. However, it misses the specific mention of physicians retaining \"control\" in decision-making. This omission affects completeness."
        },
        {
            "query_idx": 463,
            "query": "How do CAR-NK cells execute their tumor-eliminating function, and what unique features of NK92 cell lines contribute to the effectiveness of CAR-NK therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    936,
                    937
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "CAR-NK cells utilize #Perforin# and #Granzyme# for tumor elimination by #recognition#. #NK92 cell lines# in CAR-NK therapy offer #unlimited proliferation# and are sourced from #various options#.",
            "predicted_answer": "CAR-NK cells execute tumor-eliminating functions through mechanisms like cytotoxic granule secretion, FasL/TRAIL-induced apoptosis, and ADCC. NK92 cell lines are effective in CAR-NK therapy due to their unlimited proliferation, ease of genetic modification, and no need for patient blood extraction.",
            "score": 3,
            "explanation": "The predicted answer covers the mechanisms of CAR-NK cells' function, mentioning cytotoxic granule secretion akin to perforin and granzyme. It addresses NK92 cell features like proliferation and genetic modification ease. However, it omits \"recognition\" and sourcing from \"various options.\""
        },
        {
            "query_idx": 464,
            "query": "How does a widespread viral outbreak alter the standard treatment procedures for thyroid cancer, and what are the potential consequences on these procedures?",
            "retrieved_metrics": {
                "reference_idx": [
                    2155,
                    2149
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "During a #viral outbreak#, #surgical resection# remains a primary treatment for thyroid cancer, but #treatment strategies# adjust significantly due to the #impact on cancer management#.",
            "predicted_answer": "A widespread viral outbreak, such as COVID-19, may alter standard treatment procedures for thyroid cancer by delaying surgeries and shifting focus to less invasive treatments like pharmacotherapy. This could potentially lead to delayed diagnosis and treatment, increasing the risk of disease progression and complications.",
            "score": 3,
            "explanation": "The predicted answer addresses the impact of a viral outbreak on thyroid cancer treatment, mentioning delays and altered focus, aligning with the reference answer's theme of impact on management. However, it omits \"surgical resection remains primary\" and \"treatment strategies adjust,\" leading to some incompleteness."
        },
        {
            "query_idx": 465,
            "query": "What sequence of chemical transformations begins with 5-bromo-6-chloronicotinic acid and results in a final compound formed by coupling with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate?",
            "retrieved_metrics": {
                "reference_idx": [
                    1089,
                    1095
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The sequence starts with conversion to #bromonicotinamide 40#, progressing through steps resulting in #coupled compound 129# after coupling with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate using palladium(II).",
            "predicted_answer": "The sequence begins with the conversion of 5-bromo-6-chloronicotinic acid to a chloride derivative using thionyl chloride, followed by coupling with 4-(chloro-difluoromethoxy)aniline. The resulting nicotinamide is then treated with (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate in the presence of a palladium catalyst to form the final compound.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference by starting with a conversion process and ending with a coupling using (2-fluoro-6-hydroxyphenyl)potassium trifluoroborate and a palladium catalyst. However, it misses specific details: \"#bromonicotinamide 40#\" and \"#coupled compound 129#\"."
        },
        {
            "query_idx": 466,
            "query": "What critical components are missing from tumor models that decrease their effectiveness, and what substitution practice results in variability among experimental outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1453,
                    2077
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The effectiveness of tumor models is reduced by #absence of stromal components#, while #substituting with murine stroma# leads to variability in experimental results.",
            "predicted_answer": "The critical components missing from tumor models that decrease their effectiveness are the stroma and microenvironment. Substituting human tumor stroma with murine stroma results in variability among experimental outcomes due to species-specific cytokines and paracrine effects.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the critical components missing from tumor models—stroma and microenvironment. It also correctly identifies substitution with murine stroma as causing variability due to species-specific cytokines. All key facts and details from the reference are present and aligned."
        },
        {
            "query_idx": 467,
            "query": "What limitations are associated with using lipid nanoparticles (LNPs) for delivering complex genetic materials, and how do their design and structural components help address these limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    976,
                    977
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The delivery system of #LNPs# faces #constraints in delivering complex genes# yet benefits from #design flexibility# and #enhanced targeting capabilities# to mitigate these challenges.",
            "predicted_answer": "Limitations of LNPs include liver burden and potential side effects like allergic reactions and immune responses. Design optimizations, such as adjusting lipid ratios and reducing dosage, enhance stability and reduce toxicity, addressing these limitations.",
            "score": 1,
            "explanation": "The predicted answer acknowledges LNP limitations but omits key reference points like \"constraints in delivering complex genes,\" \"design flexibility,\" and \"enhanced targeting capabilities.\" Only the overall trend of addressing limitations with design is reflected, but multiple key facts are missing."
        },
        {
            "query_idx": 468,
            "query": "What are the differing results observed in the studies of adjuvant autogene cevumeran and mRNA-4650 involving early personalized mRNA-based vaccines with respect to tumor recurrence and clinical response?",
            "retrieved_metrics": {
                "reference_idx": [
                    419,
                    986
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In studies, the adjuvant autogene cevumeran #delayed tumor recurrence#, while mRNA-4650 showed #no objective clinical responses# despite eliciting T-cell responses.",
            "predicted_answer": "Adjuvant autogene cevumeran showed delayed tumor recurrence up to three years and poly-specific T-cell responses, while mRNA-4650 elicited T-cell responses but no objective clinical responses in metastatic gastrointestinal cancer patients.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the Reference Answer by noting that autogene cevumeran delays tumor recurrence and mRNA-4650 does not lead to objective clinical responses, both reflecting key facts. Thus, the Predicted Answer covers both emphasized points from the Reference Answer."
        },
        {
            "query_idx": 469,
            "query": "Which compound has been synthesized for its anti-proliferative effects and interaction with a kinase relevant to pancreatic cancer, while also exhibiting properties suitable for pharmacokinetics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1253,
                    1256
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #1,2,4-oxadiazole topsentin analogues# target #GSK3β#, while exhibiting #good pharmacokinetic properties# for potential investigation, demonstrating targeted anti-proliferative effects on pancreatic cancer cells.",
            "predicted_answer": "Compound 16 has been synthesized for its anti-proliferative effects against pancreatic cancer, interaction with CDK1, and exhibits suitable pharmacokinetic properties.",
            "score": 1,
            "explanation": "The predicted answer identifies Compound 16 instead of 1,2,4-oxadiazole topsentin analogues, incorrectly mentions CDK1 instead of GSK3β, thus missing two key facts. While both answers mention anti-proliferative and pharmacokinetic properties, the mismatch in specific targets affects completeness and does not align with the reference."
        },
        {
            "query_idx": 470,
            "query": "Modify the multi-hop query:  \nWhat specific evaluation process must be confirmed before advancing cancer drugs to later stages, and which drugs are tested in randomized perioperative trials for certain brain tumor conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    287,
                    300
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "Before advancing cancer drugs to later stages, the specific evaluation process must confirm target engagement in tumor tissue, associated molecular changes, and their impact on tumor cell proliferation, cell death, and the Tumor Microenvironment (TME). Drugs tested in randomized perioperative trials for certain brain tumor conditions include pembrolizumab for recurrent GBM and vorasidenib/ivosidenib for recurrent nonenhancing mIDH LGG.",
            "score": 3,
            "explanation": "The predicted answer includes key aspects like confirming target engagement, molecular changes, and TME impact before drug advancement. It names pembrolizumab and vorasidenib/ivosidenib for certain brain tumors. Without the reference's # details, it's unclear if facts match fully, but trends align."
        },
        {
            "query_idx": 471,
            "query": "How does metformin influence transcription factor levels and impact the abilities of cancer stem cells to self-renew?",
            "retrieved_metrics": {
                "reference_idx": [
                    810,
                    809
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Metformin decreases #HNF4 α# levels and inhibits #CSCs' self-renewal abilities# via AMPK pathway activation, impacting both the transcription factor and cellular regeneration capabilities.",
            "predicted_answer": "Metformin influences transcription factor levels, such as HNF4α, through AMPK activation, which modulates pathways like WNT. This impacts cancer stem cells by reducing their self-renewal capacities and expression of markers like CD44 and CD133.",
            "score": 5,
            "explanation": "The predicted answer includes both key elements of the reference: the decrease in HNF4α levels and the inhibition of cancer stem cells' self-renewal through AMPK pathway activation. While terminology differs slightly, the meaning is consistent, covering the key facts without significant omissions."
        },
        {
            "query_idx": 472,
            "query": "How are specialized organic methodologies utilized alongside elemental target compositions in the production of radiotracers for medical imaging diagnostics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1531,
                    1527
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Specialized #organic methodologies# with C-C bond formations use #carbon-11 radionuclides# generated from nitrogen-based targets for creating PET radiotracers, aiding medical imaging diagnostics.",
            "predicted_answer": "Specialized organic methodologies, such as C-C bond formation and metal-catalyzed reactions, are used to insert carbon-11 radionuclides into organic biomolecules, creating target-based PET radiotracers for medical imaging diagnostics.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key facts: use of specialized organic methodologies, C-C bond formations, and carbon-11 radionuclides for creating PET radiotracers. However, it misses the detail about radionuclides being generated from nitrogen-based targets, affecting completeness slightly. Overall, trends are aligned."
        },
        {
            "query_idx": 473,
            "query": "What is a first-line treatment for an advanced type of cancer that involves a drug also used in other malignancies, including ovarian cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1013,
                    1044
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The first-line treatment for advanced #hepatocellular carcinoma (HCC)# is the combination of #Bevacizumab# and #Atezolizumab#, reflecting #Bevacizumab#’s expanded use in cancers like #ovarian cancer#.",
            "predicted_answer": "Bevacizumab, a drug used in various malignancies including ovarian cancer, is a first-line treatment for advanced cancers like hepatocellular carcinoma when combined with immune checkpoint inhibitors.",
            "score": 3,
            "explanation": "The predicted answer mentions Bevacizumab and its use in advanced cancers like hepatocellular carcinoma, aligning with the reference answer. However, it omits mention of Atezolizumab as a treatment partner, missing a key fact crucial for completeness."
        },
        {
            "query_idx": 474,
            "query": "What drugs approved by the FDA as of March 2024 have a complex operational mechanism involving multiple steps and offer benefits over chemotherapy in terms of reduced systemic toxicity?",
            "retrieved_metrics": {
                "reference_idx": [
                    169,
                    920
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #ADCs# class, with #15 FDA-approved drugs# as of March 2024, has a complex mechanism and offers #reduced systemic toxic side effects# compared to chemotherapy.",
            "predicted_answer": "The FDA approved 15 ADC drugs as of March 2024, which offer reduced systemic toxicity compared to chemotherapy due to their specific antigen-antibody targeting mechanism.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions that ADCs have a complex mechanism and specifies the number of FDA-approved drugs as 15, aligning with the reference. It also highlights reduced systemic toxicity compared to chemotherapy. All key facts are present, and no significant details are missing."
        },
        {
            "query_idx": 475,
            "query": "Which enzyme ensures the preservation of DNA methylation patterns during replication, and which enzymes have antagonistic functions regarding the methylation status of histone tails?",
            "retrieved_metrics": {
                "reference_idx": [
                    459,
                    461
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The enzyme #DNMT1# maintains DNA methylation during replication, while #histone methyltransferases (HMTs)# and #histone demethylases (HDMs)# act in opposition to determine histone methylation status.",
            "predicted_answer": "DNMT1 ensures the preservation of DNA methylation patterns during replication. Antagonistic functions regarding histone methylation status are performed by histone methyltransferases (HMTs) and histone demethylases (HDMs).",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: DNMT1 for DNA methylation preservation and both histone methyltransferases (HMTs) and histone demethylases (HDMs) as antagonistic enzymes for histone methylation status. The interpretation reflects the emphasized points accurately without contradictions or omissions."
        },
        {
            "query_idx": 476,
            "query": "What changes are being implemented in Europe to address regulatory frameworks for phage therapies, and what global initiatives are contributing to the harmonization of these regulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    65,
                    100
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Europe is improving #regulatory accommodations for medicinal phages#, while global initiatives, like ICH, focus on #harmonization efforts worldwide#, streamlining processes, and ensuring consistent regulatory standards.",
            "predicted_answer": "Europe is evolving its regulatory framework to better accommodate phage therapies, aiming to streamline approval processes. Global initiatives, such as those by the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH), are contributing to the harmonization of these regulations, ensuring consistent safety and efficacy standards worldwide.",
            "score": 5,
            "explanation": "The predicted answer captures the key points from the reference answer, namely Europe's improved regulatory accommodations for phage therapies and the global harmonization efforts led by the ICH. The details about streamlining processes and regulatory standards are covered, albeit in different wording. There are no significant omissions."
        },
        {
            "query_idx": 477,
            "query": "How did legislative initiatives by the US and EU specifically address economic challenges in developing treatments for low-incidence diseases, and what impact did these initiatives have on innovation for oncological conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1199,
                    1898
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Orphan Drug# acts by the US and EU tackled economic barriers in developing #orphan drugs# for #rare diseases#, significantly boosting innovation in #oncological treatments# by offering financial and research incentives.",
            "predicted_answer": "The US Orphan Drug Act (1983) and EU Orphan Drug legislation (2000) provided incentives like tax credits and market exclusivity to encourage R&D for low-incidence diseases, including rare cancers. These initiatives spurred innovation by reducing financial risks and increasing profitability prospects, thereby fostering equitable R&D for oncological treatments.",
            "score": 5,
            "explanation": "Both the predicted and reference answers mention the Orphan Drug acts from the US and EU, as well as the economic barriers and innovation impact on oncological treatments. The key facts, including financial incentives, are captured consistently in both without any significant omissions."
        },
        {
            "query_idx": 478,
            "query": "How are recent biomedical advancements improving disease modeling through innovative access to patient-derived biological materials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1183,
                    1196
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "New biomedical advancements, like #living biobanks#, enhance disease modeling by addressing the #limited regenerative capacity# of traditional models.",
            "predicted_answer": "Recent biomedical advancements, such as 'living biobanks,' provide access to diverse patient-derived cells and organoids, improving disease modeling by enhancing clinical mimicry and overcoming initial limitations like cell diversity and tissue crosstalk.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of \"living biobanks\" but misses the \"limited regenerative capacity\" which is addressed in reference answer. While the overall trend aligns, this missing detail affects completeness."
        },
        {
            "query_idx": 479,
            "query": "How do advanced single-cell technologies and technological advances contribute to broadening the range of epigenetic biomarkers and developing new therapeutic strategies in cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    613,
                    614
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The use of #state-of-the-art single-cell technologies# expands #epigenetic biomarkers# and advances #epidrugs development#, benefiting cancer therapy through #technological advancements#.",
            "predicted_answer": "Advanced single-cell technologies and technological advances contribute to broadening the range of epigenetic biomarkers by enabling comprehensive characterization of the cancer epigenome at single-cell resolution, identifying treatment-resistant clones, and elucidating genetic-epigenetic interplay. These advancements also guide the development of novel therapeutic strategies, improving patient stratification and rational combination treatments.",
            "score": 3,
            "explanation": "The predicted answer captures the concepts of single-cell technologies, expansion of epigenetic biomarkers, and technological advancements. However, it omits the specific mention of \"epidrugs development,\" which is a key fact in the reference answer. The overall trend is consistent, but this omission affects completeness."
        },
        {
            "query_idx": 480,
            "query": "What are two categories of pharmacological agents known for targeting cell populations in oncology, one aiming at resistant cancer stem cells and the other at inflammatory pathways linked to cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2256,
                    2257
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Metformin# targets and eradicates resistant #cancer stem cells#; #NSAIDs#, especially #COX-2 inhibitors#, focus on reducing cancer progression by targeting #inflammatory pathways#.",
            "predicted_answer": "Two categories of pharmacological agents in oncology are: 1) CSC inhibitors like metformin and thioridazine targeting resistant cancer stem cells, and 2) NSAIDs like COX-2 inhibitors targeting inflammatory pathways linked to cancer progression.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference, mentioning both #metformin# for #cancer stem cells# and #NSAIDs#, specifically #COX-2 inhibitors#, for #inflammatory pathways#. All key facts and concepts are present without contradictions or significant omissions."
        },
        {
            "query_idx": 481,
            "query": "What transformation facilitates metastasis in cells, and which specific factor influences this transformation in the context of breast cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    398,
                    2034
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The transformation that facilitates metastasis is #epithelial-mesenchymal transition#, with #TGF-β# serving as the influential factor in breast cancer.",
            "predicted_answer": "The transformation facilitating metastasis in cells is epithelial-mesenchymal transition (EMT). The specific factor influencing this transformation in breast cancer is TGF-β.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures both key facts emphasized in the Reference Answer: the transformation of epithelial-mesenchymal transition (EMT) and the factor TGF-β in breast cancer. The overall meaning is consistent with no omissions or errors."
        },
        {
            "query_idx": 482,
            "query": "What positron-emitting radiotracers are utilized in both PET molecular imaging applications and clinical research, contributing to improved biodistribution and advancements in drug development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1505,
                    1537
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The radiotracers #carbon-11# and #fluorine-18# are used in PET imaging applications, with #carbon-11# showing improved biodistribution in clinical research advancements.",
            "predicted_answer": "Positron-emitting radiotracers like carbon-11 ([$^{11}$C]TMP) and fluorine-18 are utilized in PET molecular imaging for improved biodistribution and advancements in drug development.",
            "score": 5,
            "explanation": "The predicted answer mentions both radiotracers, carbon-11 and fluorine-18, and emphasizes their role in PET imaging and improvements in biodistribution and drug development, aligning closely with the reference. No significant key facts are missing, and no contradictory details are present."
        },
        {
            "query_idx": 483,
            "query": "Which program established by a European medicine agency in 2004 facilitates the transformation of preliminary drug authorizations into permanent approvals under specific conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1922,
                    1923
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #EMA# established a #conditional approval program# in #2004#, allowing initial drug authorizations to become full approvals on average after #4 years#, subject to stringent conditions.",
            "predicted_answer": "The program established by the European Medicines Agency (EMA) in 2004 that facilitates the transformation of preliminary drug authorizations into permanent approvals is the Conditional Approval Program.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns with the key facts in the 'Reference Answer' by mentioning the European Medicines Agency (EMA), the program being for conditional approval, and being established in 2004. However, it omits the detail about the average timeline of 4 years, which affects completeness."
        },
        {
            "query_idx": 484,
            "query": "Which antibody-drug conjugate uses a topoisomerase inhibitor payload and targets HER3, demonstrating significant efficacy specifically in breast cancer with low HER2 expression?",
            "retrieved_metrics": {
                "reference_idx": [
                    189,
                    918
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #HER3-directed ADC# uses a #topoisomerase I inhibitor payload#, achieving #significant efficacy# in breast cancer with #low HER2 expression#.",
            "predicted_answer": "Patritumab deruxtecan (U3-1402) is an antibody-drug conjugate that uses a topoisomerase I inhibitor payload and targets HER3, demonstrating significant efficacy in breast cancer with low HER2 expression.",
            "score": 5,
            "explanation": "The predicted answer mentions Patritumab deruxtecan (U3-1402), an ADC with a topoisomerase I inhibitor payload, targeting HER3, and showing significant efficacy in breast cancer with low HER2 expression. All key facts in the reference (HER3, payload, efficacy, low HER2) are covered in the predicted answer."
        },
        {
            "query_idx": 485,
            "query": "What non-invasive tests have shown specific performance levels for monitoring bladder-related conditions and received significant regulatory acknowledgment recently?",
            "retrieved_metrics": {
                "reference_idx": [
                    504,
                    502
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #Bladder EpiCheck test# shows sensitivity from 68.2% to 91.7% for #NMIBC monitoring# with 88% specificity, while #UriFind# gained #FDA BDD# for bladder cancer #screening#.",
            "predicted_answer": "The Bladder EpiCheck test, a CE-certified non-invasive urinary assay, has shown specific performance levels for monitoring bladder conditions, with a sensitivity of 68.2% and specificity of 88%. It received significant regulatory acknowledgment recently.",
            "score": 1,
            "explanation": "The predicted answer includes the Bladder EpiCheck test with 68.2% sensitivity and 88% specificity. However, it misses the full sensitivity range (up to 91.7%) and details about NMIBC monitoring and UriFind's FDA BDD for bladder cancer screening, which affects completeness."
        },
        {
            "query_idx": 486,
            "query": "Which regulatory agencies are involved in the oversight of phage-based therapeutic products in both the United States and Europe, dictating the standards for their authorization?",
            "retrieved_metrics": {
                "reference_idx": [
                    97,
                    96
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In the U.S., phage-based therapeutics are regulated by the #FDA#, while Europe entrusts this responsibility to the #EMA#.",
            "predicted_answer": "The regulatory agencies involved in the oversight of phage-based therapeutic products in the United States are the Food and Drug Administration (FDA), and in Europe, the European Medicines Agency (EMA). Both agencies dictate the standards for authorization, ensuring quality, safety, and efficacy.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the FDA and EMA as the responsible regulatory agencies in the U.S. and Europe, respectively, matching the key facts emphasized in the reference answer. It maintains consistency with the overall meaning and provides additional context without contradiction."
        },
        {
            "query_idx": 487,
            "query": "Which method is used for detailed DNA methylation profiling in human cancer studies, and what associated dataset provides extensive information across numerous tumor types?",
            "retrieved_metrics": {
                "reference_idx": [
                    473,
                    475
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #bisulfite conversion-dependent methylation arrays# method is used, with #450K DNA methylation profiles of TCGA samples# providing extensive tumor-type data.",
            "predicted_answer": "Bisulfite conversion-dependent methylation arrays, specifically the Infinium HumanMethylation450 BeadChip (450K) arrays, are used for detailed DNA methylation profiling in human cancer studies. The associated dataset from The Cancer Genome Atlas (TCGA) provides extensive information across numerous tumor types.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer: the \"bisulfite conversion-dependent methylation arrays\" and the dataset context of \"TCGA\" and \"450K\" arrays providing comprehensive data on tumor types. There are no significant omissions, and the trends and key details are aligned."
        },
        {
            "query_idx": 488,
            "query": "What trial method is utilized to study the effectiveness of investigational drugs for their penetration capacity in surgery-related recurring brain tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    295,
                    292
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "A #randomized design# in #perioperative trials# is utilized to evaluate investigational drugs for blood-brain barrier penetration in recurring brain tumors.",
            "predicted_answer": "Perioperative trials in neurooncology, particularly for recurrent brain tumors, utilize randomized designs to study the effectiveness of investigational drugs, such as PD-1 checkpoint inhibitors, in enhancing drug penetration and efficacy.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of a #randomized design# and #perioperative trials#. However, it mentions PD-1 checkpoint inhibitors instead of referencing blood-brain barrier penetration. This subtlety does not impact the overall alignment with the reference, but it misses the focus on penetration evaluation."
        },
        {
            "query_idx": 489,
            "query": "What are the challenges faced by AI systems in predicting protein structures used in developing anticancer drugs, and how do these challenges affect the identification of resistance mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    271,
                    275
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The AI system #fails to predict multi-domain proteins#, like #transmembrane receptors#, crucial for anticancer drugs, affecting #structure-based discovery# and understanding #resistance mechanisms#.",
            "predicted_answer": "AI systems like AlphaFold2 face challenges in predicting structures of multi-domain proteins, such as transmembrane receptors, which are crucial for anticancer drugs. These limitations hinder accurate identification of resistance mechanisms, affecting drug efficacy and development.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the challenges AI systems face with multi-domain proteins, including transmembrane receptors, aligning with the Reference. It also reflects issues in identifying resistance mechanisms, but misses specific mention of \"structure-based discovery,\" affecting completeness."
        },
        {
            "query_idx": 490,
            "query": "What chemical modification enhances the absorption and bioavailability of drugs while overcoming challenges in drug development and approval for various medical treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1081,
                    1107
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #fluorination# process enhances drug absorption, increasing bioavailability, leading to the approval of #fluorinated drugs# despite development challenges.",
            "predicted_answer": "Fluorination enhances drug absorption and bioavailability by improving lipophilicity, facilitating passive transportation through cell membranes, and increasing potency. This modification helps overcome challenges in drug development and approval.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, mentioning fluorination as a chemical modification that enhances drug absorption and bioavailability by addressing development challenges. The key facts, such as \"fluorination\" and effects on \"absorption, increasing bioavailability,\" are present, ensuring consistency without significant omissions."
        },
        {
            "query_idx": 491,
            "query": "What combination of inhibitors and immune-blocking antibodies is evaluated in PDOs to enhance the efficacy of immune-checkpoint therapies in cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    1175,
                    1176
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The development of #CDK4/6# inhibitors shows #synergy# with anti-PD-1 antibodies, enhancing T cell activation in PDOs to boost treatment efficacy.",
            "predicted_answer": "The combination of cyclin-dependent kinase inhibitors (CDK4/6) and anti-PD-1 blocking antibodies is evaluated in PDOs to enhance the efficacy of immune-checkpoint therapies in cancer research.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer, namely \"CDK4/6 inhibitors\" and \"anti-PD-1 antibodies,\" consistent with the synergy seen in enhancing T cell activation in PDOs. Although it doesn't mention synergy directly, it aligns with the overall trend."
        },
        {
            "query_idx": 492,
            "query": "What are the specific structural and environmental challenges in in vitro systems that affect nutrient uptake and lead to cellular heterogeneity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1184,
                    2083
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Tissue geometry# is challenging to replicate, affecting #nutrient distribution# which causes non-uniform cell development.",
            "predicted_answer": "The specific challenges in in vitro systems affecting nutrient uptake and leading to cellular heterogeneity include: 1) Difficulty in controlling tissue geometry and shape, resulting in high model variability and limited biomimicry; 2) Non-uniform distribution of nutrients in 3D spheroid models, causing uneven cell growth; 3) Use of long-term culture-adapted cell lines that may not match tissue pathology.",
            "score": 5,
            "explanation": "The predicted answer addresses the challenge of controlling tissue geometry and the resulting impact on nutrient distribution, aligning well with the key facts highlighted in the reference answer. However, it introduces more detail, which does not contradict the reference answer. Therefore, it covers the main points."
        },
        {
            "query_idx": 493,
            "query": "What receptor's expression level is critical for applying a specific combination of targeted inhibitors and chemotherapy in a form of breast cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    110,
                    1039
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The receptor #HER2# plays a key role in #HER2#-positive breast cancer, treated using #HER2# inhibitors like Trastuzumab plus Pertuzumab alongside chemotherapy.",
            "predicted_answer": "The receptor's expression level critical for applying a specific combination of targeted inhibitors and chemotherapy in breast cancer treatment is HER2.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies HER2 as the critical receptor for the treatment described. It aligns with the reference regarding the role of HER2 in breast cancer treatment, covering the key fact emphasized with #. While specific drug names are omitted, overall the key concept is captured."
        },
        {
            "query_idx": 494,
            "query": "What is the period during which anticancer drug approvals were examined, and how are these indications classified according to the number of affected individuals?",
            "retrieved_metrics": {
                "reference_idx": [
                    1059,
                    1073
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Anticancer drug approvals were analyzed from #1 January 2000 to 1 January 2022#, and indications are classified by affected individuals as #common, rare, and ultra-rare#.",
            "predicted_answer": "The period examined for anticancer drug approvals was from 1 January 2000 to 1 January 2022. These indications are classified based on the number of affected individuals: common (>200,000), rare (200,000-6,600), and ultra-rare (<6,600).",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer by covering the timeframe from 1 January 2000 to 1 January 2022 and classifying indications as common, rare, and ultra-rare. The predicted answer provides additional details on classification thresholds but aligns with the key facts and overall trends in the reference."
        },
        {
            "query_idx": 495,
            "query": "Which in vitro model is used for predicting patient responses in personalized oncology and requires protocol standardization for acceptance in the drug development process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1486,
                    1500
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The in vitro model #tumoroids# is vital for #predicting patient responses# in personalized oncology and requires #standardization# of protocols for widespread application in drug development.",
            "predicted_answer": "Patient-derived tumoroids are used for predicting patient responses in personalized oncology and require protocol standardization for acceptance in the drug development process.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies \"tumoroids\" as the in vitro model, which is essential for \"predicting patient responses\" and highlights the need for \"standardization\" of protocols, aligning well with the reference answer. All key facts are present without omissions."
        },
        {
            "query_idx": 496,
            "query": "Which treatment marked a significant advancement in breast cancer therapy by utilizing a targeted approach, and which protein does this treatment specifically address to achieve its effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    111,
                    869
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The treatment #Trastuzumab# marked a significant advancement in breast cancer therapy by targeting the #HER-2# protein, making it a pioneering targeted therapy in this field.",
            "predicted_answer": "Trastuzumab (Herceptin) marked a significant advancement in breast cancer therapy by targeting the HER2 protein.",
            "score": 5,
            "explanation": "The 'Predicted Answer' correctly identifies both #Trastuzumab# and the #HER-2# protein, aligning with the 'Reference Answer' and covering all key facts emphasized. Both answers convey the same meaning and details, without significant omissions or errors."
        },
        {
            "query_idx": 497,
            "query": "What specific tools and techniques have contributed to improvements in patient outcomes, and how do distinct predictive biomarkers facilitate this process in targeted therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    415,
                    467
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Implementing #personalized treatment# using #predictive genomic biomarkers# enhances #progression-free survival# and improves the effectiveness of #targeted therapies#.",
            "predicted_answer": "Next-generation sequencing (NGS), whole-exome sequencing (WES), and longitudinal liquid biopsy analysis have improved patient outcomes by enabling adaptive therapy and precise monitoring of tumor evolution. Predictive biomarkers like EGFR mutations in NSCLC facilitate targeted therapies, enhancing survival.",
            "score": 1,
            "explanation": "The predicted answer mentions predictive biomarkers like EGFR mutations for facilitating targeted therapies, which aligns generally with personalized treatment using biomarkers. However, it lacks specific mention of \"personalized treatment,\" \"penetrated genomic biomarkers,\" and \"progression-free survival,\" missing two key facts."
        },
        {
            "query_idx": 498,
            "query": "Which genetic screening technology is pivotal in modifying immune cells for enhancing cancer therapy, and what specific type of engineered cells shows efficacy in targeting cancer cells without MHC restrictions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2108,
                    2112
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9# system is pivotal in enhancing T-cell therapies, while engineered #CAR-T cells# efficiently target cancer cells with MHC-independent antigen recognition.",
            "predicted_answer": "CRISPR-Cas9 technology is pivotal in modifying immune cells for enhancing cancer therapy. Engineered CAR-T cells show efficacy in targeting cancer cells without MHC restrictions.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies #CRISPR-Cas9# as pivotal in modifying immune cells and mentions #engineered CAR-T cells# as effective in MHC-independent targeting. Both key facts from the reference are present, with no significant omissions or errors, aligning with the overall trend."
        },
        {
            "query_idx": 499,
            "query": "What technologies and methods support the advancement and refinement of targeted cancer therapies, considering both the creation of innovative molecular targets and the integration of patient-derived data?",
            "retrieved_metrics": {
                "reference_idx": [
                    270,
                    1217
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The advancement of targeted cancer therapies involves #AI# in #creating CRISPR-based targets# and #utilizing patient-specific data# to optimize #personalized treatment strategies#, enhancing precision oncology.",
            "predicted_answer": "AI technologies, including machine learning and neural networks, support targeted cancer therapies by validating tumor profiling hypotheses, identifying molecular targets, and designing in silico molecules. Integration of patient-derived data optimizes personalized treatment strategies and refines therapy based on real-world outcomes.",
            "score": 3,
            "explanation": "The predicted answer includes AI technologies and patient-derived data, aligning with the reference. However, it misses the creation of \"CRISPR-based targets\" specifically mentioned in the reference. This omission affects the completeness regarding the specific molecular targets process."
        },
        {
            "query_idx": 500,
            "query": "Which methylation-based assays are used in cervical cancer screening, and what specific genes do these assays analyze for hypermethylation?",
            "retrieved_metrics": {
                "reference_idx": [
                    495,
                    496
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #FAM19A4/miR124-2# and #PAX1 methylation# assays screen for cervical cancer. The #GynTect test# analyzes hypermethylation in #DLX1#, #ITGA4#, #RXFP3#, #SOX17#, and #ZNF671#.",
            "predicted_answer": "Methylation-based assays used in cervical cancer screening include FAM19A4/miR124-2, Cervi-M (PAX1), and GynTect (DLX1, ITGA4, RXFP3, SOX17, ZNF671). These assays analyze for hypermethylation in specific genes to detect cervical cancer and precancerous lesions.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts present in the reference answer, such as the FAM19A4/miR124-2, PAX1, and GynTect assays, along with the specific genes DLX1, ITGA4, RXFP3, SOX17, and ZNF671. There are no omissions or contradictions, maintaining accuracy and completeness."
        },
        {
            "query_idx": 501,
            "query": "What is the effectiveness of Apatinib in treating a specific type of lung cancer, and which therapeutic category does this approach fall under?",
            "retrieved_metrics": {
                "reference_idx": [
                    870,
                    1015
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Apatinib shows a #76.7% disease control rate# in treating #NSCLC#, and this treatment falls under the category of #targeted therapies for non-small cell lung cancer#.",
            "predicted_answer": "Apatinib is effective in treating non-small cell lung cancer (NSCLC) with a 76.7% disease control rate in resistant patients. It falls under the therapeutic category of anti-angiogenic drugs, targeting VEGFR-2.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the key facts highlighted in the reference answer: \"76.7% disease control rate\", \"NSCLC\", and the therapy's category as anti-angiogenic, which aligns with targeted therapies. The meaning is consistent and lacks significant omissions."
        },
        {
            "query_idx": 502,
            "query": "How do a marine sponge-derived compound and 4-(R)-6'-debromohamacanthin A influence human cancer cell lines and cellular signaling pathways differently?",
            "retrieved_metrics": {
                "reference_idx": [
                    1252,
                    1270
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The marine sponge-derived #isobromodeoxytopsentin# targets five cancer cell lines, whereas #Compound 58# influences VEGF-induced MAPK and PI3K/AKT/mTOR signaling pathways.",
            "predicted_answer": "The marine sponge-derived compound bromodeoxytopsentin (5) and 4-(R)-6'-debromohamacanthin A (58) both exhibit cytotoxicity against human cancer cell lines. Bromodeoxytopsentin is more potent, while 4-(R)-6'-debromohamacanthin A weakly inhibits HCT15 cells and affects VEGF-induced MAPKs and PI3K/AKT/mTOR pathways.",
            "score": 1,
            "explanation": "The predicted answer mentions \"bromodeoxytopsentin\" but should be \"isobromodeoxytopsentin\" and includes \"4-(R)-6'-debromohamacanthin A\" as \"Compound 58,\" aligning with the cancer cell lines and signaling pathways. However, there are two compounds in the predicted, when only \"Compound 58\" influences signaling pathways in the reference."
        },
        {
            "query_idx": 503,
            "query": "Which gene-editing method targets immunomodulatory genes to alter checkpoints, thereby boosting the efficacy of a certain cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2106,
                    2113
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #CRISPR-Cas9# technique targets and disrupts genes impacting #immune checkpoints#, significantly boosting the #immunotherapy response# against cancer.",
            "predicted_answer": "CRISPR-Cas9 targets immunomodulatory genes like PD-1 and CTLA-4 to disrupt immune checkpoints, enhancing cancer treatment efficacy.",
            "score": 3,
            "explanation": "The predicted answer successfully identifies CRISPR-Cas9 as the method targeting immunomodulatory genes and mentions immune checkpoints, aligning with the emphasis on both CRISPR-Cas9 and immune checkpoints in the reference answer. However, it does not explicitly mention \"immunotherapy response,\" affecting completeness."
        },
        {
            "query_idx": 504,
            "query": "Which compound modulates gut microbiota, affects inflammatory and immune responses, utilizes tryptophan pathways in metabolism, and is associated with cancer prevention and treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    849,
                    850
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compound #EVO# modulates gut microbiota, #affects inflammatory and immune responses#, and via #tryptophan pathways influences metabolism#, impacting cancer #prevention and therapeutic strategies#.",
            "predicted_answer": "EVO modulates gut microbiota, affects inflammatory and immune responses, utilizes tryptophan pathways in metabolism, and is associated with cancer prevention and treatment strategies.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all the key facts emphasized in the reference answer. \"EVO\" as the compound, modulation of gut microbiota, impacts on inflammatory and immune responses, utilization of tryptophan pathways in metabolism, and association with cancer prevention and treatment strategies are all covered."
        },
        {
            "query_idx": 505,
            "query": "Based on the suggestions, the modified multi-hop query:\nHow do liposome carriers enhance drug delivery in cancer treatment, and which specific liposome formulations used for this purpose have regulatory approval for specific types of cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1017,
                    1018
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modified answer based on the suggestions:",
            "predicted_answer": "Liposome carriers enhance drug delivery in cancer treatment by leveraging the EPR effect, protecting drugs from degradation, and controlling release. Specific liposome formulations like Doxil, Myocet, and Abraxane have FDA approval for treating breast cancer and non-small cell lung cancer.",
            "score": 5,
            "explanation": "The predicted answer correctly explains the role of liposome carriers, highlighting the EPR effect, drug protection, and controlled release. It also mentions approved formulations Doxil, Myocet, and Abraxane for specific cancers, aligning with the reference. No significant details are missing, ensuring a comprehensive match."
        },
        {
            "query_idx": 506,
            "query": "Which therapeutic interventions use CRISPR-Cas9 to manage a genetic condition by addressing protein misfolding and simultaneously employ it to reduce immune cell-related adverse effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    965,
                    2100
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "CRISPR-Cas9 is applied in #gene knockout in T cells# to mitigate #immune cell toxicity# and via #NTLA-2001# therapy to address #protein misfolding# in hereditary #ATTR#.",
            "predicted_answer": "The therapeutic intervention using CRISPR-Cas9 to manage a genetic condition by addressing protein misfolding and reducing immune cell-related adverse effects is exemplified by \"NTLA-2001\" for hereditary Transthyretin amyloidosis (ATTR).",
            "score": 1,
            "explanation": "The predicted answer identifies \"NTLA-2001\" for hereditary ATTR and addresses protein misfolding, aligning with the reference. However, it omits details about \"gene knockout in T cells\" and \"immune cell toxicity.\" This missing information affects the completeness despite being generally aligned with the reference."
        },
        {
            "query_idx": 507,
            "query": "Which pairs of genes are identified as synthetic lethal in melanoma, with each pair associated with a different mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1952,
                    1963
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #DUSP4/DUSP6# pair is synthetic lethal in #NRAS mutant melanoma#, and the #MAP2K1/MAP2K2# pair is synthetic lethal in #BRAF mutant melanoma#.",
            "predicted_answer": "The identified synthetic lethal pairs in melanoma are DUSP4/DUSP6 associated with NRAS mutation and MAP2K1/MAP2K2 associated with BRAF mutation.",
            "score": 5,
            "explanation": "The predicted answer fully includes all key facts emphasized with # symbols in the reference answer: DUSP4/DUSP6 with NRAS mutation and MAP2K1/MAP2K2 with BRAF mutation in melanoma. The information is consistent with the reference without omissions or contradictions."
        },
        {
            "query_idx": 508,
            "query": "How are economically disadvantaged regions with a high incidence of life-threatening diseases attempting to overcome the challenges of high treatment costs and limited accessibility to essential medications?",
            "retrieved_metrics": {
                "reference_idx": [
                    737,
                    745
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Biosimilars# are proposed in LMICs to mitigate the #prohibitive cost# of original biologics, confronting the #limited resources# amid a #high cancer burden#.",
            "predicted_answer": "Economically disadvantaged regions with high incidence of life-threatening diseases are addressing challenges through biosimilar development, promoting local clinical trials, and advocating for post-trial access to essential medications.",
            "score": 1,
            "explanation": "The predicted answer includes \"biosimilar development,\" aligning with the #Biosimilars# mentioned in the reference. However, it misses key facts such as \"#prohibitive cost#,\" \"#limited resources#,\" and \"#high cancer burden#.\" Thus, it aligns with the trend but lacks several key details."
        },
        {
            "query_idx": 509,
            "query": "What molecular interaction impacts specific complexes in Ewing sarcoma, and what is the resultant effect of inhibiting one of these components on the immune characteristics of cancer cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    584,
                    596
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In Ewing sarcoma, #EWS/FLI# affects LSD1 complexes, and inhibiting LSD1 enhances #immunogenicity#, boosting immune responses typically limited in some cancer therapies.",
            "predicted_answer": "LSD1 inhibition impacts Ewing sarcoma by altering transcriptional regulation and enhancer landscape, enhancing tumor immunogenicity and T-cell infiltration, thereby improving immune response against cancer cells.",
            "score": 3,
            "explanation": "The predicted answer mentions LSD1 inhibition's impact on immunogenicity and immune response, aligning with the reference's discussion on boosting immune responses. However, it lacks the mention of the key element #EWS/FLI#. Thus, it misses one key fact, affecting completeness."
        },
        {
            "query_idx": 510,
            "query": "What experimental technique is used to assess interactions between compounds and cancer-related proteins, and to evaluate the repurposing potential of existing drugs for treating other cancer types?",
            "retrieved_metrics": {
                "reference_idx": [
                    262,
                    2243
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The technique is #molecular docking#, crucial for evaluating #non-covalent interactions# with cancer proteins, and essential for #drug repurposing# by analyzing drugs like #thalidomide# for treating various cancers.",
            "predicted_answer": "Molecular docking is used to assess interactions between compounds and cancer-related proteins, and to evaluate the repurposing potential of existing drugs for treating other cancer types.",
            "score": 1,
            "explanation": "The 'Predicted Answer' mentions \"molecular docking\" and its purpose but omits specifics like \"non-covalent interactions,\" \"drug repurposing,\" and the example \"thalidomide.\" Therefore, it misses more than one key fact emphasized in the 'Reference Answer,' impacting completeness. Trends are aligned, with no contradictions."
        },
        {
            "query_idx": 511,
            "query": "What material is essential for creating a single-cell environment in CRC organoid culture, and which biological factor has been pivotal in this methodology since 2009?",
            "retrieved_metrics": {
                "reference_idx": [
                    1399,
                    1403
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Matrigel# is essential for creating a suitable environment for single cells, and #Lgr5 stem cells# have been pivotal in CRC organoid culture since 2009.",
            "predicted_answer": "Matrigel is essential for creating a single-cell environment in CRC organoid culture. Since 2009, epidermal growth factor (EGF) has been pivotal in this methodology.",
            "score": 0,
            "explanation": "The Predicted Answer accurately identifies Matrigel as essential for the single-cell environment. However, it incorrectly mentions epidermal growth factor (EGF) instead of Lgr5 stem cells as being pivotal in CRC organoid culture since 2009, leading to a significant information discrepancy."
        },
        {
            "query_idx": 512,
            "query": "Which compounds from the genus Spongosorites are characterized by specific structural features and tested for their IC₅₀ values on certain cancer cell lines, while others inhibit specific phosphatases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1272,
                    1273
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Dragmacidin G# contains a #pyrazine ring# and #two indole rings#, effective on #PANC-1, MIA PaCa-2, BxPC-3, ASPC-1# with specific #IC₅₀ values#, while Dragmacidon A inhibits #PP1# and #PP2A# phosphatases.",
            "predicted_answer": "Dragmacidin G from the genus Spongosorites has specific structural features including a pyrazine ring and two indole rings. It exhibits IC₅₀ values on PANC-1, MIA PaCa-2, BxPC-3, and ASPC-1 cancer cell lines, while Dragmacidon A inhibits PP1 and PP2A phosphatases.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts marked by # in the reference answer: \"Dragmacidin G,\" \"pyrazine ring,\" \"two indole rings,\" specific IC₅₀ values on \"PANC-1, MIA PaCa-2, BxPC-3, ASPC-1,\" and Dragmacidon A's inhibition of \"PP1\" and \"PP2A\" phosphatases. The overall alignment is complete, with no omissions."
        },
        {
            "query_idx": 513,
            "query": "Modify the multi-hop query:\nHow does the FDA Modernization Act 2.0 impact the integration of specific in vitro cancer models within the drug discovery process, particularly concerning preclinical methods and alternative to animal testing?",
            "retrieved_metrics": {
                "reference_idx": [
                    1800,
                    1819
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Modify the answer:",
            "predicted_answer": "The FDA Modernization Act 2.0 promotes the use of 3D in vitro cancer models like spheroids and organoids in drug discovery, reducing animal testing and improving preclinical methods. These models may become a mandatory step between 2D in vitro and in vivo animal models, enhancing translational success and ethical standards.",
            "score": 3,
            "explanation": "Since the reference is not provided, evaluation is limited. The predicted answer reflects trends about alternatives to animal testing and integration of in vitro models in preclinical methods. Without specific reference details, it appears consistent but completeness can't be fully assessed."
        },
        {
            "query_idx": 514,
            "query": "Which prodrugs undergo conversion into triphosphate forms to act as RNA polymerase inhibitors for the treatment of viral infections, specifically targeting SARS-CoV-2?",
            "retrieved_metrics": {
                "reference_idx": [
                    1103,
                    1105
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The prodrugs #Favipiravir# and #4'-Fluorouridine (4'-FIU)# are converted to triphosphate forms, enabling them to inhibit RNA polymerase and target SARS-CoV-2.",
            "predicted_answer": "Favipiravir and 4'-Fluorouridine (4'-FIU) are prodrugs that convert to triphosphate forms to inhibit RNA polymerase, targeting SARS-CoV-2.",
            "score": 5,
            "explanation": "The predicted answer accurately includes all key facts: both Favipiravir and 4'-Fluorouridine (4'-FIU) as prodrugs, their conversion to triphosphate forms, and their role in inhibiting RNA polymerase to target SARS-CoV-2, aligning fully with the reference answer."
        },
        {
            "query_idx": 515,
            "query": "How do iterative processes and holistic approaches contribute to optimizing drug dosing strategies for oncology treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1594,
                    1598
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "An #iterative process# ensures continual dose optimization, while a #holistic approach# using a ToE mindset optimizes oncology regimens, integrating comprehensive data for effective treatment.",
            "predicted_answer": "Iterative processes refine dosing strategies by updating them with new data, while holistic approaches integrate diverse evidence, including patient-specific factors and real-world data, to optimize oncology treatments.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer by mentioning both iterative processes and holistic approaches. However, it lacks mention of the \"ToE mindset\" specifically and does not detail the integration of \"comprehensive data\" as in the reference. Thus, it misses these key facts."
        },
        {
            "query_idx": 516,
            "query": "How are ADCs internalized and processed within cells, and how does this process alter the dynamics of antigens involved in combination therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    209,
                    917
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "ADCs undergo #endocytosis# where they are internalized, processed in lysosomes, and facilitate #antigen turnover or degradation#, impacting their dynamics in combination therapies.",
            "predicted_answer": "ADCs are internalized into cells via endocytosis, leading to their breakdown in lysosomes. This process can alter antigen dynamics, potentially increasing antigen expression and turnover, which may enhance the efficacy of combination therapies by improving antibody-antigen engagement.",
            "score": 5,
            "explanation": "The predicted answer matches the reference with key facts of ADCs being internalized by endocytosis and processed in lysosomes. It mentions altering antigen expression and turnover, aligning with the reference's \"antigen turnover or degradation.\" Both imply enhanced efficacy in combination therapies, covering the core points."
        },
        {
            "query_idx": 517,
            "query": "What are the design challenges of bioink in 3D bioprinting for modeling tumor tissues, and how do these impact the ability to adjust specific properties of the tumor microenvironment?",
            "retrieved_metrics": {
                "reference_idx": [
                    2049,
                    2047
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "In 3D bioprinting, #bioink# design addresses challenges in accurately modeling tumor tissues by adjusting properties such as #TME# stiffness, crucial for replicating the tumor environment.",
            "predicted_answer": "Design challenges of bioink in 3D bioprinting for tumor tissue modeling include selecting bioink with appropriate mechanical and physiological properties, achieving high resolution, and ensuring cell survival. These challenges impact the ability to adjust specific properties of the tumor microenvironment, such as stiffness and biochemical factor distribution, crucial for studying tumor development and interactions.",
            "score": 3,
            "explanation": "The predicted answer includes key aspects like bioink design and the importance of adjusting properties of the tumor microenvironment (TME) like stiffness. However, it lacks emphasis on replicating the tumor environment precisely as mentioned in the reference. Minor details are missing but the overall trend is aligned."
        },
        {
            "query_idx": 518,
            "query": "How do chemical modifications and amino acid alterations address the challenges associated with peptide cancer therapies, including their physicochemical limitations and administration route issues?",
            "retrieved_metrics": {
                "reference_idx": [
                    894,
                    895
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Chemical modifications# like acetylation improve peptide #stability#, while the use of #synthetic amino acids# and design strategies enhances #membrane permeability# and #oral bioavailability#.",
            "predicted_answer": "Chemical modifications, such as acetylation and methylation, protect peptides from protease clearance and improve stability. Amino acid alterations, like using non-canonical amino acids, enhance membrane permeability and oral bioactivity, addressing physicochemical limitations and administration route issues in peptide cancer therapies.",
            "score": 3,
            "explanation": "The Predicted Answer includes key elements from the Reference Answer: chemical modifications (acetylation), improving stability, amino acid alterations using non-canonical amino acids, enhancing membrane permeability, and addressing oral bioactivity issues. It aligns with the trend and meaning but misses the mention of \"synthetic amino acids.\""
        },
        {
            "query_idx": 519,
            "query": "What technique is pivotal in discerning cellular targets and resistance mechanisms in drug development, and which comprehensive strategy evaluates gene influence on medication response and immune activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2090,
                    2102
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#CRISPR-Cas-mediated gene knockout# is crucial for discerning drug targets and resistance, while #genome-wide lentiviral CRISPR libraries# evaluate gene influence on drug response and immune activation.",
            "predicted_answer": "CRISPR-Cas9 is pivotal in discerning cellular targets and resistance mechanisms. Genome-wide CRISPR screening evaluates gene influence on medication response and immune activation.",
            "score": 3,
            "explanation": "The predicted answer captures the overarching concepts of \"CRISPR-Cas9\" for discerning drug targets and \"genome-wide CRISPR screening\" for evaluating gene influence. However, it omits key details specified as \"CRISPR-Cas-mediated gene knockout\" and \"genome-wide lentiviral CRISPR libraries,\" affecting completeness."
        },
        {
            "query_idx": 520,
            "query": "What challenges related to economic viability and regulations hinder drug repurposing, and why do these challenges necessitate expanding available cancer treatment options?",
            "retrieved_metrics": {
                "reference_idx": [
                    859,
                    1830
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The #limited return on investment# and #regulatory issues# obstruct drug repurposing innovation, necessitating #portfolio expansion# due to the #complex nature of cancer treatment#.",
            "predicted_answer": "Challenges in economic viability and regulations hinder drug repurposing due to limited return on investment and inadequate regulatory incentives. These challenges necessitate expanding cancer treatment options to address the complexity and variability of cancer progression and the need for more effective, less toxic therapies.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: it mentions \"limited return on investment,\" \"regulatory incentives\" (aligned with \"regulatory issues\"), the need for \"expanding cancer treatment options\" (aligned with \"portfolio expansion\"), and references the \"complexity\" of cancer. The essential elements are present and consistent with the reference."
        },
        {
            "query_idx": 521,
            "query": "How can an analytical tool contribute to the development of evaluation criteria for drug efficacy in 3D spheroid and organoid models, and what are the implications for research practices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1805,
                    1814
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "#Standardized evaluation methods# for drug efficacy in 3D models can be achieved through #mathematical modeling#, which aids analysis and reduces experimental trials.",
            "predicted_answer": "An analytical tool can contribute by providing quantitative evaluation methods for drug efficacy in 3D spheroid and organoid models, addressing current limitations in assay accuracy. This enhances research practices by standardizing methods, reducing experimental costs, and predicting outcomes, thereby improving drug development efficiency.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference by mentioning the need for standardization and the benefits of improving efficiency in drug development. However, it misses the specific mention of \"mathematical modeling\" as a key factor in achieving standardized evaluation methods. Hence, one key fact is missing."
        },
        {
            "query_idx": 522,
            "query": "How do insurers handle the complexities introduced by the lack of comprehensive clinical data when assessing drugs approved through accelerated processes, particularly concerning medical effectiveness and financial considerations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1912,
                    1929
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "Insurers face difficulty with #clinical outcomes# assessment and uncertain #therapeutic value# due to accelerated #drug approval#, impacting financial decisions and coverage policies.",
            "predicted_answer": "Insurers handle the complexities by using tools like managed entry agreements (MEAs) with clinical and economic restrictions, particularly in Europe, to account for the uncertainty in clinical benefits and cost-effectiveness of drugs approved through accelerated processes.",
            "score": 1,
            "explanation": "The Predicted Answer aligns with the overall trend regarding dealing with uncertainty due to accelerated drug approval. However, it lacks explicit mention of #clinical outcomes#, #therapeutic value#, and how financial decisions and coverage policies are impacted, which are key facts in the Reference Answer."
        },
        {
            "query_idx": 523,
            "query": "What are the key electrical properties and simulation results that identify the compound showing the highest effectiveness in cancer treatment according to the research findings?",
            "retrieved_metrics": {
                "reference_idx": [
                    261,
                    267
                ],
                "num_of_contexts": 2
            },
            "groundtruth_answer": "The compounds' #high ion-attracting capacity# suggests promising properties, while #Compound (8b)'s free-binding energy attributes# highlight its #greatest potential as an anticancer agent#.",
            "predicted_answer": "Compound (8b) showed the highest effectiveness in cancer treatment, identified by its free-binding energy influenced by both electrostatic and non-electrostatic forces.",
            "score": 3,
            "explanation": "The predicted answer includes Compound (8b) and its identification through free-binding energy, aligning with the reference. However, it omits the compound's high ion-attracting capacity, a key fact, affecting completeness. While generally aligned, this omission is significant."
        },
        {
            "query_idx": 524,
            "query": "What sophisticated adaptive strategies inherent in the receptor-binding mechanisms of bacteriophages orchestrate their targeted engagement and heightened operational efficacy in combating antibiotic-resistant bacterial strains?",
            "retrieved_metrics": {
                "reference_idx": [
                    7
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage specificity and efficiency are enhanced by #rapid evolution# of receptor-binding domains, enabling adaptation to bacterial surface variations and improving targeting of #antibiotic-resistant# strains.",
            "predicted_answer": "Phage receptor-binding proteins (RBPs) undergo rapid evolution, enabling them to adapt to bacterial surface variations and enhance specificity and efficiency, crucial for targeting antibiotic-resistant bacteria.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"rapid evolution\" and \"antibiotic-resistant,\" both emphasized in the reference answer. The meaning and trend of enhancing phage specificity and efficiency through receptor-binding proteins are consistent, indicating a comprehensive alignment with the reference."
        },
        {
            "query_idx": 525,
            "query": "What influence do the symphonic arrangements of replication gene clusters within bacteriophage genomic compositions exert in enhancing the intricate understanding of their diverse propagation blueprints?",
            "retrieved_metrics": {
                "reference_idx": [
                    8
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #modular arrangement# of replication genes in bacteriophage genomes enhances understanding of #DNA replication mechanisms#, illuminating diverse propagation strategies through phage-host interactions.",
            "predicted_answer": "The symphonic arrangements of replication gene clusters within bacteriophage genomes enhance the understanding of their diverse propagation blueprints by allowing systematic exploration and interplay between phage-encoded and host-replication factors, as discussed by Salmond and Fineran (2015) and Weigel et al. (2006).",
            "score": 1,
            "explanation": "Both the 'modular arrangement' of gene clusters and the focus on 'DNA replication mechanisms' are missing in the predicted answer. While the general trend of understanding propagation through gene arrangements is present, the lack of these specific key facts impacts completeness, leading to a less aligned answer."
        },
        {
            "query_idx": 526,
            "query": "Within the symbiotic ballet of microbial engagement, what strategic maneuverings are undertaken by receptor-binding proteins (RBPs) as vigilant molecular custodians, and how do they refine the tactical precision and discriminatory competence of phages in surmounting the defenses of antibiotic-resistant bacterial fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    9
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Receptor-binding proteins (RBPs) enhance phage #specificity# and #efficiency# by evolving to adapt to bacterial surface variations, enabling phages to overcome antibiotic-resistant bacteria defenses.",
            "predicted_answer": "Receptor-binding proteins (RBPs) in phages adapt to bacterial surface variations, enhancing specificity and efficiency in targeting antibiotic-resistant bacteria. These proteins refine phage precision by evolving rapidly to overcome bacterial defenses.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts emphasized with # in the reference answer: \"specificity\" and \"efficiency\" are mentioned as enhancements due to RBPs adapting to bacterial variations. The overall meaning and trend are consistent, with no significant errors or omissions."
        },
        {
            "query_idx": 527,
            "query": "What profound structural elucidations did the work of Hu et al. (2013) contribute to the comprehension of the bacteriophage T7 DNA translocation infrastructure, specifically in its adeptness at transcending and subduing microbial defensive constructs during the genetic encroachment phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    10
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hu et al. (2013) elucidated the #architecture# of bacteriophage #T7# DNA-injection machinery, revealing how phages overcome bacterial defenses during genome injection.",
            "predicted_answer": "Hu et al. (2013) elucidated the architecture of bacteriophage T7's DNA-injection machinery, revealing how it overcomes bacterial defenses during genome injection, enhancing understanding of its translocation infrastructure and microbial defense subduing.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately captures the key points emphasized in the 'Reference Answer': the architecture of bacteriophage T7's DNA-injection machinery and its role in overcoming bacterial defenses. All emphasized key facts are included, with no omissions or errors and consistent meaning."
        },
        {
            "query_idx": 528,
            "query": "What differential impacts on the intricate dance of genetic interchange and antibiotic resilience can be observed between modulated phages—sculpted through bioengineering—and their primal counterparts, which emerge through natural evolutionary processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    12
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Engineered phages, designed via #synthetic biology#, selectively remove resistance genes, minimizing harmful gene transfer, whereas natural phages navigate an evolutionary arms race impacting #therapy effectiveness#.",
            "predicted_answer": "Engineered phages can selectively target and remove resistance genes, minimizing harmful gene transfer and enhancing therapeutic benefits, while natural phages contribute to genetic interchange and antibiotic resistance through evolutionary processes.",
            "score": 1,
            "explanation": "The predicted answer aligns overall with the reference but misses key facts: \"synthetic biology\" and the impact on \"therapy effectiveness.\" These omissions affect completeness and detail, but it otherwise captures the general comparison trend between engineered and natural phages without contradicting facts."
        },
        {
            "query_idx": 529,
            "query": "Amidst the complex interplay of phages orchestrating bacterial genetic exchanges, what mechanisms do these viral agents employ to traverse the molecular conduits enhancing the challenge of antibiotic resistance, and through which stratagems do tailored phages propose to counteract this dissemination risk?",
            "retrieved_metrics": {
                "reference_idx": [
                    15
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phages enhance #antibiotic resistance# through horizontal gene transfer, while #engineered phages# counteract this by specifically targeting and mitigating resistance gene spread.",
            "predicted_answer": "Phages employ mechanisms like adsorption, genetic injection, and horizontal gene transfer to spread antibiotic resistance. Engineered phages aim to counteract this by targeting specific bacteria and minimizing resistance gene transfer.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of phages enhancing antibiotic resistance via horizontal gene transfer and engineered phages targeting bacteria to mitigate resistance spread. It aligns well with the reference answer, maintaining accuracy and completeness of details."
        },
        {
            "query_idx": 530,
            "query": "What underlying advantage does the finely tuned bacteriophage application confer in addressing the intricate challenge of methicillin-resistant Staphylococcus aureus (MRSA) management, particularly regarding its selective affinity for bacterial hosts and the preservation of ecological microbial equilibrium?",
            "retrieved_metrics": {
                "reference_idx": [
                    17
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The finely tuned bacteriophage application offers #targeted treatment# for MRSA, reducing secondary infections and preserving #microbial equilibrium# without affecting beneficial bacteria.",
            "predicted_answer": "The finely tuned bacteriophage application selectively targets MRSA, preserving ecological microbial equilibrium by avoiding harm to beneficial microbiota and reducing resistance development.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of \"targeted treatment\" for MRSA and \"preserving microbial equilibrium,\" aligning with the key ideas in the reference. However, it lacks specific mention of reducing secondary infections, which is a key fact emphasized in the reference. Therefore, it is missing one crucial aspect."
        },
        {
            "query_idx": 531,
            "query": "What central repository or information fountainhead was utilized in the curation of the anthology summarizing exploratory clinical endeavours involving microbe-targeting viral elements?",
            "retrieved_metrics": {
                "reference_idx": [
                    20
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central repository utilized is the #ClinicalTrials.gov# database from the National Library of Medicine.",
            "predicted_answer": "The central repository utilized was the ClinicalTrials.gov database from the National Library of Medicine.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key fact of the repository being the ClinicalTrials.gov database, which matches the information marked with # in the 'Reference Answer'. The information is consistent and complete with no omissions or contradictions."
        },
        {
            "query_idx": 532,
            "query": "Within the complex interplay of microbial resistance strategies and therapeutic interventions, what catalytic influence does the conjoint stratagem of phage and antibiotic infusion exert on the reclaimed vulnerabilities of Acinetobacter baumannii strains to the ceftazidime agent, particularly those initially displaying fortitude against phage intrusion?",
            "retrieved_metrics": {
                "reference_idx": [
                    24
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phage-antibiotic# combination therapy resensitizes #Acinetobacter baumannii# strains to ceftazidime, showing improved effectiveness over phage-only treatment in reducing bacterial burden.",
            "predicted_answer": "The conjoint stratagem of phage and antibiotic infusion can resensitize initially phage-resistant Acinetobacter baumannii strains to ceftazidime, significantly reducing bacterial burden and restoring antibiotic efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes the key elements of the phage-antibiotic combination and its effect on Acinetobacter baumannii regarding resensitization to ceftazidime. It highlights both the reduction in bacterial burden and restoration of antibiotic efficacy, although it doesn't explicitly compare to phage-only treatment as mentioned in the reference."
        },
        {
            "query_idx": 533,
            "query": "In the orchestration of microbially mediated defenses, which enzymatic conductors within the biofilm symphony precipitate the liberation of viral sentinels embedded in the biocompatible protective fabric?",
            "retrieved_metrics": {
                "reference_idx": [
                    31
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enzymatic conductors are #biofilm-associated enzymes# that trigger the release of phages from the biocompatible polymer matrix.",
            "predicted_answer": "The enzymatic conductors within the biofilm symphony that precipitate the liberation of viral sentinels are biofilm-associated enzymes, which trigger the release of encapsulated phages in a biocompatible polymer matrix.",
            "score": 5,
            "explanation": "The predicted answer completely mirrors the reference answer in terms of key facts and overall trend. It accurately identifies \"biofilm-associated enzymes\" and the action of releasing phages within a \"biocompatible polymer matrix.\" No key elements are missing or incorrect."
        },
        {
            "query_idx": 534,
            "query": "What intricate interplay of diverse microbial methodologies is essential for orchestrating the ongoing dissolution of bacterial fortifications and maintaining equilibrium among microbial entities to thwart the rise of phage-resistant strains?",
            "retrieved_metrics": {
                "reference_idx": [
                    36
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay involves using a cocktail of bacteriophages with #different physiological characteristics# to lyse bacteria continuously and prevent the rise of #phage-resistant strains#.",
            "predicted_answer": "The intricate interplay involves using phage cocktails with diverse physiological characteristics and advanced delivery methods like hydrogels to continuously dissolve bacterial fortifications and suppress phage-resistant strains.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: #different physiological characteristics# of phages and the prevention of #phage-resistant strains#. It adds detail about delivery methods (hydrogels), which aligns with the reference answer without conflicting. Thus, it fully covers essential aspects of the reference."
        },
        {
            "query_idx": 535,
            "query": "How does the pre-neck appendage entity known as Dpo7 orchestrate the modulation within the complex matrix of host immunological defenses, specifically amid the stalwart presence of biofilm-related bacterial incursions?",
            "retrieved_metrics": {
                "reference_idx": [
                    39
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dpo7 disrupts and inhibits biofilm formation of #staphylococcal species#, potentially aiding the #immune response# against biofilm-associated infections.",
            "predicted_answer": "Dpo7, a pre-neck appendage protein, disrupts and inhibits biofilm formation, potentially modulating the host's immune response to biofilm-embedded bacteria.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact that Dpo7 disrupts and inhibits biofilm formation, aligning with immune modulation. However, it lacks specificity regarding the #staphylococcal species# mentioned in the reference. The reference information about aiding the #immune response# is correctly represented in the predicted answer."
        },
        {
            "query_idx": 536,
            "query": "What architectural paradigm involving the utilization of dendritic mesoporous silica nanoparticles has been conceptualized as a strategic vector to augment phage efficacy in the microbial stronghold against Mycobacterium tuberculosis?",
            "retrieved_metrics": {
                "reference_idx": [
                    47
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Beitzinger et al. (2021) conceptualized utilizing #dendritic mesoporous silica nanoparticles# as a strategic #vector to augment phage efficacy# against Mycobacterium tuberculosis.",
            "predicted_answer": "The architectural paradigm involving dendritic mesoporous silica nanoparticles has been conceptualized as a strategic vector to augment phage efficacy in the microbial stronghold against Mycobacterium tuberculosis, enhancing phage delivery and activity.",
            "score": 5,
            "explanation": "The predicted answer captures both key facts: the use of #dendritic mesoporous silica nanoparticles# and their role as a #vector to augment phage efficacy#. The meaning aligns closely with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 537,
            "query": "In the strategic narrative of combating drug-resistant Chlamydia trachomatis, what are the specific enhancements and potential research pathways that the engineered pGFPΦ CPG1 phage offers over the archetype Φ CPG1 in terms of its groundbreaking utility and investigational opportunities in confronting antibiotic resistance and facilitating vaccine discoveries?",
            "retrieved_metrics": {
                "reference_idx": [
                    46
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #engineered pGFPΦ CPG1# phage enhances research on #CT drug resistance# and vaccine development, expanding investigational opportunities beyond the archetype Φ CPG1 in combating antibiotic-resistant Chlamydia trachomatis.",
            "predicted_answer": "The engineered pGFPΦ CPG1 phage enhances the archetype Φ CPG1 by providing a tool for visualizing and studying Chlamydia trachomatis infections, facilitating research on antibiotic resistance and vaccine development.",
            "score": 3,
            "explanation": "The predicted answer includes the key enhancements of the engineered pGFPΦ CPG1 over the archetype in terms of antibiotic resistance research and vaccine development. However, it does not explicitly mention \"CT drug resistance,\" which is underlined in the reference, impacting completeness."
        },
        {
            "query_idx": 538,
            "query": "What is the symphonic interaction between the molecular architects of bacteriophages and the innate immunological network that propels their function as biological conveyors in the context of self-adjuvanting effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    50
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #capsid proteins# and genetic elements of bacteriophages interact with Toll-like receptors, priming the innate #immune response# by serving as pathogen-associated molecular patterns (PAMPs).",
            "predicted_answer": "The symphonic interaction involves phage components like capsid proteins and DNA acting as PAMPs, binding to TLRs (2, 3, 4, 7, 8, 9) to prime the innate immune response, enhancing their function as biological conveyors with self-adjuvanting effects.",
            "score": 5,
            "explanation": "The predicted answer includes both emphasized key facts from the reference answer, “capsid proteins” and “immune response,” within its explanation. It correctly identifies phage components as PAMPs interacting with TLRs, aligning with the reference trends. No significant details are missing."
        },
        {
            "query_idx": 539,
            "query": "What catalytic interactions within cellular signaling cascades initiate the phosphorylation sequence of the IKK molecular consortium, thereby facilitating the translocation narrative of NFκB into the nuclear domain and orchestrating the cellular symphony of pro-inflammatory cytokines and interferons' emergence?",
            "retrieved_metrics": {
                "reference_idx": [
                    54
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PAMPs binding to TLRs activate the #Myd88 pathway#, which phosphorylates the #IKK complex# (IKKα, IKKβ, NEMO), enabling NFκB nuclear translocation and pro-inflammatory cytokine, interferon expression.",
            "predicted_answer": "The catalytic interactions within cellular signaling cascades, initiated by the binding of PAMPs to TLRs and activation of the Myd88 pathway, lead to the phosphorylation of the IKK complex (IKKα, IKKβ, and NEMO). This phosphorylation facilitates the release and nuclear translocation of NFκB, which orchestrates the expression of pro-inflammatory cytokines and interferons.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies all key facts: PAMPs binding to TLRs, Myd88 pathway activation, phosphorylation of the IKK complex, and NFκB's role. Details align closely with the Reference Answer, with no contradictions or major omissions."
        },
        {
            "query_idx": 540,
            "query": "What nuanced mechanisms guide the symphony of immune modulation via phage-guided immunological navigators, resulting in the aligned activation of both CD4+ helper and CD8+ cytotoxic T cell agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    59
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage-presented antigens crucially activate #CD4+# helper and #CD8+# cytotoxic T cells, promoting proliferation, differentiation, and subsequent immune responses via phage-based vaccines.",
            "predicted_answer": "Phage-guided immunological navigators present antigens to activate both CD4+ helper T cells for antibody production and CD8+ cytotoxic T cells for cellular immunity, aligning their activation through antigen specificity.",
            "score": 3,
            "explanation": "The predicted answer includes the activation of CD4+ helper and CD8+ cytotoxic T cells (both emphasized facts) and aligns with the overall mechanism described in the reference. It lacks details on proliferation, differentiation, and immune response through vaccines, resulting in some missing details affecting completeness."
        },
        {
            "query_idx": 541,
            "query": "In what orchestrated symphony do bacteriophages partake, as deciphered by contemporary scholarship, to both conceal their presence and reveal their potential as strategic allies in the uncharted territories of oncological therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    69
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bacteriophages engage in an orchestrated #immune-mediated attack# against tumors and aid in #tumor detection#, enhancing cancer therapy precision and efficacy.",
            "predicted_answer": "Bacteriophages partake in orchestrating immune-mediated attacks on tumors, as evidenced by studies showing their ability to induce tumor destruction and modulate the tumor-immune microenvironment, revealing their potential as strategic allies in oncological therapy.",
            "score": 3,
            "explanation": "The predicted answer covers the key fact of an \"immune-mediated attack\" emphasized in the reference but omits the crucial aspect of \"tumor detection.\" While the potential of bacteriophages in cancer therapy is noted, the absence of tumor detection affects completeness."
        },
        {
            "query_idx": 542,
            "query": "What strategies are employed by the enigmatic architectures of phage capsids that enable them to act as formidable sentinels, ensuring the unyielding resilience and safeguarded trajectory of medicinal compounds through the intricate passages of drug delivery systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    83
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage capsids provide a #protective environment# for payloads, shielding them from degradation and enzymes, ensuring effective therapeutic delivery and minimizing off-target effects.",
            "predicted_answer": "Phage capsids employ strategies such as encapsulating payloads to protect them from degradation and enzymatic activity, ensuring stability and effective delivery to target sites while minimizing off-target effects.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of phage capsids creating a protective environment for payloads, shielding them from degradation and enzymatic activity. It aligns with the trend of stability and effective delivery with minimized off-target effects. There are no significant omissions or errors."
        },
        {
            "query_idx": 543,
            "query": "Within the intricate dance of molecular architecture, what is the influence exerted by the phage display methodology upon the creation of bispecific fusion proteins designed to counteract MERS-CoV, as depicted in the exploration by Wang et al. (2019)?",
            "retrieved_metrics": {
                "reference_idx": [
                    89
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phage display influences the creation of bispecific fusion proteins against MERS-CoV by facilitating the design of antibodies with #enhanced# properties like higher #affinity# and specificity, as shown by Wang et al. (2019).",
            "predicted_answer": "Phage display methodology significantly influences the creation of bispecific fusion proteins against MERS-CoV by enabling the engineering of antibodies with enhanced affinity and specificity, as described by Wang et al. (2019).",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: it mentions phage display's role in engineering antibodies with enhanced affinity and specificity, in alignment with the reference answer's emphasis on \"enhanced\" properties, \"affinity,\" and specificity. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 544,
            "query": "What are the possible longitudinal consequences within the immune ecosystem from repetitive phage interactions that might influence the evolving therapeutic potency of phage-based interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    92
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Repetitive phage interactions may lead to the development of #neutralizing antibodies#, potentially reducing the #efficacy# of phage-based interventions over time.",
            "predicted_answer": "Repetitive phage interactions may lead to the development of neutralizing antibodies, reducing phage therapy efficacy over time and necessitating comprehensive safety evaluations.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: the development of neutralizing antibodies and the potential reduction in phage therapy efficacy over time. The additional mention of safety evaluations does not contradict the reference. All crucial information is covered."
        },
        {
            "query_idx": 545,
            "query": "What are the comparative proportions of nations residing across the spectrum of affluence that engage in the realms of holistic oncological care, projecting therapeutic completeness, versus those encumbered by economic limitations, navigating varied medical landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    107
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#90%# of high-income countries have comprehensive holistic oncological care, compared to #15%# of low-income countries.",
            "predicted_answer": "High-income countries have 90% comprehensive oncological care, compared to 15% in low-income countries, highlighting a significant gap in therapeutic completeness due to economic limitations.",
            "score": 5,
            "explanation": "Both key facts, the figures #90%# and #15%#, are present in the predicted answer and match those in the reference answer. The predicted answer captures the significant trend of disparity between high-income and low-income countries regarding comprehensive oncological care without contradictions."
        },
        {
            "query_idx": 546,
            "query": "In the context of elucidating transformative therapeutic avenues within the complex realm of cancer pharmacotherapy, what strategic functions do interconnected computational frameworks imbued with network topologies and machine learning dynamics employ in navigating the intricate challenges associated with the multifaceted molecular characteristics of oncological drugs?",
            "retrieved_metrics": {
                "reference_idx": [
                    108
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Interconnected computational frameworks using #network topologies# and #machine learning# address intricate challenges in cancer pharmacotherapy by exploring polypharmacological drug effects and multifaceted molecular characteristics.",
            "predicted_answer": "Interconnected computational frameworks with network topologies and machine learning dynamics help navigate the multifaceted molecular characteristics of oncological drugs by analyzing complex protein-drug interactions and predicting polypharmacological effects, aiding in the development of targeted therapies.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of network topologies, machine learning, and polypharmacological effects, similar to the reference answer. It aligns with the trend of using computational frameworks to address molecular characteristics and drug effects, without missing or contradicting essential details."
        },
        {
            "query_idx": 547,
            "query": "What are the intricate pathways that machine learning systems might traverse to enhance the refinement of clinical attribute prognosis within precision oncology, considering the nuanced interplay of methodological challenges and the enigmatic utility of experimental preclinical paradigms as elaborated in the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    109
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Machine learning enhances #clinical prognosis# in precision oncology by utilizing #population-scale data# and optimizing patient feature mixes, but preclinical models' efficacy remains uncertain.",
            "predicted_answer": "Machine learning systems refine clinical attribute prognosis in precision oncology by analyzing population-scale data sets with clinical and molecular annotations, optimizing patient feature mixes, and leveraging preclinical models like patient-derived xenografts and in vitro drug response studies, despite challenges in predicting treatment efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes key factors like refining clinical prognosis, the use of population-scale data, optimizing patient feature mixes, and mentions preclinical models. It aligns with the reference answer, though it expands on preclinical models, without contradiction or missing core facts."
        },
        {
            "query_idx": 548,
            "query": "What intrinsic element can be seen as the cornerstone of enlightenment, guiding artificial intelligence's prowess in decrypting the intricate tapestry of data generated within the realm of healthcare, thus unlocking pathways to enhanced human welfare?",
            "retrieved_metrics": {
                "reference_idx": [
                    114
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Integration of Big Data# is the cornerstone of AI's ability to decode healthcare data, unlocking pathways to enhanced #human welfare#.",
            "predicted_answer": "The intrinsic element guiding AI's prowess in healthcare is the integration of big data, enabling analysis of vast datasets to enhance patient outcomes.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies \"integration of big data\" as the cornerstone of AI in healthcare, aligning with the reference. However, it does not explicitly mention \"human welfare,\" which is a key element. Thus, one crucial aspect is missing, affecting completeness."
        },
        {
            "query_idx": 549,
            "query": "In the context of embracing the symbiosis of artificial intelligence with cancer recognition, what veiled complexities and ethical conundrums emerge at the intersection of technological infiltration and diagnostic imperatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    122
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ethical conundrums# include data privacy, algorithm interpretability, standardization, bias, and #equal access# to AI-driven diagnostic tools in cancer recognition.",
            "predicted_answer": "Veiled complexities include data privacy, algorithm interpretability, and standardized procedures. Ethical conundrums involve bias in algorithms and equitable access to AI-driven diagnostics.",
            "score": 3,
            "explanation": "The predicted answer covers data privacy, algorithm interpretability, bias, and equitable access as ethical concerns. However, it omits the mention of standardization as an ethical conundrum, which is emphasized in the reference answer. The overall trend and key facts are mostly aligned, but one key fact is missing."
        },
        {
            "query_idx": 550,
            "query": "In what manner do algorithmic entities engage in the intricate strategic process of elevating precision within the broader oncological domain, through the sophisticated molecular classification of tumorigenic structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    118
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Algorithmic entities enhance precision in #oncology# by employing molecular #classification# of tumors, using machine learning on proteomics, metabolomics, and genomes, enabling specialized and individualized treatment plans.",
            "predicted_answer": "Algorithmic entities enhance precision in oncology by analyzing molecular data from proteomics, metabolomics, and genomes to classify tumors into subtypes, enabling tailored treatment plans based on unique molecular traits.",
            "score": 3,
            "explanation": "The Predicted Answer contains the key facts: use of molecular data (proteomics, metabolomics, genomes) and tumor classification. It aligns with the overall trend of enhancing precision in oncology and individualized treatment plans, but it misses the explicit term \"machine learning\" emphasized in the Reference Answer."
        },
        {
            "query_idx": 551,
            "query": "What roles do prognostic frameworks play as guiding lights in the orchestration of tailored interventions and vigilance schemes to address the nuanced needs of populations preconditioned to distinct health outcomes within the intricate dynamics of healthcare provision?",
            "retrieved_metrics": {
                "reference_idx": [
                    129
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Prognostic frameworks #identify# high-risk groups, guiding #tailored interventions# and vigilance schemes, thereby optimizing screening, interventions, and follow-up care for populations with distinct health outcomes.",
            "predicted_answer": "Prognostic frameworks guide tailored interventions and vigilance schemes by identifying high-risk subgroups, optimizing post-clinical care, and providing patient-focused decision support, enhancing healthcare effectiveness and patient outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference answer: it mentions identifying high-risk groups (#identify#) and guiding tailored interventions (#tailored interventions#). Trends are aligned, with both focusing on enhancing healthcare through targeted actions. No significant omissions or errors are present."
        },
        {
            "query_idx": 552,
            "query": "How do cognitive augmentation technologies influence the dynamics of collaborative autonomy, empowering individuals to immerse themselves in the coalescent pathways of innovation and treatment within the oncological domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    132
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cognitive augmentation technologies empower individuals by enhancing #patient engagement# and #shared decision-making#, enabling active participation in oncology innovation and treatment pathways.",
            "predicted_answer": "Cognitive augmentation technologies, such as AI, enhance collaborative autonomy by empowering individuals with personalized insights, enabling informed decision-making in oncological treatment and innovation pathways.",
            "score": 1,
            "explanation": "The predicted answer aligns with the overall trend of the reference, emphasizing empowerment and informed decision-making in oncology. However, it lacks key facts: enhancement of #patient engagement# and #shared decision-making#. This omission affects the answer's completeness."
        },
        {
            "query_idx": 553,
            "query": "In the unfolding narrative of skill enlightenment and equitable access transmission, what pivotal influence do educational beacons wield in harmonizing the infusion of algorithmic paradigms into diverse therapeutic ecosystems?",
            "retrieved_metrics": {
                "reference_idx": [
                    134
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Educational #beacons# play a pivotal role in harmonizing algorithmic paradigms by providing #education# and training to ensure healthcare personnel effectively utilize AI technologies, enhancing equitable access.",
            "predicted_answer": "Educational beacons play a pivotal role in harmonizing the infusion of algorithmic paradigms into diverse therapeutic ecosystems by providing necessary skills and democratizing access to AI technologies, ensuring equitable impact and fostering trust through evidence-based research.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer, mentioning the role of educational beacons in providing skills and democratizing AI access. However, it misses the key detail of specifically training healthcare personnel, which is crucial for enhancing equitable access."
        },
        {
            "query_idx": 554,
            "query": "Through the prism of precision-focused therapeutic innovations and immune system harnessing strategies, what metamorphosis occurred within the chronological survival journey of lung cancer patients over the timeframe spanning 2014 to 2021, as perceived and communicated by the institution named the American Cancer Society?",
            "retrieved_metrics": {
                "reference_idx": [
                    135
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #three-year survival# rate for lung cancer patients increased from #21% to 31%# between 2014 and 2021, according to the American Cancer Society.",
            "predicted_answer": "The American Cancer Society reported a significant increase in the three-year survival rate for lung cancer patients from 2014 to 2021, rising from 21% to almost 31%, attributed to advancements in targeted therapies and immunotherapeutics.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts and figures emphasized in the reference answer: the increase in the three-year survival rate for lung cancer patients from 21% to 31% between 2014 and 2021. The trends and details are consistent and complete."
        },
        {
            "query_idx": 555,
            "query": "Within the vast tapestry of computational explorations that seek to unveil drug-target interactions, in what manner does the end-to-end learning mechanism inherent in the EEG-DTI paradigm cultivate an enriched canvas of predictive refinement, especially when devoid of explicit spatial configurations, thus offering a nuanced augmentation over traditional methods absent of neural complexities?",
            "retrieved_metrics": {
                "reference_idx": [
                    142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EEG-DTI# paradigm uses #graph convolutional networks# to learn feature representations and predict DTIs effectively without needing 3D structures, enhancing prediction over traditional methods.",
            "predicted_answer": "The EEG-DTI paradigm employs an end-to-end learning mechanism through heterogeneous graph convolutional networks, enabling predictive refinement by learning low-dimensional feature representations of drugs and targets, thereby enhancing accuracy without explicit spatial configurations.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts, such as the use of the EEG-DTI paradigm and graph convolutional networks for feature learning, without requiring spatial configurations, aligning with the reference. These details reflect the core of the reference answer, ensuring completeness and accuracy."
        },
        {
            "query_idx": 556,
            "query": "What was the fundamental aspiration of Shao et al. when contemplating the transformation of drug-target interaction forecasting into a paradigm of inferential connectivity assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    143
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Shao et al. aimed to transform DTI prediction into an #inferential connectivity assessment paradigm# using a #heterogeneous graph with attention mechanism# to improve prediction performance.",
            "predicted_answer": "The fundamental aspiration of Shao et al. was to transform drug-target interaction forecasting into a paradigm of inferential connectivity assessment to improve prediction performance and address the explanation problem of deep learning.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of transforming DTI prediction into an inferential connectivity assessment paradigm. However, it omits key aspects like the use of a \"heterogeneous graph with attention mechanism,\" which affects completeness. No contradictions are present."
        },
        {
            "query_idx": 557,
            "query": "What overarching objective does the AI system known as DrugnomeAI aim to achieve within the domain of druggable target identification, and through what probabilistic scaffold of cognition and learning is its existence architected?",
            "retrieved_metrics": {
                "reference_idx": [
                    144
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DrugnomeAI's objective is to predict the #druggability# of drug targets using a #stochastic semi-supervised# machine learning framework.",
            "predicted_answer": "DrugnomeAI aims to predict the druggability of drug targets in the human exome using a stochastic semi-supervised machine learning framework.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: it states that DrugnomeAI predicts the \"druggability\" of drug targets and utilizes a \"stochastic semi-supervised\" machine learning framework. These elements align completely with the reference, with no significant omissions or errors."
        },
        {
            "query_idx": 558,
            "query": "How does the integrative molecular fingerprinting stratagem formulated by Hutter synthesize various molecular structures into a cohesive data enhancement mechanism, contrasting with traditional approaches that employ an isolated molecular blueprint?",
            "retrieved_metrics": {
                "reference_idx": [
                    146
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hutter's integrative molecular fingerprinting synthesizes structures into a cohesive mechanism by #improving utilization# of data, unlike traditional approaches that use isolated molecular blueprints.",
            "predicted_answer": "Hutter's integrative molecular fingerprinting stratagem synthesizes various molecular structures into a cohesive data enhancement mechanism by considering all structure data in the calculation, improving data utilization and combining molecular fingerprinting with experimental data, contrasting with traditional isolated molecular blueprint approaches.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact from the reference about \"improving utilization\" of data through an integrated approach that contrasts with traditional isolated strategies. It reflects the comprehensive synthesis described, aligning with the overall trend without contradictions."
        },
        {
            "query_idx": 559,
            "query": "In the intricate tapestry of chemical exploration, what conceptual divergences delineate the AI-driven molecular genesis from the established pathway of employing extensive compound catalogues, particularly with respect to their unified aim yet distinctly varied methodologies in traversing the chemical cosmos?",
            "retrieved_metrics": {
                "reference_idx": [
                    149
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AI-driven molecular genesis, through #de novo drug design#, generates molecules with AI, contrasting with traditional #high-throughput screening#, which screens existing compound libraries to identify suitable molecules.",
            "predicted_answer": "AI-driven molecular genesis differs from traditional methods by generating new molecules rather than screening existing ones, leveraging artificial intelligence for optimization.",
            "score": 3,
            "explanation": "The predicted answer covers the key concepts of AI-driven molecular generation and its contrast with traditional methods. However, it misses specific terms like \"de novo drug design\" and \"high-throughput screening,\" which affects the completeness of the alignment with the reference answer."
        },
        {
            "query_idx": 560,
            "query": "What are the trio of synthetic transmutation strategies synergistically intertwined with the RNN fabrication framework devised by Moret et al., which enable the forging of molecular constructs encapsulating desired attributes?",
            "retrieved_metrics": {
                "reference_idx": [
                    150
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthetic transmutation strategies synergistically intertwined with the RNN fabrication framework by Moret et al. are #data augmentation#, #temperature sampling#, and transfer learning.",
            "predicted_answer": "The trio of synthetic transmutation strategies devised by Moret et al. are data augmentation, temperature sampling, and transfer learning, which synergistically enhance the RNN fabrication framework for molecular construct generation with desired attributes.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized with # symbols in the reference answer: data augmentation and temperature sampling. It is consistent with the reference, mentioning transfer learning and the context of the RNN framework. No significant omissions or errors are present."
        },
        {
            "query_idx": 561,
            "query": "What metaphorical approach does the Mol-Cycle GAN method undertake using the alchemist's philosophy embedded in generative models to traverse the complex landscape of molecular harmonic convergence, especially regarding challenging synthesis routes and structural similitude in novel drug creation?",
            "retrieved_metrics": {
                "reference_idx": [
                    151
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Mol-Cycle GAN# method metaphorically traverses the #complex landscape# of molecular synthesis by optimizing challenging synthesis routes and generating structurally similar molecules in novel drug creation.",
            "predicted_answer": "Mol-Cycle GAN uses a generative adversarial network to optimize drug design and synthesis by generating molecules with similar structures and desired properties, metaphorically traversing the complex landscape of molecular harmonic convergence.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts emphasized with # symbols: \"Mol-Cycle GAN\" and \"complex landscape.\" It captures the essence of optimizing synthesis and generating structurally similar molecules. However, it lacks specificity about \"challenging synthesis routes,\" affecting completeness."
        },
        {
            "query_idx": 562,
            "query": "What navigational schematics do cognitive predictive frameworks employ within the artificial intelligence domain to maneuver the reallocation of pharmacological constructs, particularly through a dual-lens approach, contemplating the convergence of target-centric and disease-centric paradigms of interaction?",
            "retrieved_metrics": {
                "reference_idx": [
                    154
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cognitive predictive frameworks in AI utilize #target-centric# and #disease-centric# paradigms to navigate the reallocation of pharmacological constructs.",
            "predicted_answer": "Cognitive predictive frameworks in AI use navigational schematics like machine learning algorithms and computational models to maneuver drug reallocation. They employ a dual-lens approach, integrating target-centric and disease-centric paradigms to predict drug-target and drug-disease interactions for drug repurposing.",
            "score": 5,
            "explanation": "The Predicted Answer includes the integration of target-centric and disease-centric paradigms, aligning with the emphasis in the Reference Answer. Both answers talk about drug reallocation and predict interactions. All key facts are covered without contradictions or omissions."
        },
        {
            "query_idx": 563,
            "query": "What underlying qualities embodied in the strategic maneuvering of pharmaceutical repurposing pathways suggest this route might transcend the uncertainties and prolonged undertakings typical of the exploratory journey involved in the genesis of novel oncologic molecular innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    153
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Repurposing drugs is #faster#, #safer#, and less expensive than developing new cancer drugs, suggesting it can overcome uncertainties and lengthy timelines.",
            "predicted_answer": "The strategic maneuvering of pharmaceutical repurposing pathways suggests faster, safer, and less expensive routes compared to novel oncologic molecular innovations, potentially transcending uncertainties and prolonged undertakings.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by including the key facts of being \"faster\" and \"safer\" and mentions \"less expensive,\" mirroring the intended meaning. There are no significant omissions or errors, maintaining consistency with the overall trend."
        },
        {
            "query_idx": 564,
            "query": "What pioneering orchestration does ReLeaSE utilize in the sculpting and crafting of therapeutic compounds with oncological potential, leveraging the convergence of computational paradigms and decision sciences?",
            "retrieved_metrics": {
                "reference_idx": [
                    152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ReLeaSE orchestrates compound design by integrating #deep learning# and #reinforcement learning# in generative and predictive neural networks to create molecules with specified oncological properties.",
            "predicted_answer": "ReLeaSE utilizes deep reinforcement learning to design molecules with desired properties, integrating generative and predictive neural networks to create novel libraries of therapeutic compounds with oncological potential.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the key elements of \"deep reinforcement learning,\" \"generative and predictive neural networks,\" and \"design molecules with oncological potential,\" which align with the reference answer's mention of \"deep learning\" and \"reinforcement learning.\" The core facts and trend are maintained."
        },
        {
            "query_idx": 565,
            "query": "Within the theoretical constructs Precily and DRUML, which sophisticated methodologies or esoteric frameworks were harnessed to navigate the predictive landscape of drug sensitivity and the hierarchical assessment of anti-neoplastic drug effectiveness, correspondingly?",
            "retrieved_metrics": {
                "reference_idx": [
                    157
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Precily uses #gene expression# and drug structural properties. DRUML uses #omics data# for ranking anti-cancer drugs by efficacy.",
            "predicted_answer": "Precily utilizes deep neural networks with gene expression and drug structural properties, while DRUML employs omics data to rank anti-cancer drugs based on efficacy.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts emphasized in the reference answer. It covers Precily using \"gene expression\" and \"drug structural properties,\" and DRUML using \"omics data\" for ranking drugs. The prediction aligns completely with the reference, with no omissions or errors."
        },
        {
            "query_idx": 566,
            "query": "What sophisticated paradigm did Zhao et al. cultivate to navigate the complexities of pharmacological adverse effect manifestation frequencies, setting it apart from traditional methodologies fixated on mere occurrence prediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    158
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zhao et al. developed a novel #graphical attention model# to predict drug side effect #frequency# using multi-view data, distinguishing it from traditional occurrence-focused methodologies.",
            "predicted_answer": "Zhao et al. cultivated a novel graphical attention model to predict drug side effect frequency from multi-view data, addressing the limitations of traditional methodologies focused on mere occurrence prediction.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: \"graphical attention model,\" \"frequency,\" and \"multi-view data,\" which align with the reference answer. Both responses focus on differentiating this novel approach from traditional methodologies. The predicted answer is consistent and complete without any significant omissions."
        },
        {
            "query_idx": 567,
            "query": "Amidst the complex symphony of cellular metabolic harmonies orchestrated in the expanse of lung adenocarcinomas, which specific orchestral sections and interwoven movements are subtly influenced by Ouabain's therapeutic presence, as mapped out by the algorithmic insights of GPSnet?",
            "retrieved_metrics": {
                "reference_idx": [
                    155
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ouabain specifically influences #HIF1 α /LEO1-mediated# cellular metabolic pathways in #lung adenocarcinomas#, as identified by GPSnet.",
            "predicted_answer": "Ouabain subtly influences the HIF1α/LEO1-mediated cellular metabolic pathways in lung adenocarcinomas, as identified by GPSnet's algorithmic insights.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in terms of meaning and key facts. It mentions the HIF1α/LEO1-mediated cellular metabolic pathways and lung adenocarcinomas as influenced by Ouabain, consistent with the GPSnet insights. No significant omissions or errors are present."
        },
        {
            "query_idx": 568,
            "query": "How did Recursion's AI-powered synthesis unveil REC-2282 as an auspicious prospect for mitigating ailments entwined with NF2 gene irregularities, within the intricate theater of anti-oncogenic compound development?",
            "retrieved_metrics": {
                "reference_idx": [
                    160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Recursion's AI-driven #Recursion OS# identified #REC-2282# as a potential treatment for NF2 gene mutation-related diseases.",
            "predicted_answer": "Recursion's AI-driven platform, Recursion OS, identified REC-2282 as a promising candidate for treating NF2 gene mutations by analyzing vast datasets and predicting its efficacy in mitigating related ailments.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer, namely #Recursion OS# and #REC-2282#, both part of the AI-driven process targeting NF2 gene mutations. It does not contain contradictory information or omissions that impact completeness."
        },
        {
            "query_idx": 569,
            "query": "What are the triumvirate of structural underpinnings involving molecular recognition agents, lethality conveyors, and molecular bridges, which collectively bolster ADCs in the precise pursuit of tumor cell engagement?",
            "retrieved_metrics": {
                "reference_idx": [
                    167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triumvirate involves #monoclonal antibodies# for targeting, a #cytotoxic drug payload# for lethality, and a cleavable or non-cleavable linker as a molecular bridge in ADCs.",
            "predicted_answer": "The triumvirate of structural underpinnings in ADCs includes molecular recognition agents (monoclonal antibodies), lethality conveyors (cytotoxic drugs), and molecular bridges (linkers), which collectively enhance tumor cell engagement.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies and aligns with the three components of the ADC structure: monoclonal antibodies, cytotoxic drugs, and linkers, paralleling the reference answer's monoclonal antibodies, cytotoxic drug payload, and molecular bridges. There are no omissions or contradictions in the key facts."
        },
        {
            "query_idx": 570,
            "query": "In the realm of ADC-influenced oncological pursuits, how does the nuanced affinity of lysine-based conjugation intricately reshape the bystander whisper, guiding the therapeutic narrative within targeted cellular domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    170
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The nuanced affinity of #lysine-based conjugation# reshapes the bystander whisper by promoting drug retention within targeted cells, influencing the #therapeutic narrative# in ADC applications.",
            "predicted_answer": "The nuanced affinity of lysine-based conjugation in ADCs can attenuate the bystander effect by promoting drug retention within targeted tumor cells, thereby guiding the therapeutic narrative to more precisely impact the intended cellular domains.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"lysine-based conjugation\" and the impact on the \"therapeutic narrative\" through drug retention in targeted cells, aligning with the reference answer. No significant information is omitted or contradictory, maintaining consistency with the reference's overall trend."
        },
        {
            "query_idx": 571,
            "query": "What unique confluence of physiological harmonies and molecular predispositions inherent in the IgG1 subclass formulates a preeminent design matrix, elevating it above its sibling subclasses in the sophisticated orchestration of contemporary ADCs?",
            "retrieved_metrics": {
                "reference_idx": [
                    171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IgG1# subclass combines optimal #solubility#, long serum half-life, and high binding affinity to Fc γ receptors, making it superior for contemporary ADC development.",
            "predicted_answer": "The IgG1 subclass's unique combination of solubility, long serum half-life, and high affinity for Fc γ receptors makes it the preferred choice for modern ADCs, surpassing its sibling subclasses.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: the IgG1 subclass is mentioned, as well as its solubility, long serum half-life, and high affinity for Fc γ receptors, aligning them with its suitability for contemporary ADCs. The overall trend and specifics are covered without contradiction."
        },
        {
            "query_idx": 572,
            "query": "What is the environmental catalyst threshold required to initiate the liberation of molecular contents within enzymatic vaults via a hydrazone interface?",
            "retrieved_metrics": {
                "reference_idx": [
                    172
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #pH threshold# required to initiate liberation is #pH 4.8# using a hydrazone interface.",
            "predicted_answer": "The environmental catalyst threshold required is a specific pH, typically around pH 4.8, which induces the hydrolysis of the hydrazone interface, leading to the liberation of molecular contents within enzymatic vaults.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the #pH threshold# as #pH 4.8#, which matches the reference answer's emphasized information. It further elaborates on the process without conflicting with the reference answer, aligning with its key facts. No significant details are missing."
        },
        {
            "query_idx": 573,
            "query": "Within the constellation of HDAC inhibitors, by what confluence of patient attunement and potential adverse manifestations does REC-2282 distinguish itself, particularly considering its prolonged orchestration and cardiological implications?",
            "retrieved_metrics": {
                "reference_idx": [
                    161
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "REC-2282 distinguishes itself by being #well tolerated# even when used over years, with potential #reduced cardiotoxicity# compared to other HDAC inhibitors.",
            "predicted_answer": "REC-2282 distinguishes itself by its reduced cardiotoxicity and prolonged tolerability, making it unique among HDAC inhibitors.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of \"reduced cardiotoxicity\" present in the reference answer. However, it misses the detail of being \"well tolerated even when used over years.\" The trend is generally aligned but lacks completeness due to the missing tolerability aspect."
        },
        {
            "query_idx": 574,
            "query": "In what distinct orchestration do immune-stimulating antibody conjugates engage the immune response choreography, diverging from the harmonic execution observed in the checkpoint blockade approach?",
            "retrieved_metrics": {
                "reference_idx": [
                    176
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Immune-stimulating antibody conjugates (#ISACs#) activate myeloid #antigen-presenting cells# and stimulate the immune system differently from checkpoint blockade, focusing on tumor anti-immunity.",
            "predicted_answer": "Immune-stimulating antibody conjugates (ISACs) engage the immune response by activating myeloid antigen-presenting cells, promoting tumor anti-immunity through a distinct mechanism from checkpoint blockade, which primarily targets T-cell inhibition.",
            "score": 5,
            "explanation": "The predicted answer mentions ISACs activating myeloid antigen-presenting cells and focusing on tumor anti-immunity, aligning with the key facts in the reference. No contradictory information is present. The overall trend matches the description of ISAC functioning differently from checkpoint blockade."
        },
        {
            "query_idx": 575,
            "query": "How does the engagement of TLR8 by the intricate molecular entity SBT6050 choreograph the intricate interplay of lymphocytic activation and the emission of cytokine signals within the tapestry of the innate immune system?",
            "retrieved_metrics": {
                "reference_idx": [
                    177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SBT6050 engages #TLR8#, inducing #lymphocytic activation# and cytokine secretion via NFκ B pathway activation within the innate immune system.",
            "predicted_answer": "SBT6050, by engaging TLR8, activates NF-κB, leading to cytokine secretion and lymphocyte activation, thereby enhancing innate immune responses.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the engagement of TLR8 by SBT6050, leading to lymphocytic activation and cytokine secretion through the NF-κB pathway. All key facts, numbers, and technical details emphasized with # in the reference are present in the predicted answer."
        },
        {
            "query_idx": 576,
            "query": "Within the intricate signaling cascades of oncogenic receptor families, what initiates the synergistic formation of HER receptor dyads in the specialized context of lung cancer pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    178
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ligand binding to #HER1#, #HER3#, or HER4 initiates the synergistic formation of HER receptor dyads in lung cancer pathology.",
            "predicted_answer": "Ligand binding to HER1, HER3, or HER4 initiates the synergistic formation of HER receptor dyads in lung cancer pathology.",
            "score": 5,
            "explanation": "The predicted answer includes the critical points of ligand binding to HER1 and HER3, which are emphasized in the reference answer. The meaning and key facts are consistent, despite minor differences in wording. All emphasized elements are present in the predicted answer."
        },
        {
            "query_idx": 577,
            "query": "What is the numerical portion of the participant population that exhibited HER2 IHC as graded 2+, discerned within the sphere of their commencement into the evaluative phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    183
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#79.6%# of the participants exhibited HER2 IHC graded #2+ at commencement.",
            "predicted_answer": "The numerical portion of the participant population that exhibited HER2 IHC as graded 2+ is 79.6%.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key fact emphasized in the Reference Answer: \"79.6% of the participants exhibited HER2 IHC graded 2+\" at commencement. The meaning and details are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 578,
            "query": "What contrasting manifestations of resonance amplification were encountered among individuals presenting disparate patterns of signal strength in their biological marker overexpression scales, particularly when comparing the groups delineated as IHC 3+ versus IHC 2+?",
            "retrieved_metrics": {
                "reference_idx": [
                    184
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with #IHC 3+# had a 20.0% ORR and 6.0-month median DOR. IHC 2+ had a 25.6% ORR; DOR not specified.",
            "predicted_answer": "The contrasting manifestations of resonance amplification were evident in the response rates: IHC 3+ showed an ORR of 20.0%, while IHC 2+ had an ORR of 25.6%.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact about the ORR percentages for both IHC 3+ (20.0%) and IHC 2+ (25.6%), aligning with the reference answer. However, it omits the median DOR information for IHC 3+. This omission affects the completeness of the response."
        },
        {
            "query_idx": 579,
            "query": "What role does the auxiliary biomarker, embodied by nuanced variations in HER3 levels, play in the labyrinthine context of resistance phenomena, when tasked with the potentially nebulous endeavor of distinguishing categorical treatment outcomes as one might isolate a signal from overwhelming static?",
            "retrieved_metrics": {
                "reference_idx": [
                    190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #auxiliary biomarker#, with nuanced HER3 variations, does not clearly distinguish treatment #outcomes# in the context of EGFR TKI resistance phenomena.",
            "predicted_answer": "The auxiliary biomarker HER3 levels do not clearly distinguish treatment responders from non-responders in the context of resistance phenomena, complicating the task of categorizing treatment outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures the main idea that HER3 levels, as an auxiliary biomarker, do not clearly distinguish treatment outcomes in resistance phenomena. Both emphasize the unclear role of HER3 in treatment categorization, with no contradictions or major omissions."
        },
        {
            "query_idx": 580,
            "query": "In the realm of pulmonary neoplastic transformations, how prominently do adenocarcinoma and squamous cell carcinoma variants express Trop2 as a pivotal molecular signature, and what implications arise from this altered cellular narrative in terms of survival dynamics and cellular resistance?",
            "retrieved_metrics": {
                "reference_idx": [
                    195
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Adenocarcinoma expresses #Trop2# in 64% and squamous cell carcinoma in 75%, linked to #reduced survival# and potential chemotherapy resistance.",
            "predicted_answer": "In pulmonary neoplastic transformations, Trop2 is prominently expressed in 64% of adenocarcinoma and 75% of squamous cell carcinoma, associated with reduced survival and potential resistance to chemotherapy and CD8+ T-cell apoptosis.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all key facts emphasized in the 'Reference Answer': Trop2 expression in adenocarcinoma (64%) and squamous cell carcinoma (75%), associated with reduced survival and potential chemotherapy resistance. It adds detail about CD8+ T-cell apoptosis, but this does not contradict reference facts."
        },
        {
            "query_idx": 581,
            "query": "What constitutes the molecular concordance measure reflective of the conjugated balance within the pharmaceutical constellation of sacituzumab govitecan (SG)?",
            "retrieved_metrics": {
                "reference_idx": [
                    197
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #molecular concordance measure# of sacituzumab govitecan is reflected in its #high DAR ratio# of 7.6, indicating its efficient conjugated balance.",
            "predicted_answer": "The molecular concordance measure reflective of the conjugated balance within sacituzumab govitecan (SG) is characterized by the high drug-antibody ratio (DAR) of 7.6, achieved through the linkage of the anti-Trop2 monoclonal antibody sacituzumab to the topoisomerase I inhibitor SN-38 via a hydrolysable cleavable linker.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts from the reference answer, including the \"molecular concordance measure\" and the \"high DAR ratio of 7.6.\" It also correctly describes this in the context of sacituzumab govitecan's conjugated balance, aligning with the overall trend and providing no contradicting information."
        },
        {
            "query_idx": 582,
            "query": "In the pursuit of pioneering therapeutic avenues within the domain of NSCLC, what discreet molecular hallmark, distinguished by its amplified presentation amidst advanced disease phases, is under active investigation as a prospective axis for targeted treatment approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    203
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The discreet molecular hallmark under active investigation for NSCLC targeted treatment is #tissue factor#, noted for its #amplified presentation# in advanced disease phases.",
            "predicted_answer": "The discreet molecular hallmark under active investigation is tissue factor (TF), which is amplified in advanced NSCLC and being explored as a targeted treatment approach.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies \"tissue factor\" as the discreet molecular hallmark under investigation and notes its amplified presence in advanced NSCLC, matching all key facts emphasized in the reference answer. The overall trend and details are fully aligned with the reference."
        },
        {
            "query_idx": 583,
            "query": "What enigmatic interactions and undisclosed pathways within the cellular environment are responsible for the distinctive respiratory perturbations seen with trastuzumab-linked constructs such as deruxtecan and duocarmycin, while the comparable T-DM1 exhibits significantly fewer such perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    204
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab-linked constructs, #deruxtecan# and #duocarmycin#, cause pulmonary toxicities through unknown mechanisms, differing from T-DM1, which shows fewer respiratory perturbations.",
            "predicted_answer": "The distinctive respiratory perturbations seen with trastuzumab-linked constructs like deruxtecan and duocarmycin are likely due to enigmatic interactions and undisclosed cellular pathways, possibly related to their different payloads and mechanisms of action, unlike T-DM1 which exhibits fewer such perturbations.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts about deruxtecan and duocarmycin causing respiratory perturbations due to enigmatic interactions, and mentions T-DM1 exhibiting fewer perturbations. It aligns well with the reference answer, and no crucial information is omitted, despite differences in phrasing."
        },
        {
            "query_idx": 584,
            "query": "In what manner might bispecific antibody constructs manifest their inherent potential to refine the precision and enhance the multi-layered biological synergy of antibody-drug conjugates, particularly in their nuanced engagement with tumor-specific antigens?",
            "retrieved_metrics": {
                "reference_idx": [
                    208
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bispecific antibody constructs can enhance #precision# and #synergy# by improving receptor aggregation and accelerating target internalization when engaging with tumor-specific antigens in ADCs.",
            "predicted_answer": "Bispecific antibody constructs can enhance antibody-drug conjugates (ADCs) by improving tumor specificity and internalization through receptor aggregation, leading to faster target internalization and multi-layered biological synergy.",
            "score": 5,
            "explanation": "The 'Predicted Answer' captures the key facts of enhancing precision and synergy through improved receptor aggregation and faster target internalization, aligning with the overall trend of the 'Reference Answer'. All emphasized concepts are present with no significant omissions or errors."
        },
        {
            "query_idx": 585,
            "query": "Amidst the evolving landscape of clinical ADC evaluations, what conceptualized strategic synthesis and collaborative frameworks are envisaged to amplify the potency of these therapeutics in overcoming the elusive resistance dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    207
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rationale combination strategies and collaborative frameworks focusing on #predictive biomarkers# and #assays# are envisaged to enhance ADC efficacy against resistance dynamics.",
            "predicted_answer": "Strategic synthesis and collaborative frameworks for ADC evaluations include rational combination strategies to augment activity and overcome resistance, along with developing validated assays and predictive biomarkers.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer, mentioning \"predictive biomarkers\" and \"assays,\" as well as the overall trend of using rational combination strategies. The response aligns well with the reference answer, leaving no significant omissions."
        },
        {
            "query_idx": 586,
            "query": "What is the process through which the ensemble of catalytic intrinsics, led by pseudomonas exotoxin A, orchestrates the cessation of cellular functions through its engagement with elongation factor-2, within the conceptual arena of LMB-100’s apoptotic initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    211
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "LMB-100, with #pseudomonas exotoxin A#, induces apoptosis by #inhibiting elongation factor-2#, ceasing cellular functions through its catalytic mechanism.",
            "predicted_answer": "The process involves Pseudomonas exotoxin A inhibiting elongation factor-2, leading to apoptosis by halting cellular protein synthesis.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies the role of Pseudomonas exotoxin A and its mechanism of inhibiting elongation factor-2 to induce apoptosis, aligning with the Reference Answer. However, it lacks explicit mention of the role of LMB-100 in this process."
        },
        {
            "query_idx": 587,
            "query": "What enduring dilemmas in the oncological landscape perpetuate the demand for groundbreaking therapeutic innovations, notwithstanding significant advancements in cancer treatment methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    213
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The persistence of #drug resistance# and #toxicity# in cancer treatments perpetuates the demand for groundbreaking therapeutic innovations despite significant advancements.",
            "predicted_answer": "Drug resistance, toxicity, and the spread of cancer to other parts of the body perpetuate the demand for innovative therapeutic advancements in oncology.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes the key facts of \"drug resistance\" and \"toxicity\" as mentioned in the Reference Answer. Additionally, it identifies \"the spread of cancer,\" which, while relevant, does not contradict the reference information. The core information aligns closely with the reference."
        },
        {
            "query_idx": 588,
            "query": "Considering the advances in understanding molecular conformation via sophisticated structural elucidation techniques over recent years, what are the macromolecular engagement loci within DNA that frequently serve as the nexus of covalent interaction for anticancer compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    216
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DNA atomic sites# often targeted for covalent interaction by anticancer compounds are those identified using #high-resolution techniques# like X-ray diffraction and nuclear magnetic resonance.",
            "predicted_answer": "The macromolecular engagement loci within DNA that frequently serve as the nexus of covalent interaction for anticancer compounds are specific DNA atomic sites, particularly those targeted by drug covalent actions.",
            "score": 3,
            "explanation": "The predicted answer mentions \"specific DNA atomic sites\" but does not specify the use of \"high-resolution techniques\" like X-ray diffraction and NMR, which are key facts in the reference answer. Thus, the predicted answer is incomplete and missing important details, aligning with the reference trend, but lacks a key element."
        },
        {
            "query_idx": 589,
            "query": "What are the prominent atomic loci within the DNA macromolecule that consistently partake in covalent engagements with therapeutic entities aimed at oncological intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    218
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #prominent atomic loci# in DNA that frequently engage in #covalent actions# with anticancer drugs are specific targeted sites on the DNA macromolecule.",
            "predicted_answer": "Prominent atomic loci within the DNA macromolecule that consistently partake in covalent engagements with therapeutic entities include specific DNA atomic sites frequently targeted by drug covalent actions.",
            "score": 3,
            "explanation": "The predicted answer mentions \"prominent atomic loci,\" aligning with the reference. It also notes covalent engagements with therapeutic entities, which matches \"covalent actions\" in the reference. However, it lacks emphasis on \"anticancer drugs\" as the therapeutic entities, missing a critical detail."
        },
        {
            "query_idx": 590,
            "query": "What complex interplays of molecular tapestry are illuminated when the nuanced sulfonamide motifs supplant the traditional carboxylic configurations, considering their comparable aqueous-bound intrinsic structures and the saga of crossing cellular fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    217
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sulfonamide motif# mirrors the carboxylic group's hydrogen bonding network, reducing passive diffusion issues and offering diverse biological activities like #anti-bacterial# and anti-cancer.",
            "predicted_answer": "The sulfonamide motif can form a comparable hydrogen bond network to carboxylic groups, aiding in crossing cellular barriers. This supplantation enhances passive diffusion and reduces toxicity, offering diverse biological actions from antibacterial to anticancer.",
            "score": 5,
            "explanation": "The predicted answer aligns with the key facts in the reference answer, noting the sulfonamide motif's comparable hydrogen bonding and diverse biological activities, including antibacterial actions. The mention of reduced toxicity and enhanced diffusion are additional but non-contradictory details. No key facts are missing."
        },
        {
            "query_idx": 591,
            "query": "Within the convoluted realm of anti-cancer pursuits centered around sulphonamide derivatives, what are the inferred strategic roles of the genomic custodian known as p53, the orchestrators of apoptosis identified as caspases, and the transcriptional regulator called NFκ B in discerning the compounds' potential for therapeutic innovation?",
            "retrieved_metrics": {
                "reference_idx": [
                    219
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "p53 targets mutations in cancer, serving as a #therapeutic# target. Caspases induce apoptosis, crucial for cell death. NFκB is involved in transcription regulation, influencing anti-cancer strategies.",
            "predicted_answer": "In the context of sulphonamide derivatives, p53 acts as a genomic guardian, caspases orchestrate apoptosis, and NFκB regulates transcription, all playing crucial roles in discerning the compounds' therapeutic potential by targeting cancer progression and inducing cell death.",
            "score": 3,
            "explanation": "The predicted answer captures the critical roles of p53, caspases, and NFκB mentioned in the reference answer. However, it lacks the specific #therapeutic# focus related to p53 as a target, creating a slight gap in completeness. Overall, key facts and the trend are mostly aligned."
        },
        {
            "query_idx": 592,
            "query": "In what manner do the intricate engagements between pro-apoptotic caspases and sulphonamide compounds facilitate the modulation of cellular demise pathways, contributing to the multidimensional stratagem of oncological interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    220
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate engagement between pro-apoptotic #caspases# and #sulphonamide# compounds potentially modulates apoptosis, facilitating programmed cell death and contributing to oncological interventions.",
            "predicted_answer": "The intricate engagements between pro-apoptotic caspases and sulphonamide compounds facilitate the modulation of cellular demise pathways by targeting critical cancer proteins like p53 and NFκB, thereby contributing to the multidimensional stratagem of oncological interventions.",
            "score": 1,
            "explanation": "The predicted answer presents the interaction between pro-apoptotic caspases and sulphonamide compounds. While it includes modulation of cellular pathways and oncological interventions, it does not specifically mention apoptosis or programmed cell death, missing key elements emphasized by # in the reference."
        },
        {
            "query_idx": 593,
            "query": "What role does the intricate choreography of molecular dynamic simulations play in deciphering the stability tapestry of protein-ligand complexes, ultimately facilitating the exploration of potential anticancer lead compounds within their biochemical symphony?",
            "retrieved_metrics": {
                "reference_idx": [
                    221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular dynamic simulations reveal time-dependent changes in protein-ligand interactions, deciphering the #stability# and facilitating exploration of potential #anticancer# lead compounds.",
            "predicted_answer": "Molecular dynamic simulations play a crucial role in deciphering the stability of protein-ligand complexes by studying time-dependent interactions, ultimately aiding in the exploration of potential anticancer lead compounds.",
            "score": 5,
            "explanation": "The predicted answer captures the key concepts of \"stability\" and \"anticancer lead compounds\" that are emphasized in the reference answer. The trend and role of molecular dynamic simulations are generally aligned with the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 594,
            "query": "Regarding the intrinsic characteristics and interactive potential of compound (8a), what specific quantitative measure reflects its electron-attracting inclination as discerned in the comprehensive evaluation?",
            "retrieved_metrics": {
                "reference_idx": [
                    225
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The specific quantitative measure reflecting compound #8a#'s electron-attracting inclination is its electron #accepting power# of 0.246.",
            "predicted_answer": "The specific quantitative measure reflecting compound (8a)'s electron-attracting inclination is its electron-accepting power, which is 0.246.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts from the Reference Answer: it mentions compound 8a, its electron-accepting power, and the quantitative measure of 0.246. Both answers are aligned in meaning, with no omissions or contradictions. Key details are covered accurately and completely."
        },
        {
            "query_idx": 595,
            "query": "How does the central orchestrator NF-B facilitate the nuanced interplay of cellular mechanisms, thereby sculpting responses pivotal to the paradigms of cancer research?",
            "retrieved_metrics": {
                "reference_idx": [
                    229
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "NF-B regulates #inflammation#, cell survival, and proliferation, crucial for cellular responses, making it central in #cancer research# to assess drug interactions with cancer proteins.",
            "predicted_answer": "NF-B, a transcription factor, regulates inflammation, cell survival, and proliferation, which are crucial in cancer research. Its nuanced interplay with cellular mechanisms shapes critical responses, influencing cancer paradigms.",
            "score": 3,
            "explanation": "The 'Predicted Answer' accurately states that NF-B regulates inflammation, cell survival, and proliferation, and also correctly connects these roles to cancer research. However, it omits the specific connection to assessing drug interactions with cancer proteins. Despite this, the overall trend aligns well."
        },
        {
            "query_idx": 596,
            "query": "What are the understated molecular dialogues and nuanced relational tapestries that delineate the suboptimal embrace of NFκB-cisplatin, Caspase 3-cisplatin, and DNA-cisplatin complexes, as perceived through their subdued affinity landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    233
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #NFκB-cisplatin#, #Caspase 3-cisplatin#, and DNA-cisplatin complexes exhibit suboptimal binding affinity due to fewer hydrogen bonding and hydrophobic interactions, necessitating ligand or target protein optimization.",
            "predicted_answer": "The suboptimal embrace of NFκB-cisplatin, Caspase 3-cisplatin, and DNA-cisplatin complexes is characterized by weak binding affinities, fewer hydrogen bonds, and limited hydrophobic interactions, suggesting the need for ligand or target optimization.",
            "score": 5,
            "explanation": "The predicted answer captures the core ideas of weak binding affinities, fewer hydrogen bonds, and limited hydrophobic interactions for NFκB-cisplatin and Caspase 3-cisplatin complexes, along with the need for optimization. All emphasized key facts in the reference are present without contradictions."
        },
        {
            "query_idx": 597,
            "query": "What is the spatial distance discerned between the molecular entities Gln241 and Lys221, reflecting the quintessential dimensions characteristic of conventional intermolecular hydrogen connections?",
            "retrieved_metrics": {
                "reference_idx": [
                    237
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spatial distance discerned between Gln241 and Lys221 for hydrogen bonds is #3.4 Å# and #2.4 Å#.",
            "predicted_answer": "The spatial distance between Gln241 and Lys221 is approximately 2.4 Å, typical for conventional intermolecular hydrogen bonds.",
            "score": 3,
            "explanation": "The predicted answer mentions the spatial distance as \"2.4 Å,\" which is one of the key distances in the reference answer. However, it omits \"3.4 Å,\" the other emphasized key distance. While not contradictory, this omission affects the completeness of the answer."
        },
        {
            "query_idx": 598,
            "query": "In the intricate dance of molecular interactions, what elusive molecular characteristics contribute to the reduced interactive synergy of compound (8b) with the p53 protein framework, in comparison to compound (8a)?",
            "retrieved_metrics": {
                "reference_idx": [
                    240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduced interactive synergy# of compound (8b) with p53 is due to the absence of key hydrogen bonding residues and shorter #hydrogen bond length#.",
            "predicted_answer": "The reduced interactive synergy of compound (8b) with the p53 protein is attributed to the absence of key hydrogen bonding residues and shorter hydrogen bond length compared to compound (8a).",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts from the Reference Answer. It mentions both the \"absence of key hydrogen bonding residues\" and \"shorter hydrogen bond length,\" which are marked with # in the Reference Answer, covering all emphasized details fully."
        },
        {
            "query_idx": 599,
            "query": "In what manner might the nuanced dance of molecular forces initiated by Compound 8b's affinity for particular amino acid residues and the resulting shifts in binding dynamics influence the core functional paradigm of the p53 structural entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    238
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound 8b may impair p53's core function through interactions involving #hydrogen bonds# with Arg203, Tyr92, Glu89 and #hydrophobic interactions# with various residues, potentially affecting p53's structural integrity.",
            "predicted_answer": "Compound 8b's affinity for specific amino acid residues, forming hydrogen bonds and hydrophobic interactions, could disrupt p53's structural integrity and impair its functional activity.",
            "score": 3,
            "explanation": "The predicted answer mentions both \"hydrogen bonds\" and \"hydrophobic interactions,\" which are highlighted in the reference. However, it lacks specific amino acid residues involved in these interactions, such as Arg203, Tyr92, and Glu89. Thus, while aligned with the trend, it misses one key detail affecting completeness."
        },
        {
            "query_idx": 600,
            "query": "In the molecular ballet orchestrated amidst the Caspase-3 -8b complex, what influence do the intricate molecular tendrils and hydrophobic veils hold over the observed structural coherence as outlined by the MD simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    251
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hydrophobic #interactions# and #hydrogen bonds# are crucial for maintaining structural coherence in the Caspase-3 -8b complex during MD simulations.",
            "predicted_answer": "The intricate molecular tendrils and hydrophobic veils, particularly hydrogen bonds and hydrophobic interactions, play a crucial role in maintaining the structural coherence and stability of the Caspase-3 -8b complex as observed in MD simulations.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions both \"hydrophobic interactions\" and \"hydrogen bonds,\" which are the key details highlighted in the reference answer. It aligns well with the overall trend and context, maintaining the focus on structural coherence in the Caspase-3 -8b complex during MD simulations."
        },
        {
            "query_idx": 601,
            "query": "Within the interpretive ballet of molecular architecture, what insights emerge concerning the adaptive vicissitudes of the p53-(8a) complex's configurational landscape from a modulation in RMSD spanning 1.8 Å to 2.8 Å throughout the simulation period?",
            "retrieved_metrics": {
                "reference_idx": [
                    252
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RMSD# increase from #1.8 Å# to 2.8 Å reflects conformational changes in the p53-(8a) complex, maintaining overall stability during the simulation.",
            "predicted_answer": "The p53-(8a) complex exhibited adaptive conformational changes, transitioning from 1.8 Å to 2.8 Å RMSD, indicating dynamic stability and maintaining overall structural integrity during the simulation.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the key facts that the RMSD increased from 1.8 Å and resulted in dynamic changes in the complex, consistent with maintaining stability during the simulation. However, the term \"2.8 Å\" is implied rather than explicitly stated, resulting in minor incompleteness."
        },
        {
            "query_idx": 602,
            "query": "What convoluted sequence of methodological orchestrations ceases the biochemical interplay, and by what systematic avenues is the emergent optical discernment translated within the assay's interpretative paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    257
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The assay ceases biochemical interplay with #sodium dodecyl sulfate#. Optical discernment is translated through #absorbance measurement# at 575 nm using a microplate reader.",
            "predicted_answer": "The biochemical interplay is ceased by adding 10% sodium dodecyl sulfate, and the emergent optical discernment is translated by measuring optical density at 575 nm using a microplate reader.",
            "score": 5,
            "explanation": "The predicted answer mentions the ceasing of biochemical interplay with \"10% sodium dodecyl sulfate\" and optical discernment via \"measuring optical density\", which matches the key facts of \"sodium dodecyl sulfate\" and \"absorbance measurement\" at 575 nm. The only minor difference is the specification of \"10%\"."
        },
        {
            "query_idx": 603,
            "query": "How was the degree of transparency and clarity in the genetic essence harvested from Herring sperm evaluated through the analysis of spectral light interactions, specifically within the framework of molecular binding phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    258
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #transparency# and #clarity# of Herring sperm DNA were evaluated by examining the 260/280 absorbance ratio, confirming sufficient purity for spectrophotometric analysis.",
            "predicted_answer": "The degree of transparency and clarity in the genetic essence was evaluated by preparing a stock solution of Lyophilized Herring sperm DNA, calculating its concentration using the 260/280 absorbance ratio, and ensuring a ratio between 1.6 and 1.9 for sufficient purity.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts mentioned in the reference answer: both discuss the evaluation of transparency and clarity of Herring sperm DNA using the 260/280 absorbance ratio for confirming purity. The minor differences in phrasing do not affect the meaning or completeness significantly."
        },
        {
            "query_idx": 604,
            "query": "What transformations within the photonic profiles hint at molecular dialogues between investigational entities and the genomic tapestry, and through what deciphering methods are the patterns of affinity and their vigor unveiled?",
            "retrieved_metrics": {
                "reference_idx": [
                    259
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformations in photonic profiles, indicated by changes in #spectra#, suggest molecular dialogues, with #binding constants# and interaction modes deciphered through UV absorption spectra analysis.",
            "predicted_answer": "The transformations in photonic profiles, such as changes in UV absorption spectra, indicate molecular dialogues between investigational entities and DNA. These patterns of affinity and their vigor are unveiled through methods like measuring binding constants and modes of interaction from the spectra.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of transformations in photonic profiles and analysis through UV absorption spectra, as well as deciphering through binding constants and interaction modes. These match the emphasized details in the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 605,
            "query": "What algorithmic frameworks and elemental coordinate systems were orchestrated to refine molecular architectures and analyze the equilibrium proclivities of N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide within the realm of electronic properties exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    260
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DFT# calculations using the #B3LYP# functional and 6-31G* basis set optimized geometries and analyzed stability of N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide.",
            "predicted_answer": "The DFT framework with B3LYP functional and 6-31G* basis set was used to refine molecular architectures and analyze equilibrium proclivities of N-ethyl toluene-4-sulphonamide and 2,5-Dichlorothiophene-3-sulfonamide for electronic properties exploration.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts: the use of the DFT framework, B3LYP functional, and 6-31G* basis set. It aligns well with the reference answer. However, it misses mentioning that the DFT calculations optimized geometries and analyzed stability, which are part of the reference's emphasized details."
        },
        {
            "query_idx": 606,
            "query": "How do the dynamics of protonation alterations act as pivotal determinants in the web of electrostatic orchestration, affecting the molecular handshake's affinity and specificity calibration during the multidimensional analyses of docking simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    263
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Protonation alterations modulate #electrostatic interactions#, significantly influencing #binding affinity# and specificity in docking simulations by affecting the protonation states of amino acids in the active site.",
            "predicted_answer": "Protonation alterations influence electrostatic interactions, affecting binding affinity and specificity by modulating amino acid states in the active site during molecular docking simulations.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of protonation alterations affecting electrostatic interactions and binding affinity, in line with the reference. However, it does not explicitly mention the significant influence on affinity as highlighted in the reference's key facts. This omission affects completeness."
        },
        {
            "query_idx": 607,
            "query": "What comprehensive array of molecular fine-tuning techniques and electrostatic adaptations were executed on the PDB-sourced proteins to ensure seamless incorporation into the structured confines of the docking matrix as detailed in the scientific investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    264
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Proteins underwent #fine-tuning# by removing water, adding polar hydrogens, and incorporating #Gasteiger charges# to integrate smoothly into the docking matrix.",
            "predicted_answer": "The study executed molecular fine-tuning by removing water and hetero-atoms, adding polar hydrogen atoms, and incorporating Gasteiger charges. Electrostatic adaptations included setting a grid box with one angstrom spacing for docking.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as removing water, adding polar hydrogen atoms, and incorporating Gasteiger charges, which align with the reference answer's fine-tuning description. The mention of setting a grid box is additional but does not contradict. No significant omissions are present."
        },
        {
            "query_idx": 608,
            "query": "What conceptual benchmarks facilitate the determination of success in the molecular coupling strategy relative to the spatial validation of the synthesized co-crystal construct?",
            "retrieved_metrics": {
                "reference_idx": [
                    265
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The success in the molecular coupling strategy is determined by an #RMSD# of fewer than #two angstroms# between the original and rebuilt positions during docking validation.",
            "predicted_answer": "The conceptual benchmarks for determining success in the molecular coupling strategy include verifying the docking procedure with an RMSD of fewer than two angstroms between the original and rebuilt positions of the co-crystal ligand.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts emphasized in the Reference Answer, including the RMSD of fewer than two angstroms for success in the molecular coupling strategy. The core meaning and benchmarks are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 609,
            "query": "In the landscape of calculated boundaries and repeating domains, what was the inaugural methodology applied to harmonize systemic energies and circumvent elemental convergence prior to the main sequence of dynamic equilibrium establishment?",
            "retrieved_metrics": {
                "reference_idx": [
                    266
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inaugural methodology was #2000 steps# for #minimizing energy# to harmonize systemic energies and circumvent elemental convergence.",
            "predicted_answer": "The inaugural methodology applied was a 2000-step energy minimization under periodic boundary conditions to prevent atomic collisions, followed by NPT equilibration at 300 K and 1.01 bar.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"#2000 steps#\" and \"#minimizing energy#\", matching the emphasis in the reference answer. While it includes additional context (periodic boundary conditions and NPT equilibration), it fully covers the key facts and aligns with the reference without omissions or contradictions."
        },
        {
            "query_idx": 610,
            "query": "Amidst the intricate process of scientific revelation, what role do vector-based algorithmic frameworks play in unraveling the complexities of pharmacokinetic conduits and systemic gatekeeping mechanisms for therapeutics in oncological pharmacology?",
            "retrieved_metrics": {
                "reference_idx": [
                    272
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vector-based algorithmic frameworks help predict #pharmacokinetic properties# and #blood-brain barrier permeability#, aiding the understanding of drug behaviors in oncological pharmacology.",
            "predicted_answer": "Vector-based algorithmic frameworks, such as vector machine models, play a crucial role in predicting pharmacokinetic properties, blood-brain barrier permeability, and intestinal absorption for anticancer drugs, aiding in the optimization of therapeutic efficacy and systemic distribution.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts regarding \"pharmacokinetic properties\" and \"blood-brain barrier permeability,\" aligning with the reference answer. It also introduces \"intestinal absorption,\" which does not contradict the reference. Therefore, it fully covers the essential points highlighted."
        },
        {
            "query_idx": 611,
            "query": "What serendipitous intersections of unforeseen observations and scientific inquiry delineated the path leading to the transformative recognition of cisplatin and valproic acid as pivotal compounds in their respective therapeutic realms during the 1960s?",
            "retrieved_metrics": {
                "reference_idx": [
                    273
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #unforeseen observations# of valproic acid's ability to reduce seizures and cisplatin's inhibition of E. coli division catalyzed their recognition as pivotal therapeutic compounds.",
            "predicted_answer": "The discovery of valproic acid as an anti-epileptic drug in 1962 was serendipitous, stemming from its use as a solvent in cough syrups. Similarly, cisplatin's anticancer potential was uncovered in the 1960s when its ability to inhibit E. coli division was observed during a magnetic field experiment.",
            "score": 5,
            "explanation": "The predicted answer includes the unforeseen observation of valproic acid's reduction of seizures as an anti-epileptic drug and cisplatin's inhibition of E. coli division, aligning with the reference. Both key facts emphasized by # are present, and there is no contradictory information."
        },
        {
            "query_idx": 612,
            "query": "In the landscape of oncological exploration, what strands of molecular tapestry underscore the precedence of Compound 8b as a potent adversary, illustrating a distinct chemistry in binding loci, while deftly contrasting its stability and interactive dynamic with both the time-honored cisplatin and the venerable Doxorubicin in therapeutic pursuits?",
            "retrieved_metrics": {
                "reference_idx": [
                    268
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #8b# has a strong affinity for #Caspase-3#, exhibiting better docking scores than cisplatin and comparable docking scores to Doxorubicin, indicating potential as an anticancer compound.",
            "predicted_answer": "Compound 8b's precedence in oncological exploration is underscored by its strong affinity for Caspase-3, superior docking scores compared to cisplatin, and comparable scores to Doxorubicin, indicating potent binding and stability.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference answer. It includes the strong affinity for Caspase-3, better docking scores than cisplatin, and comparable scores to Doxorubicin, reflecting Compound 8b's potential as an anticancer compound. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 613,
            "query": "What are the implications of applying virtual pharmacological simulacra to explore the nuanced interstice between novel synthesis and derivative replication in the evolution of echo pharmaceuticals, especially when evaluated against conventional empirical methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    277
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Applying #virtual pharmacological simulacra# can improve drug development by using #in silico trials#, enhancing treatment design and addressing the limitations of me-too drugs versus empirical methodologies.",
            "predicted_answer": "Applying virtual pharmacological simulacra can enhance the exploration of novel synthesis and derivative replication in echo pharmaceuticals by leveraging in silico trials, improving treatment design, and offering innovative solutions compared to conventional empirical methodologies.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key terms, \"virtual pharmacological simulacra\" and \"in silico trials,\" mentioned in the Reference Answer. It also aligns in terms of improving exploration and treatment design, matching the trend outlined. No significant omissions identified."
        },
        {
            "query_idx": 614,
            "query": "What are the intrinsic conceptual bottlenecks encountered in the evolving blueprints of oncologic defense strategies, as they manifest in the intricate dance of stakeholders orchestrating expeditions through the therapeutic frontiers of immunological checkpoint inhibition?",
            "retrieved_metrics": {
                "reference_idx": [
                    278
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic conceptual bottlenecks are trial design #redundancy# and complex stakeholder #interactions# in the development of immunological checkpoint inhibition strategies.",
            "predicted_answer": "The intrinsic conceptual bottlenecks in oncologic defense strategies, particularly in immunological checkpoint inhibition, include trial design redundancy, complex stakeholder interactions, and the \"Wild West\" phenomenon in drug development, leading to inefficient resource allocation and potential oversaturation of similar treatments.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts emphasized in the Reference Answer: trial design redundancy and complex stakeholder interactions. Additionally, it mentions extra details like the \"Wild West\" phenomenon and inefficient resource allocation, which do not contradict the Reference Answer. Thus, it fully aligns with the Reference Answer."
        },
        {
            "query_idx": 615,
            "query": "What intrinsic difficulties are encountered by traditional methodological frameworks in therapeutic exploration when attempting to unearth synergistic combinations of pharmaceutical regimens within the confines of limited participant availability in the field of immunotherapeutic trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    279
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Traditional frameworks face difficulties like inadequate rules, limited #participants#, and risk of missing active combinations when exploring #synergistic combinations# in immunotherapeutic trials.",
            "predicted_answer": "Traditional methodological frameworks face intrinsic difficulties in therapeutic exploration due to limited participant availability, risking the omission of synergistic pharmaceutical combinations in immunotherapeutic trials.",
            "score": 3,
            "explanation": "The predicted answer includes key points: limited participant availability and the challenge of missing synergistic pharmaceutical combinations in immunotherapeutic trials. However, it misses the detail about inadequate rules from the reference answer, affecting completeness."
        },
        {
            "query_idx": 616,
            "query": "What are the potential pathways through which digital avatars, born from the confluence of data and algorithmic intelligence, might abbreviate the temporal and financial horizons of oncological treatment explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    282
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Digital avatars# aggregate and structure data to create 'real simulated patients,' potentially reducing the #duration and cost# of therapeutic trials in oncology.",
            "predicted_answer": "Digital avatars can abbreviate oncological treatment explorations by predicting patient responses, identifying trial candidates, and reducing trial duration and costs through AI-driven data analysis and simulation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by mentioning digital avatars, reducing duration and cost of trials, and AI data analysis, matching the key facts about abbreviation of trials through data. However, it doesn't explicitly mention the creation of \"real simulated patients.\""
        },
        {
            "query_idx": 617,
            "query": "How does the grand design for integrating cognitive automata aim to intricately stitch a novel paradigm into the fabric of pharmaceutical oversight and foster dialogues with critical orchestras resembling ultimate adjudicators?",
            "retrieved_metrics": {
                "reference_idx": [
                    283
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The grand design integrates cognitive automata through #digital innovation#, facilitating engagement with #regulators# like the FDA, promoting a new paradigm in pharmaceutical oversight and stakeholder dialogues.",
            "predicted_answer": "The grand design aims to integrate cognitive automata into pharmaceutical oversight by leveraging AI for decision-making, enhancing drug regulation, and fostering dialogue with key stakeholders like the FDA, ultimately improving patient representation and drug response evaluation.",
            "score": 3,
            "explanation": "The predicted answer captures the overall trend of employing cognitive automata to enhance pharmaceutical oversight and mentions engagement with key stakeholders, including the FDA. However, it omits the specific emphasis on \"digital innovation,\" which is a key fact in the reference."
        },
        {
            "query_idx": 618,
            "query": "What intrinsic barriers and systemic detriments have coalesced at the crossroads of scientific inquiry and industry objectives, thwarting the progressive advancement of treatment modalities for CNS WHO grade 4 glioblastoma as per recent delineations?",
            "retrieved_metrics": {
                "reference_idx": [
                    285
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic barriers include the #heterogeneity# of gliomas, while systemic detriments involve focusing on expanding existing therapies over developing new agents for #glioblastoma# treatment.",
            "predicted_answer": "Intrinsic barriers include tumor heterogeneity and infiltration, while systemic detriments involve inadequate early-stage development and focus on expanding approved therapies rather than innovating for glioblastoma (CNS WHO grade 4).",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"tumor heterogeneity\" and the focus on \"expanding existing therapies over innovation,\" which aligns with the reference answer's emphasis on \"heterogeneity\" and \"glioblastoma.\" Both answers maintain the same overall trend without any contradictory information."
        },
        {
            "query_idx": 619,
            "query": "Through what multidimensional synthesis inherent in the jinkō trial simulation's orchestrated rehearsal did it catalyze an expedited unveiling of the prospective timelines for AstraZeneca's phase III investigation of FLAURA2?",
            "retrieved_metrics": {
                "reference_idx": [
                    281
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #jinkō trial simulation# predicted AstraZeneca's FLAURA2 timelines in one month, expediting the process compared to the actual 3-year clinical trial.",
            "predicted_answer": "The jinkō trial simulation expedited the unveiling of prospective timelines for AstraZeneca's FLAURA2 phase III investigation by synthesizing multidimensional data in a one-month simulation, contrasting with the three-year clinical trial duration.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts emphasized in the reference. It correctly mentions the \"jinkō trial simulation\" and compares the expedited one-month prediction to the actual three-year clinical trial, aligning with the outlined trend and critical information."
        },
        {
            "query_idx": 620,
            "query": "In the intricate dance of pharmacological exploration, how do the conceptual trajectories and ultimate aspirations of window-of-opportunity trials manifestly contrast with those of phase 0 endeavors, particularly regarding their stationing within the developmental symphony and their envisioned outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    291
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Window-of-opportunity trials occur #post-phase I# and assess biologic effects, while phase 0 trials, positioned between preclinical and phase I, focus on #microdosing# and pharmacokinetics.",
            "predicted_answer": "Window-of-opportunity trials focus on pharmacodynamic evaluation post-phase I, aiming to assess biologic effects within a specific timeframe. Phase 0 trials, positioned between preclinical and phase I, use microdosing to establish human pharmacokinetics, contrasting in timing and objectives.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies window-of-opportunity trials as post-phase I and focused on biological effects and phase 0 trials on microdosing and pharmacokinetics. It correctly contrasts timing and objectives, covering all emphasized points from the reference without omissions or contradictions."
        },
        {
            "query_idx": 621,
            "query": "What underlying dimensions could manifest as navigational impediments influencing the temporal crossroads in the relay of therapeutic potentials while orchestrating the prelude exploration of an investigational entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    289
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Potential delays# in providing therapies and ensuring #biologically meaningful# results are impediments influencing the temporal crossroads in the relay of therapeutic potentials.",
            "predicted_answer": "The underlying dimensions influencing navigational impediments at temporal crossroads include potential delays in therapy provision, uncertainty in trial results, and the need for relevant controls and validated assays.",
            "score": 3,
            "explanation": "The predicted answer captures \"potential delays in therapy provision,\" aligning with the reference's \"Potential delays.\" However, it misses \"biologically meaningful results,\" an emphasized key fact in the reference. Overall, the trend aligns but lacks one crucial detail impacting completeness."
        },
        {
            "query_idx": 622,
            "query": "Within the intricate theater of perioperative neurooncological inquiries, what conceptual assemblages and comparative stratagems are paramount to architect a formidable investigational architecture, thereby distilling critical and illuminating insights?",
            "retrieved_metrics": {
                "reference_idx": [
                    294
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paramount conceptual assemblages and comparative stratagems include the incorporation of #controls#, such as earlier resection comparisons, external samples, or a placebo arm, in perioperative neurooncology.",
            "predicted_answer": "The paramount conceptual assemblages and comparative stratagems in perioperative neurooncological inquiries include incorporating controls such as patient-matched resections, archival samples, placebo arms, and combinations thereof.",
            "score": 3,
            "explanation": "The Predicted Answer aligns with the Reference Answer by mentioning the use of controls in perioperative neurooncological inquiries. However, it misses key specifics like \"earlier resection comparisons\" and \"external samples,\" deviating slightly from the completeness of the Reference Answer."
        },
        {
            "query_idx": 623,
            "query": "What are the dual strategic benefits imbued within the application of stochastic methodologies during the initial preparatory phase of the clinical investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    296
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #random assignment# in the preparatory phase ensures consistent treatment protocols and enhances #confidence# in results, allowing effective tissue-based comparisons and clinical efficacy assessments.",
            "predicted_answer": "The dual strategic benefits of applying stochastic methodologies in the initial phase of clinical investigation include ensuring patient homogeneity and treatment similarity, enhancing confidence in tissue-based comparisons, and enabling comparison of clinical efficacy endpoints.",
            "score": 3,
            "explanation": "The predicted answer includes elements like ensuring consistency in treatment and tissue-based comparisons, which aligns with the reference's theme of enhanced confidence through \"random assignment.\" However, it omits directly mentioning \"random assignment,\" a key fact, despite containing no contradictions."
        },
        {
            "query_idx": 624,
            "query": "Within the structured confines of an experimentally altered setting, what significant revelations were observed from deploying PD-1 antibody therapy pertaining to the evaluations that succeed surgery, which potentially indicated a remarkable enlargement in patient survival timelines?",
            "retrieved_metrics": {
                "reference_idx": [
                    297
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The postoperative evaluations revealed #doubling of survival# in patients receiving #PD-1 monoclonal antibody# therapy in the neoadjuvant setting.",
            "predicted_answer": "Deploying PD-1 antibody therapy in an experimentally altered setting revealed a significant doubling of survival in patients receiving the therapy post-surgery, indicating a remarkable enlargement in patient survival timelines.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: the doubling of survival and the use of PD-1 antibody therapy, aligning with the reference answer. However, it misses specifying that the therapy is a \"monoclonal antibody\" and used in a \"neoadjuvant setting,\" affecting completeness."
        },
        {
            "query_idx": 625,
            "query": "In the grand orchestrations of perioperative inquiry, what were the nuanced intentions nestled in the quest to unravel the enigma of the central nervous system's permeability and the subsequent molecular metamorphosis incited by the antitumor agents, specifically within IDH-mutated glioma scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    298
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The study aimed to assess #CNS permeability# of agents, reduce #2-hydroxyglutarate# levels, restore DNA function, reverse gene expression changes, and reduce tumor proliferation in IDH-mutated gliomas.",
            "predicted_answer": "The study aimed to assess the CNS penetration of antitumor agents, reduce 2-hydroxyglutarate levels, restore DNA 5-hydroxymethylcytosine, reverse mIDH-associated gene expression, and inhibit tumor cell proliferation in IDH-mutated gliomas.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all key facts highlighted in the reference answer: CNS permeability, 2-hydroxyglutarate level reduction, DNA function restoration, reversal of gene expression changes, and tumor proliferation reduction for IDH-mutated gliomas. The details are complete and well-aligned with no significant omissions."
        },
        {
            "query_idx": 626,
            "query": "What catalytic element instigated an intensified wave of scholarly drive to navigate the uncharted paths of mIDH inhibitor exploration, even as it remained unintegrated with standard paradigms applied to glioma investigational traditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    301
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The catalytic element was the #determination of tumor growth rates#, which sparked increased enthusiasm for mIDH inhibitor exploration but remains unintegrated with #standard glioma evaluation#.",
            "predicted_answer": "The catalytic element was the observation of sustained tumor shrinkage or stabilization with mIDH inhibitors, despite not meeting response criteria, which intensified the scholarly drive to explore these inhibitors further.",
            "score": 1,
            "explanation": "The predicted answer mentions \"sustained tumor shrinkage or stabilization\" as the catalytic element, which differs from the reference answer's \"determination of tumor growth rates.\" Additionally, the predicted answer lacks the point about \"unintegrated with standard glioma evaluation,\" leading to the absence of two key facts."
        },
        {
            "query_idx": 627,
            "query": "How does the existing evaluative paradigm within neuro-oncological assessments metaphorically fail to unearth pharmacological beacons for glioblastoma, as illuminated by the stagnation in survival statistics and the surplus of non-affirmative drug trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    293
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #existing evaluative paradigm# fails to identify effective treatments for #glioblastoma#, evidenced by stagnant survival rates and numerous unsuccessful drug trials.",
            "predicted_answer": "The existing evaluative paradigm in neuro-oncology fails to identify effective treatments for glioblastoma, as evidenced by stagnant survival rates and numerous negative drug trials, indicating a need for improved assessment criteria.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer, including the evaluative paradigm's failure, the focus on glioblastoma, stagnation in survival statistics, and numerous negative drug trials. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 628,
            "query": "What intricate arrangement methodology is suggested to unveil the impact of each therapeutic entity and their collective orchestration on the tumor microenvironment, deliberately excluding any unproductive autonomous interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    299
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The suggested methodology is a #factorial design# to unveil the impact of each therapeutic entity and their #combination# on the tumor microenvironment, excluding ineffective single-agent treatments.",
            "predicted_answer": "A factorial design is suggested to unveil the impact of each therapeutic entity and their collective orchestration on the tumor microenvironment, excluding unproductive autonomous interventions. This design helps attribute effects to each therapy and combination, avoiding late-stage evaluations of ineffective single-agent treatments.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the #factorial design# and the #combination# of therapies, as emphasized in the reference answer. It aligns with the reference's trend and meaning without contradictions, covering all key details required."
        },
        {
            "query_idx": 629,
            "query": "How does analyzing initial proliferation pathways of tumorigenic masses potentially refine the intellectual approach to therapeutic orchestration, particularly in calibrating dosage, timing, and patient subgroup partitioning within solid neoplasm studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    303
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Analyzing #initial proliferation pathways# can refine therapeutic approaches by enhancing #sensitivity# in identifying treatment impacts, optimizing dose, timing, and patient subgroup selection in solid tumor studies.",
            "predicted_answer": "Analyzing initial proliferation pathways can refine therapeutic orchestration by enhancing sensitivity to treatment impact, enabling better decisions on dosage, timing, and patient subgroup partitioning in solid neoplasm studies.",
            "score": 5,
            "explanation": "The predicted answer contains the emphasized key facts: \"initial proliferation pathways,\" \"sensitivity,\" and concepts related to optimizing treatment through \"dosage,\" \"timing,\" and \"patient subgroup partitioning\" in the context of solid tumor/neoplasm studies. Despite slight wording differences, it aligns well with the reference."
        },
        {
            "query_idx": 630,
            "query": "What emergent benefits could stem from harnessing theoretically advanced surrogate comparators in unilateral investigative frameworks, particularly in propelling the terminal phase progression of therapeutic regimes for exceedingly rare and therapeutically complex cancers, exemplified by glioblastoma multiforme?",
            "retrieved_metrics": {
                "reference_idx": [
                    306
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harnessing #synthetic controls# in single-arm trials can provide #preliminary evidence# of activity, offering cost-effectiveness, rapid enrollment, and patient preference, aiding late-stage development for rare cancers.",
            "predicted_answer": "Emergent benefits include faster enrollment, cost efficiency, and preliminary evidence of activity in single-arm trials using synthetic controls, crucial for advancing terminal-phase therapies in rare cancers like glioblastoma multiforme.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of using synthetic controls and preliminary evidence of activity, aligned with the reference. It mentions faster enrollment and cost efficiency, similar to the reference, but omits patient preference. Overall, it aligns well but misses this one key detail."
        },
        {
            "query_idx": 631,
            "query": "What intricate ripple effects manifest in GBM pharmacological advancements when experimental constructs lack statistical vigor or misapply numerical strategies, potentially skewing the perception of treatment impact?",
            "retrieved_metrics": {
                "reference_idx": [
                    305
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #misapplication of numerical strategies# in GBM studies can lead to #overestimation# or underestimation of treatment effects, affecting the rationale for RCTs or hindering further testing.",
            "predicted_answer": "Experimental constructs lacking statistical rigor or misapplying numerical strategies in GBM pharmacological advancements can lead to overestimation or underestimation of treatment effects, potentially skewing the perception of treatment impact and affecting further testing and definitive RCTs.",
            "score": 5,
            "explanation": "The 'Predicted Answer' successfully covers the key facts: the misapplication of numerical strategies, overestimation or underestimation of treatment effects, and impact on further testing and RCTs. It aligns with the 'Reference Answer' with no contradictions or significant omissions."
        },
        {
            "query_idx": 632,
            "query": "Within the intricate odyssey of advancing therapies for cerebral malignancies, what catalytic advantages could potentially be unveiled by the synergistic fusion of intrinsic oversight mechanisms with external evaluative constructs during the clinical trials' multi-layered pursuit?",
            "retrieved_metrics": {
                "reference_idx": [
                    308
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synergistic fusion enables prospective bias evaluation and enhances #efficiency# in trials, increasing chances of timely discontinuing ineffective treatments while avoiding premature halting of effective therapies.",
            "predicted_answer": "The synergistic fusion of intrinsic oversight mechanisms with external evaluative constructs (ECs) in clinical trials could enhance interim analysis, increase the likelihood of early stopping for ineffective treatments, and reduce premature discontinuation of effective therapies, while also addressing potential biases introduced by ECs.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by mentioning early stopping for ineffective treatments and avoiding premature discontinuation of effective therapies. However, it misses the emphasis on enhancing \"efficiency\" in trials, which is a key fact highlighted in the reference."
        },
        {
            "query_idx": 633,
            "query": "What methodologies of temporal layer modifications and legacy data incorporation act to dynamically fortify the evaluative distinctions between the established reference arm and the investigational contingents within the study's operational schema?",
            "retrieved_metrics": {
                "reference_idx": [
                    311
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The methodologies include #temporal adjustments# to the control arm's effect, leveraging #legacy data# from prior studies to enhance power and evaluative distinctions.",
            "predicted_answer": "Temporal layer modifications involve adjusting the control arm based on time effects and incorporating legacy data by including prior study arms with appropriate adjustments. This dynamic approach fortifies evaluative distinctions between the established reference arm and investigational contingents.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of “temporal adjustments” and “legacy data” as emphasized in the reference answer. It appropriately describes the incorporation of time effects and legacy data to enhance evaluative distinctions, consistent with the reference context."
        },
        {
            "query_idx": 634,
            "query": "What are the dual phases inherent in the GBM AGILE architectural framework, and through what intricate mechanisms do they underpin its registration efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    310
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #two stages# in GBM AGILE are screening and confirmation, ensuring detailed evaluation of #three subtypes# of GBM for registration efficacy.",
            "predicted_answer": "The dual phases in GBM AGILE are the screening phase and the registration phase. These phases underpin its registration efficacy through ongoing preplanned interim evaluations and Bayesian adaptive approaches.",
            "score": 1,
            "explanation": "The Predicted Answer identifies the phases as \"screening\" and \"registration,\" while the Reference Answer describes them as \"screening\" and \"confirmation.\" Furthermore, the Reference highlights \"three subtypes\" of GBM, which the Predicted Answer omits. Thus, it misses more than one key fact."
        },
        {
            "query_idx": 635,
            "query": "In what manner do sophisticated adaptive platforms like GBM AGILE recalibrate the methodological paradigm of pharmaceutical explorations in glioblastoma trials, enabling concurrent multifaceted inquiries and dynamic longitudinal evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    312
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sophisticated adaptive platforms like #GBM AGILE# recalibrate pharmaceutical explorations by enabling concurrent multifaceted inquiries and dynamic longitudinal evaluations, exploring multiple #subtypes# and study arms efficiently within trials.",
            "predicted_answer": "Sophisticated adaptive platforms like GBM AGILE recalibrate the methodological paradigm by enabling concurrent multifaceted inquiries and dynamic longitudinal evaluations, allowing multiple questions to be asked simultaneously and over time, enhancing efficiency and flexibility in glioblastoma trials.",
            "score": 3,
            "explanation": "The predicted answer covers the concept of concurrent multifaceted inquiries and dynamic longitudinal evaluations, consistent with the reference. However, it lacks mention of \"subtypes\" and \"study arms,\" which are key elements emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 636,
            "query": "How do the multifaceted biochemical symphonies inherent in Rubus chingii Hu shape its profound impact on various human health functionalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    313
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rubus chingii Hu's #bioactive components# significantly impact human health by providing #anti-oxidant#, anti-inflammatory, and antitumor benefits.",
            "predicted_answer": "The multifaceted biochemical symphonies in Rubus chingii Hu, including terpenoids, flavonoids, alkaloids, and polysaccharides, contribute to its profound impact on human health by enhancing antioxidant, anti-inflammatory, and antitumor capacities.",
            "score": 5,
            "explanation": "The predicted answer includes the key biochemical components (terpenoids, flavonoids, alkaloids, polysaccharides) that contribute to the impact on human health. It mentions antioxidant, anti-inflammatory, and antitumor benefits, aligning with the reference's focus on bioactive components and their effects. Key facts are present and trends are aligned."
        },
        {
            "query_idx": 637,
            "query": "Within the symphony of enzymatic expressions found in the genetic landscape of R. chingii, how do the orchestrations of the CXE and UGT gene-directed pathways contribute to the emergence and diversification of hydrolysable tannin structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    315
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CXE# and #UGT# gene-directed pathways contribute to hydrolysable tannin diversification through tannin hydrolase and gallic acid glycosyltransferase functions, respectively.",
            "predicted_answer": "The CXE and UGT gene-directed pathways in R. chingii contribute to the diversification of hydrolysable tannin structures by encoding enzymes that catalyze the hydrolysis and glycosylation of tannins, respectively.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the CXE and UGT pathways contributing to tannin diversification through enzymatic functions, aligning with the reference. However, it lacks specific reference to \"tannin hydrolase\" and \"gallic acid glycosyltransferase,\" which are key, missing details."
        },
        {
            "query_idx": 638,
            "query": "What symphony of biochemical engagement do oleanolic acid and ursolic acid conduct within the intricate theatre of prostate malignancy cellular assemblages as contemplated by Li et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    318
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oleanolic acid (#OA#) inhibits prostate cancer cell viability and proliferation, promotes apoptosis, and causes #G0/G1 phase# cell cycle arrest.",
            "predicted_answer": "Oleanolic acid and ursolic acid inhibit prostate cancer cell viability and proliferation, promote apoptosis, and induce G0/G1 phase arrest in PC-3, DU145, and LNCaP cells, as demonstrated by Li et al.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the inhibition of prostate cancer cell viability and proliferation, promotion of apoptosis, and induction of G0/G1 phase arrest. It extends the reference by adding specific cell lines (PC-3, DU145, and LNCaP), aligning with all critical aspects of the reference."
        },
        {
            "query_idx": 639,
            "query": "Regarding the intricate repertoires of neurobehavioral outcomes, how do amplified proportions of raspberry extractions orchestrate amelioration within cognitive compromise frameworks precipitated by multifarious chemical inducers in biological test subjects?",
            "retrieved_metrics": {
                "reference_idx": [
                    323
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Amplified proportions of #raspberry extractions# improve #cognitive compromise# in test subjects by reducing brain free radical injury and enhancing cholinergic function, particularly against scopolamine and sodium nitrite.",
            "predicted_answer": "Amplified proportions of raspberry extractions improve cognitive functions by enhancing brain cholinergic activity, reducing free radical damage, and ameliorating memory impairments caused by chemical inducers in biological test subjects.",
            "score": 3,
            "explanation": "The predicted answer includes the key elements of raspberry extractions, cognitive improvement, enhanced cholinergic activity, and free radical damage reduction. However, it does not specifically mention \"scopolamine and sodium nitrite,\" which are key in the reference. Overall trends align, but a crucial detail is missing."
        },
        {
            "query_idx": 640,
            "query": "In what manner do the intricate communication networks, governed by transcriptional maestros, interface with cellular orchestrations to manifest the antineoplastic harmonies elicited by alkaloid interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    322
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Alkaloids interface with cellular orchestrations by modifying #transcription factors# such as NFκ B, MYC, FOS, CREB, and mTOR, influencing signal pathways to elicit #antineoplastic# effects.",
            "predicted_answer": "Alkaloid interventions interface with cellular orchestrations by modulating transcription factors like NFκB, MYC, and mTOR, thereby downregulating VEGF and signaling molecules, and inhibiting tumor growth and metastasis.",
            "score": 3,
            "explanation": "The 'Predicted Answer' covers some key facts like transcription factors NFκB, MYC, and mTOR. However, it omits FOS and CREB mentioned in the 'Reference Answer'. It captures the overall trend of antineoplastic effects but lacks completeness due to missing transcription factors."
        },
        {
            "query_idx": 641,
            "query": "Through what intricate mechanisms does EA partake in modulating the dynamic equilibrium of liver enzyme kinetics and fortifying the biochemical sentinel against oxidative agitators, within the nuanced landscape of free radical-induced hepatic ailment?",
            "retrieved_metrics": {
                "reference_idx": [
                    325
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "EA modulates liver enzyme kinetics and fortifies biochemical defenses through #Nrf2# activation, reducing serum liver enzymes and bilirubin levels, thus counteracting oxidative stress in #free radical-induced liver# ailments.",
            "predicted_answer": "EA modulates liver enzyme kinetics by reducing serum levels of liver enzymes and bilirubin, enhancing antioxidant capacity. It fortifies the biochemical sentinel through Nrf2 activation, mitigating oxidative stress and liver injury from free radicals.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of Nrf2 activation and the reduction of serum liver enzymes and bilirubin found in the reference. It aligns with the trend of mitigating oxidative stress in free radical-induced liver conditions. No significant details are missing or contradictory."
        },
        {
            "query_idx": 642,
            "query": "In what manner do the sophisticated molecular pathways within the cellular tapestry of BV2 microglia become orchestrated by tiliroside, effectuating a diminution of neuroinflammatory responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    324
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tiliroside orchestrates #neuroinflammation# reduction in BV2 microglia through TRAF6-mediated activation of NFκ B and p38 MAPK signaling #pathways#, likely due to its antioxidant properties.",
            "predicted_answer": "Tiliroside orchestrates the molecular pathways in BV2 microglia by inhibiting TRAF6-mediated NFκB and p38 MAPK signaling, thereby reducing neuroinflammatory responses, likely due to its anti-oxidant properties.",
            "score": 1,
            "explanation": "The predicted answer covers key aspects such as TRAF6, NFκB, and p38 MAPK signaling pathways, aligning with the reduction of neuroinflammation but incorrectly mentions inhibiting the signaling instead of activating it. The trend aligns but this reversal impacts accuracy, missing crucial detail about the pathways’ activation."
        },
        {
            "query_idx": 643,
            "query": "In what nuanced manner does quercetin navigate and subtly disrupt the orchestrating influence of seminal genetic promoters that are crucial in the nascent phase of prostate cancer genesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    321
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Quercetin indirectly disrupts prostate cancer genesis by blocking the activity of promoters for crucial genes such as #AR# and #PSA#.",
            "predicted_answer": "Quercetin subtly disrupts the orchestrating influence of seminal genetic promoters, such as AR and PSA, which are crucial in the nascent phase of prostate cancer genesis by indirectly blocking their activity.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer, AR and PSA, and aligns with the nuance of how quercetin disrupts prostate cancer genesis. The details about the indirect disruption of genetic promoters are effectively conveyed, with no significant omissions or contradictions."
        },
        {
            "query_idx": 644,
            "query": "What complex interplays characterize the transformations of kaempferol 3-rutinoside, and how do these manifest in enhancing the antioxidative defense matrix amidst oxidative perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    326
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The complex interplay of #kaempferol 3-rutinoside# increases #antioxidant capacity# and enzyme activities, reducing MDA content, thus enhancing antioxidative defense amidst oxidative perturbations.",
            "predicted_answer": "Kaempferol 3-rutinoside enhances the antioxidative defense matrix by increasing total antioxidant capacity, superoxide dismutase, glutathione peroxidase activity, and glutathione content, while reducing malondialdehyde levels.",
            "score": 5,
            "explanation": "The predicted answer captures all key points emphasized in the reference: it discusses kaempferol 3-rutinoside, enhancement of antioxidant capacity, enzyme activities, and reduction in malondialdehyde (MDA) levels. No significant omissions or contradictions are present, and the overall trend aligns with the reference."
        },
        {
            "query_idx": 645,
            "query": "In the realm of biochemical interplay, what distinguishes the molecular adhesion propensity of ursolic acid in orchestrating superoxide dismutase activity from the parallel enzyme interaction paradigm presented by quercetin?",
            "retrieved_metrics": {
                "reference_idx": [
                    328
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ursolic acid's #binding affinity# to SOD is higher compared to quercetin, providing enhanced #antioxidant activity# through SOD inhibition.",
            "predicted_answer": "Ursolic acid (UA) has a higher binding affinity (-5.4 kcal/mol) inhibiting superoxide dismutase (SOD) compared to quercetin, indicating stronger molecular adhesion propensity in orchestrating SOD activity.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the higher binding affinity of ursolic acid to superoxide dismutase compared to quercetin, matching the key fact from the reference. However, it omits the role in providing enhanced antioxidant activity, a crucial aspect from the reference."
        },
        {
            "query_idx": 646,
            "query": "In the realm of metabolic symphony, what transformative influence does the multifarious compound, ellagic acid, exert on the expression rhythm of UCP1, the brown adipose herald, within the storage matrix of lipid-laden rodent physiology?",
            "retrieved_metrics": {
                "reference_idx": [
                    329
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ellagic acid #improved expression# of the #UCP1 gene# in white adipose tissue of obese rats, promoting browning and addressing obesity-related conditions.",
            "predicted_answer": "Ellagic acid promotes the browning of white adipose tissue and enhances the expression of UCP1 in rodents, potentially mitigating obesity-related dyslipidemia and hepatic steatosis.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer's trends but misses the specific mention of \"expression of the UCP1 gene\" and the specific context of \"obese rats,\" which affects completeness. Both cover browning and obesity-related conditions, but specific details are lacking."
        },
        {
            "query_idx": 647,
            "query": "How does the ethanol-derived phytochemical infusion from R. chingii foliage engage with circulatory and metabolic pathways to exert its pharmacological influence in both empirical laboratory conditions and dynamic biological systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    332
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The ethanol-derived phytochemical infusion from R. chingii foliage exhibits #α-glucosidase# inhibition and has potential #anti-thrombotic effects#, impacting metabolic and circulatory pathways in laboratory and biological systems.",
            "predicted_answer": "The ethanol-derived phytochemical infusion from R. chingii foliage engages with circulatory and metabolic pathways by exhibiting anti-thrombotic effects and inhibiting α-glucosidase, which supports anti-diabetic, anti-obesity, and anti-cardiovascular properties.",
            "score": 5,
            "explanation": "The predicted answer accurately includes both key facts: α-glucosidase inhibition and anti-thrombotic effects, which were emphasized in the reference answer. There are no significant omissions, and the key aspects of engaging with metabolic and circulatory pathways are covered, reflecting a high degree of alignment."
        },
        {
            "query_idx": 648,
            "query": "Within the landscape of genetic pathways and empirical inquiry led by Tang et al., what investigative approaches were employed to affirm the genomic equilibrium of R. chingii Hu, specifically through exploratory trials on mice?",
            "retrieved_metrics": {
                "reference_idx": [
                    334
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tang et al. used the #micronucleus test#, #Ames test#, and sperm abnormality test to affirm the genomic equilibrium of R. chingii Hu in mice.",
            "predicted_answer": "Tang et al. employed acute toxicity tests, bone marrow cell micronucleus test, Ames test, and sperm abnormality test in mice to affirm the genomic equilibrium of R. chingii Hu.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions three of the investigative approaches: the micronucleus test, Ames test, and sperm abnormality test, which are the key facts in the reference. It includes additional information (acute toxicity tests) but aligns well with the reference without contradictory information."
        },
        {
            "query_idx": 649,
            "query": "What insights are gleaned from the TEAC assay by Arts et al. in relation to the relative prowess of quercetin in its custodial safeguarding of plasma anti-oxidant capacity vis-à-vis the baseline established by trolox?",
            "retrieved_metrics": {
                "reference_idx": [
                    327
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Arts et al. found quercetin's contribution to plasma anti-oxidant capacity to be #6.24 times# greater than #trolox#, significantly boosting endogenous anti-oxidant protection.",
            "predicted_answer": "The TEAC assay by Arts et al. revealed that quercetin's contribution to plasma antioxidant capacity is 6.24 times greater than trolox, indicating its superior custodial safeguarding ability.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts of quercetin's contribution being 6.24 times greater than that of trolox, as emphasized in the reference answer. The meaning regarding the relative antioxidant capacity and the elements emphasized are consistent without significant omissions or errors."
        },
        {
            "query_idx": 650,
            "query": "What is the conjectured biochemical essence harbored within the R. chingii extract that is deemed to impart its significant anti-fungal attributes against pathogenic fungal entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    333
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The conjectured biochemical essence in the R. chingii extract attributed to its significant anti-fungal attributes are the #triterpenoid# components.",
            "predicted_answer": "The conjectured biochemical essence within the R. chingii extract that imparts significant anti-fungal attributes is its triterpenoid components.",
            "score": 5,
            "explanation": "The predicted answer fully aligns with the reference answer. The key fact, which is the presence of \"triterpenoid\" components in R. chingii extract as the source of its anti-fungal properties, is accurately captured. There are no omissions or contradictory information."
        },
        {
            "query_idx": 651,
            "query": "In the 2015 edition of the pharmacopeial manuscript dedicated to R. chingii Hu, which symbolic molecular entities are entrusted with the task of representing compositional benchmarks for its profound evaluation?",
            "retrieved_metrics": {
                "reference_idx": [
                    335
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The symbolic molecular entities representing compositional benchmarks for R. chingii Hu in 2015 are #ellagic acid# and #kaempferol-3o-rutoside#.",
            "predicted_answer": "Ellagic acid and kaempferol-3-O-rutoside are the symbolic molecular entities representing compositional benchmarks for R. chingii Hu in the 2015 edition of the Chinese Pharmacopoeia.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer: \"ellagic acid\" and \"kaempferol-3o-rutoside\" (noting the slight spelling difference, \"kaempferol-3-O-rutoside,\" which does not alter the meaning). There are no omissions or errors affecting the completeness."
        },
        {
            "query_idx": 652,
            "query": "What statistical ensemble, reflecting underlying epidemiological dynamics, represents the probability that a woman will face the emergence of invasive mammary carcinoma throughout her lifespan?",
            "retrieved_metrics": {
                "reference_idx": [
                    337
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The statistical ensemble representing the probability that a woman will face invasive #breast cancer# throughout her lifespan is #1 in 8#.",
            "predicted_answer": "The statistical ensemble representing the probability that a woman will face the emergence of invasive mammary carcinoma throughout her lifespan is approximately 1 in 8 women.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the probability value of \"1 in 8 women,\" aligning with the reference. However, it uses the term \"invasive mammary carcinoma\" instead of the reference's \"breast cancer.\" The different terminology does not alter the meaning, maintaining consistency with the key facts."
        },
        {
            "query_idx": 653,
            "query": "Within the intricate tapestry of estrogenic modulation in oncological treatments, which potential avenue remains a largely untraversed frontier, particularly reflecting upon catalysts of estrogenic equilibrium yet to be thoroughly exploited in therapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    338
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The largely untraversed frontier in oncological treatments is targeting #estrogen sulfotransferase# (SULT1E1), which is not yet thoroughly exploited in therapeutic paradigms.",
            "predicted_answer": "The potential avenue largely untraversed in oncological treatments is the exploration of estrogen sulfotransferase (SULT1E1) as a therapeutic target in estrogen-dependent cancers.",
            "score": 5,
            "explanation": "The Predicted Answer identifies \"estrogen sulfotransferase (SULT1E1)\" as a potential therapeutic target, matching the key fact emphasized in the Reference Answer. Both responses align in trend and meaning, with no significant omissions or contradictions."
        },
        {
            "query_idx": 654,
            "query": "What methodical choreography governs the dexterous extraction and infusion process of the nutrient abyss from the cultured matrices, designed to maintain the sanctity of cellular tranquility while orchestrating the unruffled replenishment?",
            "retrieved_metrics": {
                "reference_idx": [
                    343
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The method involves #slow# removal and addition of medium using a #200 ml multichannel pipette# at a 90-degree angle, ensuring no disturbance to the plates.",
            "predicted_answer": "The process involves careful medium removal and addition using a 200 ml multichannel pipette at a 90-degree angle, maintaining minimal disturbance to cells, and ensuring precise drug treatment after each medium change.",
            "score": 3,
            "explanation": "The predicted answer includes the use of a \"200 ml multichannel pipette\" and maintaining minimal disturbance, aligning with the reference. However, it lacks the emphasis on \"slow\" removal and addition of medium. The answer is generally correct but misses this specific detail, affecting completeness."
        },
        {
            "query_idx": 655,
            "query": "Within the elaborate framework of cellular microcosms, what cascading biochemical influences does STX64 exert upon the autonomously configured cell collectives, particularly when bearing in mind their affinity-driven interactions modulated through the lens of estrogen synthesis and subsequent activity inhibition?",
            "retrieved_metrics": {
                "reference_idx": [
                    345
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STX64 inhibits #STS# activity, reducing the conversion of inactive estrogen sulfates into #active estrogens# in MCF-7 cell spheroids.",
            "predicted_answer": "STX64 inhibits STS, an estrogen synthase, thereby reducing the conversion of inactive estrogen sulfates to active estrogens, which can influence cell interactions and collective behavior in MCF-7 cell spheroids.",
            "score": 5,
            "explanation": "The predicted answer successfully covers the key facts emphasized with # symbols: it mentions the inhibition of STS and the conversion to active estrogens in MCF-7 cell spheroids. The overall meaning is consistent with the reference answer, and no significant details are missing."
        },
        {
            "query_idx": 656,
            "query": "What quantitative spectrum and chronological sequence delineate the capacity of PPT to exert a discernible influence on the proliferation kinetics of MCF-7 cellular spheroids, as substantiated through methodological findings derived from the t-Test analytical framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    348
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PPT does not significantly inhibit MCF-7 spheroid growth for 0.05 to 5.0 µM after #two weeks#, but moderately inhibits growth at these concentrations beyond this period.",
            "predicted_answer": "PPT exerted a discernible influence on MCF-7 spheroid proliferation kinetics, showing no significant inhibition within two weeks but moderate inhibition after two weeks at concentrations of 0.05 to 5.0 µM, as substantiated by t-Test results.",
            "score": 5,
            "explanation": "The 'Predicted Answer' accurately mentions that PPT does not significantly inhibit MCF-7 spheroid growth within the first two weeks and moderately inhibits it after two weeks, aligning with the 'Reference Answer'. All key facts, such as the time frame and concentration range, are present."
        },
        {
            "query_idx": 657,
            "query": "What are the dual strategic imperatives of chemical warfare employed against breast malignancy, as articulated within the explanatory framework provided?",
            "retrieved_metrics": {
                "reference_idx": [
                    352
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The dual strategic imperatives are killing unseen #cancer cells# post-surgery (adjuvant) and shrinking tumors pre-surgery (neoadjuvant) for less extensive removal.",
            "predicted_answer": "The dual strategic imperatives of chemical warfare against breast malignancy are: 1) adjuvant chemotherapy to eliminate residual cancer cells post-surgery, and 2) neoadjuvant chemotherapy to shrink tumors pre-surgery, enhancing surgical outcomes.",
            "score": 5,
            "explanation": "The predicted answer aligns closely with the reference answer, covering both key points: adjuvant chemotherapy to target post-surgery cancer cells, and neoadjuvant chemotherapy to shrink tumors pre-surgery. While the wording differs, the essential meaning and strategy are maintained with no omissions."
        },
        {
            "query_idx": 658,
            "query": "How do the enzymatic artisans known as SULT1E1 and STS choreograph the biochemical relay of sulfonate transformation and hydrolytic revival, which captures the imagination of pioneers in the realm of estrogen-centric breast cancer therapeutic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    351
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SULT1E1 #sulfates# estrogens for solubility; STS #hydrolyzes# them to active forms, impacting estrogen receptor activity crucial in breast cancer therapy.",
            "predicted_answer": "SULT1E1 sulfates estrogens for solubility, and STS hydrolyzes them back to active forms, influencing estrogen-centric breast cancer therapies.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes the key activities of SULT1E1, which is to \"sulfate\" estrogens, and of STS, to \"hydrolyze\" them. However, it misses the detail about the impact on \"estrogen receptor activity\". Thus, one key fact is missing, but the trend is mostly aligned."
        },
        {
            "query_idx": 659,
            "query": "In the analysis of spheroidal response within MCF-7 cultures, how do the divergent efficacious signatures and alternative inhibitory pathways of TAM and STX64 manifest in terms of their impact on spheroid integrity and cellular viability?",
            "retrieved_metrics": {
                "reference_idx": [
                    353
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TAM leads to #spheroid breakdown# and cell death, while STX64 inhibits #spheroid growth# without causing death.",
            "predicted_answer": "TAM causes MCF-7 spheroid breakdown and cell death, while STX64 inhibits spheroid growth without causing death, impacting spheroid integrity and cellular viability differently.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer: TAM causes spheroid breakdown and cell death, while STX64 inhibits spheroid growth without causing death. Both answers align in terms of their impact on spheroid integrity and cellular viability, with no significant omissions."
        },
        {
            "query_idx": 660,
            "query": "What are the quartet of existential pathways reflected within the HIV-1 genomic panorama, each embodying an odyssey of autonomous interspecies narrative transformations mapped within the central western African milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    357
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quartet of existential pathways within the HIV-1 genomic panorama are #lineages M#, #N#, O, and P, each from independent cross-species transmission in central western Africa.",
            "predicted_answer": "The quartet of existential pathways in HIV-1 genomic panorama includes lineages M, N, O, and P, each representing distinct cross-species transmissions in central western Africa.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all key facts emphasized in the reference answer, including the HIV-1 lineages (M, N, O, and P) and their origins from independent cross-species transmissions in central western Africa. The meaning is consistent without omissions or contradictory information."
        },
        {
            "query_idx": 661,
            "query": "In the grand design of the HIV-1 M virus, how do the dual outer-layer sentinels, abstractly coined as the signal conduit gp120 and the fusion archetype gp41, manifest within the viral architecture to mediate engagement with the cellular interface of its host?",
            "retrieved_metrics": {
                "reference_idx": [
                    360
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #gp120# glycoprotein acts as a signal conduit, while #gp41# serves as a fusion archetype, both mediating interaction with host cell receptors in HIV-1 M virus.",
            "predicted_answer": "The signal conduit gp120 and the fusion archetype gp41 are surface glycoproteins on the HIV-1 M virus's outer layer. gp120 binds to host cell receptors, while gp41 facilitates membrane fusion, enabling viral entry.",
            "score": 5,
            "explanation": "The predicted answer captures the key aspects of the reference answer: gp120 as a signal conduit and gp41 as a fusion archetype, both mediating interaction with host cell receptors. It accurately describes these roles without omitting any critical information."
        },
        {
            "query_idx": 662,
            "query": "Within the intricate dance of molecular adaptation, what underlying complexities in genomic fluidity and mechanistic evolution contribute to HIV-1's expansive diversity and its profound resonance across global socio-economic landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    362
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HIV-1's #genetic heterogeneity# is driven by high reverse transcription #error rates#, extensive recombination, and prolific virion generation, enhancing its global socio-economic impact.",
            "predicted_answer": "HIV-1's expansive diversity stems from high error rates in reverse transcription, extensive recombination, and massive virion production, contributing to its profound socio-economic impact globally.",
            "score": 3,
            "explanation": "The predicted answer accurately covers the key facts of high reverse transcription error rates, recombination, and massive virion production contributing to HIV-1's diversity and socio-economic impact. However, it omits the term \"genetic heterogeneity,\" impacting completeness slightly."
        },
        {
            "query_idx": 663,
            "query": "During the final tableau of HIV's existential cycle, what dynamic interplay does the proteolytic architecture constructed by PR invoke in the unleashing of viral assemblies, and in what manner does this interplay critically undermine the stalwart defenses of host cellular immunity?",
            "retrieved_metrics": {
                "reference_idx": [
                    363
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The proteolytic architecture of #PR# releases viral assemblies, depleting #CD4+ T-cells#, leading to the collapse of host cellular immunity.",
            "predicted_answer": "The proteolytic architecture constructed by HIV's protease (PR) in the final tableau of its cycle invokes a dynamic interplay that facilitates the assembly and release of viral particles, critically undermining host cellular immunity by depleting CD4+ T-cells and weakening the immune response.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference: it mentions the proteolytic architecture of PR, its role in the release of viral assemblies, and the depletion of CD4+ T-cells, which undermines host cellular immunity. The overall meaning and important details are preserved."
        },
        {
            "query_idx": 664,
            "query": "What are the essential challenges that serve as barriers to the optimal functioning of prophylactic strategies, such as pre-exposure and post-exposure pharmacological measures, when operating within the economic and societal terrains of developing regions?",
            "retrieved_metrics": {
                "reference_idx": [
                    365
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The main barriers to effective prophylactic strategies like #PrEP# and #PEP# in developing regions are lack of compliance and challenging affordability.",
            "predicted_answer": "The essential challenges include lack of compliance with medication regimens and the high cost of prophylactic drugs, which are particularly problematic in developing regions.",
            "score": 3,
            "explanation": "The predicted answer mentions \"lack of compliance\" and \"high cost,\" echoing key barriers. However, it omits specific references to #PrEP# and #PEP#, critical to the reference. Thus, it aligns with the trend but lacks complete coverage of emphasized details."
        },
        {
            "query_idx": 665,
            "query": "In what ways do innovative immunological frameworks seek to unravel the enigma of carbohydrate-heavy barriers that shroud HIV's protective coat, aiming to forge potent counteroffensive strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    367
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Innovative immunological frameworks focus on inducing #broadly neutralizing antibodies# or using #cytomegalovirus vectors# to target glycosylated barriers of HIV for effective counteroffensive strategies.",
            "predicted_answer": "Innovative immunological frameworks aim to design vaccines that induce broadly neutralizing antibodies (bnABs) to bind conserved epitopes on heavily glycosylated HIV envelope glycoproteins, overcoming epitope masking and enhancing immune responses.",
            "score": 3,
            "explanation": "The Predicted Answer discusses inducing broadly neutralizing antibodies, which aligns with the focus of the Reference Answer. However, it omits the mention of using cytomegalovirus vectors, which is a key fact highlighted in the Reference Answer, impacting completeness."
        },
        {
            "query_idx": 666,
            "query": "What nuanced defensive architectures within the intricate landscape of vaginal mucosa serve as guardian structures, adeptly countering the potential transmission vectors of HIV and other sexually communicated infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    368
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vaginal mucosa# features a protective #mucus layer#, stratified squamous epithelium, and intercellular connections like tight junctions and desmosomes, guarding against infections.",
            "predicted_answer": "The vaginal mucosa's stratified squamous epithelium, protected by a lubricating mucus, and reinforced by tight junctions and desmosomes, serves as a robust defensive architecture against HIV and sexually transmitted infections.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the #vaginal mucosa#, #mucus layer#, stratified squamous epithelium, tight junctions, and desmosomes—all highlighted in the reference answer. The key facts and trends are consistently aligned, with no omissions or contradictions."
        },
        {
            "query_idx": 667,
            "query": "What convoluted biological mechanisms underpin the formidable barriers thwarting the realization of a globally effective HIV vaccine, considering the virus's perpetual genomic transformation and its adept evasion of immune fortifications through latent viral repositories?",
            "retrieved_metrics": {
                "reference_idx": [
                    366
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The formidable barriers to a globally effective HIV vaccine include #high mutation rate# causing diversity in HIV strains and #latent viral reservoirs# enabling immune evasion.",
            "predicted_answer": "The formidable barriers to a globally effective HIV vaccine include the virus's high mutation rate leading to diverse strains, its ability to evade adaptive immune responses by infiltrating and invalidating the immune system, and the establishment of latent viral reservoirs in immune cells, which are difficult to target.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference answer, specifically the high mutation rate causing diversity in HIV strains and the establishment of latent viral reservoirs. The wording differs slightly, but the overall meaning is consistent and complete."
        },
        {
            "query_idx": 668,
            "query": "What trio of biological artificers does HIV-1 cunningly recruit to execute its ongoing biological integration within the protective realm of host cellular defenders?",
            "retrieved_metrics": {
                "reference_idx": [
                    361
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HIV-1 recruits the trio of biological artificers: #reverse transcriptase# (RT), #integrase# (IN), and protease (PR) for integration within host cells.",
            "predicted_answer": "HIV-1 recruits reverse transcriptase, integrase, and protease to execute its biological integration within host cells.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: reverse transcriptase, integrase, and protease. It captures the essential information for HIV-1's integration within host cells without contradictions. The alignment and completeness with respect to key details are high."
        },
        {
            "query_idx": 669,
            "query": "What enzymatic catalysts are incapacitated through pharmacological interventions to unravel the replication apparatus of HIV, aiming to mitigate its viral signature?",
            "retrieved_metrics": {
                "reference_idx": [
                    364
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Antiretroviral drugs incapacitate #reverse transcriptase#, #integrase#, and protease to paralyze HIV's replication machinery and mitigate its viral signature.",
            "predicted_answer": "Reverse transcriptase, integrase, and protease are enzymatic catalysts incapacitated by antiretroviral drugs to disrupt HIV's replication machinery.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies reverse transcriptase, integrase, and protease as targets of antiretroviral drugs to disrupt HIV's replication machinery, aligning with the reference answer. No key information is missing, and there is no contradictory information. The key facts are fully covered."
        },
        {
            "query_idx": 670,
            "query": "What mechanisms do vaginal epithelial cells employ as custodians of microbial equilibrium to ensure the perpetuation of an acidic ecological niche within the cervicovaginal domain, acting both as barriers and metabolic supporters?",
            "retrieved_metrics": {
                "reference_idx": [
                    380
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vaginal epithelial cells maintain microbial equilibrium by producing glycogen, which aids lactobacilli fermentation, and form a #physical barrier# comprising multiple layers, fostering an #acidic niche#.",
            "predicted_answer": "Vaginal epithelial cells maintain microbial equilibrium by producing and storing glycogen, which lactobacilli ferment to produce lactic acid, maintaining an acidic pH that inhibits pathogen growth. This dual role acts as both a physical barrier and metabolic supporter.",
            "score": 3,
            "explanation": "The predicted answer covers key concepts like glycogen production, lactic acid fermentation by lactobacilli, and maintaining an acidic pH. It mentions both the physical barrier and metabolic support roles. However, it lacks explicit mention of the \"#physical barrier comprising multiple layers#\" found in the reference."
        },
        {
            "query_idx": 671,
            "query": "What multifarious and territorially entrenched aspects of the anatomical layout associated with pancreatic tumors are responsible for rendering surgical navigations exceedingly arduous, exacerbated by the tumor's invasive synergy with contiguous organ systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    382
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #location# of pancreatic tumors in the #abdominal retroperitoneal space# and their infiltration into neighboring organs make surgical navigation exceedingly arduous.",
            "predicted_answer": "The anatomical layout of pancreatic tumors, deeply embedded in the retroperitoneal space and surrounded by vital organs and vessels, makes surgical navigation challenging, especially when tumors have invaded neighboring structures.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer, notably the #location# of pancreatic tumors in the #abdominal retroperitoneal space# and their interaction with neighboring structures. The meaning is consistent with no significant omissions or errors noted."
        },
        {
            "query_idx": 672,
            "query": "In the elaborate symphony of oncogenic advancement, how do tumor-associated neutrophils (TANs), as polarized harmonizers in the immunological ensemble, influence the metamorphosis and metastatic journey of cancerous entities through their transformational attributes and molecular harmonics within the intricate tapestry of the tumor's microcosmic environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    390
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor-associated neutrophils (#TANs#) in the #tumor# microenvironment enhance cancer progression and metastasis by promoting an immunosuppressive phenotype and secreting cytokines and proteases.",
            "predicted_answer": "Tumor-associated neutrophils (TANs) influence cancer progression and metastasis by polarizing towards an immunosuppressive N2 phenotype, secreting cytokines and proteases that remodel the tumor microenvironment, enhancing chemotherapy resistance and systemic inflammation.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, capturing key facts: the role of TANs in cancer progression and metastasis, their promotion of an immunosuppressive phenotype, and secretion of cytokines and proteases. Despite added details on chemotherapy resistance and inflammation, none of the emphasized key facts are omitted."
        },
        {
            "query_idx": 673,
            "query": "In what manner do regulatory architects craft a covert suppressive ecosystem that subtly alters the operational dynamics of cytotoxic agents within the complex contours of tumor domains, thereby affecting their infiltration and functional capacity?",
            "retrieved_metrics": {
                "reference_idx": [
                    391
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Regulatory architects create a #covert suppressive ecosystem# by secreting cytokines like TGF-ß and IL-10, inhibiting cytotoxic agents and #facilitating immune evasion# within tumor domains.",
            "predicted_answer": "Regulatory architects craft a covert suppressive ecosystem by leveraging Tregs to secrete cytokines like TGF-ß and IL-10, which inhibit cytotoxic CD8+ T cells, CD4+ T-helper cells, and NK cells. This prevents infiltration and functional capacity of cytotoxic agents within tumor domains.",
            "score": 3,
            "explanation": "The predicted answer covers the creation of a covert suppressive ecosystem via secretion of TGF-ß and IL-10 cytokines, aligning with the reference answer. However, it omits the key fact about \"facilitating immune evasion,\" impacting the completeness of the response."
        },
        {
            "query_idx": 674,
            "query": "What particular genomic contingents, belonging to the viral entity and its cellular residing partners, found themselves at the focal point of strategic molecular choreography, contrived through the application of cholesterol-bound genetic silencers, to hinder HSV-2's invasive endeavor in the murine model?",
            "retrieved_metrics": {
                "reference_idx": [
                    377
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chol-siRNAs targeted #HSV-2# viral genes and #EC host genes# required for viral entry to inhibit infection in mice.",
            "predicted_answer": "The genomic contingents targeted by cholesterol-bound genetic silencers in the murine model to hinder HSV-2's invasive endeavor include HSV-2 viral genes and host genes required for viral entry in the vaginal epithelium.",
            "score": 5,
            "explanation": "The predicted answer successfully captures both key facts emphasized in the reference answer: targeting \"HSV-2 viral genes\" and \"host genes required for viral entry.\" These align with the \"EC host genes\" targeting in the reference. There are no significant omissions or errors in the predicted answer."
        },
        {
            "query_idx": 675,
            "query": "In the complex orchestration of pharmacological itineraries, what intrinsic obstacles complicate the transit of medicinal compounds to skeletal strongholds, and how do these diverge, akin to contrasting courses, from the formidable barriers encountered when penetrating the cerebral bastions of neural metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    400
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #blood-bone barrier# and #dense bone matrix# impede drug transit to bones, unlike the blood-brain barrier, which challenges drug delivery to cerebral metastasis.",
            "predicted_answer": "The intrinsic obstacles complicating drug transit to skeletal strongholds include the blood-bone barrier, dense bone matrix, and poor drug solubility in bone tissue. These diverge from the formidable barriers of the blood-brain barrier encountered in neural metastasis, which is more selective and less permeable.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts in the reference answer, including the \"blood-bone barrier\" and \"dense bone matrix\", and correctly contrasts them with the \"blood-brain barrier\". It also provides additional context on solubility, which does not contradict the reference."
        },
        {
            "query_idx": 676,
            "query": "In the evolving landscape of oncological sciences, what are the intricate trademarks of pancreatic cancer that construct formidable fortresses around therapeutic efficacy, thereby obstructing the seamless progress of treatment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    401
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate trademarks of pancreatic cancer obstructing treatment include its #specific TME# and #broad genetic diversity#, which hinder therapeutic efficacy.",
            "predicted_answer": "Pancreatic cancer's formidable barriers include its specific Tumor Microenvironment (TME), broad genetic diversity, and metastatic potential, which hinder therapeutic efficacy.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer: #specific TME# and #broad genetic diversity#. Although the predicted answer adds \"metastatic potential,\" it does not contradict the reference. The trends and key elements are well-aligned and complete."
        },
        {
            "query_idx": 677,
            "query": "In what manner does the labyrinthine diversity of clonal entities within a tumor mold the dependability of singular histological evaluations in capturing the holistic genetic portrait necessary for crafting oncologic therapeutic avenues and prospective prognostic insights?",
            "retrieved_metrics": {
                "reference_idx": [
                    402
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #diversity# of clonal entities within a tumor limits the accuracy of singular histological evaluations in capturing its complete genetic portrait necessary for #treatment# and prognostic guidance.",
            "predicted_answer": "The labyrinthine diversity of clonal entities within a tumor complicates the dependability of singular histological evaluations, as a single biopsy may not capture the holistic genetic portrait necessary for accurate oncologic therapeutic strategies and prognostic insights.",
            "score": 5,
            "explanation": "The predicted answer effectively conveys the impact of clonal diversity on the reliability of singular histological evaluations, aligning well with the reference answer. It captures the essence of both treatment and prognostic implications, though it uses \"oncologic therapeutic strategies\" in place of \"treatment.\""
        },
        {
            "query_idx": 678,
            "query": "What mechanisms do the emissarial cellular constructs from neoplasm sites employ to refine distant ecological sanctuaries, thereby nurturing the ascension of colonizing cellular insurgents in unprepared anatomical domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    399
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Emissarial cellular constructs utilize #exosomes# from primary tumors to induce a #premetastatic niche#, enhancing colonization by metastatic cells in distant anatomical sites.",
            "predicted_answer": "Emissarial cellular constructs from neoplasm sites refine distant ecological sanctuaries by sending tumor-cell-derived exosomes carrying tumorigenic micro-RNAs, such as miR-200, to create premetastatic niches, thereby nurturing colonization in unprepared anatomical domains.",
            "score": 5,
            "explanation": "The predicted answer mentions \"exosomes\" and \"premetastatic niches,\" which are key facts emphasized in the reference answer. It further elaborates by specifying \"tumorigenic micro-RNAs,\" providing more detail but still aligning with the trends and key facts of the reference. No significant omissions or errors are present."
        },
        {
            "query_idx": 679,
            "query": "What life prolongation dynamics, metaphorically illustrating the augmentation of the horizon of being, are associated with the intricate regimen of FOLFIRINOX as aligned against the singular trajectory of gemcitabine treatment in the realm of advanced pancreatic cancer patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    405
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "FOLFIRINOX extends median #overall survival# in advanced pancreatic cancer patients by #4 months# compared to gemcitabine alone.",
            "predicted_answer": "FOLFIRINOX extends the horizon of being in advanced pancreatic cancer by offering a median overall survival benefit of approximately 4 months compared to gemcitabine alone.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts emphasized in the reference answer, including the extension of median overall survival and the specific survival benefit of 4 months with FOLFIRINOX over gemcitabine in advanced pancreatic cancer. Both trend and details are completely aligned."
        },
        {
            "query_idx": 680,
            "query": "What process of molecular enhancement involves the metaphorical adornment of therapeutic substances with an adaptive polymer sheath, stepping up their persistence within the circulatory expanse?",
            "retrieved_metrics": {
                "reference_idx": [
                    404
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The process is #pegylation#, involving the attachment of polyethylene glycol, enhancing therapeutic substances' persistence within the circulation.",
            "predicted_answer": "Pegylation involves the attachment of polyethylene glycol to therapeutic substances, enhancing their persistence in the circulatory system.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions \"pegylation,\" the attachment of polyethylene glycol, and the enhancement of therapeutic substances' persistence in the circulatory system. All key facts are present, the overall trend aligns with the reference answer, and no important details are missing."
        },
        {
            "query_idx": 681,
            "query": "Within the intricate tapestry of the tumorous domain, what inherent function do the pancreatic architectural weavers fulfill in reinforcing the complex stromal matrix, and by what pathways might molecular modulators such as losartan intervene in reshaping these cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    410
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pancreatic #stellate cells# produce collagen and hyaluronan, reinforcing the stromal matrix. #Losartan# targets these cells, inhibiting their proliferation and reshaping tumor dynamics.",
            "predicted_answer": "Pancreatic stellar cells reinforce the stromal matrix by producing collagen and hyaluronan. Losartan, an angiotensin inhibitor, can intervene by inhibiting tumor-promoting stellar cell proliferation.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, mentioning \"pancreatic stellar cells,\" \"collagen and hyaluronan production,\" and \"losartan\" as an \"angiotensin inhibitor\" that \"inhibits tumor-promoting stellar cell proliferation.\" Minor wording differences do not affect key fact alignment or overall meaning."
        },
        {
            "query_idx": 682,
            "query": "Within the complex framework of strategic therapeutic endeavors targeting malignancies, what tactical advantage does verapamil provide in navigating the molecular defense mechanisms constituted by efflux-pump-associated multidrug resistance barriers?",
            "retrieved_metrics": {
                "reference_idx": [
                    413
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Verapamil offers a tactical advantage by #inhibiting efflux pumps#, potentially overcoming #multidrug resistance# and enhancing chemotherapy effectiveness.",
            "predicted_answer": "Verapamil enhances chemotherapy efficacy by inhibiting efflux pumps, allowing drugs to accumulate in cancer cells and overcome multidrug resistance.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures both key facts from the Reference Answer: it mentions \"inhibiting efflux pumps\" and \"overcoming multidrug resistance,\" aligning well with the overall trend of enhancing chemotherapy effectiveness. Therefore, the Predicted Answer is fully consistent with the Reference Answer."
        },
        {
            "query_idx": 683,
            "query": "In the nuanced landscape of precision oncology, what strategic function does the Know Your Tumor ® paradigm fulfill as a cartographer in delineating the intricate map of individually-tailored therapeutic strategies, and how does it influence the evolutionary journey towards optimized therapeutic endpoints for individuals confronting pancreatic malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    414
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Know Your Tumor®# program serves as a strategic #cartographer#, utilizing molecular tumor profiling to personalize therapy and improve outcomes for pancreatic cancer patients by identifying actionable mutations.",
            "predicted_answer": "The Know Your Tumor ® paradigm serves as a strategic tool in precision oncology by mapping individual tumor profiles to tailor therapeutic strategies, significantly influencing the optimization of treatment outcomes for pancreatic malignancies through actionable genetic mutations and targeted therapies.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It mentions the Know Your Tumor ® paradigm, its role in mapping individual tumor profiles to tailor therapies, and optimizing outcomes through actionable genetic mutations. However, it misses explicitly stating the 'cartographer' aspect. Nonetheless, the key strategic function is covered."
        },
        {
            "query_idx": 684,
            "query": "What is the symbiotic immunological orchestrating required to facilitate a harmonized cellular and humoral defense within a therapeutic oncological vaccine designed to target an ensemble of tumorigenic signatures?",
            "retrieved_metrics": {
                "reference_idx": [
                    417
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #therapeutic# vaccine requires orchestrating both #humoral# and T-cell responses, activating CD4+ T-helper cells and CD8+ cytotoxic T lymphocytes, targeting multiple tumorigenic antigens.",
            "predicted_answer": "The symbiotic immunological orchestration in a therapeutic oncological vaccine involves targeting multiple tumorigenic antigens to activate both humoral (antibody-mediated) and cellular (T-cell-mediated) defenses, ensuring comprehensive immune response against cancer.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer, indicating orchestration of both humoral and cellular responses while targeting multiple tumorigenic antigens. However, it doesn't specifically mention CD4+ T-helper and CD8+ cytotoxic T lymphocytes, which are key components."
        },
        {
            "query_idx": 685,
            "query": "What intricately convoluted anatomical systems predispose the hepatic domain to preferential colonization by pancreatic neoplastic cells, and how do these spatial and structural complexities contrast with the elevated surgical hurdles faced when addressing cerebral metastatic challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    418
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pancreatic cancer cells metastasize to the #liver# due to the portal vein connection, whereas #brain# metastasis is rarer and more challenging surgically, lacking regenerative capabilities.",
            "predicted_answer": "The hepatic domain is predisposed to pancreatic neoplastic cell colonization due to the portal vein, which facilitates direct transport from the pancreas. This contrasts with cerebral metastatic challenges, which face higher surgical hurdles due to the brain's complex anatomy and limited regenerative capacity.",
            "score": 3,
            "explanation": "The predicted answer accurately identifies the #liver# as the target for pancreatic metastasis via the portal vein and describes cerebral challenges due to the brain's anatomy and lack of regeneration. However, it does not specify brain metastasis is rarer, which is a key point missing."
        },
        {
            "query_idx": 686,
            "query": "What emergent effects might arise from employing agents designed to obscure the cryptic dialogue within oncogenic landscapes, specifically through Hedgehog signaling inhibitors, in the endeavor to attenuate the relentless tide of cancerous proliferation?",
            "retrieved_metrics": {
                "reference_idx": [
                    422
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The use of Hedgehog #inhibitors# is likely to #slow down# cancer progression by affecting the tumor microenvironment and metastasis.",
            "predicted_answer": "Employing Hedgehog signaling inhibitors may reduce cancer progression and metastasis by disrupting the cryptic dialogue within oncogenic landscapes, potentially attenuating cancerous proliferation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer regarding the use of Hedgehog inhibitors to affect cancer progression and metastasis. However, it lacks reference to the specific key fact of #slowing down# cancer progression. Overall, the trend is aligned, but one key fact is missing."
        },
        {
            "query_idx": 687,
            "query": "What distinct junctures in the voyage of neoplastic cellular transitions, characterized by shifts in identity and spatial engagements, elucidate potential interventional loci promising for therapeutic modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    421
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The distinct junctures include #epithelial-mesenchymal transformation# at the primary tumor, migration as #circulating tumor cells#, and formation of metastatic colonies in distant organs.",
            "predicted_answer": "The distinct junctures in neoplastic cellular transitions include epithelial-mesenchymal transformation, migration as circulating tumor cells, and formation of metastatic colonies in distant organs, offering potential therapeutic targets for intervention.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts emphasized in the Reference Answer, specifically the \"epithelial-mesenchymal transformation,\" \"circulating tumor cells,\" and \"formation of metastatic colonies in distant organs.\" The overall trend and key details are consistent and well-aligned."
        },
        {
            "query_idx": 688,
            "query": "What intricate interplay exists within the oncogenic biosphere when the mechanistic catalyst known as mTOR is modulated, ensuing in a potential bifurcation of chemotherapy resilience and susceptibility among malignant cellular contingencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    423
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The modulation of #mTOR# influences an intricate interplay, potentially leading to bifurcation by fostering #chemotherapy resistance# and simultaneously increasing chemosensitivity in certain cancer cell populations.",
            "predicted_answer": "The modulation of mTOR can lead to a complex interplay where mTOR inhibition initially promotes chemotherapy resistance but paradoxically enhances chemosensitivity in resistant cancer cells, highlighting the intricate balance between chemotherapy resilience and susceptibility.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: modulation of mTOR, chemotherapy resistance, and increased chemosensitivity. It captures the same intricate balance and bifurcation concept mentioned in the reference. There are no significant omissions or contradictions, ensuring alignment with the reference's key points."
        },
        {
            "query_idx": 689,
            "query": "What paradigm of therapeutic intervention, utilizing biomimetic nanostructures cloaked in platelet-like membranes, was evidenced to disrupt the metastatic trajectory orchestrated by CTCs and simultaneously orchestrate the assembly of immune sentinels within a rodent oncological framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    425
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #paradigm# utilizes #platelet-coated# nanoparticles to prevent metastasis formation and recruit T cells to CTCs, as demonstrated in a rodent cancer model.",
            "predicted_answer": "The paradigm of therapeutic intervention involves using platelet-membrane biomimetic nanostructures to disrupt the metastatic trajectory of CTCs and assemble immune sentinels within a rodent oncological framework.",
            "score": 3,
            "explanation": "The predicted answer closely aligns with the reference answer, capturing the essential concept of using biomimetic nanostructures to disrupt metastatic trajectories and assemble immune cells. However, it omits 'platelet-coated' and 'recruit T cells,' which are crucial and affect completeness."
        },
        {
            "query_idx": 690,
            "query": "In what manner do primary molecular access points and additional cellular channels orchestrate the intricate engagement process of AAV serotype 2 with the cellular microenvironment?",
            "retrieved_metrics": {
                "reference_idx": [
                    433
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Primary molecular access points like #heparan sulfate proteoglycans# coordinate with secondary receptors such as #FGFR# and c-Met to mediate AAV2's engagement with cellular environments.",
            "predicted_answer": "AAV serotype 2 engages with the cellular microenvironment through primary receptors like heparan sulfate proteoglycans and secondary receptors such as fibroblast growth factor receptor (FGFR) and integrin.",
            "score": 3,
            "explanation": "The predicted answer includes key facts like \"heparan sulfate proteoglycans\" and \"FGFR\" but omits \"c-Met,\" a secondary receptor emphasized in the reference answer. The overall trend aligns, but the omission of \"c-Met\" impacts completeness."
        },
        {
            "query_idx": 691,
            "query": "Amidst the intricate dance of cellular safeguard and genetic augmentation, wherein viral vectors are meticulously harnessed as agents of genetic restoration, what array of pathophysiological phenomena is presently under systematic investigation within the context of clinical trial enterprises exploring these viral avenues for gene transfer therapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    432
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Viral vectors are being investigated in clinical trials for treating #cardiovascular# diseases, muscular, metabolic, neurological, hematological, ophthalmological diseases, infectious disorders, and #cancers#.",
            "predicted_answer": "Pathophysiological phenomena under investigation include cardiovascular, muscular, metabolic, neurological, hematological, ophthalmological diseases, infectious disorders, and cancers, using viral vectors like adenovirus, AAV, retroviral, and lentiviral vectors.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts marked by #: cardiovascular diseases and cancers, along with the other pathophysiological phenomena listed in the reference. There are no omissions or contradictions in important details, ensuring consistency with the reference."
        },
        {
            "query_idx": 692,
            "query": "What critical juncture marked the cessation of uninhibited zeal for genetic therapy explorations at the tail end of the 20th century?",
            "retrieved_metrics": {
                "reference_idx": [
                    434
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The critical juncture was the #1999# death of an #18-year-old# receiving gene therapy, which resulted in a lethal immune reaction.",
            "predicted_answer": "The critical juncture was the 1999 death of an 18-year-old patient due to a lethal immune reaction to a viral vector in a gene therapy trial.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: the year #1999#, the #18-year-old# patient, the gene therapy trial, and the lethal immune reaction. It aligns with the reference without omissions or contradictory information, covering all essential points."
        },
        {
            "query_idx": 693,
            "query": "What transformative episode catalyzed a significant alteration in the pathway of gene-therapy innovations, inducing a notable hiatus in the realm of biomedical exploration, eventually leading to a rejuvenation period?",
            "retrieved_metrics": {
                "reference_idx": [
                    436
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The transformative episode was the activation of an #oncogene# in five SCID-X1 children causing #leukemia#, halting gene-therapy development until a recent renaissance.",
            "predicted_answer": "The transformative episode was the activation of an oncogene in SCID-X1 patients, causing leukemia and halting gene therapy development until a recent renaissance.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key aspects: activation of an oncogene, SCID-X1, leukemia, halt in gene therapy, and a renaissance. However, it lacks the specific detail of \"five children,\" leaving out one key fact. The overall trend is aligned, but completeness is slightly affected."
        },
        {
            "query_idx": 694,
            "query": "Which pioneering intervention, delivered by a molecular chariot and marking a significant milestone in the authoritative quest to rectify an inherited metabolic conundrum, emerged as the foremost sanction of its kind within the domain of rAAV-transported solutions?",
            "retrieved_metrics": {
                "reference_idx": [
                    437
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pioneering intervention is #alipogene tiparvovec# (Glybera), an #EMA-approved# gene therapy using rAAV to treat familial lipoprotein lipase deficiency, approved in 2012.",
            "predicted_answer": "Alipogene tiparvovec (Glybera), an rAAV-based gene therapy, marked a significant milestone as the first EMA-approved intervention for familial lipoprotein lipase deficiency (LPLD).",
            "score": 3,
            "explanation": "The predicted answer mentions \"Alipogene tiparvovec (Glybera)\" and acknowledges its status as an \"rAAV-based gene therapy\" and the \"first EMA-approved intervention,\" aligning with key facts from the reference. However, it omits the #2012 approval year#, a significant detail. Hence, it is generally aligned but incomplete."
        },
        {
            "query_idx": 695,
            "query": "In the context of a transgenic murine conduit simulating the visceral journey of prostate carcinoma towards osseous territories, what sophisticated biochemical confrontation was employed to avert the skeletal ensnarement by malignant cells, and through what intricate cellular ballet did it execute its preventive quest?",
            "retrieved_metrics": {
                "reference_idx": [
                    424
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Atelocollagen-delivered #miR-16# was used to prevent skeletal metastasis by regulating #cell-cycle control# genes in a prostate cancer murine model.",
            "predicted_answer": "A sophisticated biochemical confrontation employed to avert skeletal ensnarement by malignant cells in a transgenic murine conduit involved the delivery of tumor-suppressive miR-16 via atelocollagen, which inhibited bone metastasis by regulating cell-cycle control genes.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of #miR-16# and #cell-cycle control#, aligned with the overall trend of the reference answer. It correctly identifies the atelocollagen delivery method and the purpose of inhibiting bone metastasis, with no significant omissions or errors."
        },
        {
            "query_idx": 696,
            "query": "What conceptual frameworks or strategic insights inspire the advent of gene therapy as a paradigm-shifting solution for hemophilia A, considering the intricate balance of its therapeutic promise against the enduring complexities of existing treatment modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    443
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The advent of #gene therapy# as a paradigm-shifting solution for hemophilia A is inspired by the promise of a curative approach and reducing the #bleeding phenotype# substantially.",
            "predicted_answer": "Gene therapy for hemophilia A is inspired by the need for a curative approach, addressing the burdens of lifelong injections and high costs. The success of emicizumab highlights the potential of mimicking factor VIII, while raising factor levels above 10-15% reduces bleeding, justifying gene therapy's promise.",
            "score": 3,
            "explanation": "The predicted answer captures the idea of gene therapy as a curative approach, addressing lifelong issues in hemophilia A treatment, aligning with the reference. However, it misses the specific emphasis on the \"bleeding phenotype.\" This key fact omission affects the answer's completeness."
        },
        {
            "query_idx": 697,
            "query": "What are the dual impediments that manifest as fading echoes of transgene presence within the vector-borne genetic blueprint in rAAV-mediated therapeutic ventures?",
            "retrieved_metrics": {
                "reference_idx": [
                    439
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transgene presence fades due to #episomal loss# during cell division, and #epigenetic silencing# of vector genomes, necessitating redosing in rAAV-mediated therapies.",
            "predicted_answer": "The dual impediments are the loss of episomes during cell division and epigenetic silencing of the vector genome, leading to fading transgene expression and necessitating redosing, which faces barriers from the host's immune response.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts of #episomal loss# and #epigenetic silencing# as mentioned in the reference answer. It also accurately describes the consequences, such as fading transgene expression and the need for redosing. The overall meaning and important details are consistent with the reference."
        },
        {
            "query_idx": 698,
            "query": "Within the hepatic microcosm, which cellular architects primarily oversee the liberation of factor VIII, and what ripple effects do these entities engender in the clinical symphony of hemophilia A's characteristic manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    442
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Factor VIII is primarily released by #sinusoidal endothelial# cells in the liver, and its deficiency in hemophilia A leads to joint and muscle bleeding, causing significant morbidity.",
            "predicted_answer": "Sinusoidal endothelial cells in the liver primarily oversee the liberation of factor VIII. A deficiency in factor VIII leads to hemophilia A, characterized by frequent joint and muscle bleeds, potentially causing hemophilic joint arthropathy and intracranial bleeds.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the \"sinusoidal endothelial\" cells' role in releasing factor VIII and explains the resulting effects on hemophilia A, matching the reference answer's focus on joint and muscle bleeding. The trend and key facts are consistent, with no significant omissions."
        },
        {
            "query_idx": 699,
            "query": "In the intricate symphony of genetic engineering aimed at addressing hemophilia A, what nuanced alteration within the AAV5 molecular conveyance mechanism enabled it to encapsulate and convey the recontextualized blueprint of the coagulation FVIII gene, surmounting inherent dimensional limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    445
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #AAV5 vector# encapsulates the #B-domain deleted# version of the coagulation FVIII gene, reducing its size to 4.9 kb to fit within packaging constraints.",
            "predicted_answer": "The nuanced alteration within AAV5 involved encapsulating a B-domain deleted version of the coagulation FVIII gene, reducing its size to 4.9 kb, which slightly surpasses the vector packaging capacity but enables conveyance.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: use of the #AAV5 vector#, #B-domain deleted version# of the gene, and its reduced size for packaging. The slight variance in phrasing does not affect the overall alignment and completeness of the answer."
        },
        {
            "query_idx": 700,
            "query": "What potential metamorphoses within the chronicle of managing congenital coagulopathies do prolonged-release medical agents herald, especially when juxtaposed with the enduring tribulations of perpetual therapeutic regimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    446
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Prolonged-release agents in congenital coagulopathy management could ease #therapeutic burden# by reducing the frequency of intravenous injections and improving #bioavailability# of clotting factors.",
            "predicted_answer": "Prolonged-release medical agents can reduce the frequency of intravenous injections and improve bioavailability, easing the burden of lifelong therapy for congenital coagulopathies.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts from the Reference Answer: reducing the frequency of intravenous injections and improving bioavailability, thus easing the therapeutic burden of lifelong therapy. There are no significant omissions, and the meaning is consistent with the reference."
        },
        {
            "query_idx": 701,
            "query": "What intrinsic factor enables Hemgenix to perpetuate enduring genetic presence, whereas Roctavian contends with diminishing molecular continuity within circulatory networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    451
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An intrinsic factor enabling #Hemgenix#'s enduring genetic presence is the #FIX-Padua variant#, which provides sustainable higher activity, unlike Roctavian's declining plasma FVIII levels.",
            "predicted_answer": "Hemgenix perpetuates enduring genetic presence due to sustainable transgene expression of FIX, while Roctavian contends with diminishing molecular continuity due to declining plasma levels of FVIII.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies Hemgenix's enduring genetic presence due to the sustainable expression of FIX, and it notes the diminishing levels of FVIII in Roctavian. However, it misses the specific fact about the \"FIX-Padua variant\" emphasized in the reference answer."
        },
        {
            "query_idx": 702,
            "query": "What are the inherent attributes and biological nuances that lend extracellular vesicles superiority as conveyors of therapeutic genetic blueprints when juxtaposed against the conventional viral entities within gene therapy paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    455
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Extracellular vesicles are superior due to their #non-immunogenic# nature, #biodegradability#, universal availability, and ability to cross biological barriers, including the blood-brain barrier.",
            "predicted_answer": "Extracellular vesicles (EVs) are superior due to their non-immunogenic nature, biodegradability, universal cell origin, and ability to traverse biological barriers, making them a promising alternative to viral vectors in gene therapy.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by mentioning the non-immunogenic nature, biodegradability, universal origin, and ability to traverse biological barriers of extracellular vesicles. However, it omits the specific reference to the blood-brain barrier, which is a key fact in the reference."
        },
        {
            "query_idx": 703,
            "query": "How do the intricate refinements within the architecture of AAV vectors orchestrate the amplified efficacy of gene therapy 2.0, heralding a substantial departure from the foundational limitations of its antecedent iteration?",
            "retrieved_metrics": {
                "reference_idx": [
                    450
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate refinements in #AAV vectors# lead to #amplified efficacy# by enabling targeted transgene delivery and optimizing packaging, reducing risks like insertional mutagenesis compared to gene therapy 1.0.",
            "predicted_answer": "The intricate refinements in AAV vectors enhance gene therapy 2.0 by optimizing transgene delivery, expression, and safety, overcoming the limitations of gene therapy 1.0.",
            "score": 3,
            "explanation": "The predicted answer mentions enhancements in AAV vectors and improved transgene delivery and safety, aligning with the reference's mention of targeted delivery and risk reduction. However, it lacks specifics on optimizing packaging and insertional mutagenesis, missing one key fact."
        },
        {
            "query_idx": 704,
            "query": "In the intricate ballet of molecular change, what role do the evolving architectures of DNA methylation blueprints play in weaving the tale of tumor advancement and the enigmatic journey of metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    458
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Evolving #DNA methylation# architectures orchestrate tumor #progression# and metastasis by altering methylation patterns, impacting gene expression in tumors.",
            "predicted_answer": "Evolving DNA methylation blueprints play a crucial role in tumor advancement and metastasis by orchestrating shifts in methylation patterns, influencing gene expression and cellular behavior.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized in the reference answer: \"DNA methylation,\" \"tumor advancement\" (similar to \"tumor progression\"), and the impact on \"gene expression\" and \"metastasis.\" The overall trend and meaning of the reference are captured without contradictions."
        },
        {
            "query_idx": 705,
            "query": "In the grand chessboard of cellular transformation, how does the fluidity of epigenomic modulation enhance its appeal for novel therapeutic avenues, juxtaposed with the unyielding nature of genomic alterations in crafting anticancer strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    460
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #fluidity# of epigenomic modulation enhances therapeutic appeal through its #reversibility# compared to the unyielding nature of permanent genomic alterations in anticancer strategies.",
            "predicted_answer": "The fluidity of epigenomic modulation enhances its appeal for novel therapeutic avenues by allowing reversibility, contrasting with the unyielding nature of genomic alterations, which are irreversible and less tractable for anticancer strategies.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key facts and meaning present in the reference answer. It accurately reflects the importance of the #fluidity# and #reversibility# of epigenomic modulation, contrasting with the #unyielding nature# of genomic alterations in anticancer strategies, without any significant omissions or contradictions."
        },
        {
            "query_idx": 706,
            "query": "What nuanced divergence manifests within the cellular microcosms of life, when juxtaposing the cryptic silencing rituals of promoter-anchored CpG islands with the ubiquitous yet subtly structured methylation of gene bodies, across the dualistic nature of oncogenic and physiologic cellular realities?",
            "retrieved_metrics": {
                "reference_idx": [
                    463
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Promoter-anchored CpG #hypermethylation# silences tumor suppressor genes in #cancer# cells, while gene body methylation maintains active gene expression in normal physiology, but diminishes in cancer.",
            "predicted_answer": "In oncogenic cells, promoter-anchored CpG island hypermethylation silences tumor suppressor genes, while gene body methylation is prevalent in active genes in physiologic cells. Cancer cells exhibit global DNA methylation loss, promoting chromosomal instability.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of CpG island hypermethylation silencing tumor suppressor genes in cancer cells and gene body methylation's role in active gene expression, aligning with the reference. However, it omits that gene body methylation diminishes in cancer, affecting completeness."
        },
        {
            "query_idx": 707,
            "query": "What mechanisms do the consortiums of bromodomain and extraterminal segment components and methyl-CpG-binding domain factions employ to decode the epigenetically marked lexicon on histone filaments, thereby modulating chromatin architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    462
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Bromodomain# proteins recognize acetylated lysines, while #Methyl-CpG-binding# domain proteins bind methylated DNA, modulating chromatin architecture to influence transcriptional activation or repression.",
            "predicted_answer": "The consortiums of bromodomain and extraterminal segment components (BETs) and methyl-CpG-binding domain factions (MBDs) decode epigenetic marks on histone filaments by recognizing specific modifications like acetylated lysines and methylated DNA, respectively, to modulate chromatin architecture and transcriptional activity.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts from the reference answer: bromodomain proteins recognizing acetylated lysines and methyl-CpG-binding domain proteins binding methylated DNA to modulate chromatin architecture. It aligns well with the trend and contains the essential details without contradiction."
        },
        {
            "query_idx": 708,
            "query": "What role did the chemical allure of bisulfite-treated strands play as a navigational compass in elucidating the epigenetic alchemy of methyl motifs, thereby unveiling hidden patterns embedded within the molecular tapestry of oncogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    469
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #chemical allure# of bisulfite-treated strands enabled #genome-wide# mapping of methylated cytosines, revealing crucial patterns in cancer epigenetics.",
            "predicted_answer": "Bisulfite-treated strands provided a chemical contrast to distinguish methylated from unmethylated CpGs, enabling precise mapping of DNA methylation patterns crucial for uncovering epigenetic mechanisms in oncogenesis.",
            "score": 3,
            "explanation": "The predicted answer captures the functional role of bisulfite-treated strands in identifying DNA methylation, aligning with the highlighted key fact of \"chemical allure.\" However, it lacks the specific detail of \"genome-wide\" mapping present in the reference answer."
        },
        {
            "query_idx": 709,
            "query": "What are the salient molecular architectures or functional motifs deployed in the intricate dance of capturing epigenetic signatures, marked notably by their selective engagement with methyl-laden cytosine epitopes?",
            "retrieved_metrics": {
                "reference_idx": [
                    470
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Antibodies# against methylated DNA and #MBD proteins# are key motifs for capturing epigenetic signatures, specifically targeting methylated cytosine epitopes.",
            "predicted_answer": "The salient molecular architectures include antibodies against methylated DNA (MeDIP) and methyl-CpG-binding domain proteins (MBDs), which selectively engage with methyl-laden cytosine epitopes.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both 'antibodies against methylated DNA' and 'MBD proteins,' which are the key motifs for targeting methyl-laden cytosine epitopes, as emphasized in the 'Reference Answer.' No key facts are missing, and the overall meaning aligns well with the reference."
        },
        {
            "query_idx": 710,
            "query": "What is the transformative influence of the Human MethylationEPIC BeadChip in the sophisticated landscape of tumor genome decryption, specifically through its synergistic alignment with enhancer sites discovered by ambitious genomic cartography endeavors like ENCODE and FANTOM5, as elucidated in modern characterization efforts?",
            "retrieved_metrics": {
                "reference_idx": [
                    474
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Human MethylationEPIC BeadChip# enhances tumor genome decoding by integrating CpG sites in enhancer regions identified by #ENCODE# and FANTOM5, improving epigenomic characterization of tumors.",
            "predicted_answer": "The Human MethylationEPIC BeadChip significantly enhances tumor genome decryption by integrating CpG sites from enhancer regions identified by ENCODE and FANTOM5, providing a comprehensive epigenomic characterization of human tumors.",
            "score": 5,
            "explanation": "The predicted answer includes all the key elements from the reference: the Human MethylationEPIC BeadChip, the CpG sites, and the involvement of ENCODE and FANTOM5 in enhancing tumor genome decryption and epigenomic characterization. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 711,
            "query": "What is the inherent superiority of nanopore sequencing in altering the landscape of methylation detection through its unique electric signal modulation as compared to the traditional chemical transformations employed by bisulfite treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    476
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Nanopore sequencing's #electric current intensity# detection directly identifies DNA methylation, unlike bisulfite treatment's #chemical transformations#, offering a more direct and potentially simpler method.",
            "predicted_answer": "Nanopore sequencing's inherent superiority lies in its ability to directly detect DNA methylation through electric signal modulation, bypassing the need for traditional chemical transformations like bisulfite treatment, thus offering more precise and efficient methylation detection.",
            "score": 3,
            "explanation": "The predicted answer captures the key ideas of nanopore sequencing detecting methylation through electric signal modulation and contrasting with bisulfite's chemical transformations. However, it does not explicitly mention \"electric current intensity\" emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 712,
            "query": "How does the steadfast nature of epigenetic whispers — specifically DNA methylation — bestow upon it a notable advantage in the complex orchestration of specimen transitions and analytic endeavors within clinical paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    477
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #stability# of #DNA methylation# ensures its reliability in clinical specimen transitions and analyses, unaffected by sample processing or storage conditions.",
            "predicted_answer": "DNA methylation's steadfast nature ensures stability, unaffected by sample processing or storage, making it reliable for precise specimen transitions and analytic endeavors in clinical paradigms.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts from the reference answer: the stability of DNA methylation, its reliability in clinical processes, and its resilience against sample processing or storage conditions. Both answers share consistent meaning and align well without significant omissions."
        },
        {
            "query_idx": 713,
            "query": "What detective procedure effectively illuminates a substantial spectrum of CpG archipelagos by deploying a methylation-unaffected cleavage instrument in the intricate matrix of genomic exploration, and which paramount cog is customarily engaged in this scientific odyssey?",
            "retrieved_metrics": {
                "reference_idx": [
                    472
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Reduced-representation bisulfite sequencing effectively illuminates a substantial spectrum of #CpG islands# by using a #methylation-insensitive# restriction endonuclease, typically MspI.",
            "predicted_answer": "Reduced-representation bisulfite sequencing effectively illuminates CpG archipelagos by using a methylation-insensitive CpG restriction endonuclease, typically MspI, to capture 85% of CpG islands.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: \"CpG islands\" and \"methylation-insensitive\" restriction endonuclease with MspI. It aligns with the overall trend of the reference and introduces no contradictions. However, it claims a capture of \"85% of CpG islands,\" which is not emphasized in the reference."
        },
        {
            "query_idx": 714,
            "query": "What triadic constructs serve as the scaffolding for the stratification of experimental inquiries centered on the diagnostic and prognostic utility of epigenetic modulation through DNA methylation?",
            "retrieved_metrics": {
                "reference_idx": [
                    481
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triadic constructs are: #market#, #investigative#, and exploratory categories of clinical trials involving DNA methylation-based strategies.",
            "predicted_answer": "The triadic constructs serving as scaffolding for the stratification of experimental inquiries are market, investigative, and exploratory categories, focusing on DNA methylation-based strategies.",
            "score": 1,
            "explanation": "The predicted answer includes \"market\" and \"investigative,\" aligning partially with the reference answer. However, it omits the specific context of \"clinical trials,\" which is a crucial detail emphasized in the reference answer. This affects the completeness significantly."
        },
        {
            "query_idx": 715,
            "query": "What foundational dynamics govern the intricate variability observed in ctDNA amidst the cfDNA continuum, and what drives the necessity for utilizing bespoke containment to safeguard the integrity of diagnostic evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    482
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The variability in ctDNA amidst the cfDNA continuum is governed by factors like #tumor volume# and #cancer stage#, necessitating bespoke containment to prevent masking of ctDNA signals.",
            "predicted_answer": "The foundational dynamics governing ctDNA variability include tumor volume, localization, vascularization, and tumor type. The necessity for bespoke containment arises to prevent nucleated cell lysis, ensuring accurate diagnostic evaluations by preserving the integrity of ctDNA signal amidst cfDNA.",
            "score": 3,
            "explanation": "The predicted answer covers tumor volume but omits the key fact of cancer stage mentioned in the reference. Additionally, while it mentions preventing nucleated cell lysis, it doesn't explicitly state the prevention of ctDNA signal masking as a necessity for containment. Thus, overall completeness is affected."
        },
        {
            "query_idx": 716,
            "query": "What embodies the unique diagnostic signature among individuals, within the experimental continuum denoted NCT01397747, whose prognostic pathways exhibit either subdued or void developments?",
            "retrieved_metrics": {
                "reference_idx": [
                    485
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unique diagnostic signature is embodied by #nonadvanced/negative findings# with higher specificity in #FIT# (86.6% vs. 94.9%), within the NCT01397747 trial.",
            "predicted_answer": "The unique diagnostic signature among individuals in NCT01397747 is characterized by higher specificity in FIT for nonadvanced or negative findings, as compared to Cologuard.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of higher specificity in FIT for nonadvanced or negative findings within the NCT01397747 trial but omits the exact specificity percentages (86.6% vs. 94.9%). While the central ideas are conveyed, this omission affects completeness."
        },
        {
            "query_idx": 717,
            "query": "How is the temporal framework for CRC diagnostic revival intervals crafted by the trio of health governance bodies—NCCN, ACS, and FDA—within their sanctioned protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    486
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #NCCN# and #ACS# recommend CRC rescreening every 3 years, aligning with FDA approval.",
            "predicted_answer": "The temporal framework for CRC diagnostic revival intervals is crafted by the NCCN, ACS, and FDA to suggest rescreening every 3 years, as approved by the FDA.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference answer, containing the key facts regarding rescreening intervals and FDA approval. However, it incorrectly mentions the FDA as a recommending body instead of aligning with their approval, impacting the completeness. Thus, one key fact is inaccurately reflected."
        },
        {
            "query_idx": 718,
            "query": "In the domain of post-therapeutic biochemical landscapes, what is the quantified advancement propensity, manifesting as hazard potential, associated with the presence of genetic disturbance markers compared to their absence, specifically concerning the trajectory of deterioration?",
            "retrieved_metrics": {
                "reference_idx": [
                    488
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #BCAT1/IKZF1-methylated# ctDNA after treatment increases the hazard potential for disease progression by a #hazard ratio of 9.7# compared to its absence.",
            "predicted_answer": "The presence of BCAT1 or IKZF1 methylated ctDNA after treatment is associated with a significantly higher hazard potential for disease progression (HR, 9.7; 95% CI, 2.5-37.6) compared to their absence.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key facts emphasized in the reference answer, such as the presence of \"BCAT1 or IKZF1 methylated ctDNA\" and the \"hazard ratio of 9.7\". The wording may differ, but the essential information and trends are accurately captured with no omissions."
        },
        {
            "query_idx": 719,
            "query": "What roles do the complex architectures of epigenetic frameworks play in guiding the transformation journey from initial latent cervical epithelial stages to advanced precursors of malignancy, thereby supporting the innovation of diagnostic pathways for in vitro medical exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    492
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #epigenetic frameworks# guide the transformation from #CIN1 to CIN3#, supporting innovation in diagnostic pathways for developing in vitro diagnostic medical devices.",
            "predicted_answer": "The complex architectures of epigenetic frameworks guide the transformation from latent cervical epithelial stages to advanced precursors of malignancy by influencing neoplastic progression. This supports the innovation of diagnostic pathways for in vitro medical exploration by identifying epigenetic biomarkers, enhancing the accuracy of cervical cancer risk assessment.",
            "score": 3,
            "explanation": "The Predicted Answer covers the role of epigenetic frameworks and their contribution to diagnostic innovations. However, it lacks specificity regarding the stages from CIN1 to CIN3 mentioned in the Reference Answer. The general trend aligns, but it misses one key fact affecting completeness."
        },
        {
            "query_idx": 720,
            "query": "Within the landscape of negative outcomes from prevalent viral diagnostics, what role do the identified molecular signatures play as epigenetic hallmarks in discerning the profound intricacies that distinguish severe intra-cervical lesions from mere inflammatory or minor dysplastic presentations?",
            "retrieved_metrics": {
                "reference_idx": [
                    498
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular signatures of #EPB41L3 and JAM3# methylation identify severe intra-cervical lesions by differentiating ≥CIN2 from inflammation/CIN1 in cases negative for #hrHPV#.",
            "predicted_answer": "Molecular signatures, such as EPB41L3 and JAM3 methylation, serve as epigenetic hallmarks that differentiate severe intra-cervical lesions (≥ CIN2) from minor presentations (CIN1/inflammation) in cases with negative hrHPV results.",
            "score": 5,
            "explanation": "The predicted answer contains all the essential elements of the reference answer: the mention of \"EPB41L3 and JAM3\", their role as epigenetic hallmarks, and the differentiation of severe intra-cervical lesions from minor presentations in negative hrHPV cases. The key facts and overall trends are completely aligned."
        },
        {
            "query_idx": 721,
            "query": "In what manner does QIAsure employ its advanced methodological framework to transcend standard genomic limitations and uncover diverse cervical cancer manifestations, including those elusive to hrHPV-based identification protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    500
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "QIAsure examines #methylation# of FAM19A4 and hsa-mir124-2, detecting >98% of cervical cancers, including rare cases and those missed by hrHPV identification protocols.",
            "predicted_answer": "QIAsure employs its advanced methodological framework by analyzing the methylation status of FAM19A4 and hsa-mir124-2, enabling the detection of over 98% of cervical cancers, including rare histotypes and hrHPV-negative cases.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, addressing the methylation analysis of FAM19A4 and hsa-mir124-2, and identifying over 98% of cervical cancers, including rare and hrHPV-negative types. All key facts are covered with no contradictions or omissions."
        },
        {
            "query_idx": 722,
            "query": "What is the characteristic temporal endurance median for patients manifesting overt clinical symptoms in the advanced progression stage of hepatocellular carcinoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    497
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The characteristic temporal endurance median for patients with overt clinical symptoms in advanced-stage hepatocellular carcinoma is #12-18 months#.",
            "predicted_answer": "The characteristic temporal endurance median for patients manifesting overt clinical symptoms in the advanced progression stage of hepatocellular carcinoma is 12-18 months.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact emphasized in the reference answer: the temporal endurance median of 12-18 months for patients with advanced-stage hepatocellular carcinoma. There are no significant omissions, errors, or contradictions, making the responses consistent in meaning."
        },
        {
            "query_idx": 723,
            "query": "In the realm of genetic diagnostics, what particular epigenetic signatures does the EsoGuard assay examine to elucidate the concealed affliction of Barrett esophagus within its molecular confines?",
            "retrieved_metrics": {
                "reference_idx": [
                    505
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "EsoGuard examines epigenetic signatures of hypermethylation in #CCNA1# and #VIM# genes to detect Barrett esophagus.",
            "predicted_answer": "The EsoGuard assay examines DNA methylation markers CCNA1 and VIM in esophageal brush cells to detect Barrett esophagus.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, covering the key facts of examining DNA methylation markers in the CCNA1 and VIM genes for detecting Barrett esophagus. The meaning and technical details are consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 724,
            "query": "Within the context of the DOCUMENT examination, what delineated interval demarks the probability permutation indicator when esteemed as an autonomous forecasting element by the epigenetic scrutiny lens?",
            "retrieved_metrics": {
                "reference_idx": [
                    509
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DOCUMENT# study identified the interval as #OR 2.69, 95% CI 1.60-4.51# for the epigenetic assay as an autonomous forecasting element.",
            "predicted_answer": "The delineated interval that demarks the probability permutation indicator as an autonomous forecasting element by the epigenetic scrutiny lens is the 95% confidence interval (CI), which ranges from 1.60 to 4.51 in the DOCUMENT examination.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the 95% confidence interval (CI) ranging from 1.60 to 4.51 and mentions the DOCUMENT examination, matching the reference. However, it omits the \"OR 2.69\" value, leading to incomplete coverage of key facts. Overall trends are aligned."
        },
        {
            "query_idx": 725,
            "query": "What are the perceptual precision and forecast reliability statistics of the neoplastic categorization apparatus when discerning the complexities of CUP biopsy analyses, as depicted in validation metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    511
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #neoplastic categorization apparatus# shows #99.6% specificity# and 97.7% sensitivity in CUP biopsy analyses, with 88.6% PPV and 99.9% NPV across 7691 tumors in validation metrics.",
            "predicted_answer": "The neoplastic categorization apparatus exhibits high perceptual precision and forecast reliability in CUP biopsy analyses, with 99.6% specificity, 97.7% sensitivity, 88.6% PPV, and 99.9% NPV in a validation set of 7691 tumors.",
            "score": 5,
            "explanation": "The Predicted Answer contains all the key statistics emphasized in the Reference Answer, including specificity (99.6%), sensitivity (97.7%), PPV (88.6%), NPV (99.9%), and the validation set size (7691 tumors). The answers are highly consistent in meaning and completeness."
        },
        {
            "query_idx": 726,
            "query": "What level of predictive precision characterizes the alignment of diagnostic signals in determining the specific oncological categorization, expressed in terms of reliability percentages?",
            "retrieved_metrics": {
                "reference_idx": [
                    514
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predictive precision of diagnostic signals for cancer categorization is characterized by a #97%# accuracy.",
            "predicted_answer": "The alignment of diagnostic signals in determining specific oncological categorization has a predictive precision of 97% in terms of reliability percentages.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact of a #97%# precision highlighted in the reference answer. Both answers convey the same information regarding the reliability percentages of diagnostic signals in cancer categorization, with no significant omissions or errors."
        },
        {
            "query_idx": 727,
            "query": "In what manner does the Therascreen PITX2 RGQ PCR assay function as a critical instrument for prognostic analysis, especially regarding its influence on therapeutic expectations and decisions for breast cancer patients classified as high-risk undergoing chemotherapy regimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    516
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The Therascreen PITX2 RGQ PCR assay is a #robust# test predicting the outcome of #anthracycline#-based chemotherapy in high-risk breast cancer patients, aiding prognostic analysis and therapeutic decisions.",
            "predicted_answer": "The Therascreen PITX2 RGQ PCR assay predicts outcomes of anthracycline-based chemotherapy in high-risk breast cancer patients by assessing PITX2 promoter methylation, influencing therapeutic expectations and decisions.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of the Therascreen PITX2 RGQ PCR assay predicting outcomes for anthracycline-based chemotherapy and its role in influencing therapeutic decisions for high-risk breast cancer patients. However, it doesn't mention the assay being \"robust,\" slightly affecting completeness."
        },
        {
            "query_idx": 728,
            "query": "What genomic custodians undergo methylation status discernment in biopsies that are bereft of malignant confirmation, thereby informing the clinician's strategic decision regarding subsequent biopsy procedures?",
            "retrieved_metrics": {
                "reference_idx": [
                    507
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #methylation status# of #GSTP1#, APC, and RASSF1 genes is analyzed in biopsies lacking malignant confirmation to guide decisions on repeat prostate biopsies.",
            "predicted_answer": "The genomic custodians GSTP1, APC, and RASSF1 undergo methylation status discernment in PCa-negative biopsies, guiding physician decisions on subsequent prostate biopsies.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: the methylation status of the GSTP1, APC, and RASSF1 genes in biopsies without malignant confirmation, aiding decisions on repeat prostate biopsies. The relevant details are present, with no contradictions or significant omissions."
        },
        {
            "query_idx": 729,
            "query": "How does the employment of DNA methylation profiling as a diagnostic paradigm transform the landscape of accurately discerning and classifying enigmatic malignant entities characterized by petite azure cellular formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    521
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DNA #methylation profiling# enhances precise #classification# of challenging tumors with small blue round cell histology, transforming cancer diagnosis and improving clinical management.",
            "predicted_answer": "DNA methylation profiling enhances accurate classification of small blue round cell tumors, transforming diagnostic precision and improving clinical management.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"DNA methylation profiling,\" \"classification,\" and its role in transforming diagnostic precision for \"small blue round cell tumors,\" aligning with the reference. No significant omissions or errors are present, maintaining consistency with the reference answer."
        },
        {
            "query_idx": 730,
            "query": "How does PanSeer demonstrate its foresight and analytical clarity over the three-to-four-year interlude preceding the conventional horizon of tumor emergence detection?",
            "retrieved_metrics": {
                "reference_idx": [
                    520
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PanSeer demonstrates foresight with #83.9%-95.7% sensitivity# for cancer detection 3-4 years before conventional diagnosis, highlighting its #analytical clarity#.",
            "predicted_answer": "PanSeer demonstrates foresight and analytical clarity by achieving sensitivity rates of 83.9%-95.7% in detecting tumors 3-4 years before conventional diagnosis, with specificities of 94.7%-96.1%.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of achieving sensitivity rates of 83.9%-95.7% and highlights analytical clarity in detecting tumors 3-4 years before conventional diagnosis. It also adds specificity rates, which do not contradict the reference and enhance the answer."
        },
        {
            "query_idx": 731,
            "query": "What innovative paradigm, leveraging a technologically guided symphonic interaction, is being scrutinized in the BRAINFUL initiative to intensify the transmission of neoplastic genetic markers into the circulatory realm?",
            "retrieved_metrics": {
                "reference_idx": [
                    522
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #BRAINFUL# initiative explores using #magnetic resonance-guided focused ultrasound# to transiently disrupt the blood-brain barrier for enhanced release of tumor DNA into circulation.",
            "predicted_answer": "The innovative paradigm being scrutinized in the BRAINFUL initiative is magnetic resonance-guided focused ultrasound, which transiently disrupts the blood-brain barrier to enhance the transmission of neoplastic genetic markers into the circulatory realm.",
            "score": 5,
            "explanation": "The predicted answer accurately describes the key elements emphasized in the reference: the use of \"magnetic resonance-guided focused ultrasound\" and the goal of \"transiently disrupting the blood-brain barrier\" to enhance the transmission of neoplastic genetic markers. All critical facts are present with no omissions."
        },
        {
            "query_idx": 732,
            "query": "Amidst the vast analysis of population health dynamics, what variety of organic substrate is characteristically utilized for the detection of oncological transformations pertaining to the cervix?",
            "retrieved_metrics": {
                "reference_idx": [
                    524
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Exfoliative #cytology# samples are characteristically utilized for the detection of oncological transformations pertaining to the #cervix#.",
            "predicted_answer": "Exfoliative cytology samples are characteristically utilized for the detection of oncological transformations pertaining to the cervix.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It includes all key emphasized facts: \"cytology\" and \"cervix,\" consistent with the essential details provided in the reference answer. There are no omissions or contradictory information."
        },
        {
            "query_idx": 733,
            "query": "In what capacity do cerebrospinal molecular blueprints, characterized by epigenetic landscapes, contribute to steering the vigilance over therapeutic effectiveness and the re-emergence of oncogenic specters in the pediatric medulloblastoma sphere?",
            "retrieved_metrics": {
                "reference_idx": [
                    523
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cerebrospinal molecular blueprints, through #DNA methylation profiles#, help monitor #treatment response# and tumor recurrence in pediatric medulloblastoma, offering insights into therapeutic effectiveness and oncogenic resurgence.",
            "predicted_answer": "Cerebrospinal molecular blueprints, characterized by epigenetic landscapes, contribute to steering therapeutic effectiveness and monitoring tumor recurrence in pediatric medulloblastoma by providing DNA methylation profiles for treatment response and tumor re-emergence detection.",
            "score": 5,
            "explanation": "The predicted answer mentions \"DNA methylation profiles,\" \"treatment response,\" and \"tumor re-emergence,\" capturing all key elements emphasized in the reference. The details align well, with no significant omissions or contradictory information, ensuring the meaning is consistent with the reference answer."
        },
        {
            "query_idx": 734,
            "query": "In the realm of oropharyngeal cancer inquiry, what is the cardinal purpose underpinning the PROMEO trial's analytical endeavor to decipher comparative molecular signatures from salivary samples of affected individuals against those of a control group?",
            "retrieved_metrics": {
                "reference_idx": [
                    526
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PROMEO trial# aims to identify #biomarkers# for noninvasive diagnosis by comparing proteomic and methylation profiles in saliva from oropharyngeal cancer patients with controls.",
            "predicted_answer": "The cardinal purpose of the PROMEO trial's analytical endeavor is to identify robust biomarkers for noninvasive diagnosis of oropharyngeal cancer by comparing proteomic and methylation profiles in salivary samples from affected individuals against a control group.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, covering all key facts: the PROMEO trial, biomarkers, and comparison of proteomic and methylation profiles in salivary samples. There are no significant omissions or contradictions, and the predicted answer is highly consistent with the reference."
        },
        {
            "query_idx": 735,
            "query": "What influence do the orchestrated fluctuations of H3K9 and H3K27 chromatin adaptors exert in the cessation of gene expression dialogues, and in what manner do these epigenetic harmonics play as ambiguous harbingers for the prognostic narrative across various cancer frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    527
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orchestrated #fluctuations# of H3K9 and H3K27 chromatin adaptors lead to #aberrant# gene silencing, influencing prognosis narratives across various cancers.",
            "predicted_answer": "The orchestrated fluctuations of H3K9 and H3K27 chromatin adaptors influence gene silencing in cancers, serving as ambiguous harbingers for prognosis. These epigenetic changes predict cancer risk and recurrence.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by indicating the role of H3K9 and H3K27 in influencing prognosis in cancers and mentions gene silencing. However, it omits the key detail of \"aberrant\" gene silencing. Thus, it misses one key fact affecting completeness."
        },
        {
            "query_idx": 736,
            "query": "What aggregate sum of participant entities do the EC-METHY2 and EC-METHY3 trials propose to converge upon in the pursuit of illuminating the precision evaluation of CDO1 and CELF4 methylation analysis, amidst the broader exploration of these methodologies in cervical cytology samples?",
            "retrieved_metrics": {
                "reference_idx": [
                    525
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EC-METHY2# and #EC-METHY3# trials propose to recruit a total of 17,000 cases for evaluating CDO1 and CELF4 methylation in cervical cytology samples.",
            "predicted_answer": "The EC-METHY2 and EC-METHY3 trials propose to converge upon a total of 17,000 participant cases to evaluate CDO1 and CELF4 methylation in cervical cytology samples.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts and numbers emphasized in the reference answer, including the trials EC-METHY2 and EC-METHY3, the participant count of 17,000, and the focus on evaluating CDO1 and CELF4 methylation in cervical cytology samples. The phrasing differs slightly but the meaning is consistent."
        },
        {
            "query_idx": 737,
            "query": "What biological imprint is strategically utilized in clinically orchestrated inquiries to decode the modulation impact exerted by EZH2-particularized agents on the spectrum of therapeutic response dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    533
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biological imprint strategically utilized is #H3K27me3#, employed as a #biomarker# to decode the modulation impact of EZH2-specific agents on therapeutic response dynamics.",
            "predicted_answer": "The biological imprint strategically utilized in clinically orchestrated inquiries to decode the modulation impact exerted by EZH2-particularized agents on therapeutic response dynamics is H3K27me3 levels, analyzed in blood before and after treatment.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key fact #H3K27me3# but misses the detail that it is employed as a #biomarker#. The answer does not contradict the Reference Answer and aligns with its overall trend but lacks this one emphasized key element."
        },
        {
            "query_idx": 738,
            "query": "What alteration within the epigenetic framework, resembling a molecular fingerprint, serves as a diagnostic compass to differentiate melanoma linked to childhood congenital melanocytic nevi from its benign proliferative counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    529
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #loss of H3K27me3# expression serves as a diagnostic marker to differentiate melanoma from benign proliferative nodules linked to congenital melanocytic nevi.",
            "predicted_answer": "The alteration within the epigenetic framework that serves as a diagnostic compass to differentiate melanoma linked to childhood congenital melanocytic nevi from benign proliferative counterparts is the detection of H3K27me3 expression, which is present in benign nodules but lost in melanomas.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the key epigenetic marker, H3K27me3, and correctly notes that its loss is associated with melanoma. Although the phrasing varies, it captures the essential diagnostic distinction highlighted in the reference answer without introducing contradictions."
        },
        {
            "query_idx": 739,
            "query": "What are the mechanisms through which the infusion of azacitidine into RNA frameworks instigates a series of cascading effects that disrupt the physiological balance in individuals undergoing treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    539
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Azacitidine incorporates into #RNA#, causing ribosomal disassembly and translation prevention, disrupting physiological balance by impairing normal cellular processes in both cancer and normal cells.",
            "predicted_answer": "Azacitidine disrupts physiological balance by incorporating into RNA, inducing ribosomal disassembly, and preventing translation, impairing normal cellular processes and increasing side effects in both cancer and normal cells.",
            "score": 5,
            "explanation": "The predicted answer captures the integration of azacitidine into RNA, leading to ribosomal disassembly and prevention of translation, thus impairing normal cellular processes. It aligns with the reference answer and includes all key facts highlighted, without omissions or contradictions."
        },
        {
            "query_idx": 740,
            "query": "What are the complex biochemical paradigms utilized to navigate the methodical breakdown of enzymatic constructs, such as those belonging to HDAC and BET classes, through the implementation of chimeric dismantlers and adhesive molecular orchestrators within the intricate molecular tapestry of cellular systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    538
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PROTACs and molecular glues utilize the #ubiquitin proteasome# system to degrade #HDACs and BET# proteins within cellular systems.",
            "predicted_answer": "Complex biochemical paradigms include PROTACs and molecular glues that degrade HDACs and BET proteins by hijacking the ubiquitin-proteasome system, targeting acetylated lysines in histone tails.",
            "score": 5,
            "explanation": "The predicted answer includes the key elements: the use of PROTACs and molecular glues, and the degradation of HDACs and BET proteins via the ubiquitin-proteasome system. It captures the main ideas without contradiction or significant omissions, with some added context about targeting acetylated lysines."
        },
        {
            "query_idx": 741,
            "query": "Within the intricate dance of genomic choreography, which specific archetypes of molecular orchestrators stand as focal points for synthetic modulating agents aiming to recalibrate the trajectories of genetic expression through strategic engagements with the epigenetic framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    545
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Specific archetypes of molecular orchestrators as focal points include #epigenetic writers# like DNMTs and #epigenetic erasers# such as LSD1/KDM1A, targeted by synthetic modulating agents.",
            "predicted_answer": "Epigenetic writers (DNMTs, EZH2, DOT1L), erasers (LSD1/KDM1A, HDACs), and readers (BET proteins) are key molecular orchestrators targeted by synthetic modulating agents to influence genetic expression through the epigenetic framework.",
            "score": 5,
            "explanation": "The predicted answer includes all key archetypes: epigenetic writers (DNMTs), erasers (LSD1/KDM1A), and adds more details (EZH2, DOT1L, HDACs, and BET proteins). While the additional details don’t contradict, the key facts in the reference are covered. Thus, it aligns fully with the reference answer."
        },
        {
            "query_idx": 742,
            "query": "What was the achievement rate of the therapeutic alliance comprising venetoclax and azacitidine within the ambit of the investigative pursuit identified as VIALE-A?",
            "retrieved_metrics": {
                "reference_idx": [
                    543
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The achievement rate of the therapeutic alliance in VIALE-A was #37%# for the venetoclax and azacitidine group.",
            "predicted_answer": "The achievement rate of the therapeutic alliance comprising venetoclax and azacitidine in the VIALE-A study was 37% for complete response (CR).",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in terms of the key fact that the achievement rate for the venetoclax and azacitidine group in the VIALE-A study was 37%. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 743,
            "query": "What intricate epigenetic dialogue differentiates GSK3685032 from its pyrimidine predecessors in its selective interplay with DNMT1, crafting a transient yet impactful narrative in DNA's methylation and transcriptional landscape, while demonstrating superior in vivo resilience?",
            "retrieved_metrics": {
                "reference_idx": [
                    548
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "GSK3685032 is a #non-nucleoside# DNMT1 inhibitor that selectively penetrates hemimethylated DNA, inducing rapid hypomethylation and transcription activation, with superior #in vivo# resilience compared to pyrimidine analogs.",
            "predicted_answer": "GSK3685032 differentiates itself from pyrimidine predecessors by being a nonnucleoside, reversible, and selective DNMT1 inhibitor, which competes with DNMT1's active site to induce rapid DNA hypomethylation and transcriptional activation, demonstrating superior in vivo resilience and tolerability.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts that GSK3685032 is a non-nucleoside and has superior in vivo resilience. It aligns with the reference by mentioning DNMT1 inhibition and rapid hypomethylation, yet misses the key detail of selectively penetrating hemimethylated DNA."
        },
        {
            "query_idx": 744,
            "query": "What spheres of therapeutic and safety exploration are intricately examined in the first phase of the OMNIVERSE endeavor, involving the amalgamation of ONUREG and venetoclax, specifically targeting the spectrum of newly diagnosed, relapsed, or resistant states within the realm of acute myeloid leukemia?",
            "retrieved_metrics": {
                "reference_idx": [
                    546
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #OMNIVERSE# phase 1 study examines the #safety# and tolerability of ONUREG with venetoclax in newly diagnosed, relapsed, or refractory acute myeloid leukemia (AML).",
            "predicted_answer": "The first phase of the OMNIVERSE endeavor focuses on evaluating the safety, tolerability, and preliminary efficacy of combining ONUREG with venetoclax in patients with newly diagnosed, relapsed, or resistant acute myeloid leukemia (AML).",
            "score": 3,
            "explanation": "The predicted answer covers most key points from the reference answer, including the focus on safety and tolerability of the combination treatment in specific AML patient states. However, it introduces \"preliminary efficacy,\" which is not mentioned in the reference, and omits \"refractory,\" affecting completeness."
        },
        {
            "query_idx": 745,
            "query": "Within the symphonic exploration merging the essence of guadecitabine with immune arbiters, which oncological spectra are subjected to scrutiny in the diverse tapestry of corporeal afflictions?",
            "retrieved_metrics": {
                "reference_idx": [
                    549
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The combination of guadecitabine with immune arbiters is explored in #lung cancer#, #melanoma#, renal cell carcinoma, and urothelial tumors.",
            "predicted_answer": "The oncological spectra under scrutiny include lung cancer, melanoma, renal cell carcinoma, and urothelial tumors when guadecitabine is combined with immune arbiters like anti-PD1 or anti-PD-L1.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: lung cancer, melanoma, renal cell carcinoma, and urothelial tumors are mentioned as oncological spectra under scrutiny. The meaning is consistent with no significant omissions or errors, aligning fully with the reference."
        },
        {
            "query_idx": 746,
            "query": "How do the orchestration dynamics of DNMTi agents function as integral conductors in the complex interplay of immune checkpoint activation scenarios, thereby potentially enhancing the perceptual acuity of neoplastic cellular entities within the realm of therapeutic synergy?",
            "retrieved_metrics": {
                "reference_idx": [
                    550
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DNMTi agents enhance #tumor visibility# by re-expressing silenced genes, thus potentially improving immune checkpoint inhibitor efficacy and #therapeutic synergy# in cancer treatments.",
            "predicted_answer": "DNMTi agents orchestrate immune checkpoint activation by re-expressing silenced tumor antigens, enhancing tumor visibility to the immune system and potentially improving the efficacy of immune checkpoint inhibitors.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of \"#tumor visibility#\" and the concept of \"#therapeutic synergy#\" by stating that DNMTi agents enhance tumor visibility and potentially improve the efficacy of immune checkpoint inhibitors. The meaning aligns with the reference answer, with no significant omissions."
        },
        {
            "query_idx": 747,
            "query": "Within the intricate symphony of chromatin sculptors, what pivotal non-metallic agent underpins the functional disarmament choreography unique to the subset of histone deacetylases that diverge from zinc-dependent choreography, thereby facilitating their specialized biochemical performance?",
            "retrieved_metrics": {
                "reference_idx": [
                    555
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pivotal non-metallic agent for sirtuins' unique functionality is #nicotinamide adenine dinucleotide (NAD+)#.",
            "predicted_answer": "Nicotinamide adenine dinucleotide (NAD+) is the pivotal non-metallic agent that underpins the functional disarmament choreography in class III histone deacetylases (sirtuins), facilitating their specialized biochemical performance.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies nicotinamide adenine dinucleotide (NAD+) as the pivotal non-metallic agent, aligning perfectly with the reference answer's emphasized key fact. The meaning and specific information are consistent, with no significant omissions or errors observed."
        },
        {
            "query_idx": 748,
            "query": "In the realm of therapeutic exploration pitting radiological and pharmacological forces against neuroblastoma, what was the quantified measure of therapeutic success when MIBG harmonized with vorinostat within the nuanced phase of clinical exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    559
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ORR# when MIBG was combined with vorinostat in the phase 2 trial was #32%#.",
            "predicted_answer": "The quantified measure of therapeutic success when MIBG harmonized with vorinostat in neuroblastoma was an Objective Response Rate (ORR) of 32% (95% CI, 18%-51%) after the first course.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key fact emphasized in the reference answer regarding the ORR being 32% when MIBG was combined with vorinostat. The additional details in the predicted answer do not contradict the reference. The key information and trend are consistent."
        },
        {
            "query_idx": 749,
            "query": "Within the domain of investigational treatment paradigms for malignancies shielded from endocrine influence, what quantifiable response rate coalesced from the phase 2 exploration of the molecular interplay between the apoptosis-inducing vorinostat and the estrogen-interfering tamoxifen?",
            "retrieved_metrics": {
                "reference_idx": [
                    556
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ORR# of the phase 2 study combining vorinostat and tamoxifen was #19%#.",
            "predicted_answer": "The phase 2 study combining vorinostat with tamoxifen in hormone therapy-resistant breast cancer patients reported an objective response rate (ORR) of 19%.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: the objective response rate (ORR) and the specific percentage of 19%. The details about the study's context in hormone-resistant breast cancer patients align with the reference, maintaining consistency in meaning and information."
        },
        {
            "query_idx": 750,
            "query": "What statistical metric articulates the deviation in resilience prognostication within the therapeutic amalgamation as opposed to the singular regimen paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    566
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The statistical metric articulating deviation in resilience prognostication is the #hazard ratio# (#HR# = 0.59), showing improved survival in the combination over the singular regimen.",
            "predicted_answer": "The statistical metric that articulates the deviation in resilience prognostication is the Hazard Ratio (HR) with its 95% Confidence Interval (CI). In the context provided, the HR was 0.59 (95% CI, 0.36-0.97) for the combination arm versus the singular regimen.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts from the Reference Answer, including the statistical metric (HR), its value (0.59), and the context of improved outcomes in the combination over the singular regimen. There are no significant omissions or errors, and the trends are aligned."
        },
        {
            "query_idx": 751,
            "query": "What implications might the documented instance of a partial acknowledgement in an individual exhibiting endocrine disruption-resistant characteristics have on the prospective horizons of epigenetic therapeutic application?",
            "retrieved_metrics": {
                "reference_idx": [
                    568
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The instance suggests that individuals with #hormone-resistant# characteristics may benefit from #epigenetic therapy#, potentially expanding therapeutic applications in this area.",
            "predicted_answer": "The documented instance of partial acknowledgement in an individual exhibiting endocrine disruption-resistant characteristics suggests that a subset of hormone-resistant patients may benefit from epigenetic therapy, potentially broadening the horizons of epigenetic therapeutic application.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key points emphasized with # symbols in the reference answer. It mentions \"hormone-resistant\" and \"epigenetic therapy,\" indicating consistency with the reference answer's key facts and trends. No critical information is missing or contradictory."
        },
        {
            "query_idx": 752,
            "query": "In what manner does the temporal tapestry of life expectancy and individual triumphs unfold amidst the structured symphony of epigenetic interventions administered to NSCLC patients, with particular emphasis on the resultant median temporal span of survival and distinctive patient journeys?",
            "retrieved_metrics": {
                "reference_idx": [
                    567
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #median survival# for NSCLC patients receiving epigenetic therapy is #6.4 months#, with one patient achieving CR/PR and surviving without progression for 2 years post-therapy.",
            "predicted_answer": "The temporal tapestry of life expectancy and individual triumphs in NSCLC patients under epigenetic interventions, such as low-dose azacitidine and entinostat, reveals a median survival of 6.4 months, with notable cases of prolonged survival and disease remission.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the median survival of 6.4 months, which matches the reference answer. However, it does not mention the specific detail of a patient achieving CR/PR and surviving without progression for 2 years, which is a key fact. Overall, it aligns with the trend but lacks completeness."
        },
        {
            "query_idx": 753,
            "query": "What are the cascading repercussions on the molecular symphony within the cellular microcosm of epithelioid sarcoma, emerging from the orchestrated molecular dynamics shaped by the absence of INI1/SMARCB1 and its subsequent epigenetic modulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    573
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The absence of #INI1/SMARCB1# in epithelioid sarcoma leads to constitutive and oncogenic activation of #EZH2#, influencing molecular dynamics and epigenetic modulations.",
            "predicted_answer": "The absence of INI1/SMARCB1 in epithelioid sarcoma leads to EZH2 activation, disrupting chromatin remodeling and epigenetic regulation, thereby fostering oncogenic progression and resistance to treatment.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the absence of INI1/SMARCB1 and the activation of EZH2, which are crucial in the reference. However, it omits the explicit mention of \"constitutive and oncogenic activation,\" which is significant in understanding its full implications on molecular dynamics."
        },
        {
            "query_idx": 754,
            "query": "What distinct biochemical ligand conjoins with the HDAC6-focused modulator, Nexturastat A, to devise the construction of molecular catalysts endowed with antiproliferative capabilities within the context of multiple myeloma cellular environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    570
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biochemical ligand that conjoins with the HDAC6 modulator Nexturastat A is #pomalidomide#, forming molecular catalysts with #antiproliferative capabilities# in multiple myeloma cells.",
            "predicted_answer": "Pomalidomide conjoins with Nexturastat A to devise HDAC6-targeting PROTACs with antiproliferative capabilities in multiple myeloma cells.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"pomalidomide\" as the ligand and mentions the \"antiproliferative capabilities\" in multiple myeloma cells, aligning fully with the key facts emphasized in the reference answer. The important details and trends are maintained without any contradictions."
        },
        {
            "query_idx": 755,
            "query": "Within the therapeutic venture involving tazemetostat against malignancies defined by BAP1 anomalies, what fraction of the cohort achieved a refined condition of status quo stability during the investigative pursuit of mesothelioma management?",
            "retrieved_metrics": {
                "reference_idx": [
                    578
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the study on #tazemetostat# for BAP1-anomalous mesothelioma, #64%# of the cohort achieved disease stability.",
            "predicted_answer": "64% of patients with BAP1-mutant mesothelioma achieved disease stabilization during tazemetostat treatment.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes the key facts from the Reference Answer, such as the specific use of #tazemetostat#, the cohort characterized by #BAP1# anomalies, and the #64%# who achieved disease stability. There are no omissions or errors."
        },
        {
            "query_idx": 756,
            "query": "In the intricate landscape of therapeutic endeavors targeting a range of solid tumor pathologies, what is the codified distinction ascribed to the collaborative exploration of tazemetostat and durvalumab?",
            "retrieved_metrics": {
                "reference_idx": [
                    579
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #collaborative exploration# of tazemetostat and durvalumab is referred to as a phase #2 clinical trial# (ClinicalTrials.gov identifier NCT04705818) targeting multiple solid tumors.",
            "predicted_answer": "The codified distinction for the collaborative exploration of tazemetostat and durvalumab is their combination in phase 2 clinical trials targeting multiple solid tumors.",
            "score": 3,
            "explanation": "The predicted answer identifies the collaboration between tazemetostat and durvalumab as a phase 2 clinical trial targeting multiple solid tumors, aligning with the key facts emphasized in the reference. However, it omits the ClinicalTrials.gov identifier, which is a specific detail included in the reference."
        },
        {
            "query_idx": 757,
            "query": "In the intricate choreography of cellular genetic frameworks, what underlying mechanisms enable the singular histone architect to influence the discordant expression of pivotal regulators within domains reshaped by MLL gene rearrangement in acute myeloid malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    580
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DOT1L# histone methyltransferase influences gene expression in acute myeloid malignancies by promoting #ectopic expression# of genes through recruitment by chimeric MLL proteins.",
            "predicted_answer": "The underlying mechanism involves the recruitment of DOT1L by chimeric MLL proteins to aberrant target sites, promoting the ectopic expression of genes like HOXA9 and MEIS1, which influence gene expression in acute myeloid malignancies.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference answer: involvement of DOT1L, recruitment by MLL proteins, and ectopic gene expression influencing acute myeloid malignancies. All essential concepts are present with no significant omissions or contradictions."
        },
        {
            "query_idx": 758,
            "query": "What transmutation affects the catalytic paradigm of LSD1 during its nexus with the androgen receptor, and through what mechanisms does this influence propagate across the genomic tapestry of androgen-responsive target sequences?",
            "retrieved_metrics": {
                "reference_idx": [
                    581
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Transmutation# of LSD1 alters its catalytic paradigm through #H3K9me1/2# demethylation, influencing androgen-responsive gene expression by de-repressing AR target sequences.",
            "predicted_answer": "The transmutation affecting the catalytic paradigm of LSD1 during its nexus with the androgen receptor involves a shift in enzymatic specificity from H3K4me1/2 to H3K9me1/2, leading to the de-repression of androgen receptor target genes across the genomic tapestry.",
            "score": 5,
            "explanation": "The LLM's predicted answer includes the key facts of \"transmutation\" and \"H3K9me1/2\" demethylation, influencing gene expression by de-repressing androgen receptor target genes. It aligns with the overall trend and key details of the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 759,
            "query": "What is the prevalence metric of chronological endurance observed in patients with neuroendocrine neoplasms within the scope of the pulrodemstat trial, specifically exceeding a temporal stability threshold of more than half a year?",
            "retrieved_metrics": {
                "reference_idx": [
                    582
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#30%# of patients with neuroendocrine neoplasms showed #stable disease# exceeding six months in the pulrodemstat trial.",
            "predicted_answer": "The prevalence metric of chronological endurance exceeding a temporal stability threshold of more than half a year in patients with neuroendocrine neoplasms within the pulrodemstat trial is 30% (8 out of 27 patients).",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer: the #30%# prevalence metric of patients with #stable disease# exceeding six months. The details align with those in the reference without contradictions or omissions."
        },
        {
            "query_idx": 760,
            "query": "In what manner does the orchestrated demethylation action stimulated by LSD1 serve as a conductor in preserving the intricate equilibrium and operational essence of DNMT1’s presence in a cellular context?",
            "retrieved_metrics": {
                "reference_idx": [
                    586
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "LSD1-dependent demethylation #stabilizes# DNMT1, #maintaining# global DNA methylation, crucial for preserving DNMT1's equilibrium and operational essence in a cellular context.",
            "predicted_answer": "LSD1-mediated demethylation stabilizes DNMT1, preserving global DNA methylation and maintaining cellular equilibrium. This action ensures DNMT1's functional integrity in the cellular context.",
            "score": 5,
            "explanation": "The predicted answer correctly captures the key details of LSD1-mediated demethylation stabilizing DNMT1 and maintaining global DNA methylation, which aligns with the preservation of DNMT1's functional integrity in a cellular context. All essential aspects from the reference are included without any significant omissions."
        },
        {
            "query_idx": 761,
            "query": "What is the intricate framework of the clinical investigative endeavor currently orchestrating the assessment of seclidemstat in subjects diagnosed with R/R Ewing sarcoma, particularly in terms of the layered therapeutic strategies and the delineated phases of study exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    585
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phase 1/2 study# of seclidemstat involves #monotherapy or combination# with topotecan and cyclophosphamide for patients with R/R Ewing sarcoma featuring FET-family translocations (NCT03600649).",
            "predicted_answer": "The clinical investigation of seclidemstat in R/R Ewing sarcoma involves a phase 1/2 study evaluating its efficacy in monotherapy or combination with topotecan and cyclophosphamide, with a rollover protocol for continued access.",
            "score": 3,
            "explanation": "The predicted answer covers the key information, such as the phase 1/2 study and the involvement of monotherapy or combination with topotecan and cyclophosphamide. However, it lacks the detail of \"FET-family translocations,\" which is a significant aspect of the study."
        },
        {
            "query_idx": 762,
            "query": "In the layered architecture of cellular dynamics contributing to malignancy genesis, what mechanisms do bromodomain and extraterminal domain proteins employ as critical navigators in chromatin ecosystems to conduct the symphony of oncogenic scripts or potentially broader transcriptional narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    588
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#BET proteins# recognize acetylated lysines, triggering chromatin remodeling and transcriptional activation. They control super enhancers regulating oncogenes like #MYC# and globally regulate transcription elongation.",
            "predicted_answer": "Bromodomain and extraterminal domain (BET) proteins recognize acetylated lysines to trigger chromatin remodeling and transcriptional activation, acting as key regulators of oncogene expression through super enhancers and influencing global transcription elongation.",
            "score": 3,
            "explanation": "The predicted answer accurately describes BET proteins recognizing acetylated lysines, triggering chromatin remodeling and transcriptional activation, and influencing global transcription elongation. However, it lacks any mention of oncogens like #MYC# specifically. Overall, the trend aligns well, but the omission of #MYC# fact affects completeness."
        },
        {
            "query_idx": 763,
            "query": "In the domain of clinical investigations tied to archetype NCT01587703, engaging the investigative agent molibresib, what is the quantifiable fraction of participants bearing the medical condition termed NMC who underwent a discernible journey towards a partial reversion, either corroborated or speculative, relative to their cancer progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    589
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Of the #19# NMC patients, #4# experienced a confirmed or unconfirmed partial reversion in the molibresib trial NCT01587703.",
            "predicted_answer": "In the trial NCT01587703 with molibresib, 4 out of 19 participants with NMC achieved a partial reversion (PR) or stable disease as their best response.",
            "score": 5,
            "explanation": "The predicted answer accurately contains the key facts emphasized in the reference answer: #19# NMC patients, and #4# experienced a partial reversion. Both answers reflect a consistent interpretation of the trial results, ensuring no significant omissions or errors."
        },
        {
            "query_idx": 764,
            "query": "What complex synergisms and strategic blockade methodologies are invoked by BETi agents to counteract adaptive resistance mechanisms, thereby magnifying treatment effectiveness, specifically within the sophisticated environments of TNBC and BRAF-mutant melanoma when conjoined with additional molecular inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    594
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BETi agents prevent transcription of resistance-driving kinases, enhancing treatment effectiveness in #TNBC# and #BRAF-mutant melanoma# by overcoming kinase reprogramming and resistance mechanisms.",
            "predicted_answer": "BETi agents counteract adaptive resistance in TNBC and BRAF-mutant melanoma by suppressing transcription of resistance-driving kinases, enhancing treatment effectiveness when combined with molecular inhibitors.",
            "score": 3,
            "explanation": "The Predicted Answer correctly includes the prevention of transcription of resistance-driving kinases and mentions TNBC and BRAF-mutant melanoma, in alignment with the Reference Answer. However, it omits the details about overcoming \"kinase reprogramming and resistance mechanisms,\" a key emphasized fact."
        },
        {
            "query_idx": 765,
            "query": "What exploratory endeavor is being undertaken in the intermediary phase to elucidate the interaction of synergistic modalities for ovarian cancer patients who have ventured past the confines of preceding PARPi therapy advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    595
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A #phase 2 trial# is testing the efficacy of #ZEN-3694 and talazoparib# in ovarian cancer patients who progressed on prior PARPi therapy.",
            "predicted_answer": "A phase 2 trial is underway to assess the efficacy of ZEN-3694 and talazoparib in ovarian cancer patients who have progressed on prior PARPi therapy, aiming to elucidate synergistic interactions between these modalities.",
            "score": 5,
            "explanation": "The Predicted Answer covers all key facts from the Reference Answer, including the phase 2 trial with ZEN-3694 and talazoparib for ovarian cancer patients post-PARPi therapy. It also mentions elucidating synergistic interactions, which aligns with the intended purpose. There are no significant omissions or errors."
        },
        {
            "query_idx": 766,
            "query": "What are the representative numerical codes assigned to the research inquiries involving the molecular disruptors FHD-609 and CFT8634, as they embark upon clinical explorations for synovial sarcoma and SMARCB1-deficient solid tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    597
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The research inquiries for FHD-609 and CFT8634 have identifiers #NCT04965753# and #NCT05355753#, respectively, for clinical exploration in synovial sarcoma and SMARCB1-deficient tumors.",
            "predicted_answer": "The representative numerical codes for the research inquiries involving FHD-609 and CFT8634 are NCT04965753 and NCT05355753, respectively.",
            "score": 5,
            "explanation": "The predicted answer accurately replicates the key facts (numerical codes NCT04965753 and NCT05355753) mentioned in the reference answer. It correctly associates them with FHD-609 and CFT8634, matching identifiers used in the context of clinical research for the specified conditions."
        },
        {
            "query_idx": 767,
            "query": "What essential culmination in managing persistent suppression of abnormal cellular advancements was manifested through the strategic orchestration of intermittent epigenetic inhibition alongside perpetual oncological duotherapy, juxtaposed against the deleterious triad's regimen?",
            "retrieved_metrics": {
                "reference_idx": [
                    602
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intermittent #BETi# with continuous #BRAFi/MEKi# treatment was tolerable and improved durable tumor inhibition compared to the toxic triple combination regimen.",
            "predicted_answer": "The essential culmination in managing persistent suppression of abnormal cellular advancements was manifested through the strategic orchestration of intermittent epigenetic inhibition (BETi) alongside perpetual oncological duotherapy (BRAFi/MEKi), which improved durable tumor inhibition outcomes and was tolerable, contrasting with the toxic triple combination regimen.",
            "score": 5,
            "explanation": "The 'Predicted Answer' fully includes all the key facts emphasized in the 'Reference Answer': intermittent #BETi# and continuous #BRAFi/MEKi#, improved tumor inhibition, and tolerability compared to the toxic triple regimen. The overall meaning and details align well, with no omissions or contradictions."
        },
        {
            "query_idx": 768,
            "query": "In the context of molecular interventions targeting chromatin dynamic regulators, what impact does the ARV-771 entity, functioning as a pan-BET disruptor, have on reshaping the oncogenic equilibrium within experimental murine models of androgen-independent prostatic cellular deviations?",
            "retrieved_metrics": {
                "reference_idx": [
                    605
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #pan-BET degrader# ARV-771 demonstrates #antitumor potential# by suppressing AR signaling and levels in castration-resistant PCa mouse models.",
            "predicted_answer": "ARV-771, as a pan-BET disruptor, suppresses androgen receptor signaling and levels, reshaping the oncogenic equilibrium in murine models of androgen-independent prostate cancer.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer, highlighting ARV-771 as a pan-BET disruptor that suppresses androgen receptor signaling in androgen-independent prostate cancer. However, it doesn't explicitly mention ARV-771's antitumor potential, which affects completeness slightly."
        },
        {
            "query_idx": 769,
            "query": "How has the chromatin landscape been orchestrated to form a unified directive that alleviates the endurance depletion of pivotal immune informants within the realm of basal cell carcinoma, as discerned through the sophisticated lens of scATAC-seq chromatin probing?",
            "retrieved_metrics": {
                "reference_idx": [
                    611
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #shared regulatory program# identified via #scATAC-seq# controls T-cell exhaustion, aiding endurance in basal cell carcinoma by coordinating chromatin landscapes in immune informants.",
            "predicted_answer": "The chromatin landscape in basal cell carcinoma has been orchestrated through scATAC-seq to identify shared regulatory programs controlling T-cell exhaustion, alleviating endurance depletion of immune informants.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer, specifically the \"shared regulatory program,\" \"scATAC-seq,\" and addressing \"T-cell exhaustion.\" Both answers acknowledge that the chromatin landscape impacts immune informants in basal cell carcinoma. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 770,
            "query": "In the scope of the NOA-16 trial that navigated the peptide vaccine realm specifically for the IDH1(R132H) alteration, what were the discernible observational milestones at the juncture of biennial and triennial temporal scrutiny phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    609
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the NOA-16 trial, the #2-year# PFS rate was 82%, and the #3-year# PFS rate was 63%.",
            "predicted_answer": "The discernible milestones at the biennial and triennial phases of the NOA-16 trial were a 2-year PFS rate of 82% and a 3-year PFS rate of 63%, respectively.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer, including the 2-year PFS rate of 82% and the 3-year PFS rate of 63%. There is no contradictory information, and the overall trend and details are consistent."
        },
        {
            "query_idx": 771,
            "query": "What is the proportional fiscal alleviation uncovered by the orphan designation for ventures in experimental drug development endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    619
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #orphan designation# provides a proportional fiscal alleviation through #tax credits# of #25%# on qualified R&D expenditures for drug development.",
            "predicted_answer": "The orphan designation provides ventures in experimental drug development with a 25% tax credit on qualified R&D expenditures.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: mention of \"orphan designation,\" \"tax credit,\" and \"25%\" related to R&D expenditures. The meaning is consistent, and there are no significant omissions or errors. The overall trend aligns with the reference answer."
        },
        {
            "query_idx": 772,
            "query": "What intricate paradigms underpinned the curation of cancer-targeted therapeutic agents, considering the temporal framework post-FDA sanctioning from the beginning of 2013, ensuing the legislative enactment of the Breakthrough Therapy Designation in 2012?",
            "retrieved_metrics": {
                "reference_idx": [
                    622
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #curation paradigm# of cancer-targeted therapeutic agents post-2013 involved excluding non-oncology and supportive care drugs, focusing on anti-cancer indications approved post-FDA sanctioning of #Breakthrough Therapy Designation#.",
            "predicted_answer": "The curation of cancer-targeted therapeutic agents post-FDA sanctioning from 2013 involved screening anti-cancer drugs approved after January 1, 2013, focusing on those with original and supplemental indications, and collecting data from marketing authorization documents, clinicaltrials.gov, and scientific publications.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer by discussing the focus on cancer-targeted therapies approved post-2013. However, it omits reference to the exclusion of non-oncology and supportive care drugs and the impact of the \"Breakthrough Therapy Designation,\" missing two key details."
        },
        {
            "query_idx": 773,
            "query": "How do the foundational parameters distinguish the molecular imprint statuses, embraced as confirmatory or dismissive, regarding their stipulated confines in usage considerations?",
            "retrieved_metrics": {
                "reference_idx": [
                    624
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Foundational parameters distinguish molecular imprint statuses based on #biomarker# status, categorized as positive or negative, affecting their use in specified disease conditions.",
            "predicted_answer": "The foundational parameters distinguish molecular imprint statuses by categorizing indications based on biomarker status (positive or negative) and line of treatment (first-line, second-line, etc.), which determine whether the usage is confirmatory or dismissive within stipulated confines.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of using #biomarker# status (positive or negative) to influence molecular imprint statuses. It aligns with the trend of determining usage confines, though it includes additional detail about treatment lines. No critical omissions affect the foundational concept."
        },
        {
            "query_idx": 774,
            "query": "Amidst the labyrinth of regulatory transitions, how do these sequential accreditations, ordained by the FDA, subtly modulate the dimensional tapestry of patient vitality, as discerned through Chambers et al.'s lens of quality-adjusted prognostic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    620
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patient #health benefit# increases as #FDA designations# accumulate, enhancing quality-adjusted life years according to Chambers et al.'s study.",
            "predicted_answer": "The sequential accreditations by the FDA, as observed by Chambers et al., enhance patient vitality by increasing incremental quality-adjusted life years (QALYs), reflecting improved quality-adjusted prognostic evolution.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference answer, noting the enhancement of quality-adjusted life years and the role of FDA accreditations, aligned with findings by Chambers et al. It mentions patient vitality but does not explicitly state \"health benefit,\" which impacts completeness slightly."
        },
        {
            "query_idx": 775,
            "query": "How does the evaluative construct articulated by Lanthier et al. classify therapeutic agents into the pioneering, emerging, or supplementary categories within their respective domains, considering their distinctive modus operandi and typological attributes?",
            "retrieved_metrics": {
                "reference_idx": [
                    623
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lanthier et al. classify therapeutic agents into #pioneering#, #emerging#, or supplementary categories based on their first-in-class, advance-in-class, or addition-to-class status and #distinctive modus operandi#.",
            "predicted_answer": "Lanthier et al.'s evaluative construct classifies therapeutic agents into pioneering, emerging, or supplementary categories based on their innovativeness: first-in-class (pioneering), advance-in-class (emerging), and addition-to-class (supplementary), considering their mechanism of action and product type.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of classifying agents into pioneering and emerging categories but misses the explicit mention of \"distinctive modus operandi\" emphasized in the reference. However, it doesn't contradict and mostly aligns with the intent of the reference answer."
        },
        {
            "query_idx": 776,
            "query": "What structural determinants are operationalized to stratify experimental therapeutic investigations within the dataset, and how do these intricate categorizations articulate the distinctions among the principal investigative objectives for each inquiry?",
            "retrieved_metrics": {
                "reference_idx": [
                    626
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Clinical trials are stratified by #phase#, #design#, blinding, and number of arms to clarify distinctions in primary endpoints: OS, PFS, and tumor response.",
            "predicted_answer": "The structural determinants operationalized to stratify experimental therapeutic investigations within the dataset include trial phase, design, blinding, number of arms, and primary endpoint (OS, PFS, tumor response). These categorizations articulate distinctions among principal investigative objectives by differentiating trial characteristics and outcomes.",
            "score": 5,
            "explanation": "The predicted answer captures the key structural determinants: trial phase, design, blinding, number of arms, and primary endpoints (OS, PFS, tumor response). It aligns with the reference answer, reflecting the distinctions among investigative objectives. No significant omissions or errors are evident."
        },
        {
            "query_idx": 777,
            "query": "What complex inferences regarding the latent therapeutic deficits of a malignancy can be elucidated by examining the therapeutic modalities' abundance in conjunction with the systemic health burden metrics as delineated by the GBD study?",
            "retrieved_metrics": {
                "reference_idx": [
                    627
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Examining #therapeutic modalities' abundance# and #DALYs# data reveals latent therapeutic deficits, indicating high unmet needs for cancers with few treatment options and substantial systemic health burdens.",
            "predicted_answer": "The GBD study's systemic health burden metrics, such as DALYs, combined with the abundance of therapeutic modalities, can reveal complex inferences about latent therapeutic deficits in malignancies. Cancer entities with high DALYs and few therapeutic options indicate significant unmet needs and potential areas for therapeutic innovation.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the meaning and key facts of the reference answer, including the use of DALYs and therapeutic modalities to identify latent therapeutic deficits and unmet needs in cancer treatment. It aligns with the reference answer without any significant omissions."
        },
        {
            "query_idx": 778,
            "query": "How does the intricate interplay between the relative effectiveness measures of pharmaceutical treatments (HRs/RRs/ORRs) and the array of distinguished endorsements in clinical contexts relate to the augury of life-prolongation significance intertwined with these endorsements as elucidated through advanced statistical explorations such as meta-regressions and in-depth interpretative analyses?",
            "retrieved_metrics": {
                "reference_idx": [
                    629
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay between #HRs/RRs/ORRs# and special designations relates to the #survival benefit# through meta-regressions and interpretative analyses, highlighting their significance in clinical contexts.",
            "predicted_answer": "The intricate interplay between the relative effectiveness measures (HRs/RRs/ORRs) and distinguished endorsements in clinical contexts is explored through advanced statistical methods like meta-regressions and weighted-least squares regressions, which quantify the correlation between these measures and special designations, ultimately assessing their impact on life-prolongation significance.",
            "score": 3,
            "explanation": "The predicted answer captures the relationship between HRs/RRs/ORRs and special designations, as well as the use of meta-regressions. However, it lacks explicit mention of the \"survival benefit,\" which is a key fact. Overall, the trend is aligned, but one important detail is missing."
        },
        {
            "query_idx": 779,
            "query": "What was the central ratio of distinctive accolades granted per therapeutic milestone within the sphere of FDA-sanctioned oncology endeavors over the decade spanning 2013 to 2022?",
            "retrieved_metrics": {
                "reference_idx": [
                    630
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central ratio of distinctive accolades granted per therapeutic milestone was #2.4# special designations for each FDA-approved cancer indication between #2013 and 2022#.",
            "predicted_answer": "The central ratio of distinctive accolades granted per therapeutic milestone within FDA-sanctioned oncology endeavors from 2013 to 2022 was approximately 2.4 special designations per indication, with a median of 2 and an IQR of 2 to 3.",
            "score": 5,
            "explanation": "The predicted answer and reference answer both report the central ratio as 2.4 special designations per FDA-approved cancer indication from 2013 to 2022. The predicted answer includes additional statistical details (median and IQR), but all key facts are present without contradiction or omission."
        },
        {
            "query_idx": 780,
            "query": "What intricate interplay of ripple effects does each successive accolade, granted by a regulatory body, introduce upon the multifaceted calculus of survival metrics, thereby modulating the undertones of hazard dynamics and their subsequent temporal medians?",
            "retrieved_metrics": {
                "reference_idx": [
                    632
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Each FDA accolade decreases OS and PFS hazard ratios by #-0.04# and #-0.08#, enhancing median improvements by #3.0# and 1.8 months, respectively.",
            "predicted_answer": "Each successive accolade reduces hazard ratios and increases median survival times, impacting overall survival (OS) and progression-free survival (PFS) metrics.",
            "score": 1,
            "explanation": "The predicted answer captures the influence of accolades on hazard ratios and survival times. However, it misses specific key facts such as the precise changes in OS and PFS hazard ratios (-0.04 and -0.08) and exact median improvements (3.0 and 1.8 months), affecting completeness."
        },
        {
            "query_idx": 781,
            "query": "In what manner does the intricate tapestry of therapeutic innovation endow certain pharmacological and clinical designations with an aura of distinction within the diverse realms of patient demographics encountered in advanced disease intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    635
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Innovativeness# and the specific #patient population# treated endow pharmacological and clinical designations with distinction in advanced disease intervention.",
            "predicted_answer": "Therapeutic innovations with special pharmacological and clinical designations are distinguished by their innovativeness, the specific patient populations they treat, and the advanced disease settings they address, addressing unmet needs in refractory cases.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: \"innovativeness\" and \"specific patient populations,\" aligning with the overall trend. The addition of \"advanced disease settings\" and \"unmet needs\" does not contradict the reference. No significant omissions are noted."
        },
        {
            "query_idx": 782,
            "query": "What potential distortions in the collective interpretation of therapeutic benefit might arise from clinical evaluation architectures that lack foundational robustness for uniquely-labeled medical conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    638
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Non-robust, biased clinical trial designs for #special-designated indications# may cause #overestimation# of efficacy outcomes, leading to distorted interpretations of therapeutic benefit.",
            "predicted_answer": "Potential distortions include overestimation of efficacy due to non-robust and biased clinical trial designs for special-designated indications, which may lead to an inflated perception of therapeutic benefit.",
            "score": 5,
            "explanation": "The predicted answer captures both key facts emphasized in the reference: “special-designated indications” and “overestimation of efficacy.” It reflects the overall trend of distorted therapeutic benefit interpretation due to biased trial designs. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 783,
            "query": "What is the variance in the continuum of lifespan extension for therapeutic scenarios possessing quintuple distinguished merits of recognition against scenarios lacking any form of conferred distinction?",
            "retrieved_metrics": {
                "reference_idx": [
                    637
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #lifespan extension# for indications with five special designations is #11.8 months#, compared to 3.7 months without any designation.",
            "predicted_answer": "The variance in lifespan extension is 8.1 months, with therapeutic scenarios possessing quintuple distinguished merits extending life by 11.8 months compared to 3.7 months for those lacking any distinction.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer, including the lifespan extensions of 11.8 months and 3.7 months and the variance of 8.1 months, which is calculated from these two figures. The meanings are consistent with no significant omissions or errors."
        },
        {
            "query_idx": 784,
            "query": "In what ways could the inclination towards showcasing selectively positive experimental outcomes distort the collective perception of therapeutic value for oncology-based treatment solutions that achieve regulatory endorsement?",
            "retrieved_metrics": {
                "reference_idx": [
                    642
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inclination towards showcasing #positive experimental outcomes# may distort perceptions by #overestimating efficacy# of oncology treatments that achieve regulatory endorsement.",
            "predicted_answer": "Showcasing selectively positive outcomes can distort the perception of therapeutic value by overestimating efficacy, leading to biased prescribing, pricing, and reimbursement decisions, despite potential negative trial results being undisclosed.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the inclination to showcase positive outcomes and the overestimation of efficacy. Additionally, it elaborates on consequences like biased prescribing and pricing. It aligns with the reference, but mentions potential negative trial results, absent in the reference."
        },
        {
            "query_idx": 785,
            "query": "In what manner does the transformation of evidentiary thresholds dictated by pharmaceutical governance impact the ratification of anticancer therapeutics that possess a panoply of selective commendations?",
            "retrieved_metrics": {
                "reference_idx": [
                    643
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The transformation leads to #lowered evidentiary standards#, resulting in anticancer drugs often being approved based on #poor clinical trial design#.",
            "predicted_answer": "The transformation of evidentiary thresholds in pharmaceutical governance has led to the approval of anticancer therapeutics with lower clinical trial standards, often based on comparisons to placebo or no treatment, impacting the ratification process.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer's trend by mentioning lower clinical trial standards and the impact on drug ratification. However, it fails to mention \"poor clinical trial design,\" which restricts its completeness regarding the key facts emphasized in the reference."
        },
        {
            "query_idx": 786,
            "query": "What constituted the central thematic inquiry in the exploration of FDA-endorsed oncological treatment designations from 2012 to 2022 within this analytical examination, particularly through the prism of regulatory deliberations, treatment efficacy, and dynamic healthcare needs?",
            "retrieved_metrics": {
                "reference_idx": [
                    634
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central thematic inquiry focused on #FDA#-endorsed treatment #efficacy#, examining drugs with special designations to address unmet medical needs in oncology from 2012 to 2022.",
            "predicted_answer": "The central thematic inquiry focused on evaluating the efficacy, clinical evidence, and dynamic healthcare needs of FDA-endorsed oncological treatments from 2012 to 2022, particularly through regulatory deliberations and special designations.",
            "score": 3,
            "explanation": "The predicted answer captures the examination of FDA-endorsed treatments and emphasizes treatment efficacy and regulatory deliberations. However, it lacks explicit mention of \"unmet medical needs\" from the reference answer, which is a key focus of the thematic inquiry."
        },
        {
            "query_idx": 787,
            "query": "What are the complex ramifications entailed by the FDA's sophisticated strategies, as they orchestrate a delicate equilibrium through specialized evaluative frameworks, for pharmaceuticals aimed at existential therapeutic deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    645
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA's strategies include #incentivizing# pharmaceutical development, #expediting# patient access, designing ethical trials, and ensuring drug safety and effectiveness for serious conditions with unmet medical needs.",
            "predicted_answer": "The FDA's strategies involve balancing investor incentives, expediting patient access, ensuring ethical trials, and safeguarding drug safety and efficacy, leading to the development of life-saving pharmaceuticals for serious conditions.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of incentivizing pharmaceutical development and expediting patient access, as indicated by the # symbols. It also mentions ethical trials and ensuring drug safety and efficacy, aligning with the reference. There are no significant omissions or errors."
        },
        {
            "query_idx": 788,
            "query": "For those navigating the hereditary spectrums characterized by von Hippel-Lindau disease, how does the orchestration of belzutifan as a hypoxia-inducible factor 2 alpha inhibitor manifest into an extracted advantage, altering the clinical bearings and potentially resonating as treatment echoes across their therapeutic horizon?",
            "retrieved_metrics": {
                "reference_idx": [
                    647
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with von Hippel-Lindau disease may benefit from #belzutifan#, a #hypoxia-inducible# factor 2 alpha inhibitor, enhancing therapeutic options by targeting the underlying pathological mechanisms.",
            "predicted_answer": "Belzutifan, as a hypoxia-inducible factor 2 alpha inhibitor, offers therapeutic advantages for those with von Hippel-Lindau disease by targeting the VHL gene, potentially altering clinical outcomes and expanding treatment options.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key facts: belzutifan's role as a hypoxia-inducible factor 2 alpha inhibitor and its therapeutic potential for von Hippel-Lindau disease. It mentions targeting VHL and altering clinical outcomes, aligning well with the Reference Answer's focus on enhancing therapeutic options by addressing underlying mechanisms."
        },
        {
            "query_idx": 789,
            "query": "What intrinsic genetic architecture's primordial shift within the lineal cohort designated as Family G has been validated to precipitate a sequence of sequence-specific genetic oscillations, consequently engendering a heightened predisposition towards colorectal carcinoma vulnerability?",
            "retrieved_metrics": {
                "reference_idx": [
                    650
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primordial shift in Family G's intrinsic genetic architecture is a germline mutation in the #MSH2 gene#, causing #microsatellite instability# and increased susceptibility to colorectal cancer.",
            "predicted_answer": "The primordial shift in the intrinsic genetic architecture within Family G, validated through sequencing of 929 descendants, involves a germline mutation in the MSH2 gene, causing microsatellite instability and heightened susceptibility to colorectal carcinoma.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer by identifying the key facts: the germline mutation in the MSH2 gene and resultant microsatellite instability, which heightens susceptibility to colorectal cancer. These details align perfectly with the referenced emphasized information, ensuring accuracy and completeness."
        },
        {
            "query_idx": 790,
            "query": "What were the predominant manifestations of substantial consequence, graded within the higher echelons of severity, as discerned across the trio of clinical investigations employing PARPi as a solitary therapeutic intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    653
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant grade #3-4# manifestations of consequence were #hematologic toxicity#, necessitating close monitoring and management during the trials.",
            "predicted_answer": "The predominant manifestations of substantial consequence in the higher echelons of severity across the trio of clinical investigations employing PARPi as a solitary therapeutic intervention were primarily hematologic toxicity, with the most common grade 3-4 events.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions \"hematologic toxicity\" and \"grade 3-4 events,\" aligning with key facts emphasized in the reference answer. It maintains the overall trend and completeness without any contradictions or omissions."
        },
        {
            "query_idx": 791,
            "query": "In the realm of inherited complexities, dissected through the insightful lens of the triad Collins, Hippel, and Lindau, which particular proliferative phenomena ingrained in the variegated bodily landscapes serve as the quintessential manifestations of the von Hippel-Lindau constellation?",
            "retrieved_metrics": {
                "reference_idx": [
                    648
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Retinal #hemangioblastomas# and cerebellar and spinal #hemangioblastomas# are quintessential manifestations of von Hippel-Lindau syndrome.",
            "predicted_answer": "The quintessential manifestations of the von Hippel-Lindau constellation, as dissected by Collins, Hippel, and Lindau, include retinal hemangioblastomas and cerebellar and spinal hemangioblastomas.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions the key facts, \"retinal hemangioblastomas\" and \"cerebellar and spinal hemangioblastomas,\" as highlighted in the Reference Answer. The meaning is consistent, with no omissions or errors, fully covering all essential information."
        },
        {
            "query_idx": 792,
            "query": "What proportion of individuals traversing the intricate journey of the MEDIOLA exploration, dealing with the quandary of metastatic HER2-negative breast malignancy while inheriting the legacy of BRCA1/2 genetic variations, exhibited a meaningful clinical echo after a span of twelve weeks?",
            "retrieved_metrics": {
                "reference_idx": [
                    654
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "63% of individuals with metastatic #HER2-negative# breast cancer and #BRCA1/2# mutations exhibited an objective response rate (ORR) after twelve weeks in the MEDIOLA trial.",
            "predicted_answer": "80% of individuals with metastatic HER2-negative breast cancer and BRCA1/2 mutations in the MEDIOLA trial achieved disease control at 12 weeks.",
            "score": 1,
            "explanation": "The predicted answer contains the information about individuals with metastatic HER2-negative breast cancer and BRCA1/2 mutations but states that 80% achieved disease control, which differs from the reference's 63% objective response rate (ORR). This discrepancy in the percentage and terminology is a significant omission."
        },
        {
            "query_idx": 793,
            "query": "What vital aspects must be judiciously navigated when orchestrating suitable movement regimes in the presence of concurrent therapy-induced erythrocytic and thrombocyte deficiencies?",
            "retrieved_metrics": {
                "reference_idx": [
                    659
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Caution must be taken to #determine activity level# when orchestrating exercise regimes in the presence of #anemia or thrombocytopenia# due to concurrent therapy.",
            "predicted_answer": "When orchestrating movement regimes in the presence of therapy-induced erythrocytic and thrombocyte deficiencies, prioritize nonpharmacological treatments like exercise with caution, considering the level of activity due to anemia and thrombocytopenia.",
            "score": 5,
            "explanation": "The predicted answer captures the need to determine activity level and references both anemia and thrombocytopenia, in line with the key facts in the reference answer. The focus on caution and exercise aligns with the meaning of the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 794,
            "query": "What quantitative representation exists for individuals whose engagement with olaparib was curtailed by adverse physiological responses, and in what manner does this align with the cessation metrics within the assemblage devoid of active therapeutic agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    661
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "10% of patients discontinued olaparib due to toxicity, compared to #4%# in the #placebo# arm.",
            "predicted_answer": "10% of patients discontinued olaparib due to toxicity, aligning with cessation metrics in the placebo arm (4%). This represents adverse physiological responses curtailing engagement with olaparib.",
            "score": 5,
            "explanation": "The predicted answer accurately presents the key facts from the reference answer, including the 10% discontinuation rate due to toxicity and the 4% rate in the placebo arm. The alignment with the reference answer is clear, with no significant omissions or errors present."
        },
        {
            "query_idx": 795,
            "query": "Within the NeoTALA 55 clinical scenario, designed to explore the effects of regimented exposure to talazoparib at a consistent dosage of 1 mg/day over a period of 24 weeks on the pathophysiological journey of TNBC patients, what proportional culmination of pathologic responses was predominantly attained?",
            "retrieved_metrics": {
                "reference_idx": [
                    664
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant pathologic response attained was a #49%# #pathologic complete response# in TNBC patients exposed to talazoparib at 1 mg/day for 24 weeks.",
            "predicted_answer": "In the NeoTALA 55 clinical scenario, a pathologic complete response was achieved in 49% of TNBC patients after 24 weeks of talazoparib at 1 mg/day.",
            "score": 5,
            "explanation": "The Predicted Answer closely mirrors the Reference Answer, accurately including the key facts: a 49% pathologic complete response in TNBC patients, with a regimen of talazoparib at 1 mg/day over 24 weeks. The key details emphasized are fully captured without any significant omissions."
        },
        {
            "query_idx": 796,
            "query": "What proportion of pancreatic ductal adenocarcinoma stakeholders embody inherent genetic blueprint alterations indicative of germline BRCA mutations that manifest as homologous recombination disruption within their cellular matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    666
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Up to #9%# of pancreatic ductal adenocarcinoma stakeholders have #germline BRCA mutations# causing homologous recombination defects.",
            "predicted_answer": "Approximately 9% of pancreatic ductal adenocarcinoma stakeholders have germline BRCA mutations, leading to homologous recombination disruption.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer in all key facts: \"9%\", \"germline BRCA mutations\", and \"homologous recombination disruption\". There are no significant omissions or incorrect details, and the overall meaning is consistent with the reference."
        },
        {
            "query_idx": 797,
            "query": "In the realm of genetic architectures and their economic viability, what is it about the molecular blueprints of hereditary anomalies like BRCA mutations that underscores the necessity for their targeted discovery in the orchestration of robust cancer mitigation strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    670
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The identification of #BRCA mutations# is crucial due to their impact on #cancer control# as revealed by the genetic economics of frequency penetrance.",
            "predicted_answer": "BRCA mutations, part of a highly polygenic genomic architecture, are economically viable for targeted discovery due to their high frequency and penetrance, making them impactful for cancer control strategies.",
            "score": 3,
            "explanation": "The predicted answer includes the key components of \"BRCA mutations\" and their significance in \"cancer control,\" consistent with the reference answer. However, it does not explicitly cover \"genetic economics of frequency penetrance,\" which is a key detail, affecting completeness."
        },
        {
            "query_idx": 798,
            "query": "In the sphere of pancreatic ductal adenocarcinoma, what profound ripple effect might the exploration of inherited BRCA mutation conundrums yield, surpassing the conventional therapeutic resonance attributed to olaparib utilization?",
            "retrieved_metrics": {
                "reference_idx": [
                    669
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The exploration of inherited #BRCA mutations# could lead to improved #survival# by recognizing hereditary syndromes, enabling targeted follow-ups, reducing second tumor incidence and mortality.",
            "predicted_answer": "The exploration of inherited BRCA mutations in pancreatic ductal adenocarcinoma could significantly impact survival by identifying hereditary syndromes, leading to dedicated follow-up and reducing second tumors and mortality among relatives.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of exploring inherited BRCA mutations, leading to improved survival through identifying hereditary syndromes. It mentions follow-ups, reducing second tumors, and mortality. All crucial details from the reference answer are reflected, maintaining alignment in meaning and trend."
        },
        {
            "query_idx": 799,
            "query": "What prospective strategic directions might be considered for those embodying the multifaceted genomic landscape of TNBC coupled with g BRCA anomalies, particularly when the journey does not culminate in a pathologic complete transformation?",
            "retrieved_metrics": {
                "reference_idx": [
                    673
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining #olaparib# and #pembrolizumab# might be a future option for TNBC patients with g BRCA mutation who do not achieve a pathologic complete response.",
            "predicted_answer": "Prospective strategic directions for TNBC with g BRCA anomalies might include combining olaparib and pembrolizumab, especially for patients not achieving a pathologic complete response. Early g BRCA testing is crucial for selecting the best treatment strategy.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of #combining olaparib and pembrolizumab# for TNBC with g BRCA anomalies, matching the reference answer. It also mentions testing for selecting treatment, which does not contradict or omit any essential information from the reference."
        },
        {
            "query_idx": 800,
            "query": "What nuanced molecular dance, dictated by transformations in proline attributes within an oxygen-modulated domain, orchestrates the convergence between von Hippel-Lindau stewards and regulators of hypoxia?",
            "retrieved_metrics": {
                "reference_idx": [
                    674
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydroxylation of proline# residues on HIFs' oxygen-dependent degradation domain facilitates the interaction between von Hippel-Lindau protein and regulators of hypoxia.",
            "predicted_answer": "The convergence between von Hippel-Lindau stewards and regulators of hypoxia is orchestrated by the hydroxylation of proline residues on HIFs' oxygen-dependent degradation domain, a process modulated by oxygen levels.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of \"hydroxylation of proline residues on HIFs' oxygen-dependent degradation domain\" orchestrating the interaction between von Hippel-Lindau and hypoxia regulators, reflecting the meaning and key details of the reference answer without contradictions or omissions."
        },
        {
            "query_idx": 801,
            "query": "Within the complex choreography of cellular expansion spurred by dysfunctional genetic symphonies, what specific role do tyrosine kinase inhibitors fulfill in modulating the aberrant expression of genes associated with Von Hippel-Lindau syndrome and sporadic manifestations of renal cell carcinoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    676
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tyrosine kinase inhibitors #target VEGF receptors# to modulate #gene overexpression# associated with VHL syndrome and renal cell carcinoma.",
            "predicted_answer": "Tyrosine kinase inhibitors modulate aberrant gene expression in Von Hippel-Lindau syndrome and renal cell carcinoma by targeting vascular endothelial growth factor receptors, reducing angiogenic gene overproduction.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference answer by stating that tyrosine kinase inhibitors target vascular endothelial growth factor (VEGF) receptors and reduce gene overexpression in both Von Hippel-Lindau syndrome and renal cell carcinoma. All key facts (#target VEGF receptors# and #gene overexpression#) are present."
        },
        {
            "query_idx": 802,
            "query": "Within the framework of the pazopanib investigation, what fraction of the participant demographic required modification in their dosing strategy due to perturbations in hepatic biochemical indicators?",
            "retrieved_metrics": {
                "reference_idx": [
                    678
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#67%# of participants required dosing modification due to #elevated transaminases#.",
            "predicted_answer": "67% of the participants required dose reduction due to elevated transaminases.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer, including the specific percentage (#67%#) and the reason for dose modification (#elevated transaminases#). The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 803,
            "query": "What latent architectural element within the configurational tapestry of the HIF2a PAS-B domain catalyzed the pioneering creation of initial HIF2a inhibitive agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    680
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #290-Å 3 internal cavity# within the HIF2a PAS-B domain catalyzed the creation of initial #HIF2a inhibitors#.",
            "predicted_answer": "The latent architectural element within the HIF2a PAS-B domain that catalyzed the creation of initial HIF2a inhibitive agents is the 290-Å³ internal cavity, which is required for interaction with the aryl hydrocarbon receptor nuclear translocator.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact of the \"#290-Å³ internal cavity#\" and its role in catalyzing the creation of initial \"HIF2a inhibitory agents,\" aligning closely with the reference. The inclusion of \"interaction with the aryl hydrocarbon receptor nuclear translocator\" is additional but not contradictory."
        },
        {
            "query_idx": 804,
            "query": "What proportion of individuals, identified with the specific vascular irruption within the cerebral complex, manifested a notable beneficial interaction in alignment with the investigative outcomes presented?",
            "retrieved_metrics": {
                "reference_idx": [
                    682
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#100%# of patients with retinal hemangioblastoma showed improvement according to the study outcomes.",
            "predicted_answer": "30% of individuals with central nervous system hemangioblastoma manifested a notable beneficial interaction in alignment with the investigative outcomes.",
            "score": 1,
            "explanation": "The predicted answer incorrectly states #30%# instead of the reference's #100%#. It also mentions #central nervous system# hemangioblastoma instead of #retinal# hemangioblastoma. These discrepancies impact completeness, as they are key facts marked with # in the reference. Despite alignment with non-contradictory trends, accuracy is compromised."
        },
        {
            "query_idx": 805,
            "query": "What cascade of cellular events and recognition failures emerge when the catalytic 'engines' of prolyl hydroxylases are rendered inactive, unable to transform proline into its hydroxylated counterpart amidst an oxygen-deprived milieu, influencing broader physiological pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    686
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When #prolyl hydroxylases# are inactive in hypoxia, HIFs aren't hydroxylated, preventing pVHL recognition, leading to #HIFs accumulation# and disrupted ubiquitination, affecting physiological pathways.",
            "predicted_answer": "When prolyl hydroxylases are inactive in low oxygen, they fail to hydroxylate proline residues on HIFs, preventing pVHL recognition and leading to HIF accumulation, which disrupts normal cellular processes and contributes to conditions like renal cell carcinoma.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: prolyl hydroxylases' inactivity, failure to hydroxylate HIFs, lack of pVHL recognition, and HIF accumulation. Although it doesn't explicitly mention disrupted ubiquitination, it reflects the overall trend of pathway disruption linked to physiological effects."
        },
        {
            "query_idx": 806,
            "query": "What particular inherited biochemical script has been identified as the conductor of the unique molecular choreography affecting the energetic transformations experienced by debrisoquine and sparteine?",
            "retrieved_metrics": {
                "reference_idx": [
                    688
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CYP2D6# gene has been identified as the conductor of the unique molecular choreography affecting #debrisoquine# and sparteine metabolism.",
            "predicted_answer": "The conductor of the unique molecular choreography affecting the energetic transformations experienced by debrisoquine and sparteine is the genetic variant of the cytochrome P450 2D6 (CYP2D6) gene.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the #CYP2D6# gene as the conductor and includes debrisoquine. However, it omits sparteine metabolism, which is a key fact in the reference. Thus, the answer is missing one key point but aligns with the overall trend."
        },
        {
            "query_idx": 807,
            "query": "What potential repercussions on the toxicological profile of fluorouracil might emerge when the intrinsic catalytic mechanism of dihydropyrimidine dehydrogenase finds its operational vigor significantly subdued or compromised within the patient’s metabolic spectrum during treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    691
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #toxicological profile# of fluorouracil may show increased #significant toxicity# due to prolonged half-life from subdued dihydropyrimidine dehydrogenase activity.",
            "predicted_answer": "The potential repercussions include significantly prolonged half-life of fluorouracil, leading to increased cytotoxic effects and higher rates of grade 3/4 toxicities such as diarrhea, mucositis, and leucopenia.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by discussing increased toxicity due to a prolonged half-life of fluorouracil from subdued enzyme activity. It includes details on specific toxicities, which supports the overall trend and meaning. No key facts are missing, and there are no contradictions."
        },
        {
            "query_idx": 808,
            "query": "How does the unique molecular signature crafted by genetic variability modulate the intricate balance of efficacy and safety within the framework of anticancer pharmacotherapy, specifically with respect to compounds like fluorouracil?",
            "retrieved_metrics": {
                "reference_idx": [
                    689
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unique #genetic variability# modulates the balance of #efficacy and safety# in anticancer pharmacotherapy, influencing treatment outcomes with compounds like fluorouracil.",
            "predicted_answer": "Genetic variability influences the efficacy and safety of anticancer drugs like fluorouracil by affecting individual drug response, potentially leading to treatment failure or toxicity. Understanding genetic profiles can optimize pharmacotherapy, reducing adverse effects and improving outcomes.",
            "score": 5,
            "explanation": "The Predicted Answer includes key concepts like \"genetic variability,\" \"efficacy and safety,\" and their impact on treatment with fluorouracil. It aligns well with the Reference Answer in terms of the main idea and important details, with no significant omissions or contradictions."
        },
        {
            "query_idx": 809,
            "query": "Within the realm of exploratory dose-escalation trials (NCT02974738), pursuing the control of complex neoplastic conditions, what pivotally determined quantum of administration crystallized from this prior investigation, guiding its influx into the subsequent evaluative echelon, unencumbered by toxicity-inflicted constraints?",
            "retrieved_metrics": {
                "reference_idx": [
                    684
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #recommended phase II dose# for the study was determined as #120-mg once daily#.",
            "predicted_answer": "The pivotal administration quantum determined from the exploratory dose-escalation trial (NCT02974738) was 120 mg once daily, as it was the recommended phase II dose without dose-limiting toxicities.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts emphasized in the Reference Answer: the recommended phase II dose and the 120 mg once daily dosage. It aligns with the overall trend and provides a consistent meaning without omissions or contradictions."
        },
        {
            "query_idx": 810,
            "query": "In the intricate landscape of medicinal guidance, wherein genomic storylines intertwine with treatment paradigms, what portfolio of pharmacological agents is documented with germline genetic directionality within official regulatory narratives, despite the tangible impediments confronting the complete integration of such personalized pharmacological scripting?",
            "retrieved_metrics": {
                "reference_idx": [
                    693
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The portfolio of pharmacological agents documented with germline genetic directionality includes #belinostat#, #tamoxifen#, dabrafenib, and others, according to FDA drug labeling, despite integration impediments.",
            "predicted_answer": "The FDA includes germline pharmacogenomic information in drug labels for belinostat, belzutifan, binimetinib, capecitabine, cisplatin, dabrafenib, erdafitinib, fluorouracil, gefitinib, irinotecan, lenalidomide, mercaptopurine, nilotinib, pazopanib, rucaparib, sacituzumab-govitecan, tamoxifen, thioguanine, and trametinib.",
            "score": 5,
            "explanation": "The predicted answer includes both #belinostat# and #tamoxifen#, which are referenced with germline genetic directionality in the reference answer. Therefore, it covers all key facts emphasized with # symbols in the reference answer and aligns with the overall trend provided."
        },
        {
            "query_idx": 811,
            "query": "What constitutes the central theme of the preliminary therapeutic inquiry into the discovery phase of treatment potency calibration within the realm of oncology, particularly concerning the navigation of initial pharmacological cycles?",
            "retrieved_metrics": {
                "reference_idx": [
                    697
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The central theme is identifying the #MTD# via monitoring for #DLTs# during the first treatment cycle to maximize clinical benefit.",
            "predicted_answer": "The central theme of the preliminary therapeutic inquiry is to identify the Maximum Tolerated Dose (MTD) or Highest Tested Dose (HTD) by monitoring for Dose-Limiting Toxicities (DLTs) during the initial pharmacological cycles, aiming to maximize antitumor effect while ensuring safety.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts #MTD# and #DLTs#, consistent with the reference answer. It thoroughly covers the central theme with no significant omissions. While it expands on the context by mentioning safety, it aligns with maximizing clinical benefit during initial cycles."
        },
        {
            "query_idx": 812,
            "query": "What potential destabilizing influences could jeopardize the sequential innovation phases when the dose determination is subtly swayed by individuals with intrinsic susceptibilities to adverse reactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    702
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Intrinsic susceptibilities# to toxicity could lead to #sub-optimal dose# selection, potentially delaying drug development and risking the innovation process due to safety concerns.",
            "predicted_answer": "Potential destabilizing influences include early detection of dose-limiting toxicities in genetically predisposed patients, leading to sub-optimal dose selection and program delays or risks. Additionally, small sample sizes in Phase 1 may result in doses that are not tolerated in later phases.",
            "score": 3,
            "explanation": "The predicted answer mentions \"genetically predisposed patients,\" which correlates with \"intrinsic susceptibilities\" in the reference answer. It also highlights \"sub-optimal dose\" and potential risks, consistent with the reference. However, it misses the broader impact on drug development and innovation."
        },
        {
            "query_idx": 813,
            "query": "In the initial examination of the selective mesenchymal-epithelial transition modulator's journey in Japan, which nuanced genetic stratification approach was employed to delineate participants by their cytochrome enzymatic pathway variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    704
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Participants were delineated by #CYP2C19# genetic stratification into normal metabolizers (#NMs#) with two *1 alleles and poor metabolizers with *2 and/or *3 alleles.",
            "predicted_answer": "A nuanced genetic stratification approach based on CYP2C19 genotype was employed, dividing participants into Normal Metabolizers (NMs) and Poor Metabolizers (PMs).",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the genetic stratification based on CYP2C19 and identifies the groups as Normal Metabolizers (NMs) and Poor Metabolizers (PMs). However, it omits the specific alleles (*1, *2, *3) used to define these groups, affecting completeness."
        },
        {
            "query_idx": 814,
            "query": "What role does the examination of genetic blueprints play in steering the metabolic choreography and consequential risk modulation of antibody-bound therapeutic constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    705
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The examination of #genetic blueprints# is crucial for modulating #antibody-drug conjugate# metabolism, affecting payload transport, and modifying the toxicity profile.",
            "predicted_answer": "The examination of genetic blueprints helps in steering the metabolic choreography and risk modulation of antibody-bound therapeutic constructs by identifying genetic variants that affect metabolism and toxicity profiles, as recommended by the FDA for antibody-drug conjugates (ADCs).",
            "score": 3,
            "explanation": "The 'Predicted Answer' captures the role of genetic blueprints in ADCs' metabolic and toxicity profiles, aligning well with the 'Reference Answer.' However, it lacks details on the specific roles of payload transport and antibody-drug conjugates, affecting completeness. Thus, one key fact is missing."
        },
        {
            "query_idx": 815,
            "query": "In the intricate choreography of therapeutic pathway calibrations for emergent oncological formulations, what synergistic frameworks and nuanced analytical constructs might underpin the refinement of dosing protocols during the nascent investigational phases and the exploration of dosage spectrums?",
            "retrieved_metrics": {
                "reference_idx": [
                    707
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Individualized dosing approaches leveraging #pharmacogenomics# and #pharmacodynamics# are crucial for refining dosing protocols, especially in early trials and dose-ranging studies, enhancing drug development and clinical outcomes.",
            "predicted_answer": "Synergistic frameworks like pharmacogenomics, therapeutic drug monitoring, and pharmacodynamics are crucial for refining dosing protocols in emergent oncological formulations, especially during early clinical trials and dosage exploration phases.",
            "score": 5,
            "explanation": "The predicted answer includes the key elements of \"pharmacogenomics\" and \"pharmacodynamics\", which are present in the reference answer, and the context is correctly focused on early clinical trials and dosage exploration phases, aligning with the reference's trends and key details."
        },
        {
            "query_idx": 816,
            "query": "In the realm of calculated molecule delivery, particularly sotorasib at a milieu of 960 mg, directed towards entities specified by a genetic hallmark in the oncological continuum, what was the emergent pattern observed in relation to therapeutic efficacy during the second tier of methodological trial assessment?",
            "retrieved_metrics": {
                "reference_idx": [
                    706
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The emergent pattern observed was a #36% response rate# and an #81% disease control rate# in patients with KRAS G12C-positive NSCLC during Phase 2 trial of sotorasib 960 mg.",
            "predicted_answer": "In the second tier of methodological trial assessment, sotorasib 960 mg showed a 36% response rate and 81% disease control rate in KRAS G12C-positive NSCLC patients, with no evidence of a dose-response relationship.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # symbols in the reference answer: a 36% response rate, an 81% disease control rate, and mentions the context of KRAS G12C-positive NSCLC patients during the trials. It aligns well with the reference answer without omissions or contradictions."
        },
        {
            "query_idx": 817,
            "query": "In contemplating Milligan's thorough analysis, how could the strategic foresight bestowed by M&S have illuminated the intricate web of exposure-response dynamics, mechanistic pathways, and intervention strategies within distinct populations, potentially circumventing the foundational missteps that led to the cessation of the 68 clinical evaluations?",
            "retrieved_metrics": {
                "reference_idx": [
                    708
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "M&S could have revealed crucial #exposure-response# dynamics and #mechanistic pathways# in specific populations, potentially preventing the failed clinical trials by informing design and strategy.",
            "predicted_answer": "M&S could have illuminated exposure-response dynamics, mechanistic pathways, and intervention strategies in distinct populations, potentially preventing the foundational missteps that led to the cessation of the 68 clinical evaluations.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer, covering the key facts of \"exposure-response dynamics\" and \"mechanistic pathways\" in distinct populations. Both answers reflect using M&S to prevent issues in clinical trials. The mention of \"intervention strategies\" adds detail but doesn't contradict the reference."
        },
        {
            "query_idx": 818,
            "query": "Within the complex domain of therapeutic fine-tuning, what pivotal functions are ascribed to the analytical frameworks of pharmacometrics and the methodological intricacies of M&S models in steering dosage modulation in light of the genetic variegation landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    711
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pharmacometrics and #M&S models# play pivotal roles in #dose optimization# by analyzing genetic variations and clinical data, influencing decisions on drug interactions, age, body weight, and organ functions.",
            "predicted_answer": "Pharmacometrics and M&S models are pivotal in steering dosage modulation by analyzing genetic variegation impacts on PK and PD, informing dose optimization decisions based on genetic variations.",
            "score": 1,
            "explanation": "The predicted answer includes the roles of pharmacometrics and M&S models in dose modulation and the importance of genetic variations. However, it omits key points about incorporating clinical data and specific considerations like age, body weight, and organ functions critical to dose optimization."
        },
        {
            "query_idx": 819,
            "query": "What delineated biochemical indices function as the dual augury of both enhanced survival prognostics and adverse physiological manifestations when subjected to imatinib therapeutic protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    713
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Imatinib# plasma concentrations serve as indicators: >#1000 ng/mL# improves survival outcomes, while >1685 ng/mL predicts toxicities.",
            "predicted_answer": "Imatinib plasma concentrations above 1000 ng/mL predict enhanced survival prognostics, while those above 1685 ng/mL predict adverse physiological manifestations like diarrhea and edema.",
            "score": 5,
            "explanation": "The predicted answer accurately includes both key facts: imatinib plasma concentrations as markers, >1000 ng/mL for improved survival, and >1685 ng/mL for toxicity risks. It aligns with the reference answer's trend and details without significant omissions or errors."
        },
        {
            "query_idx": 820,
            "query": "To what extent can modeling and simulation be viewed as instruments of computational insight, refining the complex tapestry of decision paradigms within anticancer drug genesis, with explicit regard to the nuanced articulation of dosage determination and the subsequent clinical trajectory?",
            "retrieved_metrics": {
                "reference_idx": [
                    709
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modeling and simulation (#M&S#) serve as instrumental tools in dose selection for anticancer drugs, enhancing #clinical decision-making# by predicting exposure and effects through PK/PD analyses.",
            "predicted_answer": "Modeling and simulation (M&S) are integral in refining decision paradigms in anticancer drug genesis, particularly in dosage determination and clinical trajectory. M&S integrates PK/PD analyses to predict exposure and effects, guiding dose selection and clinical trial design.",
            "score": 3,
            "explanation": "The predicted answer includes key details about modeling and simulation (M&S) and their role in dose selection and clinical trials. It mentions PK/PD analyses for predicting exposure and effects, aligning with the reference. However, it lacks a direct mention of \"enhancing clinical decision-making.\""
        },
        {
            "query_idx": 821,
            "query": "In the intricate landscape of pharmacological endeavors, what specialized roles do the genetic architects CYP2D6, DPYD, NUDT15, and TPMT assume within the regulatory symphonies to orchestrate the calibration of drug dosing efficacy, as elucidated by the pivotal frameworks provided by the FDA and the Clinical Pharmacogenetics Implementation Consortium?",
            "retrieved_metrics": {
                "reference_idx": [
                    720
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CYP2D6, DPYD, NUDT15, and TPMT are crucial for optimizing #dose selection# to reduce #drug toxicity# and improve efficacy as per the FDA and CPIC guidelines.",
            "predicted_answer": "CYP2D6, DPYD, NUDT15, and TPMT are genetic factors that influence drug metabolism, guiding personalized dosing to enhance efficacy and reduce toxicity, as supported by FDA and CPIC guidelines.",
            "score": 5,
            "explanation": "The predicted answer covers the roles of CYP2D6, DPYD, NUDT15, and TPMT in drug metabolism and personalizing dosing to improve efficacy and reduce toxicity. It aligns with the reference answer's key facts about optimizing dose selection per FDA and CPIC guidelines. No contradictory information is present."
        },
        {
            "query_idx": 822,
            "query": "What fundamental catalyst necessitates the pursuit of exhaustive exploration into the pharmacokinetic and pharmacodynamic interplay amidst the foundational stages of novel targeted therapeutic creation, as it relates to optimizing patient-specific dosing paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    721
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fundamental catalyst is the #exposure-response# relationship, crucial for understanding #inter-patient variability# and optimizing patient-specific dosing paradigms in early drug development.",
            "predicted_answer": "The fundamental catalyst is the need to understand inter-patient variability and the exposure-response relationship during early drug development, enabling optimized patient-specific dosing paradigms.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both the key facts: exposure-response relationship and inter-patient variability, as highlighted in the 'Reference Answer.' The major elements are covered and aligned with the overall trend in early drug development. There are no contradictions or omissions."
        },
        {
            "query_idx": 823,
            "query": "In the intricate tapestry of pharmacokinetics, by what unique trajectory of chemical conversion does afatinib chart its distinct course, setting it apart from the metabolic pathways navigated by gefitinib, erlotinib, and osimertinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    726
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Afatinib is #not metabolized# by #cytochrome P450s#, distinguishing its metabolic pathway as it is primarily excreted through feces, unlike gefitinib, erlotinib, and osimertinib.",
            "predicted_answer": "Afatinib is unique in that it is not metabolized by cytochrome P450 enzymes, unlike gefitinib, erlotinib, and osimertinib, which are metabolized by CYP3A4 and other enzymes. Afatinib is primarily excreted through the feces.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects that afatinib is not metabolized by cytochrome P450 enzymes and is excreted through feces, similarly to the reference. These are the key points emphasized with # symbols, and they are present in the predicted answer."
        },
        {
            "query_idx": 824,
            "query": "What configurations of allelic expression enveloped in the single nucleotide polymorphism rs4143815, within the intricate framework of the PD-L1 genetic realm, align with augmented durations of progression-free survival, particularly among NSCLC patients under the regimen of nivolumab's remedy?",
            "retrieved_metrics": {
                "reference_idx": [
                    733
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with #CC# and #CG# genotypes of rs4143815 in the PD-L1 gene have longer progression-free survival when treated with nivolumab for NSCLC compared to the GG genotype.",
            "predicted_answer": "The CC and CG genotypes of the SNP rs4143815 in the PD-L1 gene are associated with higher median progression-free survival (PFS) in NSCLC patients treated with nivolumab.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: the #CC# and #CG# genotypes of rs4143815 in the PD-L1 gene are linked with longer progression-free survival in NSCLC patients treated with nivolumab. It omits mentioning the comparison to the GG genotype, which slightly impacts completeness."
        },
        {
            "query_idx": 825,
            "query": "What intrinsic genetic trajectories are charted by polymorphic shifts in FCGR2A and FCGR3A, and in what manner do they entwine with the paradigm of ADCC potentials? Moreover, within the realm of cetuximab's kinetic odyssey, how does the structural motif embedded within the FcRn promoter region orchestrate its systemic traversal and tenure?",
            "retrieved_metrics": {
                "reference_idx": [
                    739
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Polymorphic shifts in #FCGR2A# and #FCGR3A# alter ADCC activity. Within cetuximab's kinetics, FcRn promoter VNTR affects distribution, clearance, and half-life.",
            "predicted_answer": "The polymorphic shifts in FCGR2A and FCGR3A, such as rs1801274 and rs396991, influence ADCC activity by altering receptor function. The structural motif in the FcRn promoter region, particularly the VNTR, affects cetuximab's systemic traversal and tenure, impacting distribution, clearance, and half-life.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies polymorphic shifts in FCGR2A and FCGR3A affecting ADCC and mentions the VNTR in the FcRn promoter impacting cetuximab's distribution, clearance, and half-life. All key facts in the reference answer are present with consistent meaning."
        },
        {
            "query_idx": 826,
            "query": "Through what mechanisms do the smoke-born aromatic hydrocarbons from cigarettes trigger an enhancement in the enzymatic expression of CYP1A2, thus evolving the metabolic processing of erlotinib into a pathway of increased expurgation and diminished therapeutic exposure?",
            "retrieved_metrics": {
                "reference_idx": [
                    728
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Aromatic hydrocarbons in #cigarette smoke# induce #CYP1A2# expression, increasing erlotinib metabolism and clearance, resulting in reduced drug exposure and efficacy.",
            "predicted_answer": "Cigarette smoke contains polycyclic aromatic hydrocarbons that induce CYP1A2 expression, enhancing erlotinib's metabolic processing and increasing its clearance, thereby reducing therapeutic exposure.",
            "score": 5,
            "explanation": "The Predicted Answer accurately conveys the essential aspects highlighted in the Reference Answer: it mentions #cigarette smoke#, #CYP1A2# induction, increased metabolism and clearance of erlotinib, and the subsequent reduction in drug exposure. The overall meaning and key facts match fully without any omissions or contradictions."
        },
        {
            "query_idx": 827,
            "query": "What intricate procedural constructs and thresholds potentially contribute to the augmentation of financial outlays when transitioning medicinal breakthroughs from economically constrained to affluent territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    743
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The augmentation of financial outlays is due to increased #development costs# from rigorous #regulatory requirements# and compliance issues in high-income countries (HICs).",
            "predicted_answer": "The augmentation of financial outlays during the transition of medicinal breakthroughs from economically constrained to affluent territories is primarily due to increased regulatory requirements, compliance issues, and more rigorous safety and efficacy tests in affluent territories.",
            "score": 3,
            "explanation": "The predicted answer aligns generally with the reference answer, covering regulatory requirements, compliance, and tests. However, it misses the key fact of \"development costs\" emphasized in the reference. While the overall trend is consistent, this omission affects completeness."
        },
        {
            "query_idx": 828,
            "query": "To what extent do the multifaceted drivers, such as economic efficiency and prevailing health conditions, render lower- and middle-income regions as prime landscapes for high-income countries’ exploratory medical inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    744
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Economic efficiency# and #higher incidence rates# make LMICs attractive for HICs' medical inquiries, reducing costs and time for patient recruitment in clinical trials.",
            "predicted_answer": "The multifaceted drivers, including economic efficiency and prevailing health conditions, make lower- and middle-income regions attractive for high-income countries' exploratory medical inquiries due to larger treatment-naive populations and higher disease incidence, reducing costs and time for clinical trials.",
            "score": 5,
            "explanation": "The predicted answer covers key facts of economic efficiency and higher disease incidence, aligning with the reference. It includes additional relevant details like larger treatment-naive populations, complementing the reference by elaborating on cost and time efficiency in clinical trials without contradictions."
        },
        {
            "query_idx": 829,
            "query": "In the collective embrace of biosimilar trastuzumab by the distinguished constellation of EU5 countries, what expansive spectrum of fiscal reverberations, articulated as a harmonious convergence of economic liberation, might unfurl?",
            "retrieved_metrics": {
                "reference_idx": [
                    746
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #EU5 countries# could achieve #cost-savings# ranging from €19 million to €172 million with the use of biosimilar trastuzumab.",
            "predicted_answer": "The adoption of biosimilar trastuzumab by EU5 countries could lead to significant cost savings, ranging from €19 million to €172 million, fostering economic liberation and expanding access to affordable cancer treatments.",
            "score": 5,
            "explanation": "The Predicted Answer includes all the key facts from the Reference Answer: the involvement of EU5 countries, cost-savings from €19 million to €172 million, and the use of biosimilar trastuzumab. It expands on economic impact but does not contradict the Reference Answer. Therefore, it fully covers the key information."
        },
        {
            "query_idx": 830,
            "query": "How might the intricate interplay of procedural dynamics within the biochemical synthesis tapestry of biosimilar production manifest as a domino effect, potentially giving rise to emergent hypersensitivity reactions and altered therapeutic efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    747
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #procedural dynamics# in biosimilar production can lead to #hypersensitivity reactions# and reduced therapeutic effectiveness due to minor manufacturing alterations affecting antibody response.",
            "predicted_answer": "The intricate interplay of procedural dynamics in biosimilar production can lead to small alterations in biochemical synthesis, potentially inducing antibody responses that cause hypersensitivity reactions and altered therapeutic efficacy.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer's key facts: it discusses procedural dynamics, hypersensitivity reactions, altered efficacy, and antibody responses. Although the predicted answer does not explicitly mention \"reduced therapeutic effectiveness,\" the meaning is consistent with the reference, with no significant omissions."
        },
        {
            "query_idx": 831,
            "query": "What fraction of the globe's cancer-related fiscal allocation is channeled toward economically constrained regions, whose substantial cancer fatality figures underscore a striking asymmetry in resource deployment?",
            "retrieved_metrics": {
                "reference_idx": [
                    742
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Only #5%# of global cancer-related fiscal allocation is spent in economically constrained regions, despite these regions witnessing #64%# of global cancer deaths.",
            "predicted_answer": "Approximately 5% of global cancer resources are allocated to economically constrained regions, despite these regions accounting for 64% of global cancer deaths.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects both key facts emphasized with # symbols in the reference answer: 5% of global cancer fiscal allocation to economically constrained regions and these regions accounting for 64% of global cancer deaths. The information is consistent and complete with no omissions or errors."
        },
        {
            "query_idx": 832,
            "query": "How might navigators of medical ethics recalibrate their stance when faced with a conduit for medicinal progression that leans towards accelerated pharmacological affirmation, as illustrated by the LIGHTHOUSE initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    748
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Navigators of medical ethics should prioritise #patient benefit# and take a firm stance against trials aiming solely for #expedited drug approval# like the LIGHTHOUSE initiative.",
            "predicted_answer": "Navigators of medical ethics should prioritize patient benefit over expedited drug approval, ensuring trials like LIGHTHOUSE align with patient care and quality of life.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference by emphasizing the priority of patient benefit and the concern over expedited drug approval. However, it misses the key fact that navigators should take a firm stance against such trials, as highlighted for LIGHTHOUSE."
        },
        {
            "query_idx": 833,
            "query": "What intricate ethical and regulatory calculations led to the scenario where atezolizumab was removed from therapeutic use in high-income nations for triple-negative breast cancer, while it continues to be distributed across less financially affluent regions globally?",
            "retrieved_metrics": {
                "reference_idx": [
                    749
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Atezolizumab was removed due to #ineffectiveness# in HICs but remains available in LMICs despite ethical concerns over #global use# with no proven benefits.",
            "predicted_answer": "The removal of atezolizumab from therapeutic use in high-income nations for triple-negative breast cancer was due to its lack of demonstrated benefits in confirmatory trials, leading to withdrawal by the FDA. Despite this, it continues to be distributed in less financially affluent regions, raising ethical concerns.",
            "score": 5,
            "explanation": "The predicted answer mentions atezolizumab's removal due to lack of benefits and ethical concerns regarding its use in less affluent regions, matching the reference's #ineffectiveness# and #global use with no proven benefits#. Thus, key facts are present and trends are aligned."
        },
        {
            "query_idx": 834,
            "query": "What navigational obstacles do economic thresholds and regulatory mazes present for nations with emerging marketplaces in their pursuit of crafting viable and cost-accessible biosimilar entities and strategically recontextualized medicinal compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    751
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Economic thresholds and regulatory mazes pose #investment# hurdles and patent policy #obstacles# for emerging markets developing biosimilars and repurposed drugs.",
            "predicted_answer": "Economic thresholds and regulatory mazes present obstacles such as substantial investment requirements, patent policies of innovator companies, and challenges in repurposing drugs, hindering the development of cost-accessible biosimilars and recontextualized medicinal compounds in emerging marketplaces.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies \"investment requirements\" and \"patent policy obstacles,\" covering the key facts emphasized with # in the Reference Answer. It is fully aligned with the reference answer's trend, mentioning the hindrance in drug development in emerging marketplaces."
        },
        {
            "query_idx": 835,
            "query": "How do the intertwined perceptual barriers and logistical disparities within academic channels contribute to the distortion of a just global knowledge ecology in cancer research, especially when considering the storytelling potential from regions systematically positioned at the margins of the epistemic community?",
            "retrieved_metrics": {
                "reference_idx": [
                    752
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intertwined #perceptual barriers# and #logistical disparities# in academic channels distort global knowledge ecology by limiting publication opportunities and mentorship for LMICs in cancer research.",
            "predicted_answer": "The intertwined perceptual barriers and logistical disparities within academic channels, such as publication bias against studies from low- and middle-income countries (LMICs), distort a just global knowledge ecology in cancer research. This bias marginalizes regions, limiting their storytelling potential and equitable contributions to global cancer care advancements.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as \"perceptual barriers,\" \"logistical disparities,\" and the idea of marginalizing regions akin to limiting \"publication opportunities,\" aligning with the reference. However, it omits \"mentorship\" mentioned in the reference. Alignment is generally intact, but it lacks one emphasized detail."
        },
        {
            "query_idx": 836,
            "query": "What multifaceted hindrances arise within the substratum of international endeavors aiming to augment therapeutic access across the layered terrains of LMICs, entailing the nuanced interconnection of cultural variances, fiscal disparities, and the quandary of shared yet individualistic scientific recognition on the global stage?",
            "retrieved_metrics": {
                "reference_idx": [
                    754
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cultural differences, #lack of adequate funding#, communication barriers, and inadequate #representation in scientific publications# hinder international efforts to improve therapeutic access in LMICs.",
            "predicted_answer": "Multifaceted hindrances in international endeavors to enhance therapeutic access in LMICs include cultural differences, inadequate funding, communication barriers, and lack of global scientific recognition, complicating equitable access to effective treatments.",
            "score": 1,
            "explanation": "The predicted answer includes most of the key factors like cultural differences and communication barriers but misses \"lack of adequate funding\" and \"inadequate representation in scientific publications,\" both highlighted in the reference. This affects completeness significantly, aligning with the overall trend but with two key omissions."
        },
        {
            "query_idx": 837,
            "query": "Amidst the intricate ballet of molecular pathways and cellular dynamics, what abstracts of influence do the selective modulations by calcium influx perturbers, notably those channeling the L-type variances, impart on the morphogenetic architecture of filopodial extensions and the thwarting of oncogenic cellular encroachments, as unveiled through the lens of phenotypic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    765
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "L-type calcium channel blockers, like #amlodipine#, inhibit #filopodia# formation and prevent cancer cell invasion, crucially regulating calcium entry and filamentous pore stabilization in cancer cells.",
            "predicted_answer": "L-type calcium channel blockers inhibit filopodia formation and prevent cancer cell invasion, highlighting their role in calcium entry regulation and filamentous pore stabilization.",
            "score": 3,
            "explanation": "The predicted answer covered most key facts such as L-type calcium channel blockers inhibiting filopodia formation and preventing cancer cell invasion, aligning with the overall trend. However, it missed mentioning specific examples like \"amlodipine,\" slightly affecting completeness."
        },
        {
            "query_idx": 838,
            "query": "In what manner does the omission of cellular entities, metaphorically viewed as the 'architectural symphony directors' within the mesenchymal tapestry, neural pathways, and immune surveillance systems, inhibit the comprehensive re-creation of oncological intricacies in tumoroid paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    763
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The omission of #mesenchymal tissues#, #neural cells#, and immune cells in tumoroid models restricts their capacity to replicate the full oncological intricacies.",
            "predicted_answer": "The omission of cellular entities like mesenchymal tissues, neural cells, and immune cells in tumoroid paradigms inhibits the comprehensive re-creation of oncological intricacies, limiting their ability to fully mimic tumor complexity and functionality.",
            "score": 5,
            "explanation": "The predicted answer includes key facts from the reference, such as the omission of mesenchymal tissues and neural cells, which are highlighted with # in the reference. It aligns with the overall trend and accurately captures the key aspects. No significant details are missing."
        },
        {
            "query_idx": 839,
            "query": "In what manner does the intricate choreography of evaluative methodologies function to discern which epigenetic modulators rise as candidates of discernible potential within the complex ecosystem surrounding breast cancer organoids?",
            "retrieved_metrics": {
                "reference_idx": [
                    768
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate choreography of evaluative methodologies identifies epigenetic modulators like #BML-210#, #GSK-LSD1#, and CUDC-101 through high-throughput screening with patient-derived breast cancer organoids and cytotoxic T cells.",
            "predicted_answer": "The intricate choreography of evaluative methodologies involves high-throughput screening to identify epigenetic modulators like BML-210, GSK-LSD1, and CUDC-101, which show significant antitumor effects in breast cancer organoids.",
            "score": 1,
            "explanation": "The predicted answer incorporated key facts like BML-210 and GSK-LSD1, identified through high-throughput screening. However, it omits crucial elements such as the involvement of patient-derived organoids and cytotoxic T cells, affecting completeness significantly."
        },
        {
            "query_idx": 840,
            "query": "Within the molecular theater of cellular conduct, what abstract roles does salidroside undertake to potentially subvert cellular expansion and migration schemes in prostate and HeLa cells, particularly by interacting with pivotal biochemical cascades and signaling harmonics?",
            "retrieved_metrics": {
                "reference_idx": [
                    770
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Salidroside #suppresses# prostate and HeLa cell proliferation by inhibiting the #PI3K/AKT# pathway, triggering apoptosis and hampering migration, indicating its potential as an anticancer agent.",
            "predicted_answer": "Salidroside potentially subverts cellular expansion and migration in prostate and HeLa cells by inhibiting the PI3K/AKT pathway and activating apoptosis, thereby disrupting pivotal biochemical cascades and signaling harmonics.",
            "score": 1,
            "explanation": "The predicted answer captures the main concepts of inhibiting the PI3K/AKT pathway and inducing apoptosis, aligning with the reference answer. However, it does not explicitly mention \"suppressing proliferation\" or \"hampering migration,\" missing two key emphasized facts."
        },
        {
            "query_idx": 841,
            "query": "Within the spectrum of cellular cessation, how does the genetically choreographed symphony of structured cellular conclusion delineate itself from the spontaneous termination that unfolds devoid of genetic orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    771
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Regulated cell death# involves a genetically encoded process, whereas #accidental cell death# is an uncontrolled, spontaneous termination without genetic orchestration.",
            "predicted_answer": "The genetically choreographed symphony of structured cellular conclusion refers to regulated cell death (RCD), which involves genetically encoded molecular mechanisms for stability. Spontaneous termination, or accidental cell death (ACD), is an uncontrolled process devoid of genetic orchestration.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures the two key facts emphasized in the Reference Answer: \"regulated cell death\" as a genetically encoded process and \"accidental cell death\" as a spontaneous process without genetic orchestration. The meanings are consistent without any significant omissions."
        },
        {
            "query_idx": 842,
            "query": "In the intricate dance of oncological evolution, what cascade of orchestrated outcomes unfolds as a result of the attenuation of the cellular gatekeeper β-catenin, especially in terms of autophagic gateway formations and the symphonic orchestration of terminal cellular transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    774
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The attenuation of #β-catenin# leads to #autophagic vacuole# formation, increased apoptosis, and induces autophagic cell death.",
            "predicted_answer": "The attenuation of β-catenin leads to the formation of autophagic vacuoles, increased apoptosis, and induction of autophagic cell death, contributing to terminal cellular transformations in oncological evolution.",
            "score": 5,
            "explanation": "The 'Predicted Answer' covers all key facts emphasized in the 'Reference Answer': attenuation of β-catenin, autophagic vacuole formation, increased apoptosis, and the induction of autophagic cell death. There are no significant omissions or errors, aligning with the reference's meaning."
        },
        {
            "query_idx": 843,
            "query": "In the mysterious dance of cellular transformations dictated by the influence of Triptolide, which structural reconfigurations materialize within these microscopic realms, and how do the orchestrators gasdermin E and gasdermin B engage in the tapestry of this cellular evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    773
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cells exposed to #Triptolide# experience non-apoptotic death with cytoplasmic swelling, membrane disruption, and increased expression of #gasdermin E# and gasdermin B.",
            "predicted_answer": "Triptolide induces cellular transformations through non-apoptotic cell death, causing cytoplasmic swelling and membrane disruption. Gasdermin E and gasdermin B are upregulated, playing key roles in these structural reconfigurations.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the #Triptolide# causing non-apoptotic cell death, leading to cytoplasmic swelling and membrane disruption. It also mentions the increased expression of #gasdermin E# and gasdermin B. Therefore, all crucial details aligned with the reference are covered."
        },
        {
            "query_idx": 844,
            "query": "Within the complex realm of molecular interplay, what specific sequence of biochemical obstructions implemented by leflunomide facilitates the stalling of proliferative advancement in human A375 melanoma cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    780
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Leflunomide #suppresses melanoma# growth in A375 cells by causing nucleotide depletion, reducing chromatin occupancy of the RNA helicase protein #DDX21#, thereby impeding transcription elongation.",
            "predicted_answer": "Leflunomide stalls proliferative advancement in human A375 melanoma cells by impeding de novo pyrimidine biosynthesis via DHODH inhibition and reducing chromatin occupancy of RNA helicase protein DDX21.",
            "score": 5,
            "explanation": "The predicted answer matches the key facts in the reference: it describes leflunomide's role in stalling A375 melanoma cell growth by reducing chromatin occupancy of DDX21, consistent with the reference. It mentions DHODH inhibition and nucleotide depletion, aligning with the reference's nucleotide depletion aspect. No significant omissions or errors."
        },
        {
            "query_idx": 845,
            "query": "What multifaceted interplay of dynamic intracellular processes does TPL's interaction with prostate oncocytes orchestrate, inducing autophagic sequences through nuanced modulation of cellular communication pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    779
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TPL's interaction with prostate oncocytes induces autophagy by #activating# the CAMKKb-AMPK pathway, inhibiting mTOR, and activating beclin-1 and #ULK1#.",
            "predicted_answer": "TPL's interaction with prostate oncocytes induces autophagy by stimulating calcium release, promoting ER stress, and activating the CAMKKb-AMPK pathway, which inhibits mTOR and activates beclin-1 and ULK1.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: activation of the CAMKKb-AMPK pathway, inhibition of mTOR, and activation of beclin-1 and ULK1. It also mentions additional detail about calcium release and ER stress, which doesn't contradict the reference and aligns with the trend."
        },
        {
            "query_idx": 846,
            "query": "What avenue within the multifaceted domain of enzymatic inhibition positions simvastatin to exhibit unparalleled efficacy among its statin kin in the orchestration of therapeutic responses across an array of cancer phenotypes?",
            "retrieved_metrics": {
                "reference_idx": [
                    785
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Simvastatin exhibits unparalleled efficacy in cancer therapy through #activation of mutant P53#, providing therapeutic responses across various cancer phenotypes by targeting deregulated cancer cell growth pathways.",
            "predicted_answer": "Simvastatin's unparalleled efficacy in cancer therapy is attributed to its potent inhibition of HMGCR, which disrupts cholesterol biosynthesis and impacts cancer cell growth, particularly through activation of mutant P53.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes the key fact of \"activation of mutant P53,\" which is emphasized in the 'Reference Answer'. Additionally, it describes simvastatin's impact on cancer cell growth, which aligns with the overall trend of the reference. Thus, it covers the essential aspects without contradictory information."
        },
        {
            "query_idx": 847,
            "query": "What influence do catalytic particles exert in the molecular symphony of DHA to disentangle the endoperoxide nexus, thereby unlocking potential therapeutic pathways in the realm of disease eradication and regulation of cell growth?",
            "retrieved_metrics": {
                "reference_idx": [
                    792
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Catalytic particles, like #iron ions#, cleave the endoperoxide bridge in DHA, releasing #cytotoxic ROS# and facilitating therapeutic pathways for disease eradication and cell growth regulation.",
            "predicted_answer": "Catalytic particles, such as iron ions, influence DHA by cleaving the endoperoxide bridge, releasing cytotoxic ROS to inhibit cell growth and angiogenesis, thus potentially unlocking therapeutic pathways for disease eradication.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts: the role of #iron ions# as catalytic particles and the release of #cytotoxic ROS#, aligning with the therapeutic implications mentioned in the reference. However, it omits 'cell growth regulation', affecting completeness slightly but no contradiction is present."
        },
        {
            "query_idx": 848,
            "query": "In what manner does the phenomenon of epithelial-mesenchymal transmutation influence the expansive cellular journey involving pervasive tissue infiltration and the distant orchestration of oncological demise?",
            "retrieved_metrics": {
                "reference_idx": [
                    795
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The phenomenon of epithelial-mesenchymal transition (#EMT#) influences tumor invasion and #metastasis#, contributing to increased tumor-related mortality by enabling pervasive tissue infiltration and distant cancer spread.",
            "predicted_answer": "Epithelial-mesenchymal transition (EMT) promotes cancer cell invasion and metastasis by enabling pervasive tissue infiltration and distant organ colonization, significantly contributing to oncological demise.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of #EMT# and #metastasis#, aligning with the reference by describing the role of EMT in cancer invasion, tissue infiltration, and organ colonization, all contributing to oncological demise. The trend and meaning are consistent with no significant omissions."
        },
        {
            "query_idx": 849,
            "query": "In what diverse and integrative manner does human telomerase reverse transcriptase (hTERT) act as a critical conductor in the persistent replication and intricate modulation of signaling pathways within cancerous cells, thereby surpassing conventional checkpoints of cellular aging and programmed cell death?",
            "retrieved_metrics": {
                "reference_idx": [
                    787
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Human telomerase reverse transcriptase (#hTERT#) acts as a transcriptional regulator in cancer cells, activating crucial genes for proliferation and survival via #WNT/β-catenin# and NFκB signaling pathways.",
            "predicted_answer": "Human telomerase reverse transcriptase (hTERT) acts as a critical conductor in cancer cells by elevating telomerase activity to evade cellular aging and programmed cell death. It also modulates signaling pathways like WNT/β-catenin and NF-κB to promote tumor proliferation and survival, thereby surpassing conventional checkpoints.",
            "score": 3,
            "explanation": "The predicted answer captures the role of hTERT in modulating WNT/β-catenin and NF-κB signaling pathways but misses its function as a transcriptional regulator and activation of crucial genes for proliferation. While generally aligned, it omits this significant aspect, affecting completeness."
        },
        {
            "query_idx": 850,
            "query": "In the complex interplay of biochemical signals within the realm of human epithelial MDA-MB-231 breast cancer cells, what is the nuanced effect of simvastatin on the expression dynamics of the deviant sentinel protein and the transmutation marker of cellular migration potential?",
            "retrieved_metrics": {
                "reference_idx": [
                    794
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Simvastatin increases #mutant P53# expression and represses #CD44# expression, reducing migratory and invasive abilities of MDA-MB-231 breast cancer cells.",
            "predicted_answer": "Simvastatin reduces the expression of the transmutation marker CD44, essential for migration, and increases mutant P53 expression, thereby diminishing the migratory potential of MDA-MB-231 cells.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects both key facts: it notes that simvastatin reduces CD44 expression and increases mutant P53 expression, aligning with the reference. Both answers indicate simvastatin diminishes migratory potential, maintaining consistency without missing significant details."
        },
        {
            "query_idx": 851,
            "query": "What multifaceted strategies do tumor cells deploy to convolute and dampen the vigilance of lymphoid warriors during the relentless march of oncogenic evolution?",
            "retrieved_metrics": {
                "reference_idx": [
                    796
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor cells express #PD-L1# to bind #PD-1# on lymphocytes, inhibiting their activity and suppressing anti-tumor immunity during tumor progression.",
            "predicted_answer": "Tumor cells deploy multifaceted strategies such as expressing PD-L1 to inhibit NK and T cells, dampening lymphoid vigilance during oncogenic evolution.",
            "score": 1,
            "explanation": "The predicted answer includes the expression of PD-L1 by tumor cells, which is a key fact. However, it omits the interaction with PD-1 on lymphocytes and the detail about suppressing anti-tumor immunity, resulting in missing more than one key fact."
        },
        {
            "query_idx": 852,
            "query": "What molecular or structural anomalies function as the triggers for the orchestration of genomic stability assurance systems during the progression of neoplastic cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    798
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#DNA damage# such as germline or somatic defects, oncogene-induced #replication stress#, and flawed mitotic chromosome segregation trigger genomic stability assurance systems.",
            "predicted_answer": "Molecular anomalies such as DNA damage, oncogene-induced replication stress, flawed mitotic chromosome segregation, and clashes between replication and transcription machinery trigger genomic stability assurance systems during neoplastic cellular dynamics.",
            "score": 5,
            "explanation": "The predicted answer successfully includes #DNA damage#, #replication stress#, and flawed mitotic chromosome segregation, which are the key facts emphasized in the reference answer. The trends and context are aligned, with no significant omissions or errors."
        },
        {
            "query_idx": 853,
            "query": "What role does the intricate convergence of genistein with diverse cancer therapy paradigms play as the principal axis in scrutinizing its clinical efficacy through trial investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    801
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate convergence of genistein with diverse cancer therapy paradigms plays a #synergistic# role, enhancing its potential as a #chemopreventive# agent in clinical trials.",
            "predicted_answer": "Genistein's role in cancer therapy involves exploring its synergistic effects with radiotherapy and chemotherapy, aiming to enhance clinical efficacy and safety through rigorous trial investigations.",
            "score": 3,
            "explanation": "The predicted answer includes the key aspect of genistein's \"synergistic\" role with cancer therapies but misses the specific mention of it as a \"chemopreventive\" agent. The answer is aligned with the general trend but omits a key detail, affecting completeness."
        },
        {
            "query_idx": 854,
            "query": "In the grand cosmic choreography of cellular processes, what role does DHA play in the orchestration of VEGFR1’s expression, and through which mechanistic blockade does it induce a state of cellular self-digestion in the endothelial realm of HUVECs?",
            "retrieved_metrics": {
                "reference_idx": [
                    804
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DHA enhances #VEGFR1# expression by upregulating ETS-1 and induces autophagy in HUVECs by blocking the #AKT/mTOR# signaling pathway.",
            "predicted_answer": "DHA enhances VEGFR1 expression through ETS-1 upregulation and induces autophagy in HUVECs by suppressing the AKT/mTOR pathway, leading to cellular self-digestion.",
            "score": 5,
            "explanation": "The predicted answer accurately captures all key facts from the reference answer: it mentions DHA's role in enhancing VEGFR1 expression through ETS-1 upregulation and inducing autophagy by blocking the AKT/mTOR pathway. Both the meaning and key technical details are consistently reflected."
        },
        {
            "query_idx": 855,
            "query": "In what manner do the tripartite processes of cellular dynamism, each interfering in their unique capacity with the path of cellular specialization, manifest themselves during the intricate tapestry of organismal development?",
            "retrieved_metrics": {
                "reference_idx": [
                    806
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The tripartite processes in cellular dynamism manifest as #dedifferentiation#, #blocked differentiation#, and transdifferentiation, disrupting cellular specialization during organismal development.",
            "predicted_answer": "The tripartite processes of cellular dynamism—dedifferentiation, blocked differentiation, and transdifferentiation—manifest during organismal development by disrupting cellular specialization, potentially leading to unrestrained phenotypic plasticity and tumor formation.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of dedifferentiation, blocked differentiation, and transdifferentiation, which align with the reference answer. It further expands on the consequences, such as phenotypic plasticity and tumor formation, without contradicting the reference answer."
        },
        {
            "query_idx": 856,
            "query": "What pathways might the intricate symphony of SMAD4's genetic echoes unfurl in modulating the proliferative dance induced by WNT signals amidst tumor resilience, and how could the inventive recycling of therapeutic compounds herald novel medical revelations?",
            "retrieved_metrics": {
                "reference_idx": [
                    808
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplay of #SMAD4# can potentially suppress #WNT-induced# proliferation, and drug repurposing, like using metformin, may lead to novel therapeutic breakthroughs.",
            "predicted_answer": "SMAD4 promotes differentiation, counteracting WNT-induced proliferation in tumors. Therapeutic compounds like metformin, repurposed for their anti-tumor effects, could unveil new medical strategies by modulating these pathways.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference: #SMAD4# and #WNT-induced# proliferation, and the role of metformin in drug repurposing. The core message and details are consistent and complete without contradictions, effectively reflecting the reference."
        },
        {
            "query_idx": 857,
            "query": "What insight does the probabilistic risk modulation vector afford when elucidating the nuanced role of metformin as a transformative agent within the oncological narrative of ovarian cancer prevalence, particularly when juxtaposed with other therapeutic modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    811
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #risk modulation vector# reveals metformin's transformative role, showing a lower #ovarian cancer# prevalence (HR = 0.47) compared to other therapies.",
            "predicted_answer": "The probabilistic risk modulation vector highlights metformin's significant reduction in ovarian cancer risk (HR = 0.47, 95% CI: 0.27 - 0.82) compared to other therapies, underscoring its transformative role in oncology.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized with # in the reference answer, mentioning the \"risk modulation vector,\" \"ovarian cancer,\" and the comparison of metformin's risk reduction to other therapies. The HR value in both answers is consistent, aligning with the overall trend."
        },
        {
            "query_idx": 858,
            "query": "How do the intricate bioactive agents originating from Oroxylum indicum, notably the flavonoid intervention, execute the modulation of hypoxia-induced cellular resilience mechanisms, thereby impacting tamoxifen resistance in breast cancer cell populations confronted by diminished oxygen levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    812
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The flavonoid #Baicalein# helps reverse tamoxifen resistance in hypoxic breast cancer cells by #downregulating HIF-1 α# levels.",
            "predicted_answer": "The flavonoid baicalein from Oroxylum indicum downregulates HIF-1α levels, reversing hypoxia-induced tamoxifen resistance in breast cancer cells by modulating cellular resilience mechanisms.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the key facts from the reference answer: the flavonoid \"baicalein,\" \"downregulating HIF-1α levels,\" and the impact on reversing tamoxifen resistance in hypoxic breast cancer cells. There are no significant omissions or errors, and the meaning is consistent with the reference."
        },
        {
            "query_idx": 859,
            "query": "How does the molecular fulcrum, known as Fusobacterium adhesin A embedded in Fusobacterium nucleatum, orchestrate its influence under the confluence of biochemical signals that shape the neoplastic narrative in colorectal cancer advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    816
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fusobacterium adhesin A in #Fusobacterium nucleatum# influences colorectal cancer progression via the #E-cadherin/WNTβ-catenin# signaling pathway under biochemical signals.",
            "predicted_answer": "Fusobacterium adhesin A in Fusobacterium nucleatum promotes colorectal cancer progression by influencing the E-cadherin/WNTβ-catenin signaling pathway, altering microbial ecology and disrupting homeostasis.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions key facts: Fusobacterium adhesin A in Fusobacterium nucleatum and its influence on colorectal cancer progression via the E-cadherin/WNTβ-catenin signaling pathway. However, it adds details about microbial ecology and homeostasis not in the reference but doesn't miss any key facts."
        },
        {
            "query_idx": 860,
            "query": "What function does the enzymatic conduit involving 6-phosphogluconate dehydrogenase play in orchestrating the molecular blueprint transformations, specifically involving histone modulation and DNA epigenetic alterations, as cells journey through the tumor advancement phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    815
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #6-phosphogluconate dehydrogenase# facilitates histone H3K9 and #DNA methylation# reshaping, upregulating N-cadherin transcription, promoting EMT, and distant metastasis during tumor progression.",
            "predicted_answer": "The enzymatic conduit involving 6-phosphogluconate dehydrogenase orchestrates molecular blueprint transformations by reshaping histone H3K9 and DNA methylation patterns, promoting N-cadherin-induced distant metastasis during tumor advancement.",
            "score": 1,
            "explanation": "The predicted answer correctly mentions \"6-phosphogluconate dehydrogenase\" and \"DNA methylation,\" aligning with key points in the reference. However, it omits \"upregulating N-cadherin transcription\" and \"promoting EMT,\" impacting completeness. The trend towards histone and DNA alteration is captured, but crucial details are missing."
        },
        {
            "query_idx": 861,
            "query": "What revelations emanated from the inaugural experimental foray using 211 BE amidst the battlefields of hormone-resistant prostate malignancy—in terms of both its healing promise and its safety perimeter?",
            "retrieved_metrics": {
                "reference_idx": [
                    813
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #phase 1 trial# of #211 BE# revealed promising therapeutic efficacy and safety in hormone-refractory prostate cancer patients. Further studies are needed for comprehensive understanding.",
            "predicted_answer": "The inaugural experimental use of 211 BE in hormone-resistant prostate malignancy showed promising therapeutic efficacy and safety in a phase 1 clinical trial, but further studies are needed to fully understand its mechanisms and broader implications.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the key facts from the reference: it discusses the phase 1 trial, the therapeutic efficacy, and the safety of 211 BE in hormone-resistant prostate cancer, aligning with the overall trend. No significant omissions are found."
        },
        {
            "query_idx": 862,
            "query": "What enigmatic dance do senescent cells engage in within the malignant sphere, wherein they simultaneously act as both sentinels against and instigators of oncogenic transformations, illustrating their Janus-faced nature in the realm of tumor dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    821
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Senescent cells engage in a #paradoxical role# by providing a barrier against cancer but also #promoting tumor growth# through mechanisms like the senescence-associated secretory phenotype.",
            "predicted_answer": "Senescent cells engage in an enigmatic dance by acting as both sentinels against and instigators of oncogenic transformations, primarily through their senescence-associated secretory phenotype (SASP), which can promote tumor growth under certain conditions.",
            "score": 5,
            "explanation": "The predicted answer captures the #paradoxical role# of senescent cells as both sentinels and instigators, and explicitly mentions their role in #promoting tumor growth# via the senescence-associated secretory phenotype (SASP). The key facts and trends align with the reference answer."
        },
        {
            "query_idx": 863,
            "query": "In what manner does the incorporation of inulin gel as an exemplary modulator within the intricate biological micro-ecosystem influence the symbiotic mechanisms of immune system enhancement and the intricate dynamics of neoplastic growth containment as interpreted from the context's exposition?",
            "retrieved_metrics": {
                "reference_idx": [
                    820
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Inulin gel #invigorates immune# response and #inhibits tumor# proliferation by reformulating gut microbiota, enhancing immune checkpoint therapy efficacy, and extending oncogenesis latency phase.",
            "predicted_answer": "Incorporating inulin gel modulates gut microbiota, enhances immune checkpoint therapy efficacy, and inhibits tumor proliferation, thereby boosting immune system responses and containing neoplastic growth.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key points from the reference answer, including the modulation of gut microbiota, enhancement of immune response, and inhibition of tumor proliferation. No significant details emphasized with # are missing, and the overall trend is consistent with the reference."
        },
        {
            "query_idx": 864,
            "query": "In the realm of oncological transformation, what intrinsic systemic barriers must be surmounted to enable quercetin's expansive integration, and what novel mechanistic solutions have emerged to deftly traverse these formidable challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    826
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic systemic barriers include #limited bioavailability# and instability. Novel solutions involve using #lipid nanoparticles# and chitosan nanoparticles to enhance quercetin's bioavailability for oncological integration.",
            "predicted_answer": "Intrinsic systemic barriers to quercetin's integration in oncology include limited bioavailability, instability, and lack of tumor targeting. Novel mechanistic solutions involve enhancing bioavailability using lipid nanoparticles and chitosan nanoparticles.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as \"limited bioavailability,\" \"instability,\" and the use of \"lipid nanoparticles\" and \"chitosan nanoparticles\" to enhance bioavailability. All key elements emphasized in the reference answer are present, with no significant omissions or contradictions."
        },
        {
            "query_idx": 865,
            "query": "In the complex ecological interactions and molecular choreography of the tumor's surrounding environment, what pivotal roles do the constituents of this intricate system play in potentially directing and modulating therapeutic outcomes in oncological treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    828
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Constituents of the #tumor microenvironment# regulate #therapeutic outcomes# by supporting cancer cell survival, proliferation, and modifying molecule interactions, making it crucial for developing cancer therapies.",
            "predicted_answer": "The constituents of the tumor microenvironment (TME) play pivotal roles in directing and modulating therapeutic outcomes by influencing cancer cell proliferation, survival, and migration. Understanding the TME, including its immune, metabolic, hypoxic, and mechanical components, is crucial for developing effective cancer therapies.",
            "score": 3,
            "explanation": "The predicted answer mentions the tumor microenvironment (TME) and its influence on cancer cell survival and proliferation, which aligns with the key facts in the reference answer. However, it omits the aspect of modifying molecule interactions emphasized by the reference, which affects completeness."
        },
        {
            "query_idx": 866,
            "query": "What elaborate interactions define the role of apigenin in altering the molecular exhibition of PD-L1, as prompted by IFN-γ's influence, especially when considering the intricate dynamics of its effect within particular breast cancer and melanoma tumor participants?",
            "retrieved_metrics": {
                "reference_idx": [
                    829
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Apigenin effectively negates #IFN-γ-induced# PD-L1 upregulation in breast cancer and melanoma cell lines, highlighting its potential as an #immunomodulator# in cancer therapy.",
            "predicted_answer": "Apigenin alters PD-L1 expression in breast cancer and melanoma cells by counteracting IFN-γ-induced upregulation, potentially enhancing immunotherapy efficacy.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: Apigenin's role in altering PD-L1 expression, counteraction of IFN-γ's influence, and its potential impact on immunotherapy. While it doesn't explicitly mention \"immunomodulator,\" it adequately describes the effect on IFN-γ-induced upregulation and aligns with the trend in the reference answer."
        },
        {
            "query_idx": 867,
            "query": "What is the intricate mechanism by which tadalafil orchestrates its influence in the layered framework of immune modulation, focusing on its synergistic role against myeloid-derived suppressor cells during the controlled, preliminary stage of clinical exploration involving perioperative intramuscular influenza vaccination?",
            "retrieved_metrics": {
                "reference_idx": [
                    830
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tadalafil, a #phosphodiesterase-5 inhibitor#, is used to counteract myeloid-derived suppressor cell inhibition of NK cells, enhancing immune modulation in preliminary clinical exploration with #influenza vaccination#.",
            "predicted_answer": "Tadalafil enhances immune modulation by counteracting myeloid-derived suppressor cells (MDSCs) to support NK cell activity, as evaluated in a phase 1 clinical trial involving perioperative intramuscular influenza vaccination.",
            "score": 3,
            "explanation": "The predicted answer misses the key fact that tadalafil is a \"phosphodiesterase-5 inhibitor.\" While it mentions the role against myeloid-derived suppressor cells and the context of an influenza vaccination, the absence of this technical detail affects completeness."
        },
        {
            "query_idx": 868,
            "query": "How do the architects of vascular structures engage in the absorption of fermentation derivatives to instigate the expansion of malignancies through metabolic adaptation?",
            "retrieved_metrics": {
                "reference_idx": [
                    831
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architects of vascular structures, like endothelial cells, engage in #lactate uptake#, enhancing angiogenesis and #tumor growth# by increasing IL-8, VEGF, VEGFR2 expression, and AKT phosphorylation.",
            "predicted_answer": "Architects of vascular structures, such as endothelial cells, absorb fermentation derivatives like lactate to induce angiogenesis and promote tumor growth through increased expression of growth factors and metabolic adaptation.",
            "score": 1,
            "explanation": "The predicted answer aligns overall with the reference answer regarding lactate uptake and promotes angiogenesis and tumor growth. However, it lacks the specific details of IL-8, VEGF, VEGFR2 expression, and AKT phosphorylation, which are key facts highlighted in the reference. This omission affects completeness."
        },
        {
            "query_idx": 869,
            "query": "What symphonic interplays and covert molecular dialogues by the elusive CAF conductors initiate the structural renaissance of ECM and facilitate cellular metamorphosis, potentially via arcane emissary proteins or cryptic signaling orchestrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    834
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CAFs# initiate ECM restructuring and cellular transformation through the secretion of #MMPs# or activating Yes-associated protein, which promotes ECM degradation and remodeling.",
            "predicted_answer": "Elusive CAF conductors initiate structural renaissance of ECM through secretion of MMPs like MMP-2, MMP-3, and MMP-9, promoting ECM degradation, EMT, and cellular metamorphosis via integrin and Rho signaling.",
            "score": 3,
            "explanation": "The predicted answer accurately captures the roles of CAFs and MMPs in ECM restructuring, aligning with the reference. It refers to ECM degradation, aligning with mentioned ECM restructuring. However, it omits the activation of Yes-associated protein, a key detail missing from the predicted answer."
        },
        {
            "query_idx": 870,
            "query": "What nuanced interplay of transcriptional governance orchestrated by curcumin articulates the down-regulation of TFAP2A pathways in the specialized sphere of LGR5(+) colorectal cancer stemness, affecting the cellular epicenter at a molecular dimension?",
            "retrieved_metrics": {
                "reference_idx": [
                    836
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin orchestrates #down-regulation# of TFAP2A pathways by promoting autophagy and repressing TFAP2A-regulated ECM in LGR5(+) colorectal cancer stem cells.",
            "predicted_answer": "Curcumin down-regulates TFAP2A pathways in LGR5(+) colorectal cancer stem cells by transcriptional repression, affecting cellular proliferation and the ECM pathway.",
            "score": 1,
            "explanation": "The key fact of \"down-regulation\" is present in the predicted answer, but it misses \"promoting autophagy\" and \"repressing TFAP2A-regulated ECM.\" The main trend is consistent, yet critical mechanisms like autophagy are omitted, impacting completeness."
        },
        {
            "query_idx": 871,
            "query": "What is the role of ascorbic acid in the biochemical orchestration with HIF-1α, as they together navigate the cellular landscape under duress, especially when considering the avant-garde paradigms of anticancer strategies that harness the symphony of genetic choreography and immune ballet?",
            "retrieved_metrics": {
                "reference_idx": [
                    838
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ascorbic acid contributes to #anticancer strategies# by engaging with #HIF-1α# in tumor hypoxia, supporting epigenetics, immunomodulation, and selective cytotoxicity in innovative treatments.",
            "predicted_answer": "Ascorbic acid, as an antioxidant, protects against free radicals and interacts with HIF-1α to modulate the hypoxic microenvironment in tumors, enhancing anticancer strategies through epigenetics and immunomodulation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by highlighting ascorbic acid's role in cancer strategies through interaction with HIF-1α. It covers anticancer strategies, HIF-1α, and epigenetics/immunomodulation but omits selective cytotoxicity, slightly affecting completeness."
        },
        {
            "query_idx": 872,
            "query": "In the labyrinthine dynamics of the mechanical matrix surrounding tumorous formations, what are the discrete strands of genetic articulation and production choreography that curcumin intricately influences to unveil its formidable antitumor virtuosity?",
            "retrieved_metrics": {
                "reference_idx": [
                    835
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin influences #α-SMA# and #COX-2# gene expression and reduces PGE2 production in CAFs to exhibit its antitumor effects.",
            "predicted_answer": "Curcumin influences genetic articulation by targeting α-SMA and COX-2 genes, reducing PGE2 production, and modulating the mechanical microenvironment to exhibit antitumor properties.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer: #α-SMA#, #COX-2#, and reduced PGE2 production, capturing the necessary genetic influences of curcumin. It aligns with the trend and details of the reference, with no significant omissions or contradictions."
        },
        {
            "query_idx": 873,
            "query": "What are the potential ramifications on the dissemination propensity and molecular signal variations that suggest markers of cellular transition in melanoma cells subject to an externally imposed acidic microenvironment over a 24-hour period?",
            "retrieved_metrics": {
                "reference_idx": [
                    841
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Exposure of melanoma cells to an #acidic microenvironment# for 24 hours may increase the expression of #EMT markers# and enhance their invasiveness.",
            "predicted_answer": "Exposure of melanoma cells to an acidic microenvironment for 24 hours increases expression of EMT markers, enhances invasiveness, and may reduce antitumor agent functionality.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts marked by # in the reference answer: \"acidic microenvironment\" and \"EMT markers\" along with increased invasiveness. Although it adds \"may reduce antitumor agent functionality,\" it is not contradictory. All key aspects are covered with no significant omissions or errors."
        },
        {
            "query_idx": 874,
            "query": "How might β-adrenergic antagonists, through a repurposed alliance in therapeutic symphonies, act as transformative agents within the complex tapestry of cancer treatment, potentially amplifying the overall impact against stubborn neoplastic resilience?",
            "retrieved_metrics": {
                "reference_idx": [
                    847
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "β-adrenergic antagonists may #reverse resistance# to therapies like trastuzumab, improving #cancer treatment# efficacy, but larger clinical trials are necessary for conclusive evidence.",
            "predicted_answer": "β-adrenergic antagonists, repurposed as anticancer drugs, can reverse catecholamine-induced resistance and enhance targeted therapy efficacy, potentially improving cancer treatment outcomes.",
            "score": 3,
            "explanation": "The Predicted Answer mentions reversing resistance and improving cancer treatment, aligning with the key facts in the Reference Answer. However, it omits specific therapies like trastuzumab and the need for larger clinical trials. This affects completeness, thus fulfilling most points but missing one key detail."
        },
        {
            "query_idx": 875,
            "query": "What intricate correlation is delineated, within the intricate environment of MSI-high colorectal cancer habitats, between the genomic presence of F. nucleatum and the variable abundance of immunological cells, specifically the suppressive ensemble of FOXP3-positive T cells contrasted against M2-skewed macrophages?",
            "retrieved_metrics": {
                "reference_idx": [
                    848
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The genomic presence of #F. nucleatum# in MSI-high CRC is inversely correlated with FOXP3-positive T cells and positively correlated with #M2-like TAMs# abundance.",
            "predicted_answer": "In MSI-high colorectal cancer, F. nucleatum presence is inversely correlated with FOXP3+ T cell density and positively correlated with M2-like macrophage ratio, suggesting it promotes tumor progression via immune suppression.",
            "score": 5,
            "explanation": "The predicted answer successfully captures both key facts emphasized with # symbols in the reference: the inverse correlation with FOXP3+ T cells and the positive correlation with M2-like TAMs (macrophages). The overall trend and meaning are consistent, with no omissions or contradictions."
        },
        {
            "query_idx": 876,
            "query": "What transformations within each oncogenic phase could modulate the diverse potentialities exhibited by recontextualized pharmacological agents when interfacing with the intricate milieu of cancer's evolving narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    852
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformations within each #oncogenic phase# may affect #repurposed drugs# by influencing their efficacy through cancer's evolving stages, due to diverse microenvironments and mechanisms.",
            "predicted_answer": "The transformations within each oncogenic phase could modulate the diverse potentialities of recontextualized pharmacological agents by affecting their interaction with the evolving tumor microenvironment (TME), which includes metabolic, mechanical, hypoxic, and microbial components.",
            "score": 1,
            "explanation": "The predicted answer mentions the concept of \"oncogenic phases\" and the impact on \"diverse potentialities of recontextualized pharmacological agents,\" aligning with the reference's mention of \"repurposed drugs.\" However, it misses key details about \"efficacy through cancer's evolving stages,\" leading to an incomplete response."
        },
        {
            "query_idx": 877,
            "query": "Through which mechanistic pathways does the nanocarrier interventional approach alter the augmentation of bioavailability and the equilibrium of cytological destruction, contrasting it with the phenomena manifested by the unconjugated fenbendazole/rapamycin ensemble within ovarian neoplastic treatment landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    855
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #M-FR system# enhances cytotoxicity and bioavailability by re-engineering RAPA into a tumoricidal agent, unlike the unconjugated #fenbendazole/rapamycin# combination.",
            "predicted_answer": "The nanocarrier interventional approach, such as the M-FR system, enhances bioavailability and cytological destruction by improving drug delivery and antitumor effects, contrasting with the unconjugated fenbendazole/rapamycin ensemble, which shows reduced cytotoxicity and proliferation inhibition in ovarian neoplastic treatment.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts about the M-FR system enhancing bioavailability and cytological destruction and contrasts it with the unconjugated fenbendazole/rapamycin ensemble, aligning with the reference. However, it misses the detail about re-engineering RAPA into a tumoricidal agent."
        },
        {
            "query_idx": 878,
            "query": "What are the ethereal constructs and inherent molecular symphonies of silk fibroin that underpin its capacity to serve as a fundamental framework within synergistic medicinal delivery paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    853
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #biocompatible# and #biodegradable# properties of silk fibroin, along with its unique scaffolding abilities, underpin its capability as a framework in medicinal delivery systems.",
            "predicted_answer": "Silk fibroin's ethereal constructs include its biocompatible and biodegradable protein structure, while its inherent molecular symphonies refer to its exceptional cell compatibility and scaffolding properties. These attributes underpin its capacity to serve as a fundamental framework in medicinal delivery paradigms.",
            "score": 5,
            "explanation": "The Predicted Answer includes key facts of silk fibroin's biocompatibility and biodegradability, as emphasized in the Reference Answer. It also correctly highlights the scaffolding properties, aligning with the trend of the Reference Answer without any omissions. The phrasing differences do not affect the meaning."
        },
        {
            "query_idx": 879,
            "query": "Within the dynamic architecture of pharmacological endeavors, how do the innate augmentation capabilities and diverse adaptability of polymeric micelles position them as superior vessels for the strategic conveyance of reengineered compounds such as rapamycin, across a spectrum of administration routes?",
            "retrieved_metrics": {
                "reference_idx": [
                    856
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Polymeric micelles (#PMs#) are superior for drug delivery due to their enhanced #adaptability#, biocompatibility, and advanced pharmacokinetics, facilitating varied administration routes for compounds like rapamycin.",
            "predicted_answer": "Polymeric micelles (PMs) are superior vessels for the strategic conveyance of reengineered compounds like rapamycin due to their enhanced biocompatibility, advanced pharmacokinetics, and adaptability across various administration routes, ensuring better absorption and reduced side effects.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference answer: it mentions polymeric micelles (PMs), adaptability, biocompatibility, advanced pharmacokinetics, and various administration routes for rapamycin. The alignment is consistent, and there are no significant omissions or errors."
        },
        {
            "query_idx": 880,
            "query": "What biochemical complexities and systemic hurdles in the realm of pharmacodynamics contribute to the potential diminution of efficacy in redirecting pharmacological entities towards innovative therapeutic avenues?",
            "retrieved_metrics": {
                "reference_idx": [
                    857
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Biochemical complexities in drug repurposing include #pharmacological challenges# where original drugs may not achieve #clinical efficacy# for new therapeutic purposes, affecting efficacy in novel treatments.",
            "predicted_answer": "Biochemical complexities include drug repurposing challenges and varying efficacy across different therapeutic targets. Systemic hurdles involve potential failure in clinical trials, regulatory issues, and pharmacology-related challenges, which can diminish the efficacy of redirected pharmacological entities.",
            "score": 3,
            "explanation": "The predicted answer mentions \"pharmacology-related challenges,\" which aligns with the reference's \"pharmacological challenges.\" However, it does not explicitly address \"clinical efficacy,\" a key term in the reference. The overall trend is consistent, but one key aspect is missing."
        },
        {
            "query_idx": 881,
            "query": "How might the innovative redirection of medicaments such as simvastatin and metformin within the cancer treatment paradigm illuminate unforeseen molecular pathways and elicit unanticipated biological consequences, particularly in the domains of lipid regulation and glycemic stability?",
            "retrieved_metrics": {
                "reference_idx": [
                    858
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #repurposing# of simvastatin and metformin for cancer might disrupt #lipid regulation# and glycemic stability, potentially causing hypolipidemia and hypoglycemia due to unforeseen molecular interactions.",
            "predicted_answer": "The innovative redirection of simvastatin and metformin in cancer treatment could illuminate unforeseen molecular pathways by binding to off-target molecules, potentially leading to unanticipated biological consequences such as hypolipidemia and hypoglycemia.",
            "score": 5,
            "explanation": "The predicted answer captures the key concepts of #repurposing# simvastatin and metformin, and mentions potential effects on #lipid regulation# and glycemic stability. It aligns with the reference by mentioning hypolipidemia and hypoglycemia. Minor terminological differences exist but do not impact the core facts."
        },
        {
            "query_idx": 882,
            "query": "How does the orchestration of the mevalonate biochemical cascade act as a pivotal catalyst in modulating the therapeutic potential of statin compounds amidst the complex molecular landscapes of gastric, pancreatic, and colon cancers?",
            "retrieved_metrics": {
                "reference_idx": [
                    864
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #mevalonate# cascade's orchestration enhances statins' therapeutic potential by targeting dysregulated lipid metabolism in #gastric, pancreatic, and colon cancers#.",
            "predicted_answer": "The mevalonate biochemical cascade, targeted by statins like simvastatin, inhibits HMG-CoA reductase, blocking cholesterol synthesis. This pathway's dysregulation is common in gastric, pancreatic, and colon cancers, making statins potential therapeutic agents by modulating lipid metabolism and cell mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts like the \"mevalonate cascade\" and its relevance in \"gastric, pancreatic, and colon cancers\" as emphasized in the reference answer. It aligns with the trend of targeting lipid metabolism to enhance statins' therapeutic potential. There are no omissions or significant errors."
        },
        {
            "query_idx": 883,
            "query": "What are the predominant frameworks of conceptual strategies that serve as navigational pathways in the process of pharmacological reconfiguration, integrating genomic insights with clinical data to synergistically enhance tumoral mitigation within the sphere of contemporary oncological practices?",
            "retrieved_metrics": {
                "reference_idx": [
                    863
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The predominant frameworks are #experimental# and computational approaches, utilizing clinical symptoms, genome, and transcriptome data for drug repurposing to enhance tumor treatment.",
            "predicted_answer": "The predominant frameworks include drug repurposing combined with nanomaterials and synergistic drug combinations targeting new mechanisms, integrating genomic insights with clinical data to enhance tumoral mitigation.",
            "score": 1,
            "explanation": "The predicted answer mentions drug repurposing and integrating genomic insights but omits the #experimental# and computational approaches. It includes new mechanisms and nanomaterials not in the reference. This results in missing key facts and lacks alignment with the reference's emphasized focus."
        },
        {
            "query_idx": 884,
            "query": "What are the primary challenges associated with the in-depth evaluation processes regarding the enduring effects and assurance of safety for novel nanoparticle drug delivery systems repurposed for cancer therapy trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    862
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primary challenges are the lack of #safety testing# and unknown #long-term toxicity# of nanocarrier materials in cancer therapy trials.",
            "predicted_answer": "The primary challenges include ensuring long-term safety and toxicity of nanocarrier materials, as well as the lack of comprehensive clinical trials for repurposed nanoparticle drug delivery systems in cancer therapy.",
            "score": 3,
            "explanation": "The predicted answer addresses the #long-term safety# and #toxicity# of nanocarrier materials, aligning with the reference answer. However, it omits the explicit mention of the lack of #safety testing#. While generally aligned, this missing key fact affects completeness."
        },
        {
            "query_idx": 885,
            "query": "When reevaluating therapeutic paradigms to align with the differentiated molecular landscapes and environmental dynamics of distinct cancer manifestations, what critical complexities and strategic frameworks must be thoroughly examined?",
            "retrieved_metrics": {
                "reference_idx": [
                    865
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When reevaluating therapeutic paradigms, consider the complexity of #genetic backgrounds# and the need for optimizing #dosages# and administration frequencies based on distinct cancer characteristics.",
            "predicted_answer": "Critical complexities include distinct genetic backgrounds, biomarkers, and microenvironment interactions. Strategic frameworks must thoroughly examine pharmacodynamics, pharmacokinetics, optimal dosages, and potential drug interactions to align with differentiated molecular landscapes and environmental dynamics.",
            "score": 5,
            "explanation": "The predicted answer covers the genetic backgrounds and optimal dosages, aligning with the key facts in the reference answer. Despite differing wording, there are no significant omissions or contradictions, maintaining alignment with the reference answer's general trend and details."
        },
        {
            "query_idx": 886,
            "query": "Within the context of neural infiltration and its synergistic dance with the oncologic milieu, what intricate role does β-adrenergic signaling assume in modulating cellular metamorphosis and augmenting metastatic trajectories through its engagement with complex biochemical orchestrations as illuminated in cutting-edge scientific discourse?",
            "retrieved_metrics": {
                "reference_idx": [
                    845
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "β-adrenergic signaling promotes #EMT# and increases metastatic potential via #VEGF/MMP# and STAT3/ERK/MAPK pathways, and enhances macrophage migration into tumor tissue.",
            "predicted_answer": "β-adrenergic signaling promotes cellular metamorphosis and metastasis by enhancing epithelial-mesenchymal transition (EMT) and activating pathways like VEGF/MMP and STAT3/ERK/MAPK, thereby augmenting tumor growth and macrophage migration.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized with # symbols in the reference answer: EMT, VEGF/MMP pathways, and the role of β-adrenergic signaling in metastasis and macrophage migration. The trends and technical details align well with the reference answer, with no significant omissions."
        },
        {
            "query_idx": 887,
            "query": "What theoretical constructs and strategic blueprints could be contemplated as guides for surmounting the intricate clinical conundrums linked with precision-based molecular agents, peptide-centric regimens, immune system enhancers, cellular strategies, and genetic alteration techniques in the evolution of novel cancer therapies?",
            "retrieved_metrics": {
                "reference_idx": [
                    866
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Understanding the #merits/limitations# of precision-based therapies like peptide drugs and genetic alteration can guide researchers in overcoming clinical challenges in #cancer therapies# development.",
            "predicted_answer": "Theoretical constructs and strategic blueprints for overcoming clinical challenges in precision-based molecular agents, peptide-centric regimens, immune system enhancers, cellular strategies, and genetic alteration techniques include comprehensive understanding of each method's development status, clinical challenges, and potential solutions.",
            "score": 3,
            "explanation": "The predicted answer discusses the development status, clinical challenges, and potential solutions for the techniques mentioned, aligning with the reference answer's focus on understanding merits and limitations for overcoming clinical challenges. However, it doesn't explicitly mention \"cancer therapies,\" which is a crucial omission."
        },
        {
            "query_idx": 888,
            "query": "In the intricate evolution of therapeutic frontiers, what groundbreaking and paradigm-shifting development did Carl June orchestrate that marked a defining moment in the 2011 landscape of oncological innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    871
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In #2011#, Carl June's #CAR-T cell therapy# for leukemia marked a groundbreaking and paradigm-shifting development in oncological innovations.",
            "predicted_answer": "Carl June orchestrated the successful application of CAR-T cell therapy for leukemia treatment in 2011, marking a significant step forward in immunotherapy.",
            "score": 5,
            "explanation": "The predicted answer captures all emphasized key facts from the reference: the year \"2011,\" \"CAR-T cell therapy,\" and its application for leukemia treatment as a significant development. There are no omissions or contradictions, and the essential meaning is upheld."
        },
        {
            "query_idx": 889,
            "query": "What innovative strategic pivot in the oncology pharmacopeia emphasizes the orchestration of innate immune symphonies over the classical siege and surrender of neoplastic fortresses?",
            "retrieved_metrics": {
                "reference_idx": [
                    874
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #strategic pivot# in oncology highlights #regulating self-immune activation# over traditional inhibition of tumor cell functions.",
            "predicted_answer": "The innovative strategic pivot in oncology emphasizes the use of combination therapies, including immunomodulators and targeted therapies, to orchestrate innate immune responses against tumors.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference by focusing on orchestrating innate immune responses. However, it misses the key fact about \"regulating self-immune activation\" specifically, which affects the completeness of capturing the strategic pivot's essence."
        },
        {
            "query_idx": 890,
            "query": "How does the symbiotic melding of macrostructural biological frameworks and atomically resolved cartography facilitate the embryonic conceptualization of potent molecular archetypes for initial lead substance discernment in the realm of targeted inhibitory agents?",
            "retrieved_metrics": {
                "reference_idx": [
                    876
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #symbiotic melding# of biological structures and atomic cartography aids the conceptualization of molecular archetypes, aiding initial lead substance discovery for targeted #inhibitory agents#.",
            "predicted_answer": "The symbiotic melding of macrostructural biological frameworks and atomically resolved cartography enables precise design of potent molecular archetypes by integrating computational modeling with atomic resolution data, facilitating initial lead substance identification for targeted inhibitory agents.",
            "score": 5,
            "explanation": "The predicted answer captures the key ideas of \"symbiotic melding\" and \"inhibitory agents\" as highlighted in the reference answer. It aligns with the overall trend and meaning, although expressed with more technical depth, it does not omit or contradict any crucial information."
        },
        {
            "query_idx": 891,
            "query": "What complex barriers within the realm of molecular therapeutics arise in the pursuit of developing refined pharmacological agents, especially when negotiating with proteins frequently regarded as beyond the clasp of conventional intervention, thereby complicating endeavors in the domain of cancer treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    879
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Developing refined pharmacological agents in cancer treatment is complicated by #undruggable proteins# and limited efficacy on #membrane proteins# and secretory proteins.",
            "predicted_answer": "Developing refined pharmacological agents for cancer treatment faces challenges such as targeting undruggable proteins, limited inhibitory effects on membrane and secretory proteins, and difficulties in dosage adjustment due to metabolism.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of targeting \"undruggable proteins\" and mentions \"membrane and secretory proteins\" with limited inhibitory effects, aligning with the reference. Additionally, it discusses dosage challenges, which is extra information but not contradictory."
        },
        {
            "query_idx": 892,
            "query": "What are the dual intricate barriers confronting the orchestration of molecular symphonies by allosteric inhibitors that invoke the pursuit of enhanced intellectual alchemy and experimental refinement?",
            "retrieved_metrics": {
                "reference_idx": [
                    886
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The dual barriers are #computational power# shortcomings for allosteric site identification and issues with #drug-resistant mutations#, necessitating more research to maintain effectiveness.",
            "predicted_answer": "The dual intricate barriers are: 1) the need for increased computational power and algorithmic improvements to identify allosteric sites, and 2) drug-resistant mutations and species differences affecting binding, requiring in-depth research.",
            "score": 5,
            "explanation": "The predicted answer addresses both key barriers: \"computational power\" and \"drug-resistant mutations,\" which are crucial elements emphasized in the reference. The predicted answer also mentions \"species differences\" as an additional detail, but it does not contradict the reference. Thus, it fully captures the core facts."
        },
        {
            "query_idx": 893,
            "query": "What sophisticated method does Asciminib utilize to circumvent the formidable drug-resistant mutation T315I in chronic myeloid leukemia, subtly transforming the conformational state of associated protein structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    885
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Asciminib uses #allosteric inhibition# by binding to the #myristoyl pocket#, locking BCR-ABL1 in an inactive conformation to overcome the drug-resistant T315I mutation in chronic myeloid leukemia.",
            "predicted_answer": "Asciminib utilizes allosteric inhibition to bind to the myristoyl pocket (STAMP) on BCR-ABL1, locking it in an inactive conformation and overcoming the T315I mutation in chronic myeloid leukemia.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts from the reference answer, including \"allosteric inhibition,\" \"myristoyl pocket,\" and overcoming the \"T315I mutation.\" The phrasing is consistent, and no significant details are missing or contradictory."
        },
        {
            "query_idx": 894,
            "query": "In what manner does the strategic embedding of enduring chemical enlaces in molecular architectures enable the unlocking of cellular vaults for proteinaceous structures bereft of typical conformational landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    884
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #strategic embedding# of covalent bonds enables targeting proteins without surface pockets, effectively unlocking cellular vaults by altering protein function through stable #chemical enlaces#.",
            "predicted_answer": "The strategic embedding of enduring chemical bonds in molecular architectures can enable the unlocking of cellular vaults by covalently modulating proteins, such as KRAS, which lack typical binding pockets, through stable and irreversible interactions.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by discussing the strategic embedding of enduring chemical bonds, targeting proteins without typical binding pockets through stable interactions. However, it uses slightly different terminology like \"enduring chemical bonds\" for \"covalent bonds\" and lacks explicit mention of \"altering protein function,\" which affects completeness."
        },
        {
            "query_idx": 895,
            "query": "What encapsulates the evolutionary likelihood of resistance emergence within the temporal framework of an annual therapeutic protocol, specifically during the molecular intervention trajectory utilizing inaugural and successive iterations of EGFR tyrosine kinase modulations in patients harboring EGFR mutations?",
            "retrieved_metrics": {
                "reference_idx": [
                    891
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with EGFR mutations treated with #first-# and #second-generation# EGFR tyrosine kinase inhibitors have a 50-60% chance of developing resistance within one year.",
            "predicted_answer": "The evolutionary likelihood of resistance emergence within an annual therapeutic protocol, specifically during molecular intervention using inaugural and successive iterations of EGFR tyrosine kinase modulations, is approximately 50-60% within one year of treatment in patients with EGFR mutations.",
            "score": 3,
            "explanation": "The predicted answer covers the main points, stating the likelihood of resistance (50-60%) within one year for EGFR mutations, using both inaugural and successive EGFR tyrosine kinase modulations. However, it lacks the specific mention of \"first- and second-generation\" inhibitors, which is a key fact."
        },
        {
            "query_idx": 896,
            "query": "Within the sophisticated landscape of peptide tracer visualizations for neuroendocrine delineations, what sophisticated modalities harness the synergy of radioactive canvas to elucidate cellular landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    892
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The sophisticated modalities are #Peptide Scintigraphy# and #PRRT#, which use radiolabeled peptides with isotopes like 111In and 68Ga for cellular visualization.",
            "predicted_answer": "Peptide Scintigraphy and Peptide Receptor Radionuclide Therapy (PRRT) use radioactive isotopes like 111In and 68Ga to visualize and target neuroendocrine tumor cells via specific peptide receptors.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: the modalities #Peptide Scintigraphy# and #PRRT#, and the use of radioactive isotopes like #111In and 68Ga#. The meanings and key details are consistent between the two answers."
        },
        {
            "query_idx": 897,
            "query": "In the realm of molecular navigation and cellular orchestration, what intricate role does the technetium-99m labeled peptide GX1 assume in the nuanced mapping and visualization of vascular characteristics within the tumor landscapes of gastric, colorectal, and glioma malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    893
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #technetium-99m labeled peptide GX1# plays a crucial role in mapping and visualizing #vascular characteristics# in gastric, colorectal, and glioma tumors by specifically binding to tumor vessels.",
            "predicted_answer": "Technetium-99m labeled peptide GX1 specifically binds to tumor vessels in gastric, colorectal, and glioma malignancies, aiding in the visualization and mapping of vascular characteristics within these tumor landscapes.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the technetium-99m labeled peptide GX1 and its role in binding to tumor vessels, aiding in visualization and mapping of vascular characteristics in gastric, colorectal, and glioma tumors. All key facts from the reference (marked by #) are covered, with no omissions."
        },
        {
            "query_idx": 898,
            "query": "In what manner does the molecular choreography facilitated by MGDs culminate in a superior pharmacokinetic narrative compared to PROTACs, in the realms of cellular ingress, systemic permeation, and cerebral reach?",
            "retrieved_metrics": {
                "reference_idx": [
                    890
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MGDs exhibit superior pharmacokinetic properties over PROTACs, with enhanced #membrane permeability# and #blood-brain barrier penetration#, improving cellular uptake and systemic and cerebral distribution.",
            "predicted_answer": "MGDs facilitate superior pharmacokinetic properties compared to PROTACs by enhancing membrane permeability, cellular uptake, and blood-brain barrier penetration, leading to improved systemic and cerebral reach.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized with # in the reference answer, namely #membrane permeability# and #blood-brain barrier penetration#. It correctly states that MGDs result in better pharmacokinetic properties, including cellular uptake and systemic/cerebral reach. The trend and meaning are consistent without omissions or contradictions."
        },
        {
            "query_idx": 899,
            "query": "What complex amalgamations of molecular partnerships and pathway facilitators are employed to optimize both the temporal robustness and systemic conveyance capabilities of therapeutic peptides in medical applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    899
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining peptides with protease inhibitors and #permeation enhancers# like #citric acid# and EDTA increases oral delivery efficiency and systemic conveyance of therapeutic peptides.",
            "predicted_answer": "Complex amalgamations include combining peptides with protease inhibitors and permeation enhancers like citric acid and EDTA for oral delivery, and binding with plasma proteins like albumins to extend half-life and reduce renal clearance.",
            "score": 5,
            "explanation": "The predicted answer correctly includes the key facts emphasized in the reference answer: \"#permeation enhancers#\" and \"#citric acid#\". It provides additional supportive details about peptide stabilization, indicating alignment with the general trend without contradictions, covering all the emphasized details mentioned."
        },
        {
            "query_idx": 900,
            "query": "What inherent molecular attributes and strategic therapeutic advantages endow IgG1 and IgG4 isotypes with a privileged status in the realm of monoclonal antibody construction for oncological interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    896
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#IgG1# and #IgG4# are favored in monoclonal antibody development for cancer due to their extended half-life and high affinity, enhancing their therapeutic effectiveness.",
            "predicted_answer": "IgG1 and IgG4 isotypes are privileged in oncological monoclonal antibody construction due to their extended half-life, high affinity, and potent cancer-targeting capabilities.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of the reference: #IgG1#, #IgG4#, extended half-life, and high affinity. It also adds \"potent cancer-targeting capabilities,\" which complements rather than contradicts. All emphasized details are covered, aligning with the overall trend."
        },
        {
            "query_idx": 901,
            "query": "In the intricate interplay of molecular defenses against unchecked cellular proliferation, which pivotal surface sentinels are undermined by the agents trastuzumab and cetuximab, and across which specific oncological domains do these molecular disruptions yield pronounced therapeutic outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    897
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab targets #HER-2#, and cetuximab targets #EGFR#, primarily affecting HER2+ breast cancer, metastatic colorectal cancer, and advanced head and neck cancer.",
            "predicted_answer": "Trastuzumab undermines HER-2 receptors, yielding therapeutic outcomes in HER2+ breast cancer. Cetuximab targets EGFR, providing significant benefits in metastatic colorectal and advanced head and neck cancers.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions trastuzumab targets HER-2 in HER2+ breast cancer and cetuximab targets EGFR, with outcomes in metastatic colorectal and advanced head and neck cancers. All key facts emphasized in the Reference Answer are present and trends align closely."
        },
        {
            "query_idx": 902,
            "query": "Within the sphere of the HIMALAYA clinical exploration, what temporal augmentation in survival emerges from the synergistic clinical interplay between tremelimumab and durvalumab as juxtaposed with the singular sorafenib pathway in hepatic carcinoma patients?",
            "retrieved_metrics": {
                "reference_idx": [
                    901
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #HIMALAYA clinical trial# shows a survival benefit of #2.63 months# with tremelimumab and durvalumab compared to sorafenib alone in liver cancer patients.",
            "predicted_answer": "In the HIMALAYA trial, the combination of tremelimumab and durvalumab resulted in a median overall survival (OS) of 16.43 months in hepatic carcinoma patients, compared to 13.8 months with sorafenib alone.",
            "score": 5,
            "explanation": "The Predicted Answer contains all the key facts and information emphasized in the Reference Answer. It mentions the HIMALAYA trial, compares tremelimumab and durvalumab to sorafenib, and specifies a survival benefit of 2.63 months (16.43 - 13.8 months). Phrasing differences do not alter the meaning."
        },
        {
            "query_idx": 903,
            "query": "Within the paradigm where targeted oncological interventions coexist with conventional cellular warfare, what specific privileges do monoclonal antibodies confer in terms of precision-tuned targeting and mitigation of inadvertent systemic toxicity, especially when contrasted with traditional modalities like chemotherapy and radiotherapy?",
            "retrieved_metrics": {
                "reference_idx": [
                    906
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Monoclonal antibodies offer #precision-tuned targeting# by specifically recognizing antigens, minimizing damage to normal cells and reducing #systemic toxicity# compared to chemotherapy and radiotherapy.",
            "predicted_answer": "Monoclonal antibodies offer precision-tuned targeting by specifically binding to cancer antigens, reducing systemic toxicity compared to traditional modalities like chemotherapy and radiotherapy, which can damage normal cells.",
            "score": 5,
            "explanation": "The predicted answer correctly emphasizes the #precision-tuned targeting# by stating that monoclonal antibodies specifically bind to cancer antigens. It also addresses the reduction of #systemic toxicity# by comparing it to the broader effects of chemotherapy and radiotherapy. All key facts are covered without contradiction."
        },
        {
            "query_idx": 904,
            "query": "How does the molecular sentinel referred to as TIM-3 curate the ensemble of cellular defense mechanisms, and what underlies its pivotal designation within therapeutic advancements, despite its absence from the commercial pharma stage?",
            "retrieved_metrics": {
                "reference_idx": [
                    902
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TIM-3 curates cellular defense by suppressing Th1 and proinflammatory responses. Its pivotal role in #immunotherapy# advancements remains despite the lack of commercial #drugs#.",
            "predicted_answer": "TIM-3 curates cellular defense by suppressing Th1 and proinflammatory responses, crucial for immune regulation. Its pivotal designation in therapeutic advancements stems from its role in immune response, despite no marketed drugs targeting it yet.",
            "score": 3,
            "explanation": "The predicted answer accurately reflects the suppression of Th1 and proinflammatory responses by TIM-3 and acknowledges its pivotal therapeutic role, aligning with the reference. However, it does not explicitly mention \"immunotherapy\" as emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 905,
            "query": "What architectural blueprints are employed to magnify the therapeutic spectrum of monoclonal antibodies by reconfiguring the molecular interaction dance with Fc receptors, thus navigating complex augmentation pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    910
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architectural blueprints include #mutagenesis# of the Fc region and the use of alternative antibody #isotypes#, such as IgG2, to enhance monoclonal antibody therapeutic effectiveness through improved Fc receptor interaction.",
            "predicted_answer": "Architectural blueprints include exploring alternative antibody isotypes, engineering the Fc region through mutagenesis, and enhancing Fc affinity for Fc receptors to augment therapeutic effectiveness and cytotoxicity.",
            "score": 5,
            "explanation": "The key facts of #mutagenesis# and #isotypes# are present in the predicted answer. It mentions engineering the Fc region through mutagenesis and exploring alternative antibody isotypes. The predicted answer aligns with the reference answer's overall trend, with no missing key details or contradictions."
        },
        {
            "query_idx": 906,
            "query": "What foundational properties and molecular complexities elevate the IgG1 molecular framework to a pivotal stature within the orchestrated deployment of antibody-drug conjugates, particularly in terms of target engagement and functionality?",
            "retrieved_metrics": {
                "reference_idx": [
                    915
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IgG1# framework is pivotal due to its prolonged half-life, high specificity, enhanced Fc γ R binding, potent #ADCC# and CDC effects, and reduced immunogenicity and oligomer formation.",
            "predicted_answer": "The IgG1 molecular framework is pivotal in antibody-drug conjugates due to its prolonged blood half-life, enhanced FcγR binding, potent ADCC and CDC effects, and reduced oligomer formation, enabling effective target engagement and functionality.",
            "score": 3,
            "explanation": "The predicted answer correctly mentions the IgG1 framework's prolonged half-life, enhanced FcγR binding, potent ADCC and CDC effects, and reduced oligomer formation. However, it omits \"reduced immunogenicity\" while ensuring alignment with the overall trend. Thus, one key fact is missing."
        },
        {
            "query_idx": 907,
            "query": "What emergent benefits do bispecific ADCs reveal within the domain of preclinical therapeutic investigations, particularly involving the molecular duality of EGFR/c-MET and HER2/PRLR, as understood from their preliminary study results?",
            "retrieved_metrics": {
                "reference_idx": [
                    921
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Bispecific ADCs targeting #EGFR/c-MET# and #HER2/PRLR# reveal benefits of improved internalization, increased affinity, and decreased toxicity in preclinical therapeutic investigations.",
            "predicted_answer": "Bispecific ADCs for EGFR/c-MET and HER2/PRLR show improved internalization, increased affinity, and decreased toxicity in preclinical studies.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer, specifically the presence of \"EGFR/c-MET\" and \"HER2/PRLR\" as targets, along with the benefits of improved internalization, increased affinity, and decreased toxicity. The information is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 908,
            "query": "What intricate array of interwoven factors delineates the differential molecular stability and complex metabolic transformations in ADCs, given their convergence on an identical antigenic target yet varied systemic manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    922
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ADCs targeting the same antigen show differential #molecular stability# and metabolic transformations due to variations in #antigen epitope# recognition, linker sites, coupling chemistry, and small molecule toxins.",
            "predicted_answer": "The intricate array of interwoven factors includes variations in antigen epitope recognition, linker sites, coupling chemistry, and small molecule toxins, leading to differential molecular stability and complex metabolic transformations in ADCs targeting the same antigen.",
            "score": 5,
            "explanation": "The Predicted Answer successfully covers all the key facts emphasized with # symbols in the Reference Answer. It includes \"molecular stability,\" \"antigen epitope recognition,\" \"linker sites,\" \"coupling chemistry,\" and \"small molecule toxins.\" The meaning aligns well, with no significant omissions or errors."
        },
        {
            "query_idx": 909,
            "query": "In the intricate molecular framework of chimeric antigen receptors, how does the intermediary passage that bridges external antigen acknowledgment with internal signal propagation manifest its operational capacity?",
            "retrieved_metrics": {
                "reference_idx": [
                    923
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intermediary passage in chimeric antigen receptors manifests its operational capacity through the #transmembrane domain#, linking the extracellular domain to the #intracellular signaling# domain.",
            "predicted_answer": "The intermediary passage in chimeric antigen receptors (CARs) that bridges external antigen acknowledgment with internal signal propagation is manifested through the transmembrane domain, which connects the extracellular antigen recognition domain (scFv) to the intracellular signaling domain.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: the transmembrane domain and its role in linking the extracellular antigen recognition domain to the intracellular signaling domain. The overall meaning and key details are consistent with the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 910,
            "query": "Within the complex paradigm of immune system orchestration in CAR-T cell therapy, what is the paramount benefit rendered by these chronicle sentinels in maintaining an enduring safeguard against malignant relapse?",
            "retrieved_metrics": {
                "reference_idx": [
                    925
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paramount benefit of CAR-T cell therapy is the #memory T cells# that provide #long-term protection# against malignant relapse.",
            "predicted_answer": "The paramount benefit of CAR-T cell therapy is the formation of memory T cells, which provide long-term protection against malignant relapse by persisting in the body and maintaining a sustained anti-tumor response.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the key facts emphasized in the reference answer, specifically #memory T cells# and #long-term protection# against malignant relapse. The phrasing captures the essence and meaning of the key points, aligning with the reference completely."
        },
        {
            "query_idx": 911,
            "query": "In the transformative journey of individuals grappling with the intricate patterns of refractory-relapsed B-acute lymphoblastic landscapes, what enigmatic fraction of the assembly attained the summit of molecular negativity aligned with the intricate dance of complete or near-complete recovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    931
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Among the #50 patients#, #47# (94%) achieved molecular negativity aligned with complete or near-complete recovery.",
            "predicted_answer": "94% of the 50 R/R B-ALL patients achieved molecular negativity (MRD -CR/CRi) aligned with complete or near-complete recovery.",
            "score": 5,
            "explanation": "The predicted answer aligns with the key facts of the reference answer: it states that 94% of the 50 R/R B-ALL patients achieved molecular negativity with recovery. No key details are missing, and the numbers match the reference."
        },
        {
            "query_idx": 912,
            "query": "What transformative paradigms are employed to enhance the efficacy of CAR-T cells as they traverse the suppressive tumor milieu and surmount the structural impediments analogous to fortifications within solid tumor landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    934
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Transformative paradigms include combining #CAR-T cells# with immune checkpoint inhibitors and genetically modifying CAR-T cells to enhance their #immune response# and resistance to inhibitory factors.",
            "predicted_answer": "Transformative paradigms include combining CAR-T cells with immune checkpoint inhibitors, genetically modifying CAR-T cells to enhance immune response, and using alternative delivery routes like intrathoracic injection to overcome tumor barriers.",
            "score": 5,
            "explanation": "The predicted answer includes combining CAR-T cells with immune checkpoint inhibitors and genetic modification to enhance the immune response, aligning with the reference. However, it introduces an unmentioned point about alternative delivery routes, but all key facts are present, without any contradictory information impacting the score."
        },
        {
            "query_idx": 913,
            "query": "In what ways do the strategies of architectural alteration in chimeric antigen receptor constructs and the orchestrated targeting of cytokine cascades serve to mitigate the entwined adversities of toxicity and potent cytokine surges within CAR-T cell therapeutic applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    932
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Architectural alterations in CAR constructs #reduce immunogenicity#, improving safety. Targeting cytokine cascades, especially #IL-6#, helps to diminish cytokine surges without impairing CAR-T functionalities.",
            "predicted_answer": "Architectural alterations in CAR constructs, such as humanizing antibodies, reduce immunogenicity and toxicity. Targeting cytokine cascades, like inhibiting IL-6 and GM-CSF, mitigates cytokine surges and associated toxicities without impairing CAR-T activities.",
            "score": 5,
            "explanation": "The predicted answer covers the reduction of immunogenicity, targets IL-6, and addresses cytokine surges, aligning with the reference. It also mentions GM-CSF, enhancing completeness. No significant omissions affect the overall meaning."
        },
        {
            "query_idx": 914,
            "query": "Within the discussed narrative, what representational impediments challenge the strategic expansion of CAR-T therapeutics from the fluidic aberrations to the more rigid cellular terrains, focusing on the scarceness of distinguishable cellular markers and the implications on essential anatomical entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    933
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #scarcity of tumor-specific antigens# limits CAR-T expansion to solid tumors, as common antigens are present on #essential organs#, hindering strategic development.",
            "predicted_answer": "The strategic expansion of CAR-T therapeutics into solid tumors faces challenges due to the scarcity of distinguishable cellular markers, such as tumor-specific antigens (TSA) being rare in solid tumors. This limitation affects the targeting of essential anatomical entities, as common tumor-associated antigens (TAA) like CEA, HER2, and GPC3 are often expressed on vital organs, restricting CAR-T application.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts from the reference answer, including the scarcity of tumor-specific antigens and the issue of common antigens being present on essential organs, hindering CAR-T's strategic expansion to solid tumors. All critical details in the reference are reflected in the predicted answer."
        },
        {
            "query_idx": 915,
            "query": "Within the intricate dynamics of the tumor's biological symphony, in what manner do the modulatory agents Tregs, MDSCs, and M2 macrophages orchestrate the suppression of CAR-T cell robustness against solid neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    938
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tregs, MDSCs, and M2 macrophages suppress CAR-T cell robustness by releasing #cytokines# like TGF-β and IL-10, reducing CAR-T cell effectiveness against #solid tumors#.",
            "predicted_answer": "Tregs, MDSCs, and M2 macrophages in the tumor microenvironment release cytokines like TGF-β and IL-10, which suppress CAR-T cell activity and diminish their effectiveness against solid tumors.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts emphasized with # symbols in the reference answer, including the cytokines TGF-β and IL-10 and their effect on CAR-T cells against solid tumors. The predicted answer aligns with the reference answer, with no significant omissions."
        },
        {
            "query_idx": 916,
            "query": "What implicit barriers reminiscent of CAR-T might the chimeric emissaries of CAR-M encounter within the adversarial milieu of tumor microenvironments, and how might novel insights from the artistry of macrophage generation via induced pluripotent stem constructions offer covert pathways to surmount such challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    951
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CAR-M may face #migration# and #inhibition# challenges within the tumor microenvironment, similar to CAR-T. Induced pluripotent stem cells offer potential to overcome cell population limitations.",
            "predicted_answer": "CAR-M may encounter barriers like migration and inhibition within tumor microenvironments, similar to CAR-T. Novel insights from CAR-iM generation via iPSCs offer potential solutions to these challenges, enhancing tumor elimination through cytoburial mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers key facts like migration and inhibition challenges faced by CAR-M similar to CAR-T. It also mentions the use of induced pluripotent stem cells, consistent with the reference answer. There are no significant omissions or errors impacting completeness."
        },
        {
            "query_idx": 917,
            "query": "What was the observed favorable manifestation prevalence resulting from the deployment of immune-modulating cellular therapy targeting the viral protein HPV-16 E7 in the expansive landscape of metastatic HPV-induced neoplastic disorders?",
            "retrieved_metrics": {
                "reference_idx": [
                    950
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The observed favorable manifestation prevalence was #50%# for patients receiving immune-modulating cellular therapy targeting the viral protein #HPV-16 E7# in metastatic HPV-induced neoplastic disorders.",
            "predicted_answer": "The observed favorable manifestation prevalence was 50% in patients treated with viral protein HPV-16 E7 TCR-T cell therapy for metastatic HPV-associated cancers.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized with # in the Reference Answer: the observed favorable manifestation prevalence of 50%, targeting of HPV-16 E7, and the context of metastatic HPV-associated cancers. The meaning is consistent with the Reference Answer without any significant omissions."
        },
        {
            "query_idx": 918,
            "query": "What are the transformative molecular symphonies conducted by mRNA platforms that harmonize with oncological initiatives as illustrated within the referential boundaries of the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    955
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "mRNA platforms conduct #oncological symphonies# by encoding #neoantigens for cancer vaccines#, activating T-cells, inhibiting tumor progression, and enabling gene therapy through innovative mRNA applications.",
            "predicted_answer": "mRNA platforms orchestrate transformative molecular symphonies by encoding neoantigens, tumor-associated antigens, tumor suppressors, CAR constructs, and genome-editing proteins, harmonizing with oncological initiatives.",
            "score": 1,
            "explanation": "The predicted answer covers some key points like #encoding neoantigens#, aligning with cancer treatment initiatives, but misses #activating T-cells, inhibiting tumor progression, and enabling gene therapy#. Although it reflects the general trend, these omissions affect completeness."
        },
        {
            "query_idx": 919,
            "query": "What was the observed manifestation of Carisma Therapeutics' macrophage-driven cellular innovation within the experimental framework targeting the SKOV3 ovarian cancer biological model, and how did it reflect in the overall survival metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    956
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CAR-M demonstrated #effective tumor killing# and extended #overall survival# in the SKOV3 human ovarian cancer mouse model.",
            "predicted_answer": "Carisma Therapeutics' CAR-M therapy in the SKOV3 ovarian cancer model showed effective tumor killing and extended overall survival in mice.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer, stating that CAR-M therapy demonstrated effective tumor killing and extended overall survival in the SKOV3 ovarian cancer model. Both key facts emphasized with # are present, and the trend is consistent."
        },
        {
            "query_idx": 920,
            "query": "Amid the extensive chronicle of investigational pursuits from May 2005 to the dawn of 2024, which segment of the mRNA pharmacological exploration undertook its journey fueled by the transformative wave of the COVID-19 epoch?",
            "retrieved_metrics": {
                "reference_idx": [
                    954
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The segment of #mRNA pharmacological exploration# that was notably accelerated by the #COVID-19# epoch includes neoantigen research and mRNA drug studies.",
            "predicted_answer": "The segment of mRNA pharmacological exploration that saw rapid progress fueled by the COVID-19 epoch is the development of research targeting neoantigens, with 13 related clinical trials occurring between 2022 and March 2024.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the mRNA pharmacological exploration as focusing on neoantigen research accelerated by COVID-19. However, it omits the mention of mRNA drug studies, a key fact emphasized in the reference answer, affecting completeness."
        },
        {
            "query_idx": 921,
            "query": "How do the labyrinthine dynamics intrinsic to the architectural assembly of zinc finger nucleases, in terms of their elaborate and costly genomic targeting endeavors, compare with the streamlined design ease associated with the CRISPR paradigm in the context of cancerous therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    960
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CRISPR system# offers a more #streamlined# and cost-effective design compared to the complex and costly synthesis of zinc finger nucleases for cancer therapeutic strategies.",
            "predicted_answer": "Zinc finger nucleases (ZFNs) are complex and costly to design due to their intricate protein engineering requirements, unlike CRISPR, which offers a streamlined and modular approach, making it more efficient and cost-effective for cancer therapeutic strategies.",
            "score": 5,
            "explanation": "The predicted answer covers key facts: it describes CRISPR as offering a \"streamlined\" approach and indicates its efficiency and cost-effectiveness compared to the complex design of zinc finger nucleases for cancer therapy. All key facts symbolized by # in the reference answer are present in the predicted answer."
        },
        {
            "query_idx": 922,
            "query": "In the realm of genomic artistry where cellular scripts are meticulously altered, what advanced mechanistic strategies do zinc finger nucleases deploy to orchestrate targeted modifications within the genetic framework of eukaryotic organisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    958
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zinc finger nucleases leverage #double-strand DNA breaks# and cellular repair mechanisms like #nonhomologous end joining# or homology-directed repair to orchestrate targeted genetic modifications in eukaryotic cells.",
            "predicted_answer": "Zinc finger nucleases (ZFNs) deploy engineered zinc finger proteins to bind specific DNA sequences, creating double-strand breaks (DSBs) at targeted loci. These breaks are then repaired by cellular mechanisms like nonhomologous end joining (NHEJ) or homology-directed repair (HDR), enabling precise genetic modifications in eukaryotic cells.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference: it mentions #double-strand DNA breaks#, and the repair mechanisms of #nonhomologous end joining# or homology-directed repair. It is consistent with the reference answer and there are no significant omissions or errors."
        },
        {
            "query_idx": 923,
            "query": "Within the intricate framework of genomic customization, what intrinsic obstacles surface when utilizing lentivirus-based delivery mechanisms for TALEN frameworks, especially when contrasted with the vector dynamics offered by adenovirus-based delivery paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    962
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic obstacles using #lentivirus# for TALENs include #instability# in tandemly repeated sequences, recombination during reverse transcription, and constrained co-delivery packaging capacity.",
            "predicted_answer": "The intrinsic obstacles when using lentivirus-based delivery for TALEN frameworks include size constraints, instability of tandem repeats, and recombination during reverse transcription. Adenovirus-based delivery offers a more stable and efficient alternative.",
            "score": 3,
            "explanation": "The predicted answer captures the instability of tandem repeats and recombination during reverse transcription, both highlighted in the reference. However, while it mentions \"size constraints,\" it lacks the specific mention of \"constrained co-delivery packaging capacity,\" a key aspect in the reference."
        },
        {
            "query_idx": 924,
            "query": "Within the molecular architecture of the TALEN mechanism, how do the 12th and 13th elemental amino architects of the TALE module dictate the precision of the genomic interaction dance, influencing the specificity of the DNA accord?",
            "retrieved_metrics": {
                "reference_idx": [
                    961
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #12th and 13th# amino acids in each TALE module of TALEN dictate the DNA binding site's precision, allowing high #specificity# by recognizing almost any sequence.",
            "predicted_answer": "The 12th and 13th amino acids in each TALE module determine the DNA binding specificity by encoding the target nucleotide sequence, allowing TALENs to recognize specific DNA sites with high precision.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the 12th and 13th amino acids' role in determining DNA binding specificity, aligning well with the reference. Both answers emphasize high specificity in recognizing DNA sequences, covering all key facts. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 925,
            "query": "In the intricate choreography of genome modulation employed by Prime Editing, what is the function of the spacetime anchor motif in harmonizing the realignment of DNA sequences during the subtle molecular undertaking of mutation rectification?",
            "retrieved_metrics": {
                "reference_idx": [
                    967
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #spacetime anchor motif# anchors the pegRNA to the DNA, ensuring precise #realignment# of sequences during mutation rectification in Prime Editing.",
            "predicted_answer": "The spacetime anchor motif in Prime Editing aligns the pegRNA spacer with the DNA's protospacer adjacent motif (PAM), facilitating precise DNA sequence realignment and mutation rectification.",
            "score": 5,
            "explanation": "The 'Predicted Answer' successfully includes the key facts of the spacetime anchor motif's role in pegRNA alignment and precise sequence realignment, aligning with the 'Reference Answer's core details. No contradictory information is present, and there are no significant omissions impacting completeness."
        },
        {
            "query_idx": 926,
            "query": "What functional capacities do the molecular variants BE3-Gam and BE4-Gam fulfill within the intricate framework of nucleotide transformation to ensure the diminution of unintended DNA interruptions and the elevation of molecular synthesis precision?",
            "retrieved_metrics": {
                "reference_idx": [
                    968
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BE3-Gam and BE4-Gam utilize the #Gam# protein to reduce unintended #indels# and enhance product purity in nucleotide transformation.",
            "predicted_answer": "BE3-Gam and BE4-Gam enhance nucleotide transformation precision by protecting DNA from unintended double-strand breaks (DSBs), reducing accidental indels, and increasing product purity.",
            "score": 5,
            "explanation": "The Predicted Answer adequately captures the key facts from the Reference Answer, including the use of BE3-Gam and BE4-Gam to reduce unintended indels and enhance product purity. Referencing DNA protection from DSBs aligns with the overall trend but doesn't contradict the Reference Answer, supporting completeness."
        },
        {
            "query_idx": 927,
            "query": "What is perceived as the foundational visionary goal underlying the integration of CRISPR within the sophisticated landscape of ex vivo T-cell modification, particularly in the strategic confrontation with cancerous anomalies?",
            "retrieved_metrics": {
                "reference_idx": [
                    970
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The foundational visionary goal of integrating #CRISPR# in ex vivo T-cell modification is to #enhance anti-cancer properties# by refining gene editing techniques.",
            "predicted_answer": "The foundational visionary goal is to enhance T-cell anti-cancer properties through CRISPR-based gene editing, aiming to eliminate PD-1 expression and improve therapeutic efficacy against cancerous anomalies.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of using CRISPR to enhance T-cell anti-cancer properties, consistent with the Reference Answer. However, it includes specifics on eliminating PD-1 expression not explicitly highlighted with # in the Reference Answer, but this does not affect the alignment with the overall vision."
        },
        {
            "query_idx": 928,
            "query": "Within the realm of AAV's genetic conveyance, how do the enigmatic architects, Rep and Cap, facilitate the complex orchestration required for synthesizing and structuring the viral entities through precise replication, assembly, and packaging?",
            "retrieved_metrics": {
                "reference_idx": [
                    972
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Rep# proteins mediate viral #replication#, while Cap proteins are crucial for viral assembly and packaging, enabling efficient synthesis and structuring of AAV entities.",
            "predicted_answer": "Rep proteins initiate replication by binding to ITRs, while Cap proteins form the viral capsid, facilitating assembly and packaging of the viral genome. Together, they ensure precise replication, assembly, and packaging of AAV.",
            "score": 5,
            "explanation": "The predicted answer captures the key roles of Rep proteins in replication and Cap proteins in assembly and packaging, reflecting the main trend of the reference. Although phrasing differs slightly, no significant information is omitted from the key facts emphasized in the reference."
        },
        {
            "query_idx": 929,
            "query": "What symphonic nuance do trans-splicing vectors introduce in the complex choreography of gene expression protocols within AAV vector frameworks, specifically through their splice donor sequences, to achieve meticulous protein synthesis reconstitution?",
            "retrieved_metrics": {
                "reference_idx": [
                    974
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trans-splicing vectors introduce splice donor sequences to achieve #precise# and #controlled# gene expression, facilitating meticulous protein synthesis reconstitution within AAV vector frameworks.",
            "predicted_answer": "Trans-splicing vectors introduce precise gene expression control in AAV frameworks by using splice donor sequences to achieve meticulous protein synthesis reconstitution.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference by mentioning \"precise gene expression control\" and \"meticulous protein synthesis reconstitution,\" aligning well with \"precise\" and \"controlled gene expression\" in the reference. Important details are covered with no significant omissions or contradictions."
        },
        {
            "query_idx": 930,
            "query": "What multifaceted biological approach, diverging from algorithmic foresight, facilitates the acquisition of immune-reactive neoantigenic moieties through the engagement of intrinsic antigen-presenting frameworks with tumoral derivatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    980
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An alternative approach involves #loading autologous antigen-presenting cells# with tumor lysates to facilitate the acquisition of #immune-reactive neoantigenic moieties#.",
            "predicted_answer": "The multifaceted biological approach involves loading autologous antigen-presenting cells (APCs) with tumor lysates and validating them ex vivo by co-culturing with T cells.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of loading autologous antigen-presenting cells with tumor lysates, capturing the main concept. Additionally, it introduces validation of this process through co-culturing with T cells, which aligns with the acquisition of immune-reactive neoantigenic moieties. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 931,
            "query": "What underlying technological constellations and predictive mechanisms form the scaffold for the preliminary in silico discernment of emergent neoantigen signatures in neoplastic cellular entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    979
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The scaffold for in silico neoantigen discernment includes #next-generation sequencing# and #multi-omics# technologies, using tumor genome or transcriptome comparisons to normal ones.",
            "predicted_answer": "The preliminary in silico discernment of emergent neoantigen signatures in neoplastic cellular entities relies on multi-omics technologies, including genome sequencing and mass spectrometry, to identify genetic alterations and predict neoantigens through comparative analysis of tumor and normal genomes or transcriptomes.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: it mentions \"multi-omics technologies\" and \"genome sequencing,\" which aligns with \"next-generation sequencing\" and \"multi-omics\" in the reference. It also reflects the comparison of tumor and normal genomes, aligning with the reference's core meaning. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 932,
            "query": "What extent of reduction in the HepG2-driven oncological proliferation symphony was harmonized through the collaborative deployment of the sg-VEGFR2 and Cas9 molecular partnership encapsulated in the PNPs concerted framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    981
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sg-VEGFR2# and Cas9 molecular partnership within PNPs achieved over #70%# suppression of HepG2-induced HCC tumor progression.",
            "predicted_answer": "The collaborative deployment of sg-VEGFR2 and Cas9 in PNPs led to more than 70% suppression of HepG2-induced HCC tumor progression.",
            "score": 5,
            "explanation": "The predicted answer effectively captures both key facts emphasized in the reference: the involvement of sg-VEGFR2 and the more than 70% suppression of HepG2-induced HCC tumor progression through their combination with Cas9 within PNPs. All crucial elements are present without contradictions."
        },
        {
            "query_idx": 933,
            "query": "In the realm of malignancies impacting the ovaries, what evolutions transpired in the nuanced fabric of the immune defense system subsequent to the administration of a genetic blueprint targeting IGFBP-2?",
            "retrieved_metrics": {
                "reference_idx": [
                    985
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #DNA vaccine# targeting IGFBP-2 enhanced the #T helper-1 immune response#, increasing IFN γ-secreting and T-bet positive T cells in ovarian cancer patients.",
            "predicted_answer": "The administration of a genetic blueprint targeting IGFBP-2 in ovarian cancer patients led to an activation of the T helper-1 immune response, with increased IFN-γ-secreting T cells and T-bet positive T cells.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer. It mentions the targeting of IGFBP-2 and the enhancement of the T helper-1 immune response, including increases in IFN-γ-secreting and T-bet positive T cells. The term \"#DNA vaccine#\" in the reference is synonymous with \"genetic blueprint,\" reflecting the same concept."
        },
        {
            "query_idx": 934,
            "query": "How do the unique surface identifiers orchestrate the navigational and interactional pathways of oncolytic viral particles to target and dismantle anomalously overexpressed cellular topographies within neoplastic entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    987
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oncolytic viral particles recognize #surface markers# abnormally overexpressed on cancer cells, enabling navigation and interaction to target and dismantle #neoplastic entities#.",
            "predicted_answer": "Oncolytic viral particles target and dismantle overexpressed cellular topographies by recognizing unique surface markers on cancer cells, entering them, and triggering cell lysis or apoptosis, depending on virus types and modification strategies.",
            "score": 5,
            "explanation": "The predicted answer includes recognition of unique surface markers on cancer cells and the targeting of neoplastic entities, consistent with the reference. However, it adds details about triggering cell lysis or apoptosis, which is not in the reference answer. The key facts are present and aligned."
        },
        {
            "query_idx": 935,
            "query": "Within the nuanced paradigm of oncological immunotherapy, by what means do the supportive molecular constituents in peptide-based vaccination frameworks sculpt the immunological landscape to enhance resistance to cancerous entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    982
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Supportive molecular constituents in peptide-based vaccination frameworks, such as #immunoadjuvants#, shape the immunological landscape by enhancing the #immune response# against cancerous entities.",
            "predicted_answer": "Peptide-based vaccination frameworks enhance resistance to cancer by inducing tumor-specific immunity and long-term immune memory, often with the aid of immunoadjuvants to boost the immune response.",
            "score": 5,
            "explanation": "The predicted answer successfully mentions the use of \"immunoadjuvants\" and their role in enhancing the \"immune response,\" aligning well with the key facts in the reference answer. It covers all the emphasized information without introducing contradictions or missing elements."
        },
        {
            "query_idx": 936,
            "query": "What unique cellular insurgency was catalyzed in breast carcinoma subjects who participated in the 2014 preliminary phase analysis involving the mammaglobin-A inscribed genomic schema, as noted in reported outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    984
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2014# study showed the mammaglobin-A DNA vaccine effectively elicited cytotoxic #antigen-specific T cells# in breast carcinoma patients, leading to prolonged progression-free survival (PFS).",
            "predicted_answer": "The unique cellular insurgency catalyzed in breast carcinoma subjects was the elicitation of cytotoxic antigen-specific T cells, leading to prolonged progression-free survival (PFS).",
            "score": 3,
            "explanation": "The predicted answer captures key facts from the reference: the induction of cytotoxic antigen-specific T cells and prolonged PFS. However, it misses the specific mention of the #2014# study, which slightly affects completeness, though the overall trend and information are aligned without contradictions."
        },
        {
            "query_idx": 937,
            "query": "Within the complex interplay of immune orchestration against advanced lung malignancies, what specific indicators of enhanced therapeutic potency were revealed by the T-cell response mechanistic evaluation during the Neo-DCVac pilot exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    988
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Neo-DCVac# pilot exploration revealed enhanced therapeutic potency through a strong increase in T-cell #IFN γ# secretion and cytotoxicity.",
            "predicted_answer": "The T-cell response mechanistic evaluation during the Neo-DCVac pilot exploration revealed enhanced therapeutic potency through increased IFN-γ secretion and cytotoxicity.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer: the enhanced therapeutic potency during the Neo-DCVac pilot exploration was due to increased IFN-γ secretion and cytotoxicity by T-cells. All emphasized details (#Neo-DCVac#, #IFN γ#) are present and aligned with the reference, maintaining consistency in meaning."
        },
        {
            "query_idx": 938,
            "query": "What intricate molecular choreography orchestrates the infiltration of tumor cells by herpes simplex viruses, and how does this complex pathway differ from the distinctive cellular ingress mechanism favored by measles viruses?",
            "retrieved_metrics": {
                "reference_idx": [
                    989
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Herpes simplex viruses use #HVEM# and #nectin-1# for tumor cell entry, while measles viruses recognize CD46 upregulated on tumor cells for infiltration.",
            "predicted_answer": "Herpes simplex viruses use HVEM and nectin-1 for tumor cell infiltration, while measles viruses recognize CD46 on tumor cells, differing in their cellular entry mechanisms.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized with # symbols in the reference answer, specifically mentioning HVEM and nectin-1 for herpes simplex viruses, and CD46 for measles viruses. It is consistent with the reference answer without any significant omissions or errors."
        },
        {
            "query_idx": 939,
            "query": "Within the delicate interplay of genetic engineering, what specific molecular embellishment embedded in Talimogene laherparepvec facilitates the metamorphic amplification of the immune orchestra, targeting the stubborn adversary of recurrent unresectable melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    990
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Talimogene laherparepvec's #insertion of GM-CSF# facilitates immune activation by recruiting antigen-presenting cells, thereby targeting recurrent unresectable melanoma.",
            "predicted_answer": "The specific molecular embellishment in Talimogene laherparepvec (T-VEC) that facilitates the amplification of the immune response is the insertion of the human granulocyte macrophage colony-stimulating factor (GM-CSF) gene, which recruits antigen-presenting cells and activates T-cells to target recurrent unresectable melanoma.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact emphasized in the reference answer, the \"insertion of GM-CSF,\" and explains its role in immune activation, aligning well with the reference. There are no significant omissions or contradictions, and the explanation is consistent with the reference."
        },
        {
            "query_idx": 940,
            "query": "Which couple of cellular constructs, depicted as intricate biological vessels within the narrative, assumes the role of delivering viral composites, and what designated viral identities are they crafted to ferry?",
            "retrieved_metrics": {
                "reference_idx": [
                    995
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Neural stem cells# deliver #CRAd-S-pk7# and bone marrow-derived mesenchymal stem cells carry #Icovir-5#.",
            "predicted_answer": "The cellular constructs depicted as neural stem cells and mesenchymal stem cells assume the role of delivering viral composites. They are crafted to ferry Adenovirus-based CRAd-S-pk7 and Icovir-5, respectively.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies \"neural stem cells\" and their role in delivering \"CRAd-S-pk7\". However, it errors by stating \"mesenchymal stem cells\" instead of \"bone marrow-derived mesenchymal stem cells,\" but it correctly identifies \"Icovir-5\" as the viral composite they deliver. Missing the \"bone marrow-derived\" detail affects completeness."
        },
        {
            "query_idx": 941,
            "query": "Following the revelation of a serendipitous interaction entailing reduction of tumor presence alongside erysipelas affliction, what specific amalgamation did William Coley employ in his endeavor to address sarcoma, informed by his observation of this peculiar phenomenon?",
            "retrieved_metrics": {
                "reference_idx": [
                    996
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "William Coley used a specific amalgamation of #Streptococcus erysipelas# and #Bacillus prodigiosus# toxins, known as Coley's toxins, to treat sarcoma.",
            "predicted_answer": "William Coley used a mixture of toxins from Streptococcus erysipelas and Bacillus prodigiosus, known as Coley's toxins, to treat sarcoma.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # in the reference answer: \"Streptococcus erysipelas\" and \"Bacillus prodigiosus\" toxins used by William Coley for treating sarcoma. The phrasing is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 942,
            "query": "What potential orchestration of immune system dynamics, influenced by the biological catalyst Bacillus Calmette-Guérin (BCG), might contribute to the eventual demise of malignant formations in the context of bladder cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    997
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BCG may #activate# NK cells, induce cytokine secretion, and promote #immune cell# infiltration, contributing to the destruction of malignant formations in bladder cancer.",
            "predicted_answer": "BCG can activate innate immunity, inducing proinflammatory cytokines and immune cell infiltration, potentially activating NK cells to contribute to the demise of malignant formations in bladder cancer.",
            "score": 5,
            "explanation": "The predicted answer includes key aspects: BCG activating NK cells, inducing cytokines, and promoting immune cell infiltration, aligning well with the reference. The overall meaning and key facts are consistent and complete, with the primary orchestrating elements of immune response present."
        },
        {
            "query_idx": 943,
            "query": "Through what mechanisms do the sentinel-like modulators within the antigen-presenting cellular framework orchestrate the interlinked complexities of adaptive response pathways in the context of T cells’ immune activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    998
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sentinel-like modulators, like #Toll-like receptors#, orchestrate adaptive response pathways by activating antigen-presenting cells, inducing proinflammatory cytokines, and stimulating adaptive immunity in #T cells#.",
            "predicted_answer": "Sentinel-like modulators, such as Toll-like receptors (TLRs), activate antigen-presenting cells (APCs) like macrophages and dendritic cells, inducing cytokine secretion. This activation stimulates adaptive immunity in T cells, orchestrating the complex pathways of immune response.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as \"Toll-like receptors\", \"activating antigen-presenting cells\", \"cytokine secretion\", and \"stimulating adaptive immunity in T cells\", aligning closely with the reference answer. Although phrasing differs slightly, it captures necessary elements without omitting critical details."
        },
        {
            "query_idx": 944,
            "query": "How does the orchestration of the synthetic compound G100 in orchestrating within the realms of a malignant cellular peculiarity initiate a sequence of defensive immune orchestrations culminating in an oncological withdrawal for participants in the initial phase of investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    999
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "G100, a synthetic #TLR4# agonist, initiates immune responses by increasing #T cell# infiltration and activation, resulting in sustained tumor regression in a phase I study on Merkel Cell Carcinoma.",
            "predicted_answer": "The synthetic TLR4 agonist G100, when administered intratumorally, activates immune responses by increasing T cell infiltration, leading to sustained tumor regression and potential oncological withdrawal in initial phase investigations.",
            "score": 3,
            "explanation": "The Predicted Answer captures most key elements: G100 as a TLR4 agonist, its role in increasing T cell infiltration, and its effect on tumor regression. However, it omits \"Merkel Cell Carcinoma\" from the specific context. Overall, the trend and mechanism described are aligned."
        },
        {
            "query_idx": 945,
            "query": "How do the multi-dimensional quests for crafting and operationalizing biomedical synergy amplifiers and elemental immune catalysts unfold, particularly in the context of achieving targeted influence while navigating the hazards of uncontrolled inflammatory surges and potential habituation over extensive horizons?",
            "retrieved_metrics": {
                "reference_idx": [
                    1001
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Developing #biomedical synergy# and immune modulators involves ensuring safety and efficacy while addressing inflammation and habituation risks in complex immune environments over time.",
            "predicted_answer": "The development of biomedical synergy amplifiers and elemental immune catalysts involves navigating challenges like uncontrolled inflammatory surges and potential habituation. These activators may lack specificity, leading to excessive responses and resistance issues over time. Careful consideration in their development and application is crucial for safety and efficacy.",
            "score": 3,
            "explanation": "The predicted answer captures the key elements: development of biomedical synergy and immune catalysts, challenges of inflammatory surges, and habituation risks. However, it lacks explicit mention of \"complex immune environments\" as noted in the reference. The trends and key facts mostly align without contradictions."
        },
        {
            "query_idx": 946,
            "query": "Over the span of a year following therapeutic engagement, what were the deciphered outcomes from histopathological assessments, correlating to the ability of light-reactive metallic particulates to eradicate neoplastic tissue within prostate oncological sites?",
            "retrieved_metrics": {
                "reference_idx": [
                    1006
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "After 12 months, histopathological assessments showed that #13 of 15# patients were #cancer-free# at the ablation zones following light-activated goldsilica nanoshell therapy in prostate cancer sites.",
            "predicted_answer": "Over the span of a year, histopathological assessments showed that light-reactive metallic particulates (GSNs) eradicated neoplastic tissue in 13 out of 15 prostate cancer patients, achieving cancer-free status in the ablation zones.",
            "score": 5,
            "explanation": "The predicted answer closely aligns with the reference by stating that 13 out of 15 patients were cancer-free in ablation zones, matching the reference key facts about numbers and outcomes. Light-reactive metallic particulates correspond to the reference \"gold-silica nanoshell therapy.\""
        },
        {
            "query_idx": 947,
            "query": "What architectural discrepancies and distinctive dynamic phenomena characterize the vascular development within malignant growths as opposed to the harmonized and regulated vascular proliferation witnessed in typical biological processes such as embryogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1010
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Tumor angiogenesis# is characterized by a #disordered structure#, high permeability, and absence of pericytes and smooth muscle cells, unlike the regulated process in normal angiogenesis.",
            "predicted_answer": "Malignant growths exhibit disordered vascular structure, high permeability, and lack of pericytes/smooth muscle cells, contrasting with the harmonized angiogenesis in embryogenesis.",
            "score": 3,
            "explanation": "The predicted answer includes key facts about the disordered vascular structure, high permeability, and lack of pericytes/smooth muscle cells in malignant growths, aligning with the reference's tumor angiogenesis description. However, it misses explicitly mentioning \"tumor angiogenesis,\" affecting completeness."
        },
        {
            "query_idx": 948,
            "query": "How do the intricate dynamics of photonic energy navigation through corporeal domains pose challenges to the strategic effectiveness of light-initiated cellular ablation methodologies, particularly in relation to voluminous or subterranean neoplastic configurations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1009
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #depth of light penetration# in PTT and PDT limits their effectiveness against #voluminous or subterranean neoplastic# configurations, posing challenges in targeting and treatment efficacy.",
            "predicted_answer": "The intricate dynamics of photonic energy navigation through corporeal domains pose challenges to light-initiated cellular ablation methodologies, particularly in relation to voluminous or subterranean neoplastic configurations, due to limitations in light penetration depth and the need for precise temperature control to avoid collateral damage.",
            "score": 5,
            "explanation": "The predicted answer mentions \"limitations in light penetration depth,\" aligning with the reference's \"depth of light penetration.\" It also acknowledges challenges with \"voluminous or subterranean neoplastic configurations.\" Both key facts are covered, and trends are aligned without contradictions or omissions."
        },
        {
            "query_idx": 949,
            "query": "What dynamic influence do the fibroblast growth factors and their receptor interactions wield within the complex tapestry of tumor vascular proliferation, and how crucial are these biomolecular conversations in the context of oncological prognostic assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1011
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fibroblast growth factors (#FGFs#) and their receptor interactions play a significant role in tumor #angiogenesis#, with prognostic significance, although mechanisms are not fully understood.",
            "predicted_answer": "Fibroblast growth factors (FGFs) and their receptors significantly influence tumor vascular proliferation, with overexpression linked to prognostic significance. These interactions are crucial for oncological prognostic assessments, though their mechanisms are not fully understood.",
            "score": 3,
            "explanation": "The predicted answer covers the emphasized key facts: \"FGFs,\" \"receptors,\" and \"prognostic significance.\" However, it misses the specific mention of \"angiogenesis,\" which is a key fact in the context. The general trend is aligned without contradictions, but one key fact is missing."
        },
        {
            "query_idx": 950,
            "query": "In the ethereal landscape of tumor vascular origination, what principal orchestrated symphonies are initiated by the binding interaction of VEGF-A with VEGFR2, setting off the cellular cascade, as expounded through a mechanistic framework of molecular symphony and signaling choreography in the provided context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1014
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The binding of #VEGF-A# to #VEGFR2# initiates tumor angiogenesis through endothelial cell reprogramming, proliferation, and migration by activating RAS, ERK-MAPK, and PI3K-AKT pathways.",
            "predicted_answer": "The binding of VEGF-A to VEGFR2 initiates endothelial cell reprogramming, proliferation, and migration, activating downstream pathways such as RAS, ERK-MAPK, and PI3K-AKT signaling in tumor angiogenesis.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer closely, covering the key facts such as the binding interaction of VEGF-A with VEGFR2 and the activation of RAS, ERK-MAPK, and PI3K-AKT pathways leading to endothelial cell activities. The core information and sequence are present without contradictions or significant omissions."
        },
        {
            "query_idx": 951,
            "query": "What role does the molecular symphony conducted by the epidermal growth factor clan play in the orchestration of vascular proliferation within a neoplastic context, considering both direct receptor-mediated interactions and auxiliary extracellular signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1012
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #epidermal growth factor# family promotes #tumor angiogenesis# by directly stimulating endothelial cell proliferation via EGFR and indirectly increasing VEGF secretion from smooth muscle cells.",
            "predicted_answer": "The epidermal growth factor (EGF) clan plays a pivotal role in vascular proliferation within a neoplastic context by directly stimulating endothelial cell proliferation via EGFR and indirectly enhancing VEGF secretion, thereby orchestrating angiogenesis.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by noting the epidermal growth factor (EGF) family's pivotal role in promoting vascular proliferation and tumor angiogenesis, directly through EGFR and indirectly via VEGF secretion. It misses the detail about VEGF secretion from smooth muscle cells, impacting completeness."
        },
        {
            "query_idx": 952,
            "query": "How do the minuscule entities composed of iron oxide operate as instrumental amplifiers within the diagnostic landscape, enriching the intricate visualization of neoplastic formations during the pursuit of oncological discernment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1019
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Iron oxide nanoparticles, like #Fe3O4#, act as #contrast agents# in MRI, enhancing visualization of tumors for better diagnostic precision in oncology.",
            "predicted_answer": "Iron oxide nanoparticles enhance tumor visualization in MRI by acting as contrast agents, improving the diagnostic landscape for oncological discernment.",
            "score": 3,
            "explanation": "The predicted answer includes most key facts like \"iron oxide nanoparticles\" and \"contrast agents\" for \"enhancing tumor visualization in MRI.\" However, it omits mentioning \"Fe3O4,\" a specific type of iron oxide, affecting the completeness."
        },
        {
            "query_idx": 953,
            "query": "What was the magnitude of change observed in the fundamental parameter of lesion activity subsequent to a series of three administrations of synthetic hypericin, as documented in the comprehensive Snapshot inquiry targeting the preliminary spectrum of MF/CTCL treatment methodology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1008
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ILRR# increased to #49%# after three administrations of synthetic hypericin.",
            "predicted_answer": "The magnitude of change observed in lesion activity subsequent to three administrations of synthetic hypericin was an increase in the index lesion response rate (ILRR) to 49%.",
            "score": 5,
            "explanation": "The Predicted Answer accurately captures the key facts that are emphasized with # in the Reference Answer: \"ILRR\" and \"49%.\" Both answers mention these key details, and no critical information is missing. The trend and meaning are consistent with the Reference Answer."
        },
        {
            "query_idx": 954,
            "query": "What roles do naturally occurring liposome-like vesicular envoys, particularly those secreted by phagocytic cells, play in optimizing the distribution and effectiveness of anticancer compounds utilized against malignant breast tissues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1020
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Exosomes# secreted by macrophages optimize #anticancer drug# delivery like Doxorubicin in malignant breast tissues by enhancing cell communication and carrying therapeutic molecules.",
            "predicted_answer": "Naturally occurring liposome-like vesicles, such as exosomes secreted by phagocytic cells, optimize the distribution and effectiveness of anticancer compounds by enhancing drug delivery to malignant breast tissues, as demonstrated by their use in delivering Doxorubicin for breast cancer treatment.",
            "score": 3,
            "explanation": "The predicted answer mentions exosomes secreted by phagocytic cells, referring to the key point of #exosomes#. It also mentions enhancing drug delivery, which aligns with optimizing #anticancer drug# delivery. However, it misses the aspect of \"enhancing cell communication and carrying therapeutic molecules.\""
        },
        {
            "query_idx": 955,
            "query": "In the multifaceted orchestration of cellular alchemy, what transformational roles do the constructs of TiO2 and ZnO assume in the genesis of reactive oxygen species, as they choreography their selective incursion on malign cellular architectures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1021
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#TiO2# and #ZnO# generate reactive oxygen species (ROS) under light exposure to selectively kill tumor cells.",
            "predicted_answer": "TiO2 and ZnO generate reactive oxygen species (ROS) under light exposure, selectively targeting and killing tumor cells, playing a crucial role in nanomedicine.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both #TiO2# and #ZnO#, mentioning their role in generating ROS under light to target tumor cells, consistent with the reference. The added context about their role in nanomedicine does not contradict the reference, ensuring alignment with the overall trend."
        },
        {
            "query_idx": 956,
            "query": "What quantifiable enhancement in median longevity metrics is discernible with the innovative therapeutic paradigm when positioned against the survival parameters established by sorafenib within the bounds of the Chinese patient cohort?",
            "retrieved_metrics": {
                "reference_idx": [
                    1026
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The innovative therapeutic paradigm extends median overall survival to #two years# compared to #11.4 months# with sorafenib in the Chinese patient cohort.",
            "predicted_answer": "The innovative therapeutic paradigm extended median overall survival (mOS) to two years in the Chinese patient cohort, compared to 11.4 months with sorafenib.",
            "score": 5,
            "explanation": "The Predicted Answer fully covers all key facts emphasized in the Reference Answer. It accurately includes \"two years\" and \"11.4 months\" as the respective median survival metrics for the innovative therapeutic paradigm and sorafenib in the Chinese patient cohort. The key facts and overall trend are consistent."
        },
        {
            "query_idx": 957,
            "query": "Within the intricate narrative woven by the SPOTLIGHT study, what is the quantitative measure by which zolbetuximab coupled with mFOLFOX6 recalibrates the course of advanced gastric cancer's progression or demise, contrasted with the traditional placebo-assisted mFOLFOX6 methodology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1028
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Zolbetuximab with mFOLFOX6 reduces the risk of #disease progression# or #death# by 24.9% compared to placebo with mFOLFOX6 in advanced gastric cancer.",
            "predicted_answer": "The SPOTLIGHT study showed that zolbetuximab with mFOLFOX6 reduced the risk of disease progression or death by 24.9% compared to placebo + mFOLFOX6, with median progression-free survival of 10.61 months versus 8.67 months.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer, mentioning the 24.9% risk reduction in disease progression or death and aligning with the reference's overall trend. Additional numerical details in the prediction do not contradict the reference."
        },
        {
            "query_idx": 958,
            "query": "Through what intricate dance do ions of iron, unfurling from the porous architecture of mesoporous Prussian blue constructs camouflaged within macrophage facades, propel the transformation of tumor-associated macrophage allegiances, whilst concurrently influencing the fervent activation of cytotoxic T cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1022
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Iron ions from mesoporous Prussian blue induce M1-like macrophage differentiation via the #IRF5 pathway#, stimulating cytotoxic #T cells# for antitumor effects.",
            "predicted_answer": "Iron ions released from mesoporous Prussian blue constructs camouflaged within macrophages promote M1-like TAM differentiation via the IRF5 pathway, stimulating cytotoxic T cells and enhancing antitumor effects.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized by # symbols: the \"IRF5 pathway\" and \"T cells,\" aligning well with the reference answer. It captures the essential process involving iron ions and M1-like macrophage differentiation, ensuring no significant omissions or errors."
        },
        {
            "query_idx": 959,
            "query": "In the context of orchestrating the strategic navigation of genetic elements, what favorable attributes do specialized polymer-enhanced nanocarriers exhibit that distinguish them during their mission to transport the p53 tumor suppressor blueprint, contrasting with the unrestricted journey of the unadulterated gene?",
            "retrieved_metrics": {
                "reference_idx": [
                    1029
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Specialized #dendrimer-functionalized nanocarriers# improve #antiproliferative effects# and enhance stability, bioavailability, and circulation time compared to the free p53 gene.",
            "predicted_answer": "Specialized polymer-enhanced nanocarriers, like dendrimers, improve stability, target specificity, and therapeutic efficacy of p53 tumor suppressor gene delivery, contrasting with the less stable and less targeted journey of the unadulterated gene.",
            "score": 3,
            "explanation": "The predicted answer captures the stability and the targeted delivery aspects mentioned in the reference, aligning with key features of dendrimer functionalization. However, it omits the critical aspect of improved antiproliferative effects and bioavailability, which affects the completeness of the response."
        },
        {
            "query_idx": 960,
            "query": "In the context of comprehensive clinical explorations, what is the harvested chronicle of longevity among those facing the daunting resurgence or far-reaching expansion of nasopharyngeal carcinoma, as they embark on a therapeutic journey entwined with tislelizumab and its chemotherapeutic counterpart, as chronicled by the esteemed JUPITER-02 exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1030
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #JUPITER-02# study showed that treatment with #tislelizumab# and chemotherapy improved overall survival for recurrent or metastatic nasopharyngeal carcinoma, with a 3-year OS rate of 64.5%.",
            "predicted_answer": "The JUPITER-02 study found that tislelizumab combined with chemotherapy significantly improved overall survival (OS) in recurrent or metastatic nasopharyngeal carcinoma (NPC), with a 3-year OS rate of 64.5% and a 37% reduction in the risk of death.",
            "score": 5,
            "explanation": "The predicted answer covers all the key facts and numbers emphasized in the reference answer. Both mention the JUPITER-02 study, treatment with tislelizumab and chemotherapy, improved overall survival, and the 3-year OS rate of 64.5%. The 37% risk reduction aligns with improved survival. No significant details are missing."
        },
        {
            "query_idx": 961,
            "query": "What archetype of malignant cellular emergence finds itself at the forefront of therapeutic focus through the convergence of Nivolumab and Ipilimumab, within the analytical breadth provided by studies spanning from 2006 to March 20, 2024?",
            "retrieved_metrics": {
                "reference_idx": [
                    1031
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The combination of #Nivolumab and Ipilimumab# focuses primarily on treating #melanoma# among various cancers.",
            "predicted_answer": "The archetype of malignant cellular emergence at the forefront of therapeutic focus through the convergence of Nivolumab and Ipilimumab is non-small cell lung cancer (NSCLC).",
            "score": 0,
            "explanation": "The predicted answer states the primary therapeutic focus as non-small cell lung cancer (NSCLC), while the reference answer highlights melanoma. This represents a contradiction to the key fact emphasized in the reference answer about the treatment focus of Nivolumab and Ipilimumab."
        },
        {
            "query_idx": 962,
            "query": "What profound interwoven hindrances and multifaceted constraints are obstructing the seamless transition of nanoparticle nanomedicinal innovations from auspicious laboratory frameworks to practical therapeutic arenas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1034
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Biological challenges#, regulatory hurdles, and #high cost# hinder the transition of nanoparticle nanomedicines from lab innovations to practical therapies, compounded by safety, efficacy, manufacturing, and IP issues.",
            "predicted_answer": "The seamless transition of nanoparticle nanomedicinal innovations is hindered by biological challenges, biocompatibility and safety concerns, large-scale manufacturing issues, government regulations, intellectual property, and cost-effectiveness compared to current therapies. Additionally, the distribution, metabolism, and clearance mechanisms of these nanomaterials in the body are not fully understood, affecting their safety and efficacy.",
            "score": 3,
            "explanation": "The predicted answer captures two of the three key facts: \"biological challenges\" and \"high cost\" from the reference. It misses specifying \"regulatory hurdles\" as a hindrance. However, other details like safety, manufacturing, and efficacy issues are acknowledged, aligning with the general trend."
        },
        {
            "query_idx": 963,
            "query": "What is the emblematic primary intervention recommended within the intricate protocols for addressing the advanced atypical pathology of non-clear cell renal carcinoma, considering the therapeutic results delineated in the provided exposition?",
            "retrieved_metrics": {
                "reference_idx": [
                    1035
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The recommended primary intervention for advanced atypical #non-clear cell# renal carcinoma is #Pembrolizumab and Lenvatinib# as first-line treatment.",
            "predicted_answer": "The emblematic primary intervention for advanced non-clear cell renal carcinoma is the combination of Pembrolizumab and Lenvatinib, supported by a 49% objective response rate and 82% 12-month overall survival rate.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"Pembrolizumab and Lenvatinib\" as the primary intervention for advanced non-clear cell renal carcinoma, matching the reference. Additional statistics in the prediction enhance it without contradiction. All key facts are present, and the trend aligns perfectly."
        },
        {
            "query_idx": 964,
            "query": "What measure of temporal elongation within the structured pathway of disease progression was discerned in the context of RELATIVITY-047's trial when synthesizing Relatlimab and Nivolumab in the therapeutic domain addressing metastatic melanoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1037
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #median PFS# for Relatlimab and Nivolumab increased from #4.6 months# to 10.1 months in the RELATIVITY-047 trial for metastatic melanoma.",
            "predicted_answer": "The measure of temporal elongation discerned in the RELATIVITY-047 trial was a significant improvement in median Progression-Free Survival (PFS) from 4.6 months to 10.1 months with the combination of Relatlimab and Nivolumab in metastatic melanoma.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by accurately reflecting the key fact of \"median PFS\" increasing in the RELATIVITY-047 trial for metastatic melanoma, covering the period from \"4.6 months\" to \"10.1 months\". No crucial details or technical elements are missing from the explanation."
        },
        {
            "query_idx": 965,
            "query": "What underlying transformational dynamic is catalyzed within the PD-1 + TCF-1 + progenitor-like CD8 + T cell population in response to the orchestrated synergy of PD-1 plus IL-2 interactive treatment strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1038
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The PD-1 + IL-2 combination therapy #significantly alters# the differentiation program of #PD-1 + TCF-1 + stem-like# CD8 + T cells.",
            "predicted_answer": "The underlying transformational dynamic catalyzed within the PD-1 + TCF-1 + progenitor-like CD8 + T cell population is the significant alteration of their differentiation program, enhancing their tumor-killing efficacy.",
            "score": 3,
            "explanation": "The predicted answer mentions the significant alteration of the differentiation program, which aligns with the #significantly alters# part of the reference. However, it refers to the cell type as progenitor-like instead of #stem-like#, missing this specific detail. Though the trend is consistent, one key fact is missing."
        },
        {
            "query_idx": 966,
            "query": "Which synergistic alliance identified in Zheng et al.'s study exemplifies a strategic convergence of molecular inhibition and targeted genetic intervention, manifesting as synthetic lethality within the landscape of hepatic oncogenesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1041
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synergistic alliance identified is #GSK-J4# exhibiting synthetic lethality with #donafenib# in liver cancer.",
            "predicted_answer": "The synergistic alliance identified in Zheng et al.'s study that exemplifies strategic convergence of molecular inhibition and targeted genetic intervention is the combination of GSK-J4 and donafenib, which exhibits synthetic lethality in liver cancer.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer by identifying the combination of GSK-J4 and donafenib as the synergistic alliance, showing synthetic lethality in liver cancer. All key facts emphasized with # symbols are present without any contradiction or missing information."
        },
        {
            "query_idx": 967,
            "query": "Within the context of a meticulously structured investigational pursuit involving the fusion of Bevacizumab and Erlotinib as counteractive forces against the advancement of ovarian pathology, what temporal oasis, quantified as the median span of progression-free resilience, emerged from this clinical synergy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1047
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The median span of progression-free resilience for the #Bevacizumab# and #Erlotinib# combination in advanced ovarian cancer was 25.6 months.",
            "predicted_answer": "The median progression-free survival (mPFS) in the clinical trial combining Bevacizumab and Erlotinib for advanced ovarian cancer was 25.6 months.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects all key facts emphasized with # symbols in the reference answer, specifically mentioning the combination of Bevacizumab and Erlotinib and the correct median progression-free survival of 25.6 months. There are no omissions or errors in the information provided."
        },
        {
            "query_idx": 968,
            "query": "In the enigmatic dance of cervix-related diagnostic intricacies, what emerges as the degree of discernment showcased by Huawei's AI paradigm concerning the interpretative clarity for slides devoid of pathological manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1049
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Huawei's AI paradigm shows a remarkable interpretative clarity with an accuracy exceeding #99%# for slides devoid of #pathological manifestations#.",
            "predicted_answer": "Huawei's AI paradigm achieves an interpretation accuracy for negative cervical slides surpassing 99%, showcasing high discernment in diagnosing slides without pathological manifestations.",
            "score": 5,
            "explanation": "The Predicted Answer conveys the key facts from the Reference Answer: an accuracy surpassing 99% and a focus on slides without pathological manifestations. It aligns well with the reference, capturing the essential details without contradictions or omissions."
        },
        {
            "query_idx": 969,
            "query": "What distinct pathological state, marked by intrinsic HRR genetic anomalies in an advanced physiological arena resistant to hormone deprivation, was the strategic amalgamation of talazoparib and enzalutamide officially sanctioned to address in the concluding phase of 2023?",
            "retrieved_metrics": {
                "reference_idx": [
                    1050
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The talazoparib and enzalutamide combination was approved to treat #HRR gene-mutated# metastatic #castration-resistant prostate cancer# in November 2023.",
            "predicted_answer": "Metastatic castration-resistant prostate cancer with HRR gene mutations.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the key facts from the reference, including \"HRR gene mutations\" and \"metastatic castration-resistant prostate cancer.\" While it does not specify \"November 2023,\" this detail doesn't critically impact the overall meaning. The answers are highly consistent, with no significant omissions."
        },
        {
            "query_idx": 970,
            "query": "How do the intricacies of lipid-based energetic frameworks command the proliferative and migratory tendencies of neoplastic cells, particularly through the orchestration of membrane architecture and electrochemical homeostasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1054
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Fatty acid metabolism# supports tumor cell growth and #metastasis# by aiding membrane synthesis, signal transduction, β-oxidation for energy, and NADPH for redox balance.",
            "predicted_answer": "Lipid-based energetic frameworks, particularly fatty acid metabolism, influence neoplastic cell proliferation and migration by maintaining membrane architecture and electrochemical homeostasis through phospholipid synthesis and redox balance.",
            "score": 1,
            "explanation": "The predicted answer includes \"fatty acid metabolism\" and mentions \"membrane architecture\" and \"redox balance,\" aligning with the reference answer. However, it misses \"metastasis\" and specifics like \"signal transduction,\" \"β-oxidation,\" and \"NADPH.\" The general trend is present but lacks critical details affecting completeness."
        },
        {
            "query_idx": 971,
            "query": "In what manner does the identity of Helicobacter as a preeminent microbial architect influence oncogenic terrains, as reflected in its standing within global health adjudications concerning cancer genesis pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1055
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Helicobacter, identified as a #Group 1 carcinogen# by WHO, influences oncogenic terrains by associating with primary liver and gastric cancers, impacting global cancer genesis pathways.",
            "predicted_answer": "Helicobacter's identity as a Group 1 carcinogen influences oncogenic terrains by promoting primary liver and gastric cancers, reflecting its significant role in global health adjudications concerning cancer genesis pathways.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies Helicobacter as a \"Group 1 carcinogen\" and mentions its association with primary liver and gastric cancers, which aligns with the key facts emphasized in the reference answer. There are no significant omissions or errors, and the trend is consistent."
        },
        {
            "query_idx": 972,
            "query": "To what degree have the monetary escalations of proprietary pharmaceutical formulations for less prevalent maladies diverged when juxtaposed with those targeting more ubiquitous conditions throughout the era beginning in the 2000s to the contemporary timeframe?",
            "retrieved_metrics": {
                "reference_idx": [
                    1056
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Monetary escalations of proprietary formulations for #orphan indications# rose by #94%#, while those for non-orphan indications increased by 50% from 2005 to 2023.",
            "predicted_answer": "The monetary escalations of proprietary pharmaceutical formulations for less prevalent maladies, particularly ultra-rare orphan indications, have diverged significantly from those targeting more ubiquitous conditions. From 2005 to 2023, prices for orphan indications increased by 94%, compared to 50% for non-orphan indications.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts from the reference answer, noting that monetary escalations for orphan indications rose by 94%, compared to 50% for non-orphan indications from 2005 to 2023. The overall trend and meaning are consistent with the reference. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 973,
            "query": "In the complex biochemical theatre of tumorigenic dynamics, what is the contributory essence of phosphoenolpyruvate carboxykinase 1's catalytic prowess, as a conductor of lipid biosynthesis harmonies in the relentless expansion of cancerous cells, as elucidated in the academic explorations of Lu Zhimin's research activities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1053
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Phosphoenolpyruvate carboxykinase 1 catalyzes lipid biosynthesis by using #GTP# as a phosphate donor, stimulating #tumor lipid synthesis# and promoting cancer cell expansion.",
            "predicted_answer": "Phosphoenolpyruvate carboxykinase 1 (PCK1) catalyzes lipid synthesis, promoting tumor progression by phosphorylating substrates with GTP, enhancing lipid biosynthesis in cancer cells.",
            "score": 5,
            "explanation": "The key facts, such as the use of #GTP# as a phosphate donor and stimulation of #tumor lipid synthesis#, are present in the predicted answer. The predicted answer mentions phosphorylating substrates with GTP and enhancing lipid biosynthesis, aligning with the reference's focus on cancer cell expansion."
        },
        {
            "query_idx": 974,
            "query": "What strategic resolution mechanisms were implemented to ensure alignment of divergent perspectives in the intricate process of elucidating data from FDA label sources?",
            "retrieved_metrics": {
                "reference_idx": [
                    1061
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Disagreements were resolved by #consensus# between reviewers or by consulting an experienced oncologist (#TB#) to align divergent perspectives.",
            "predicted_answer": "Strategic resolution mechanisms included cross-checking data with clinicaltrials.gov and peer-reviewed publications, resolving disagreements through consensus, and consulting an experienced oncologist.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer, including consensus and consulting an oncologist. However, it introduces additional elements like cross-checking data with clinicaltrials.gov and peer-reviewed publications, which are not in the reference, and misses the emphasis on TB, a resolved disagreement method."
        },
        {
            "query_idx": 975,
            "query": "What part does the revelation of complex molecular compositions through spatial proteomics data play in empowering the nuanced architecture of precision-designed therapeutic regimes, nestled in the overarching analysis of clinical trial landscapes, particularly for B-cell Non-Hodgkin's Lymphoma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1051
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The revelation of #complex molecular compositions# via spatial proteomics empowers precision-designed therapeutic regimes by guiding precision trials and tailoring targeted therapy for #B-cell Non-Hodgkin's Lymphoma#.",
            "predicted_answer": "The revelation of complex molecular compositions through spatial proteomics data enhances the precision of therapeutic regimes for B-cell Non-Hodgkin's Lymphoma by guiding clinical trials and predicting drug effects based on tumor molecular data.",
            "score": 3,
            "explanation": "The predicted answer contains the key facts of \"complex molecular compositions\" and \"B-cell Non-Hodgkin's Lymphoma\" from the reference. It reflects the trend of using spatial proteomics to enhance therapeutic precision. However, it misses details about \"precision trials\" and specifics about \"tailoring targeted therapy,\" impacting completeness."
        },
        {
            "query_idx": 976,
            "query": "What analytical mechanism was enlisted to illuminate contrasts between these niche therapeutic frameworks known as orphan designations and the broader spectrum of non-orphan counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1063
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Cochran's Q test# was used to illuminate contrasts between #orphan# and non-orphan therapeutic frameworks.",
            "predicted_answer": "The analytical mechanism used to illuminate contrasts between orphan designations and non-orphan counterparts includes Cox regression models, Fisher's exact tests, Kruskal-Wallis tests, meta-analyses, Cochran's Q test, Student's t test, and analysis of variance.",
            "score": 5,
            "explanation": "The predicted answer includes multiple analytical mechanisms, including the key method #Cochran's Q test# mentioned in the reference. It also accurately aligns with the general analytic purpose concerning contrasts between #orphan# and non-orphan frameworks, without contradicting information."
        },
        {
            "query_idx": 977,
            "query": "What fraction of therapeutic constructs tailored for commonly acknowledged orphan disease typologies consists of intricately formulated small molecules engaging in a purposefully directed molecular interaction framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1065
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Therapeutic constructs for common orphan disease typologies primarily consist of #80%# small molecules with a #targeted mechanism# of action.",
            "predicted_answer": "Approximately 80% of therapeutic constructs tailored for commonly acknowledged orphan disease typologies consist of intricately formulated small molecules engaging in a purposefully directed molecular interaction framework.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes both key facts emphasized in the Reference Answer: \"80%\" and \"targeted mechanism\" (rephrased as \"purposefully directed molecular interaction framework\"). The meaning and key facts in the Reference Answer are fully reflected in the Predicted Answer with no significant omissions."
        },
        {
            "query_idx": 978,
            "query": "What intricate criteria are utilized to conceptually derive the designation of rare classification for therapeutic agents targeting the BRAF mutation, encompassing the whole gamut of neoplastic conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1075
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The designation of rare classification for therapeutic agents targeting the #BRAF mutation# requires fewer than #200,000 patients# with the mutation across all cancer types.",
            "predicted_answer": "The designation of rare classification for therapeutic agents targeting the BRAF mutation is based on fewer than 200,000 patients with BRAF mutations across all tumor entities, not limited to a single cancer type.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes both key facts: the 'BRAF mutation' and 'fewer than 200,000 patients' across 'all tumor entities'. It aligns with the 'Reference Answer' and does not contain contradictory information. All critical details are present, ensuring completeness and accuracy."
        },
        {
            "query_idx": 979,
            "query": "What intricate reformative pathway could Medicare and Medicaid theorize to enact, flanked by stakeholder negotiation chessboard strategies, to recalibrate the market dynamics of highly valued pharmaceutical innovations within the niche of orphan drug delineations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1076
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Medicare and Medicaid could implement #value based pricing# for orphan drugs using #cost effectiveness analyses# and negotiating strategies, extending powers to include ultra-rare disease assessments.",
            "predicted_answer": "Medicare and Medicaid could theorize a reformative pathway involving value-based pricing for orphan drugs, leveraging stakeholder negotiation strategies to recalibrate market dynamics. This could include special assessment pathways for ultra-rare diseases, informed by cost-effectiveness analyses and European examples.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of implementing value-based pricing and cost-effectiveness analyses as emphasized with # in the reference answer. It also aligns with the negotiation strategy and the focus on ultra-rare diseases. All key elements are present without contradictions."
        },
        {
            "query_idx": 980,
            "query": "What instrumentalities ought to be forged within the symphony of trial designs for navigating the uncharted waters of ultra-rare diseases, especially when the pursuit of participant accrual is a formidable endeavor and endpoints are intangible specters?",
            "retrieved_metrics": {
                "reference_idx": [
                    1077
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "To navigate ultra-rare diseases, instrumentalities like #synthetic control arms# and #natural history studies# should be employed, encouraging diverse and innovative trial designs.",
            "predicted_answer": "To navigate trials for ultra-rare diseases, instrumentalities like public-private partnerships, synthetic control arms, and natural history studies should be used, especially when participant accrual is challenging and endpoints are intangible.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: \"synthetic control arms\" and \"natural history studies.\" It also aligns with the overall trend of encouraging diverse and innovative trial designs. No key facts are missing, and there are no contradictions."
        },
        {
            "query_idx": 981,
            "query": "What complex molecular deterrents exhibiting fluorinated functionality undertake an orchestrated engagement with viral and cellular components, and how do these interactions harmonize with the overarching framework of pandemic mitigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1080
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Fluorinated drugs# target viral or host proteins, significantly contributing to #pandemic mitigation# by controlling COVID-19 through these interactions.",
            "predicted_answer": "Fluorinated drugs interact with viral and cellular components by targeting viral proteins or host proteins, contributing to pandemic control. These interactions enhance drug efficacy and specificity, aligning with the overarching goal of pandemic mitigation.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: \"fluorinated drugs,\" \"targeting viral or host proteins,\" and \"contributing to pandemic control,\" which aligns with the reference answer's emphasis on pandemic mitigation. There are no significant omissions or errors that impact accuracy or completeness."
        },
        {
            "query_idx": 982,
            "query": "What conceptual framework might the Centers for Medicare and Medicaid Services employ to cultivate a perpetual loop of evaluative re-examination concerning the advantageous potentials of ultra-scarce medicinal entities following their inaugural approval in the commercial pharmaceutical domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    1078
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The Centers for Medicare and Medicaid Services might use #Coverage with Evidence Development# to reassess ultra-scarce medicines' benefits after a #pre-defined period#.",
            "predicted_answer": "The Centers for Medicare and Medicaid Services might employ a framework involving higher cost-effectiveness thresholds and mandatory Coverage with Evidence Development, ensuring continuous reassessment of ultra-scarce medicinal entities' benefits after a defined period, such as three years.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts emphasized in the Reference Answer: \"Coverage with Evidence Development\" and the concept of reassessing after a \"pre-defined period,\" here mentioned as three years. There are no significant omissions or contradictions, indicating good alignment overall."
        },
        {
            "query_idx": 983,
            "query": "In what manner do the transformative potentials of adaptable molecular architectures orchestrate the biofunctional interactions with macromolecular entities, shaping the innovative trajectories of therapeutic developments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1082
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #conformational flexibility# of adaptable molecular architectures changes ligand properties, optimizing #biofunctional interactions# with macromolecules, thus advancing therapeutic developments.",
            "predicted_answer": "Adaptable molecular architectures facilitate biofunctional interactions by leveraging conformational flexibility, enabling precise ligand conformations that enhance recognition by biomacromolecules, thereby driving innovative therapeutic developments.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of the reference answer, specifically #conformational flexibility# and #biofunctional interactions#. It aligns well with the reference answer, indicating that adaptable molecular architectures optimize these interactions to drive therapeutic developments. No significant details are missing."
        },
        {
            "query_idx": 984,
            "query": "Through what mechanisms does the infusion of $^{18}$F-laden constructs reshape the investigative framework of positron emission tomography, thereby enriching the narrative of biochemical dynamics and metabolic odysseys?",
            "retrieved_metrics": {
                "reference_idx": [
                    1084
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The infusion of #^{18}#F-laden constructs in PET enables studying #biochemical transformations#, enhancing noninvasive diagnostic capabilities for surveying living tissue and functional processes.",
            "predicted_answer": "The infusion of $^{18}$F-laden constructs enhances positron emission tomography (PET) by providing precise imaging of biochemical transformations and metabolic processes, thereby enriching the understanding of dynamic biological functions.",
            "score": 3,
            "explanation": "The predicted answer captures the use of $^{18}$F-laden constructs in PET for studying biochemical transformations, which aligns with the reference. However, it omits the specific enhancement of noninvasive diagnostic capabilities for surveying living tissue and functional processes, leading to a partial match."
        },
        {
            "query_idx": 985,
            "query": "What latent dynamics are set in motion by the incorporation of fluorine into the molecular tapestry of synthetic glycoform replicas and structural proteins, and how do these dynamics recalibrate their intrinsic and extrinsic interaction paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1083
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The incorporation of #fluorine# enhances #hydrophobicity#, stabilizing proteins against unfolding and improving binding affinities in glycoform replicas and structural protein interactions.",
            "predicted_answer": "The incorporation of fluorine into synthetic glycoform replicas and structural proteins enhances hydrophobicity, improving binding affinities and stability. This recalibrates intrinsic interactions by stabilizing structures and extrinsic interactions by enhancing binding affinities.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference: the incorporation of fluorine enhances hydrophobicity, stabilizes structures, and improves binding affinities. All the emphasized elements in the reference are present in the predicted answer, showing alignment in meaning and trends without omissions."
        },
        {
            "query_idx": 986,
            "query": "How does the application of $^{19}$F MRI technology enable the decoding of intricate molecular dialogues among diverse macromolecular structures such as proteins, enzymes, and lipid matrices, thus illuminating their recognition narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1085
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The application of #$^{19}$F MRI# technology enables the understanding of the recognition behavior of #ligands# with proteins, enzymes, and lipid matrices.",
            "predicted_answer": "$^{19}$F MRI technology uses fluorinated tracers like perflubron to visualize and understand the recognition mechanisms between ligands and diverse macromolecules such as proteins, enzymes, and lipids.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: use of $^{19}$F MRI technology and understanding ligand interactions with proteins, enzymes, and lipids. While it mentions the tracer (perflubron), it covers the essential recognition mechanisms. The critical elements from the reference answer are present."
        },
        {
            "query_idx": 987,
            "query": "What are the molecular intricacies of Scemblix™-ABL001's chiral center and difluorinated components that guide its strategic interference in the pathological ensemble of chronic myeloid leukemic activity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1086
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scemblix™-ABL001's #chiral center# at (R)-configuration and #difluorinated moiety# strategically interfere with BCR-ABL1 protein activity in chronic myeloid leukemia.",
            "predicted_answer": "Scemblix™-ABL001 (asciminib) has an (R)-configuration chiral center and a difluorinated moiety, which strategically interfere with the BCR-ABL1 protein, inhibiting chronic myeloid leukemia activity.",
            "score": 5,
            "explanation": "The predicted answer accurately presents the (R)-configuration chiral center and the presence of a difluorinated moiety, which are the emphasized key facts in the reference answer. It also correctly outlines the interference with the BCR-ABL1 protein and its role in chronic myeloid leukemia, aligning well with the reference answer."
        },
        {
            "query_idx": 988,
            "query": "What are the intricate biochemical dialogues and multi-faceted molecular engagements through which BCR-ABL1 kinase domain inhibitors facilitate the redefinition of chronic myelogenous leukemia into a state characterized by enduring manageability?",
            "retrieved_metrics": {
                "reference_idx": [
                    1087
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "BCR-ABL1 kinase inhibitors, like #imatinib#, target the #ATP-binding site#, disrupting BCR-ABL1 activity, thereby managing CML through altered cell growth and survival signaling.",
            "predicted_answer": "BCR-ABL1 kinase domain inhibitors, such as imatinib, dasatinib, and nilotinib, target the ATP-binding site of the BCR-ABL1 protein, inhibiting its kinase activity and normalizing signaling pathways, thereby transforming chronic myelogenous leukemia into a manageable condition.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of targeting the ATP-binding site and inhibiting BCR-ABL1 activity using kinase inhibitors like imatinib. However, it lacks explicit mention of altering cell growth and survival signaling, which affects completeness."
        },
        {
            "query_idx": 989,
            "query": "Within the complex realm of molecular interactions, what are the ramifications of the trifluorobenzene component's presence in atogepant next to its structurally unembellished counterpart regarding their respective interaction propensities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1090
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #trifluorobenzene# component in atogepant results in higher #affinity# (Kᵢ = 0.015 nM) compared to its unsubstituted counterpart (Kᵢ = 0.067 nM).",
            "predicted_answer": "The trifluorobenzene component in atogepant enhances its affinity for the target receptor, with a K$_{i}$ of 0.015 nM compared to 0.067 nM for the unsubstituted derivative, indicating stronger molecular interactions.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts in the reference answer: the presence of trifluorobenzene in atogepant, its enhanced affinity (K$_{i}$ = 0.015 nM), and comparison with the unsubstituted counterpart (K$_{i}$ = 0.067 nM). The overall meaning and details are consistent and complete."
        },
        {
            "query_idx": 990,
            "query": "What intricate encounter, as revealed by X-ray diffraction studies, does the fluorine entity of asciminib engage in with the carbonyl arrangement of leucine L359 within the multifaceted spatial conformation of the BCR-ABL1 oncoprotein framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1088
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fluorine atom of asciminib #interacts# with the #carbonyl carbon# of leucine L359 in the deep pocket of the BCR-ABL1 oncoprotein.",
            "predicted_answer": "The fluorine entity of asciminib engages in a specific interaction with the carbonyl carbon of leucine L359 within the deep pocket of the BCR-ABL1 oncoprotein, as revealed by X-ray diffraction studies.",
            "score": 5,
            "explanation": "The predicted answer includes key information about the interaction between the fluorine of asciminib and the carbonyl carbon of leucine L359 within the BCR-ABL1 oncoprotein, as highlighted in the reference answer. The main facts are accurately represented, with no significant omissions."
        },
        {
            "query_idx": 991,
            "query": "What intricate series of molecular adjustments and architectural shifts catalyze the genesis of the intricate spirocyclic architecture described as compound 61 within the synthesis continuum delineated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1091
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spirocyclic architecture of compound #61# is formed through mesylation of diol #59# and base-catalyzed alkylation with SEM-protected azaoxindole 60.",
            "predicted_answer": "The genesis of compound 61 involves a series of molecular adjustments including esterification, bromination, reduction, mesylation, and base-catalyzed alkylation, culminating in the formation of the spirocyclic architecture.",
            "score": 1,
            "explanation": "The predicted answer mentions mesylation and base-catalyzed alkylation, which are key steps indicated in the reference. However, it omits specifics like \"diol 59\" and \"SEM-protected azaoxindole 60,\" missing two key details that affect completeness but aligns with the trend."
        },
        {
            "query_idx": 992,
            "query": "In the intricate design of cabotegravir's molecular structure, what pivotal role do the fluorine atoms assume as both stabilizing columns and dynamic influencers in shaping its overall pharmacological efficacy and adaptability through modulated molecular interactions and optimized metabolic characteristics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1093
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fluorine atoms in #cabotegravir# enhance #metabolic stability#, affecting pharmacological efficacy through optimized lipophilicity and permeability.",
            "predicted_answer": "Fluorine atoms in cabotegravir enhance metabolic stability and optimize pharmacological parameters, such as lipophilicity and permeability, thereby improving its overall efficacy and adaptability.",
            "score": 5,
            "explanation": "The predicted answer contains the key facts about fluorine atoms enhancing metabolic stability and optimizing pharmacological aspects such as lipophilicity and permeability in cabotegravir. These details align with the reference, and no critical information is missing, ensuring consistent trends."
        },
        {
            "query_idx": 993,
            "query": "In the grand biochemical symphony, what quintessential molecular distinctions of the chiral construct known as Ukoniq orchestrate its dual functionality as a modulator of PI3K-delta and CK1-epsilon signal transductions, particularly within the cellular theaters of distinct lymphatic oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1097
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ukoniq's #chiral# structure with #three mono F-atoms# on phenyl moieties enables its functionality as a kinase inhibitor of PI3K-delta and CK1-epsilon in lymphatic oncology.",
            "predicted_answer": "Ukoniq's chiral structure, with three mono F-atoms and phenyl moieties, enables its dual inhibition of PI3K-delta and CK1-epsilon, crucial for modulating lymphatic oncology signaling pathways.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts from the Reference Answer: the chiral structure of Ukoniq, its three mono F-atoms on phenyl moieties, and its role in dual inhibition of PI3K-delta and CK1-epsilon in lymphatic oncology. No significant omissions or contradictions are found."
        },
        {
            "query_idx": 994,
            "query": "What unique differentiation markers delineate Vericiguat's position as an avant-garde therapeutic innovation within the orchestration of the nitric oxide-soluble guanylate cyclase-cyclic GMP cascade, impacting various cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1096
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Vericiguat is characterized as the #first-in-class# stimulator of soluble guanylate cyclase (#sGC#), restoring the defective NO-sGC-cGMP pathway across various cell types.",
            "predicted_answer": "Vericiguat uniquely restores the defective NO-sGC-cGMP pathway, targeting soluble guanylate cyclase (sGC) in diverse cell types, marking it as an innovative therapeutic in cardiovascular and other cellular contexts.",
            "score": 3,
            "explanation": "The predicted answer mentions the restoration of the defective NO-sGC-cGMP pathway and the targeting of soluble guanylate cyclase, but it omits the key fact that Vericiguat is a \"first-in-class\" stimulator of soluble guanylate cyclase, affecting the completeness of the provided answer."
        },
        {
            "query_idx": 995,
            "query": "In the intricate scheme of molecular alterations progressing from compound 154 to the stereoisomerically distinct alcohol 170 (S), what orchestrating function does R-alpine borane undertake in facilitating the enantioselective conversion of molecular architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    1098
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "R-alpine borane orchestrates the #enantioselective reduction# of keto derivative 169 to #alcohol 170 (S)#, aiding the stereoisomeric conversion process.",
            "predicted_answer": "R-alpine borane facilitates the enantioselective reduction of keto derivative 169 to stereoisomerically distinct alcohol 170 (S), orchestrating the conversion of molecular architecture.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, containing both key facts: the \"enantioselective reduction\" and the conversion to \"alcohol 170 (S)\". The core meaning and details are consistent, with no significant omissions or contradictory information."
        },
        {
            "query_idx": 996,
            "query": "What intricate sequence does the automated reactor's chamber perform to achieve the $^{18}$F-fortified metamorphosis of pylarify, with a spotlight on the molecular choreography transfiguring compound 184 through its critical alchemical phases to achieve its ultimate formation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1100
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The automated reactor's chamber performs a sequence of drying, activation of [$^{18}$F]fluoride, nucleophilic substitution into compound #184#, followed by protecting group removal for final radiolabeled #pylarify#.",
            "predicted_answer": "The automated reactor's chamber achieves $^{18}$F-fortified metamorphosis of pylarify through three steps: drying and activating [$^{18}$F]fluoride, nucleophilic substitution into compound 184, and removing tert-butyl groups with HCl, followed by HPLC purification.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by detailing the drying and activation of [$^{18}$F]fluoride and nucleophilic substitution into compound 184. It also mentions removing protecting groups with HCl, leading to purification, matching the final radiolabeled stage. All key facts and trends are present."
        },
        {
            "query_idx": 997,
            "query": "What constitutes the pivotal element driving the energetic transmutation within the radiolabelled investigative apparatus dedicated to positron-mediated diagnostic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1099
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pivotal element is #Piflufolastat $^{18}$F#, driving energetic transmutation within the radiolabelled investigative apparatus for positron emission tomography imaging.",
            "predicted_answer": "The pivotal element driving energetic transmutation in the radiolabelled investigative apparatus is the positron emission from the $^{18}$F radioactive diagnostic agent, facilitating positron emission tomography imaging.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies the key process (positron emission) and application (positron emission tomography imaging), but it omits the specific key element, Piflufolastat $^{18}$F, emphasized with # in the Reference Answer, affecting completeness."
        },
        {
            "query_idx": 998,
            "query": "What is the nature of the temporal attenuation phase observed in simian and canine subjects concerning its enteral assimilation capability and the enduring continuity within hepatic enzymatic interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1102
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The temporal #attenuation phase# in simian and canine subjects showcases long elimination half-life due to high #metabolic stability#, indicating strong enteral assimilation and enduring hepatic enzymatic interactions.",
            "predicted_answer": "The temporal attenuation phase in simian and canine subjects exhibits long elimination half-lives (10 and 30 hours, respectively), excellent oral bioavailability, and high metabolic stability, indicating robust enteral assimilation and enduring hepatic enzymatic interactions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: the \"attenuation phase,\" \"metabolic stability,\" and strong \"enteral assimilation\" and \"enduring hepatic enzymatic interactions.\" All essential details are covered, showing a strong alignment and no significant omissions."
        },
        {
            "query_idx": 999,
            "query": "What process does the corrective agent, Sofosbuvir, utilize as a strategic mechanism within the molecular fabric to establish a defense stronghold against the incursion of the Hepatitis C Virus?",
            "retrieved_metrics": {
                "reference_idx": [
                    1104
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sofosbuvir acts as an #RNA-dependent RNA polymerase# inhibitor, blocking Hepatitis C Virus replication and establishing a defense mechanism.",
            "predicted_answer": "Sofosbuvir inhibits the Hepatitis C Virus by acting as an RNA-dependent RNA polymerase (RdRp) inhibitor, preventing viral replication.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies Sofosbuvir as an RNA-dependent RNA polymerase (RdRp) inhibitor, aligning with the key fact emphasized in the reference answer. It also mentions inhibiting viral replication, consistent with the reference’s description of blocking replication. No significant details are missing; both answers convey the same core information."
        },
        {
            "query_idx": 1000,
            "query": "What contemporary inventive frameworks have materialized that revisit conventional charge-mediated interactions, surpassing the standard lexicon of electrophilic and nucleophilic approaches, to enable the creation of fluorine-enriched molecular assemblies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1106
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Radical fluorination#, along with #thermal and photochemical# approaches, revisits conventional charge-mediated interactions for creating fluorine-enriched molecular assemblies.",
            "predicted_answer": "Contemporary inventive frameworks include radical fluorination and late-stage fluorination, which surpass conventional electrophilic and nucleophilic approaches, enabling the creation of fluorine-enriched molecular assemblies.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes \"radical fluorination,\" which covers one key fact. However, it misses \"thermal and photochemical approaches,\" thus affecting completeness. The general trend aligns with the 'Reference Answer', but missing key details leads to an incomplete matching of key facts."
        },
        {
            "query_idx": 1001,
            "query": "How does Ensitrelvir, as a nonpeptidic and noncovalent actor in the realm of antiviral interventions, distinguish itself in its orchestrative approach towards neutralizing SARS-CoV-2 across diverse protease-targeting methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1101
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ensitrelvir distinguishes itself as the first #nonpeptidic# and #noncovalent# oral 3CL$^{pro}$ inhibitor, targeting SARS-CoV-2 by working on various variants and coronavirus families.",
            "predicted_answer": "Ensitrelvir distinguishes itself by being the first nonpeptidic, noncovalent, oral 3CL$^{pro}$ inhibitor, effectively targeting a range of SARS-CoV-2 variants and coronavirus families.",
            "score": 5,
            "explanation": "The predicted answer includes the key details about Ensitrelvir being \"nonpeptidic\" and \"noncovalent,\" similar to the reference answer. Both answers describe it as the first of its kind, orally targeting 3CL$^{pro}$, effective against variants and families. There are no significant omissions or errors."
        },
        {
            "query_idx": 1002,
            "query": "How does the quintessential RAS molecule, via its strategic interaction with the mechanistic catalyst GAP, conduct an orchestration leading to the quelling of its communicative endeavors by enabling a pivotal transition in its molecular state?",
            "retrieved_metrics": {
                "reference_idx": [
                    1109
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quintessential RAS molecule, via interaction with #GAP#, facilitates GTP hydrolysis, transitioning RAS-GTP to #RAS-GDP#, thereby halting signaling.",
            "predicted_answer": "The quintessential RAS molecule, through its interaction with the mechanistic catalyst GAP, promotes GTP hydrolysis, converting RAS-GTP to RAS-GDP, thereby switching its conformation and halting signaling.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies GAP's role in facilitating GTP hydrolysis and the conversion of RAS-GTP to RAS-GDP, which is a key fact emphasized in the reference answer. There are no omissions or contradictions, and the key facts are fully covered."
        },
        {
            "query_idx": 1003,
            "query": "In the molecular symphony orchestrated by the protein architecture of GAP, which residue elements specifically participate in the amphiphobic ensemble that interacts with the cycloheptane segment of the compound's enigmatic construct?",
            "retrieved_metrics": {
                "reference_idx": [
                    1126
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #cycloheptane# segment interacts with the hydrophobic sidechains of #L787#, F788, M891, V895, and L902 residues from the GAP protein.",
            "predicted_answer": "The amphiphobic ensemble in GAP that interacts with the cycloheptane segment includes residues L787, F788, M891, V895, and L902 from the α 13 and α 19 helices.",
            "score": 5,
            "explanation": "The predicted answer lists the interacting residues (L787, F788, M891, V895, L902) with the correct relation to the cycloheptane segment, consistent with the reference. The mention of helices α 13 and α 19 adds detail but does not contradict or omit key facts."
        },
        {
            "query_idx": 1004,
            "query": "What multidimensional evidence and systemic indicators converge to affirm the hypothesis that compound 14, administered at a dosage of 6 mg/kg, preserves physiological equilibrium in laboratory organisms within diverse experimental frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1119
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound 14 at #6 mg/kg# shows #nontoxicity#, evidenced by stable body weight and liver weight-body weight ratios, confirming physiological equilibrium in laboratory organisms.",
            "predicted_answer": "Multidimensional evidence includes non-toxicity at 6 mg/kg, stable body weight, and nonsignificant liver weight changes, affirming physiological equilibrium preservation in diverse experimental frameworks.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key elements: \"6 mg/kg,\" \"nontoxicity,\" \"stable body weight,\" and \"physiological equilibrium.\" However, it refers to \"nonsignificant liver weight changes,\" while the reference states \"liver weight-body weight ratios.\" The core meaning is aligned, but one detail differs."
        },
        {
            "query_idx": 1005,
            "query": "Amidst the ecosystem of cellular propagation, which distinct nurturing substrate is designated for the perennial support of the endothelial lineage termed HUVEC-TERT?",
            "retrieved_metrics": {
                "reference_idx": [
                    1134
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HUVEC-TERT cells are cultured in #Endothelial# cell #basal medium-2# (EBM-2).",
            "predicted_answer": "Endothelial cell basal medium-2 (EBM-2) is designated for the perennial support of the endothelial lineage termed HUVEC-TERT.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies \"Endothelial cell basal medium-2 (EBM-2)\" as the substrate for HUVEC-TERT, matching the emphasized key facts in the Reference Answer. The meaning is consistent with no significant omissions or errors, fully capturing the required information."
        },
        {
            "query_idx": 1006,
            "query": "What are the elaborate compositional divergences in nutrient frameworks observed between the RPMI/IMDM mediums enriched with fundamental serum symphonies, and the bespoke nurturing tapestries fashioned for the CCD-986Sk and HUVEC-TERT cellular environments, inclusive of their unique supplemental intricacies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1135
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RPMI/IMDM mediums# contain 10% FBS and 1% Penicillin/Streptomycin, while #CCD-986Sk# uses 20% FBS; HUVEC-TERT employs an EGM-2 kit, highlighting nutrient framework differences.",
            "predicted_answer": "The RPMI/IMDM mediums were enriched with 10% FBS and 1% Penicillin/Streptomycin, while CCD-986Sk cells used 20% FBS, and HUVEC-TERT cells were cultured in Endothelial Growth Medium-2 (EGM-2) with specific supplements.",
            "score": 5,
            "explanation": "The predicted answer covers all the essential facts emphasized in the reference answer, including RPMI/IMDM mediums with 10% FBS and 1% Penicillin/Streptomycin, CCD-986Sk cell use of 20% FBS, and HUVEC-TERT cultivation in EGM-2. The key details are present without contradiction."
        },
        {
            "query_idx": 1007,
            "query": "In the elaborate dance of docking algorithms, what primary dynamic attribute within the FRIGATE digital framework facilitates the diminishment of energetic amalgamation across the protein-ligand conglomerate amid the docking sequence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1137
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The primary dynamic attribute is the ability to rotate #all rotational bonds#, facilitating energetic minimization of the protein-ligand complex during docking in the FRIGATE framework.",
            "predicted_answer": "The primary dynamic attribute within the FRIGATE digital framework that facilitates the diminishment of energetic amalgamation across the protein-ligand conglomerate amid the docking sequence is the allowance of all rotational bonds of each small molecule to rotate, minimizing the joint energy of the complex.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the key dynamic attribute as the ability to rotate all rotational bonds, aligning with the reference. It fully captures the concept of minimizing energy in the protein-ligand complex during docking, with no omissions or errors."
        },
        {
            "query_idx": 1008,
            "query": "What multi-dimensional computational construct is employed to derive the volumetric expansion representation of the BxPC3 cellular mass, utilizing paired axial calibrations in the context of the investigative regimen described?",
            "retrieved_metrics": {
                "reference_idx": [
                    1143
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The multi-dimensional computational construct employed is the formula #V = ab² × π / 6#, using paired axial calibrations of tumor length and width.",
            "predicted_answer": "A multi-dimensional computational construct used to derive the volumetric expansion representation of the BxPC3 cellular mass is the ellipsoid volume formula \\( V = \\frac{\\pi}{6} \\times a \\times b^2 \\), where \\( a \\) and \\( b \\) are the paired axial calibrations (length and width).",
            "score": 5,
            "explanation": "The predicted answer accurately describes the ellipsoid volume formula \\( V = \\frac{\\pi}{6} \\times a \\times b^2 \\), which corresponds to #V = ab² × π / 6# in the reference. Both mention the use of paired axial calibrations (length and width), capturing all key details consistently."
        },
        {
            "query_idx": 1009,
            "query": "What methodological assessment is employed for deriving the vitality quotient after the alchemical transition of purple precipitates in a dichotomous solvent medium, followed by their optical quantification at a wavelength of 570 nm, specifically considering static comparisons with baseline parallels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1138
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vitality quotient# is derived by measuring absorbance at #570 nm#, subtracting background absorbance, and comparing treated wells to the control baseline, set at 100% viability.",
            "predicted_answer": "The methodological assessment involves dissolving purple formazan crystals in a DMSO-ethanol solution, measuring absorbance at 570 nm, and determining cell viability relative to untreated controls, with baseline parallels set arbitrarily at 100%.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference in that it mentions measuring absorbance at 570 nm and comparing results to untreated controls with a 100% baseline. However, it omits the key step of \"subtracting background absorbance\" which impacts the completeness of the answer."
        },
        {
            "query_idx": 1010,
            "query": "What diverse intensities of molecular cocktails were orchestrated to navigate the biological paradigms of pancreatic carcinoma constructs and normal cellular assemblies in the depicted experimental choreography?",
            "retrieved_metrics": {
                "reference_idx": [
                    1139
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cells were treated with molecular cocktails at concentrations ranging from #15 nM# to #100 µM# to study pancreatic carcinoma and normal cell interactions.",
            "predicted_answer": "Various concentrations of compounds (15 nM-100 µM) were used to treat both pancreatic cancer and non-cancerous cell lines, dissolved in DMSO, to navigate the biological paradigms in the experimental setup.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, covering key facts like the concentration range (#15 nM# to #100 µM#) and the context of treating pancreatic carcinoma and normal cells. No key facts are missing, and it mirrors the trend of the Reference Answer without contradictions."
        },
        {
            "query_idx": 1011,
            "query": "In probing the tangible and nuanced repercussions of compound 14 on the experimental mice ensemble, what refined collection of biological metrics was employed to unravel the intricacies of its toxicological profile, especially concerning their longevity, hepatic health, observable conduct alterations, and corporeal mass dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The refined biological metrics included evaluations of #lifespan#, #liver toxicity#, behavior, appearance, and body weight of the experimental mice over 15 days.",
            "predicted_answer": "Biological metrics included life span, liver toxicity, behavior, appearance, and body weight, monitored for 15 days to assess compound 14's toxicological profile.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key metrics from the reference answer: #lifespan#, #liver toxicity#, behavior, appearance, and body weight. Both accounts mention the 15-day monitoring period. No significant omissions or contradictions are noted; therefore, the meaning and key facts are consistent."
        },
        {
            "query_idx": 1012,
            "query": "In the intricate orchestration of the differential scanning fluorimetry inquiry, what scientific choreography unraveled the thermal nous of the proteins to elucidate their melting thresholds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1147
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #differential scanning fluorimetry# elucidated proteins' #melting thresholds# by determining melting points from the first negative derivative of melting curves.",
            "predicted_answer": "Differential scanning fluorimetry measured protein melting points by detecting fluorescence on the HEX channel as samples were heated from 25 to 85 °C, with melting thresholds determined from the first negative derivative of the melting curves.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts emphasized in the reference, such as \"differential scanning fluorimetry,\" \"melting thresholds,\" and \"first negative derivative of melting curves,\" with additional details about the fluorescence detection method. The key information is consistent with the reference answer."
        },
        {
            "query_idx": 1013,
            "query": "Which intricate analytical paradigm was employed to elucidate the nuanced biosystemic perturbations instigated by the experimental compound within the scope of the investigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1148
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The analytical paradigm employed was #nonlinear fitting# to determine the growth-rate coefficient of the tumor and average doubling time for each group.",
            "predicted_answer": "The context does not provide information on the analytical paradigm used to elucidate biosystemic perturbations. Therefore, the answer relies on model knowledge: The analytical paradigm employed likely involved systems biology and computational modeling to understand the compound's effects on the biosystem.",
            "score": 1,
            "explanation": "The predicted answer does not mention the key fact of \"nonlinear fitting\" emphasized with # in the reference answer. The predicted details about systems biology and computational modeling are not aligned with the specific analytical method used, resulting in significant information missing."
        },
        {
            "query_idx": 1014,
            "query": "What inferential architecture was employed to evaluate inter-group disparities, and how are the outcomes encapsulated via luminescent inscriptions within the analytical tapestry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1149
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Welch's correction# t-test analyzed inter-group disparities, with luminescent inscriptions represented by symbols *, **, ***, and **** indicating significance levels from #p ≤ 0.05# to p ≤ 0.0001.",
            "predicted_answer": "The inferential architecture employed was a two-tailed unpaired t-test with Welch's correction. Outcomes of inter-group disparities are encapsulated via significance symbols (*, **, ***, ****) in the analytical tapestry.",
            "score": 3,
            "explanation": "The predicted answer includes the use of Welch's correction and the significance symbols (*, **, ***, ****) for inter-group disparities. However, it omits the key detail of significance levels starting from #p ≤ 0.05#, which is a crucial part of the reference answer."
        },
        {
            "query_idx": 1015,
            "query": "In what manner was the integrity of the molecular assemblage evaluated amidst the procedural cascade, and what delineation did the foundational benchmark of refinement achieve in the analytical aftermath?",
            "retrieved_metrics": {
                "reference_idx": [
                    1146
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The purity of the molecular assemblage was evaluated using #SDS PAGE# analysis, achieving a foundational benchmark of refinement with purity levels exceeding #95%#.",
            "predicted_answer": "The integrity of the molecular assemblage was evaluated through SDS-PAGE analysis, showing >95% purity. The foundational benchmark of refinement achieved a delineation of high purity in the analytical aftermath.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions the use of \"SDS-PAGE\" for evaluation and specifies \">95% purity,\" aligning with the reference answer's emphasis on \"SDS PAGE\" and \"purity levels exceeding 95%.\" All key facts are present, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1016,
            "query": "In what ways do the results of genetic intervention, influenced by the sophisticated interaction of intrinsic species traits and ethical-pharmacological dilemmas, manifest differently across the liver terrains of rodent and primate genetic models when deploying base editing methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Base editing methodologies in liver terrains yield #61% efficacy# in rodents and #26%# in primates, influenced by species-specific gene sequences and therapeutic efficacy differences.",
            "predicted_answer": "The results of genetic intervention manifest differently across liver terrains of rodent and primate genetic models due to species-specific genetic sequences and therapeutic efficacy. Base editors achieve 61% in vivo gene editing efficacy in mice liver versus 26% in primates.",
            "score": 5,
            "explanation": "The predicted answer contains all the key facts emphasized in the reference answer: #61% efficacy# in rodents, and #26%# in primates. It also mentions the species-specific genetic sequences and therapeutic efficacy differences. The information is consistent with the reference, fully covering key details."
        },
        {
            "query_idx": 1017,
            "query": "What nuanced capability do lung fibroblast assemblages in a three-dimensional architectural framework exhibit over those in a planar configuration, especially in the context of the manifestation of TNF conduits and the subsequent NF-κB orchestral activation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1155
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lung fibroblast #3D cultures# mimic in vivo #TNF receptor# expression and NF-κB activation patterns more closely than 2D configurations, enhancing their capability in these areas.",
            "predicted_answer": "Lung fibroblast assemblages in a three-dimensional architectural framework exhibit more accurate in vivo-like TNF receptor expression and NF-κB activation patterns compared to planar configurations.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of #3D cultures# with an architectural framework, #TNF receptor# expression, and NF-κB activation, aligning well with the reference answer. It reflects the trend that 3D models mimic in vivo conditions better than 2D, maintaining overall accuracy and completeness."
        },
        {
            "query_idx": 1018,
            "query": "In the multifaceted realm of drug evolution, what is the prevailing role played by models grounded in human biology, particularly in the domain of gauging substance safety, despite their inherent intricacies and nascent exploitation in swift throughput methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1159
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The prevailing role of #human-based models# is in #toxicity testing# during preclinical and clinical research, despite their complexity and limited use in high-throughput methods.",
            "predicted_answer": "Human-based models are crucial for gauging substance safety in drug evolution, despite their complexity and limited use in high-throughput methods. They are primarily used for toxicity testing and are increasingly applied in preclinical and clinical research.",
            "score": 5,
            "explanation": "The predicted answer includes the role of human-based models in toxicity testing and mentions their use in preclinical and clinical research. Despite differences in wording, all key points from the reference are covered, and there's no contradictory information."
        },
        {
            "query_idx": 1019,
            "query": "What impediments confront planar biological constructs in their quest to mirror the sequential maturation phenomena innate to stratified epithelial layers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1158
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Planar #biological constructs# struggle to replicate #epithelial differentiation# stages of stratified layers, such as skin, in 2D cultures.",
            "predicted_answer": "The primary impediments for planar biological constructs include the inability to replicate the sequential maturation and stratification of epithelial layers, such as those found in skin, due to the limitations of 2D cell cultures.",
            "score": 3,
            "explanation": "The Predicted Answer accurately identifies planar biological constructs and their inability to replicate epithelial layer maturation, which aligns with the key facts in the Reference Answer. However, it lacks specific mention of \"epithelial differentiation\" as a stage, impacting completeness slightly."
        },
        {
            "query_idx": 1020,
            "query": "What is the systemic impact of the mechanical disturbances orchestrated by SARS-CoV-2 on the concerted integrity and signaling nexus of endothelial constructs within the simulated vascular milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1161
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SARS-CoV-2 disrupts endothelial constructs by impairing #endothelial barrier# function and increasing #pro-inflammatory cytokine# release, affecting vascular integrity and signaling.",
            "predicted_answer": "The systemic impact of SARS-CoV-2 mechanical disturbances on endothelial constructs includes reduced barrier function, perturbed vascular endothelial-cadherin junctions, and increased pro-inflammatory cytokine release, affecting signaling nexus and integrity within simulated vascular milieu.",
            "score": 5,
            "explanation": "The predicted answer captures key elements from the reference: #endothelial barrier# function impairment and #pro-inflammatory cytokine# release. It aligns with the trend of impacting integrity and signaling in endothelial constructs. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1021,
            "query": "How do the intrinsic biological divergences within rodent-derived investigative frameworks impose constraints on the elucidation of Zika virus pathogenic pathways, contrasting with the enriched cerebral stratification intrinsic to human models?",
            "retrieved_metrics": {
                "reference_idx": [
                    1163
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rodent models are limited in studying #Zika virus# pathogenic pathways due to lack of an additional cortical layer with #radial glial cells# found in the human brain.",
            "predicted_answer": "Rodent models lack the enriched cerebral stratification found in humans, which includes an additional cortical layer with radial glial cells, making them inadequate for fully elucidating Zika virus pathogenic pathways leading to microcephaly.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: the lack of an additional cortical layer and radial glial cells in rodent models, as noted in the reference answer. It also mentions the inadequacy of rodent models for studying Zika virus pathways, aligning well with the reference's trend."
        },
        {
            "query_idx": 1022,
            "query": "Considering the subdued presence of conventional portals like ACE2 in brain-like structures, what supplementary pathways validate their significance in enabling the invasion and amplifying the proliferation of viral elements within these neural analogs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1162
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In brain-like structures, alternative receptors #CD147# and #DPP4# enable SARS-CoV-2 invasion and proliferation, compensating for low ACE2 levels.",
            "predicted_answer": "Supplementary pathways like CD147 and DPP4 in brain organoids validate their significance in enabling viral invasion and proliferation, despite the subdued presence of ACE2.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions the key receptors, CD147 and DPP4, highlighted in the reference answer. It aligns with the reference by noting these receptors' roles in viral invasion and proliferation in brain structures despite low ACE2 presence. All emphasized facts are fully covered."
        },
        {
            "query_idx": 1023,
            "query": "In what manner might the deployment of organ-on-chip technologies serve as a revealing lens into the complex symphony of biochemical dialogues shared between the intestinal, hepatic, and neural corridors, thereby offering novel insights into the modulation of neurodegenerative chronicles such as those observed in Parkinsonian spectrums?",
            "retrieved_metrics": {
                "reference_idx": [
                    1164
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The deployment of #organ-on-chip# technologies can elucidate biochemical interactions in the gut-liver-brain axis, offering insights into #Parkinsonian# disease modulation.",
            "predicted_answer": "Organ-on-chip technologies can simulate the gut-liver-brain axis, revealing biochemical interactions that contribute to neurodegenerative diseases like Parkinson's. This approach offers novel insights into how intestinal, hepatic, and neural pathways modulate neurodegeneration.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"organ-on-chip technologies\" and \"Parkinsonian\" disease, accurately reflecting the biochemical interactions in the gut-liver-brain axis and their role in neurodegeneration. There are no significant omissions or errors, and the overall trend aligns with the reference answer."
        },
        {
            "query_idx": 1024,
            "query": "In what manner does an endogenous feature inherent to the two-dimensional phenotypic diagnostic landscape enable the exploration and revelation of therapeutic pathways for neurodegenerative afflictions characterized by motor neuron degeneration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1166
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2D phenotypic diagnostic landscape# facilitates the discovery of #therapeutic pathways# by enabling the identification of drugs through alterations in diseased cell phenotypes without known specific targets.",
            "predicted_answer": "The endogenous feature inherent to the two-dimensional phenotypic diagnostic landscape enables the exploration and revelation of therapeutic pathways for neurodegenerative afflictions by allowing phenotypic screening in genetically engineered cell lines, leading to the discovery of drugs like risdiplam and branaplam for motor neuron degeneration.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the endogenous feature enabling therapeutic discovery but focuses on phenotypic screening in cell lines. It mentioned drug examples instead of the broader idea of identifying drugs through phenotypic changes. This misses the idea of changes \"without known specific targets.\""
        },
        {
            "query_idx": 1025,
            "query": "Which triad of biochemically active formulations demonstrates their unparalleled capability in sophisticated tri-dimensional biological constructs, effectively halting viral penetration via a regulated gradient of concentrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The triad of biochemically active formulations is #amodiaquine#, #toremifene#, and #clomiphene#, demonstrating capability in 3D constructs to halt viral penetration.",
            "predicted_answer": "The triad of biochemically active formulations—amodiaquine, toremifene, and clomiphene—demonstrates unparalleled capability in sophisticated tri-dimensional biological constructs, effectively halting viral penetration via a regulated gradient of concentrations.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized in the Reference Answer, specifically mentioning \"amodiaquine,\" \"toremifene,\" and \"clomiphene.\" It accurately captures the concept of their use in sophisticated 3D constructs to halt viral penetration. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1026,
            "query": "What cascade of biological reverberations initiated by the Zika virus influences cerebral precursor entities and consequently impacts the developmental blueprint for cognitive potential, culminating in a condition of reduced cranial parameters?",
            "retrieved_metrics": {
                "reference_idx": [
                    1165
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Zika virus# targets neural progenitor cells, increasing neural cell death and reducing proliferation, thereby impacting #neurogenesis# and causing microcephaly.",
            "predicted_answer": "The Zika virus infects neural progenitor cells, leading to increased cell death and reduced proliferation, which hampers neurogenesis and causes microcephaly. This cascade impacts cerebral precursor entities and developmental cognitive potential.",
            "score": 5,
            "explanation": "The predicted answer fully captures the key facts of the Zika virus targeting neural progenitor cells, increasing cell death, and reducing proliferation, which affects neurogenesis and leads to microcephaly. The meaning is consistent, with no significant omissions or contradictory information."
        },
        {
            "query_idx": 1027,
            "query": "How does the complex endeavor of pinpointing potential candidates for CFTR modulator therapies manifest challenges when navigating the multifaceted genetic tapestries of cystic fibrosis individuals, especially those distinguished by uncommon mutational fabrications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Pinpointing candidates for CFTR modulator therapies is challenging due to #rare mutations# in cystic fibrosis, complicating the identification of potential #responders#.",
            "predicted_answer": "Pinpointing potential candidates for CFTR modulator therapies is challenging due to the rarity and diversity of CFTR mutations, particularly in individuals with uncommon genetic variations, making it difficult to predict response to specific treatments.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of \"rare mutations\" but misses the emphasis on identifying \"responders,\" which affects the completeness. The predicted answer aligns with the overall trend but lacks specific mention of identifying potential responders as emphasized in the reference."
        },
        {
            "query_idx": 1028,
            "query": "In what manner did the initial exploratory methodologies, traversing the intricate domain of molecular targeting, manifest the therapeutic potential of amivantamab within patient-derived cellular structures containing the EGFR Exon20ins mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1170
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The initial methods successfully tested #amivantamab#'s efficacy using patient-derived cells with #EGFR Exon20ins# mutations, enhancing therapeutic potential and leading to clinical trial replication and approval.",
            "predicted_answer": "Initial exploratory methodologies demonstrated the therapeutic potential of amivantamab in patient-derived cellular structures with EGFR Exon20ins mutations by preclinically testing its efficacy against EGFR and MET, leading to its approval for non-small cell lung cancer treatment.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of \"amivantamab\" and \"EGFR Exon20ins\" mutations, aligning with the reference answer. The focus on preclinical testing and approval aligns in trend, with no contradictory information. However, it misses mentioning clinical trial replication explicitly."
        },
        {
            "query_idx": 1029,
            "query": "Through what mechanisms did the biochemical agent azeliragon exert its dampening effect on intensified pro-inflammatory cascades observed within the alveolar biomimetic systems in the context of severe COVID-19 manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1168
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Azeliragon exerted its dampening effect by #suppressing# the overshooting of inflammatory responses via inhibition of the receptor for advanced glycation end products (#RAGE#).",
            "predicted_answer": "Azeliragon dampened intensified pro-inflammatory cascades in alveolar biomimetic systems by suppressing the overshooting of inflammatory responses, likely through its action as an RAGE inhibitor.",
            "score": 5,
            "explanation": "The predicted answer matches the reference answer's key facts, noting azeliragon's suppression of inflammatory response and its action as an RAGE inhibitor, using slightly different wording. Both align with the overall mechanism described with no significant omissions or contradictions."
        },
        {
            "query_idx": 1030,
            "query": "What are the nuanced mechanisms through which ephemeral carbon compounds subtly influence the orchestration of oxidative death pathways within cerebral constructs pertaining to Parkinsonian perturbations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1174
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ephemeral carbon compounds, such as #short-chain fatty acids#, subtly influence oxidative death pathways by increasing the expression of pathways related to #ferroptosis# in Parkinson disease models.",
            "predicted_answer": "Ephemeral carbon compounds, such as short-chain fatty acids, increase ferroptosis pathways, contributing to dopaminergic cell death in Parkinson's disease models.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts—mention of short-chain fatty acids and ferroptosis—aligned with the reference answer. Both answers describe the influence of ephemeral carbon compounds on oxidative death pathways in Parkinson’s disease models, with no contradictory information. The explanation is consistent and complete."
        },
        {
            "query_idx": 1031,
            "query": "In what manner can the skewed gender dynamics within the nascent phase of clinical experimentation impede the balance of pharmacological insights, and how might bespoke paradigms of disease modeling serve to rectify these inherent disparities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Skewed #gender dynamics# in early clinical trials impair #pharmacological# balance, as differences in drug metabolism are overlooked. Bespoke disease modeling can address these disparities by highlighting individual differences.",
            "predicted_answer": "Skewed gender dynamics in clinical experimentation can impede pharmacological insights by underrepresenting women, leading to sex-related differences in drug efficacy and safety being overlooked. Bespoke disease modeling, incorporating both sexes and diverse ethnicities, can rectify these disparities by identifying inter-individual differences and improving therapeutic assessment.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer, capturing the impact of skewed gender dynamics on pharmacological insights and the role of bespoke disease modeling in addressing disparities. However, it misses specific mention of \"early clinical trials\" and \"drug metabolism,\" which affects completeness."
        },
        {
            "query_idx": 1032,
            "query": "How do the ineffable waves of temporal variability resist harmonization within the conceptual frameworks of direct and allometric dimensional adjustments, thereby complicating the task of aligning the rhythmic symphony of physiological model simulations with real-world temporal cadences?",
            "retrieved_metrics": {
                "reference_idx": [
                    1178
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ineffable waves# of temporal variability resist harmonization because #direct and allometric scaling# do not account for time scale, complicating physiological model simulation alignment with real-world temporal cadences.",
            "predicted_answer": "The ineffable waves of temporal variability resist harmonization within direct and allometric dimensional adjustments due to their inability to accurately scale time-dependent processes, leading to discrepancies between model simulations and real-world temporal cadences.",
            "score": 3,
            "explanation": "The predicted answer captures the ineffable waves and mentions direct and allometric adjustments but omits the detail about these adjustments not accounting for time scale. This missing piece affects the completeness while the overall trend is aligned, without any contradictions."
        },
        {
            "query_idx": 1033,
            "query": "What underlying mechanisms intrinsic to organ-on-chip constructs allow for a nuanced orchestration of interconnected human system analogs, enabling them to transcend conventional paradigms in replicating intricate disease phenomena in vitro?",
            "retrieved_metrics": {
                "reference_idx": [
                    1160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #interconnected human organs# in organ-on-chip constructs enable nuanced orchestration, allowing them to emulate intricate disease phenomena through #complex communication and interactions#.",
            "predicted_answer": "The underlying mechanisms intrinsic to organ-on-chip constructs include the interconnection of multiple human organs, automated biophysical processes like chip perfusion, and real-time monitoring of tissue function, enabling nuanced orchestration of interconnected human system analogs and replication of intricate disease phenomena in vitro.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of \"interconnected human organs\" and the concept of replicating \"intricate disease phenomena.\" However, it misses the specific mention of \"complex communication and interactions,\" which is crucial. The overall trend is aligned, but this omission affects completeness."
        },
        {
            "query_idx": 1034,
            "query": "What biological simulation parameters are typically employed within the frameworks of functional scaling to ensure that these miniaturized biological echoes achieve a level of physiological mimicry with their larger organ counterpart, particularly in terms of essential operational metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1179
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniaturized biological models require careful calculation of #perfusion, diffusion, permeation, nutrient, and metabolic rates# to match key functional indices like drug clearance or filtration rates for physiological mimicry.",
            "predicted_answer": "Biological simulation parameters typically include matching perfusion, diffusion, permeation, nutrient, and metabolic rates to ensure physiological mimicry, focusing on key functional indices like drug clearance or filtration rates.",
            "score": 5,
            "explanation": "The Predicted Answer fully covers all the emphasized key facts in the Reference Answer, accurately mentioning the matching perfusion, diffusion, permeation, nutrient, and metabolic rates, as well as the focus on drug clearance or filtration rates for physiological mimicry. The meaning and details are consistent with no significant omissions."
        },
        {
            "query_idx": 1035,
            "query": "In what manner do the orchestrated symbiosis of physiological mechanical forces refine the harmonic orchestration of cellular contractions and the accelerated relay of electrical currents in artificially crafted myocardial replicas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1181
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #contractility# and #conduction velocity# of bioengineered heart tissue are improved by mechanical forces mimicking cardiac preload and afterload.",
            "predicted_answer": "The orchestrated symbiosis of physiological mechanical forces refines the harmonic orchestration of cellular contractions and the accelerated relay of electrical currents in artificially crafted myocardial replicas by mimicking cardiac preload and afterload, which improves contractility, cell alignment, and conduction velocity.",
            "score": 5,
            "explanation": "The predicted answer includes key facts like the improvement of contractility and conduction velocity due to mechanical forces mimicking cardiac preload and afterload. The meaning is consistent with the reference answer, reflecting all essential points without omissions or contradictions."
        },
        {
            "query_idx": 1036,
            "query": "What strategies does the similarity scaling paradigm employ, utilizing the interconnected tapestry of algebraic constructs, to reconcile the fluidic orchestration in OoC architectures with the temporal coordination required for drug administration scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    1180
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The similarity scaling paradigm employs #dimensional analysis# and #similitude# to reconcile fluidic orchestration with temporal coordination in OoC architectures, using algebraic constructs to balance input variables and parameters.",
            "predicted_answer": "The similarity scaling paradigm employs dimensional analysis and similitude to systematically reconcile fluidic orchestration in OoC architectures with temporal coordination for drug administration by algebraically linking input variables and parameters to ensure correct dimensional consistency.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts of #dimensional analysis# and #similitude#, matching the reference answer's focus. Both answers emphasize the role of algebraic constructs and the goal of using these methods for fluidic orchestration and coordination, with no significant omissions or errors."
        },
        {
            "query_idx": 1037,
            "query": "Through what complex interplay do modifications in the structural codes of the desmoplakin gene steer the methodological symphony of biomechanical determinants in the crafted landscapes of myocardial disruptions, further impacting the nuanced calibrations involved in electing prototypical model archetypes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1182
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modifications in the #desmoplakin gene# cause cardiomyopathy, emphasizing the need for biomechanical cues in model selection, impacting prototypical model archetypes for myocardial disruptions.",
            "predicted_answer": "Modifications in the desmoplakin gene lead to cardiomyopathy, affecting heart muscle stiffness and function. This impacts the selection of bioengineered models by necessitating the integration of biomechanical cues relevant to disease mechanisms.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of modifications in the \"desmoplakin gene\" leading to cardiomyopathy. It addresses the need for integrating biomechanical cues in model selection, aligning with the reference answer. However, it does not explicitly mention \"myocardial disruptions,\" affecting completeness."
        },
        {
            "query_idx": 1038,
            "query": "How do the interconnected predicaments presented by the employment of zoological proxies and sophisticated synthetic human constructs surface, especially in the enigmatic endeavor of mapping human physiological distortions, amid the shared anatomical features and complex biological architectures?",
            "retrieved_metrics": {
                "reference_idx": [
                    1185
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Interconnected predicaments arise due to #translational failure# in animal models and uncertainty in bioengineered constructs' #predictive# capacity for human pathophysiology despite shared anatomical features.",
            "predicted_answer": "The employment of zoological proxies and synthetic human constructs raises questions about the complexity and relevance of models in mapping human physiological distortions. While some animal models share anatomical features with humans, their predictive value remains uncertain. Similarly, synthetic human models must balance complexity and simplicity to accurately reflect human pathophysiology.",
            "score": 3,
            "explanation": "The predicted answer discusses the complexity and relevance of zoological proxies and synthetic human constructs, similar to the reference. It mentions uncertainty about predictive value but is missing the specific term \"translational failure\". Overall alignment is present, but one key fact is absent."
        },
        {
            "query_idx": 1039,
            "query": "What are the mechanistic frameworks through which the intensified expression of transcriptional orchestrators like ETV2 and NGN1 recalibrates the biological programming needed to expedite the metamorphosis of pluripotent cellular terrains into structured tissue matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1186
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The overexpression of #ETV2# and #NGN1# activates rapid cell differentiation, expediting the formation of multicellular and spatially patterned organoids without external cues.",
            "predicted_answer": "The intensified expression of transcriptional orchestrators like ETV2 and NGN1 accelerates cell differentiation by rapidly switching on the biological programming needed for tissue formation, facilitated by controlled spatial patterning and 3D printing of pre-programmed iPS cells.",
            "score": 3,
            "explanation": "The predicted answer mentions the intensified expression of ETV2 and NGN1 and their role in accelerating cell differentiation, aligning with the reference answer's key facts. However, it adds 3D printing and spatial patterning not present in the reference, and it misses the detail on formation without external cues, impacting completeness."
        },
        {
            "query_idx": 1040,
            "query": "What nuanced impediments impede the seamless integration of tailored biomedical constructs such as PDOs into the broad spectrum of clinical methodologies, considering their establishment efficiency and expansion duration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1187
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #low efficiency# of PDO establishment and their #lengthy generation# and expansion times impede integration into clinical methodologies.",
            "predicted_answer": "The integration of tailored biomedical constructs like PDOs into clinical methodologies is hindered by low establishment efficiencies (60-70%, with some up to 90%) and lengthy generation times, often spanning several weeks or months. Emerging technologies aim to shorten this process.",
            "score": 5,
            "explanation": "The predicted answer accurately captures both key facts emphasized in the reference: \"low efficiency\" and \"lengthy generation\" times of PDOs. The additional details on efficiency percentages and durations enhance, rather than contradict, the reference. The overall trend and meaning align well."
        },
        {
            "query_idx": 1041,
            "query": "Within the intricate tapestry of bioengineering practices, what pivotal act of diligent scrutiny, central to verifying the primacy or equivalence of anthropogenic constructs vis-à-vis natural forms, remains frequently eclipsed though critical?",
            "retrieved_metrics": {
                "reference_idx": [
                    1188
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rigorous #disease model validation# is pivotal for verifying the #equivalence# or superiority of anthropogenic constructs over natural forms, yet often remains neglected.",
            "predicted_answer": "Rigorous disease model validation is frequently overlooked, despite being crucial for verifying the equivalence or superiority of bioengineered constructs over natural forms.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # in the reference answer, such as \"disease model validation\" and \"equivalence or superiority\" of constructs. It aligns with the overall trend and meaning, with no omissions or contradictions."
        },
        {
            "query_idx": 1042,
            "query": "Within the spectrum of engineered emulations for physiological simulation, what intrinsic barriers and operational confines inhibit commercially sourced organotypic platforms from effectively encapsulating tridimensional biological matrices and tailoring models for investigatory pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1191
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Commercially# available organotypic platforms are costly, lack #customization#, focus on preclinical safety, and predetermined chips limit integration and dimensions, inhibiting effective 3D tissue modeling.",
            "predicted_answer": "Intrinsic barriers include high costs, lack of customizability, and limited availability of disease models. Operational confines involve pre-set chips restricting tissue type and dimension, and small setup sizes hindering effective 3D tissue cultivation.",
            "score": 3,
            "explanation": "The predicted answer accurately identifies the key barriers, such as high costs and lack of customizability, aligning with the reference. It also notes pre-set chips and limitations in 3D modeling. However, it misses mentioning the platforms' focus on preclinical safety, which affects completeness."
        },
        {
            "query_idx": 1043,
            "query": "What intrinsic scholarly reservations are there that discourage the adoption of microenvironmental platforms by the scientific community, and how might the creation of centralized hubs of innovation alleviate such impediments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1194
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scholarly reservations include #high costs# and lack of ready-to-use systems. #Centralized hubs# offering training and models can help reduce these barriers and promote adoption.",
            "predicted_answer": "Intrinsic scholarly reservations include the lack of ready-to-use systems, high costs, and entry barriers. Centralized hubs of innovation, such as dedicated core facilities, can alleviate these impediments by providing hands-on training, ready-to-use tissue models, and scientific advice, making microenvironmental platforms more accessible and promoting their adoption.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer, mentioning both \"high costs\" and \"lack of ready-to-use systems,\" which are the key facts marked with #. Additionally, it includes information on \"centralized hubs,\" which aligns with the reference, ensuring all key points are present."
        },
        {
            "query_idx": 1044,
            "query": "What are the pivotal waypoints in the intricate journey of integrating human disease simulation constructs within the realms of preclinical and clinical drug crafting, ensuring their transformative essence is harnessed effectively?",
            "retrieved_metrics": {
                "reference_idx": [
                    1195
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Meeting key milestones such as #validation criteria#, benchmarking, regulatory approval, and standardized manufacturing processes are pivotal in integrating human disease simulation constructs in drug development effectively.",
            "predicted_answer": "The pivotal waypoints in integrating human disease simulation constructs include: defining robust criteria for model validation, benchmarking against patient-derived data, securing regulatory approval, establishing legal frameworks, and creating scalable, robust manufacturing processes.",
            "score": 5,
            "explanation": "The predicted answer covers all key points emphasized in the reference: validation criteria, benchmarking, regulatory approval, and standardized manufacturing processes. Although the phrasing differs slightly, it captures the meaning without errors or omissions, ensuring alignment with the reference's intent."
        },
        {
            "query_idx": 1045,
            "query": "What orchestrated endeavor, conceived in the year 2013, seeks to transform the landscape of scrutinizing new pharmaceuticals' arrhythmogenic risks, and which entities comprise its collective genius?",
            "retrieved_metrics": {
                "reference_idx": [
                    1193
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CiPA initiative#, conceived in #2013#, aims to improve assessing arrhythmogenic risks of new drugs, involving regulatory authorities, pharmaceutical companies, and academics.",
            "predicted_answer": "The orchestrated endeavor is the CiPA initiative, launched in 2013 to improve the assessment of new drugs' arrhythmogenic risks. It comprises regulatory authorities like the FDA and EMA, pharmaceutical companies, and academics.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the CiPA initiative, its launch year (2013), and its goal of improving new drugs' arrhythmogenic risk assessment. It also lists the involved entities (regulatory authorities, pharmaceutical companies, academics) matching the key facts of the reference answer without any contradictions or omissions."
        },
        {
            "query_idx": 1046,
            "query": "What sophisticated genomic deciphering technique empowers the molecular landscape cartography needed for unveiling elusive cellular ensembles and unraveling pivotal cellular genetic catalysts within disease genesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Single-cell RNA-seq# empowers genomic deciphering by profiling individual cells, identifying #rare cell populations#, and detecting cell type-specific driver genes in disease.",
            "predicted_answer": "Single-cell RNA sequencing (RNA-seq) empowers molecular landscape cartography by profiling individual cells, identifying rare populations, and detecting cell type-specific driver genes crucial for disease genesis.",
            "score": 5,
            "explanation": "The predicted answer mentions \"Single-cell RNA sequencing,\" covering the key fact #Single-cell RNA-seq#. It also includes \"rare populations,\" aligning with #rare cell populations#, and discusses identifying driver genes in disease. It matches all key details from the reference without omissions or contradictions."
        },
        {
            "query_idx": 1047,
            "query": "What nuanced limitations curtail the forward trajectory of single-cell proteomics in its endeavor to decode the elaborate symphonies of cellular individuality, in contrast to the encompassing scope of bulk-level proteomic methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1192
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Single-cell proteomics face limitations such as #expensive# and time-consuming measurements and a #limited dynamic range#, resulting in low throughput compared to bulk-level methodologies.",
            "predicted_answer": "Single-cell proteomics faces limitations such as low throughput, high cost, and limited dynamic range, which hinder its ability to fully capture cellular heterogeneity compared to bulk-level proteomics.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of \"expensive\" (high cost) and \"limited dynamic range,\" both emphasized in the reference. However, it does not mention \"time-consuming\" measurements, a key fact that affects completeness. Trends are aligned without contradictions."
        },
        {
            "query_idx": 1048,
            "query": "What emblematic indicators operate as surrogates representing the spectrum of research and development exertions contained within the oncological dataset's analysis of malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1201
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Clinical trials per year#, the #number of enrolled patients#, and the duration of clinical trials represent R&D efforts in the oncological dataset's analysis.",
            "predicted_answer": "The emblematic indicators representing research and development efforts in oncological datasets include the number of clinical trials per year, number of enrolled patients, and duration of clinical trials.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer: clinical trials per year, number of enrolled patients, and the duration of clinical trials. The prediction is fully consistent with the reference, without any significant omissions or errors."
        },
        {
            "query_idx": 1049,
            "query": "What are the intricate roles of each foundational strand within the diverse tapestry of data amalgamation, which collectively construct the analytical paradigm for cancer type exploration, conceived within the temporal investigation spectrum of 1996 to 2016?",
            "retrieved_metrics": {
                "reference_idx": [
                    1202
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Each #foundational strand# provides data: Clinicaltrial.gov on #trial numbers#, Orpha.net on rare cancer trials, and Rarecarenet.eu on epidemiological stats for 2007, collectively informing cancer type analysis.",
            "predicted_answer": "The foundational strands in data amalgamation for cancer type exploration (1996-2016) include: clinical trial data from Clinicaltrial.gov and Orpha.net, and epidemiological data from Rarecarenet.eu. These collectively construct the analytical paradigm.",
            "score": 3,
            "explanation": "The predicted answer recognizes the foundational strands vital for cancer type exploration and sources like Clinicaltrial.gov, Orpha.net, and Rarecarenet.eu. However, it omits specific key details about trial numbers and rare cancer trials, which are emphasized in the reference answer, affecting completeness."
        },
        {
            "query_idx": 1050,
            "query": "What reconfiguration of focus trajectories for clinical trials delineating rare oncology phenomena can be discerned across each investigatory echelon subsequent to legislative enactment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1205
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "After the legislation, clinical trials maintained #pro-low need# inequity for non-rare cancers, but transitioned to #pro-high need# focus in all phases for rare cancers.",
            "predicted_answer": "Reconfiguration of focus trajectories for clinical trials delineating rare oncology phenomena shows pro-high need inequalities in all phases for rare cancers, persisting only in phases 2 and 3 for non-rare cancers post-legislative enactment.",
            "score": 0,
            "explanation": "The 'Predicted Answer' indicates \"pro-high need\" focus for rare cancers in all phases, which matches the 'Reference Answer'. However, it incorrectly states these persist only for non-rare cancers in phases 2 and 3, contradicting the reference's \"pro-low need\" inequity. Therefore, key facts are not completely aligned."
        },
        {
            "query_idx": 1051,
            "query": "What implication arises from an empirical measure indicating maximal deviation towards the lesser necessity spectrum within oncological investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1203
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The implication is a #pro-low need inequality#, meaning research is heavily focused on #low-need cancers#, as indicated by the maximal deviation in the empirical measure.",
            "predicted_answer": "The empirical measure indicating maximal deviation towards the lesser necessity spectrum suggests that research is concentrated on low-need cancers, indicating a pro-low need inequality.",
            "score": 5,
            "explanation": "The predicted answer includes both emphasized key facts from the reference answer: \"pro-low need inequality\" and \"low-need cancers.\" It captures the overall trend and implication without any significant omissions or contradictions. The meanings are consistent, ensuring a comprehensive alignment."
        },
        {
            "query_idx": 1052,
            "query": "What are the multifarious obstacles to the pursuit of novel trajectories in oncology innovation, considering the intricate web of technical complexities and disparities that manifest within clinical investigation landscapes and therapeutic formulation odysseys?",
            "retrieved_metrics": {
                "reference_idx": [
                    1207
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pursuit of novel oncology trajectories faces obstacles like #technical complexity# in disease understanding and inequities in clinical trial distribution and investment.",
            "predicted_answer": "The pursuit of novel trajectories in oncology innovation faces obstacles such as technical complexities, disparities in clinical trial distribution, and inefficiencies in drug development, influenced by varying disease pathogenesis and technical project failures.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as technical complexities and disparities in clinical trials. However, it also mentions inefficiencies and pathogenesis not emphasized in the reference. Despite this, the predicted answer aligns with the overall trend without contradictions but lacks mention of investment inequities, missing one key fact."
        },
        {
            "query_idx": 1053,
            "query": "What strategies do intelligence-enhanced decision ecosystems adopt in harnessing immediate clinical data flows to refine therapeutic pathways and foster patient compliance landscapes using prognosis-centric analytical frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intelligence-enhanced decision ecosystems use #AI# to integrate real-time clinical data to adapt therapeutic interventions, ensuring timely treatment modifications for improved #patient compliance#.",
            "predicted_answer": "Intelligence-enhanced decision ecosystems use AI to analyze real-time clinical data, predict outcomes, and adapt interventions, improving therapeutic pathways and patient compliance.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts of using AI, analyzing real-time clinical data, and improving therapeutic pathways and patient compliance. Though phrasing differs slightly, it aligns well with the Reference Answer's emphasis on AI, real-time data integration, and patient compliance enhancements."
        },
        {
            "query_idx": 1054,
            "query": "What sophisticated frameworks and methodological blueprints should healthcare entities orchestrate to preserve the sanctity of patient information, thereby ensuring these defensive structures synergize with existing legislative tenets like HIPAA, amidst the transformative influences of AI in healthcare?",
            "retrieved_metrics": {
                "reference_idx": [
                    1223
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Healthcare entities should implement #encryption# and #anonymization# methods along with access controls to safeguard patient data, ensuring compliance with HIPAA and addressing AI-related challenges like algorithmic bias and accountability.",
            "predicted_answer": "Healthcare entities should implement sophisticated frameworks like encryption, anonymization, and access controls, ensuring they align with HIPAA. These defensive structures must synergize with legislative tenets to preserve patient information amidst AI's transformative influence.",
            "score": 3,
            "explanation": "The Predicted Answer contains the key elements: encryption, anonymization, and access controls, aligned with HIPAA compliance. However, it omits AI-related challenges like algorithmic bias and accountability, which limits its completeness. Overall, it follows the Reference Answer's trend but misses one key detail."
        },
        {
            "query_idx": 1055,
            "query": "What complex and perhaps unforeseen paradigms might manifest from the intertwining of artificial cognition into the sanctified tapestry of healthcare decision-making, stepping beyond the realm of algorithmic impartiality and the limitations of representational datasets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1226
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The integration of #AI# in healthcare may raise concerns about #algorithmic bias#, challenge medical norms, and question accountability, autonomy, and fairness in decision-making processes.",
            "predicted_answer": "The intertwining of artificial cognition in healthcare may lead to complex paradigms such as algorithmic bias, accountability issues, and challenges to professional autonomy, necessitating careful integration with clinical guidelines and patient preferences.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of #algorithmic bias#, #accountability issues#, and challenges to #professional autonomy#. However, it omits the key aspects of questioning #fairness# and #autonomy# in decision-making processes. The general trend is aligned, but missing these aspects affects completeness."
        },
        {
            "query_idx": 1056,
            "query": "What mechanisms of cognitive convergence, enabled by digital harmonization strategies, influence the orchestration of innovative data conduits within clinical trial ecosystems, particularly in fostering dynamic trial blueprints and participatory recruitment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1227
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Digital harmonization mechanisms, like #Federated Learning#, enable collaboration, ensuring #privacy# and enhancing clinical trials through dynamic designs and participatory recruitment while integrating real-world data effectively.",
            "predicted_answer": "Digital harmonization strategies, such as federated learning and AI integration with real-world data, enable cognitive convergence by enhancing data privacy, real-time monitoring, and predictive modeling. These mechanisms foster dynamic trial blueprints and participatory recruitment paradigms by optimizing trial design, improving patient recruitment, and expediting regulatory approval.",
            "score": 5,
            "explanation": "The predicted answer includes key points from the reference such as federated learning, privacy, real-world data integration, and the impacts on dynamic trial designs and recruitment. It aligns well, although some specific words like \"ensuring\" collaboration are absent, the core details remain intact."
        },
        {
            "query_idx": 1057,
            "query": "Within the intricate weave of digital equitability, what pivotal systemic conundrum must be unraveled to prevent digital architectures from exacerbating well-being imbalances across oncological realms, particularly concerning marginalized cohorts dwelling within the societal health spectrum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1228
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A pivotal systemic conundrum is addressing #algorithmic bias# to prevent AI-driven healthcare disparities among #marginalized# groups, ensuring equitable access and fairness.",
            "predicted_answer": "Addressing algorithmic bias and fairness in AI systems is crucial to prevent exacerbating well-being imbalances, particularly for marginalized oncological patients. Ensuring equitable access to AI-driven technologies and accountability in healthcare delivery is pivotal.",
            "score": 5,
            "explanation": "The Predicted Answer addresses algorithmic bias and fairness, aligning with the key facts in the Reference Answer, such as the need for equitable access and focus on marginalized groups. It covers all emphasized points without significant omissions or errors, maintaining alignment with the reference's intent."
        },
        {
            "query_idx": 1058,
            "query": "In the intricate interplay of artificial intelligence and oncological exploration, what role does the synthesis of diverse biomolecular spectra play in unraveling the concealed genesis and acceleration of neoplastic conditions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1231
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthesis of diverse biomolecular spectra in AI-assisted cancer research aids in unveiling the #genesis# and #progression# of neoplastic conditions through multi-omics integration.",
            "predicted_answer": "The synthesis of diverse biomolecular spectra, such as transcriptomics, proteomics, and metabolomics, aids in understanding the complex biological mechanisms underlying cancer initiation and progression, enhancing AI's role in oncological research.",
            "score": 5,
            "explanation": "The predicted answer mentions the synthesis of diverse biomolecular spectra aiding in understanding cancer initiation and progression, which aligns with the reference's emphasis on \"genesis\" and \"progression.\" All key aspects, including the role in cancer research, are covered without any omissions or contradictions."
        },
        {
            "query_idx": 1059,
            "query": "How might the composite realignment of trust toward AI-empowered diagnostic architectures be nurtured in the intricate weave of clinical practice, especially amidst the prevailing reservations concerning their analytic fidelity and operational pertinence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "To nurture trust in AI-diagnostic systems, clinicians need #education# and evidence of #effectiveness#, alongside collaboration and training to enhance integration into clinical practice.",
            "predicted_answer": "To nurture trust in AI-empowered diagnostic architectures, clinicians must be educated, trained, and provided with evidence of AI's effectiveness. Utilizing advanced imaging technologies can enhance AI's sensitivity and specificity, addressing concerns about analytic fidelity and operational pertinence.",
            "score": 3,
            "explanation": "The predicted answer includes key points about the necessity of clinician education, training, and evidence of AI's effectiveness, aligning with the reference. However, it lacks the emphasis on collaboration as a means to integrate AI into clinical practice, omitting this key detail."
        },
        {
            "query_idx": 1060,
            "query": "What role does the metaphorical 'battlefront' of rampant cellular upheaval play in magnifying both the inherent deadliness of cancer and the labyrinthine obstacles encountered by therapeutic endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1242
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The metaphorical 'battlefront' of #cellular upheaval# magnifies cancer's #deadliness# and complicates therapeutic efforts by contributing to metastasis and treatment challenges like drug resistance.",
            "predicted_answer": "The metaphorical 'battlefront' of rampant cellular upheaval in cancer highlights the rapid, uncontrolled growth and spread of abnormal cells, complicating therapeutic efforts due to metastasis, drug resistance, and treatment challenges.",
            "score": 5,
            "explanation": "The predicted answer includes key concepts of \"cellular upheaval,\" \"deadliness,\" \"metastasis,\" \"drug resistance,\" and \"treatment challenges,\" aligning with the reference. There are no significant omissions or contradictions, capturing all key facts emphasized in the reference."
        },
        {
            "query_idx": 1061,
            "query": "Amidst the intricate tapestry of marine-sourced pharmaceutical innovations, celebrated for their therapeutic diversity, what is the particular proportion attributable to these compounds that actively engage in the suppression of oncogenic cell expansion?",
            "retrieved_metrics": {
                "reference_idx": [
                    1244
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#11# out of #20# clinically used drugs derived from marine sources exhibit antitumor effects, representing the proportion actively engaging in the suppression of oncogenic cell expansion.",
            "predicted_answer": "Approximately 55% of marine-sourced pharmaceutical compounds actively engage in the suppression of oncogenic cell expansion.",
            "score": 3,
            "explanation": "The predicted answer states that 55% of marine-sourced pharmaceutical compounds suppress oncogenic cell expansion, while the reference specifies 11 out of 20 drugs. The key fact regarding the specific ratio (11/20) is missing in the prediction, affecting completeness."
        },
        {
            "query_idx": 1062,
            "query": "In what manner do the technological constructs of AI-enhanced liquid biopsy systems partake in the symphony of medical anticipation, interpreting genomic narratives and biological exchanges to recalibrate therapeutic pathways for those contending with cancer's manifold transformations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1249
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AI-enhanced liquid biopsy systems interpret genomic and biological changes, tracking #tumor biology# and #genomic evolution#, enabling early intervention and adaptive cancer treatment strategies.",
            "predicted_answer": "AI-enhanced liquid biopsy systems analyze circulating tumor DNA and cells to track treatment response, detect minimal residual disease, and identify resistance mechanisms, enabling early intervention and adaptive therapy for cancer patients.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of tracking tumor biology, genomic evolution, early intervention, and adaptive therapy, as mentioned in the reference answer. It aligns with the key facts signaled with #. Although phrasing differs, there are no significant omissions or errors."
        },
        {
            "query_idx": 1063,
            "query": "How does the presence of the interlocking carbonyl component enhance the adaptive interplay of topsentin compounds as they navigate the molecular landscape of the CDK1 enzymatic core?",
            "retrieved_metrics": {
                "reference_idx": [
                    1255
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #carbonyl# component enhances topsentin compounds' #flexibility#, allowing better adaptation and interaction with the CDK1 enzymatic core through hydrogen bonding at the ATP binding site.",
            "predicted_answer": "The interlocking carbonyl component enhances the adaptive interplay of topsentin compounds by providing flexibility and acting as a hydrogen bond receptor, allowing better interaction with the ATP binding site and amino acid residues at the CDK1 active site.",
            "score": 5,
            "explanation": "The predicted answer captures the key elements of the carbonyl component's role, including its impact on flexibility and interaction through hydrogen bonding with the ATP binding site. It aligns well with the reference, even though the phrasing differs slightly. No significant details are missing."
        },
        {
            "query_idx": 1064,
            "query": "Among the synthesized derivatives engaged in the biochemical odyssey of enhancing cellular adversity, which entity achieves the pinnacle of extermination capacity against P388 cellular life, as discerned through comparative subjugation indices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1254
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Analogue #8# achieves the pinnacle of extermination capacity against P388 cells with an IC$\\_{50}$ value of #0.3 µg/mL#.",
            "predicted_answer": "Analogue 8 achieves the highest extermination capacity against P388 cells with an IC$_{50}$ of 0.3 µg/mL.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies Analogue 8 and the IC$_{50}$ value of 0.3 µg/mL, which are the key facts emphasized in the reference answer. The meaning is consistent, with no omissions or errors. Thus, it fully aligns with the reference."
        },
        {
            "query_idx": 1065,
            "query": "In the nuanced orchestration of molecular transformations within human mammary carcinoma expressions, which processes are intricately interwoven with the symphonic cessation of cellular vitality, prompted by extrinsic catalysts and evidenced through phenomena such as membrane phosphatidylserine externalization, chromatin textural condensation, and cellular cycle phase modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1267
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The processes intricately involved are #apoptosis# promotion, involving phosphatidylserine externalization, chromatin condensation, and cell cycle modulation to the #G0-G1 phase#.",
            "predicted_answer": "Apoptosis is intricately interwoven with membrane phosphatidylserine externalization, chromatin textural condensation, and cellular cycle phase modulation in human mammary carcinoma expressions.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference, mentioning apoptosis and the relevant phenomena. However, it omits the specific detail of cell cycle modulation to the G0-G1 phase. Despite the omission, no contradictory information is present, maintaining general alignment with the reference."
        },
        {
            "query_idx": 1066,
            "query": "What mechanistic symphony do the molecular virtuosos numbered 49, 50, and 51 conduct upon the cyclical cadence of the MCF-7 cell populace's proliferative journey?",
            "retrieved_metrics": {
                "reference_idx": [
                    1269
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Derivatives #49#, #50#, and 51 promote apoptosis, disrupt the cell cycle, reduce G0/G1 and S phase cells, and increase G2/M phase cells in MCF-7 cells.",
            "predicted_answer": "The molecular virtuosos 49, 50, and 51 induce apoptosis and disrupt the cell cycle in MCF-7 cells, reducing G0/G1 and S phases while increasing G2/M and sub-G1 populations.",
            "score": 5,
            "explanation": "The predicted answer closely aligns with the reference answer, covering the key facts of promoting apoptosis, disrupting the cell cycle, and showing similar phase population changes in MCF-7 cells. Although \"sub-G1 populations\" is extra detail, no critical information is missing or contradictory."
        },
        {
            "query_idx": 1067,
            "query": "What precise quantitative threshold characterizes the subtle inhibitory discourse of Dendridine A when engaging with the cellular domain of murine leukemia L1210 specimens?",
            "retrieved_metrics": {
                "reference_idx": [
                    1281
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dendridine A exhibits weak cytotoxicity to mouse leukemia L1210 cells, characterized by an IC$\\_{50}$ of #32.5 µg/mL#.",
            "predicted_answer": "The subtle inhibitory discourse of Dendridine A with murine leukemia L1210 specimens is characterized by an IC$_{50}$ of 32.5 µg/mL.",
            "score": 5,
            "explanation": "The predicted answer contains the exact key fact emphasized in the reference answer: \"IC$_{50}$ of 32.5 µg/mL\". Both answers convey the same quantitative threshold information for Dendridine A's activity on L1210 cells. There is no contradiction or omission of critical details."
        },
        {
            "query_idx": 1068,
            "query": "Through which intricate biochemical symphony does staurosporine attenuate a molecular pathway, thus modulating the intrinsic resistance mechanisms of neoplastic cells to bolster their susceptibility to cisplatin's cytotoxic impact?",
            "retrieved_metrics": {
                "reference_idx": [
                    1284
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Staurosporine attenuates molecular pathways by #down-regulating# the #p62# mechanism, enhancing cancer cell susceptibility to cisplatin's cytotoxic effects.",
            "predicted_answer": "Staurosporine attenuates a molecular pathway by down-regulating the p62 mechanism, thereby modulating intrinsic resistance in neoplastic cells and enhancing their susceptibility to cisplatin's cytotoxic impact.",
            "score": 5,
            "explanation": "The predicted answer matches the reference in key aspects, including the down-regulation of the p62 mechanism and its impact on neoplastic cell susceptibility to cisplatin. Both answers describe the modulation of intrinsic resistance via down-regulation of p62, covering all emphasized facts."
        },
        {
            "query_idx": 1069,
            "query": "Within the spectrum of molecular engagements and cellular interplay, what represent the quantitative determinations of efficacy for compounds 100 and 101 in the cellular microenvironment of human cervical neoplasms? Moreover, do these molecular forms induce any perturbations within the intrinsic stability of HEK-293 cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1282
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compounds 100 and 101 have #IC₅₀ values# of 4.6 µM and #1.3 µM# in human cervical cancer cells, respectively, showing no cytotoxicity in HEK-293 cell lines.",
            "predicted_answer": "The IC$_{50}$ values for compounds 100 and 101 in human cervical neoplasms are 4.6 µM and 1.3 µM, respectively. These compounds do not induce cytotoxic effects on HEK-293 cells.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts from the Reference Answer, including IC₅₀ values of 4.6 µM and 1.3 µM for compounds 100 and 101, respectively, and the lack of cytotoxicity in HEK-293 cells. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1070,
            "query": "How do the cytostatic thresholds embodied in the IC₅₀ values of biochemical entities dubbed A and B elucidate their varying potency in breaching the cellular defenses of KB cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1283
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Chondriamide #A# exhibits greater potency with an IC₅₀ of 0.5 µg/mL, indicating stronger capability in breaching KB cell defenses compared to chondriamide #B#.",
            "predicted_answer": "The IC₅₀ values of biochemical entities A and B elucidate their varying potency in breaching the cellular defenses of KB cells by indicating the concentration required to inhibit 50% of cell growth. Chondriamide A has an IC₅₀ of 0.5 µg/mL, while chondriamide B has an IC₅₀ of <1 µg/mL, suggesting B is more potent against KB cells.",
            "score": 0,
            "explanation": "The Predicted Answer incorrectly suggests chondriamide B is more potent, contradicting the Reference Answer, which states chondriamide A exhibits greater potency. This error misrepresents the relationship between A and B, missing the key emphasis on A's greater potency."
        },
        {
            "query_idx": 1071,
            "query": "Within the complex theater of cellular interactions, what convoluted sequence of molecular disruptions culminates in the unraveling of TET1's structural integrity amidst the B-ALL cell environment, specifically under the influence of the biochemical orchestrators: staurosporine and ATM inhibitory compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1286
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Staurosporine and ATM inhibitors inhibit #phosphorylation#, causing #TET1 instability# and a synergistic killing effect in B-ALL cells.",
            "predicted_answer": "Staurosporine and ATM inhibitors disrupt TET1 phosphorylation, causing structural instability and synergistic killing of B-ALL cells.",
            "score": 5,
            "explanation": "The 'Predicted Answer' correctly captures both key facts: the inhibition/disruption of phosphorylation and the resulting TET1 instability, as emphasized in the 'Reference Answer'. The phrasing varies, but it does not contradict or omit the essential facts required for completeness."
        },
        {
            "query_idx": 1072,
            "query": "In the dynamic realm of intracellular symphonies, what distinct molecular motifs are subdued by UCN-01, and which critical catalyst in the orchestration of kinases does it decisively counteract?",
            "retrieved_metrics": {
                "reference_idx": [
                    1288
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UCN-01 subdues molecular motifs #thymidylate synthase# and #E2F-1#, and decisively counteracts the DNA damage checkpoint kinase #Chk1#.",
            "predicted_answer": "UCN-01 selectively inhibits protein kinase C and Checkpoint kinase 1 (Chk1), subduing critical molecular motifs involved in DNA damage response and cell cycle regulation.",
            "score": 1,
            "explanation": "The predicted answer correctly identifies Chk1 as a target of UCN-01, aligning with the reference. However, it incorrectly names protein kinase C instead of thymidylate synthase and E2F-1, missing two key facts needed for complete alignment. No contradictions are present."
        },
        {
            "query_idx": 1073,
            "query": "What is the role of UCN-01 in modulating the intricate molecular networks to ultimately facilitate the initiation of programmed cell demise within neuroblastoma cellular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1289
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UCN-01 #inhibits# cell proliferation and induces #apoptosis# in neuroblastoma cells through caspase activation and PARP cleavage.",
            "predicted_answer": "UCN-01 modulates molecular networks in neuroblastoma cells by inhibiting PDK1, leading to Akt inactivation and inducing apoptosis through caspase activation and PARP cleavage.",
            "score": 5,
            "explanation": "The predicted answer mentions the inhibition of PDK1 and inactivation of Akt, which aligns with but is more detailed than the reference. Both highlight apoptosis induction via caspase activation and PARP cleavage (emphasized facts). Thus, the key facts are present, and trends are aligned."
        },
        {
            "query_idx": 1074,
            "query": "In what capacity does lestaurtinib function as a conductor in the molecular ballet of prostate cancer cellular systems, altering the intricate choreography that governs SRF activity activated by androgenic influences?",
            "retrieved_metrics": {
                "reference_idx": [
                    1290
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lestaurtinib functions by inhibiting #PKN1#, which affects #SRF activity# induced by androgens in prostate cancer cells.",
            "predicted_answer": "Lestaurtinib functions as an inhibitor of PKN1, which alters SRF activity in prostate cancer cells, thereby affecting the cellular response to androgenic influences.",
            "score": 5,
            "explanation": "The predicted answer accurately covers both key facts: the inhibition of #PKN1# and the effect on #SRF activity# induced by androgenic influences in prostate cancer cells. It aligns with the reference answer without omissions or contradictions."
        },
        {
            "query_idx": 1075,
            "query": "Through what nuanced molecular ballet do the entities AZD2461 and UCN-01 guide the cellular fate towards programmed demise and autophagic engagement, delineating uniquely tailored pathways within the disparate terrains of multiple myeloma versus primary effusion lymphoma cellular environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1291
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AZD2461 and UCN-01 orchestrate #cellular demise# via CHK1 inhibition, downregulating xbp1, inducing UPR imbalance, leading to apoptosis and autophagy in MM and PEL cells.",
            "predicted_answer": "AZD2461 and UCN-01 guide cellular fate by inhibiting PARP and CHK1, downregulating c-Myc, and upregulating CHOP, leading to UPR imbalance and cell death. They trigger autophagy via PERK/eIF2alpha in multiple myeloma and IRE1alpha/JNK1/2 in primary effusion lymphoma.",
            "score": 3,
            "explanation": "The predicted answer includes the main points of cellular fate guidance via CHK1 inhibition and UPR imbalance leading to cell death and autophagy. However, it misses the exact matching term \"downregulating xbp1,\" though it mentions c-Myc and CHOP adjustments. Overall alignment is good, but one key fact is incomplete."
        },
        {
            "query_idx": 1076,
            "query": "In what manner does the elusive entity designated as compound 138 harmonize the intricate web of signaling conduits within the microenvironment of MDA-MB-231 cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1294
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #138# harmonizes signaling conduits in MDA-MB-231 cells by regulating #ERK1/2#, Akt, and p38 MAPK pathways, and downregulating myc.",
            "predicted_answer": "Compound 138 harmonizes signaling conduits in MDA-MB-231 cells by regulating ERK1/2, Akt, and p38 MAPK pathways and downregulating myc, reducing metastasis and increasing tumor necrosis.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as the regulation of ERK1/2, Akt, and p38 MAPK pathways, and downregulating myc, which are emphasized in the reference. However, it adds details about reducing metastasis and increasing tumor necrosis, not mentioned in the reference."
        },
        {
            "query_idx": 1077,
            "query": "In the context of Rhopaladin B's interaction with cyclin-dependent kinase 4 and the c-erbB-2 kinase, how do the delineated half maximal inhibitory concentration values illuminate its inherent capacity to perturb molecular stability within oncogenic frameworks, and what extrapolative assertions can be made about its cytotoxic potentialities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1295
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rhopaladin B's #IC₅₀ values# of 12.5 and 7.4 µg/mL suggest notable #cytotoxic potential# against oncogenic pathways, impacting molecular stability within tumor cells.",
            "predicted_answer": "Rhopaladin B's IC50 values of 12.5 µg/mL for CDK4 and 7.4 µg/mL for c-erbB-2 kinase suggest strong inhibitory activity, indicating its potential to destabilize oncogenic pathways and exhibit significant cytotoxicity to human tumor cells.",
            "score": 5,
            "explanation": "Both the predicted and reference answers mention the IC₅₀ values of 12.5 µg/mL and 7.4 µg/mL, implying Rhopaladin B's cytotoxic potential and its impact on oncogenic pathways. The predicted answer fully reflects the key facts, covering the IC₅₀ values and cytotoxic potential without omissions."
        },
        {
            "query_idx": 1078,
            "query": "What are the quantifiable indices of inhibition potency, specifically concerning the molecular entities termed luteoalbusins A and B, as they navigate the biological complexes of SF-268 and NCI-H460 cellular structures, in terms of their interactive physiological thresholds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1297
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Luteoalbusins A and B show #cytotoxicity# against SF-268 cancer cells with IC$\\_{50}$ values of 0.23-2.39 µM and #anti-proliferative# effects on NCI-H460 with IC$\\_{50}$ of 1.15-1.31 µM.",
            "predicted_answer": "The quantifiable indices of inhibition potency for luteoalbusins A and B are their IC$_{50}$ values, which range from 0.23 to 2.39 µM against SF-268 cells and 1.15 to 1.31 µM against NCI-H460 cells.",
            "score": 3,
            "explanation": "The predicted answer includes the IC$_{50}$ values for luteoalbusins A and B against both SF-268 and NCI-H460 cells, covering the quantifiable indices of inhibition potency. However, it doesn't explicitly mention the #cytotoxicity# or #anti-proliferative# effects, meaning one key fact is missing."
        },
        {
            "query_idx": 1079,
            "query": "What are the quantified lethality thresholds for the molecular entity identified as Hyrtinadine A, as well as its precursor molecular form, compound 156, when evaluated against the complex cellular assemblies designated as HCT116?",
            "retrieved_metrics": {
                "reference_idx": [
                    1296
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The IC$\\_{50}$ value for #Hyrtinadine A# against #HCT116# is >10 µM, while for compound 156, it is 3.7 µM.",
            "predicted_answer": "Hyrtinadine A has an IC$_{50}$ > 10 µM against HCT116 cells, while its precursor, compound 156, has an IC$_{50}$ of 3.7 µM against HCT116 cells.",
            "score": 5,
            "explanation": "The Predicted Answer accurately mentions both Hyrtinadine A and compound 156 in relation to their IC$_{50}$ values against HCT116 cells, aligning with the Reference Answer. All key facts are present, with no omissions or errors, maintaining consistency with the Reference Answer."
        },
        {
            "query_idx": 1080,
            "query": "In the realm of molecular architecture, which elemental moiety within the alkaloidal derivatives sourced from Dictyodendrlla verongiformis acts as the sovereign regulator, ensuring the dismantling of telomeric perpetuation phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1299
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #sulfate# part of the alkaloids from Dictyodendrlla verongiformis acts as the #sovereign regulator# in dismantling telomeric perpetuation phenomena.",
            "predicted_answer": "The sulfate moiety within Dictyodendrins A and B acts as the sovereign regulator, ensuring the dismantling of telomeric perpetuation phenomena by inhibiting telomerase activity.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies the #sulfate# part and its role as the #sovereign regulator# in the dismantling of telomeric perpetuation phenomena, aligning closely with the reference answer without any errors or omissions. The presence of additional detail about inhibiting telomerase activity does not contradict the reference answer."
        },
        {
            "query_idx": 1081,
            "query": "Through the intricate web of intracellular metabolic pathways, what ripple effect does the subversion of the CPT1a conduit have on the procurement strategies and existential robustness of malignant cells, particularly when examined within the purview of fatty acid β-oxidation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1302
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The subversion of the #CPT1a# conduit disrupts fatty acid β-oxidation, compromising #energy procurement# and existential robustness of malignant cells by limiting their energy supply.",
            "predicted_answer": "Subverting CPT1a disrupts fatty acid β-oxidation, depriving malignant cells of an essential energy source, thereby weakening their procurement strategies and existential robustness.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference answer: #CPT1a# and #energy procurement#. It correctly explains how subverting CPT1a affects fatty acid β-oxidation, energy supply, and the robustness of malignant cells. There are no significant omissions or errors."
        },
        {
            "query_idx": 1082,
            "query": "What are the intricate molecular tapestries woven by fascaplysin that invoke the symphony of autophagic rejuvenation, contributing to the heightened susceptibility of cancer cells to embrace the orchestrated cessation prompted by TRAIL pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1278
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Fascaplysin induces autophagy by activating the #ROS pathway#, inhibiting survivin, and increasing #TRAIL-induced# cancer cell death, enhancing susceptibility to programmed cell death.",
            "predicted_answer": "Fascaplysin activates autophagy via ROS and inhibits survivin, enhancing TRAIL-induced cancer cell death, making cancer cells more susceptible to TRAIL-based therapies.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized in the Reference Answer: ROS pathway activation, TRAIL-induced cancer cell death, and survivin inhibition. Both answers describe fascaplysin's role in enhancing cancer cell susceptibility to TRAIL pathways. The key details and overall trend are fully covered."
        },
        {
            "query_idx": 1083,
            "query": "What distinctive molecular adornment is embraced by Indimicin B, and upon which cellular congregation does it exert a moderate influential potency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1300
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Indimicin B features a #1$^{'}$, 3$^{'}$-dimethyl-2$^{'}$-hydroindole# moiety and exerts moderate potency on the #MCF-7# cell line.",
            "predicted_answer": "Indimicin B features a unique 1', 3'-dimethyl-2'-hydroindole moiety and exerts moderate cytotoxicity against the MCF-7 cell line.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: the \"1', 3'-dimethyl-2'-hydroindole moiety\" and \"MCF-7\" cell line. Both the molecular structure and cellular target are correctly identified with no significant omissions or contradictions."
        },
        {
            "query_idx": 1084,
            "query": "What underlying discrepancies render the crystallographic configuration of ratCPT2 an unreliable blueprint for deciphering the complex architectural enigma of CPT1A, in the realm of status quo impediments related to membrane-bound activity preservation and protein solubility?",
            "retrieved_metrics": {
                "reference_idx": [
                    1308
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The ratCPT2 structure is unreliable for CPT1A due to #low sequence similarity# and challenges in maintaining membrane-bound enzyme activity and #protein solubility#.",
            "predicted_answer": "The crystallographic configuration of ratCPT2 is unreliable for deciphering CPT1A's architecture due to low sequence similarity and the inability to maintain CPT1A's membrane-bound activity and solubility.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer, mentioning \"low sequence similarity\" and issues with \"membrane-bound activity\" and \"protein solubility\". The meaning is consistent with the reference, with no significant omissions or errors."
        },
        {
            "query_idx": 1085,
            "query": "What divergent pathways in the architectural design of the CPT1A amino acid sequence define the transition from its frontier-like N-terminal regulatory realm to the industrious expanse of its C-terminal catalytic domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    1307
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A's #N-terminal# regulatory region (47 amino acids) transitions into the industrious #C-terminal# catalytic domain through division by two transmembrane helical regions.",
            "predicted_answer": "The divergent pathways in the architectural design of CPT1A involve the N-terminal regulatory region (47 amino acids) and the C-terminal catalytic domain, separated by two transmembrane helical regions.",
            "score": 5,
            "explanation": "The Predicted Answer contains all the key facts emphasized in the Reference Answer: the N-terminal regulatory region, C-terminal catalytic domain, and the division by two transmembrane helical regions. The meaning and details are consistent with the Reference Answer."
        },
        {
            "query_idx": 1086,
            "query": "In which elusive capacity does Gly710 contribute to the nuanced molecular choreography of succinyl-transferase dynamics within the CPT1A framework, and what abstract repercussions ensue following its mutational alteration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1311
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Gly710 is crucial for #succinyl-transferase# dynamics in CPT1A. Its mutation to G710E abolishes #carnitine palmitoyl-transferase# activity but retains succinylation, affecting molecular choreography.",
            "predicted_answer": "Gly710 in CPT1A is crucial for succinyl-transferase activity, and its mutational alteration (e.g., G710E) affects carnitine palmitoyl-transferase activity while maintaining succinylation.",
            "score": 3,
            "explanation": "The predicted answer mentions the importance of Gly710 in succinyl-transferase, aligning with the reference. However, it inaccurately states that CPT1A activity is maintained, while the reference notes it is abolished. This discrepancy, regarding #carnitine palmitoyl-transferase# activity, impacts completeness."
        },
        {
            "query_idx": 1087,
            "query": "What emblematic sequences residing within the CPT1A TM2 helix serve as metaphoric linchpins, essential for the assembly into its complex oligomeric structure?",
            "retrieved_metrics": {
                "reference_idx": [
                    1310
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #GXXXG# and #GXXXA# motifs in the CPT1A TM2 helix are essential for its oligomeric structure assembly.",
            "predicted_answer": "The emblematic sequences GXXXG and GXXXA motifs in the CPT1A TM2 helix are essential for its oligomerization, serving as metaphoric linchpins for assembly into its complex oligomeric structure.",
            "score": 5,
            "explanation": "The predicted answer captures both key motifs, #GXXXG# and #GXXXA#, mentioned in the reference answer, aligning fully with the essential details required for oligomeric structure assembly. The overall trend and emphasis on their essential role are preserved, with no omissions or contradictions."
        },
        {
            "query_idx": 1088,
            "query": "Considering the molecular tapestry that CPT1A weaves, what role does the transformative dance between its tripartite and hexapartite constructs play in altering its receptive threshold to malonyl-CoA, within the broader biochemical ensemble it participates in?",
            "retrieved_metrics": {
                "reference_idx": [
                    1309
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #trimer-hexamer transition# in CPT1A may influence its #sensitivity to malonyl-CoA# within the fatty acid transfer complex in the mitochondrial outer membrane.",
            "predicted_answer": "The transformative dance between CPT1A's tripartite and hexapartite constructs influences its sensitivity to malonyl-CoA, potentially altering its receptive threshold within the fatty acid transfer complex in the mitochondrial outer membrane.",
            "score": 5,
            "explanation": "The predicted answer captures the core idea of the \"trimer-hexamer transition\" as \"transformative dance\" and acknowledges the change in \"sensitivity to malonyl-CoA,\" consistent with the reference. No contradictory information is present, and the meaning aligns with key details emphasized."
        },
        {
            "query_idx": 1089,
            "query": "How does CPT1A, as a biochemical maestro, regulate the nuanced succinylation symphony of enolase 1 and S100A10 in threading the narrative of cancer's escalating tale?",
            "retrieved_metrics": {
                "reference_idx": [
                    1312
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A #modulates succinylation# of enolase 1 to enhance breast cancer growth and S100A10 to facilitate gastric cancer spread, threading the narrative of #cancer progression#.",
            "predicted_answer": "CPT1A regulates the succinylation of enolase 1 to promote breast cancer growth and S100A10 to facilitate gastric cancer spread, influencing cancer progression.",
            "score": 5,
            "explanation": "The Predicted Answer captures the key components emphasized in the Reference Answer: CPT1A's role in \"succinylation\" and \"cancer progression\" related to enolase 1 and S100A10. The language differs slightly, but all essential facts and trends are accurately maintained."
        },
        {
            "query_idx": 1090,
            "query": "In what manner does the synergistic interplay between the molecular maestros PGC-1α and PPARα orchestrate the transcriptional ballet of CPT1A amidst the varied hormonal environs of hepatic tissues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1314
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic interplay# of PGC-1α and PPARα enhances CPT1A expression, modulating its transcription in the hepatic #hormonal environs#.",
            "predicted_answer": "PGC-1α and PPARα synergistically enhance CPT1A expression in hepatic tissues by acting as transcriptional coactivators, modulated by hormonal signals and AMPK activation.",
            "score": 5,
            "explanation": "The predicted answer captures the #synergistic interplay# of PGC-1α and PPARα in enhancing CPT1A expression in hepatic tissues, which is the key fact. Additionally, it references #hormonal signals#, though with added details about AMPK activation; there are no contradictions or omissions."
        },
        {
            "query_idx": 1091,
            "query": "What distinct sequence elements are fundamentally woven within the portion residing in the mitochondrial intermembrane expanse of the CPT1A enzymatic structure?",
            "retrieved_metrics": {
                "reference_idx": [
                    1313
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #mitochondrial intermembrane domain# of CPT1A encompasses residues #74-102#.",
            "predicted_answer": "The distinct sequence elements in the mitochondrial intermembrane expanse of CPT1A include residues 74-102, which form the intermembrane domain.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key elements mentioned in the Reference Answer: the \"mitochondrial intermembrane domain\" and the specific residues \"74-102.\" The meaning and key facts are consistent, with no significant omissions, thus fully reflecting the emphasized information."
        },
        {
            "query_idx": 1092,
            "query": "In what elaborate choreography does the conductor insulin craft a symphony with malonyl-CoA sensitivity, harmonizing CPT1A's modulation of fatty acid metamorphosis and gluconeogenic music to maintain the orchestral equilibrium of blood glucose levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1316
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Insulin #lowers# CPT1A expression, enhancing #malonyl-CoA# sensitivity, to modulate fatty acid oxidation and gluconeogenesis, thus maintaining blood glucose equilibrium.",
            "predicted_answer": "Insulin modulates CPT1A expression and sensitivity to malonyl-CoA, limiting fatty acid oxidation and gluconeogenesis to regulate blood glucose levels.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference in describing insulin's role with CPT1A in relation to malonyl-CoA sensitivity, fatty acid oxidation, and blood glucose regulation. However, it omits that insulin specifically \"lowers\" CPT1A expression and increases malonyl-CoA sensitivity, missing these key facts."
        },
        {
            "query_idx": 1093,
            "query": "What role does the hormonic catalyst thyroxine play in the transcriptional crescendo and subsequent protein manifestation of CPT1A within the hepatic biochemical landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    1317
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The hormone #thyroxine# increases #CPT1A# expression in the liver by interacting with thyroid response elements (TRE) and upregulating PGC-1α mRNA and protein levels in hepatocytes.",
            "predicted_answer": "Thyroxine enhances CPT1A transcription and protein expression in the liver by interacting with thyroid response elements and upregulating PGC-1α, thereby increasing CPT1A mRNA and protein levels.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts: the hormone thyroxine, CPT1A expression, interaction with thyroid response elements, and upregulation of PGC-1α. The predicted answer maintains consistency with the reference answer, missing no key details and follows the overall trend."
        },
        {
            "query_idx": 1094,
            "query": "In the intricate realm of genetic deviations within mitochondrial fuel-oxidation pathways, what are the defining temporal manifestations, rhythmic reappearing tendencies, and life-terminating potentialities that characterize the phenomenon of CPT1A deficiency?",
            "retrieved_metrics": {
                "reference_idx": [
                    1320
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A deficiency is characterized by #rapid onset#, frequent recurrence, and #high mortality#, causing illnesses like hepatic encephalopathy and recurrent hypoglycemia.",
            "predicted_answer": "CPT1A deficiency manifests with rapid onset, frequent recurrence, and high mortality, affecting liver and brain functions, leading to hypoglycemia and hyperammonemia.",
            "score": 3,
            "explanation": "The predicted answer includes all the key facts: rapid onset, frequent recurrence, and high mortality, consistent with the reference. It mentions hypoglycemia as a condition, aligning with the reference trend, but does not specifically mention hepatic encephalopathy. This omission slightly impacts completeness."
        },
        {
            "query_idx": 1095,
            "query": "- What are the dual manifestations of genetic sequence deviations within the molecular dynamic of CPT1A, distinguishing those alterations integral to the catalytic locus's operational disruption from those perturbing the macromolecular equilibrium, thereby indirectly influencing enzymatic efficacy?",
            "retrieved_metrics": {
                "reference_idx": [
                    1321
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Type one mutations #directly affect# the catalytic center causing activity loss, while type two mutations #affect stability# and indirectly decrease catalytic efficiency.",
            "predicted_answer": "The dual manifestations of genetic sequence deviations in CPT1A include direct alterations to the catalytic locus, causing operational disruption, and indirect alterations affecting macromolecular equilibrium, thereby perturbing enzymatic efficacy.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference answer by identifying two types of deviations: those affecting the catalytic locus (directly affecting activity) and those impacting macromolecular equilibrium (affecting stability). However, it does not specifically mention \"affect stability.\""
        },
        {
            "query_idx": 1096,
            "query": "What envisioned methodologies of metabolic intervention might be invoked to restore equilibrium in renal proton conductance amidst the enigmatic backdrop of CPT1A catalytic disturbance, in the absence of targeted pharmaceutic solutions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1322
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Metabolic intervention might include #diet control# and treatment with #medium chain triglyceride# to restore equilibrium in renal proton conductance for CPT1A deficiency.",
            "predicted_answer": "Diet control, including medium chain triglyceride supplementation, can improve renal proton conductance in CPT1A deficiency, as there are no targeted pharmaceutic solutions.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts highlighted with # in the Reference Answer: \"diet control\" and \"medium chain triglyceride\" supplementation. The information aligns well without any contradictions, maintaining the essence and accuracy of the reference response."
        },
        {
            "query_idx": 1097,
            "query": "What orchestrative approach within the realm of corrective biological symphonies can be posited to potentially alleviate the complex weave of renal scarring through the meticulous modulation of the CPT1A biochemical sonata?",
            "retrieved_metrics": {
                "reference_idx": [
                    1325
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modulating the #CPT1A gain of function# could potentially alleviate renal scarring by improving mitochondrial function, thus reducing #renal fibrosis#.",
            "predicted_answer": "The orchestrative approach of conditional overexpression or gain of function in CPT1A may alleviate renal scarring by modulating mitochondrial dysfunction and reducing fibrosis.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by acknowledging the modulation of CPT1A gain of function and its role in alleviating renal scarring through improved mitochondrial function. It mentions reducing fibrosis, which corresponds to 'renal fibrosis', covering all key facts and trends."
        },
        {
            "query_idx": 1098,
            "query": "In the complex arena of prostate cancer cell metabolism, what pivotal function is attributed to CPT1A as it modulates the dynamic interplay between the acceleration of cellular expansion and the conduct of their developmental progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    1324
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A modulates #prostate cancer# cell proliferation and differentiation by influencing metabolic reprogramming, impacting cellular expansion and developmental progression.",
            "predicted_answer": "CPT1A modulates prostate cancer cell metabolism by influencing fatty acid oxidation, which supports cellular expansion and developmental progression through NADH, NADPH, FADH2, and ATP production.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the overall role of CPT1A in prostate cancer cell metabolism, addressing both cellular expansion and developmental progression. It mentions fatty acid oxidation and consequential energy production, aligning with the reference's emphasis on modulation through metabolic reprogramming. No significant key fact is missing."
        },
        {
            "query_idx": 1099,
            "query": "What enigmatic function does elevated expression of CPT1A undertake in guiding the molecular choreography that modulates immune interactions and enhances treatment resilience in the turbulent arena of GBM tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1335
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Elevated #CPT1A# expression #enhances immune escape# in GBM tumors by increasing CD47 expression, thus reducing macrophage phagocytosis and contributing to treatment resistance.",
            "predicted_answer": "Elevated CPT1A expression in GBM tumors enhances radiotherapy resistance and immune escape via CD47, suggesting it as a target to improve treatment resilience.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of elevated CPT1A expression enhancing immune escape and treatment resistance in GBM tumors. It mentions the role of CD47, aligning with the reference’s context. However, it omits the detail about reducing macrophage phagocytosis. Thus, one key fact is missing."
        },
        {
            "query_idx": 1100,
            "query": "What are the implications of etomoxir-induced modulation on the intricate energy transmutation pathways in glioblastoma cells exhibiting resistance climates following radiotherapeutic intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    1336
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Etomoxir inhibits #OCR# and #ATP production#, indicating energy conversion shifts from glycolysis to FAO in radiotherapy-resistant glioblastoma cells.",
            "predicted_answer": "Etomoxir-induced modulation inhibits energy conversion from glycolysis to fatty acid oxidation (FAO) in radio-resistant glioblastoma cells, reducing ATP production and potentially enhancing radiotherapeutic efficacy.",
            "score": 3,
            "explanation": "The predicted answer covers key facts from the reference, including the inhibition of energy conversion and reduced ATP production. However, it doesn't mention the specific inhibition of #OCR#, which is important. The trend aligns but lacks this detail."
        },
        {
            "query_idx": 1101,
            "query": "What are the consequences of perturbing CPT1A's regulatory influence within the biochemical symphony of nucleotide precursor dynamics, and how do these effects meld with the temporal checkpoints characterizing NPC cell proliferation phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1341
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Perturbing CPT1A's influence depletes #aspartic acid# and dNTP, impairing dNTP synthesis and blocking NPC cell proliferation at the #G1/S transition#, suggesting a lipid metabolism-based treatment strategy.",
            "predicted_answer": "Perturbing CPT1A depletes aspartic acid and dNTPs, impairing de novo synthesis and DNA replication at G1/S transition, affecting NPC cell proliferation. This aligns with temporal checkpoints, suggesting a potential treatment strategy for NPC via lipid metabolism regulation.",
            "score": 5,
            "explanation": "The Predicted Answer effectively covers the key points emphasized with # in the Reference Answer. It mentions the depletion of #aspartic acid# and dNTPs, impacts on the G1/S transition, and aligns with a potential treatment strategy related to lipid metabolism. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1102,
            "query": "What intrinsic molecular dynamics enable etomoxir and TDGA to intricately interface with the catalytic epicenter of CPT1A, orchestrating their role as inhibitors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1343
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Etomoxir and #TDGA# are ethylene oxide compounds that bind to the #active site# of CPT1A, enabling their inhibitory effects.",
            "predicted_answer": "Etomoxir and TDGA interface with CPT1A's catalytic epicenter through their ethylene oxide structure, binding to the active site to inhibit enzyme activity.",
            "score": 5,
            "explanation": "The predicted answer mentions that etomoxir and TDGA bind to the active site of CPT1A, covering the key facts of TDGA and the active site. Both answers indicate their role as inhibitors through their ethylene oxide structure. No significant omissions or errors are found."
        },
        {
            "query_idx": 1103,
            "query": "How does the nuanced orchestration of biochemical specificity in ST1326 provide a superior level of selective engagement in contrast to etomoxir, particularly with respect to the finely tuned molecular symphony of hepatic enzyme modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1344
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ST1326 provides superior #selective engagement# by specifically inhibiting liver #CPT1A#, unlike etomoxir which also affects CPT1B, ensuring precise hepatic enzyme modulation.",
            "predicted_answer": "ST1326 provides superior selective engagement over etomoxir by specifically targeting liver CPT1A, whereas etomoxir also inhibits CPT1B, leading to a more finely tuned hepatic enzyme modulation.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference: #selective engagement#, #CPT1A#, and enzyme modulation, while distinguishing between the impact on #CPT1B# similar to the reference description. The meaning and details are consistent, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1104,
            "query": "In what manner does C75's embodiment of a metabolic duality, functioning simultaneously as both an invigorator and suppressor within the intricate interplay of CPT1A activity, cast a shadow over its potential as a viable candidate in the pharmacological arena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1345
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "C75's dual roles as a #stimulant# and #inhibitor# of CPT1A complicate its pharmacological viability, raising concerns about its consistent effectiveness and safety in treatments.",
            "predicted_answer": "C75's dual role as both a CPT1A stimulator and inhibitor complicates its pharmacological potential, as it may lead to inconsistent metabolic effects and therapeutic outcomes.",
            "score": 5,
            "explanation": "The predicted answer addresses C75's dual role as a CPT1A stimulator and inhibitor, mirroring the reference's emphasis on it being both a stimulant and inhibitor. While phrasing differs slightly, the key facts and overall concern regarding pharmacological potential are captured, with no major omissions or contradictions."
        },
        {
            "query_idx": 1105,
            "query": "How does the orchestrated modulation of molecular dynamics by CPT1A, through its interaction with the biochemical entity S100A10, influence the various stages of the oncogenic cascade in gastric tissue?",
            "retrieved_metrics": {
                "reference_idx": [
                    1339
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CPT1A-mediated #succinylation# of #S100A10# promotes gastric cancer progression by influencing the oncogenic cascade stages in gastric tissue.",
            "predicted_answer": "CPT1A modulates the oncogenic cascade in gastric tissue by succinylating S100A10 at lysine 47, promoting gastric cancer progression. This interaction is regulated by CPT1A-mediated succinylation and SIRT5-mediated desuccinylation.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: CPT1A-mediated succinylation and the involvement of S100A10, aligning with the reference. The mention of lysine 47 adds specificity, not contradiction. Both answers focus on promoting gastric cancer progression, maintaining consistency with the reference."
        },
        {
            "query_idx": 1106,
            "query": "In what manner could a strategic arrangement manifest to circumnavigate the complex landscape of perhexiline-induced adverse outcomes resultant from isoform incongruities, while maintaining efficacy in the realm of CPT1A-targeted therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1346
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A strategic arrangement could manifest by enhancing #isoform selectivity#, thereby reducing perhexiline-induced adverse outcomes while maintaining efficacy in #CPT1A-targeted# therapeutic interventions.",
            "predicted_answer": "A strategic arrangement could manifest by designing isoform-selective CPT1A inhibitors to avoid perhexiline-induced adverse outcomes, ensuring efficacy while minimizing toxicity.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by emphasizing the design of isoform-selective inhibitors to avoid adverse outcomes, maintaining efficacy in CPT1A-targeted interventions. Both key facts of isoform selectivity and CPT1A-targeting are present, with no significant omissions or errors."
        },
        {
            "query_idx": 1107,
            "query": "What intricate dynamics characterize the engagement of SRSF3 in the sophisticated orchestration of molecular splicing processes, determining the isoform diversification of B7-H3 within human and murine systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1353
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "SRSF3 splicing factor engages in isoform diversification of B7-H3 by #binding# directly to exon 4 and/or 6, influencing the #molecular splicing# processes in humans and mice.",
            "predicted_answer": "SRSF3 engages in molecular splicing by binding to B7-H3 exons 4 and 6, influencing isoform diversification, with human B7-H3 having two isoforms and murine B7-H3 having one.",
            "score": 5,
            "explanation": "The predicted answer mentions SRSF3 binding to exons 4 and 6, aligning with the reference's emphasis on \"#binding# directly to exon 4 and/or 6\" and influencing \"#molecular splicing#\". The general meaning is consistent, though linguistic differences exist. No significant facts are omitted, and trends align."
        },
        {
            "query_idx": 1108,
            "query": "In what capacity does the dynamic interplay within the p38 MAPK-eIF4E molecular circuitry orchestrate an upregulation of B7-H3's genetic transcriptional architecture in the varied landscape of malignant cellular constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1357
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #p38 MAPK-eIF4E# signaling axis serves as a key regulator of transcription initiation and protein expression of #B7-H3# in tumor cells.",
            "predicted_answer": "The dynamic interplay within the p38 MAPK-eIF4E molecular circuitry upregulates B7-H3's genetic transcriptional architecture by enhancing transcription initiation and protein expression in malignant cellular constructs.",
            "score": 5,
            "explanation": "The predicted answer captures the role of the p38 MAPK-eIF4E axis in regulating transcription initiation and protein expression of B7-H3 in malignant cells. It aligns well with the reference answer and does not miss significant key facts or include contradictions."
        },
        {
            "query_idx": 1109,
            "query": "Within the molecular symphony of cellular architecture, what role do the microRNA conductors—namely microRNA-199a, miR-128, and microRNA-187—play in the nuanced regulatory performance affecting the translation of B7-H3's protein expression amidst the dynamic landscape of neoplastic cellular matrices?",
            "retrieved_metrics": {
                "reference_idx": [
                    1356
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MicroRNA-199a, miR-128, and microRNA-187 regulate #B7-H3# protein expression in #cancer# by directly binding to its mRNA's 3' UTR.",
            "predicted_answer": "MicroRNA-199a, miR-128, and microRNA-187 regulate B7-H3 protein expression in cancer cells by binding to its 3' UTR, influencing post-transcriptional regulation.",
            "score": 5,
            "explanation": "The predicted answer correctly mentions that microRNA-199a, miR-128, and microRNA-187 regulate B7-H3 protein expression in cancer cells by binding to the 3' UTR, aligning with the reference's key details. All emphasized facts are present without contradiction."
        },
        {
            "query_idx": 1110,
            "query": "Within the complex interplay of immune system constituents, what role do the dual Ig and quadruple IgVCVC configurations of the B7-H3 entity perform in conducting the nuanced choreography of T cell behavior, particularly in terms of the restraint on cellular expansion and the modulation of cytokine synthesis?",
            "retrieved_metrics": {
                "reference_idx": [
                    1360
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #2Ig VC# and #4Ig VCVC# forms of B7-H3 inhibit T cell proliferation and downregulate cytokine production.",
            "predicted_answer": "The dual Ig (2Ig VC) and quadruple IgVCVC (4Ig VCVC) configurations of B7-H3 inhibit T cell proliferation and downregulate cytokine production, thereby modulating T cell behavior and restraining cellular expansion.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts \"#2Ig VC#\" and \"#4Ig VCVC#\" from the Reference Answer, as well as their role in inhibiting T cell proliferation and downregulating cytokine production. The information is consistent with the Reference Answer, with no significant omissions or errors."
        },
        {
            "query_idx": 1111,
            "query": "What is the nature of the keystone dynamics enacted by B7-H3 within the perpetual renewal systems of progenitorial malignant entities, fostering a robust array of biological fortifications against clinical interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1367
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "B7-H3 contributes to self-renewal in cancer stem cells, fostering #therapeutic resistance# and enhancing #biological fortifications# against clinical interventions.",
            "predicted_answer": "B7-H3 fosters therapeutic resistance in cancer stem cells, enhancing their self-renewal and differentiation capabilities, thereby strengthening biological defenses against clinical interventions.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts emphasized in the Reference Answer: #therapeutic resistance# and #biological fortifications#. Both the self-renewal mention and alignment in overall narrative are consistent with the Reference Answer, ensuring no key detail is missed."
        },
        {
            "query_idx": 1112,
            "query": "Which inherent tactical feature of CSCs facilitates their ability to evade immunological detection, consequently amplifying the potential for neoplastic spread, resistance to medical interventions, and deteriorating clinical outcomes as elucidated in the context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1368
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CSCs# use immunomodulatory strategies to evade #immune# detection, leading to metastasis, treatment failure, and unfavorable outcomes.",
            "predicted_answer": "The inherent tactical feature of CSCs that facilitates their ability to evade immunological detection is their immunomodulatory strategies, which protect them against immune monitoring and eradication, leading to metastasis, treatment failure, recurrence, and unfavorable patient outcomes.",
            "score": 5,
            "explanation": "The predicted answer includes key points: CSCs, immunomodulatory strategies, immune detection evasion, metastasis, treatment failure, and unfavorable outcomes. It adds detail by mentioning recurrence, but this does not contradict the reference. All supporting facts are included, maintaining alignment with the reference."
        },
        {
            "query_idx": 1113,
            "query": "How did the strategic downregulation of the cryptic regulatory entity B7-H3 reshape the developmental trajectory of precursor lipid-matrix architects, and what intricate cascade of metabolic deviations was orchestrated in the environmental narrative of the investigative study?",
            "retrieved_metrics": {
                "reference_idx": [
                    1374
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #downregulation# of B7-H3 led to reduced glucose and oxidative metabolism, impaired mitochondrial function, increased lipid storage, and spontaneous obesity, affecting #metabolic# and immune homeostasis.",
            "predicted_answer": "The strategic downregulation of B7-H3 in precursor lipid-matrix architects led to impaired mitochondrial function, increased lipid storage, and spontaneous obesity, reshaping their developmental trajectory. This triggered a cascade of metabolic deviations, including reduced glucose and oxidative metabolism, and diminished regulatory control on metabolic and immune homeostasis.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference: #downregulation# of B7-H3, leading to reduced glucose and oxidative metabolism, impaired mitochondrial function, increased lipid storage, and spontaneous obesity, resulting in metabolic deviations affecting #metabolic# and immune homeostasis. There are no omissions or contradictions."
        },
        {
            "query_idx": 1114,
            "query": "In the context of post-translational structural metamorphoses, how might the nuanced alterations of B7-H3's molecular architecture modulate its intricate interplay and potential contribution within the pathophysiological tapestries of both type I diabetes, characterized by immune system interactions, and type II diabetes, marked by metabolic challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    1375
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Post-translational modifications of #B7-H3# potentially influence its #immunoregulatory role# in type I diabetes and contribute to metabolic processes in type II diabetes.",
            "predicted_answer": "Post-translational modifications of B7-H3 could modulate its immunoregulatory role in type I diabetes and influence obesity and insulin resistance in type II diabetes, potentially affecting both immune and metabolic pathways.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of B7-H3's role in the immunoregulatory aspect in type I diabetes and its metabolic influence in type II diabetes. It aligns with the reference answer but lacks the explicit mention of \"metabolic processes\" in type II diabetes, slightly affecting completeness."
        },
        {
            "query_idx": 1115,
            "query": "How does the microbial integration of H. pylori within the gastric cellular landscapes choreograph the nuanced expression shifts of B7-H3, and what are the underlying pathways mediating this cellular modulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1378
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "H. pylori infection increases #B7-H3# expression in gastric cells via #T4SS# and p38MAPK pathways, alongside increased Th17, Treg, and mixed Th1/Th2 responses.",
            "predicted_answer": "H. pylori infection increases B7-H3 expression on gastric epithelial cells via the type 4 secretion system (T4SS), involving CagA and peptidoglycan signaling. The p38MAPK pathway is modulated, and Th17, Treg, and mixed Th1/Th2 responses are enhanced.",
            "score": 5,
            "explanation": "The key facts of \"B7-H3\" expression, \"T4SS\", Th17, Treg, and Th1/Th2 responses are present in the predicted answer. The predicted answer also mentions the p38MAPK pathway and CagA/peptidoglycan signaling, aligning closely with the reference. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1116,
            "query": "What conundrum emerges from recent scientific elucidations that contradicts the hypothesized epitopic function of TLT-2 as a mediator in B7-H3 associated co-stimulation of T lymphocytes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1380
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The conundrum is that #TLT-2# does not #bind# human B7-H3, contradicting its hypothesized role in B7-H3 co-stimulation of T lymphocytes.",
            "predicted_answer": "The conundrum is that TLT-2 was hypothesized to mediate B7-H3-associated co-stimulation of T lymphocytes, but recent studies show it does not bind B7-H3 and does not serve as a costimulatory receptor for it.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key points emphasized in the reference answer: #TLT-2# and #bind#. It mentions TLT-2 does not bind B7-H3 and clarifies that TLT-2 does not act as a costimulatory receptor. The information aligns with the reference and is complete."
        },
        {
            "query_idx": 1117,
            "query": "How does the biochemical conduit of N-glycosylation serve as an essential thread in the tapestry of B7-H3's functional narrative within the dynamic landscape of triple-negative breast cancer, particularly in harmonizing the energetic equilibrium maintenance structures central to immunosuppressive capacities on the cellular battleground?",
            "retrieved_metrics": {
                "reference_idx": [
                    1376
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #N-glycosylation# of B7-H3 is essential for its protein stability, cell surface expression, and #immunosuppressive function#, crucial in triple-negative breast cancer progression.",
            "predicted_answer": "N-glycosylation of B7-H3 enhances its stability and immunosuppressive function in triple-negative breast cancer, contributing to cancer progression and poor patient survival.",
            "score": 3,
            "explanation": "The predicted answer captures key elements like the role of N-glycosylation in B7-H3's stability and immunosuppressive function. However, it omits details about cell surface expression. Thus, it reflects the overall trend but lacks one key fact from the reference."
        },
        {
            "query_idx": 1118,
            "query": "What are the complex mechanistic insights, as revealed in the contextual narrative, that describe how the molecular beacon termed IL-20RA fortifies the defense of breast cancer cells against the insurgence of chemotherapeutic forces?",
            "retrieved_metrics": {
                "reference_idx": [
                    1383
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "IL-20RA enhances breast cancer cell defense against chemotherapy by promoting #stemness# and upregulating PD-L1 through the JAK1-STAT3-SOX2 pathway, which compromises anticancer immune cell activity.",
            "predicted_answer": "IL-20RA fortifies breast cancer cell defense by promoting chemoresistance through the JAK1-STAT3-SOX2 pathway and upregulating PD-L1 to compromise immune activity.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts that IL-20RA promotes chemoresistance and involves the JAK1-STAT3-SOX2 pathway, along with the upregulation of PD-L1. However, it misses the key fact of promoting #stemness#, emphasizing a significant aspect of the defense mechanism."
        },
        {
            "query_idx": 1119,
            "query": "What enigmatic barrier veils the progression towards authoritatively sanctioned treatments targeting the B7-H3 pathway in oncological contexts, hindering therapeutic advancement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1386
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic barrier is the #lack# of a known receptor for #B7-H3#, hindering pharmacological targeting and therapeutic advancement in oncology.",
            "predicted_answer": "The enigmatic barrier is the lack of a known receptor for B7-H3, making it difficult to target pharmacologically. Discovery of the receptor could accelerate drug development.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the lack of a known receptor for B7-H3 as the enigmatic barrier, consistent with the key facts emphasized in the reference answer. It further adds that receptor discovery could accelerate drug development, aligning with the overall trend without contradictions."
        },
        {
            "query_idx": 1120,
            "query": "What multifaceted biochemical nuances, acting within the harmonized cascade of the Wnt/β-catenin axis, serve to thwart the degradation orchestration of β-catenin, thereby weaving into the complex tapestry of colorectal cancer emergence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1391
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Increased secretion of #Wnt ligand proteins# prevents intracellular #degradation of β-catenin# by APC, Axin, GSK-3 complex, contributing to colorectal cancer emergence.",
            "predicted_answer": "The multifaceted biochemical nuances include increased Wnt ligand secretion, which enhances interaction with cell surface receptors, leading to the failure of β-catenin degradation by the APC/Axin/GSK-3 complex. This accumulation of β-catenin in the nucleus promotes transcription of genes involved in colorectal cancer development.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as increased Wnt ligand secretion and prevention of β-catenin degradation by the APC/Axin/GSK-3 complex, aligning with the reference answer. It captures the overall trend of facilitating β-catenin accumulation leading to cancer, without contradictions."
        },
        {
            "query_idx": 1121,
            "query": "What are the fundamental complexities and the intertwining lattice of restrictions that define the process of architecting organoidal constructs as pertained to the ever-evolving extracellular matrix framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1398
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fundamental complexities include #high cost# and #poor controllability# of the extracellular matrix, along with a complex specific composition and application limitations.",
            "predicted_answer": "The fundamental complexities of architecting organoidal constructs include high costs, complex specific composition, poor controllability, and limitations in application within the evolving extracellular matrix framework.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts emphasized in the Reference Answer: high cost, poor controllability, complex specific composition, and application limitations. The information is consistent and aligned with the Reference Answer, with no significant omissions or contradictory information."
        },
        {
            "query_idx": 1122,
            "query": "In the intricate dance of genetic symphony, what role do molecular anomalies akin to APC and TP53 mutations play, when entwined with BRAF V600E mutant organoids, in orchestrating the modulation of the ERK/MAPK pathway's activity and shaping the dynamic growth patterns of colorectal neoplastic aggregations within their shared cocultural milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1410
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular anomalies like #APC# deletion and #TP53# mutation reduce ERK/MAPK pathway activity, improving growth in BRAF V600E mutant organoids within the colorectal neoplastic coculture environment.",
            "predicted_answer": "APC and TP53 mutations, when combined with BRAF V600E mutant organoids, reduce ERK/MAPK pathway activity, influencing colorectal neoplastic growth and proliferation.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference in stating that APC and TP53 mutations affect ERK/MAPK activity and colorectal neoplastic growth, but it misses the detail that APC mutation is specifically a deletion and that this alteration improves growth in the specific cocultural environment."
        },
        {
            "query_idx": 1123,
            "query": "Within the multifaceted arena of preclinical investigative platforms, what intricate roles do the contextual dimensions undertake in shaping the disparate pharmacological outcomes observed with 5-fluorouracil and AZD8931 interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1416
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Contextual dimensions influence drug response disparities for #5-fluorouracil# and #AZD8931# by varying preclinical model environments and colorectal carcinogenesis mechanisms.",
            "predicted_answer": "The contextual dimensions in preclinical models influence the disparate pharmacological outcomes of 5-fluorouracil and AZD8931 by affecting drug sensitivity and resistance, particularly through variations in the RAS/RAF pathway and the environment of the model.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts about 5-fluorouracil and AZD8931. It aligns with the reference answer by addressing the influence of contextual dimensions, particularly in terms of drug sensitivity and model environment. However, it omits specifics on colorectal carcinogenesis mechanisms, making it incomplete."
        },
        {
            "query_idx": 1124,
            "query": "In the intricate ballet of colorectal cellular dynamics, what nuanced influence does the synergistic employment of inhibitors disrupting the Wnt pathway in conjunction with 5-fluorouracil exert, particularly when juxtaposed against the solitary orchestration of 5-fluorouracil, in the backdrop of the cellular canvas painted by mutational choreography such as TP53 and RNF43 variations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1415
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic employment# of Wnt inhibitors with 5-fluorouracil reduces tumor re-aggregation and recurrence compared to #5-fluorouracil alone#, despite the resistance from RNF43 mutations.",
            "predicted_answer": "The synergistic use of Wnt pathway inhibitors with 5-fluorouracil reduces tumor cell re-aggregation and CRC recurrence, overcoming resistance seen with 5-fluorouracil alone, especially in TP53-mutated cases. However, RNF43 mutations can still confer resistance.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by covering the synergistic employment of Wnt inhibitors with 5-fluorouracil, their effect on reducing tumor re-aggregation, and acknowledges RNF43 mutation-related resistance. However, it missed mentioning the comparison specifically to 5-fluorouracil alone."
        },
        {
            "query_idx": 1125,
            "query": "What role do the nuanced variances within the genetic architecture of KRAS play in shaping the collaborative interaction between cetuximab and trametinib, specifically in tailoring the therapeutic response landscape for individuals navigating the complex molecular terrain of colorectal oncology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1420
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The nuanced variances within #KRAS# genetic architecture influence the collaborative interaction between cetuximab and #trametinib#, tailoring diverse and individualized therapeutic responses in colorectal oncology.",
            "predicted_answer": "The nuanced variances within the genetic architecture of KRAS influence the collaborative interaction between cetuximab and trametinib by enhancing drug response in patients benefiting from cetuximab, tailoring the therapeutic response landscape in colorectal oncology.",
            "score": 3,
            "explanation": "The predicted answer captures the role of KRAS genetic architecture and the interaction between cetuximab and trametinib in colorectal oncology. However, it focuses only on enhancing drug response for cetuximab beneficiaries, omitting the emphasis on diverse and individualized therapeutic responses."
        },
        {
            "query_idx": 1126,
            "query": "What are the multifaceted influences exerted by nivolumab as an immunological modulator on the infiltrative behavior of CD8+ cytotoxic T-lymphocytes and the transformation of programmed death-ligand 1 presentation within tumor organoids manifesting an overabundance of PD-L1?",
            "retrieved_metrics": {
                "reference_idx": [
                    1421
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Nivolumab increases #CD8+ T-cell infiltration#, decreases #PD-L1 expression#, and reduces tumor cell proliferation in PD-L1-overexpressing tumor organoids, with effects dependent on concentration.",
            "predicted_answer": "Nivolumab increases CD8+ T-cell infiltration, decreases PD-L1 expression, and reduces tumor cell proliferation in PD-L1-overexpressing tumor organoids, suggesting its potential as a PD-1 targeting agent.",
            "score": 3,
            "explanation": "The predicted answer fully covers the key facts emphasized with # symbols in the reference answer: increased CD8+ T-cell infiltration and decreased PD-L1 expression. Although it omits the concentration-dependence detail, it captures the core impact of nivolumab without contradiction."
        },
        {
            "query_idx": 1127,
            "query": "In the convoluted interplay of cellular alliances, how does the role of DKK1, conceptualized as a regulatory arbiter, modulate the tactical impact of PD-1 inhibitors, especially in the context of CRC treatment scenarios where the Wnt/β-catenin pathway is in a state of disarray?",
            "retrieved_metrics": {
                "reference_idx": [
                    1422
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DKK1 serves as a #regulatory arbiter# by inhibiting #PD-1 inhibitors#, primarily through limiting CD8+ T cell immune function and enhancing tumor cell activation in CRC with aberrant Wnt/β-catenin pathway.",
            "predicted_answer": "DKK1 modulates the impact of PD-1 inhibitors in CRC by inhibiting the Wnt/β-catenin pathway, which limits CD8+ T cell immune function and enhances tumor cell activation. Blocking DKK1 could potentially enhance PD-1 inhibitor efficacy.",
            "score": 0,
            "explanation": "The predicted answer correctly mentions DKK1's role in inhibiting the Wnt/β-catenin pathway and its impact on CD8+ T cells and tumor cell activation in CRC. However, it inaccurately states that DKK1 inhibits PD-1 inhibitors, which contradicts the reference."
        },
        {
            "query_idx": 1128,
            "query": "What were the discernible patterns and demographic transformations observed within diverse racial and ethnic garlands in the pioneering stages of phase 1 metastatic cancer treatment trials conducted across the United States, spanning the years from 2000 to the terminal echoes of 2018, as juxtaposed with established registry benchmarks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1425
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The study found discernible #patterns# of racial and ethnic diversity in phase 1 metastatic cancer trials lacking #alignment# with registry benchmarks from 2000 to 2018.",
            "predicted_answer": "The study observed that racial and ethnic minority groups were underrepresented in phase 1 metastatic cancer treatment trials from 2000 to 2018, with proportions lower than those in the Cancer in North America registry.",
            "score": 3,
            "explanation": "The predicted answer captures the lack of racial and ethnic diversity in trials compared to benchmarks, aligning with the key fact about patterns not aligning with registry data. However, it emphasizes underrepresentation without explicitly mentioning \"patterns,\" leading to a minor omission."
        },
        {
            "query_idx": 1129,
            "query": "What prognostic vision was proposed concerning the demographic tapestry featured by racial and ethnic minorities within the initial customary exploration of pharmacological advancements for metastatic cancer treatment across the United States from the year 2000 to the year 2018?",
            "retrieved_metrics": {
                "reference_idx": [
                    1427
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The prognostic vision proposed that there would be continued overrepresentation of #White# participants in early drug trials for metastatic cancer treatment from #2000 to 2018#.",
            "predicted_answer": "The prognostic vision proposed was that there would be continued overrepresentation of White participants in early drug trials for metastatic cancer treatment, despite the need for representative populations to ensure drug safety and efficacy.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of continued overrepresentation of White participants, aligning with the reference. However, it lacks the timeframe \"from 2000 to 2018,\" which slightly affects completeness but does not contradict the trends or facts provided."
        },
        {
            "query_idx": 1130,
            "query": "In what manner do the parameters of confluence delineate the integrative phases, facilitating their passage through the analytical gateway for inclusion, specifically requiring phase 1 data to emerge distinct from phase 2 narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1430
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Parameters of #confluence# require phase 1 data to be reported separately from phase 2 narratives to facilitate their integration through the #analytical gateway#.",
            "predicted_answer": "The parameters of confluence delineate integrative phases by requiring phase 1 data to be reported separately from phase 2 data, facilitating their passage through the analytical gateway for inclusion.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer. It mentions the need for phase 1 data to be reported separately from phase 2, matching the key elements of \"confluence\" and \"analytical gateway.\" All key facts are covered without omissions or contradictions."
        },
        {
            "query_idx": 1131,
            "query": "What strategic recalibrations within the intertwined frameworks of participant selection criteria might unveil entrenched biases and promote equitable demographic participation across multifaceted clinical research landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1435
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "By adjusting #inclusion/exclusion criteria# to overcome historic standards, researchers can address systemic biases and promote #equitable demographic# participation in clinical research.",
            "predicted_answer": "Strategic recalibrations in participant selection criteria should focus on addressing historical biases, improving trust, and ensuring inclusive outreach to diverse demographic groups, thereby promoting equitable participation in clinical research.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer's overall trend. It adequately covers the focus on addressing biases and promoting equitable demographic participation. However, it lacks explicit mention of the adjustment of \"inclusion/exclusion criteria\" as emphasized in the reference, affecting completeness."
        },
        {
            "query_idx": 1132,
            "query": "What portion of the explorative initiatives elucidated the spectrum of racial and ethnic representations throughout the analytical span stretching from the inception of the 21st century to eighteen years hence, within the cohort of 330 scrutinized inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1433
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Of the #330 inquiries#, #221 reported# on racial and ethnic representations from 2000 to 2018.",
            "predicted_answer": "Of the 330 scrutinized inquiries, 221 reported at least 1 race and ethnicity, representing 8309 patients, from the inception of the 21st century to eighteen years hence.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference: \"330 inquiries,\" \"221 reported,\" and the timeframe \"from the inception of the 21st century to eighteen years hence\" which matches \"from 2000 to 2018.\" Patient number details in the prediction do not contradict the reference."
        },
        {
            "query_idx": 1133,
            "query": "In the early chronicles of 2009, what watershed revelation by Sato et al. in the realm of cultivating cellular miniatures signified a breakthrough moment in the grand narrative of organoid model development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1444
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The breakthrough moment in 2009 was Sato et al.'s establishment of long-term organoid cultures from a single #ASC# (adult stem cell).",
            "predicted_answer": "Sato et al. in 2009 established long-term organoid cultures from a single intestinal stem cell (ASC), marking a breakthrough in organoid model development.",
            "score": 5,
            "explanation": "The predicted answer captures the critical detail that Sato et al. established long-term organoid cultures from a single intestinal stem cell, which aligns with the reference answer's mention of \"single #ASC# (adult stem cell).\" The information is consistent, with no significant omissions."
        },
        {
            "query_idx": 1134,
            "query": "Within the intricate realm of biomimetic landscapes, what concealed potentialities do multi-tissue-oriented organ-in-chip assemblies possess that distinctly enhance their repertoire over basic organoid models in orchestrating the replication of life's complex biological symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1447
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Multi-tissue-oriented #organ-in-chip# assemblies contain #concealed potentialities# for enhanced replication of biological interactions, over basic organoid models, through complex cellular interplay and advanced tissue replication.",
            "predicted_answer": "Multi-tissue-oriented organ-in-chip assemblies enhance replication of complex biological processes like angiogenesis and neuronal organization, better mimicking cellular interplay and tissue structure compared to basic organoid models.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by highlighting the capabilities of multi-tissue-oriented organ-in-chip assemblies over organoid models in complex biological processes. While it mentions angiogenesis and neuronal organization, it covers the concealed potentialities and advanced tissue replication aspects sufficiently."
        },
        {
            "query_idx": 1135,
            "query": "In the realm of simulated miniature ecosystems mimicking intestinal and pancreatic domains, how have metaphorical sentinels embedded at cellular barricades emerged as harbingers of preemptive immune vigilance within scholarly investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1451
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In #intestinal and pancreatic# tissue studies, #intraepithelial lymphocytes# (IELs) show cytokine signaling and lymphocyte motility, offering a preventative immunosurveillance approach.",
            "predicted_answer": "Metaphorical sentinels, such as intraepithelial lymphocytes (IELs), have emerged as preemptive immune vigilance harbingers in simulated miniature ecosystems, particularly in intestinal and pancreatic domains, demonstrating cytokine signaling and lymphocyte motility, potentially offering a preventative immunosurveillance approach.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts: \"intestinal and pancreatic\" and \"intraepithelial lymphocytes\" (IELs), as well as the details of cytokine signaling, lymphocyte motility, and preventative immunosurveillance. The meaning is consistent with no significant omissions or errors."
        },
        {
            "query_idx": 1136,
            "query": "In what manner does the intricate labyrinth of interconnected dynamics challenge the faithful illustration of intestinal maladies, particularly IBS, within PDO constructs, and how might these frameworks be deficient in encapsulating the essential cellular mosaic that governs tissue-specific mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1454
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate dynamics challenge PDO constructs in modeling IBS by missing the #microbiome-gut-brain# axis and failing to mimic #inflammatory cell# cascades and tissue-specific mechanisms.",
            "predicted_answer": "The intricate labyrinth of interconnected dynamics, including immune responses and microbiome-gut-brain axis interactions, challenges faithful illustration of intestinal maladies like IBS within PDO constructs. These frameworks may be deficient in encapsulating the essential cellular mosaic that governs tissue-specific mechanisms, particularly due to the complexity of intracellular relationships and tissue-defining processes.",
            "score": 5,
            "explanation": "The predicted answer mentions both the \"microbiome-gut-brain axis\" and \"immune responses,\" aligning with the reference's emphasis on microbiome-gut-brain axis and inflammatory cell cascades. Key facts are present, and trends are aligned fully with the reference. No significant omissions."
        },
        {
            "query_idx": 1137,
            "query": "What complex potentialities are unlocked when a compendium of RAS-mutation-associated colorectal malignancy samples is utilized within a lattice of combinatorial pharmacologic trials, in exploring the evolution of treatment methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1457
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Utilizing a #biobank# of RAS-mutant colorectal cancers in #combinatorial pharmacologic trials# enables testing thousands of drug combinations efficiently, crucial for overcoming acquired resistance.",
            "predicted_answer": "Utilizing a compendium of RAS-mutation-associated colorectal malignancy samples in combinatorial pharmacologic trials can explore treatment evolution, test combination therapies for resistance, and enable high-throughput testing of thousands of drug combinations.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of using RAS-mutant colorectal cancer samples in combinatorial trials and the ability to test thousands of drug combinations for resistance. However, it does not explicitly mention the #biobank#, which is a key component, affecting completeness."
        },
        {
            "query_idx": 1138,
            "query": "Within the framework of the experimental milieu of the OIC paradigm, how do the tailored, temporal, electro-conductive modulations upon myocardial cellular formations guide their progression towards maturity and alter their chemotherapeutic engagement dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1461
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tailored, temporal, electro-conductive modulations in the #OIC model# guide cardiomyocyte maturation and alter their #chemotherapeutic response# by identifying biokinetic influences of the tumor microenvironment.",
            "predicted_answer": "Within the OIC paradigm, tailored temporal electro-conductive modulations guide myocardial cell maturation by altering electrical stimulation, thereby influencing their response to chemotherapeutic agents.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer by addressing tailored temporal electro-conductive modulations and their effect on myocardial cell maturation and chemotherapeutic response. However, it omits the specific mention of the \"OIC model\" and \"biokinetic influences of the tumor microenvironment.\""
        },
        {
            "query_idx": 1139,
            "query": "Within the tapestry of cellular architecture, what is the fraction of experimental organoid models illustrating disruption in their duplicative threads as contrasted against those displaying unified genomic symphony accompanied by increased susceptibility to the orchestration of poly(ADP-ribose) polymerase inhibition pathway facilitation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1464
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#61%# of experimental organoid models show disruption, compared to #6%# that display a unified genomic symphony with PARPi sensitivity.",
            "predicted_answer": "The fraction of experimental organoid models with disrupted duplicative threads is 61%, compared to 6% displaying unified genomic symphony and increased PARPi sensitivity.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts emphasized in the reference answer: #61%# of organoid models show disruption, compared to #6%# with unified genomic symphony and PARPi sensitivity. All essential information is present without contradictions."
        },
        {
            "query_idx": 1140,
            "query": "What celestial pathway's gravitational influence did the interplay of tumor responses reveal, as demonstrated in Loong et al.'s everolimus treatment investigation within the PDO landscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    1463
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Loong et al.'s investigation highlighted tumors' reliance on the #PTEN pathway# using everolimus in the PDO landscape.",
            "predicted_answer": "The interplay of tumor responses in Loong et al.'s everolimus treatment investigation revealed the gravitational influence of the PTEN pathway within the PDO landscape.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the gravitational influence as the PTEN pathway, which is the key fact indicated by # in the reference answer. The overall meaning and details are consistent, with no significant omissions or contradictions present."
        },
        {
            "query_idx": 1141,
            "query": "In the intricate mosaic of therapeutic outcomes, what proportion of individuals diagnosed with esophageal carcinoma reach an absolute fruition of predefined therapeutic interventions when subjected to early-stage chemoradiotherapeutic protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    1468
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#25%# of individuals with esophageal carcinoma achieve #complete response# to early-stage chemoradiotherapeutic protocols.",
            "predicted_answer": "Approximately 25% of individuals diagnosed with esophageal carcinoma achieve a complete response to early-stage chemoradiotherapeutic protocols.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes both key facts emphasized in the Reference Answer: \"25%\" and \"complete response.\" It aligns perfectly with the Reference Answer, maintaining consistency in meaning and containing all critical details without omission."
        },
        {
            "query_idx": 1142,
            "query": "In the intricate dance of cutting-edge medicinal strategies targeting cryptic genetic mutations like EGFR and KRAS within the advanced corridors of lung cancer adversaries, what multifaceted barriers materialize, particularly when resistance festers like a shadow over the aspirational promise of molecular specificity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1471
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The multifaceted barriers include #resistance# to therapies targeting EGFR and KRAS, despite the aspirational promise of #molecular specificity# in advanced lung cancer treatment.",
            "predicted_answer": "Multifaceted barriers include resistance to EGFR and KRAS targeted therapies, severe toxicities from platinum-based chemotherapy, and the emergence of resistance to immunotherapy, complicating advanced lung cancer treatment.",
            "score": 3,
            "explanation": "The Predicted Answer mentions resistance to EGFR and KRAS targeted therapies, aligning with the Reference Answer's emphasis on #resistance#. However, it doesn't directly address #molecular specificity#, focusing instead on chemotherapy toxicities and immunotherapy resistance, which are additional but not mentioned key points in the Reference Answer."
        },
        {
            "query_idx": 1143,
            "query": "In the expansive realm of today's medical endeavors, what is the underlying influence of harnessing the inherent biological mosaic of a patient's own tissue in charting groundbreaking pathways within the domains of pharmaceutical evolution and bespoke medical strategies, according to the outlined context?",
            "retrieved_metrics": {
                "reference_idx": [
                    1470
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harnessing a patient's #own tissue# data aids #drug development# and personalized medicine by improving preclinical efficiency and therapeutic accuracy, making oncology more affordable and effective.",
            "predicted_answer": "Harnessing a patient's own tissue enhances drug development and personalized medicine by improving preclinical efficiency and therapeutic accuracy, making oncology more effective and affordable.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer. It includes key facts such as utilizing a patient's own tissue, drug development, and personalized medicine, and emphasizes improving preclinical efficiency and therapeutic accuracy for more effective and affordable oncology. There are no significant omissions."
        },
        {
            "query_idx": 1144,
            "query": "What interplay of foundational biological structures and experimental methodologies culminates in the augmented realization of oncogenic graft establishment when employing site-specific consonance or circulatory inclusion versus the epidermal embedding approach within PDX model paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1475
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orthotopic grating or circulatory injection in PDX models has a higher success rate (#30-40%#) for oncogenic graft establishment compared to #subcutaneous grafting#.",
            "predicted_answer": "The interplay involves using orthotopic grafting or circulatory injection, which have higher success rates (30-40%) compared to epidermal embedding in PDX models, leading to better oncogenic graft establishment.",
            "score": 3,
            "explanation": "The predicted answer includes the emphasized key fact of \"30-40%\" success rates, aligning with the trend of improved outcomes using orthotopic or circulatory grafting methods. However, it omits the detail of \"subcutaneous grafting,\" a key comparison point, impacting completeness."
        },
        {
            "query_idx": 1145,
            "query": "What latent proficiencies do genetically stylized mouse models exhibit over the fleeting imitative frameworks of xenograft embodiments in deciphering the dimensional complexities of human oncological phenomena within an immunocompetent continuum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1477
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Genetically engineered mouse models (#GEMMs#) excel at replicating human tumor #genetic characteristics# and allow detailed study in immunocompetent environments, unlike xenograft models.",
            "predicted_answer": "Genetically engineered mouse models (GEMMs) exhibit superior proficiency over xenograft models by accurately reflecting human tumor genetics and immune interactions in immunocompetent environments.",
            "score": 5,
            "explanation": "The predicted answer includes all key details: the term \"GEMMs\" and the ability to reflect human tumor \"genetic characteristics\" within an \"immunocompetent environment.\" There are no significant omissions or errors, and the overall meaning aligns with the reference answer."
        },
        {
            "query_idx": 1146,
            "query": "What are the systemic characteristics that differentiate the architectural fidelity and functional mimicry found in the cellular compositions of tumoroids, as opposed to the structural representations inherent in spheroids and the biological reflections articulated within organoids, when considered through the lens of 3D lung cancer emulation models?",
            "retrieved_metrics": {
                "reference_idx": [
                    1480
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumoroids #mimic native tumors# in both architecture and function, unlike #spheroids#, which focus more on structure and less on functionality compared to organoids.",
            "predicted_answer": "Tumoroids mimic tumor functionality, organoids reflect biological functions, and spheroids focus on structural representation.",
            "score": 3,
            "explanation": "The predicted answer captures that tumoroids mimic tumor functionality but misses the key detail of architectural mimicry. It does mention that spheroids focus on structure, aligning with the reference but lacks completeness by not contrasting spheroids' functionality relative to organoids."
        },
        {
            "query_idx": 1147,
            "query": "What intrinsic and extrinsic cellular influences, decoded through advanced biomolecular scrutiny, can be perceived as the harbingers of therapeutic resilience observed within the metastatic pulmonary neoplasms when orchestrated in a microengineered multi-system environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1485
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intrinsic influences of #metastatic# resilience include increased #DNA replication# and glutathione metabolism, identified through proteomics in lung cancer cells within a microengineered system.",
            "predicted_answer": "Intrinsic influences include increased DNA replication and glutathione metabolism, while extrinsic factors involve microengineered multi-system environments. These influences, decoded through proteomic and transcriptomic analysis, contribute to therapeutic resilience in metastatic pulmonary neoplasms.",
            "score": 1,
            "explanation": "The predicted answer includes intrinsic influences like increased DNA replication and glutathione metabolism, aligning with the reference. However, it misses the specific emphasis on \"metastatic\" resilience and mention of \"lung cancer cells.\" Therefore, it lacks completeness by omitting these two key facts."
        },
        {
            "query_idx": 1148,
            "query": "What constitutes the intricate cellular tapestry forming an enigmatic barrier at a neoplastic junction, subtly obstructing the stratagems of immune-related therapeutic efforts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1488
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate cellular tapestry includes an increased proportion of #myeloid-derived suppressor cells# and a decreased proportion of #NK cells# and monocytes at the tumor site.",
            "predicted_answer": "The intricate cellular tapestry at a neoplastic junction includes myeloid-derived suppressor cells (mDSCs), reduced NK cells, and monocytes, creating an immunosuppressive microenvironment that obstructs immune-related therapeutic efforts.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies the presence of myeloid-derived suppressor cells (mDSCs) and a decrease in NK cells and monocytes. Although the wording differs slightly from the reference, all key facts highlighted by # symbols are present and there are no significant omissions or errors."
        },
        {
            "query_idx": 1149,
            "query": "Within the multifaceted dynamic of the co-culture ecosystem of PDOs and THP-1 participants, what strategic biochemical pathway did trastuzumab leverage to catalyze cellular deconstruction facilitated by immune-dependent mechanisms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1490
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Trastuzumab leveraged the antibody-dependent cell-mediated cytotoxicity (#ADCC#) biochemical pathway to catalyze cellular deconstruction via immune-dependent mechanisms in the co-culture ecosystem.",
            "predicted_answer": "Trastuzumab leveraged the antibody-dependent cell-mediated cytotoxicity (ADCC) pathway to catalyze cellular deconstruction in the co-culture of PDOs and THP-1 participants.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key fact emphasized with # symbols, identifying the ADCC pathway as the strategic biochemical pathway used by trastuzumab. The meaning and details in the predicted answer align well with the reference answer, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1150,
            "query": "What symbiotic interaction within the oncological habitat was unveiled by Dijkstra et al., through the utilization of autologous T cells and NSCLC organoid constructs, revealing the rehearsal of antigenic symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1491
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dijkstra et al. unveiled specific #tumor reactivity# and #antigen presentation# in NSCLC organoids with autologous T cells.",
            "predicted_answer": "Dijkstra et al. unveiled a symbiotic interaction where autologous T cells and NSCLC organoids co-cultured, demonstrating specific tumor reactivity and antigen presentation, crucial for the Tumor Microenvironment.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts of \"tumor reactivity\" and \"antigen presentation\" as mentioned in the Reference Answer. It correctly reflects the interaction between autologous T cells and NSCLC organoids, with no significant omissions or contradictions. Overall, the information is consistent with the reference."
        },
        {
            "query_idx": 1151,
            "query": "Amidst the multifaceted realm of oncology, particularly within the evolving narrative of advanced NSCLC stages, what proportion of individuals are discerned to exhibit heightened levels of the PD-L1 protein within their cellular framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1493
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "High #PD-L1 expression# is detected in #29.5%# of NSCLC patients at advanced stages.",
            "predicted_answer": "Approximately 29.5% of advanced NSCLC patients exhibit high PD-L1 expression.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts, \"high PD-L1 expression\" and \"29.5%,\" which match the emphasis in the reference answer. The meaning and key details are consistent, and there are no omissions or errors."
        },
        {
            "query_idx": 1152,
            "query": "What intricately designed architectonic constructs and dynamic components did Hassell et al. integrate into their microenvironment blueprint to echo the harmonious rhythm of mechanical oscillations observed in the tumor milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1496
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Hassell et al. integrated #epithelial cells#, #endothelial cells#, and compartments for mechanical breathing motions into their microenvironment blueprint to reflect tumor milieu oscillations.",
            "predicted_answer": "Hassell et al. integrated epithelial cells, endothelial cells, and two compartments reproducing mechanical breathing motions into their microenvironment blueprint to echo the harmonious rhythm of mechanical oscillations observed in the tumor milieu.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the key facts emphasized in the reference answer: #epithelial cells#, #endothelial cells#, and mechanical breathing motions. The details and overall meaning are consistent, with no significant omissions or errors in alignment."
        },
        {
            "query_idx": 1153,
            "query": "What quartet of molecular narratives, crafted in the artisanal forges of patient-derived tumoroids, serves as architects of prognostic destiny in the tapestry of survival outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1499
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quartet of molecular narratives comprises four genes: #RHOF#, #SLC16A3#, ANXA10, and CDHR1, identified as predictive biomarkers for survival.",
            "predicted_answer": "The quartet of molecular narratives, crafted in patient-derived tumoroids, includes RHOF, SLC16A3, ANXA10, and CDHR1, which serve as predictive biomarkers for survival outcomes.",
            "score": 5,
            "explanation": "The predicted answer includes all four genes: RHOF, SLC16A3, ANXA10, and CDHR1, accurately reflecting the key facts and meaning from the reference answer. There are no significant omissions or errors, and the predicted answer fully aligns with the reference answer."
        },
        {
            "query_idx": 1154,
            "query": "How does the confluence of disparate imaging realms, symbolizing the functional dynamism and anatomical precision, transmute individual deficiencies into enhanced capabilities within hybrid platforms like PET-CT and PET-MRI?",
            "retrieved_metrics": {
                "reference_idx": [
                    1504
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #confluence# of imaging realms in #hybrid platforms# like PET-CT and PET-MRI enhances capabilities by combining functional and anatomical data, overcoming individual deficiencies.",
            "predicted_answer": "The confluence of PET with CT and MRI in hybrid platforms like PET-CT and PET-MRI enhances capabilities by combining low anatomical information from PET with high anatomical precision from CT and MRI, thus addressing individual deficiencies and providing comprehensive functional and anatomical data simultaneously.",
            "score": 5,
            "explanation": "The predicted answer captures the confluence in hybrid platforms and the enhancement of capabilities by merging functional and anatomical data, consistent with the reference. It aligns well with the reference, adding detail about anatomical precision and functional data, with no crucial omissions."
        },
        {
            "query_idx": 1155,
            "query": "What defined expanse within the logarithmic octanol-water partition coefficient domain must be navigated to balance lipophilicity in radiopharmaceutical constructs, thereby ensuring they meet the parameters for optimal physiological performance in vivo?",
            "retrieved_metrics": {
                "reference_idx": [
                    1503
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The lipophilicity in radiopharmaceutical constructs should be balanced within the #log D# range of #1 ≤ log D ≤ 3#.",
            "predicted_answer": "The defined expanse within the logarithmic octanol-water partition coefficient (log D) domain to balance lipophilicity in radiopharmaceutical constructs is 1 ≤ log D ≤ 3, ensuring optimal physiological performance in vivo.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact emphasized with # symbols in the reference answer. Both specify the same log D range of 1 ≤ log D ≤ 3 for balancing lipophilicity in radiopharmaceutical constructs to ensure optimal physiological performance in vivo."
        },
        {
            "query_idx": 1156,
            "query": "In the realm of NSCLC pharmacological investigations, how do miniaturized fluidic apparatuses, by approximating the organic microcosm, orchestrate an evolution in potency assessment dynamics for panaxatriol, particularly when juxtaposed against their static environment analogues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1495
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniaturized fluidic apparatuses, by better mimicking #in vivo conditions#, enhance potency assessment of #panaxatriol# through dynamic screening, real-time monitoring, and controlled drug exposure compared to static conditions.",
            "predicted_answer": "Miniaturized fluidic apparatuses enhance potency assessment of panaxatriol in NSCLC by better mimicking in vivo conditions, allowing real-time monitoring and controlled drug exposure, which improves predictivity over static environments.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the use of miniaturized fluidic apparatuses, mimicking in vivo conditions, enhancing potency assessment, and controlled drug exposure. However, it omits \"dynamic screening\" mentioned in the reference. Thus, it aligns overall but is missing one key fact."
        },
        {
            "query_idx": 1157,
            "query": "What are the orchestrated components and nuanced methodologies woven into the fabric of PET imaging's temporal framework, with particular emphasis on the meticulous alignment of visuals and the delineation of regions within static and dynamic anatomical and physiological studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1507
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PET imaging involves setting parameters for #static# and #dynamic studies#, includes motion correction, MRI-PET coregistration, spatial normalization, ROI generation, and partial volume correction.",
            "predicted_answer": "PET imaging involves static and dynamic studies with components like data acquisition, pre-processing, and post-processing. Key methodologies include motion correction, MRI-PET coregistration, spatial normalization, ROI generation, and PVC. Dynamic studies require simultaneous arterial blood sampling for receptor quantification.",
            "score": 5,
            "explanation": "The Predicted Answer covers both static and dynamic studies, motion correction, MRI-PET coregistration, spatial normalization, ROI generation, and PVC, aligning well with the Reference Answer. It also discusses additional methodologies like arterial blood sampling for dynamic studies without contradiction. All emphasized key facts are present."
        },
        {
            "query_idx": 1158,
            "query": "In the complex landscape of radioactive transformation processes, what essential procedural convergence encompasses the transmutation of radiological components via mechanized systems or containment apparatus, ensuring adherence to stringent cGMP dogmas for human-oriented implementations within the arenas of positron emission tomography molecular visualization endeavors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1506
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The essential procedural convergence involves the #radiochemical synthesis# in automated modules or hot cell apparatus, ensuring adherence to #cGMP# compliances for human PET molecular imaging applications.",
            "predicted_answer": "The essential procedural convergence in radioactive transformation processes involves generating positron-emitting radionuclides using cyclotrons, followed by radiochemical synthesis in automated modules or hot cells, adhering to cGMP standards for human applications in PET molecular imaging.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer, including \"radiochemical synthesis\" in \"automated modules or hot cells\", and the adherence to \"cGMP\" standards for human PET molecular imaging. It even includes additional context about cyclotron use, complementing the reference without contradiction."
        },
        {
            "query_idx": 1159,
            "query": "Through which intricate methodologies do the probing evaluations of dynamic PET scanner outputs reveal the nuanced interrelations and intricate dance of radiotracers, discerned through the prism of pharmacokinetic and pharmacodynamic mappings?",
            "retrieved_metrics": {
                "reference_idx": [
                    1508
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Dynamic PET data analysis employs #tissue compartmental analysis# and #spectral analysis# to reveal pharmacokinetic and pharmacodynamic mappings of radiotracers, such as binding potential and metabolic processes.",
            "predicted_answer": "Dynamic PET scanner outputs reveal interrelations and radiotracer dynamics through pharmacokinetic and pharmacodynamic mappings using methods like tissue compartmental analysis, spectral analysis, and mathematical graphical analysis.",
            "score": 3,
            "explanation": "The Predicted Answer includes \"tissue compartmental analysis\" and \"spectral analysis,\" which match the key methodologies emphasized in the Reference Answer. However, it doesn't mention \"binding potential and metabolic processes,\" impacting completeness. Overall, it aligns with the trend but misses one key fact."
        },
        {
            "query_idx": 1160,
            "query": "Within the jurisdiction of exploratory nuclear medicine product application, which legislative provision articulates the constructs whereby PET experimental compounds, purposed for investigatory research but not therapeutic trials, traverse a stipulated exemption pathway from IND authorization, predicated on established safety and functional soundness for investigational studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1509
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Section #21 CFR 361.1# by #FDA regulations# details the exemption pathway for PET experimental compounds intended for investigatory research but not for therapeutic trials without IND authorization.",
            "predicted_answer": "Section 21 CFR 361.1 by the FDA describes the exemption pathway for PET experimental compounds used in investigational research, exempting them from IND authorization based on established safety and functional soundness for such studies.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes key facts: \"21 CFR 361.1\" and \"exemption pathway for PET experimental compounds\" as detailed in the Reference Answer. It clearly indicates the role of FDA regulations in this context. There are no substantial omissions or errors affecting the completeness."
        },
        {
            "query_idx": 1161,
            "query": "In the exploration of molecular candidate dynamics amidst the cognitive frontier, what analytical frameworks are employed to discern the intricacies of its rapport with biological mediators, particularly in relation to its metabolic choreography and traversal across the molecular conduit?",
            "retrieved_metrics": {
                "reference_idx": [
                    1512
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #proof-of-mechanism# approach analyzes a molecular candidate's interaction with biological mediators through its #metabolism# and blood-brain barrier penetration.",
            "predicted_answer": "Analytical frameworks such as target engagement, proof of mechanism, and proof-of-concept are employed to discern molecular dynamics in relation to biological mediators, focusing on metabolic interactions and molecular traversal.",
            "score": 3,
            "explanation": "The predicted answer mentions \"proof-of-mechanism,\" aligning with the reference. It also addresses \"metabolic interactions\" covering the idea of metabolism. However, it omits \"blood-brain barrier penetration\" from the reference, missing one key fact. The overall trends align, and there's no contradiction."
        },
        {
            "query_idx": 1162,
            "query": "In what manner does the conceptual framework of neuroimaging delineate the quantifiable engagement of neurotransmitter receptors by Rasagiline, translating receptor saturation into a formulaic representation within the analytical paradigms of PET studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1518
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The neuroimaging framework uses #PET studies# to calculate drug-receptor occupancy (#RO%#) by Rasagiline, translating receptor saturation into formulaic representation.",
            "predicted_answer": "The conceptual framework of neuroimaging quantifies neurotransmitter receptor engagement by Rasagiline through PET studies, using the formula for drug-receptor occupancy (RO%). This translates receptor saturation into a formulaic representation, enabling the measurement of brain Monoamine Oxidase B (MAO-B) receptor occupancy by Rasagiline.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts: \"PET studies\" and \"RO%\" (drug-receptor occupancy), both emphasized in the reference answer. It aligns with the overall trend and meaning, with no significant omissions or errors. Therefore, all critical information is present and consistent."
        },
        {
            "query_idx": 1163,
            "query": "What role does the intricate sphere of PET molecular imaging play in deciphering the layered pharmacodynamics of nascent pharmacological compounds, with a focus on orchestrating receptor engagement alterations during the varied stages of drug maturation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1521
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "PET molecular imaging in #receptor occupancy# studies measures drug efficacy, penetration, and binding, aiding in understanding #pharmacodynamics# during drug development stages.",
            "predicted_answer": "PET molecular imaging plays a crucial role in deciphering pharmacodynamics by measuring drug-receptor occupancy, assessing penetration, specific binding, and rational dosage selection during drug development stages.",
            "score": 5,
            "explanation": "The predicted answer addresses key facts such as \"receptor occupancy,\" \"pharmacodynamics,\" and measuring \"penetration and binding,\" aligning well with the reference's focus on these elements in drug development. Despite different phrasing, it provides a coherent representation without omissions or contradictions."
        },
        {
            "query_idx": 1164,
            "query": "What approaches are undertaken to render the full spectrum of receptor availability with the scarcely perceptible involvement of tracers, analogous to constructing a hidden topography of receptor dynamics via precise ligand engagements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1514
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The approaches involve using #radioligands# that occupy < 5-10% of targets to quantify the full receptor population through #specific binding#.",
            "predicted_answer": "Approaches include using radioligands with specific binding to quantify receptor populations, ensuring tracer occupancy is minimal (< 5-10%) to map receptor dynamics without significant tracer involvement.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: it mentions the use of radioligands (#radioligands#) and the importance of specific binding to quantify receptor populations (#specific binding#). The tracer occupancy limit (< 5-10%) is accurately reflected, ensuring alignment with the reference. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1165,
            "query": "What is the influence of the molecular congregation's spatial thickness and the subtle grip between molecules on delineating the potential depth of binding, within the context of the dual-compartment tissue framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1526
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #molecular congregation's spatial thickness# and subtle grip influence binding potential depth by affecting the #volume of distribution# in the dual-compartment tissue framework.",
            "predicted_answer": "The spatial thickness of molecular congregation and the subtle grip between molecules influence the potential depth of binding by affecting the volume of distribution in the dual-compartment tissue framework, which determines the binding potential based on receptor density and dissociation constant.",
            "score": 5,
            "explanation": "The Predicted Answer includes both key facts emphasized in the Reference Answer: #molecular congregation's spatial thickness# and #volume of distribution#. The response is consistent with the meaning of the Reference Answer, without omissions or contradictory information."
        },
        {
            "query_idx": 1166,
            "query": "In the intricate tapestry of transition metal interactions, how do Ruthenium π-complexes act as catalytic weavers, orchestrating the union of $^{18}$F with heteroaromatic phenols in the deoxyfluorination narrative, and what transformative potential does this hold for the domain of automated synthesis innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1528
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ruthenium π-complexes lower electron density of heteroaromatic phenols, enabling nucleophilic aromatic substitution with $^{18}$F. This aids #automated synthesis# of tyrosine derivatives with high #radiochemical yields#.",
            "predicted_answer": "Ruthenium π-complexes lower electron density in heteroaromatic phenols, activating them for $^{18}$F nucleophilic substitution, enabling automated synthesis with high radiochemical yields. This method holds transformative potential for automated synthesis innovations.",
            "score": 3,
            "explanation": "The predicted answer includes the key details about ruthenium π-complexes lowering electron density and facilitating $^{18}$F substitution, leading to the potential for automated synthesis with high radiochemical yields. However, the reference specifies \"tyrosine derivatives,\" which is absent in the prediction, affecting completeness."
        },
        {
            "query_idx": 1167,
            "query": "What are the multifaceted gains associated with the integration of iodonium constructs in the nuanced orchestration of $^{18}$F-radiolabeled biochemical entities for the purpose of engaging with the specialized domains of aromatic tyrosine residues within biomolecular frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1525
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The integration of #iodonium constructs# enables high #radiochemical yield#, regioselectivity, tolerance, and straightforward synthesis in $^{18}$F-radiopharmaceuticals targeting aromatic tyrosine residues.",
            "predicted_answer": "The integration of iodonium constructs in $^{18}$F-radiolabeling enhances radiochemical yield, regioselectivity, and synthesis simplicity, facilitating targeted engagement with aromatic tyrosine residues in biomolecules for advanced PET radiotracers in oncology and neurology.",
            "score": 3,
            "explanation": "The predicted answer captures most key facts: the integration of iodonium constructs, high radiochemical yield, regioselectivity, and engagement with aromatic tyrosine residues. However, it misses \"tolerance\" and \"straightforward synthesis,\" which affects the completeness."
        },
        {
            "query_idx": 1168,
            "query": "What are the intricate considerations involving temporal orchestration and procedural nuances that are required to strategically enhance the predominance of radioactive constituents relative to their non-radioactive counterparts in the realm of Positron Emission Tomography explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1529
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Temporal orchestration# involves optimizing radiotracer injection time, radiosynthesis duration, and bombardment time. #Procedural nuances# require managing radionuclide generation to enhance radioactive to non-radioactive atom ratios.",
            "predicted_answer": "To enhance the predominance of radioactive constituents in PET explorations, focus on radiotracer injection timing, radiosynthesis duration, radionuclide generation, and bombardment time. Ensure sufficient molar activity and adjust dose based on study type (human vs. animal).",
            "score": 3,
            "explanation": "The Predicted Answer covers key elements like radiotracer injection timing, radiosynthesis duration, bombardment time, and radionuclide generation, aligning with the Reference Answer. However, it lacks emphasis on \"enhancing the radioactive to non-radioactive atom ratios,\" missing one key procedural nuance detail."
        },
        {
            "query_idx": 1169,
            "query": "What intricate function do auxiliary synthetic intermediaries serve as essential components in the orchestration of precision-engineered radioligands tailored for specified clinical applications within research environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1530
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Auxiliary synthetic intermediaries serve as essential #building blocks# in synthesizing #target-specific# radioligands for clinical research, enhancing accessibility and precision.",
            "predicted_answer": "Auxiliary synthetic intermediaries enhance the development of precision-engineered radioligands by providing diverse secondary precursors, enabling the synthesis of target-specific radiotracers for clinical and preclinical research.",
            "score": 3,
            "explanation": "The predicted answer includes \"enhance the development\" and \"target-specific radiotracers,\" which align with \"building blocks\" and \"target-specific\" in the reference answer. However, it omits \"essential\" and \"clinical research,\" affecting completeness and crucial context regarding their clinical use."
        },
        {
            "query_idx": 1170,
            "query": "In what manner does the investigative agent $^{18}$F-Olaparib chart the path through the intricate landscape of tumor evaluation as described by Wilson et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    1533
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "$^{18}$F-Olaparib targets #PARP-1-expressing# tumors, demonstrating specific uptake in #mice xenografts# for accurate PET imaging as reported by Wilson et al.",
            "predicted_answer": "$^{18}$F-Olaparib charts the path through tumor evaluation by specifically targeting PARP-1 expression, showing good uptake in PARP-1-expressing tumor cells and xenografts, as reported by Wilson et al.",
            "score": 3,
            "explanation": "The predicted answer covers the key fact of targeting PARP-1-expressing tumors and shows uptake in xenografts, which aligns with the reference answer's emphasis. However, it lacks the specific mention of \"mice\" xenografts and \"accurate PET imaging,\" affecting completeness slightly but not the overall trend."
        },
        {
            "query_idx": 1171,
            "query": "What interpretive function does the carbon-11 enriched compound known as 3-Piperidinylethoxyanilinoquinazoline fulfill in the context of analyzing the efficacy of oncological interventions, as observed in recent investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1535
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#3-Piperidinylethoxyanilinoquinazoline# is used as a #radiotracer# to assess cancer treatment responses in oncological investigations.",
            "predicted_answer": "3-Piperidinylethoxyanilinoquinazoline, labeled with carbon-11, serves as a radiotracer to assess cancer treatment efficacy by monitoring tyrosine kinase inhibitor activity in oncological interventions.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: \"3-Piperidinylethoxyanilinoquinazoline,\" \"radiotracer,\" and assessing cancer treatment's efficacy. The additional detail on monitoring \"tyrosine kinase inhibitor activity\" complements the reference without contradiction. Nothing significant is omitted."
        },
        {
            "query_idx": 1172,
            "query": "How does the catalytic agent of metallic origin participate in steering the chemical metamorphosis detailed in the copper-centered synthesis pathway mentioned within the contextual data?",
            "retrieved_metrics": {
                "reference_idx": [
                    1536
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #copper-mediated# reaction enables the chemical transformation by facilitating the #radiofluorination# process in the synthesis pathway.",
            "predicted_answer": "The catalytic agent of metallic origin, copper, in the copper-centered synthesis pathway, facilitates the radiofluorination reaction, steering the chemical metamorphosis by mediating the incorporation of fluorine into the target molecule.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer. It mentions the copper-mediated reaction and its role in facilitating the radiofluorination process, aligning well with the reference by clarifying that it mediates the incorporation of fluorine. No significant omissions or errors were observed."
        },
        {
            "query_idx": 1173,
            "query": "Within the framework of molecular visualization, how does harnessing the [$^{18}$F]MGS3 entity as a catalytic muse contribute to delineating the heightened presence of histone deacetylases, and what inherent advantages does it reveal in examining disease states through the lattice of positron emission tomography?",
            "retrieved_metrics": {
                "reference_idx": [
                    1534
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Using #[$^{18}$F]MGS3# in PET imaging offers high brain uptake and specific binding, helping to visualize HDAC overexpression linked to cancer and neuropathologies.",
            "predicted_answer": "The [$^{18}$F]MGS3 entity enhances PET imaging by specifically binding to histone deacetylases, revealing their heightened presence in diseases like cancer and neurodegenerative disorders. This specificity provides clear imaging advantages for disease state examination.",
            "score": 3,
            "explanation": "The predicted answer captures the use of [$^{18}$F]MGS3 for revealing histone deacetylase presence, important for cancer and neurodegenerative disease examination, aligning with the reference. However, it misses \"high brain uptake\" specifically mentioned in the reference. Despite this, it aligns with the overall trend of the reference."
        },
        {
            "query_idx": 1174,
            "query": "How do the elusive 5-HT₁B receptors, functioning as molecular sentinels, influence the intricate tapestry of central nervous system ailments, as deciphered through PET imaging utilizing the distinct radioligand [$^{18}$F]AZ10419096?",
            "retrieved_metrics": {
                "reference_idx": [
                    1540
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The 5-HT₁B receptors, imaged using #[$^{18}$F]AZ10419096#, are linked to central nervous system disorders like #anxiety# and #depression#, serving as hallmarks for study with PET imaging.",
            "predicted_answer": "The [$^{18}$F]AZ10419096 radioligand, used in PET imaging, specifically targets 5-HT₁B receptors, which are implicated in central nervous system disorders like anxiety and depression. These receptors function as molecular sentinels, influencing the pathophysiology of such ailments.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference by recognizing [$^{18}$F]AZ10419096's role in imaging 5-HT₁B receptors. It correctly links these receptors to CNS disorders anxiety and depression. All key facts marked with # in the reference are present in the predicted answer, with consistent meaning."
        },
        {
            "query_idx": 1175,
            "query": "In the realm of chemogenetic orchestration within primate cerebral frameworks, what intrinsic elements account for the nearly doubled perceptive luminosity of [$^{11}$C]DCZ over the enigmatic back-current presented by [$^{11}$C]CLZ in the specialized DREADD civil engineering of neural pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1541
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #signal-to-background ratio# of [$^{11}$C]DCZ is nearly doubled because it has a #much lower background uptake# compared to [$^{11}$C]CLZ.",
            "predicted_answer": "The increased perceptive luminosity of [$^{11}$C]DCZ over [$^{11}$C]CLZ in primate cerebral frameworks is due to [$^{11}$C]DCZ's higher selectivity for DREADD hM4Di receptors and lower background uptake.",
            "score": 3,
            "explanation": "The Predicted Answer reflects the Reference Answer's key fact of a lower background uptake for [$^{11}$C]DCZ, which is a reason for its increased luminosity. However, it omits the reference to the improved signal-to-background ratio, missing one key aspect emphasized in the reference."
        },
        {
            "query_idx": 1176,
            "query": "In what manner do the intricate interplays and neuronal engagements of [$^{18}$F]FPYBF-2 within the neural tapestry substantiate its credentials as an incisive tool for illuminating the enigmatic amyloid manifestations in Alzheimer's pathology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1543
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate interplays of #[$^{18}$F]FPYBF-2# substantiate its credentials for illuminating #amyloid# manifestations in Alzheimer's by showing high uptake in gray and cerebral white matter.",
            "predicted_answer": "[$^{18}$F]FPYBF-2 demonstrates high uptake in gray and white matter in Alzheimer's patients, indicating its efficacy as a PET imaging agent for detecting amyloid plaques, crucial for diagnosing Alzheimer's pathology.",
            "score": 5,
            "explanation": "The predicted answer captures all the key elements emphasized in the reference answer, including the use of [$^{18}$F]FPYBF-2 and its high uptake in gray and white matter, crucial for identifying amyloid plaques in Alzheimer's pathology. The overall trend and meaning are consistent."
        },
        {
            "query_idx": 1177,
            "query": "In what ways does the extended temporally bound stability of fluorine-18, juxtaposed with the ephemeral nature of carbon-11, advance the perpetual synthesis cycle and analytical multiplicity in the realm of PET radiopharmacology?",
            "retrieved_metrics": {
                "reference_idx": [
                    1547
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #extended stability# of fluorine-18 enables repeated PET studies in a day, enhancing #analytical multiplicity#; carbon-11 supports diverse synthesis despite a shorter half-life.",
            "predicted_answer": "The extended half-life of fluorine-18 (110 min) allows for multiple PET studies in a single day, enhancing synthesis cycle efficiency. Carbon-11's shorter half-life (20.4 min) enables rapid, automated synthesis, contributing to analytical multiplicity and drug development accuracy.",
            "score": 5,
            "explanation": "The predicted answer covers the extended stability (#extended stability#) of fluorine-18 and its role in enabling multiple studies, aligning with #analytical multiplicity#. It also mentions carbon-11's role in diverse synthesis, covering key facts with no contradictions. Minor omission of explicit diversity in synthesis doesn't significantly impact completeness."
        },
        {
            "query_idx": 1178,
            "query": "In what intriguing capacity does the avant-garde radiotracer 10-($+$)[$^{11}$C]DTBZ operate as an illuminative vessel in the expansive tapestry of PET imaging, facilitating the decoding of Parkinson's intricate neurochemical saga?",
            "retrieved_metrics": {
                "reference_idx": [
                    1544
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The avant-garde radiotracer 10-($+$)[$^{11}$C]DTBZ operates by targeting #VMAT$_{2}$# receptors, using PET imaging to study #Parkinson's# disease.",
            "predicted_answer": "10-(+)[$^{11}$C]DTBZ operates as a PET imaging radiotracer targeting VMAT$_{2}$ receptors, providing insights into dopamine transport and storage in Parkinson's disease by visualizing synaptic vesicles.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference answer: it mentions the targeting of VMAT$_{2}$ receptors and the use in studying Parkinson's disease with PET imaging. The additional details on dopamine transport and synaptic vesicles further support its relevance without contradicting the reference."
        },
        {
            "query_idx": 1179,
            "query": "Within the multifaceted tapestry of protein modification, how might the orchestrated linkage of K63 ubiquitin chains conceptualize their role in modulating the transformative pathway of Oct4 stability amidst the cellular landscape of the mouse embryonic stem environment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1549
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "K63-linked ubiquitin chains #induce degradation# of Oct4 in #mouse embryonic stem# cells, affecting its stability.",
            "predicted_answer": "K63-linked ubiquitin chains modulate Oct4 stability in mouse embryonic stem cells by acting as degradation inducers, contrary to their typical role in regulating protein activity and localization.",
            "score": 5,
            "explanation": "The predicted answer mentions K63-linked ubiquitin chains inducing degradation of Oct4 in mouse embryonic stem cells, aligning with the key facts emphasized in the reference answer. It captures the role of these chains in modulating Oct4 stability without contradiction, fulfilling the criteria for completeness."
        },
        {
            "query_idx": 1180,
            "query": "What are the molecular nodal points within the ubiquitin architecture that serve as pivotal anchors for interlinking to form polyubiquitin chains?",
            "retrieved_metrics": {
                "reference_idx": [
                    1550
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular nodal points within the ubiquitin architecture are all #lysine (K) residues#, including K6, K11, K27, K29, K33, K48, and K63, that form polyubiquitin chains.",
            "predicted_answer": "The molecular nodal points within the ubiquitin architecture that serve as pivotal anchors for interlinking to form polyubiquitin chains include lysine residues K6, K11, K27, K29, K33, K48, and K63.",
            "score": 5,
            "explanation": "The predicted answer includes all key lysine residues (K6, K11, K27, K29, K33, K48, K63) as pivotal anchors for forming polyubiquitin chains, aligning perfectly with the reference answer. No significant details are missed, and no contradictory information is present."
        },
        {
            "query_idx": 1181,
            "query": "What complex architectural symphony defines the divergence in the bathymetry of ubiquitin unit linkages when contrasting the distinct ensemble of mixed polyubiquitin constructs to the intricate webwork inherent in branched polyubiquitin formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1548
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Mixed polyubiquitin constructs# diverge by employing #distinct residues# for linkage, whereas branched polyubiquitin formations use multiple K residues concurrently.",
            "predicted_answer": "The divergence in bathymetry of ubiquitin unit linkages is characterized by mixed polyubiquitin constructs using distinct residues for linkage, contrasting with branched formations where a single ubiquitin unit provides multiple linkages.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of mixed polyubiquitin constructs using distinct residues for linkage but lacks the specific detail about branched formations using multiple K residues concurrently. While generally aligned, this omission of detail affects completeness."
        },
        {
            "query_idx": 1182,
            "query": "In what manner do E2 enzymes orchestrate the molecular symphony that dictates the architectural nuances of ubiquitin chains within the intricate cellular milieu of human systems?",
            "retrieved_metrics": {
                "reference_idx": [
                    1551
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "E2 enzymes determine the #length# and #topology# of ubiquitin chains by orchestrating the molecular interactions in human cells.",
            "predicted_answer": "E2 enzymes determine the length and topological structure of ubiquitin chains by associating with E3 ligases and substrates, orchestrating the formation of isopeptide bonds that dictate ubiquitin chain architecture in human cells.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: E2 enzymes determine both the length and topology of ubiquitin chains, consistent with the reference answer. It adds the detail of association with E3 ligases, which aligns with the molecular function described, without contradicting it."
        },
        {
            "query_idx": 1183,
            "query": "Within the landscape of enzymatic machinations, which architectural augmentations distinctively delineate the fourth hierarchy of E2 entities in terms of their relational dynamics, as compared to their more foundational counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1552
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Class IV E2s feature extensions at #both ends#, enhancing subcellular localization and #interaction# with partners, distinguishing them from other E2 classes.",
            "predicted_answer": "Class IV E2 entities are distinctively delineated by their dual extension regions at both the C- and N-termini, which regulate subcellular localization and mediate interactions with other partners, unlike their foundational counterparts with single or no extensions.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: Class IV E2s having extensions at both the C- and N-termini (both ends) and their role in enhancing subcellular localization and interaction with partners. The meaning is consistent with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 1184,
            "query": "In the molecular chess game of life, what strategic derivatives arise from the destabilization equilibrium orchestrated by UAE inhibition on the molecular custodians such as p53, and how do these derivatives intricately rechart the pathway of progressive cellular transformation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1556
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "UAE inhibition destabilizes #endoplasmic reticulum#, leading to apoptosis and stabilizes #p53#, delaying cancer progression and activating NFκ B to suppress tumor growth.",
            "predicted_answer": "In the molecular chess game, UAE inhibition destabilizes equilibrium, stabilizing p53 and activating NFκB, which intricately recharts pathways, delaying cancer progression and suppressing malignant growth.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the stabilization of p53 and the activation of NFκB. However, it misses the key fact about the destabilization involving the endoplasmic reticulum, which is emphasized in the reference. This omission affects the completeness of the answer."
        },
        {
            "query_idx": 1185,
            "query": "What facets of the holistic corporeal scanning paradigm in state-of-the-art PET/CT systems imbue them with enhanced capacity to refine the predictive landscapes of pharmacokinetic and pharmacodynamic assessments, thereby surpassing the conventional imaging modalities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1545
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #total-body# PET/CT enhances #pharmacokinetics# and pharmacodynamics assessments by visualizing radiopharmaceutical distribution and delivering higher sensitivity dynamic scans for comprehensive systemic disease evaluation.",
            "predicted_answer": "The holistic corporeal scanning paradigm in state-of-the-art PET/CT systems enhances predictive landscapes by providing comprehensive kinetic data, higher sensitivity, and improved signal-to-noise ratio, surpassing conventional imaging modalities.",
            "score": 1,
            "explanation": "The predicted answer mentions enhanced predictability, higher sensitivity, and better signal-to-noise ratio, aligning with the reference's mention of higher sensitivity. However, it omits \"total-body\" and specifics about pharmacokinetics/pharmacodynamics assessments and dynamic scans, missing two key facts present in the reference."
        },
        {
            "query_idx": 1186,
            "query": "How does the ubiquitin proteasome system, likened to an orchestral conductor, play a crucial part in maintaining the symphony of protein homeostasis amidst the complex interplay of cellular dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1558
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #ubiquitin proteasome system# is crucial for #protein homeostasis#, akin to a conductor ensuring harmony in cellular dynamics by regulating protein modification and degradation.",
            "predicted_answer": "The ubiquitin proteasome system (UPS) regulates protein homeostasis by tagging proteins with ubiquitin, marking them for degradation, ensuring cellular balance amidst complex dynamics, akin to an orchestral conductor guiding the symphony.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of the ubiquitin proteasome system's role in protein homeostasis, comparing it to a conductor maintaining cellular harmony. It aligns with the reference by discussing protein regulation and degradation. Thus, it fully captures the critical elements without significant omissions."
        },
        {
            "query_idx": 1187,
            "query": "What unique pattern embodied within the phosphorylated constructs does the WW domain of Wwp2 meticulously engage during its molecular recognition process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1566
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The WW domain of Wwp2 engages the #phosphorylated PPxY motif# during its molecular recognition process.",
            "predicted_answer": "The WW domain of Wwp2 specifically recognizes phosphorylated PPxY motif-containing substrates during its molecular recognition process.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies that the WW domain of Wwp2 recognizes the \"phosphorylated PPxY motif,\" which is the key fact highlighted in the reference answer. The predicted response fully captures this essential detail without contradiction."
        },
        {
            "query_idx": 1188,
            "query": "In what capacity does the molecular pivot known as Rbx1 manifest within the structural edifice of the SCF Skp2 ensemble to enable the intricate dance of ubiquitin attachment, and how do its catalytic affinities guide the mechanistic overture of this biochemical sequence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1564
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rbx1, within the #SCF Skp2# complex, recruits E2 via the RING domain, forming the catalytic center with #Cul1# to facilitate ubiquitin transfer to substrates.",
            "predicted_answer": "Rbx1 in the SCF Skp2 complex acts as a molecular pivot by recruiting E2 enzymes through its RING domain, enabling ubiquitin transfer to substrates. Its catalytic affinities guide the ubiquitination process, facilitating the complex's role in protein degradation.",
            "score": 3,
            "explanation": "The predicted answer accurately describes Rbx1's role in recruiting E2 via the RING domain and enabling ubiquitin transfer. However, it omits the specific mention of Rbx1 forming the catalytic center with Cul1, which is a critical detail emphasized in the reference and affects completeness."
        },
        {
            "query_idx": 1189,
            "query": "In the realm of cellular guardians against apoptotic demise, what characteristic molecular blueprint underlies the orchestration of proteic alliances, and through what mechanism does this blueprint contribute to the propensity for neoplastic development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1567
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The characteristic molecular blueprint is the #BIR sequence#, which facilitates protein-protein interactions. This #enhances neoplastic development# by repressing apoptosis and promoting tumor growth.",
            "predicted_answer": "The characteristic molecular blueprint involves IAP proteins with baculoviral IAP repeat (BIR) domains, which facilitate protein-protein interactions. This blueprint contributes to neoplastic development by repressing apoptosis, allowing uncontrolled tumor growth.",
            "score": 5,
            "explanation": "The predicted answer includes the key molecular blueprint, the #BIR sequence#, and describes its role in facilitating protein-protein interactions. It also covers the mechanism of #enhancing neoplastic development# by repressing apoptosis, contributing to tumor growth. All emphasized key facts are present and consistent with the reference."
        },
        {
            "query_idx": 1190,
            "query": "What particular mechanistic blockade does the peptide borate entity, bortezomib, implement to disrupt the proteolytic continuum of the 26S proteasome concerning the therapeutic intervention for multiple myeloma?",
            "retrieved_metrics": {
                "reference_idx": [
                    1568
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The peptide borate entity #bortezomib# disrupts the proteolytic continuum of the 26S proteasome by blocking its #chymotrypsin-like activity# in therapeutic interventions for multiple myeloma.",
            "predicted_answer": "Bortezomib disrupts the proteolytic continuum of the 26S proteasome by blocking its chymotrypsin-like activity, which is crucial for its therapeutic intervention in multiple myeloma.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized in the reference answer: the role of bortezomib, its action of blocking chymotrypsin-like activity, and its relevance in treating multiple myeloma. The phrasing may differ slightly, but the meaning and technical details are fully aligned."
        },
        {
            "query_idx": 1191,
            "query": "What role does the molecular interplay between Wwp2 and the catalytic domain of PTEN serve as a catalyst in orchestrating the equilibrium of cellular guardianship and signaling pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1569
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular interplay between #Wwp2# and PTEN's catalytic domain stimulates PTEN's #ubiquitination# and degradation, thus influencing the equilibrium of cellular guardianship and signaling pathways.",
            "predicted_answer": "Wwp2 interacts with the catalytic domain of PTEN, promoting its ubiquitination and degradation, thereby regulating the PI3K/Akt pathway and maintaining cellular guardianship and signaling equilibrium.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of the interplay between Wwp2 and PTEN's catalytic domain, leading to ubiquitination and degradation, aligning with the reference. It also correctly mentions the regulation of cellular guardianship and signaling pathways, maintaining consistency with the reference answer."
        },
        {
            "query_idx": 1192,
            "query": "In the intricate dance of molecular interactions, which specific catalytic mechanism does the tetrapeptide epoxyketone, carfilzomib, elegantly hinder, and what subsequent ripple effects does this interference cause in the aggregation of molecular substrates within the proteasomal pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1570
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Carfilzomib inhibits the #26S proteasome#'s chymotrypsin-like activity, causing #accumulation# of ubiquitinated substrates in the proteasomal pathway.",
            "predicted_answer": "Carfilzomib inhibits the chymotrypsin-like activity of the 26S proteasome, causing accumulation of ubiquitinated substrates and disrupting protein degradation, leading to reduced aggregation of molecular substrates in the proteasomal pathway.",
            "score": 5,
            "explanation": "The predicted answer accurately covers all key facts highlighted in the reference: it mentions the inhibition of the 26S proteasome's chymotrypsin-like activity and the accumulation of ubiquitinated substrates. It further adds information about disrupting protein degradation, which aligns with the overall trend and context."
        },
        {
            "query_idx": 1193,
            "query": "How does the strategic convergence of ixazomib alongside the lenalidomide/dexamethasone constellation act to illuminate a path towards augmented longevity in individuals confronting the challenging journey of myeloma management?",
            "retrieved_metrics": {
                "reference_idx": [
                    1571
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Combining #ixazomib# with lenalidomide/dexamethasone #increases survival rate# in myeloma patients, augmenting longevity by enhancing antitumor effects.",
            "predicted_answer": "The strategic convergence of ixazomib with lenalidomide/dexamethasone enhances the survival rate of myeloma patients by leveraging ixazomib's stronger antitumor effect and synergistic action with the treatment constellation.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts: the combination of ixazomib with lenalidomide/dexamethasone and the increase in survival rate in myeloma patients. It captures the main trend and enhances the antitumor effect, aligning with the reference answer without omissions or contradictions."
        },
        {
            "query_idx": 1194,
            "query": "What intrinsic attributes could the architectural blueprints of smallness hold in contrast to the expansive molecular formations within the landscape of drug discovery, specifically in terms of their capacity for chemical refinement and the facilitation of novel protein interaction pathways for targeted degradation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1574
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular glue degraders, being #smaller#, are easier to optimize for chemical properties and enable novel #protein interactions# for targeted degradation, unlike larger PROTACs.",
            "predicted_answer": "Architectural blueprints of smallness, such as molecular glue degraders, facilitate chemical refinement and novel protein interactions by enabling smaller, more easily optimized molecules to induce targeted protein degradation through ubiquitination.",
            "score": 5,
            "explanation": "The Predicted Answer mentions \"smaller, more easily optimized molecules\" aligning with the Reference Answer's emphasis on \"smaller\" and \"easier to optimize for chemical properties.\" It also captures \"novel protein interactions\" and \"targeted degradation,\" thus covering all the key facts with no omissions or errors."
        },
        {
            "query_idx": 1195,
            "query": "In the intricate landscape of pharmacological breakthroughs targeting enzymatic realms, through what mechanisms does Tak-243 exert its modulatory prowess over UAE in the elaborate context of E1 enzyme regulation, and what prospects does this modulation signal for pioneering therapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1573
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tak-243 exerts its #modulatory prowess# over UAE by specifically inhibiting the #E1 enzyme#, signaling potential for new therapeutic paradigms targeting enzymatic regulation.",
            "predicted_answer": "Tak-243 modulates UAE by inhibiting its enzymatic activity, which could lead to novel therapeutic approaches for diseases involving E1 enzyme regulation.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies that Tak-243 modulates UAE by inhibiting enzymatic activity and mentions the potential for novel therapies. However, it omits specific mention of the \"E1 enzyme,\" which is key. Thus, it lacks one crucial detail from the reference."
        },
        {
            "query_idx": 1196,
            "query": "What are the dual manifestations of mechanistic inhibition that serdemetan strategically navigates within its antagonistic endeavors as an HDM2 E3 ligase disruptor?",
            "retrieved_metrics": {
                "reference_idx": [
                    1576
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Serdemetan strategically navigates mechanistic inhibition by preventing p53 #degradation# through HDM2 antagonism and inhibiting #cholesterol transport#.",
            "predicted_answer": "Serdemetan strategically navigates dual manifestations of mechanistic inhibition by antagonizing HDM2-p53 interaction to prevent p53 degradation and by inhibiting cholesterol transport.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"preventing p53 degradation\" and \"inhibiting cholesterol transport\" as emphasized in the reference answer. The meanings are consistent, and no significant omissions or errors are present, aligning well with the reference's overall trend."
        },
        {
            "query_idx": 1197,
            "query": "Within the framework of the therapeutic crusade against cellular aberrations, which intricate health predicaments is the molecular endeavor Tak-243 strategically aligned to address amid its clinical probing phase?",
            "retrieved_metrics": {
                "reference_idx": [
                    1572
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tak-243 is strategically aligned to address #refractory acute myeloid leukemia#, #refractory myelodysplastic syndrome#, and chronic myelomonocytic leukemia during its clinical probing phase.",
            "predicted_answer": "Tak-243 is strategically aligned to address refractory acute myeloid leukemia, refractory myelodysplastic syndrome, and chronic myelomonocytic leukemia during its clinical probing phase.",
            "score": 5,
            "explanation": "The Predicted Answer includes \"refractory acute myeloid leukemia\" and \"refractory myelodysplastic syndrome,\" both emphasized in the Reference Answer, as well as \"chronic myelomonocytic leukemia.\" All key facts and important information are present, with no significant omissions or errors in the overall trend."
        },
        {
            "query_idx": 1198,
            "query": "Within the enigmatic theatre of oncogenesis, how do RING-type E3 IAPs, functioning as subtle conductors of apoptotic inhibition, shape the evolutionary symphony toward the crafting of immune-centric therapeutic avenues?",
            "retrieved_metrics": {
                "reference_idx": [
                    1582
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#RING-type E3 IAPs# regulate oncogenesis by inhibiting apoptosis, influencing #cancer immunotherapy# development as potential therapeutic targets.",
            "predicted_answer": "RING-type E3 IAPs inhibit apoptosis, promoting cancer development, and may be targeted for immune-centric cancer therapies by enhancing immune responses against cancer cells.",
            "score": 5,
            "explanation": "The predicted answer acknowledges that RING-type E3 IAPs inhibit apoptosis and mentions their potential role in immune-centric cancer therapies, aligning with the reference's key points on oncogenesis regulation and cancer immunotherapy development. No significant details are omitted."
        },
        {
            "query_idx": 1199,
            "query": "How does the molecular conductor known as HOIP orchestrate its symphony within the human body's systemic defense mechanisms, and under what classification does this dynamic biochemical maestro fall?",
            "retrieved_metrics": {
                "reference_idx": [
                    1580
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular conductor #HOIP# orchestrates immune response regulation and falls under #RBR-type E3 inhibitors#.",
            "predicted_answer": "HOIP, a RBR-type E3 protein, regulates the human immune response. It falls under the classification of an immune response regulator, orchestrating its role within the body's systemic defense mechanisms.",
            "score": 3,
            "explanation": "The Predicted Answer correctly identifies HOIP and its role in immune response regulation, consistent with the Reference Answer. However, it incorrectly states HOIP as an immune response regulator instead of an RBR-type E3 inhibitor, missing a key classification detail emphasized in the reference."
        },
        {
            "query_idx": 1200,
            "query": "In what manner do the pharmacological enablers, such as GDC-0152 along with other clinical inhibitors, initiate the proteasome-mediated disassembly of the proteins XIAP and cIAP1, drawing upon mechanisms reminiscent of the Smac/DIABLO paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    1579
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The pharmacological enablers like #GDC-0152# initiate #proteasome-mediated disassembly# of XIAP and cIAP1 by mimicking the Smac/DIABLO mechanism.",
            "predicted_answer": "Pharmacological enablers like GDC-0152 induce proteasome-mediated degradation of XIAP and cIAP1 by mimicking the Smac/DIABLO mechanism, enabling their interaction for degradation.",
            "score": 5,
            "explanation": "The predicted answer fully captures all the key facts emphasized with # symbols in the reference answer, including the mention of GDC-0152, proteasome-mediated disassembly, and the Smac/DIABLO mechanism. The meaning is consistent with the reference, with no omissions or contradictions."
        },
        {
            "query_idx": 1201,
            "query": "In the realm of oncology research's early investigatory stages, what conceptual hurdles arise from the interplay of patient demographic paradigms and trial phase-specific dynamics when calibrating therapeutic dosages, considering the intricate mosaic of immediate and longitudinal tolerability nuances?",
            "retrieved_metrics": {
                "reference_idx": [
                    1587
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Calibrating therapeutic dosages in early oncology trials faces #complexities# due to patient demographic paradigms and differing #tolerances# for toxicities, influenced by immediate and long-term tolerability nuances.",
            "predicted_answer": "In early oncology trials, patient demographics and trial phase dynamics complicate dosage calibration due to varying risk tolerances and limited long-term tolerability data, often necessitating dose reductions and interruptions.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the complex factors involving patient demographic paradigms and tolerability that impact dosage calibration. However, it lacks explicit mention of the differing tolerances for toxicities, a key point emphasized in the reference. The overall trend is aligned, but missing this detail."
        },
        {
            "query_idx": 1202,
            "query": "What pivotal function do evolutionarily dynamic exploration frameworks serve in orchestrating and refining the strategic allocation of therapeutic dosages within the unfolding narrative of study BLC2001?",
            "retrieved_metrics": {
                "reference_idx": [
                    1590
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Evolutionarily dynamic exploration frameworks in #study BLC2001# identify and refine dosing regimens by analyzing safety and efficacy, optimizing #therapeutic dosages# in real-time.",
            "predicted_answer": "Evolutionarily dynamic exploration frameworks in study BLC2001 facilitate real-time refinement of therapeutic dosages, optimizing efficacy and safety by adapting based on biomarker data and response rates.",
            "score": 3,
            "explanation": "The predicted answer includes the key information about optimizing therapeutic dosages and real-time refinement present in the reference answer. However, it lacks the explicit mention of \"safety and efficacy\" analysis, a critical component in determining the appropriateness of dosing regimens."
        },
        {
            "query_idx": 1203,
            "query": "What potential reverberations may arise from misguided alignment in therapeutic calibrations within the initial layers of patient-centric exploratory trials, specifically regarding their complex interplay with comprehensive patient wellness and the successful manifestation of therapeutic intents?",
            "retrieved_metrics": {
                "reference_idx": [
                    1591
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Misguided alignment in therapeutic calibrations can lead to #toxicity#, reduced quality of life, frequent dose adjustments, diminished efficacy, and challenges in developing combination regimens.",
            "predicted_answer": "Misguided alignment in therapeutic calibrations during initial patient-centric trials can lead to adverse consequences such as toxicity, reduced treatment efficacy, and challenges in developing combination regimens, impacting patient wellness and therapeutic intent manifestation.",
            "score": 1,
            "explanation": "The 'Predicted Answer' includes \"toxicity\" and \"reduced treatment efficacy,\" aligning with the reference answer's #toxicity# and \"diminished efficacy.\" However, it omits \"reduced quality of life\" and \"frequent dose adjustments,\" missing two key facts. Trends are aligned, but completeness is impacted."
        },
        {
            "query_idx": 1204,
            "query": "What intricate constellation of pharmacokinetic and dynamic parameters orchestrated the institutional embrace of the recalibrated 8mg daily regimen, with a conditional enhancement to 9mg predicated on phosphorous serum metrics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1593
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Pharmacokinetic# and #pharmacodynamic# analyses indicated that the 8mg daily regimen, with an increase to 9mg if serum PO4 < 5.5mg/dL, maintained optimal PO4 levels and reduced treatment interruptions.",
            "predicted_answer": "The institutional embrace of the 8mg daily regimen, with conditional enhancement to 9mg based on phosphorous serum metrics, was orchestrated by intricate pharmacokinetic and dynamic parameters that optimized serum PO4 levels and minimized treatment interruptions.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the pharmacokinetic and dynamic parameters, the 8mg regimen, conditional enhancement to 9mg, and the goals of maintaining optimal serum PO4 levels and reducing treatment interruptions. The reference's specific condition of serum PO4 < 5.5mg/dL is missing."
        },
        {
            "query_idx": 1205,
            "query": "What influence did the revelation of advantageous nutritional dynamics exert upon the strategic calibration of ceritinib's pharmacological regimen within the intricate framework of its clinical assessment narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1595
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The revelation of a #positive food effect# led to an additional clinical trial to reconsider ceritinib's dosing strategy, aiming to improve its benefit/risk profile.",
            "predicted_answer": "The revelation of advantageous nutritional dynamics led to the strategic calibration of ceritinib's pharmacological regimen by evaluating the benefit/risk profile of fed dosing, addressing gastrointestinal toxicities and improving patient outcomes.",
            "score": 3,
            "explanation": "The predicted answer aligns with the overall trend of the reference answer. It mentions \"nutritional dynamics\" and \"benefit/risk profile,\" which suggests a reconsideration of dosing strategy. However, it misses the key fact of an \"additional clinical trial.\" Thus, a crucial detail is absent."
        },
        {
            "query_idx": 1206,
            "query": "Within the intricate weave of early-stage pharmacological investigations, as various dosage regimens are methodically examined, what underlying strategic essence does this investigative endeavor project between the realm of preliminary hypotheses and the horizon of confirmatory inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    1592
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic essence of early pharmacological investigations is to evaluate #clinical antitumor activity# and refine #dose selection# for future confirmatory trials.",
            "predicted_answer": "The strategic essence lies in refining dose optimization and safety profiles to inform dose selection for confirmatory trials, balancing preliminary hypotheses with practical data generation.",
            "score": 3,
            "explanation": "The Predicted Answer covers #dose selection# but omits #clinical antitumor activity#. While it aligns with the trend of optimizing and refining doses, the missing key fact significantly impacts completeness. Thus, it lacks one crucial element from the Reference Answer."
        },
        {
            "query_idx": 1207,
            "query": "What intricate molecular choreography does CC-90009 mobilize to orchestrate the tagging and subsequent deconstruction of GSPT1 within its destined biochemical pathway?",
            "retrieved_metrics": {
                "reference_idx": [
                    1581
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CC-90009 mobilizes the #CRL4 CRBN# E3 complex to #ubiquitinate# GSPT1, leading to its proteasomal degradation.",
            "predicted_answer": "CC-90009 recruits the CRL4 CRBN E3 complex to ubiquitinate GSPT1, tagging it for proteasomal degradation.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts and technical details with accurate terms like \"CRL4 CRBN E3 complex,\" \"ubiquitinate,\" and \"proteasomal degradation\" present and correctly applied, aligning fully with the reference answer's meaning and emphasis."
        },
        {
            "query_idx": 1208,
            "query": "How was the dose refinement symphony of the allosteric agent asciminib orchestrated to achieve tailored modulation in dosages for those navigating the chronic myeloid leukemia continuum in its standard phase, and through what differentiated metrics was the therapeutic cadence attuned for patients encapsulating the T315I genetic anomaly?",
            "retrieved_metrics": {
                "reference_idx": [
                    1599
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #dose refinement# of asciminib was achieved using PK/PD modeling, leading to tailored dosages: #40 mg# for chronic phase and 200 mg for T315I mutation patients.",
            "predicted_answer": "The dose refinement for asciminib was orchestrated using PK/PD modeling, with 40 mg for chronic phase and 200 mg twice a day for T315I mutation patients, ensuring efficacy and safety.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts about dose refinement using PK/PD modeling and the 40 mg dosage for the chronic phase. It also mentions the 200 mg dosage for T315I mutation patients, aligning with the reference while ensuring efficacy and safety. All key points are covered."
        },
        {
            "query_idx": 1209,
            "query": "In what ways do the diverse architects and artisans of therapeutic innovation harmonize their intellect to ensure that essential queries are articulated and pursued amid the dynamic narrative of the drug development odyssey using the learn-confirm MIDD framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1600
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #learn-confirm MIDD# framework unites diverse experts to ensure essential queries are pursued, focusing on #dose optimization# to maximize benefit versus risk across clinical contexts.",
            "predicted_answer": "The diverse architects and artisans of therapeutic innovation harmonize their intellect through cross-functional collaboration, ensuring essential queries are articulated and pursued using the learn-confirm MIDD framework to optimize dose selection and maximize benefit versus risk.",
            "score": 5,
            "explanation": "The predicted answer covers key aspects of the reference answer, including the use of the learn-confirm MIDD framework, cross-functional collaboration, and focus on optimizing dose to maximize benefit versus risk. All emphasized key facts from the reference are present in the predicted answer."
        },
        {
            "query_idx": 1210,
            "query": "Through what nuanced orchestration of dosimetric alignment and therapeutic substantiation was the viability and assured effectiveness of the sanctioned dosage verified for those experiencing RET fusion-integrated pulmonary malignancies and RET-mutant thyroidal growths?",
            "retrieved_metrics": {
                "reference_idx": [
                    1601
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #160 mg# twice daily dosage for selpercatinib was verified through PK/PD models, simulating tumor inhibition while considering #QTc interval prolongation# risks and correlating tumor reduction with survival probability.",
            "predicted_answer": "The viability and effectiveness of the sanctioned dosage for RET fusion-integrated pulmonary malignancies and RET-mutant thyroidal growths were verified through dosimetric alignment with PK/PD models, simulated tumor inhibition profiles, and safety assessments, ensuring tumor size reduction and improved survival.",
            "score": 1,
            "explanation": "The predicted answer mentions dosimetric alignment with PK/PD models and tumor size reduction, aligning with the reference. However, it misses two key elements: the specific dosage of #160 mg# and the consideration of #QTc interval prolongation#. Therefore, it lacks completeness."
        },
        {
            "query_idx": 1211,
            "query": "What intricate forces and multifaceted dynamics challenge the steadfast persistence of conceptual decision-making paradigms within the convoluted realms of oncological pharmacology, especially amidst the temporal constraints and the complex biological tapestries characteristic of this pharmacological labyrinth?",
            "retrieved_metrics": {
                "reference_idx": [
                    1604
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The challenges in #oncological pharmacology# include the complexity of disease, patient populations, and #accelerated development# timelines, hindering the consistent application of decision-making frameworks.",
            "predicted_answer": "The steadfast persistence of conceptual decision-making paradigms in oncological pharmacology is challenged by the complexity of disease and patient populations, accelerated development timelines, and the need for timely dose optimization, necessitating consistent application of principles like the 3 Pillar and 5R frameworks.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"oncological pharmacology,\" \"complexity of disease and patient populations,\" and \"accelerated development timelines\" from the reference answer. It aligns well with the overall trend and does not introduce contradictions or omit critical information."
        },
        {
            "query_idx": 1212,
            "query": "What prospects does an anticipatory Bayesian model harbor for refining the strategic nuances of therapeutic dose modulation in the realm of oncology trials, based on the interpretative synthesis of model-generated priors and the expansive pharmacometric appraisal of tumor dimensional trajectories?",
            "retrieved_metrics": {
                "reference_idx": [
                    1605
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An #anticipatory Bayesian model# can refine therapeutic dose modulation by using model-generated priors and pharmacometric analysis to forecast dose-efficacy relationships in #oncology trials#.",
            "predicted_answer": "An anticipatory Bayesian model can refine therapeutic dose modulation in oncology trials by integrating model-generated priors and pharmacometric analyses of tumor trajectories, potentially improving dose selection and efficacy outcomes.",
            "score": 3,
            "explanation": "The predicted answer includes the key aspects of an \"anticipatory Bayesian model\" and its application in \"oncology trials,\" aligning well with the reference. However, it misses the emphasis on \"forecast dose-efficacy relationships,\" so while it covers most points, a critical detail impacts its completeness."
        },
        {
            "query_idx": 1213,
            "query": "What latent advantages do temporal state transition frameworks exhibit over traditional oncology models in crafting a continuous dialogue between dynamic tumor morphology and survival narrative, amidst the intricate tapestry of longitudinal analysis, resistant to biases of seemingly immortal temporal spaces?",
            "retrieved_metrics": {
                "reference_idx": [
                    1606
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Temporal state transition frameworks offer #multistate modeling#, integrating tumor size, response, and survival data while countering #immortal time bias# in longitudinal analyses, unlike traditional oncology models.",
            "predicted_answer": "Temporal state transition frameworks offer advantages by dynamically linking tumor size to survival hazard, integrating response categories, and protecting against immortal time bias, fostering a continuous dialogue between tumor morphology and survival narrative.",
            "score": 3,
            "explanation": "The predicted answer addresses #immortal time bias# and includes linking tumor size to survival, aligning with the reference’s integration of tumor size, response, and survival data. However, it omits #multistate modeling#, a key fact, impacting completeness."
        },
        {
            "query_idx": 1214,
            "query": "Within the realm of constructing mechanistic paradigms aimed at analogous tumor antigen targeting, what conceptual strategies underpin the exchange and adaptation of essential biological parameters across differentiated immunotherapeutic initiatives, specifically between bispecific T-cell engagers and CAR-T therapy approaches?",
            "retrieved_metrics": {
                "reference_idx": [
                    1609
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategies involve #borrowing# biological parameters in models for dose-response and exposure-toxicity relationships between #bispecific T-cell engagers# and CAR-T therapies for similar tumor antigens.",
            "predicted_answer": "Conceptual strategies include borrowing biological parameters from mechanistic models and sharing drug-related platform knowledge, such as exposure-toxicity relationships, between bispecific T-cell engagers and CAR-T therapies targeting the same tumor antigen.",
            "score": 5,
            "explanation": "The predicted answer includes the key concepts of \"borrowing biological parameters\" and references both \"bispecific T-cell engagers\" and \"CAR-T therapies\" in the context of targeting tumor antigens. Although the reference specifies parameters like dose-response, the general concept is conveyed without contradiction."
        },
        {
            "query_idx": 1215,
            "query": "How did the predictive architecture embodied by the QSP model influence the strategic anticipation of initial experimental outcomes for a innovative ERK inhibitor within the paradigmatic shift towards BRAV600 CRC's therapeutic exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1608
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #QSP model# enabled accurate prediction of phase I clinical responses and helped evaluate potential drug combinations and biomarkers, enhancing strategic anticipation for a new #ERK inhibitor#.",
            "predicted_answer": "The QSP model's predictive architecture influenced strategic anticipation by accurately predicting phase I clinical response for the new ERK inhibitor and evaluating potential drug combinations and predictive biomarkers for CRC patients.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts: the QSP model's role in predicting phase I clinical responses and evaluating potential drug combinations and biomarkers, similar to the reference. Both highlight strategic anticipation for an ERK inhibitor, showing that all crucial details are present without omissions."
        },
        {
            "query_idx": 1216,
            "query": "How might the avant-garde orchestration of mathematical simulations enthrall and refine the calculus of therapeutic administration for neoplastic entities exhibiting a mosaic of clonal diversity and molecular intricacies, while considering resistance development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1610
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Innovative mathematical modeling enables #model-informed# dose optimization by addressing #tumor heterogeneity# and resistance in therapeutic administration for neoplastic entities.",
            "predicted_answer": "The avant-garde orchestration of mathematical simulations can refine therapeutic administration for neoplastic entities by incorporating clonal diversity and molecular intricacies into model-informed dose optimization, addressing resistance development.",
            "score": 5,
            "explanation": "The predicted answer includes \"model-informed dose optimization\" and addresses \"resistance development,\" aligning with the reference. It mentions \"clonal diversity and molecular intricacies,\" which relates to \"tumor heterogeneity.\" Therefore, it covers the key points emphasized in the reference without significant omissions."
        },
        {
            "query_idx": 1217,
            "query": "In what manner did the nuanced QSP construct integrate within the elaborate phase Ia/Ib dosing schema to influence the therapeutic navigation for patients confronted with relapsing/refractory non-Hodgkin's lymphoma, thereby facilitating a deliberate mitigation of the cytokine storm challenge via pharmacodynamic foresight?",
            "retrieved_metrics": {
                "reference_idx": [
                    1612
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #QSP model# informed the phase Ia/Ib dosing schema with #step-up dosing# regimens, effectively mitigating cytokine release syndrome (CRS) in relapsing/refractory non-Hodgkin's lymphoma patients.",
            "predicted_answer": "The nuanced QSP construct integrated within the phase Ia/Ib dosing schema by proposing pharmacologically plausible step-up dosing regimens, which mitigated the cytokine storm challenge in relapsing/refractory non-Hodgkin's lymphoma patients, enhancing therapeutic navigation.",
            "score": 3,
            "explanation": "The predicted answer covers key concepts: it mentions the QSP construct and step-up dosing regimens, aligning with the reference answer. However, it omits specific mention of cytokine release syndrome (CRS), though it implies mitigation of cytokine storm. Thus, it misses one key fact affecting completeness."
        },
        {
            "query_idx": 1218,
            "query": "Within the analytical framework of regulatory dossier evaluations post-2013, as observed by Bai et al., what has surfaced as the chief role of QSP in navigating elaborate dosing inquiries and supporting medications' dosage architecture?",
            "retrieved_metrics": {
                "reference_idx": [
                    1614
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chief role of #QSP# identified by Bai et al. is #supporting dosing# questions for phase III dose selection, pediatric study plans, and new drug application submissions.",
            "predicted_answer": "Within the analytical framework of regulatory dossier evaluations post-2013, as observed by Bai et al., QSP has surfaced as the chief role in navigating elaborate dosing inquiries by supporting phase III dose selection, pediatric study plans, and dosage architecture in new drug applications.",
            "score": 5,
            "explanation": "The predicted answer fully covers the key facts emphasized in the reference answer, including the role of QSP in supporting dose selection, pediatric study plans, and dosage architecture, without any omissions or contradictions. The meaning is consistent throughout."
        },
        {
            "query_idx": 1219,
            "query": "What inferential pharmacokinetic dynamics manifested through saturation phenomena were pivotal in rationalizing the prescribed 200mg/m² cetuximab weekly regimen, guiding its strategic implementation in the exploratory phases of clinical inquiry for metastatic colorectal and head and neck cancer treatments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1621
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cetuximab's #clearance saturation# plateaued at ~ #200mg/m²#, aiding its weekly regimen recommendation by inferring target engagement and effectiveness for clinical trials in cancer treatment.",
            "predicted_answer": "The pivotal inferential pharmacokinetic dynamics were the saturation of cetuximab clearance, which plateaued at ~200mg/m², guiding the weekly regimen for phase II trials in metastatic colorectal and head and neck cancer treatments.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as \"saturation of cetuximab clearance\" and the dosing plateau at \"~200mg/m²,\" which align with the reference. It mentions the weekly regimen, consistent with guiding clinical trial phases, capturing the trend and details without contradiction."
        },
        {
            "query_idx": 1220,
            "query": "What magnitude of pembrolizumab administration navigates to exceed a 90% interactive continuity with target cellular receptors in tumoral ensembles, as projected by physiologically based modeling simulations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1619
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A dose of #200mg q3w# pembrolizumab is projected to achieve #90%# receptor occupancy in tumoral ensembles.",
            "predicted_answer": "A 200mg q3w dose of pembrolizumab is projected to achieve at least 90% receptor occupancy in tumor ensembles, according to physiologically based modeling simulations.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts #200mg q3w# and #90%# receptor occupancy present in the reference answer. It is consistent with the reference answer, with no omissions or contradictions; therefore, it fully covers the important details."
        },
        {
            "query_idx": 1221,
            "query": "In what manner can the application of a population-scale TGI-OS modeling construct elucidate the complex interplay of durvalumab and atezolizumab within the intricate confines of urothelial carcinoma treatment, particularly regarding the identification of prognostic biomarkers and the appraisal of monotherapy versus combination therapy effectiveness?",
            "retrieved_metrics": {
                "reference_idx": [
                    1626
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A population-scale #TGI-OS modeling# construct aids in identifying #prognostic biomarkers# and evaluating the effectiveness of durvalumab and atezolizumab monotherapy versus combination therapy in urothelial carcinoma treatment.",
            "predicted_answer": "A population-scale TGI-OS modeling construct can elucidate the complex interplay of durvalumab and atezolizumab in urothelial carcinoma by identifying prognostic biomarkers and assessing the effectiveness of monotherapy versus combination therapy.",
            "score": 5,
            "explanation": "The predicted answer covers all key aspects from the reference: the use of a TGI-OS modeling construct, identification of prognostic biomarkers, and the evaluation of monotherapy versus combination therapy for durvalumab and atezolizumab in urothelial carcinoma. No significant information is missing, and trends are aligned."
        },
        {
            "query_idx": 1222,
            "query": "In the expansive domain of algorithmic therapeutic exploration, what is the intricate data-driven mechanism employed to delineate the crest of permissible limits and the strategic regimen commencement in dynamic dose-discovery pathways, and which methodological nuance guides its iterative recalibration of subsequent measurements?",
            "retrieved_metrics": {
                "reference_idx": [
                    1631
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #MISED# algorithm employs #Bayesian optimization# to delineate dose limits and iteratively recalibrate doses based on preclinical and clinical trial data responses.",
            "predicted_answer": "The intricate data-driven mechanism in dynamic dose-discovery pathways employs Model-based Iterative Search and Evaluation of Dose (MISED), which uses Bayesian optimization to iteratively adjust doses based on patient responses, guiding the recalibration of subsequent measurements.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of the reference answer, including the use of the MISED algorithm and Bayesian optimization. It aligns with the reference by describing dose adjustments based on responses, though it does not specifically mention preclinical and clinical trial data, which is not crucial here."
        },
        {
            "query_idx": 1223,
            "query": "What enlightening contributions do agent-oriented simulation frameworks offer concerning the complex interplay between bispecific T cell antibodies and the evolving landscape of tumor dynamics, alongside patient-specific responses among various anatomical milieus?",
            "retrieved_metrics": {
                "reference_idx": [
                    1632
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Agent-oriented simulation frameworks reveal the #interaction# between doses, bispecific T cell antibodies, and their impact on #tumor evolution# and patient responses across different anatomical sites.",
            "predicted_answer": "Agent-oriented simulation frameworks, such as agent-based modeling (ABM), offer insights into the complex interplay between bispecific T cell antibodies and tumor dynamics by simulating patient-specific responses across various anatomical milieus, helping to optimize dose strategies and predict tumor evolution and relapse.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts from the reference—interaction between bispecific T cell antibodies, tumor evolution, and patient-specific responses across multiple anatomical sites. However, it lacks mention of the specific interaction between doses and antibodies, which affects completeness."
        },
        {
            "query_idx": 1224,
            "query": "What are the metrics of achieving a beyond 95% rate of target malignancy inhibition within the identified cohort upon administering the translationally derived RP2D of Tepotinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    1636
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #RP2D# of #Tepotinib# achieves over 95% tumor target inhibition in more than 90% of the patient population.",
            "predicted_answer": "The metrics for achieving a beyond 95% rate of target malignancy inhibition with Tepotinib's RP2D include using translational PK/PD modeling and stochastic simulations to ensure over 95% tumor target inhibition in over 90% of the patient population.",
            "score": 5,
            "explanation": "The predicted answer includes all key points: it mentions Tepotinib, RP2D, and achieving over 95% tumor inhibition in over 90% of the population. The inclusion of PK/PD modeling and simulations does not contradict but rather supports the explanation. There are no significant omissions or errors."
        },
        {
            "query_idx": 1225,
            "query": "What fundamental underlying cause dictates the occurrence where observational methodologies involving neoplastic samples inherently yield merely a singular temporal snapshot per participant in clinical investigative settings, contrasting with serially captured data from fluid biomarkers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1635
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor biopsies inherently provide a #single temporal snapshot# per patient because they cannot be performed #serially# like fluid biomarkers.",
            "predicted_answer": "The fundamental cause is that tumor biopsies, unlike fluid biomarkers, cannot be performed serially and thus provide only a single temporal snapshot per participant.",
            "score": 5,
            "explanation": "The predicted answer accurately covers the key facts: it mentions that tumor biopsies provide a \"single temporal snapshot\" and that they cannot be performed \"serially\" like fluid biomarkers. The meaning and key facts from the reference answer are fully reflected in the predicted answer."
        },
        {
            "query_idx": 1226,
            "query": "What are the prospective implications of harmonizing pharmacometric paradigms with the evolving chronicle of ctDNA trajectories to unveil exposure-response symmetries that may refine early developmental dosing strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1642
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harmonizing pharmacometric paradigms with ctDNA #trajectories# may refine #dose# optimization by integrating exposure-response relationships in early drug development.",
            "predicted_answer": "Harmonizing pharmacometric paradigms with ctDNA trajectories could refine early developmental dosing strategies by enabling the integration of exposure-effect relationships to optimize dose based on real-time tumor kinetic data.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference: harmonizing pharmacometric paradigms with ctDNA trajectories, refining early developmental dosing strategies, and integrating exposure-response relationships. It aligns with the overall trend without contradictions, capturing the essence and key details of the reference."
        },
        {
            "query_idx": 1227,
            "query": "In what manner might the confluence of advanced imaging modalities and sophisticated textural analytics unveil the intricate choreography of cellular diversity and biological complexity inherent in tumorous compositions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1643
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The confluence of advanced imaging and textural analytics can reveal #cellular diversity# and #biological complexity# within tumors, aiding in drug efficacy prediction and robust E-R relationship establishment.",
            "predicted_answer": "Advanced imaging modalities combined with sophisticated textural analytics can reveal the intricate cellular diversity and biological complexity of tumors by analyzing textural, shape, and intensity characteristics, providing insights into tumor biology and heterogeneity.",
            "score": 1,
            "explanation": "The predicted answer includes the key facts of \"cellular diversity\" and \"biological complexity\", aligning with the reference answer. However, it omits details on \"drug efficacy prediction\" and \"robust E-R relationship establishment\", which affects the completeness of the response."
        },
        {
            "query_idx": 1228,
            "query": "In what way did the sophisticated confluence of symptom-specific patient-reported outcome measures function as a critical dimension in the evaluative framework that precipitated the endorsement of ruxolitinib for myelofibrosis in 2011?",
            "retrieved_metrics": {
                "reference_idx": [
                    1646
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #patient-reported outcome# measure focused on six #symptoms# specific to myelofibrosis, serving as a pivotal secondary endpoint alongside spleen volume reduction, leading to ruxolitinib's approval in 2011.",
            "predicted_answer": "The sophisticated confluence of symptom-specific patient-reported outcome measures provided critical data on patient quality of life, complementing spleen volume reduction as a secondary end point, which was pivotal for the 2011 endorsement of ruxolitinib for myelofibrosis.",
            "score": 3,
            "explanation": "The predicted answer captures the critical role of patient-reported outcomes in addition to spleen volume reduction as secondary endpoints, but does not explicitly mention the six specific symptoms. This omission of one key fact slightly affects completeness, although overall alignment with the reference answer is maintained."
        },
        {
            "query_idx": 1229,
            "query": "What intricacies emerge via the confluence of evaluative schemata within the intricate matrix of dose escalation processes, especially regarding the pluralistic patient settings and nascent patterns in adverse event configurations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1648
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #confluence# of evaluative schemata entails challenges due to #heterogeneous# patient populations and evolving adverse event profiles, complicating PRO assessments and dose escalation strategies.",
            "predicted_answer": "The confluence of evaluative schemata in dose escalation processes reveals challenges in defining proper PRO assessments and systematic collection methods, especially in heterogeneous patient settings and nascent adverse event patterns.",
            "score": 3,
            "explanation": "The predicted answer captures the core ideas of \"confluence,\" \"heterogeneous patient settings,\" and \"nascent adverse event patterns,\" aligning with the reference's focus on these challenges. However, it doesn't explicitly mention the impact on \"dose escalation strategies,\" which impacts completeness."
        },
        {
            "query_idx": 1230,
            "query": "What role does Model-Informed Drug Development (MIDD) assume in synergistically weaving the tapestry of intricate biological diversity and individualized therapeutic refinement, thereby orchestrating the modulation of dosing strategies amidst the complexities of cancer biology and patient heterogeneity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1650
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Model-Informed Drug Development (#MIDD#) integrates data to optimize dosing strategies by considering cancer biology complexity and patient #heterogeneity#, enhancing understanding of drug exposure, efficacy, and toxicity.",
            "predicted_answer": "Model-Informed Drug Development (MIDD) integrates data and quantitative models to understand drug exposure, efficacy, and toxicity in cancer and patient heterogeneity, aiding in personalized dosing strategies.",
            "score": 3,
            "explanation": "The Predicted Answer captures key aspects such as MIDD, drug exposure, efficacy, toxicity, cancer, and patient heterogeneity, aligning with the Reference Answer. It is missing the explicit mention of \"cancer biology complexity\" but maintains the overall theme of personalized dosing strategies."
        },
        {
            "query_idx": 1231,
            "query": "What determinants necessitate the orchestration of intrusive imagery-directed neoplastic sampling during the navigation of clinical conundrums to elucidate the pharmacodynamic footprint of investigational therapeutic entities within the oncological sphere?",
            "retrieved_metrics": {
                "reference_idx": [
                    1649
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Invasive imaging-guided# tumor biopsies are needed to evaluate #PD effects# at the action site, crucial for providing clinical proof of mechanism in pharmacological audits.",
            "predicted_answer": "Intrusive imagery-directed neoplastic sampling is necessitated by the need to evaluate pharmacodynamic effects of investigational therapeutic entities at the site of action, ensuring clinical proof of mechanism and informed decision-making in oncology.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key concepts of invasive imaging guidance and the evaluation of pharmacodynamic (PD) effects at the action site. It aligns with the overall reference, supporting clinical proof of mechanism, and informed decision-making, with no significant omissions."
        },
        {
            "query_idx": 1232,
            "query": "What conceptual challenges manifest when TGI models strive to translate the nuanced biological mechanisms of pharmacological interventions, and what supplementary intellectual apparatus could be crucial to enhance their prediction fidelity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1625
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TGI models face challenges in translating biological mechanisms due to their #semimechanistic# nature. Enhancing prediction fidelity could require #additional experimental data# and complex model formulations.",
            "predicted_answer": "Conceptual challenges include the semimechanistic nature of TGI models, which may lack resolution to infer biological mechanisms like drug inhibition or cytotoxicity. Supplementary intellectual apparatus such as additional experimental data and more complex model formulations could enhance prediction fidelity.",
            "score": 5,
            "explanation": "The Predicted Answer accurately includes the semimechanistic nature of TGI models and the need for additional experimental data and complex model formulations to enhance prediction fidelity. All key facts in the Reference Answer are reflected accurately in the Predicted Answer without omissions or contradictions."
        },
        {
            "query_idx": 1233,
            "query": "Which illustrious guilds of botanical molecular artisans stand as the primary architects of anticancer innovation amongst the pantheon of plant-sourced natural compounds?",
            "retrieved_metrics": {
                "reference_idx": [
                    1656
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #terpenoids#, #flavonoids#, and alkaloids serve as the primary architects of anti-cancer innovation among plant-sourced natural compounds.",
            "predicted_answer": "The primary architects of anticancer innovation among plant-sourced natural compounds include guilds specializing in terpenoids, flavonoids, and alkaloids.",
            "score": 5,
            "explanation": "The predicted answer matches all the key facts emphasized with # symbols in the reference answer: terpenoids and flavonoids are present. Additionally, the predicted answer does not contradict the reference answer and aligns with its overall trend."
        },
        {
            "query_idx": 1234,
            "query": "How does the PRO-Common Terminology Criteria for Adverse Events serve as a navigational compass in deciphering the multifaceted E-R dynamics, particularly concerning the nuanced interpretations of patient-reported adversities such as gastrointestinal distress exemplified by diarrhea?",
            "retrieved_metrics": {
                "reference_idx": [
                    1647
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PRO-CTCAE# helps elucidate E-R dynamics by assessing #patient-reported# adverse effects like diarrhea, balancing dose efficacy and tolerability, impacting quality of life interpretations.",
            "predicted_answer": "The PRO-Common Terminology Criteria for Adverse Events helps interpret patient-reported adversities like diarrhea by elucidating the relationship between dose and side effects, guiding dose adjustments to balance efficacy and tolerability.",
            "score": 3,
            "explanation": "The predicted answer captures the main idea of using PRO-CTCAE to interpret patient-reported adverse events such as diarrhea, impacting dose adjustments for efficacy and tolerability. It misses emphasizing the specific role of PRO-CTCAE in elucidating E-R dynamics and quality of life interpretations."
        },
        {
            "query_idx": 1235,
            "query": "In what manner do the kinetic symphonies orchestrated by Molecular Dynamics enlighten the pathway of pharmaceutical innovation when juxtaposed against the static tableaux that classical mechanisms present?",
            "retrieved_metrics": {
                "reference_idx": [
                    1658
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MD's #kinetic insights# predict molecular changes, unlike static models, enhancing #drug development# by understanding dynamic receptor structures and reducing late-stage failures.",
            "predicted_answer": "Molecular Dynamics (MD) provides a dynamic understanding of biomolecular interactions, crucial for predicting drug efficacy and reducing late-stage failures. This contrasts with static classical models, enhancing the pathway of pharmaceutical innovation by focusing on real-time molecular behavior.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer, mentioning the dynamic understanding of MD and its role in drug development. However, it does not explicitly mention \"kinetic insights\" or \"understanding dynamic receptor structures,\" missing one key detail. Overall, the key trends are aligned."
        },
        {
            "query_idx": 1236,
            "query": "What singular molecular champion was discerned as the foremost contender amidst the docking procedural dance, and by what elaborate validation process was the enduring stability of its symbiotic association with the target protein ascertained?",
            "retrieved_metrics": {
                "reference_idx": [
                    1663
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The molecular champion identified was #ST055650#, validated for stability with a #50-ns MD simulation# in complex with the target protein.",
            "predicted_answer": "The singular molecular champion identified was ST055650. Its enduring stability with the target protein was ascertained through a 50-ns MD simulation.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the molecular champion as ST055650 and mentions the validation method as a 50-ns MD simulation, encompassing all key facts and details emphasized in the reference answer. The meaning and information are consistent without omissions or errors."
        },
        {
            "query_idx": 1237,
            "query": "What strategic framework involving the intricate nexus of molecular interaction assessments did Singh et al. deploy to delineate the engagement spectrum of natural compounds with critical catalytic receptors, particularly in the domain of lung carcinoma therapeutic targets?",
            "retrieved_metrics": {
                "reference_idx": [
                    1669
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Singh et al. used #pharmacophore-guided# activity profiling of natural compounds from the ZINC database to assess interactions with five #tyrosine kinase# receptors in lung cancer therapy.",
            "predicted_answer": "Singh et al. deployed a pharmacophore-guided activity profiling framework to assess the interaction of natural compounds with critical lung carcinoma targets, including EGFR, cMET, ErbB2, FGFR, and ALK.",
            "score": 1,
            "explanation": "The predicted answer includes the phrase \"pharmacophore-guided activity profiling framework,\" matching the emphasis on \"pharmacophore-guided\" in the reference. However, it omits the ZINC database and specific mention of \"tyrosine kinase\" receptors. Therefore, more than one key fact is missing, impacting completeness."
        },
        {
            "query_idx": 1238,
            "query": "Amidst the molecular theatre of malignancy, how does DEAD box protein 3 (DDX3) maneuver within the intricate pathways of oncogenic transformation, thus impacting its multifaceted progression and cellular transfiguration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1670
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "DEAD box protein 3 (#DDX3#) is overexpressed in various cancers and plays a critical role in cancer #progression#, proliferation, and transformation.",
            "predicted_answer": "DEAD box protein 3 (DDX3) is overexpressed in various cancers and plays a crucial role in cancer progression, proliferation, and transformation by interacting with key pathways involved in oncogenic processes.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts: DDX3 is overexpressed in various cancers and is involved in cancer progression, proliferation, and transformation, as emphasized in the reference. The minor difference in wording doesn't affect meaning, thus ensuring consistency with the reference."
        },
        {
            "query_idx": 1239,
            "query": "What distinct embodiment of molecular affinity emerged from the intricate dialogues between the molecular gateway HER2 and the botanical transmitters sourced from Syzygium alternifolium, within the strategic framework targeting gastric cancer indications?",
            "retrieved_metrics": {
                "reference_idx": [
                    1668
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "HER2 exhibited maximum #affinity# with flavonoids from #Syzygium alternifolium#, showing potential against gastric cancer.",
            "predicted_answer": "The distinct embodiment of molecular affinity emerged as the maximum affinity between the molecular gateway HER2 and the flavonoids kaempferol-3-O-β-d-glucopyranoside and kaempferol-3-O-α-l-rhamnopyranoside from Syzygium alternifolium, targeting gastric cancer.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts with an emphasis on \"affinity,\" \"Syzygium alternifolium,\" and the objective of combating gastric cancer. Additionally, it provides the specific flavonoids involved, aligning well with the reference. There are no significant omissions or contradictions."
        },
        {
            "query_idx": 1240,
            "query": "What were the abstract parameters considered to discern curcumin's superior role in the intricate molecular choreography with DDX3, particularly focusing on its affinity symphony and interaction resonance within the binding spectrum?",
            "retrieved_metrics": {
                "reference_idx": [
                    1672
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin's #superior role# with DDX3 is discerned from binding affinity, key residue interactions, and molecular dynamics (#MD simulation#).",
            "predicted_answer": "The abstract parameters considered to discern curcumin's superior role in interacting with DDX3 included binding affinity, key residue interactions, and molecular dynamics simulation, identifying curcumin as the best lead molecule against DDX3.",
            "score": 5,
            "explanation": "The predicted answer includes all the key elements mentioned in the reference: binding affinity, key residue interactions, and molecular dynamics simulation, showing curcumin's superior role. No significant details are missing, and there's alignment with the reference's meaning."
        },
        {
            "query_idx": 1241,
            "query": "In the realm of molecular architecture, what pivotal function does the Hip-Hop algorithm serve in the nuanced symphony of ligand-based pharmacophore discovery, particularly when crafting selective inhibitory motifs for the exuberant CDK7 isoforms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1673
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Hip-Hop algorithm# generates #pharmacophore models# for ligand-based discovery, aiding selective inhibitory motif synthesis for CDK7 isoforms.",
            "predicted_answer": "The Hip-Hop algorithm in ligand-based pharmacophore discovery generates selective inhibitory motifs for CDK7 isoforms, aiding in the design of inhibitors targeting overexpressed CDK7 in cancers.",
            "score": 3,
            "explanation": "The predicted answer discusses the Hip-Hop algorithm's role in generating selective inhibitory motifs for CDK7, similar to the reference answer. However, it omits the mention of \"pharmacophore models,\" a key detail. Otherwise, the predicted answer aligns with the reference in trend and context."
        },
        {
            "query_idx": 1242,
            "query": "What was the intricate mechanism employed to corroborate the credibility of the ligand-originated prototype, leading to the emergence of the preeminent model for subsequent evaluative consideration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1671
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate mechanism involved using a ligand-based pharmacophore model, validated with #100 actives# and #425 decoys#, followed by screening via docking-based VS and ADMET properties.",
            "predicted_answer": "The credibility of the ligand-originated prototype was corroborated through quantitative validation with 100 actives and 425 decoys, followed by docking-based virtual screening and ADMET property analysis.",
            "score": 5,
            "explanation": "The predicted answer accurately includes all key facts from the reference answer: validation with 100 actives and 425 decoys, docking-based virtual screening, and ADMET property analysis. The predicted and reference answers are consistent with no significant omissions or errors, covering all required details."
        },
        {
            "query_idx": 1243,
            "query": "What intricate parameters and molecular thresholds did compounds T9 and B42 surpass, designating them as leading prospects in the pharmacological challenge against bladder cancer?",
            "retrieved_metrics": {
                "reference_idx": [
                    1676
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compounds #T9# and #B42# surpassed Lipinski's rule of 5, PK/PD, and toxicity parameters, marking them as promising pharmacological leads against bladder cancer.",
            "predicted_answer": "Compounds T9 and B42 surpassed Lipinski's rule of 5, PK/PD, and toxicity parameters, designating them as leading prospects in the pharmacological challenge against bladder cancer.",
            "score": 5,
            "explanation": "The predicted answer fully includes all key facts emphasized in the reference answer: compounds T9 and B42 and the criteria they surpassed (Lipinski's rule of 5, PK/PD, and toxicity). The phrasing is consistent, and no essential information is missing or contradictory."
        },
        {
            "query_idx": 1244,
            "query": "What are the divergent pathways of quality assurance employed in navigating the precision landscapes, ensuring the fidelity of the pharmacophore models crafted in this scientific inquiry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1674
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The divergent pathways are the #ROC curve# and #Güner-Henry approach#, used to validate both ligand and structure-based pharmacophore models.",
            "predicted_answer": "The divergent pathways of quality assurance include generating pharmacophore models using Hip-Hop and structure-based methods, validating with ROC curves and Güner-Henry approach, and screening compounds for ADMET properties and molecular docking.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized in the reference answer, namely the ROC curve and Güner-Henry approach, as validation methods for pharmacophore models. There are no significant omissions or contradictions, and other mentioned methods align with the inquiry's scope."
        },
        {
            "query_idx": 1245,
            "query": "Within the multi-layered framework of molecular edifices, what notable intrinsic feature in GA-1 underpins its superior efficacy in countering cancerous cell proliferation relative to its progenitor compound?",
            "retrieved_metrics": {
                "reference_idx": [
                    1678
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #C-30 carboxylic group# in #GA-1# is the intrinsic feature enhancing its anti-cancer efficacy compared to its parent compound.",
            "predicted_answer": "The notable intrinsic feature in GA-1 that underpins its superior efficacy in countering cancerous cell proliferation is the C-30 carboxylic group, which enhances its cytotoxic activity compared to its progenitor compound.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts from the reference answer: the significance of the C-30 carboxylic group in GA-1 and its enhanced cytotoxic activity/anti-cancer efficacy compared to its progenitor or parent compound. Both answers are consistent in meaning without significant omissions or errors."
        },
        {
            "query_idx": 1246,
            "query": "Within the sophisticated landscape of biochemical interactions, what elemental force was regarded as the prime catalyst of transformation pertaining to the cancer-combat potential inherent in lonchocarpin?",
            "retrieved_metrics": {
                "reference_idx": [
                    1679
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydrophobic interactions# were regarded as the prime catalyst of #transformation# for the cancer-combat potential of lonchocarpin.",
            "predicted_answer": "Hydrophobic interactions were regarded as the prime catalyst of transformation in the cancer-combat potential of lonchocarpin.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts emphasized in the reference answer, specifically \"hydrophobic interactions\" and \"transformation\" related to the cancer-combat potential of lonchocarpin. There are no significant omissions or contradictions, thus maintaining alignment with the reference."
        },
        {
            "query_idx": 1247,
            "query": "What intricate analytical mechanism was orchestrated to reveal compound P-902's potency in engaging with the breast cancer mechanistic proxies, specifically AKR1B10, NR3C1, PTGS2, and HER2, by navigating through a conceptual lattice of virtual analog mapping?",
            "retrieved_metrics": {
                "reference_idx": [
                    1675
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Compound #P-902#'s potency for breast cancer targets was revealed using 3D-QSAR via #virtual analog mapping# based on pharmacophore templates and field points-based descriptors.",
            "predicted_answer": "A 3D-QSAR model was developed using field points-based descriptors and pharmacophore templates to identify compound P-902 as the best candidate for targeting AKR1B10, NR3C1, PTGS2, and HER2 in breast cancer.",
            "score": 3,
            "explanation": "The predicted answer aligns well with the reference answer, covering the use of a 3D-QSAR model, pharmacophore templates, and field points-based descriptors for evaluating compound P-902. However, it does not explicitly mention \"virtual analog mapping,\" a key detail from the reference."
        },
        {
            "query_idx": 1248,
            "query": "What strategic molecular transfiguration influences the anabolic symphony of cardenolides, facilitating a notable augmentation in their deterrent choreography against pulmonary cell proliferation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1680
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The addition of a #sugar moiety# at the #C3 position# of cardenolides enhances their anti-proliferative impact on lung cancer cells.",
            "predicted_answer": "The strategic molecular transfiguration of adding a sugar moiety at the C3 position of cardenolides notably augments their deterrent effect against pulmonary cell proliferation.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts emphasized in the reference answer: the addition of a \"sugar moiety\" and its location at the \"C3 position\" of cardenolides. The overall trend about enhancement against pulmonary cell proliferation is consistent, with minor wording differences."
        },
        {
            "query_idx": 1249,
            "query": "What strategic matrices are engaged in the comprehensive landscapes for ADMET assessment using QikProp, and how do these matrices intricately unravel the sophisticated narrative of a compound's systemic voyage and its integrative safety dimensions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1684
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Key matrices in the ADMET assessment with QikProp are #Lipinski's Rule of 5# and #polar surface area#, which unravel a compound’s systemic voyage and safety dimensions.",
            "predicted_answer": "The strategic matrices in ADMET assessment using QikProp include Lipinski's Rule of 5, Jorgensen's Rule of 3, logP, logKHSA, loghERG, and logBB, which unravel a compound's systemic voyage and safety dimensions.",
            "score": 3,
            "explanation": "The 'Predicted Answer' includes Lipinski's Rule of 5 but omits polar surface area, which is critical according to the 'Reference Answer'. Instead, it adds other elements not emphasized in the reference. Hence, it is missing one key fact that affects completeness."
        },
        {
            "query_idx": 1250,
            "query": "What advanced methodological journey facilitated by Taha et al., marked by high-grade analytical resolution, was undertaken to navigate through the intricate molecular tapestry of plant extracts, setting the stage for the conceptualization of compound-target and compound-target-pathway interactive frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1686
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Taha et al. used #UPLC-MS/MS# to analyze plant extracts, facilitating compound-target and compound-target-pathway networks utilizing STITCH, DAVID, KEGG, and STRING databases.",
            "predicted_answer": "Taha et al. used Ultrahigh performance liquid chromatography-MS/MS (UPLCMS/MS) to analyze plant extracts, enabling the conceptualization of compound-target and compound-target-pathway interactive frameworks.",
            "score": 3,
            "explanation": "The predicted answer accurately includes the key fact that UPLC-MS/MS was used by Taha et al. to analyze plant extracts. However, it omits the crucial detail about the utilization of STITCH, DAVID, KEGG, and STRING databases, which is significant for the completeness of this analysis."
        },
        {
            "query_idx": 1251,
            "query": "What evaluative framework was employed to discern the foremost 20 focal points within the pulmonary carcinoma domain, guided by the principle of connectivity magnitude?",
            "retrieved_metrics": {
                "reference_idx": [
                    1691
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The evaluative framework employed was #degree centrality# (DC), calculated for a PPI network by CentiScaPe, to filter the top #20 targets#.",
            "predicted_answer": "The evaluative framework employed was degree centrality (DC) calculated by CentiScaPe, which filtered the top 20 targets with the highest DC value in the PPI network generated for lung cancer targets.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts from the reference answer: it mentions \"degree centrality\" (DC), the use of CentiScaPe, and identifying the \"top 20 targets\" in the PPI network for lung cancer. The phrasing is consistent, and no critical details are missing."
        },
        {
            "query_idx": 1252,
            "query": "What chemical entity, through an intricate exploration involving spatial structural interfacing and dynamic computational trajectory analysis, was recognized as a substantial affiliate with numerous targets linked to breast cellular aberrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1693
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chemical entity recognized as a substantial affiliate with numerous targets linked to #breast cellular aberrations# is #β-bourbonene#.",
            "predicted_answer": "β-bourbonene was recognized as a substantial affiliate with numerous targets linked to breast cellular aberrations through spatial structural interfacing and dynamic computational trajectory analysis.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies β-bourbonene as the chemical entity associated with numerous targets related to breast cellular aberrations, fully covering the key facts highlighted with # symbols in the reference answer. The predicted answer aligns with the reference without significant omissions or discrepancies."
        },
        {
            "query_idx": 1253,
            "query": "What assembly of 79 phytochemical orchestrators has been delineated as engaging in nuanced interactions with 35 distinctively responsive genomic expressions within the broader expanse of 384 gene variations, as identified by the interpretative matrix of SwissTargetPrediction?",
            "retrieved_metrics": {
                "reference_idx": [
                    1696
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The assembly of #79 phytochemical orchestrators# engages with #35 genomic expressions# within 384 gene variations, identified by SwissTargetPrediction.",
            "predicted_answer": "The assembly of 79 phytochemical orchestrators engages in nuanced interactions with 35 distinctively responsive genomic expressions within 384 gene variations, as identified by SwissTargetPrediction.",
            "score": 5,
            "explanation": "The predicted answer includes #79 phytochemical orchestrators#, #35 genomic expressions#, and matches the overall trend and details of the reference answer. All key facts emphasized are present in the predicted answer, with no omissions or contradictions."
        },
        {
            "query_idx": 1254,
            "query": "What fraction of the predictive success narrative, in relation to the anticipated cellular specimen responsiveness, did curcumin and resveratrol accomplish regarding their alignment with the forecasted sensitivity profiles?",
            "retrieved_metrics": {
                "reference_idx": [
                    1700
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Curcumin accomplished #6/7#, and resveratrol achieved #5/8# in aligning with the forecasted sensitivity profiles.",
            "predicted_answer": "Curcumin correctly predicted 6 out of 7 cell lines, and resveratrol correctly predicted 5 out of 8, indicating a predictive success of approximately 86% and 62.5%, respectively.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts and details from the reference answer, stating that curcumin predicted 6/7 and resveratrol 5/8 correctly, aligned with the forecasted sensitivity profiles. The additional percentage details do not contradict the reference information."
        },
        {
            "query_idx": 1255,
            "query": "In the vast landscape navigated by Rayan et al.'s analytical odyssey, what distinct compendiums of molecular assemblages were orchestrated as the articulate and dormant participants within the envisioned pharmacological matrix for unearthing anti-cancer ostensive realities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1701
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Rayan et al. orchestrated #617 approved anti-cancer drugs# as actives and #2892 phytochemicals# as inactives within the pharmacological matrix for anti-cancer discovery.",
            "predicted_answer": "Rayan et al. orchestrated distinct compendiums of molecular assemblages, including 617 approved anti-cancer drugs and 2892 phytochemicals, to develop a predictive model for identifying anti-cancer activity.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the same key facts, including \"617 approved anti-cancer drugs\" and \"2892 phytochemicals,\" matching the Reference Answer's emphasis. However, it doesn't specify the roles (actives and inactives), affecting completeness but generally follows the trend without contradictions."
        },
        {
            "query_idx": 1256,
            "query": "Within the intricate weave of predictive capability assessment, what abstracted performance criteria were utilized to discern the models' efficacy, and which entity emerged as the paragon of classification acumen upon the autonomous cohort?",
            "retrieved_metrics": {
                "reference_idx": [
                    1698
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #MACCS fingerprint# model, evaluated by #Matthew's correlation coefficient# and ROC AUC, demonstrated superior classification ability in identifying NPs, achieving 95% accuracy on the validation set.",
            "predicted_answer": "The abstracted performance criteria included Matthew's correlation coefficient and area under the receiver operating characteristic curve. The model based on MACCS fingerprints emerged as the paragon of classification acumen, correctly identifying 95% of NPs in external validation.",
            "score": 5,
            "explanation": "The predicted answer includes all key elements emphasized by # symbols: \"MACCS fingerprint\" model, \"Matthew's correlation coefficient,\" and ROC AUC. It also reflects the overall trend by noting the 95% accuracy in classification. No significant omissions or errors are present."
        },
        {
            "query_idx": 1257,
            "query": "In the context of probing the intricate networks of cellular receptivity to a suite of 17 novel pharmacological entities, through what comprehensive categorization framework were the cancer cell line populations delineated, before these formed the baseline for constructing anticipatory modeling constructs grounded in machine learning methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1699
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cancer cell lines were classified into #Sensitive, Resistant, Intermediate# groups using #K-Means clustering# in WEKA before constructing machine learning models.",
            "predicted_answer": "The cancer cell line populations were delineated into three groups (Sensitive, Resistant, and Intermediate) using the K-Means clustering algorithm in WEKA, based on IC$_{50}$ values for the 17 pharmacological entities.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the classification of cancer cell lines into three groups (Sensitive, Resistant, and Intermediate) using K-Means clustering in WEKA, which aligns with the key details emphasized in the reference answer. No significant omissions or errors are present."
        },
        {
            "query_idx": 1258,
            "query": "What influence does the dynamic spectrum of experimental concentration metrics in xenograft models exert on the calibration process of therapeutic thresholds for inaugural human administrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1707
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #dynamic spectrum# of experimental concentration metrics in xenograft models influences #calibration# of therapeutic thresholds for First-In-Human studies by guiding target concentration and dose selection.",
            "predicted_answer": "The dynamic spectrum of experimental concentration metrics in xenograft models influences the calibration process by providing a range of target concentrations in humans, aiding in dose selection for First-In-Human studies.",
            "score": 5,
            "explanation": "The 'Predicted Answer' captures the main concepts of the 'Reference Answer' such as the \"dynamic spectrum,\" \"calibration,\" and \"dose selection for First-In-Human studies.\" It reflects the key facts and overall trend, with no significant omissions or contradictions noted."
        },
        {
            "query_idx": 1259,
            "query": "What evaluative dimension, often metaphorically akin to the chronicle of dimensional fluctuation, serves as a benchmark to quantify oncological inhibition in xenografted creatures, specifically by tracking the narrative of volumetric shifts across chronological phases?",
            "retrieved_metrics": {
                "reference_idx": [
                    1708
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The evaluative dimension is #tumor volume#, serving to quantify oncological inhibition by tracking #tumor growth# over time in xenografted models.",
            "predicted_answer": "Tumor growth inhibition (TGI) serves as the benchmark to quantify oncological inhibition in xenografted creatures by tracking volumetric shifts over time.",
            "score": 3,
            "explanation": "The predicted answer and the reference answer both identify the concept of measuring oncological inhibition through volumetric changes over time. However, the predicted answer uses \"tumor growth inhibition\" instead of specifically mentioning \"tumor volume.\" This omission affects completeness but doesn't introduce contradiction."
        },
        {
            "query_idx": 1260,
            "query": "Within the spectrum of three-dimensional cellular orchestration sans external framework, what are the chief methodological stratagems employed to engender a milieu that innately reflects the intricate cell-matrix interplay, particularly in the context of tumorigenic research explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1712
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The chief methods include #cellular# self-assembly techniques: agitation-based, hanging drop, liquid overlay, magnetic levitation, and microfluidic, enabling natural #cell-matrix# interaction in tumorigenic research.",
            "predicted_answer": "The chief methodological stratagems include agitation-based, hanging drop, liquid overlay, magnetic levitation, and microfluidic techniques, which enable cancer cells to synthesize their own extracellular matrix, mimicking natural cell-matrix interactions.",
            "score": 5,
            "explanation": "The key facts in the reference, such as \"cellular\" and \"cell-matrix\" interactions, are implicitly reflected in the predicted answer despite some wording differences. The overall methodological strategies and context are present without contradictions, aligning with the reference's focus on tumorigenic research interactions."
        },
        {
            "query_idx": 1261,
            "query": "In what ways might the interplay between operational nuances of the liquid overlay and hanging drop embodiments, alongside the intrinsic self-assembly tendencies of Panc-1, Mia-PaCa, and CAKI-I cellular frameworks, pose formidable challenges to crafting cellular spheroidal constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1719
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #limited self-assembly tendencies# of Panc-1, Mia-PaCa, and CAKI-I make using #liquid overlay and hanging drop# methods challenging for forming cellular spheroidal constructs.",
            "predicted_answer": "The interplay between operational nuances of liquid overlay and hanging drop techniques and the intrinsic self-assembly tendencies of Panc-1, Mia-PaCa, and CAKI-I cells can pose challenges due to these cells' low self-aggregation ability, making it difficult to form spheroids effectively.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key aspects of the reference answer, specifically the \"limited self-assembly tendencies\" of the cell lines and the challenges in using \"liquid overlay and hanging drop\" methods. There are no significant omissions or errors affecting the completeness."
        },
        {
            "query_idx": 1262,
            "query": "What is the spectrum of triumph variability for the cultivation of personalized neoplastic miniaturized simulations, specifically when analyzing prostatic and colorectal malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1723
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The spectrum of triumph variability for personalized simulations shows a high success rate of 70-100% for #colorectal cancer# and a low rate of #15-20%# for prostate cancer.",
            "predicted_answer": "The spectrum of triumph variability for cultivating personalized neoplastic miniaturized simulations, specifically for prostatic and colorectal malignancies, ranges from 15-20% for prostate cancer to 70-100% for colorectal cancer.",
            "score": 5,
            "explanation": "The predicted answer matches all key facts from the reference answer: #colorectal cancer# and the spectrum of #15-20%# for prostate cancer. It accurately reflects the success rates mentioned for both prostate and colorectal cancer, with no omissions or contradictions."
        },
        {
            "query_idx": 1263,
            "query": "Within the realm of cellular cultivation paradigms, what intrinsic element of structural precision does an engineered hydrogel matrix offer over the variable, serendipitous nature of Matrigel, particularly in orchestrating the nuanced symphony of organoid-drug dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1725
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Synthetic hydrogels offer #precision# by being fully defined and growth-factor-free, improving control over #organoid-drug dynamics# compared to Matrigel's batch variability and animal growth factors influence.",
            "predicted_answer": "An engineered hydrogel matrix offers structural precision and reproducibility over Matrigel's variability, enabling more controlled and predictable organoid-drug interactions.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of \"precision\" by highlighting \"structural precision and reproducibility\". It also mentions the control over \"organoid-drug interactions,\" aligning with #organoid-drug dynamics#. However, it omits the emphasis on being \"fully defined and growth-factor-free\", which affects completeness."
        },
        {
            "query_idx": 1264,
            "query": "In the expansive realm of cellular construct cultivation, what emergent biological framework, often chosen in the preponderance of academic investigations, serves as the surrogate microenvironment matrix for nurturing multicellular cancerous formations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1724
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the realm of cellular construct cultivation, #Matrigel#, an animal-derived hydrogel, serves as the surrogate microenvironment for nurturing #cancer organoids#.",
            "predicted_answer": "Matrigel, a protein mixture secreted by mouse sarcoma cells, is commonly used as the surrogate microenvironment matrix for nurturing multicellular cancerous formations in cellular construct cultivation.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies \"Matrigel\" as the surrogate microenvironment matrix, as stated in the reference. It also mentions its use for nurturing multicellular cancerous formations, which aligns with \"cancer organoids\" in the reference. Both key facts are covered, with no contradiction."
        },
        {
            "query_idx": 1265,
            "query": "To what extent do the inherent murine stromal architectures intricately weave themselves into the sophisticated tapestry of processes involved in the development of organoids originating from patient-derived xenografts, consequently complicating their formation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1730
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #mouse stromal components# complicates the formation of organoids by necessitating their removal for successful PDxO development.",
            "predicted_answer": "The inherent murine stromal architectures in patient-derived xenografts (PDX) can complicate the formation of organoids by introducing additional complexity and requiring the removal of mouse stromal components.",
            "score": 5,
            "explanation": "The 'Predicted Answer' mentions the complication caused by murine stromal architectures and the requirement for their removal, aligning with the key fact in the 'Reference Answer' about mouse stromal components. There are no significant omissions or contradictions, covering all key facts emphasized."
        },
        {
            "query_idx": 1266,
            "query": "Within the realm of crafting organoid formations from PDX specimens, what complexities arise in the meticulous process of extricating non-human stromal interferences, and how proficiently did Guillen and colleagues navigate these to establish enduring organoid cultures with their PDxO iterations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1729
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Guillen# and colleagues successfully navigated stromal complexities, achieving an 85% success rate in deriving 40 PDxO lines from breast cancer PDXs, culturing them over #200 days#.",
            "predicted_answer": "The complexities in crafting organoid formations from PDX specimens include the challenge of removing non-human stromal components. Guillen and colleagues successfully navigated these by deriving 40 PDxO lines from breast cancer PDXs with an 85% success rate, maintaining cultures for over 200 days.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: the success rate of 85%, the derivation of 40 PDxO lines from breast cancer PDXs, and maintaining cultures for over 200 days. The meaning and key information are fully captured without contradictions."
        },
        {
            "query_idx": 1267,
            "query": "What fundamental physiological element within the organizational blueprint of cellular entities enables dye exclusion methodologies to identify living specimens as distinct from deceased, with regard to the permeability selectivity of their membranous barriers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1735
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #intact membrane# of living cells prevents dye entry, enabling dye exclusion assays to differentiate living from dead cells based on #membrane permeability#.",
            "predicted_answer": "The fundamental physiological element enabling dye exclusion methodologies is the intactness of the cell membrane, which selectively prevents dyes from entering living cells but allows passage in deceased cells.",
            "score": 5,
            "explanation": "The Predicted Answer covers the key facts emphasized in the Reference Answer: the #intact membrane# and #membrane permeability#. Both answers mention the ability of living cells to prevent dye entry due to the intactness of the cell membrane, aligning with the overall trend without omissions."
        },
        {
            "query_idx": 1268,
            "query": "What impediments arise in achieving a methodological uniformity for the discernment of therapeutic potency amidst the intricate mosaic of 3D in vitro cancer model assessments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1734
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Achieving methodological uniformity in #3D in vitro# cancer model assessments is impeded by the lack of standardized approaches, leading to varied assays and techniques for evaluating therapeutic potency.",
            "predicted_answer": "Impediments include the lack of standardized approaches and the use of varied assays for efficacy assessment, leading to inconsistencies in therapeutic potency discernment across 3D in vitro cancer models.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by highlighting the lack of standardized approaches and variability in assays, which are key impediments to measuring therapeutic potency in 3D in vitro cancer models. The essential facts and trends are covered without contradiction."
        },
        {
            "query_idx": 1269,
            "query": "Through what procedural enhancements and theoretical adjustments did Eilenberger et al. elevate the traditional alamarBlue viability protocol, manufacturing a more precise evaluative capacity tailored to the complex architecture of spheroid cultures within their experimentations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1736
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Eilenberger et al. enhanced #assay precision# through #optimizing# the standard alamarBlue protocol, tailoring it for the complex architecture of spheroid cultures.",
            "predicted_answer": "Eilenberger et al. enhanced the alamarBlue viability protocol by optimizing it for spheroid cultures, aiming to improve assay precision for complex architectures.",
            "score": 5,
            "explanation": "The Predicted Answer includes the key facts: \"enhanced assay precision\" and \"optimizing\" for \"spheroid cultures,\" both present in the Reference Answer. The overall meaning and key details are fully captured without omissions or contradictions, aligning with the Reference's emphasis."
        },
        {
            "query_idx": 1270,
            "query": "What transformation occurred in the fidelity of the evaluative signal's clarity due to the temporal extension to a diurnal span, specifically in the context of the spatial organoid conformations subjected to sorafenib treatment?",
            "retrieved_metrics": {
                "reference_idx": [
                    1738
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #clarity# of the evaluative signal's fidelity in #spatial organoid# conformations improved significantly, with the standard deviation range reduced to 4-10% after 24 hours.",
            "predicted_answer": "The fidelity of the evaluative signal's clarity significantly improved with the temporal extension to a diurnal span, particularly in 3D spheroids, reducing the standard deviation range to 4-10%.",
            "score": 5,
            "explanation": "Both answers mention the improved clarity of evaluative signal fidelity and the reduction of the standard deviation range to 4-10%. The predicted answer specifically mentions \"3D spheroids\" while the reference mentions \"spatial organoid conformations,\" indicating alignment in context. No critical facts are omitted or contradicted."
        },
        {
            "query_idx": 1271,
            "query": "In the intricate dynamics of comparative pharmacodynamics, what interpretative void arises from IC50's singular concentration snapshot compared to the inclusive spectrum measured by AUC's area under the concentration-response narrative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1746
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The interpretative void from IC50's snapshot is the lack of #comprehensive# information on drug effectiveness across various concentrations, unlike the inclusive spectrum measured by #AUC#.",
            "predicted_answer": "The interpretative void arises from IC50's limited focus on a single concentration, lacking the comprehensive drug effectiveness assessment provided by AUC's integration across a range of concentrations.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key idea of IC50's limitation in providing a full assessment of drug effectiveness across various concentrations, which is addressed by AUC. It aligns well with the reference answer, covering the essential element of comprehensiveness emphasized by # symbols."
        },
        {
            "query_idx": 1272,
            "query": "What is the advanced optical modality capable of capturing intricate details within substantial multilayered cellular architecture, thus metaphorically unveiling the concealed stratigraphy of such in vitro constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1749
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The advanced optical modality is #confocal microscopy#, capable of capturing intricate details within substantial multilayered cellular architecture.",
            "predicted_answer": "Confocal microscopy is the advanced optical modality capable of capturing intricate details within substantial multilayered cellular architecture, unveiling the concealed stratigraphy of in vitro constructs.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies #confocal microscopy# as the advanced optical modality, aligning with the key facts in the reference answer. It fully covers the essence of capturing intricate details within multilayered cellular architectures without omissions or errors."
        },
        {
            "query_idx": 1273,
            "query": "In the intricate tapestry of cellular exploration, what are the transcendent functions of mechanized vision systems and non-invasive molecular interpreters in comprehending the enigmatic choreography of cancer pathophysiology and pharmacological influence?",
            "retrieved_metrics": {
                "reference_idx": [
                    1751
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Mechanized vision systems offer #real-time# monitoring and detailed imaging, while non-invasive molecular interpreters like #label-free biosensors# provide insights into cancer biology and drug activity.",
            "predicted_answer": "Mechanized vision systems, like super-resolution microscopy, provide detailed insights into cancer cell dynamics and microenvironment, while non-invasive molecular interpreters, such as imaging mass cytometry, offer real-time analysis of drug effects, aiding in understanding cancer pathophysiology and pharmacological influence.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference by emphasizing detailed imaging and analysis. However, it misses \"real-time\" for mechanized vision systems and \"label-free biosensors\" specifically for non-invasive molecular interpreters, affecting completeness. No contradictory information is present."
        },
        {
            "query_idx": 1274,
            "query": "What philosophical abstractions dictate the strategic alignment of imaging methods with the nuanced volumetric reconstruction needs of spheroids, including considerations for morphological idiosyncrasies that deviate from standard spherical forms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1753
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic alignment of imaging methods relies on #spheroid morphology# and the need for accuracy in #3D reconstruction#, especially for irregular structures needing advanced 3D systems.",
            "predicted_answer": "Philosophical abstractions guiding strategic alignment of imaging methods for spheroids include considerations of morphology and measurement accuracy. For sphere-like spheroids, 2D brightfield imaging suffices, while irregular structures require advanced 3D imaging systems.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"spheroid morphology\" and the \"need for accuracy in 3D reconstruction\". It discusses methods for regular and irregular structures, aligning with the reference. No key facts are missing, and the trend is consistent, though phrasing differs slightly."
        },
        {
            "query_idx": 1275,
            "query": "In the intricate context of spheroidal study methodologies, what fundamental shift in the volumetric parameters is perceived as the ultimate gauge of treatment success?",
            "retrieved_metrics": {
                "reference_idx": [
                    1752
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduction of spheroid volume# is perceived as the #ultimate gauge# of treatment success in spheroidal studies.",
            "predicted_answer": "A reduction in spheroid volume is considered the primary endpoint of treatment efficacy in spheroid studies.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts from the reference: the \"reduction of spheroid volume\" and that it is the \"primary endpoint\"/\"ultimate gauge\" of treatment success. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1276,
            "query": "What inherent limitations within the functional construct of the Trypan Blue assay restrict its adeptness in discerning and measuring the intricate nuances of dose-responsive pharmacological activity, especially in the context of being juxtaposed with the more specialized 3D-specific evaluative methodologies in multi-dimensional cellular assay environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1741
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Trypan Blue# assay fails to capture dose dependence and exhibits high variability (#CV = 42.7#), unlike 3D-specific assays with low variability.",
            "predicted_answer": "The Trypan Blue assay's limitations include failing to capture dose-dependence and high variability in viability results, making it less adept at discerning intricate pharmacological nuances compared to specialized 3D-specific assays with lower variability and accurate dose-response identification.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the Trypan Blue assay's failure to capture dose-dependence and its high variability in results, aligning with the Reference Answer's key facts. However, it lacks the specific variability measurement (#CV = 42.7#), which affects the overall completeness of the response."
        },
        {
            "query_idx": 1277,
            "query": "In exploring the dynamic realm of onco-therapeutic validation, which specific light-reflective apparatus and analytic digital schema were harnessed by Yao et al. to depict the evolving volumetric narrative of patient-conceived cellular replicas?",
            "retrieved_metrics": {
                "reference_idx": [
                    1756
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Yao et al. used an #inverted microscope# in a brightfield setting and analyzed images with #Image-Pro Plus 6.0# software to monitor organoid size changes.",
            "predicted_answer": "Yao et al. used an inverted microscope in a brightfield setting and Image-Pro Plus 6.0 software to monitor and analyze the volumetric changes of patient-derived organoids.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized in the reference answer: the use of an \"inverted microscope\" and the \"Image-Pro Plus 6.0\" software in a brightfield setting to analyze changes in organoid size. There are no significant omissions or discrepancies."
        },
        {
            "query_idx": 1278,
            "query": "In what manner does the optical modulation index orchestrate the utilization of intrinsic cellular luminescent phenomena to elucidate transformation trends in the structural evolution of organoids within patient-derived studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1758
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #optical modulation index# utilizes cellular autofluorescence to assess changes in #organoid size# and optical redox ratio in patient-derived studies.",
            "predicted_answer": "The optical modulation index (OMI) utilizes the optical redox ratio, derived from NAD(P)H and FAD fluorescence, to monitor changes in organoid size and structural evolution, providing insights into transformation trends in patient-derived organoid studies.",
            "score": 5,
            "explanation": "The Predicted Answer aligns well with the Reference Answer, mentioning both the \"optical modulation index\" and the monitoring of \"organoid size.\" It also emphasizes the optical redox ratio, a derived and relevant concept. This covers key components effectively, with no major omissions or errors."
        },
        {
            "query_idx": 1279,
            "query": "What is the impact of metaphorically aligning growth parameters with primordial dimensional archetypes for each singular organoid construct in refining the acuity of exclusive observational tactics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1757
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Aligning growth parameters with #dimensional archetypes# for each organoid construct improves exclusive #observational tactics# by refining individual organoid monitoring and measurement precision, reducing variability.",
            "predicted_answer": "Aligning growth parameters with primordial dimensional archetypes enhances the precision of tracking individual organoid structures, reducing measurement noise and improving the acuity of exclusive observational tactics.",
            "score": 3,
            "explanation": "The predicted answer includes the alignment of growth parameters with \"primordial dimensional archetypes\" and mentions improving the acuity of exclusive observational tactics, matching the reference's key focus on \"dimensional archetypes\" and \"observational tactics.\" However, it misses the emphasis on reducing variability."
        },
        {
            "query_idx": 1280,
            "query": "In studies examining the biostructural formations subjected to therapeutic interventions, what abstractly conceptualized quantitative measure serves to encapsulate the differential impacts by contrasting the modified systematics with the unperturbed assemblages, and by which mathematical principle is this disparity meticulously articulated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1762
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The quantitative measure is #Glass's Delta# index, which encapsulates differential impacts using the mathematical principle of mean difference divided by control group's standard deviation.",
            "predicted_answer": "The Glass's Delta index serves as a quantitative measure to encapsulate the differential impacts of therapeutic interventions by contrasting modified systematics with unperturbed assemblages. This disparity is articulated through the mathematical principle of computing the mean difference between treated and control groups, normalized by the standard deviation of the control group.",
            "score": 5,
            "explanation": "The Predicted Answer accurately identifies and explains #Glass's Delta# as the quantitative measure, adhering to the mathematical principle of #mean difference divided by control group's standard deviation#. Key facts are present and trends align well with the Reference Answer."
        },
        {
            "query_idx": 1281,
            "query": "In the nuanced exploration of pharmacodynamic relationships and investigational models, particularly within the OV4453 and OV4485 cell lines, what emergent alignment exists between the resistive architectures of 3D spheroid constructs and the observed in vivo dynamics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1765
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #3D spheroids# showed higher #carboplatin resistance# than xenograft mice for OV4453 and OV4485, aligning with in vivo dynamics despite differences in specific resistance levels.",
            "predicted_answer": "The resistive architectures of 3D spheroid constructs in OV4453 and OV4485 cell lines show higher carboplatin resistance compared to in vivo xenograft mice, aligning with observed in vivo dynamics.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer: \"3D spheroids,\" \"higher carboplatin resistance,\" \"OV4453 and OV4485,\" and the alignment with \"observed in vivo dynamics.\" The information is consistent with the reference, without significant omissions or errors."
        },
        {
            "query_idx": 1282,
            "query": "Within the complex architecture of three-dimensional cellular matrices sourced from HER2-overexpressing oncogenic formations, what intrinsic molecular elements within the conjugated therapeutic paradigm of immunoliposomes conjoined with a monoclonal antibody dictate the orchestration of antiproliferative dynamics observed across variable biological contexts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1768
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The antiproliferative dynamics in #immunoliposomes# with #trastuzumab# depend on cell type, spheroid size, and treatment schedule, surpassing current anti-HER2 strategies.",
            "predicted_answer": "The intrinsic molecular elements within the conjugated therapeutic paradigm of immunoliposomes conjoined with a monoclonal antibody, such as trastuzumab, dictate the orchestration of antiproliferative dynamics by targeting HER2-overexpressing cells and enhancing cell growth reduction, as observed in different biological contexts like cell type, spheroid size, and treatment scheduling.",
            "score": 3,
            "explanation": "The predicted answer correctly includes the key elements of \"immunoliposomes,\" \"trastuzumab,\" and addresses factors such as \"cell type,\" \"spheroid size,\" and \"treatment scheduling.\" It aligns with the reference answer but lacks mention of \"surpassing current anti-HER2 strategies,\" which affects completeness."
        },
        {
            "query_idx": 1283,
            "query": "Within the diverse and layered architectures of oncological investigations, what are the salient variations in research paradigms that shape and influence the perceptual depth and evaluative clarity of the relational dynamics between PDO representations and the spectrum of patient clinical outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1769
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Diverse research paradigms vary in #tumor type#, cohort size, study design, and statistical methods, affecting the correlation between #PDO representations# and patient outcomes.",
            "predicted_answer": "The salient variations in research paradigms include differences in tumor type, patient cohort size, study design, treatment response definitions, inclusion of PDXs, and statistical methods. These factors shape the perceptual depth and evaluative clarity of PDO representations and patient clinical outcomes.",
            "score": 5,
            "explanation": "The predicted answer addresses key facts such as tumor type, cohort size, study design, and statistical methods, aligning with the reference. It also includes treatment response definitions and PDXs, which do not contradict the reference. PDO representations are explicitly mentioned, ensuring trend consistency and completeness."
        },
        {
            "query_idx": 1284,
            "query": "What delineation of cellular transformation, assessed through chronological re-calibration of pre-therapeutic and post-therapeutic benchmarks, served as a pivotal prognosticator of the regenerative trajectory in the noteworthy CinClare exploration of rectal malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1772
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #least ratio# of PDO size changes from day 0 to day 24 was a pivotal prognosticator of #tumor regression grade# in the CinClare trial for rectal malignancies.",
            "predicted_answer": "The pivotal prognosticator in the CinClare exploration was the ratio of PDO size changes at day 24 to day 0 after neoadjuvant chemoradiation, which predicted tumor regression grade upon resection.",
            "score": 5,
            "explanation": "The predicted answer mentions the 'ratio of PDO size changes at day 24 to day 0' as pivotal in predicting 'tumor regression grade'. This aligns with the reference, which refers to the 'least ratio' of PDO size changes over the same timeframe. Both discuss the role in the CinClare trial for tumor regression grade."
        },
        {
            "query_idx": 1285,
            "query": "What threshold in the metric of resilience, particularly expressed by the harmony of pharmacological conglomerations, acts as the demarcating factor for defining cellular facsimiles as steadfast against the specified medicinal coalition?",
            "retrieved_metrics": {
                "reference_idx": [
                    1777
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cellular facsimiles are classified as #resistant# if all drug components yield an AUC #≥ 0.56#.",
            "predicted_answer": "The threshold for defining cellular facsimiles as steadfast against a medicinal coalition is an AUC ≥ 0.56 for all drug components in the regimen.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts from the reference: cellular facsimiles are described as resistant (steadfast) based on an AUC ≥ 0.56 for all drug components. The terms \"steadfast\" and \"resistant\" align in this context. No significant information is missing or contradictory."
        },
        {
            "query_idx": 1286,
            "query": "What methodological divergence is apparent in Witte et al.'s approach to unraveling mechanistic outcomes of PDO responses to therapeutic symphonies in ovarian cancer treatment cohorts, and how do these orchestral compositions differ from the thematic explorations found in the CinClare and HOPE trials?",
            "retrieved_metrics": {
                "reference_idx": [
                    1781
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Witte et al.'s approach #directly evaluates# combination therapies in vitro, unlike CinClare and HOPE, which assess responses #independently# for each drug.",
            "predicted_answer": "Witte et al. used in vitro evaluation of combination treatments directly, contrasting with CinClare and HOPE trials that assessed PDO responses based on individual drug effects.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts emphasized with # symbols in the reference answer. It highlights the direct evaluation of combination therapies and contrasts it with individual drug assessments, paralleling the given details accurately, thus fully aligning with the overall trend of the reference."
        },
        {
            "query_idx": 1287,
            "query": "What abstract connections eluded the quantitative assessments of area under the curve when, notwithstanding their statistically noteworthy linkages with immediate therapeutic indicators and biomarker stabilization, they did not elucidate the profound dynamics of extended clinical prognoses like recurrence events and progression-free survival?",
            "retrieved_metrics": {
                "reference_idx": [
                    1778
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "AUCs, despite #significant correlations# with immediate indicators, failed to elucidate profound dynamics of #recurrence events# and progression-free survival.",
            "predicted_answer": "The abstract connections eluded by AUCs in quantitative assessments are the profound dynamics of extended clinical prognoses, such as recurrence events and progression-free survival, despite their statistically significant linkages with immediate therapeutic indicators and biomarker stabilization.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts emphasized in the reference, specifically the statistically significant correlations and the failure to elucidate the dynamics of recurrence events and progression-free survival. It aligns with the overall trend and covers key points without any contradictory information."
        },
        {
            "query_idx": 1288,
            "query": "What sophisticated parameters and criteria were used in Schütte et al.'s study to categorize the diverse therapeutic endpoints within the interconnected experimental landscapes of PDO and PDX models, with a focus on the gradations of pharmacological responses?",
            "retrieved_metrics": {
                "reference_idx": [
                    1780
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Schütte et al. used #IC50 values# for PDOs and relative tumor volume for PDXs to categorize drug responses into four categories: #strong-, moderate-, minor-response, or resistance#.",
            "predicted_answer": "Schütte et al. categorized therapeutic endpoints into four categories (strong-, moderate-, minor-response, or resistance) based on IC50 values for PDOs and relative tumor volume changes in PDXs.",
            "score": 5,
            "explanation": "The predicted answer includes both key points emphasized with # in the reference answer: the use of \"#IC50 values#\" for PDOs, \"#relative tumor volume#\" for PDXs, and the categorization into \"#strong-, moderate-, minor-response, or resistance#\". There are no significant omissions or errors, ensuring full alignment."
        },
        {
            "query_idx": 1289,
            "query": "Within the spectrum of molecular orchestrations seeking to unravel the resilient cellular formations' defenses, what unique interplay of mechanisms empowered complex (4) to exhibit a notably enhanced therapeutic confrontation against DU-145 spheroids over other similar constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1787
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Complex #4# exhibited enhanced anticancer activity against DU-145 spheroids due to its ability to induce #disruption# of cell aggregations, surpassing other ruthenium complexes.",
            "predicted_answer": "Complex (4) exhibited enhanced therapeutic confrontation against DU-145 spheroids due to its ability to disrupt cell aggregations, which is a key factor in overcoming the resistance typically observed in spheroids.",
            "score": 3,
            "explanation": "Both answers indicate that Complex 4 disrupts cell aggregations, a crucial mechanism linked with its anticancer activity against DU-145 spheroids. The predicted answer aligns with the reference but omits the comparison to other ruthenium complexes, a key detail. This omission affects completeness."
        },
        {
            "query_idx": 1290,
            "query": "In what manner did Huang et al. orchestrate their investigative framework to traverse the transformative pathways of drug interactions within the three-dimensional matrix-embedded cellular landscapes, specifically examining the sotorasib response across differing oxygenation levels?",
            "retrieved_metrics": {
                "reference_idx": [
                    1790
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Huang et al. used #Matrigel-based# tumor spheroids to examine #sotorasib# responses under normoxia and hypoxia, utilizing 3D matrix-embedded models.",
            "predicted_answer": "Huang et al. embedded tumor spheroids within a Matrigel-based ECM to monitor sotorasib response in non-small cell lung cancer and CRC under normoxia and hypoxia conditions.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts from the reference answer: \"Matrigel-based\" and \"sotorasib\" responses under \"normoxia and hypoxia\" within a 3D matrix-embedded context. It is aligned with the reference and fully captures the intended meaning without omissions."
        },
        {
            "query_idx": 1291,
            "query": "Within the spectrum of medical effectiveness predictions, what is the degree of inconsistency manifested by patients whose therapeutic outcomes delineated a path deviation from the orchestrated harmony of their organoid resistance alignments?",
            "retrieved_metrics": {
                "reference_idx": [
                    1774
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The degree of inconsistency is manifested by #three patients#, whose clinical outcomes deviated despite their #matched organoids# being resistant to treatments.",
            "predicted_answer": "The inconsistency in therapeutic outcomes was 15% (9 poor response, 3 good response with resistant organoids), indicating a deviation from expected organoid resistance alignments.",
            "score": 5,
            "explanation": "The predicted answer mentions \"3 good response with resistant organoids,\" aligning with the reference's \"three patients\" with \"matched organoids.\" However, it additionally notes \"9 poor response,\" which isn't covered in the reference but doesn't contradict it. Meaning aligns well with the reference."
        },
        {
            "query_idx": 1292,
            "query": "What multifaceted insights lend weight to the hypothesis that the anticancer capabilities of LXA4 derive from its inhibitory influence on the interactive dynamics of PSCs, instead of directly altering the intrinsic growth behavior of Panc-1 neoplastic constructs?",
            "retrieved_metrics": {
                "reference_idx": [
                    1792
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The anticancer effect of #LXA4# is due to its #PSC inhibition#, as tumor size reduction was noted only in PSC/Panc-1 spheroids, not in Panc-1 alone.",
            "predicted_answer": "The anticancer capabilities of LXA4 are attributed to its inhibitory influence on PSCs, as evidenced by decreased size and growth rate of PSC/Panc-1 spheroids, with no direct effect on Panc-1 cells.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact that LXA4's anticancer effects are due to its inhibitory action on PSCs, resulting in reduced size and growth of PSC/Panc-1 spheroids, and not directly impacting Panc-1 cells. This aligns well with the reference answer's meaning and key details."
        },
        {
            "query_idx": 1293,
            "query": "How do empirical measurements signal the opening of a preferential therapeutic pathway by employing a reduced concentration Olaparib scheme, intertwined with segmented radiation exposure, when compared to augmented dosage strategies in the domain of triple-negative breast neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1788
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #low-dose Olaparib# with segmented radiation improved spheroid efficacy more than #high-dose strategies# for triple-negative breast cancer, suggesting a preferential therapeutic pathway.",
            "predicted_answer": "Empirical measurements signal the opening of a preferential therapeutic pathway by showing higher efficacy of low-dose Olaparib combined with segmented radiation exposure, compared to augmented dosage strategies, in triple-negative breast neoplasms.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts: use of low-dose Olaparib with segmented radiation and its preferable efficacy over high-dose strategies for triple-negative breast cancer. It reflects the main trend of the preferential therapeutic pathway with no significant omissions or contradictions."
        },
        {
            "query_idx": 1294,
            "query": "Within the scope of transient pharmacological evaluations, what intrinsic nuance within plocabulin's potency manifestation encapsulates its divergence from conventional sustained administration protocols?",
            "retrieved_metrics": {
                "reference_idx": [
                    1798
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Plocabulin's #potency# manifesting efficiency in #short pulse# treatment diverges from conventional sustained administration protocols, maintaining strong cytotoxic activity in transient pharmacological evaluations.",
            "predicted_answer": "Plocabulin's potency manifests a divergence from conventional protocols through its strong cytotoxic activity in short pulse treatments, equivalent to continuous treatment, highlighting its suitability for transient pharmacological evaluations.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts from the reference: \"potency,\" \"short pulse treatment,\" and \"strong cytotoxic activity\" in evaluating divergence from sustained protocols, emphasizing the context of transient pharmacological evaluations. The meaning is consistent with no significant omissions or contradictions."
        },
        {
            "query_idx": 1295,
            "query": "In the realm of oncological pharmacology, what enigmatic disconnect within the empirical evaluation processes, particularly associated with planar cellular constructs and xenotransplant test beds, acts as a formidable barrier to the fluid translation of investigative outcomes into the clinical arena?",
            "retrieved_metrics": {
                "reference_idx": [
                    1799
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic disconnect is the lack of #translatability# of preclinical results from #2D cell cultures# and xenograft models to clinical applications.",
            "predicted_answer": "The formidable barrier to fluid translation of investigative outcomes into the clinical arena is the lack of translatability of preclinical results from 2D cell cultures and xenograft models.",
            "score": 5,
            "explanation": "The predicted answer fully covers all key facts emphasized in the reference answer: the issue of lack of translatability, involvement of 2D cell cultures, and xenograft models. The meaning is consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1296,
            "query": "What latent complexities and procedural intricacies must be navigated for malignant cellular avatars to transcend their current functional scope in catalyzing pharmaceutical innovations and prognosticating pharmacotherapeutic paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    1809
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #standardization# of culture protocols and the establishment of quantitative evaluation methods are key complexities in advancing cancer PDOs for pharmaceutical innovations.",
            "predicted_answer": "Navigating malignant cellular avatars' complexities involves standardizing culture protocols, assay techniques, and quantitative evaluation methods for drug efficacy. This enables accurate drug response predictions, enhancing pharmaceutical innovations and prognosticating pharmacotherapeutic paradigms.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts of #standardization# of culture protocols and #quantitative evaluation methods# mentioned in the reference answer, aligning with the overall trend. However, it misses the specific context of cancer patient-derived organoids (PDOs), affecting completeness."
        },
        {
            "query_idx": 1297,
            "query": "In what manner does the architecture of the predictive model facilitate its journey through the untested avenues of dosing regimens and its mapping out of the critical therapeutic plains crucial for the achievement of tumor eradication within the xenograft experimentative arrangement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1813
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The model predicts outcomes of #untested dosing regimens# and estimates #minimal drug concentration# needed for tumor eradication in xenograft experiments, aiding early clinical study designs.",
            "predicted_answer": "The predictive model's architecture allows it to predict untested dosing regimens, reducing in vivo studies and mapping critical therapeutic levels for tumor eradication in xenograft experiments.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of \"untested dosing regimens\" but misses the specific detail of \"minimal drug concentration.\" It aligns with the overall trend of predicting dosing outcomes and tumor eradication but lacks one key fact related to drug concentration."
        },
        {
            "query_idx": 1298,
            "query": "What was the envisaged economic magnitude encapsulating the global plight of cancer during the year 2010, and how does the anticipated financial encumbrance foreseen for oncology within the American sphere in the year 2020 juxtapose with this foundational fiscal estimate?",
            "retrieved_metrics": {
                "reference_idx": [
                    1817
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #estimated global cancer cost# was $1.16 trillion in 2010, while the #anticipated U.S. financial encumbrance# for oncology in 2020 was projected at $173 billion.",
            "predicted_answer": "The global cancer cost was approximately $1.16 trillion in 2010. In the U.S., the projected cost for 2020 was $173 billion, reflecting a significant increase.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts and figures emphasized in the reference answer, including the global cancer cost of $1.16 trillion in 2010 and the U.S. projected financial burden of $173 billion in 2020. The details align fully with the reference answer without significant omissions or contradictions."
        },
        {
            "query_idx": 1299,
            "query": "What avant-garde pharmacological methodologies have orchestrated the decryption of intricate pharmacodynamics, venturing beyond the conventional paradigm of singular target engagement?",
            "retrieved_metrics": {
                "reference_idx": [
                    1823
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "High-throughput #screening# and advancements in #pharmacogenomics# enable exploration of complex drug effects beyond single-target approaches.",
            "predicted_answer": "Avant-garde pharmacological methodologies such as high-throughput screening and pharmacogenomics have enabled the exploration of complex drug effects beyond single-target engagement.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference answer, namely high-throughput screening and pharmacogenomics. It successfully aligns with the overall trend and emphasis on exploring drug effects beyond single-target engagement, with no significant omissions or contradictions."
        },
        {
            "query_idx": 1300,
            "query": "How have the orchestrated enterprises of the 85 medicinal reimagining initiatives by Cures Within Reach traversed from theoretical innovation into the realm of patient accessibility or advanced stages of experimental validation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1824
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Out of the #85 repurposing projects# funded by Cures Within Reach, #13 drugs# have either been adopted for patient use or advanced to Phase III trials.",
            "predicted_answer": "Cures Within Reach has funded 85 repurposing projects, with 13 drugs either in use by patients or advanced to Phase III clinical trials.",
            "score": 5,
            "explanation": "The predicted answer successfully includes the key facts emphasized in the reference answer. It mentions #85 repurposing projects# and #13 drugs# that have either been adopted for patient use or advanced to Phase III trials. The meanings are consistent without any significant omissions."
        },
        {
            "query_idx": 1301,
            "query": "In what manner did the dual pharmacological facets of thalidomide, discovered post its initial market removal, contribute to its therapeutic reemergence in ameliorating hematological conditions and catalyze a financial resurgence to annual revenues surpassing the bicentennial million mark?",
            "retrieved_metrics": {
                "reference_idx": [
                    1826
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Thalidomide's #TNFα inhibition# and #antiangiogenic# properties enabled its therapeutic use in multiple myeloma, driving annual sales beyond $200 million.",
            "predicted_answer": "Thalidomide's therapeutic reemergence was driven by its dual pharmacological properties: TNFα inhibition and antiangiogenic effects, which made it effective for treating multiple myeloma, leading to annual revenues exceeding $200 million.",
            "score": 5,
            "explanation": "The key facts emphasized in the reference—TNFα inhibition and antiangiogenic properties—are fully present in the predicted answer. Both answers accurately describe thalidomide's impact on treating multiple myeloma and note the financial success of surpassing $200 million revenue, maintaining consistency without omissions."
        },
        {
            "query_idx": 1302,
            "query": "Within the realm of oncogenic signal transduction, what pivotal intermediary does thalidomide deftly compromise to abrogate the subsequent activation crescendo of the nuclear factor-kappa B process?",
            "retrieved_metrics": {
                "reference_idx": [
                    1827
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Thalidomide compromises #IkB kinase (IKK)# to abrogate nuclear factor-kappa B activation.",
            "predicted_answer": "Thalidomide compromises the IκB kinase (IKK) to inhibit the activation of nuclear factor-kappa B (NF-κB).",
            "score": 5,
            "explanation": "The predicted answer correctly identifies thalidomide’s compromise of \"IκB kinase (IKK)\" to inhibit NF-κB activation, aligning fully with the key fact in the reference answer. There are no significant omissions, and the meaning is consistent, covering all key points."
        },
        {
            "query_idx": 1303,
            "query": "In what ways do the contrasting methodologies and diagnostic paradigms between oncology and cardiology influence the predominant emphasis on ameliorative strategies for advanced neoplastic diseases vis-a-vis early stage therapeutic interdictions characteristic of cardiovascular pathologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1831
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The focus on early #biomarkers# in #CVD# allows for preventive interventions, whereas cancer treatment emphasizes managing established disease due to insufficient early detection biomarkers.",
            "predicted_answer": "The contrasting methodologies between oncology and cardiology lead to a predominant emphasis on ameliorative strategies for advanced neoplastic diseases in oncology, due to the lack of comprehensive early biomarkers, while cardiology focuses on early therapeutic interdictions using well-established biomarkers to prevent disease progression.",
            "score": 5,
            "explanation": "The predicted answer captures key concepts like \"biomarkers\" and the emphasis on advanced disease management in oncology due to insufficient early markers. It aligns with the trend of CVD focusing on early intervention based on biomarkers. No significant omissions or contradictions are present."
        },
        {
            "query_idx": 1304,
            "query": "How does the intricate interplay between the multidimensional pharmacological actions of a solitary medicinal agent and the genetic patchwork of neoplastic tissue present obstacles, especially considering the compounded challenges of pharmaceutical multifunctionality and the genetic diversity of subpopulations within tumors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1836
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #multifunctionality# of drugs and #genetic heterogeneity# in tumors complicate treatment as subclones might have resistance mutations, leading to insufficient outcomes.",
            "predicted_answer": "The intricate interplay between a medicinal agent's multidimensional pharmacological actions and the genetic diversity of neoplastic tissue creates obstacles due to pharmaceutical multifunctionality and intratumor heterogeneity, leading to potential resistance and poor outcomes.",
            "score": 3,
            "explanation": "The predicted answer reflects the key facts and trends present in the reference answer. It mentions \"pharmaceutical multifunctionality\" and \"genetic diversity\" (heterogeneity), which aligns with the reference answer. However, it does not explicitly mention \"subclones\" or \"resistance mutations,\" impacting completeness."
        },
        {
            "query_idx": 1305,
            "query": "Within the labyrinth of cellular fortification against therapeutic agents, how does the synergistic interplay between hypermutation and DNA rectification procedures forge a path to the persistent resistance observed in the genomic landscape as explicated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1835
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic interplay# between #hypermutation# and DNA repair creates a stably resistant genomic configuration, forging persistent resistance against therapeutic agents.",
            "predicted_answer": "The synergistic interplay between hypermutation and DNA rectification procedures in cellular fortification leads to the generation of resistant genotypes, which undergo selection and fixation, resulting in persistent genomic resistance to therapeutic agents.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the key facts in the Reference Answer. It mentions the \"synergistic interplay\" and \"hypermutation,\" which are critical elements. While it uses \"rectification procedures\" instead of \"DNA repair,\" the meaning remains consistent. All key points are covered, with no significant omissions."
        },
        {
            "query_idx": 1306,
            "query": "What intrinsic architectural paradigm of biological catalysts permits molecular doppelgängers to traverse a spectrum of binding scenarios, leading to collateral interactions and revealing new therapeutic horizons?",
            "retrieved_metrics": {
                "reference_idx": [
                    1837
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic architectural paradigm is #target promiscuity#, allowing kinase inhibitors to bind to various kinases, creating new therapeutic opportunities through #off-target interactions#.",
            "predicted_answer": "The intrinsic architectural paradigm of biological catalysts, such as kinase inhibitors, permits molecular doppelgängers (ATP mimics) to traverse a spectrum of binding scenarios due to high sequence similarity around ATP-binding pockets, leading to collateral interactions and revealing new therapeutic horizons through off-target activities.",
            "score": 5,
            "explanation": "The predicted answer captures the concept of kinase inhibitors binding to various targets due to architectural features, aligning with \"target promiscuity.\" It also mentions \"off-target activities,\" matching \"off-target interactions\" from the reference. Although terminology differs slightly, key facts and trends are present."
        },
        {
            "query_idx": 1307,
            "query": "In what ways have established modulators of enzymatic harmony traversed alternative oncological avenues, embarking on new therapeutic journeys without diverging from their initial molecular interaction domains?",
            "retrieved_metrics": {
                "reference_idx": [
                    1839
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Established modulators such as #VEGF inhibitor bevacizumab# and #multi-kinase inhibitor dasatinib# have been repurposed for new cancer indications without changing their initial kinase targets.",
            "predicted_answer": "Established modulators of enzymatic harmony have traversed alternative oncological avenues by repurposing kinase inhibitors for new cancer indications while maintaining the same kinase targets, such as bevacizumab for ovarian cancer and dasatinib for acute lymphoblastic leukaemia.",
            "score": 5,
            "explanation": "The predicted answer accurately mentions both #VEGF inhibitor bevacizumab# and #multi-kinase inhibitor dasatinib#, aligning with the key facts in the reference answer. The trend of maintaining their initial kinase targets is also preserved. There are no significant omissions and no contradictory information is present."
        },
        {
            "query_idx": 1308,
            "query": "What are the intricate web of socio-professional dynamics and eligibility conundrums that mold the perceptual frameworks of healthcare providers as they navigate the nuances of engaging their clientele in scientific inquiries, as influenced by systemic and operational vectors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1846
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Physician engagement#, influenced by #trial eligibility criteria#, site accessibility, resource constraints, workload, and financial incentives, shapes healthcare providers' perceptions in engaging patients in scientific inquiries.",
            "predicted_answer": "The intricate web includes socioeconomic factors, clinical trial availability, eligibility criteria complexity, physician attitudes, site accessibility, resource constraints, and financial incentives, shaping healthcare providers' perceptions and engagement in scientific inquiries.",
            "score": 3,
            "explanation": "The predicted answer successfully covers key factors like physician engagement, eligibility criteria, site accessibility, resource constraints, and financial incentives, all of which are in the reference. The mention of \"workload\" is omitted, but the overall meaning is generally consistent with no contradictions."
        },
        {
            "query_idx": 1309,
            "query": "What intrinsic challenges, within the tapestry of cancer research methodologies, might impede the integration of decentralized clinical trials, contrasting with their wider acceptance in healthcare segments addressing disorders like insomnia and neurodegenerative conditions such as Parkinson's disease?",
            "retrieved_metrics": {
                "reference_idx": [
                    1850
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The challenges include complex #inclusion criteria#, infusion-type treatments, and frequent #tumor response assessments#, hindering oncology's acceptance of decentralized clinical trials compared to other disorders.",
            "predicted_answer": "The integration of decentralized clinical trials in cancer research faces challenges due to complex inclusion criteria, infusion administration, and frequent tumor response assessments, contrasting with their wider acceptance in disorders like insomnia and Parkinson's disease.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies the key facts: complex inclusion criteria and frequent tumor response assessments. It summarizes the key challenges hindering decentralized trials in cancer research without introducing contradictions. Only the emphasis on \"infusion-type treatments\" is not as explicit, but implied."
        },
        {
            "query_idx": 1310,
            "query": "What are the cascading advantages associated with employing personal monitoring systems in the telehealth management of individuals receiving therapeutic interventions?",
            "retrieved_metrics": {
                "reference_idx": [
                    1849
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Using #wearable devices# in telehealth allows early detection of treatment-related toxicities and tracks daily activities, enhancing clinical #assessments# and involvement in therapeutic interventions.",
            "predicted_answer": "Cascading advantages include early detection of treatment-related toxicities, improved patient engagement, remote clinical assessments, and enhanced data collection for personalized care.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer in discussing early detection and clinical assessments. However, it misses the emphasis on #wearable devices# and specifically tracking #daily activities#, which are key to understanding the cascading advantages. Therefore, it lacks some completeness."
        },
        {
            "query_idx": 1311,
            "query": "What intricate delineations within the data mosaic are necessitated by the regulatory gatekeepers' latest directives, prompted by methodological shifts in trial conduct since the global health upheaval, specifically in relation to the provenance of data collection in pharmaceutical dossiers?",
            "retrieved_metrics": {
                "reference_idx": [
                    1848
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Applicants must indicate whether data were collected #remotely# or at the #trial site# due to changes in trial methodology prompted by the latest regulatory directives.",
            "predicted_answer": "Regulatory directives now require detailed data provenance, specifying whether data in pharmaceutical dossiers was collected remotely or at trial sites, reflecting methodological shifts post-COVID-19.",
            "score": 5,
            "explanation": "The Predicted Answer captures both key facts emphasized with # in the Reference Answer: the requirements to specify whether data were collected remotely or at trial sites. It accurately reflects the methodological shifts post-COVID-19 and aligns with the overall trend of the reference."
        },
        {
            "query_idx": 1312,
            "query": "What proportion of individuals within the examined assemblage, marked by their journey through various cancer typologies, are discerned as having developments within the hematopoietic disorder classification?",
            "retrieved_metrics": {
                "reference_idx": [
                    1853
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A small proportion of the 300 individuals have developments within the #hematological# disorder classification.",
            "predicted_answer": "Approximately 10% of the examined assemblage had developments within the hematopoietic disorder classification.",
            "score": 3,
            "explanation": "The predicted answer mentions \"10% of the examined assemblage\" having hematopoietic disorders, aligning with the trend that a small proportion is affected. However, it misinterprets the reference context by indicating 10% when no specific percentage is given, and slightly misstating \"hematological\" as \"hematopoietic\"."
        },
        {
            "query_idx": 1313,
            "query": "What underlying trepidations do clinical practitioners harbor about patient-driven diagnostic initiatives amidst investigational study contexts, and in what manner does this continuum of apprehension align with their adaptability to distant evaluative methodologies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1852
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Clinical practitioners harbor concerns about #decreased oversight# and #sample quality# in patient-driven diagnostics, but are confident in remote assessments like temperature and blood pressure collection.",
            "predicted_answer": "Clinical practitioners, particularly oncologists, express trepidations about reduced oversight, increased patient responsibility, and quality of samples in patient-driven diagnostic initiatives. Their apprehension aligns with adaptability to distant evaluative methodologies, with higher comfort in remote assessments like temperature and blood pressure collection but lower comfort in trial medication compliance.",
            "score": 5,
            "explanation": "The predicted answer captures key concerns of clinical practitioners about \"decreased oversight\" and \"sample quality,\" aligning with the reference answer. It also mentions confidence in remote assessments, consistent with the reference. No significant omissions or errors are present, ensuring completeness and alignment with key facts."
        },
        {
            "query_idx": 1314,
            "query": "What pivotal levers, analogized as tactical instruments in a strategic game, does the oncologist cite as weaving the intricate fabric of patient immersion in the realm of clinical trials, balancing the dual axes of educational enlightenment and streamlined access coordination?",
            "retrieved_metrics": {
                "reference_idx": [
                    1851
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The oncologist cites #education# on clinical trials and #convenient access# as pivotal levers for enhancing patient participation in clinical trials.",
            "predicted_answer": "The oncologist cites patient education, streamlined access coordination, convenience, and awareness of clinical trials as pivotal levers in enhancing patient immersion in clinical trials.",
            "score": 3,
            "explanation": "The predicted answer includes key aspects such as education and access, aligning with the reference. However, it introduces additional elements not specified in the reference (convenience and awareness) and lacks the emphasis on \"convenient access.\" Therefore, it is missing one critical detail affecting completeness."
        },
        {
            "query_idx": 1315,
            "query": "What paradigmatic facets of the dispersed investigational methodologies attained superior assessments from the participant cohort, and in what manner was the convergence of digital instrumentation, exemplified by wearable physiological monitors, received by potential contributors?",
            "retrieved_metrics": {
                "reference_idx": [
                    1854
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The paradigms of #DCT solutions# and #wearable devices# received superior assessments from participants, who felt comfortable with health-tracking technologies and telemedicine for clinical trials.",
            "predicted_answer": "The participant cohort preferred digital instrumentation like wearable physiological monitors for collecting biometric measures and telemedicine, ranking these highest. Self-administration of medication and adjusting treatment plans received the lowest rankings.",
            "score": 3,
            "explanation": "The Predicted Answer aligns in mentioning wearable devices and telemedicine, reflecting the key facts about digital instrumentation and comfort with health-tracking technologies. However, it omits the broader concept of \"DCT solutions,\" affecting completeness. There's no contradiction, but this omission impacts the assessment."
        },
        {
            "query_idx": 1316,
            "query": "What underlying tapestry of challenges presents the most significant barrier to enduring patient survival against the backdrop of metastatic bladder afflictions, despite the strategic implementation of surgical removals and age-old cisplatin-infused medicinal symphonies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1856
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #metastasis# of bladder cancer presents the most significant barrier to patient #survival#, with only about 5% surviving for at least 5 years post-diagnosis.",
            "predicted_answer": "The primary barrier to enduring patient survival in metastatic bladder cancer is the high rate of relapse and metastasis, despite surgical removal and cisplatin-based treatments. Only about 5% of metastatic patients survive 5 years post-diagnosis, highlighting the critical need for more effective therapies.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts emphasized in the reference answer: the challenge of metastasis, survival rates, and the need for more effective therapies. The information on the survival rate of around 5% aligns with the reference, with no contradictory information."
        },
        {
            "query_idx": 1317,
            "query": "What proportion of individuals embarking on a journey freshly diagnosed with bladder cancer find themselves facing the form that delves into muscular territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    1855
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #25%# of individuals newly diagnosed with bladder cancer face the #muscle-invasive# form.",
            "predicted_answer": "Approximately 25% of individuals newly diagnosed with bladder cancer face muscle-invasive bladder cancer (MIBC).",
            "score": 5,
            "explanation": "The predicted answer accurately mentions that approximately 25% of individuals with newly diagnosed bladder cancer have muscle-invasive bladder cancer, aligning fully with the key facts and overall trend in the reference answer. There are no missing details or contradictions."
        },
        {
            "query_idx": 1318,
            "query": "What intricacies and transitional hurdles are marked along the labyrinthine journey of introducing DCT solutions into the complexities of cancer care, as revealed through survey observations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1858
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Implementing #DCT solutions# in cancer care faces hurdles like ensuring #data integrity# and protection, despite positive acceptance and potential benefits in patient access and participation.",
            "predicted_answer": "The intricacies include ensuring data integrity and protection, while transitional hurdles involve integrating DCT solutions with existing healthcare systems and patient advocacy efforts.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of \"DCT solutions,\" \"data integrity,\" and \"protection\" from the reference. However, it omits details about \"positive acceptance\" and \"potential benefits in patient access and participation.\" The overall trend aligns, but the absence of these elements affects completeness."
        },
        {
            "query_idx": 1319,
            "query": "What deleterious physiological state could arise from a subtle contact with the imperceptible hazard presented by minute quantities of the elemental form of selenium or its compound derivatives?",
            "retrieved_metrics": {
                "reference_idx": [
                    1863
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Subtle contact with minute quantities of elemental selenium or its compounds can lead to #selenosis#, a deleterious physiological state.",
            "predicted_answer": "A subtle contact with minute quantities of elemental selenium or its compounds can lead to selenosis, a toxic condition characterized by symptoms like hair loss, nail damage, and neurological issues.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies \"selenosis\" as the deleterious physiological state resulting from contact with elemental selenium or its compounds, which fully aligns with the key fact emphasized in the reference answer. Additional details in the predicted answer enhance completeness without contradiction."
        },
        {
            "query_idx": 1320,
            "query": "What conceivable influence might oncogenic codes have within the intricate milieu of strategic therapeutic selection pathways for high-grade MIUC where immune-resilience is conspicuously minimal?",
            "retrieved_metrics": {
                "reference_idx": [
                    1860
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Oncogenic codes could serve as #predictive biomarker#s for therapeutic decisions in high-grade MIUC, where immune-resilience is low, guiding #biomarker-driven# treatments.",
            "predicted_answer": "Oncogenic codes, such as FGFR3, HER2, and EGFR, could serve as predictive biomarkers for therapeutic selection in high-grade MIUC, guiding the use of ADCs and other targeted therapies in immune-resilient patients.",
            "score": 1,
            "explanation": "The predicted answer identifies oncogenic codes as predictive biomarkers, aligning with the key fact in the reference. However, it inaccurately mentions usage in \"immune-resilient\" patients and ADCs, diverging from the context of low immune-resilience and biomarker-driven treatments. This leads to missing key reference details."
        },
        {
            "query_idx": 1321,
            "query": "What narrative on the interrelationship between variant selenium distribution in geographic sectors and the emergence of oncological conditions is elucidated by evaluating the disparate selenium quantifications alongside symptomatic evaluations in specified patient groups?",
            "retrieved_metrics": {
                "reference_idx": [
                    1864
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "An #inverse relationship# is observed between selenium distribution and cancer, with lower cancer rates in regions of moderate or high #selenium# levels.",
            "predicted_answer": "The narrative suggests an inverse relationship between selenium levels and cancer incidence, with lower selenium levels linked to higher cancer risk. Selenium's antitumorigenic properties and its role in antioxidant activity support its potential in reducing oncological conditions.",
            "score": 3,
            "explanation": "The predicted answer captures the key fact of an \"inverse relationship\" between selenium levels and cancer incidence. However, it lacks the specific detail of referring to \"regions\" with \"moderate or high selenium levels,\" which is a missing key fact that affects completeness. The main trend is aligned, though."
        },
        {
            "query_idx": 1322,
            "query": "Within the intricate tapestry of UC treatment modalities, and in the absence of continuity in preservation therapy following the primary intervention, which subsequent stratagem of enhanced therapeutic engagement is advocated?",
            "retrieved_metrics": {
                "reference_idx": [
                    1861
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Immunotherapy# using #Pembrolizumab# is recommended as the second-line therapy when there is no subsequent maintenance therapy after the primary intervention.",
            "predicted_answer": "In the absence of continuity in preservation therapy following the primary intervention, the subsequent stratagem advocated is immunotherapy with Pembrolizumab as the recommended second-line therapy.",
            "score": 5,
            "explanation": "The predicted answer includes both key facts emphasized in the reference: \"immunotherapy\" and \"Pembrolizumab.\" The meaning is consistent, aligning with the recommended second-line therapy when there is no maintenance therapy. There are no significant omissions or errors."
        },
        {
            "query_idx": 1323,
            "query": "What inherent attribute of diphenyl diselenide 1 acts like an internal guardian, fortifying macrophages against the disruptive influence of atherogenic pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    1866
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The inherent attribute of diphenyl diselenide 1 is its #antioxidant# properties, acting as an internal guardian to fortify macrophages against #atherogenic# pathways.",
            "predicted_answer": "The inherent attribute of diphenyl diselenide 1 that acts like an internal guardian is its excellent antioxidant and glutathione-peroxidase-like properties, which help fortify macrophages against atherogenic pathways.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of \"antioxidant properties\" and \"atherogenic pathways,\" aligning well with the reference answer. While it also mentions \"glutathione-peroxidase-like properties,\" this addition does not contradict the reference. Therefore, the meaning and key facts are consistent."
        },
        {
            "query_idx": 1324,
            "query": "What influence does Na₂SeO₃, acting as a biochemical agent, impose on the interconnected cellular phenomena and fate-altering pathways of cholangiocarcinoma entities, especially at concentrations spanning from 1 to 10 micromolar, thereby instigating pivotal changes in cellular integrity and operational traits?",
            "retrieved_metrics": {
                "reference_idx": [
                    1869
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Na₂SeO₃ at #1 to 10 µM# concentrations reduces invasion, migration, and epithelial-to-mesenchymal transition in cholangiocarcinoma by inducing #apoptosis# and downregulating N-cadherin.",
            "predicted_answer": "Na₂SeO₃ at 1-10 µM concentrations in cholangiocarcinoma cells reduces invasion, migration, and epithelial-to-mesenchymal transition by inducing apoptosis and downregulating N-cadherin, altering cellular integrity and operational traits.",
            "score": 5,
            "explanation": "The predicted answer matches all key points: Na₂SeO₃ concentrations (1-10 µM), its effects on invasion, migration, and EMT in cholangiocarcinoma, and the induction of apoptosis. The meaning aligns with the reference, and no significant details are missing or contradictory."
        },
        {
            "query_idx": 1325,
            "query": "What transformative biochemical topography is charted by the synergistic intervention of ebselen with silver to dismantle the robust defenses of ontologically resistant Gram-negative bacterial entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1873
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ebselen, combined with #silver#, disrupts Gram-negative bacteria defenses by inhibiting TrxR, increasing #reactive oxygen species# in prokaryotic cells.",
            "predicted_answer": "The synergistic intervention of ebselen with silver dismantles the robust defenses of Gram-negative bacteria by increasing reactive oxygen species (ROS) through inhibition of thioredoxin reductase (TrxR), thereby overcoming antibiotic resistance.",
            "score": 5,
            "explanation": "The key facts emphasized in the reference answer, such as the involvement of #silver# and the increase of #reactive oxygen species# (ROS), are present in the predicted answer. The predicted answer aligns with the reference but lacks specific mention of ROS in \"prokaryotic cells,\" which minimally impacts completeness."
        },
        {
            "query_idx": 1326,
            "query": "What is the numerically defined inflection point, synonymous with the biochemical prowess of diphenyl diselenide 1, that delineates its capacity to traverse intracellular pathways and metaphorically dismantle the cellular integrity of SHSY5Y neuroblastoma cells?",
            "retrieved_metrics": {
                "reference_idx": [
                    1882
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The numerically defined inflection point for diphenyl diselenide 1's capacity on SHSY5Y neuroblastoma cells is #IC50 = 30 μM#.",
            "predicted_answer": "The numerically defined inflection point for diphenyl diselenide 1 in SHSY5Y neuroblastoma cells is its IC50 value of 30 μM, which indicates its cytotoxic potency.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact emphasized in the reference answer, stating the IC50 value of 30 μM for diphenyl diselenide 1 in SHSY5Y neuroblastoma cells. The phrasing may differ, but the crucial detail is present and consistent with the reference answer."
        },
        {
            "query_idx": 1327,
            "query": "How do the inhibitory concentration thresholds, representing the molecular resistance levels, of the selenium-integrated zidovudine entities, numerically coded as 10, 11, and 24, present themselves when interacting with the structural complexities of human bladder cancer cell 5637?",
            "retrieved_metrics": {
                "reference_idx": [
                    1879
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #IC50 values# for the selenium-integrated zidovudine derivatives #10#, 11, and 24 against human bladder cancer cell 5637 are 78.85, 51.63, and 40.4 µM, respectively.",
            "predicted_answer": "The inhibitory concentration thresholds (IC50) for selenium-integrated zidovudine entities 10, 11, and 24 against human bladder cancer cell 5637 are 78.85 µM, 51.63 µM, and 40.4 µM, respectively.",
            "score": 5,
            "explanation": "The predicted answer successfully includes all key facts emphasized in the reference answer: the IC50 values and their corresponding entities (10, 11, and 24). The information is complete and consistent with the reference, covering all critical details and maintaining alignment on values and numerical details."
        },
        {
            "query_idx": 1328,
            "query": "How do the inherent characteristics of selenium, as integrated into diverse pharmacological constructs, manifest as obstacles within the complex landscape of clinical assessment, countering the substantial interest in harnessing their extensive bioactive capabilities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1888
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #high toxicity# of #selenium# limits its clinical exploration, despite its antioxidant, anticancer, and other bioactive properties integrated into pharmacological constructs.",
            "predicted_answer": "The inherent characteristics of selenium, when integrated into pharmacological constructs, manifest as obstacles in clinical assessment due to its high toxicity, limiting the exploration of selenium-based drug components despite their extensive bioactive capabilities.",
            "score": 3,
            "explanation": "The predicted answer mentions the \"high toxicity\" of \"selenium,\" which aligns with the key facts emphasized in the reference answer. However, it misses the specific mention of \"antioxidant\" and \"anticancer\" properties, excluding some key details, though no contradictory information is present."
        },
        {
            "query_idx": 1329,
            "query": "What intricate navigational paradigms do European entities employ to maneuver through the complex uncertainties of clinical trial validation and economic sustainability, specifically for therapeutic innovations authorized via exclusive regulatory conduits?",
            "retrieved_metrics": {
                "reference_idx": [
                    1890
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "European entities use #managed entry agreements# based on performance and financial metrics to navigate clinical trial evidence uncertainties and economic sustainability for innovative drugs approved via special pathways.",
            "predicted_answer": "European entities employ performance- and financial-based managed entry agreements to navigate uncertainties in clinical trial validation and economic sustainability for therapeutic innovations authorized via exclusive regulatory conduits.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer. It includes the key information of using \"performance- and financial-based managed entry agreements\" to address \"uncertainties in clinical trial validation and economic sustainability.\" The terminology differs slightly but captures the same key facts."
        },
        {
            "query_idx": 1330,
            "query": "What intrinsic frameworks do impetus-oriented incentives utilize to cultivate a fertile environment that nurtures primary technological exploration in the realm of pharmaceutical development?",
            "retrieved_metrics": {
                "reference_idx": [
                    1895
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Impetus-oriented incentives utilize #push policies# such as #public research funding# and tax credits to create a favorable environment for primary technological exploration in pharmaceutical development.",
            "predicted_answer": "Impetus-oriented incentives in pharmaceutical development utilize intrinsic frameworks like public research funding, tax credits, research grants, and government-sponsored incubators to cultivate a fertile environment for primary technological exploration.",
            "score": 3,
            "explanation": "The Predicted Answer covers the key fact of \"public research funding\" mentioned in the Reference Answer. However, it omits \"push policies.\" While generally aligned with the trend, the omission affects completeness."
        },
        {
            "query_idx": 1331,
            "query": "What is the extent of the metamorphosis in the numerical proportion of pharmaceuticals bestowed with the rarefied orphan emblem, traversing the temporal spectrum from 2003 to 2022, articulated as a growth ratio?",
            "retrieved_metrics": {
                "reference_idx": [
                    1894
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The growth ratio for pharmaceuticals with the orphan designation increased from #20%# in 2003 to #54%# in 2022.",
            "predicted_answer": "The proportion of pharmaceuticals with orphan designation grew from 20% in 2003 to 54% in 2022, representing a growth ratio of 2.7.",
            "score": 5,
            "explanation": "The predicted answer matches the key facts from the reference answer, including the percentages #20%# in 2003 and #54%# in 2022. It extends further by providing the growth ratio of 2.7, which does not contradict the key facts. The meaning and details are consistent with the reference."
        },
        {
            "query_idx": 1332,
            "query": "What triadic procedural lenses does the FDA utilize in its quest to unravel the continuum of safety and effectiveness inherent in a potential therapeutic entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    1896
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA utilizes #disease analysis#, #benefit-risk assessment#, and #risk management considerations# to evaluate a drug's safety and efficacy.",
            "predicted_answer": "The FDA utilizes triadic procedural lenses focusing on disease context, benefit-risk assessment, and risk management considerations to evaluate a drug's safety and efficacy.",
            "score": 5,
            "explanation": "The 'Predicted Answer' fully incorporates the key facts: disease analysis, benefit-risk assessment, and risk management considerations, which are emphasized in the 'Reference Answer'. The terms are paraphrased but maintain the same meaning and alignment with the reference answer's context."
        },
        {
            "query_idx": 1333,
            "query": "What strategic oversight methodology is deployed by the governing body of food and drug regulation to traverse the uncertain terrain of adverse health outcomes, especially when confronted with ambiguous patient safety scenarios?",
            "retrieved_metrics": {
                "reference_idx": [
                    1897
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #FDA# employs a #risk evaluation and mitigation strategy (REMS)# to manage adverse health outcomes in uncertain patient safety scenarios.",
            "predicted_answer": "The governing body deploys a Risk Evaluation and Mitigation Strategy (REMS) to navigate uncertain health outcomes and ambiguous patient safety scenarios, supported by expert advisory committees.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of employing a \"Risk Evaluation and Mitigation Strategy (REMS),\" aligning with the reference. However, it misses the specific mention of \"FDA,\" which is crucial. While the general trend is consistent, the omission affects completeness."
        },
        {
            "query_idx": 1334,
            "query": "What transformative ripples did the legislative enactment deemed the Orphan Drug Act impart upon the progressive saga of therapeutic approvals, from its dawn in 1983 through the horizon of 2021, within the intricate sphere of FDA endorsements for medicinal rarities?",
            "retrieved_metrics": {
                "reference_idx": [
                    1899
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Orphan Drug Act# led to #1,033 FDA approvals# for rare disease treatments from 1983 to 2021, addressing large unmet medical needs.",
            "predicted_answer": "The Orphan Drug Act (1983) significantly increased FDA approvals for rare disease treatments, with 1,033 orphan drugs approved by 2021, addressing unmet medical needs for millions of patients.",
            "score": 5,
            "explanation": "The Predicted Answer correctly identifies the Orphan Drug Act, notes the significant increase in FDA approvals, and matches the reference with the figure of 1,033 approvals. It aligns with the trend of addressing unmet medical needs, covering all key facts without omissions."
        },
        {
            "query_idx": 1335,
            "query": "What symbolism of numerical distinction delineates the heightened propensity for therapeutics designated as orphan drugs to successfully navigate clinical trial approval compared to those not bearing such a designation, when examined through the intricate interplay of statistical classifications and evaluative outcomes?",
            "retrieved_metrics": {
                "reference_idx": [
                    1903
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Orphan drugs have a higher chance of FDA approval, with an #AOR# of #2.26#, compared to non-orphan drugs, despite similar clinical development times.",
            "predicted_answer": "The numerical distinction showing a higher propensity for orphan drugs to successfully navigate clinical trial approval is an adjusted odds ratio of 2.26 (95% CI: 1.37 to 3.71), indicating a significantly higher success rate compared to non-orphan drugs.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts highlighted in the reference: the adjusted odds ratio (AOR) of 2.26 is mentioned, indicating the increased likelihood of orphan drugs' success compared to non-orphan drugs. All essential statistical details are included, with no significant omissions or errors."
        },
        {
            "query_idx": 1336,
            "query": "What is the relative probability disparity in traversing the transitional journey from the initial research stages to achieving regulatory sanction, comparing neglected pathologies with their typical counterparts within the intricate approval framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1901
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #probability# of orphan indications achieving #FDA approval# is 32.9%, compared to 10.4% for typical counterparts.",
            "predicted_answer": "The relative probability disparity in achieving regulatory sanction is higher for neglected pathologies, with orphan indications having a 32.9% chance to proceed from phase 1 to FDA approval compared to 10.4% for typical counterparts.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts and numbers emphasized in the reference answer, specifically the probabilities (32.9% for orphan indications and 10.4% for typical counterparts) achieving FDA approval. There are no significant omissions, and the meaning is consistent with the reference."
        },
        {
            "query_idx": 1337,
            "query": "What is the proportion of uncommon ailments for which therapeutic concoctions have been ingeniously crafted, and what segment of these conditions have garnered official endorsement from authoritative bodies by way of medicinal approval?",
            "retrieved_metrics": {
                "reference_idx": [
                    1900
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#15%# of rare diseases have orphan drugs, and #5%# have received FDA approval.",
            "predicted_answer": "The proportion of uncommon ailments with therapeutic concoctions is 15%, and only 5% of these conditions have received official medicinal approval.",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects both key facts from the Reference Answer: that 15% of uncommon ailments have therapeutic concoctions and 5% have received official approval, paralleling the FDA approval mentioned. No significant information is omitted, and details align correctly with the reference."
        },
        {
            "query_idx": 1338,
            "query": "What architectural blueprints have been conceived to modulate the pathways and financial streams of these biopharmaceutical entities classified under partial orphanhood within the fiscal landscapes of pharmacological anomalies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1905
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scholars proposed #patient thresholds#, #indication-specific pricing#, and indication-specific formularies to modulate pathways and financial streams of partial orphan biopharmaceuticals.",
            "predicted_answer": "Architectural blueprints proposed include patient or revenue thresholds, indication-specific pricing, and indication-specific formularies to control usage and expenditure on partial orphan drugs.",
            "score": 5,
            "explanation": "The Predicted Answer includes all key facts: #patient thresholds#, #indication-specific pricing#, and indication-specific formularies, which align well with the Reference Answer. There are no significant omissions or contradictory information, providing a consistent overall trend."
        },
        {
            "query_idx": 1339,
            "query": "What abstract evaluative parameters, anchored in multifaceted considerations of survival implications, the tapestry of life quality, and the intricate progression cadence of ailments, does the FDA utilize to decree a condition's critical standing, thereby conferring upon it the privilege of accelerated advancement under the auspices of their fast track initiative?",
            "retrieved_metrics": {
                "reference_idx": [
                    1906
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The FDA uses #survival implications#, #life quality#, and #progression characteristics# to determine a condition's seriousness for fast track eligibility.",
            "predicted_answer": "The FDA uses abstract evaluative parameters such as survival implications, quality-of-life, and disease progression to determine a condition's critical standing for fast track advancement.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of \"survival implications,\" \"quality-of-life\" (interpreted as \"life quality\"), and \"disease progression\" (interpreted as \"progression characteristics\") from the reference answer. All critical aspects are present without contradiction, aligning with the overall trend."
        },
        {
            "query_idx": 1340,
            "query": "What strategic therapeutic enhancement must a novel pharmaceutical entity embody to traverse the landscape of well-established medicinal remedies and ultimately fulfill a niche devoid of clinical solutions, when conventional interventions are prevalent?",
            "retrieved_metrics": {
                "reference_idx": [
                    1907
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "A novel pharmaceutical must demonstrate #superior efficacy# or #fewer side effects# than existing treatments to fulfill an unmet medical need amidst conventional interventions.",
            "predicted_answer": "A novel pharmaceutical entity must demonstrate superior efficacy, fewer side effects, earlier diagnosis, better treatment adherence, or address future public health needs to traverse well-established remedies and fulfill a niche.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of demonstrating \"superior efficacy\" and \"fewer side effects,\" aligning with the reference answer. However, it introduces additional points (\"earlier diagnosis\" and others) not present in the reference but does not contradict it. Therefore, it fully covers the emphasized key facts."
        },
        {
            "query_idx": 1341,
            "query": "What multifaceted hindrances do ultra-orphan therapeutic architects encounter, compared to their peers designing treatments for more prevalent afflictions, in light of the UK's emerging legislative and procedural contemplations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1908
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Ultra-orphan therapeutic architects face #challenges# in finding patients, competent investigators, and specialized centers with suitable infrastructure, unlike those working on more prevalent conditions in the UK's current legislative climate.",
            "predicted_answer": "Ultra-orphan therapeutic architects face challenges in finding sufficient patients, competent investigators, and specialized medical centers, making clinical trials more complex compared to those for more prevalent diseases.",
            "score": 1,
            "explanation": "The predicted answer aligns with the reference answer, mentioning challenges in finding patients, competent investigators, and specialized medical centers. However, it omits the UK's legislative context and infrastructure suitability, missing two key facts emphasized in the reference."
        },
        {
            "query_idx": 1342,
            "query": "What delineates the intrinsic quantum of incremental Quality-Adjusted Life Year elevation, within the spectrum outlined by Chambers et al., when contrasting entities recognized under the aegis of expeditious approval constructs against those omitted from such pathways, specifically regarding the statistical differentiation in their effectiveness emblem?",
            "retrieved_metrics": {
                "reference_idx": [
                    1909
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intrinsic quantum of incremental #QALY# elevation for fast track entities is #0.254#, compared to 0.014 for non-fast track entities (p < 0.001).",
            "predicted_answer": "The intrinsic quantum of incremental Quality-Adjusted Life Year (QALY) elevation, as outlined by Chambers et al., is 0.254 QALYs for entities under expeditious approval constructs, compared to 0.014 QALYs for those omitted, with a statistically significant difference (p < 0.001).",
            "score": 5,
            "explanation": "The predicted answer includes key facts emphasized in the reference answer, such as QALY, 0.254, and the statistically significant difference (p < 0.001). The alignment and completeness regarding the intrinsic quantum of QALY elevation are consistent with the reference. The overall trend and key facts are fully covered."
        },
        {
            "query_idx": 1343,
            "query": "In what manner do the nuanced hallmarks of medical efficacy elevation operate as pivotal determinants within the dual pathways of drug evaluation triage, as conceptualized under the restructured canons of the Prescription Drug User Fee Act?",
            "retrieved_metrics": {
                "reference_idx": [
                    1914
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #Prescription Drug User Fee Act# emphasizes #increased effectiveness# and other improvements as key determinants in prioritizing drug evaluations for expedited review.",
            "predicted_answer": "The nuanced hallmarks of medical efficacy elevation, such as increased effectiveness or reduced treatment-limiting reactions, operate as pivotal determinants in the dual pathways of drug evaluation triage under the restructured Prescription Drug User Fee Act, guiding whether a drug receives priority or standard review.",
            "score": 3,
            "explanation": "The predicted answer captures the key facts of the Prescription Drug User Fee Act and the concept of increased effectiveness as pivotal in drug evaluation. However, it does not explicitly state \"expedited review,\" which is crucial in the reference. Thus, one key fact is missing, affecting completeness."
        },
        {
            "query_idx": 1344,
            "query": "To what extent does the symbolic nomenclature attributed to pharmaceutical advancements cultivate the interpretative frameworks of consumer perception concerning their perceived therapeutic potency and the foundational pillars of scientific substantiation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1918
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #symbolic nomenclature#\"breakthrough\" enhances consumer perception of drugs' #therapeutic potency#, fostering unwarranted optimism about effectiveness and scientific evidence.",
            "predicted_answer": "Symbolic nomenclature like \"breakthrough\" cultivates consumer perception, enhancing perceived therapeutic potency and scientific substantiation, despite limited evidence.",
            "score": 3,
            "explanation": "The Predicted Answer includes the key fact of \"symbolic nomenclature\" enhancing consumer perception and mentions the therapeutic potency, as emphasized with # in the Reference Answer. However, it misses the nuance of \"fostering unwarranted optimism\" about effectiveness and scientific evidence, affecting completeness."
        },
        {
            "query_idx": 1345,
            "query": "What inferences articulated by Herink et al. illuminate the evidential tapestry concerning breakthrough-designated pharmaceuticals as a kaleidoscope of variance, and in what manner does this relate to the labyrinthine uncertainties surrounding their safety and efficacy as discussed in their 2018 scholarly exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1919
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Herink et al.# concluded that breakthrough drugs have a #heterogeneous# quality of evidence, highlighting uncertainties about their safety and efficacy.",
            "predicted_answer": "Herink et al. (2018) inferred that breakthrough-designated pharmaceuticals exhibit heterogeneous evidence quality, highlighting uncertainties about their safety and efficacy, emphasizing the need for cautious interpretation by healthcare professionals.",
            "score": 5,
            "explanation": "The Predicted Answer aligns with the Reference Answer by stating that Herink et al. discussed the heterogeneous evidence quality of breakthrough-designated pharmaceuticals and associated uncertainties in safety and efficacy. It includes all key facts and trends, with no contradictions or omissions."
        },
        {
            "query_idx": 1346,
            "query": "In what manner do the metaphorical avenues of eligibility and temporal guidance within the PRIME scheme unfurl in contrast to the FDA's breakthrough therapeutic designation, particularly in the realms of primary versus supplementary explorations?",
            "retrieved_metrics": {
                "reference_idx": [
                    1924
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PRIME program# excludes supplemental indications, offering #early guidance# based on pre-clinical data, differing from the FDA's breakthrough designation, which includes supplementary applications.",
            "predicted_answer": "The PRIME scheme primarily supports primary explorations and is limited to original, not supplemental, indications, contrasting with the FDA's breakthrough therapeutic designation, which can cover both primary and supplementary explorations.",
            "score": 3,
            "explanation": "The predicted answer captures the distinction between the PRIME program's exclusion of supplemental indications and the FDA's inclusion. However, it omits the detail about PRIME offering early guidance based on pre-clinical data. This missing key fact affects completeness, so the score is 3."
        },
        {
            "query_idx": 1347,
            "query": "In the decade-spanning examination of oncological therapies from 2012 to 2022, what quantifiable divergence exists in the pivotal measure of longevity extension between those newly recognized for transformative potential and their standard counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    1917
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Breakthrough indications extended #median overall survival# by #1.6 months# more than non-breakthrough indications from 2012 to 2022.",
            "predicted_answer": "The pivotal measure of longevity extension showed that breakthrough oncological therapies recognized from 2012 to 2022 offered significantly greater median overall survival improvements compared to standard therapies (4.8 vs. 3.2 months, p = 0.004).",
            "score": 5,
            "explanation": "The key fact from the reference answer, \"median overall survival extended by 1.6 months more,\" is captured in the predicted answer, which states an improvement of 4.8 vs. 3.2 months, showing the same 1.6-month difference. This reflects completeness and no contradiction with the reference."
        },
        {
            "query_idx": 1348,
            "query": "What is the nuanced mechanism by which molecular architects engineer the selective deconstruction of proteinaceous targets via proteolytic orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1933
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Molecular architects engineer selective deconstruction of proteins via #PROTACs#, utilizing a dual-ligand system that targets proteins for degradation by recruiting an #E3 ligase#.",
            "predicted_answer": "Molecular architects use PROTACs to selectively deconstruct proteinaceous targets. PROTACs bind to the target protein and an E3 ligase, inducing its degradation via proteolytic orchestration.",
            "score": 3,
            "explanation": "The predicted answer includes key facts such as the use of PROTACs and the recruitment of an E3 ligase, aligning with the reference. However, it lacks explicit mention of the \"dual-ligand system,\" a key aspect of the mechanism."
        },
        {
            "query_idx": 1349,
            "query": "Within the realm of genomic architects, what proportion are discerned to possess mirrored ancestral blueprints in accordance with the prescribed paradigm extracted from the Ensembl 93 archive?",
            "retrieved_metrics": {
                "reference_idx": [
                    1934
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #70%# of human protein-coding genes have an identifiable #paralog# according to the Ensembl 93-derived set of paralog pairs.",
            "predicted_answer": "Approximately 70% of human protein-coding genes have identifiable paralogs derived from Ensembl 93, suggesting a similar proportion of genomic architects possess mirrored ancestral blueprints.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts: \"approximately 70%\" and \"paralog\" in relation to human protein-coding genes, consistent with the Ensembl 93 reference. The meaning aligns fully with the reference answer, and there are no omissions or contradictions in key details."
        },
        {
            "query_idx": 1350,
            "query": "Within the multifaceted regulatory networks of cellular biomes, what distinctive dynamics does the molecular architect ARID1A execute as part of the SWI/SNF consortium to orchestrate an anti-oncogenic framework?",
            "retrieved_metrics": {
                "reference_idx": [
                    1939
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ARID1A functions as a #tumour suppressor# by encoding a #SWI/SNF# subunit, contributing to an anti-oncogenic framework within cellular biomes.",
            "predicted_answer": "ARID1A, as a SWI/SNF subunit, orchestrates an anti-oncogenic framework by regulating gene expression to suppress tumorigenesis.",
            "score": 3,
            "explanation": "The predicted answer accurately represents ARID1A as a part of the SWI/SNF consortium and aligns with the anti-oncogenic framework. However, it lacks the explicit mention of ARID1A functioning explicitly as a \"tumour suppressor,\" which is a key fact in the reference answer."
        },
        {
            "query_idx": 1351,
            "query": "In the symphony of genomic interventions, what hidden susceptibility of STAG1 emerges during the comparative exploration of STAG2-deficient cellular landscapes, as unveiled by the comprehensive CRISPR orchestration?",
            "retrieved_metrics": {
                "reference_idx": [
                    1944
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STAG1 is #selectively lethal# in #STAG2-deficient# cells, revealing its susceptibility during the comparative exploration of cellular landscapes.",
            "predicted_answer": "In STAG2-deficient cells, STAG1 emerges as selectively lethal, indicating a hidden susceptibility that is revealed through comprehensive CRISPR orchestration.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the key facts emphasized in the reference answer: \"STAG1 is selectively lethal\" and specifically in \"STAG2-deficient cells.\" The meaning and important details align well with the reference answer, with no significant omissions or errors."
        },
        {
            "query_idx": 1352,
            "query": "What is the nuanced biochemical allegory encountered in designing therapeutic agents that must achieve discriminative effectiveness against ARID1B, molded by the molecular mimicry between ARID1B and ARID1A in the context of ARID1A mutated cellular ecospheres?",
            "retrieved_metrics": {
                "reference_idx": [
                    1957
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The biochemical allegory involves the challenge of achieving #specificity# against ARID1B due to #molecular mimicry# between ARID1B and ARID1A, risking off-target effects.",
            "predicted_answer": "The nuanced biochemical allegory involves designing therapeutic agents that selectively inhibit ARID1B in ARID1A-mutated cells to avoid off-target effects on normal cells, despite molecular mimicry between ARID1A and ARID1B.",
            "score": 5,
            "explanation": "The predicted answer captures the core idea of needing to selectively inhibit ARID1B in the presence of ARID1A due to molecular mimicry, highlighting the risk of off-target effects. It aligns with the reference answer's emphasis on specificity and molecular mimicry. No key facts are missing."
        },
        {
            "query_idx": 1353,
            "query": "In what manner does employing a non-selective suppressive strategy, akin to a cellular dual-action implement, influence the selective termination of tumour cells, specifically when residing within a genetic framework altered by gene B mutation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1961
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Employing a #non-selective# suppressive strategy can result in the #selective# termination of tumor cells with a gene B mutation by targeting the synthetic lethal pair A1 and A2.",
            "predicted_answer": "Employing a non-selective suppressive strategy targeting proteins A1 and A2 can selectively terminate tumour cells with a gene B mutation by exploiting synthetic lethality, minimizing toxicity in normal cells.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of using a non-selective suppressive strategy for selective tumor cell termination and synthetic lethality with proteins A1 and A2. It aligns with the reference answer and has no significant omissions or errors, reflecting the intended meaning."
        },
        {
            "query_idx": 1354,
            "query": "What inherent characteristics of synthesized gel-like substrates underpin the continuance of uniformity across multifarious pharmacological explorations, enabling the harmonious integration of sophisticated scrutiny methodologies within the landscape of progressive research frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    1971
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synthetic and tunable hydrogels# provide controlled environments, enhancing #reproducibility#, which supports uniformity and integration in pharmacological research.",
            "predicted_answer": "The inherent characteristics of synthesized gel-like substrates, such as tunable hydrogels and controlled environments, enhance reproducibility and facilitate the integration of sophisticated scrutiny methodologies in progressive research frameworks.",
            "score": 5,
            "explanation": "The predicted answer includes \"tunable hydrogels\" and \"controlled environments,\" reflecting the key concept of \"synthetic and tunable hydrogels\" from the reference. It also mentions enhancing reproducibility and integration, aligning with the trend of supporting uniformity. All key points are accurately covered."
        },
        {
            "query_idx": 1355,
            "query": "In the intricate realm of cancer innovation, how do the cellular replicas fashioned from the enigmatic fabric of mammary Paget's disease unveil pivotal genetic and molecular dialogues that propel the understanding of breast cancer's intricate genomic tapestry?",
            "retrieved_metrics": {
                "reference_idx": [
                    1975
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#MPD organoids# reveal #genomic landscape# by showcasing copy number variations, mutational burden, and cancer-related gene mutations, enhancing breast cancer genomic understanding.",
            "predicted_answer": "Mammary Paget's disease (MPD) organoids accurately represent the genomic landscape of breast cancer, including copy number variations and specific mutations, facilitating the study of pivotal genetic and molecular dialogues in breast cancer.",
            "score": 3,
            "explanation": "The predicted answer covers the key facts from the reference answer regarding \"MPD organoids\" and \"genomic landscape.\" It mentions \"copy number variations\" and \"specific mutations,\" aligning with the reference's focus on genomic understanding. However, it omits \"mutational burden,\" making the answer incomplete."
        },
        {
            "query_idx": 1356,
            "query": "What interplay exists between the moral conundrums, such as the intricacies of patient acquiescence and the veil of genetic confidentiality, and the evolving narrative of prognostic confidence as cellular constructs shape trust in visionary models for cancer therapeutics?",
            "retrieved_metrics": {
                "reference_idx": [
                    1984
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The interplay lies in balancing #ethical implications# like patient consent and genetic privacy with building #trust# in predictive models for cancer therapeutics using organoid responses.",
            "predicted_answer": "The interplay involves navigating ethical issues like patient consent and genetic privacy to maintain trust in predictive models, crucial for effective cancer therapeutics.",
            "score": 3,
            "explanation": "The predicted answer addresses ethical issues like patient consent and genetic privacy, aligning with the ethical implications in the reference. However, it omits the specifics of building trust through \"organoid responses\" crucial for cancer therapeutics, affecting completeness."
        },
        {
            "query_idx": 1357,
            "query": "What specific cellular entities and supportive elements are advocated to be woven into the fabric of PDO frameworks to emulate the intricate tapestry of the tumor milieu?",
            "retrieved_metrics": {
                "reference_idx": [
                    1988
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Immune cells, endothelial cells, and stromal components are advocated to be woven into PDO frameworks to emulate the intricate tapestry of the #tumor milieu#.",
            "predicted_answer": "To emulate the tumor milieu in PDO frameworks, incorporate immune cells, endothelial cells, and stromal components to simulate physiological conditions more accurately.",
            "score": 5,
            "explanation": "The predicted answer includes immune cells, endothelial cells, and stromal components, aligning with the key facts from the reference answer. It correctly reflects the idea of simulating physiological conditions and emulating the tumor milieu. Hence, all fundamental elements emphasized in the reference are present."
        },
        {
            "query_idx": 1358,
            "query": "How do collaborative ensembles facilitate the construction of intricate innovation networks, thereby augmenting research productivity and reinforcing discovery mechanisms in the landscape of organoid modeling?",
            "retrieved_metrics": {
                "reference_idx": [
                    1996
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Collaborative ensembles facilitate intricate innovation networks by establishing #interdisciplinary consortia#, standardizing data sharing, validating organoid models, and creating #open-source databases#, enhancing research productivity and discovery mechanisms.",
            "predicted_answer": "Collaborative ensembles enhance organoid modeling by standardizing data sharing, validating models, and creating open-source databases, boosting research productivity and refining discovery mechanisms through interdisciplinary collaboration and technological advancements.",
            "score": 3,
            "explanation": "The predicted answer covers key elements such as standardizing data sharing, validating models, and creating open-source databases, aligning with the reference. However, it omits the specific mention of \"interdisciplinary consortia,\" which is a key fact, affecting completeness."
        },
        {
            "query_idx": 1359,
            "query": "What complex orchestration of biological interactions are researchers conducting to address the absence of crucial life flows within PDO landscapes, enhancing the capacity of immune response maneuvers in cancer therapeutic strategies?",
            "retrieved_metrics": {
                "reference_idx": [
                    1987
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Researchers are co-culturing PDOs with #immune cells# to address the absence of #continuous blood flow#, enhancing the capacity of immune response maneuvers in cancer therapeutic strategies.",
            "predicted_answer": "Researchers are addressing the absence of crucial life flows within PDO landscapes by co-culturing PDOs with immune cells to reflect dynamic tumor-immune interactions, enhancing the capacity of immune response maneuvers in cancer therapeutic strategies.",
            "score": 3,
            "explanation": "The predicted answer mentions co-culturing PDOs with immune cells, matching a key fact in the reference. However, it omits addressing the absence of \"continuous blood flow,\" which is crucial. The overall trend aligns, but the missing detail impacts completeness."
        },
        {
            "query_idx": 1360,
            "query": "How does the deliberate spatial choreography of chromosomal domains within the nuclear enclave modulate the myriad orchestrated activities and functional symphonies of genomic expression and cellular regulation?",
            "retrieved_metrics": {
                "reference_idx": [
                    1999
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The deliberate #spatial choreography# of chromosomal domains within the nucleus organizes genome expression and regulates #cellular activities# like the cell cycle, stress response, and homeostasis.",
            "predicted_answer": "The deliberate spatial choreography of chromosomal domains within the nuclear enclave modulates genomic expression and cellular regulation by organizing chromosomes into distinct territories, facilitating coordinated gene expression and physiological responses.",
            "score": 3,
            "explanation": "The predicted answer captures the concept of \"spatial choreography\" and aligns with the \"coordination of genomic expression.\" However, it lacks details about specific \"cellular activities\" like the \"cell cycle, stress response, and homeostasis,\" which are mentioned in the reference answer as crucial parts of regulation."
        },
        {
            "query_idx": 1361,
            "query": "Amidst the cellular orchestra, which particular assembly surrounding the nucleolar periphery does the SH54 molecular probe reveal within the HeLa terrain yet finds absent in the NIH3T3 bioscape?",
            "retrieved_metrics": {
                "reference_idx": [
                    2001
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #SH54 molecular probe# reveals a nuclear body identified as #PTBP1# at the nucleolar periphery in HeLa cells, absent in NIH3T3 cells.",
            "predicted_answer": "The SH54 molecular probe reveals a nuclear body at the nucleolar periphery in HeLa cells, specifically recognizing PTBP1, which is absent in NIH3T3 cells.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the role of the SH54 molecular probe in recognizing PTBP1 at the nucleolar periphery in HeLa cells and confirms its absence in NIH3T3 cells. All key facts emphasized in the reference are fully covered and aligned in the predicted answer."
        },
        {
            "query_idx": 1362,
            "query": "What underlying postulate guides the intricate approach devised to traverse the myriad of chemical elements, with the goal of recalibrating the intricate symphony of cellular mechanisms that modulate PNC prevalence within cancerous cell conglomerates?",
            "retrieved_metrics": {
                "reference_idx": [
                    2004
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The approach is guided by the postulate that reducing #PNC prevalence# can be achieved by disrupting #cellular activities# that maintain cancer cell metastatic potential or selectively inhibiting PNC-harboring cells.",
            "predicted_answer": "The underlying postulate guiding the approach is that diminishing PNC prevalence can stem from interfering with cellular activities essential for metastasis or selectively inhibiting cells with PNCs.",
            "score": 3,
            "explanation": "The predicted answer conveys the main idea of reducing PNC prevalence by interfering with cellular activities linked to metastasis and selectively targeting PNC-harboring cells. However, it omits the aspect of 'maintaining cancer cell metastatic potential.' Thus, it's missing one key emphasized fact."
        },
        {
            "query_idx": 1363,
            "query": "How do the sophisticated navigational maps presented by PNC structural entities enrich the exploratory pathways in identifying versatile molecular agents adept at traversing the complex terrain of metastasis-associated cellular landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2005
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The sophisticated navigational maps by #PNC# structural entities enhance discovering #selective# molecular agents targeting metastasis in cancer cells, improving therapeutic specificity and reducing toxicity.",
            "predicted_answer": "The sophisticated navigational maps presented by PNC structural entities enhance exploratory pathways by identifying versatile molecular agents that selectively target metastasis-associated cellular landscapes, improving therapeutic specificity and reducing toxicity.",
            "score": 5,
            "explanation": "The predicted answer captures the key elements from the reference. It mentions \"PNC structural entities\" and \"selectively target metastasis-associated cellular landscapes,\" aligning with \"PNC\" and \"selective molecular agents.\" All emphasized elements, including therapeutic specificity and toxicity reduction, are present."
        },
        {
            "query_idx": 1364,
            "query": "In what fashion does the temporal alignment of Metarrestin administration influence the continuum of life-prolongation metrics in representations with emergent versus matured macro-metastatic formations within pancreatic oncological mimicries?",
            "retrieved_metrics": {
                "reference_idx": [
                    2006
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Administering #Metarrestin# before macro-metastases formation led to #100% survival# for three months, while post-formation treatment extended survival to four months despite primary tumor growth.",
            "predicted_answer": "The temporal alignment of Metarrestin administration significantly influences life-prolongation metrics. Administering Metarrestin before macro-metastases formation results in 100% survival, while treatment after formation extends survival but eventually succumbs due to primary tumor growth.",
            "score": 3,
            "explanation": "The predicted answer accurately includes the key facts of Metarrestin administration timeline and impact on survival metrics, aligning with the reference's emphasis on 100% survival with early treatment and extended survival post-formation. However, it omits specific duration details of three and four months, affecting completeness."
        },
        {
            "query_idx": 1365,
            "query": "What element of distinction characterizes the ethereal PNC's communion with Ro-associated Pol III RNA messages, as juxtaposed with its conspicuous absence during the molecular ballet of Ro protein within the cytoplasm of HeLa cellular spheres?",
            "retrieved_metrics": {
                "reference_idx": [
                    2007
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #PNC# associates with #Ro-interacting# Pol III RNAs, located with Y1, Y4, and Y5, but is absent with Ro protein in the cytoplasm of HeLa cells.",
            "predicted_answer": "The element of distinction is the PNC's association with specific Ro-associated Pol III RNA messages (Y1, Y4, and Y5), which contrasts with its absence in Ro protein localization within HeLa cell cytoplasm.",
            "score": 5,
            "explanation": "The predicted answer closely matches the reference: it identifies the PNC's association with specific Ro-associated Pol III RNA messages (Y1, Y4, Y5) and notes its absence in the HeLa cell cytoplasm. All key facts are present, and the overall trend is consistent with the reference."
        },
        {
            "query_idx": 1366,
            "query": "What elements serve as the underlying testament to the coalescence of protein and RNA manifestations featuring RMRP within the overarching molecular assemblies associated with PNCs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2009
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "RMRP co-fractionation with #PTBP1# and #CUGBP1# in larger complexes supports the coalescence of protein and RNA manifestations in PNCs.",
            "predicted_answer": "The underlying testament to the coalescence of protein and RNA manifestations featuring RMRP within PNCs includes the co-fractionation with PTBP1 and CUGBP1 in larger complexes and confirmed protein-RNA interactions through co-precipitation.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts of co-fractionation with PTBP1 and CUGBP1 in larger complexes, as emphasized in the reference answer. It also adds the correct supporting detail of protein-RNA interactions through co-precipitation, maintaining alignment with the reference."
        },
        {
            "query_idx": 1367,
            "query": "How does the deliberate attenuation of PTBP1, in contrast to CUGBP1, manifest in the integrity of polynucleotide conclaves, and what insights does this afford into PTBP1's quintessential function in the orchestration of cellular synthesis frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2011
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Deliberate #attenuation# of PTBP1, unlike CUGBP1, disrupts PNC integrity, highlighting PTBP1's essential role in maintaining structural and functional coherence in cellular synthesis frameworks.",
            "predicted_answer": "Deliberate attenuation of PTBP1 disrupts polynucleotide conclave (PNC) integrity, highlighting its central structural role in RNA metabolism. This contrasts with CUGBP1, which does not affect PNC integrity. The disruption provides insights into PTBP1's essential function in orchestrating cellular synthesis frameworks, particularly in RNA splicing and stability.",
            "score": 5,
            "explanation": "The predicted answer accurately captures the role of PTBP1 in disrupting PNC integrity, highlighting its critical function in RNA metabolism, similar to the reference. The trend and key facts are present, and it contrasts adequately with CUGBP1, aligning well with the reference."
        },
        {
            "query_idx": 1368,
            "query": "How does the modulation of Pol I activity initiate a sequence of transformative events influencing the structural fidelity of PNC entities and the architectural evolution of nucleolar frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2016
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Modulating #Pol I# activity disrupts #PNCTR# levels, affecting PNC structure and inducing nucleolar segregation, impacting both PNC integrity and nucleolar architecture.",
            "predicted_answer": "Modulation of Pol I activity can initiate transformative events by dampening PNCTR levels, disrupting PNC integrity, and inducing nucleolar segregation, thereby influencing the structural fidelity of PNC entities and the architectural evolution of nucleolar frameworks.",
            "score": 5,
            "explanation": "The predicted answer includes the modulation of Pol I activity, affecting PNCTR levels, and mentions both PNC integrity and nucleolar framework evolution. All key aspects from the reference are covered, albeit with different phrasing, and there are no contradictions or omissions of crucial elements."
        },
        {
            "query_idx": 1369,
            "query": "What manifestations suggest that Pol III RNA embarks on its journey towards molecular convergence zones in a post-creation phase, as opposed to commencing its origination within these regions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2015
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The presence of #BrU labeling# in PNCs and #non-colocalization# of Pol III-dependent genes indicate RNA is transported to PNCs post-transcription.",
            "predicted_answer": "Pol III RNA is transported to molecular convergence zones post-transcriptionally, as indicated by its lack of colocalization with transcription sites and its association with PTBP1 at PNCs.",
            "score": 3,
            "explanation": "The predicted answer mentions \"lack of colocalization\" but misses the key fact of \"BrU labeling,\" and instead includes association with PTBP1, which is not emphasized in the reference. Therefore, it misses one key fact and introduces another element not highlighted in the reference."
        },
        {
            "query_idx": 1370,
            "query": "What segment of the population experiencing advanced stages of breast malignancy becomes enmeshed with skeletal interferences at the point of diagnostic revelation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2017
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Approximately #70%# of patients with #advanced breast cancer# develop bone metastases at the time of diagnosis.",
            "predicted_answer": "Patients with advanced breast cancer, approximately 70%, develop bone metastases at the time of diagnosis, leading to skeletal interferences.",
            "score": 5,
            "explanation": "The predicted answer includes all the key facts from the reference answer: approximately 70%, patients with advanced breast cancer, and the development of bone metastases at diagnosis. The meaning is consistent, and there are no significant omissions or errors."
        },
        {
            "query_idx": 1371,
            "query": "In what ways do the emergent complexities and inherent confines of tri-dimensional constructs manifest as obstacles in navigating the latent intricacies and multi-dimensional interplay characteristic of osteotropic metastatic inquiries?",
            "retrieved_metrics": {
                "reference_idx": [
                    2018
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The obstacles include #irregular cellular proliferation#, #autofluorescence#, and changes in genetic/epigenetic expression, complicating the study of multi-dimensional interplay in osteotropic metastatic inquiries.",
            "predicted_answer": "Emergent complexities in 3D models, such as irregular cellular proliferation and genetic changes, pose challenges in navigating the multi-dimensional interplay of osteotropic metastasis, requiring advancements in standardization and automation.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of \"irregular cellular proliferation\" and touches on \"genetic changes,\" addressing the essence of genetic/epigenetic expression changes. However, it omits \"autofluorescence,\" making the answer incomplete despite no contradictions. Overall, it aligns with the reference but misses one key fact."
        },
        {
            "query_idx": 1372,
            "query": "What is the temporal midpoint of the survival continuum for individuals grappling with metastatic breast malignancy, and through what interactions of cellular architects is the osseous spread delineated?",
            "retrieved_metrics": {
                "reference_idx": [
                    2020
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The temporal midpoint for metastatic breast cancer survival is #2-3 years#. The osseous spread is delineated through interactions between malignant cells, #osteoblasts#, and osteoclasts.",
            "predicted_answer": "The temporal midpoint for individuals with metastatic breast malignancy is approximately 1-1.5 years. Osseous spread is delineated through interactions involving malignant cells, osteoblasts, and osteoclasts, leading to osteolytic or osteoblastic bone metastases.",
            "score": 1,
            "explanation": "The predicted answer misstates the temporal midpoint of survival as 1-1.5 years, instead of the reference's 2-3 years, and omits mention of osteoblasts. While both answers discuss cellular interactions, significant deviations impact accuracy and completeness."
        },
        {
            "query_idx": 1373,
            "query": "What orchestrated strategies and transformative powers do the wandering neoplastic mammary agents deploy to mold and recalibrate the symbiotic ecosystem within their skeletal sanctuary amidst the broader narrative of mammary cancer's expansive odyssey of metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2021
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #wandering neoplastic mammary agents# induce growth factors and cytokines, activate osteoclasts, inhibit osteoblasts, causing bone resorption, disrupting the #symbiotic ecosystem# in the skeletal sanctuary.",
            "predicted_answer": "Wandering neoplastic mammary agents deploy orchestrated strategies involving the upregulation of growth factors and cytokines in the bone microenvironment, leading to osteoclast activation and osteoblast inhibition. This recalibrates the symbiotic ecosystem by inducing pathologic bone resorption and morphogen secretion, fostering an imbalance between bone formation and resorption.",
            "score": 5,
            "explanation": "The predicted answer addresses the key facts: wandering neoplastic mammary agents, activation of osteoclasts, inhibition of osteoblasts, and disruption of the symbiotic ecosystem. While more detailed, it matches the key concepts and trends of the reference accurately. No significant information is missing."
        },
        {
            "query_idx": 1374,
            "query": "In the symbiotic interplay of the bone's structural matrix, what orchestrative role do the collagenous harmonics undertake in the emergence and growth of hydroxyapatite structures?",
            "retrieved_metrics": {
                "reference_idx": [
                    2023
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Collagenous# harmonics play a key role in #hydroxyapatite# nucleation and growth within the bone's structural matrix.",
            "predicted_answer": "Collagenous harmonics in the bone's structural matrix facilitate hydroxyapatite nucleation and growth by providing a template and structural support, enhancing bone strength and mineralization.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference by mentioning the role of \"collagenous\" harmonics in \"hydroxyapatite\" nucleation and growth. It includes additional context like template provision and structural support, which are consistent with the key facts without introducing contradictions."
        },
        {
            "query_idx": 1375,
            "query": "What are the intricate interdependencies within the spatial and biochemical conversations between circulating malignant entities and their microenvironmental landscapes that may fuel the ongoing debate about the therapeutic effectiveness and adverse outcomes associated with bone-modifying compounds in the context of metastatic bone disease management?",
            "retrieved_metrics": {
                "reference_idx": [
                    2022
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #complex interplay# between malignant cells and their microenvironment affects the debate on the #efficacy# and side effects of bone-modifying compounds in metastatic bone disease management.",
            "predicted_answer": "The intricate interdependencies involve chemoattractants from osteocytes guiding malignant cells to lesions, and the complex interplay between circulating cells, tumor, and bone microenvironment. This complexity fuels the debate on bone-modifying agents' efficacy and side effects in metastatic bone disease.",
            "score": 5,
            "explanation": "The predicted answer captures the key fact of the \"complex interplay\" and mentions the \"efficacy and side effects\" of bone-modifying agents, aligning with the reference answer. There are no significant omissions or contradictions, and key concepts are accurately reflected."
        },
        {
            "query_idx": 1376,
            "query": "Which biochemical envoys and medicinal influences command the cessation of osteoclast activity, and through what mechanisms do the architects and custodians of bone establish communication with their extracellular environment through integrin pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2025
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#TGF-β#, #bisphosphonates#, and estrogen drive osteoclast apoptosis. Osteoblasts use integrins like α$_{v}$β$_{3}$ and α$_{2}$β$_{1}$ to communicate with the ECM.",
            "predicted_answer": "Transforming growth factor-β (TGF-β), bisphosphonates, and estrogen command the cessation of osteoclast activity, primarily through apoptosis. Osteoblasts and osteocytes communicate with the extracellular matrix via integrin pathways, such as αvβ3 and α2β1 for osteoblasts, and β1 and β3 for osteocytes.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts emphasized with # in the reference: #TGF-β# and #bisphosphonates#, and mentions estrogen. It covers osteoclast apoptosis and integrins like αvβ3 and α2β1. Although there are minor deviations in phrasing, the meaning is fully consistent."
        },
        {
            "query_idx": 1377,
            "query": "In the elaborate ecosystem of extracellular matrix modulation, what pivotal role do the regulatory elements identified as matrix metalloproteinases play in directing the metamorphic pathway of cellular structures, and what distinct interactive paradigm characterizes the engagement of sialoprotein with these cellular components within the matrix realm?",
            "retrieved_metrics": {
                "reference_idx": [
                    2024
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Matrix metalloproteinases (#MMP#) drive matrix #remodeling#, orchestrating MSCs to osteoblasts and osteoblasts to osteocytes. Sialoprotein interacts with cells and hydroxyapatite via RGD.",
            "predicted_answer": "Matrix metalloproteinases (MMPs) direct matrix remodeling, guiding mesenchymal stem cells to osteoblasts and osteoblasts to osteocytes. Sialoprotein interacts with cells and hydroxyapatite through RGD sequences, facilitating cellular engagement within the extracellular matrix.",
            "score": 5,
            "explanation": "The predicted answer covers all key facts emphasized with # in the reference answer, including the pivotal role of matrix metalloproteinases in matrix remodeling and the interaction of sialoprotein with cells and hydroxyapatite via RGD sequences. The overall trend and meaning are consistent."
        },
        {
            "query_idx": 1378,
            "query": "In what ways do the intertwining influences of ionic characters, specifically fluoride and carbonate, artistically modulate the mineral scaffold's structural precision in their roles as architects of the bone's crystalline blueprint?",
            "retrieved_metrics": {
                "reference_idx": [
                    2027
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intertwining influences of #fluoride# enhance crystallinity, while #carbonate# decreases crystallinity, artistically modulating the bone's mineral scaffold.",
            "predicted_answer": "Fluoride enhances crystallinity, strengthening the mineral scaffold, while carbonate decreases it, promoting flexibility. These ionic influences modulate the bone's structural precision by balancing strength and adaptability.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts that #fluoride# enhances crystallinity and #carbonate# decreases it, aligning with the reference answer. Although additional context is provided about strength and adaptability, this does not conflict with the reference. All relevant facts are present and consistent."
        },
        {
            "query_idx": 1379,
            "query": "In what manner does TGF-β engage in the complex choreography involving cellular interplays, where cancerous cell integration triggers the symbiotic degradation of osseous matter, thereby modulating cellular specialization and intensification of osteoclastic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2028
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "TGF-β #release# inhibits osteoblast differentiation and #aggravates# osteoclasts' osteolytic activity upon cancer cell-induced bone resorption.",
            "predicted_answer": "TGF-β engages by promoting osteoclast activity and inhibiting osteoblast differentiation, exacerbating bone degradation triggered by cancer cell integration.",
            "score": 3,
            "explanation": "The predicted answer captures inhibiting osteoblast differentiation and exacerbating osteoclast activity, aligning with the reference. However, the notion of TGF-β's \"release\" and its role in cancer-induced scenarios is missing, affecting completeness. Key facts are mostly present, but one is missing."
        },
        {
            "query_idx": 1380,
            "query": "What intricate interplay within the tumor-oriented microcosm presents formidable barriers to the evolution of pharmacological interventions aimed at rectifying neoplastic growth, considering the ecological interactions at play?",
            "retrieved_metrics": {
                "reference_idx": [
                    2031
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #intricate interplay# involves endothelial cells, fibroblasts, and immune cells, leading to complex #barriers# that hinder pharmacological interventions in neoplastic growth within the tumor microenvironment.",
            "predicted_answer": "The intricate interplay within the tumor microenvironment, involving endothelial cells, fibroblasts, and immune cells, creates formidable barriers to pharmacological interventions. These interactions promote tumor growth, metastasis, and immune evasion, complicating the development of effective anti-cancer treatments.",
            "score": 5,
            "explanation": "The predicted answer captures the intricate interplay involving endothelial cells, fibroblasts, and immune cells, aligning well with the reference. It additionally addresses mechanisms like tumor growth and immune evasion, offering more context. It effectively presents the complex barriers to pharmacological interventions highlighted in the reference answer."
        },
        {
            "query_idx": 1381,
            "query": "In what complex dimensions do the variable expression levels of the cytokine IL-6 intertwine with the progressive colonization of osseous tissues and the amplified invasion into numerous visceral territories?",
            "retrieved_metrics": {
                "reference_idx": [
                    2035
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The variable expression levels of #IL-6# are linked to #bone metastasis# and the number of additional metastasized organs.",
            "predicted_answer": "The variable expression levels of cytokine IL-6 intertwine with the progressive colonization of osseous tissues and amplified invasion into numerous visceral territories, influencing bone metastasis and the spread to additional organs.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that IL-6 is linked to bone metastasis and the spread to additional organs, aligning well with the reference answer. The terms \"bone metastasis\" and \"additional metastasized organs\" are captured as \"osoeous tissues\" and \"additional organs.\""
        },
        {
            "query_idx": 1382,
            "query": "In the orchestration of cellular universes within engineered tridimensional matrices, what intrinsic benefits do microcarrier-supported frameworks confer, particularly in fostering cellular expansion and augmenting pharmacological resilience during the meticulous reimagining of dense tumor landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2044
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Microcarrier-supported frameworks provide #enhanced proliferation# and #improved drug resistance#, facilitating cellular expansion and pharmacological resilience in complex tumor landscapes.",
            "predicted_answer": "Microcarrier-supported frameworks enhance cellular expansion by providing increased surface area and fostering cell-cell and cell-ECM interactions. They also augment pharmacological resilience by improving drug resistance in dense tumor landscapes.",
            "score": 5,
            "explanation": "The predicted answer captures the essential aspects of \"enhanced proliferation\" and \"improved drug resistance,\" aligning well with the reference answer's key facts, though using slightly different terminology. These cover the crucial points of cellular expansion and pharmacological resilience enhancement in tumor landscapes."
        },
        {
            "query_idx": 1383,
            "query": "What intrinsic mechanisms within the microcosm of tumor-on-chip systems afford them an unparalleled edge in swiftly determining the therapeutic value of chemotherapy agents compared to traditional methodologies within the hierarchical structures of cancer treatment paradigms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2050
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cancer-on-chip systems use #3D multichannel# microfluidics to replicate patient tumor characteristics, determining chemotherapy #success rate# in under 12 hours, unlike traditional methodologies.",
            "predicted_answer": "Cancer-on-a-chip systems offer rapid therapeutic evaluation by replicating tumor characteristics and TME physiology, enabling success rate determination of chemotherapy drugs within 12 hours, compared to traditional methods.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference, acknowledging cancer-on-chip systems' ability for rapid chemotherapy evaluation. However, it omits the specific aspect of \"3D multichannel microfluidics,\" a crucial element in the reference answer. Despite this, it captures the overall trend without contradiction."
        },
        {
            "query_idx": 1384,
            "query": "What implications arise from diminishing PTH-rP on the strategic inclinations demonstrated by breast cancer cells within their osseous colonization tactics?",
            "retrieved_metrics": {
                "reference_idx": [
                    2029
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Neutralizing #PTH-rP# eliminates the #bone metastatic# behavior of breast cancer cells, disrupting their osseous colonization tactics through decreased osteoclast activation.",
            "predicted_answer": "Diminishing PTH-rP reduces osteoclast activation and differentiation, thereby inhibiting breast cancer cells' ability to colonize bone, as PTH-rP is crucial for RANKL-mediated osteoclast induction.",
            "score": 3,
            "explanation": "The predicted answer includes the key fact of reducing PTH-rP leading to decreased osteoclast activation and affecting breast cancer cells' colonization tactics. However, it lacks the explicit mention of \"eliminates the bone metastatic behavior.\" Therefore, one key detail is missing."
        },
        {
            "query_idx": 1385,
            "query": "To what extent do the minute platforms designed for cellular assessment, particularly those manifesting from biocompatible polymeric substances, excel in providing enhanced translucent interfaces for biological monitoring and superior gaseous permeable pathways compared to other conventional material constructs used in in-vitro investigative frameworks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2052
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miniature platforms made of #PDMS# excel in providing #enhanced translucent# interfaces and superior gaseous permeability for biological monitoring compared to conventional materials in in-vitro frameworks.",
            "predicted_answer": "Minute platforms made from biocompatible polymers like PDMS excel in providing enhanced translucent interfaces for biological monitoring and superior gaseous permeable pathways, due to their transparency and high permeability to O₂ and CO₂ gases.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts such as the use of PDMS, enhanced translucent interfaces, and superior gaseous permeability for biological monitoring. The details align with the reference answer without any contradictions. All emphasized points in the reference are covered."
        },
        {
            "query_idx": 1386,
            "query": "In what ways does the bone-on-chip framework pioneered by Hao et al. offer fresh insights into the intricate traversal of breast cancer cellular entities, and how does this perspective diverge from the time-honored in vivo landscapes typically harnessed in the quest for understanding metastasis?",
            "retrieved_metrics": {
                "reference_idx": [
                    2055
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #bone-on-chip# framework reveals unique breast cancer colonization traits, enabling #in vitro# studies, diverging from traditional in vivo models with comprehensive tumor microenvironment simulations.",
            "predicted_answer": "The bone-on-chip framework by Hao et al. offers fresh insights into breast cancer cell traversal by simulating 3D tumor microenvironments and interactions with bone matrix, replicating in vivo colonization characteristics previously only observed in vivo. This perspective diverges from traditional in vivo landscapes by enabling controlled, reproducible studies with features like vasculature and mechanical properties, facilitating faster drug response predictions.",
            "score": 3,
            "explanation": "The predicted answer covers key facts such as the #bone-on-chip# framework and its application to simulate the tumor microenvironment. However, it misses the specific mention of #in vitro# studies, which is critical to the contrast with traditional in vivo models. Overall alignment is present with no contradictions."
        },
        {
            "query_idx": 1387,
            "query": "In the labyrinthine process through which these malignant envoys initiate their voyage and subsequent lodgment within the skeletal realm, what series of transformations and interactions do these cells undergo, intricately intertwining with their new microenvironment to secure their presence and thrive therein?",
            "retrieved_metrics": {
                "reference_idx": [
                    2063
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tumor cells undergo #epithelial-to-mesenchymal transition#, spread in blood circulation, lodge in bone, induce osteolytic lesions, and suppress immune response to thrive in the skeletal realm.",
            "predicted_answer": "Tumor cells undergo genetic and phenotypic changes, epithelial-to-mesenchymal transition, and interactions with the bone microenvironment to secure their presence and create osteolytic lesions.",
            "score": 1,
            "explanation": "The predicted answer includes epithelial-to-mesenchymal transition and creation of osteolytic lesions, aligning with the reference. However, it omits critical aspects such as spreading through blood circulation and immune response suppression, affecting completeness."
        },
        {
            "query_idx": 1388,
            "query": "What are the cascading repercussions when a multitude of 4T1 cellular entities is introduced into the osseous landscape, particularly concerning immediate structural impacts and secondary systemic influences at proximate and divergent corporeal locales?",
            "retrieved_metrics": {
                "reference_idx": [
                    2066
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Introducing #10,000 4T1 cells# into the tibia causes #osteolytic lesions# and can metastasize to the femur, lungs, and forelimbs, affecting local and distant anatomical sites.",
            "predicted_answer": "Introduction of 4T1 cells into bone leads to osteolytic lesions and metastasis to distant sites like lungs and forelimbs. Increased cell concentrations accelerate tumor progression and systemic spread, affecting both local and distant body regions.",
            "score": 3,
            "explanation": "The predicted answer covers key concepts like osteolytic lesions and metastasis to distant sites, maintaining alignment with the reference. However, it omits the specific detail of introducing \"10,000\" 4T1 cells into the tibia, missing this key fact, which affects completeness."
        },
        {
            "query_idx": 1389,
            "query": "In the elaborate tapestry woven by impermeable substrates and gas conduits within microfluidic domains, what nuanced roles do these elements play in orchestrating the adaptive voyage of pulmonary carcinoma cells through the influential corridors of the Wnt signaling apparatus amid chemically infused gradients?",
            "retrieved_metrics": {
                "reference_idx": [
                    2060
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Impermeable substrates and gas conduits regulate oxygen gradients, influencing #pulmonary carcinoma cells#' migration via the #Wnt signaling# pathway in chemically infused microfluidic gradients.",
            "predicted_answer": "Impermeable substrates and gas conduits in microfluidic domains create controlled chemical gradients, influencing the migration of pulmonary carcinoma cells via the Wnt signaling pathway. These elements facilitate dynamic cell responses to chemotaxis within chemically infused environments.",
            "score": 3,
            "explanation": "The predicted answer captures the essence of the reference answer by mentioning how impermeable substrates and gas conduits create chemical gradients influencing pulmonary carcinoma cells via the Wnt signaling pathway. However, it lacks explicit mention of \"oxygen gradients,\" which is crucial, impacting completeness."
        },
        {
            "query_idx": 1390,
            "query": "What are the fundamental biochemical divergences and morphological intricacies that define the limited inclination towards osseous metastasis in murine models, in contrast to the prevalent cellular migration to bone observed in human neoplastic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2070
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The limited osseous metastasis in mice is due to #metabolic activity# differences and murine #mesenchymal tissue# origins, contrasting with human epithelial-derived cancers.",
            "predicted_answer": "The limited inclination towards osseous metastasis in murine models is primarily due to fundamental biochemical divergences such as higher metabolic activity and longer telomerase in mouse cells, and morphological intricacies like the mesenchymal origin of mouse tumors versus the epithelial origin in humans.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts of \"metabolic activity\" and \"mesenchymal origins\" emphasized in the reference. However, it introduces \"telomerase\" and compares \"mesenchymal\" to \"epithelial\" rather than just origins. Although the trend is aligned, it doesn't accurately cover all emphasized facts, introducing additional elements."
        },
        {
            "query_idx": 1391,
            "query": "In exploring the conduits of neoplastic proliferation, what are the nuanced restrictions or impediments linked to deploying intracardiac, intravenous, and lipid-based injection methodologies for evoking metastatic incursions into the skeletal matrix?",
            "retrieved_metrics": {
                "reference_idx": [
                    2072
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intracardiac injection lacks #specific bone metastasis#, intravenous leads to #lung tumors#, and fat injection yields low bone metastasis incidence, requiring more subjects.",
            "predicted_answer": "Intracardiac injection lacks specificity for bone metastases, intravenous injection primarily leads to lung tumors, and lipid-based injections result in low bone metastasis rates and require more animals.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key points emphasized in the reference answer: intracardiac injection's lack of specificity for bone metastasis, intravenous injection's association with lung tumors, and lipid-based injection's low bone metastasis rates with a need for more subjects. The meaning is consistent with no omissions."
        },
        {
            "query_idx": 1392,
            "query": "How does the intricate milieu of the transplantation's ecological niche orchestrate the disparate evolutionary trajectories of neoplastic conduct and their consequential therapeutic reactions, when comparing native anatomical embedding to foreign ecological placements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2078
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #site of transplantation# influences tumor behavior and #treatment response#, differing between orthotopic and alternative sites, impacting evolutionary trajectories and therapeutic reactions.",
            "predicted_answer": "The transplantation site significantly influences tumor behavior and therapeutic responses, with orthotopic implantation leading to different tumor behaviors compared to foreign sites, altering treatment outcomes.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts such as the transplantation site influencing tumor behavior and treatment response, and the difference between orthotopic and foreign sites affecting treatment outcomes. However, it lacks mention of evolutionary trajectories, which is a key aspect."
        },
        {
            "query_idx": 1393,
            "query": "In what ways do existing biological surrogates fail to capture the intricate quiescent phase of malignant cellular entities, and how do ethical and fiscal dimensions further delineate these limitations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2080
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Existing biological surrogates fail to capture #quiescent cancer phases# as immunodeficient models don't mimic stromal interactions. #Ethical and fiscal# issues arise from needing more costly models.",
            "predicted_answer": "Existing biological surrogates, like animal models, fail to capture the quiescent phase of malignant cells due to limitations in mimicking human immunology and stromal interactions. Ethical and fiscal constraints further limit the use of more expensive models, making comprehensive studies challenging.",
            "score": 5,
            "explanation": "The predicted answer accurately addresses the two #key facts# from the reference: the failure to capture #quiescent cancer phases# due to inadequate mimicry of stromal interactions and the #ethical and fiscal# issues tied to costly models. The phrasing differs but retains essential meaning and completeness."
        },
        {
            "query_idx": 1394,
            "query": "What conceptual and practical elevations do in vivo-translated PDX models offer over the encapsulated reality of organoids, regarding dynamic therapeutic assessment and their capacity for scalable, reproducible research frameworks within cancer studies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2085
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In vivo-translated #PDX models# offer systemic evaluations and are #scalable/reproducible# compared to organoids, facilitating dynamic therapeutic assessment and broad research applications in cancer studies.",
            "predicted_answer": "In vivo-translated PDX models offer dynamic therapeutic assessment by replicating systemic disease changes and treatment effects, providing a scalable, reproducible framework for cancer research. This contrasts with organoids, which lack in vivo evaluation and systemic context.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of in vivo-translated PDX models in providing dynamic therapeutic assessment and scalability, as noted in the reference. It mentions both systemic context and the lack thereof in organoids, aligning well with the key facts emphasized in the reference."
        },
        {
            "query_idx": 1395,
            "query": "How does the CRISPR-associated RNA molecule guide the cellular molecular ensemble to choreograph the disassembly of intrusive viral nucleic sequences, ensuring the biochemical invalidation of the viral entity?",
            "retrieved_metrics": {
                "reference_idx": [
                    2086
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #CRISPR RNA# directs bacterial machinery to viral sequences, leading to the #destruction# of the invading viral genome.",
            "predicted_answer": "The CRISPR-associated RNA molecule guides the bacterial molecular machinery to the viral nucleic sequences, directing it to break and destroy the invading viral genome, ensuring the biochemical invalidation of the viral entity.",
            "score": 5,
            "explanation": "The Predicted Answer correctly incorporates the key facts from the Reference Answer, which includes the \"CRISPR RNA\" guiding bacterial machinery and the \"destruction\" of the viral genome. The overall meaning is consistent, with no missing key facts or contradictory information."
        },
        {
            "query_idx": 1396,
            "query": "How do empirical frameworks, functioning as keystones in the expansive architectural design of therapeutic articulation, vindicate the indispensable reliance placed upon them for demystifying and maneuvering extensive genomic topographies in the orchestration of novel pharmacological designs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2087
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Empirical frameworks justify reliance through #integrated studies# that use genetic data to test hypotheses, crucial for designing and validating #novel pharmacological# strategies.",
            "predicted_answer": "Empirical frameworks validate genomic data by testing hypotheses in precision models, ensuring drug efficacy and sustainability in novel pharmacological designs.",
            "score": 1,
            "explanation": "The predicted answer captures the general trend of the reference answer, focusing on the validation of genomic data and its role in drug design. However, it omits \"integrated studies\" and specifics about \"novel pharmacological strategies.\" Thus, it misses two key facts from the reference."
        },
        {
            "query_idx": 1397,
            "query": "How does the CRISPR-Cas9 orchestrate a biological symphony, catalyzing the swift emergence of bespoke animal models while bypassing the intricate web of traditional mutagenic pathways in the pharmacoscientific odyssey?",
            "retrieved_metrics": {
                "reference_idx": [
                    2096
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CRISPR-Cas9 facilitates rapid #animal model# development by enabling one-step #gene editing#, bypassing traditional breeding, thereby accelerating the drug discovery process.",
            "predicted_answer": "CRISPR-Cas9 simplifies animal model creation by enabling simultaneous gene editing in zygotes, bypassing traditional breeding methods and accelerating drug discovery.",
            "score": 5,
            "explanation": "The predicted answer successfully conveys the key facts: CRISPR-Cas9's role in rapid animal model development, one-step gene editing, bypassing traditional breeding, and accelerating drug discovery. It captures the overall trend of simplification and speed. Though phrasing varies, no key facts are missing or contradicted."
        },
        {
            "query_idx": 1398,
            "query": "What methodological intricacies arise in the context of employing genomic modulation mechanisms, specifically CRISPRa, in the orchestration of mosaic-like data assemblages that map function-loss scenarios pivotal to pharmacological innovation landscapes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2099
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#CRISPRa# may not function if the gene has a loss-of-function in the cell line of interest, and combined screens, while useful, are #experimentally complex#.",
            "predicted_answer": "Methodological intricacies include false-negative outcomes due to loss-of-function genes, experimental complexity, and reduced sensitivity in CRISPRa screening, which can hinder accurate mapping of function-loss scenarios for pharmacological innovation.",
            "score": 5,
            "explanation": "The predicted answer captures key facts, including the potential non-functioning of CRISPRa due to loss-of-function genes and the experimental complexity of combined screens. Although some details differ, both answers align well with the trends mentioned in the reference answer."
        },
        {
            "query_idx": 1399,
            "query": "In what manner does the attenuation of KEAP1 influence the intricate dance of pharmacological resistance within the cascade of MEK pathway suppression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2103
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Attenuation of #KEAP1# promotes resistance in the #MEK# inhibition pathway.",
            "predicted_answer": "The attenuation of KEAP1 promotes resistance to MEK inhibition, potentially by altering the regulatory dynamics within the MEK pathway, thereby complicating pharmacological suppression and fostering resistance mechanisms.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts that attenuation of KEAP1 promotes resistance and mentions the MEK pathway. It aligns with the reference answer in meaning. While it adds more detail about regulatory dynamics, no critical information is missing or incorrect."
        },
        {
            "query_idx": 1400,
            "query": "What intricate conundrum presents itself in the calibration of sgRNA aligned with genomic regions of amplified repetition, and in what nuanced form does this challenge echo through the modulation of the cellular phase continuum?",
            "retrieved_metrics": {
                "reference_idx": [
                    2105
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricate conundrum is #misleading positive outcomes# due to aberrant genome copy numbers, causing #replication pressure# and G2/M cell cycle arrest when targeting amplified regions.",
            "predicted_answer": "The intricate conundrum in calibrating sgRNA aligned with genomic regions of amplified repetition involves misleading positive outcomes due to aberrant copy numbers, leading to replication pressure and G2/M cell cycle arrest. This challenge echoes through the modulation of the cellular phase continuum by potentially disrupting normal cell cycle progression.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference: #misleading positive outcomes#, #replication pressure#, and the resulting G2/M cell cycle arrest are all mentioned. It is consistent and matches the overall meaning without contradictory information, thus reflecting the essential details effectively."
        },
        {
            "query_idx": 1401,
            "query": "How do the orchestrating entities, CRISPRi and CRISPRa, implement transformative modulations in the initial transcriptional overture to enhance the symphony of biological data acquisition, reflecting an expanded dialogue in cellular narratives?",
            "retrieved_metrics": {
                "reference_idx": [
                    2116
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "CRISPRi and CRISPRa target transcription start points to modulate #genetic expression#, enhancing #biological data# acquisition for expanded cellular insights.",
            "predicted_answer": "CRISPRi and CRISPRa modulate gene expression by targeting the transcriptional start point, altering initial transcription to enhance biological data acquisition and expand cellular narratives.",
            "score": 5,
            "explanation": "The predicted answer captures the essence of the reference answer by indicating that CRISPRi and CRISPRa modulate gene expression, impact biological data acquisition, and expand cellular narratives. The key concepts of \"genetic expression\" and \"biological data\" are satisfactorily reflected."
        },
        {
            "query_idx": 1402,
            "query": "How do the subtle genetic variations, reminiscent of hidden disturbances within the biological fabric, contribute to the divergence observed in CRISPR experimental paradigms, and what implications could this have for the trajectory of medicinal compound discovery?",
            "retrieved_metrics": {
                "reference_idx": [
                    2115
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Subtle genetic variations lead to #heterogeneity# in CRISPR screening, impacting consistency. This variability influences the #discovery# of medicinal compounds by complicating target identification and validation.",
            "predicted_answer": "Subtle genetic variations, such as in-frame indels, contribute to CRISPR experimental divergence by creating heterogeneous subpopulations, affecting screening results. This variability impacts drug target discovery, necessitating precise models and functional genomics for accurate medicinal compound development.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts of \"heterogeneity\" and \"discovery\" from the reference answer. It discusses how genetic variations cause heterogeneity in CRISPR screenings and their effect on drug target discovery, without contradictions. Both answers align on the implications for medicinal compound development."
        },
        {
            "query_idx": 1403,
            "query": "How do intricate molecular evolutions contribute to the creation of transformative avenues and lasting efficacy of ligand-directed siRNA structures in achieving substantial extra-hepatic reach?",
            "retrieved_metrics": {
                "reference_idx": [
                    2121
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Intricate molecular evolutions contribute to #longterm efficacy# and #stability# of ligand-conjugated siRNAs, enabling substantial extra-hepatic delivery.",
            "predicted_answer": "Intricate molecular evolutions enhance ligand-directed siRNA structures by improving stability and long-term efficacy, enabling robust extra-hepatic delivery.",
            "score": 5,
            "explanation": "The predicted answer includes key facts: \"long-term efficacy,\" \"stability,\" and \"extra-hepatic delivery,\" all of which are emphasized in the reference answer. The overall meaning is consistent, with no significant omissions or errors, aligning well with the reference."
        },
        {
            "query_idx": 1404,
            "query": "What therapeutic silencing catalyst, conceptualized to modulate systemic vascular tension, has attained the secondary phase within the spectrum of clinical investigations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2123
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The therapeutic silencing catalyst for modulating systemic vascular tension in Phase 2 clinical trials is #ALN-AGT# for the treatment of #hypertension#.",
            "predicted_answer": "ALN-AGT is a therapeutic silencing catalyst in Phase 2 trials for modulating systemic vascular tension, specifically targeting hypertension.",
            "score": 5,
            "explanation": "The 'Predicted Answer' includes all the key facts emphasized in the 'Reference Answer': it mentions #ALN-AGT# and specifies its role in Phase 2 trials for #hypertension#. The wording differs slightly, but the meaning and key details are fully consistent with the 'Reference Answer'."
        },
        {
            "query_idx": 1405,
            "query": "What is the silencing cellular mechanism that has embarked on the penultimate leg of clinical inquiry aimed at combating the ailment of ocular desiccation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2125
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The silencing cellular mechanism is #Tivanisiran# (SYL1001), currently in a #Phase 3# clinical study for treating dry eye disease.",
            "predicted_answer": "The silencing cellular mechanism being investigated for ocular desiccation is RNA interference (RNAi) therapy, specifically Tivanisiran (SYL1001), which is in Phase 3 clinical study for dry eye disease.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the silencing cellular mechanism as Tivanisiran (SYL1001) and confirms it is in a Phase 3 clinical study for dry eye disease. All key facts emphasized in the reference, such as the specific drug and study phase, are present."
        },
        {
            "query_idx": 1406,
            "query": "How do the maestros of genetic architecture, referred to as noncoding RNAs, conduct the intricate movements within the cellular symphony, notably in the arenas of transcriptional overtures and translational orchestrations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2126
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Noncoding RNAs, like #miRNAs# and #tRNAs#, regulate cellular processes by influencing transcription and translation, acting as key players in genetic architecture.",
            "predicted_answer": "Noncoding RNAs orchestrate cellular processes by regulating transcription and translation. They modulate gene expression through mechanisms like RNA interference, guiding RNA splicing, and assisting in protein synthesis.",
            "score": 3,
            "explanation": "The 'Predicted Answer' aligns with the overall trend of the 'Reference Answer' by noting that noncoding RNAs regulate transcription and translation. However, it misses the specific mention of the key types of noncoding RNAs, #miRNAs# and #tRNAs#, which are crucial for completeness."
        },
        {
            "query_idx": 1407,
            "query": "In the nuanced fabric of intricate molecular engagement, which specific proteins are designated for focused molecular interception by the siRNA initiatives ALN-APP and ARO-SOD1, amidst the strategic frameworks aimed at mitigating the symptoms of cognitive deterioration, vascular amyloid protein accumulation, and the disruption of neurodegenerative processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2127
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "ALN-APP targets #amyloid precursor proteins#, while ARO-SOD1 targets #superoxide dismutase 1#.",
            "predicted_answer": "ALN-APP targets amyloid precursor proteins (APPs) for Alzheimer's disease and cerebral amyloid angiopathy, while ARO-SOD1 targets superoxide dismutase 1 (SOD1) for amyotrophic lateral sclerosis.",
            "score": 5,
            "explanation": "The predicted answer accurately identifies the proteins targeted by both siRNA initiatives: amyloid precursor proteins for ALN-APP and superoxide dismutase 1 for ARO-SOD1. It fully covers the key facts emphasized in the reference answer with no significant omissions or contradictions."
        },
        {
            "query_idx": 1408,
            "query": "In the saga of clinical trials, which distinct trajectories are embarked upon by STP705 and STP707 through their individual mechanisms of therapeutic navigation?",
            "retrieved_metrics": {
                "reference_idx": [
                    2124
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "STP705 targets #isSCC# and #BCC# through local administration, while STP707 addresses solid tumors and fibrotic liver diseases via intravenous injection.",
            "predicted_answer": "STP705 is locally administered for in situ squamous cell carcinoma and basal cell carcinoma, while STP707 is intravenously injected for solid tumors and fibrotic liver diseases.",
            "score": 5,
            "explanation": "The predicted answer includes all key facts: STP705 is used for in situ squamous cell carcinoma (isSCC) and basal cell carcinoma (BCC) with local administration, and STP707 is used for solid tumors and fibrotic liver diseases with intravenous injection. The overall meaning aligns with the reference answer."
        },
        {
            "query_idx": 1409,
            "query": "What mechanism, resembling the dynamic of selective permeability permitting retention, contributes to the congregating of nanoscale entities in compact neoplastic structures and hepatic environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2133
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #enhanced permeability and retention (EPR) effect# contributes to the #accumulation of nanoparticles# in tumors and the liver.",
            "predicted_answer": "The Enhanced Permeability and Retention (EPR) effect contributes to the congregating of nanoscale entities in compact neoplastic structures and hepatic environments by allowing their accumulation in tumors and liver due to selective permeability and retention.",
            "score": 5,
            "explanation": "The predicted answer successfully identifies the Enhanced Permeability and Retention (EPR) effect and relates it to the accumulation of nanoscale entities, aligning with the reference answer. Both describe the concept of selective permeability in tumors and liver, capturing the key facts without missing any critical details."
        },
        {
            "query_idx": 1410,
            "query": "What strategic alignments within the intricate synergy of targeted molecular reconnaissance missions and interconnected silencing sequences advance the recalibration of systemic persistence and site-specific aggregation patterns at the cellular frontiers?",
            "retrieved_metrics": {
                "reference_idx": [
                    2139
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Strategic alignment involves using #targeting ligands# to enhance #cellular uptake#, facilitating recalibration of systemic persistence and site-specific aggregation patterns at cellular frontiers.",
            "predicted_answer": "Strategic alignments involve optimizing carrier properties and using ligand-siRNA conjugates to enhance targeted accumulation and cellular uptake, advancing systemic persistence and site-specific aggregation patterns.",
            "score": 3,
            "explanation": "The Predicted Answer mentions the use of \"ligand-siRNA conjugates\" for \"targeted accumulation and cellular uptake,\" aligning with \"targeting ligands\" and \"cellular uptake\" in the Reference Answer. It covers key points about enhancing uptake and systemic persistence but omits details on recalibration."
        },
        {
            "query_idx": 1411,
            "query": "What instances of emergent architectural blueprints within the sophisticated domain of RNA interference illustrate innovative scaffolding footprints, reflecting recent molecular choreography advancements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2138
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Instances include #asymmetric siRNAs# and #divalent siRNA scaffold#, illustrating innovative scaffolding footprints in RNA interference, reflecting recent molecular choreography advancements.",
            "predicted_answer": "Emergent architectural blueprints in RNA interference include novel monomers like GNA and 5'-(E)-VP, enhanced stabilization chemistry (ESC+), and innovative RNAi trigger structures such as sciRNAs, asymmetric siRNAs, and divalent siRNA scaffolds.",
            "score": 5,
            "explanation": "The predicted answer includes both key elements from the reference answer: \"asymmetric siRNAs\" and \"divalent siRNA scaffolds.\" Though extra elements are mentioned, they do not contradict the reference, and no key facts are missing. The overall trend is consistent."
        },
        {
            "query_idx": 1412,
            "query": "What potential therapeutic synergies could be unlocked by harmonizing siRNA's molecular reprogramming aptitude with the systemic recalibration provided by chemotherapy agents in a coordinated dual-targeting paradigm?",
            "retrieved_metrics": {
                "reference_idx": [
                    2140
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Harmonizing siRNA with chemotherapy could enhance #efficacy# and overcome drug resistance by modulating epigenetic marks, potentially #reprogramming# gene expression and reversing disease phenotypes.",
            "predicted_answer": "Combining siRNA's molecular reprogramming with chemotherapy's systemic recalibration could enhance efficacy, overcome drug resistance, and reduce off-target effects, potentially treating previously untreatable diseases.",
            "score": 1,
            "explanation": "The predicted answer mentions enhancing efficacy and overcoming drug resistance, aligning with the reference. It misses discussing \"modulating epigenetic marks\" and \"reprogramming gene expression,\" which are key to understanding the therapeutic mechanism. Thus, it omits more than one critical fact."
        },
        {
            "query_idx": 1413,
            "query": "What unexplored dimensions of potential advancement or alteration might manifest within the framework of pathological storytelling through the application of sophisticated RNA-modulating strategies that influence the expression of non-coding RNA, considering their pivotal involvement in complex disease interplays?",
            "retrieved_metrics": {
                "reference_idx": [
                    2142
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The unexplored dimensions include targeting #non-coding RNA# with advanced RNA-modulating strategies, potentially revealing new insights into disease mechanisms and enabling novel #therapeutic interventions#.",
            "predicted_answer": "The application of sophisticated RNA-modulating strategies, such as siRNA targeting non-coding RNAs (ncRNAs), could reveal new dimensions in pathological storytelling by influencing complex disease interplays and ceRNA networks, potentially leading to more effective therapeutic interventions.",
            "score": 5,
            "explanation": "The predicted answer mentions targeting non-coding RNAs, aligning with the key fact from the reference answer. It also discusses potential therapeutic interventions, consistent with the reference's emphasis on novel therapeutic interventions. The overall trend and key facts are covered effectively."
        },
        {
            "query_idx": 1414,
            "query": "What multifaceted obstacles does the guardianship of molecular architecture within CMC paradigms confront, which in turn subtly modulate the trajectory towards market entry for emerging pharmacological innovations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2144
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The guardianship of molecular architecture in #CMC# paradigms faces obstacles like #monomer supply#, quality control, impurity characterization, and the lack of unified international drug registration standards.",
            "predicted_answer": "The guardianship of molecular architecture within CMC paradigms confronts multifaceted obstacles such as monomer supply, quality control, capacity building, impurity characterization, and separation purification, which subtly modulate the trajectory towards market entry for emerging pharmacological innovations.",
            "score": 3,
            "explanation": "The predicted answer includes key obstacles such as monomer supply, quality control, and impurity characterization from the reference answer. However, it omits \"the lack of unified international drug registration standards\" and adds \"capacity building\" and \"separation purification,\" not mentioned in the reference."
        },
        {
            "query_idx": 1415,
            "query": "In the theatre of thyroid malignancies, what are the commonly perceived murmurs that patients encounter, and what are the primary nodes in the intricate network where cellular itinerants frequently commence their journey of dispersion?",
            "retrieved_metrics": {
                "reference_idx": [
                    2148
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Patients with thyroid cancer often experience #hoarseness# and #dyspnea#. Metastases commonly occur in the lymph nodes of the neck.",
            "predicted_answer": "Patients with thyroid malignancies often experience hoarseness, dysphagia, and dyspnea. The primary nodes for metastasis are the lymph nodes of the neck, followed by the lungs, brain, and bones.",
            "score": 5,
            "explanation": "The predicted answer includes the key symptoms of #hoarseness# and #dyspnea#, aligns with the general trends, and identifies the #lymph nodes of the neck# as sites of metastasis. However, it adds information about other symptoms and metastasis sites not emphasized in the reference answer."
        },
        {
            "query_idx": 1416,
            "query": "What myriad dimensions of complexity surround the enigmatic endeavor of refining diagnostic precision and stratifying therapeutic interventions in thyroid cancer treatment, especially when aligning the delicate balance between enhancing survival prospects and advancing the holistic quality of life?",
            "retrieved_metrics": {
                "reference_idx": [
                    2150
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Refining diagnostic precision and stratifying treatments for thyroid cancer involve complexity in improving #early diagnosis# and selecting #appropriate treatment# to enhance survival and quality of life.",
            "predicted_answer": "Refining diagnostic precision and stratifying therapeutic interventions in thyroid cancer involves balancing early diagnosis, appropriate treatment selection, and minimizing harm to enhance both survival and quality of life.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of #early diagnosis# and #appropriate treatment# from the reference answer. It aligns well with the overall trend of balancing survival prospects and quality of life, without any significant omissions or contradictions."
        },
        {
            "query_idx": 1417,
            "query": "What orchestrations within the genetic symphony of thyroid cellular anomalies can be traced to intricacies unveiled amid the complex interplay of SARS-CoV-2 infections?",
            "retrieved_metrics": {
                "reference_idx": [
                    2152
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Gene mutation# and #signaling pathway# abnormalities in thyroid cancer are linked to SARS-CoV-2 infections, emphasizing complex interplay in these cellular anomalies.",
            "predicted_answer": "SARS-CoV-2 infections can lead to thyroid cellular anomalies, including gene mutation, rearrangement, and signaling pathway abnormalities, particularly in thyroid cancer, where RET mutations are common.",
            "score": 3,
            "explanation": "The Predicted Answer covers key facts from the Reference Answer, mentioning gene mutations and signaling pathway abnormalities linked to SARS-CoV-2 infections in thyroid cancer, consistent with the Reference. However, the specific emphasis on #rearrangement# is not present, slightly affecting completeness."
        },
        {
            "query_idx": 1418,
            "query": "What strategic protocols should healthcare personnel implement to mitigate the propagation of minute infectious agents in the course of cellular sample acquisition utilizing slender-edge aspiration techniques, considering the dynamics of particle diffusion and ocular shield mandates?",
            "retrieved_metrics": {
                "reference_idx": [
                    2156
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Healthcare personnel should wear #protective masks# with filter respirators, use #eye protection#, and fix cytology specimens with ethanol to mitigate infectious agent spread during aspiration.",
            "predicted_answer": "Healthcare personnel should wear personal protective masks with filter respirators, face masks, and eye shields during slender-edge aspiration techniques to mitigate the spread of infectious agents. Use ethanol for specimen fixation to reduce aerosol generation.",
            "score": 5,
            "explanation": "The predicted answer includes key facts such as wearing protective masks with filter respirators and using eye protection, which align with the reference. It also mentions fixing cytology specimens with ethanol, thus fully matching the emphasized points in the reference answer."
        },
        {
            "query_idx": 1419,
            "query": "What are the reverberations within the immune architecture, specifically relating to Treg augmentation and B lymphocyte diminution as instigated by $^{131}$I treatment, and how might these immunological perturbations engage with the continuum of risk factors pertaining to COVID-19 adversity?",
            "retrieved_metrics": {
                "reference_idx": [
                    2160
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "$^{131}$I treatment increases #Treg# and decreases #B lymphocyte#, but does not enhance COVID-19 risk, morbidity, or mortality, indicating limited clinical impact from immune imbalance.",
            "predicted_answer": "$^{131}$I treatment increases Treg count and decreases B lymphocyte count, potentially leading to immune imbalance. However, it does not enhance COVID-19 risk, morbidity, or mortality, so it should not be delayed in patients with metastases.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key points: it notes the increase in Treg, decrease in B lymphocytes, and lack of impact on COVID-19 risk. The meaning and key facts are consistent with the reference, with no significant omissions affecting understanding."
        },
        {
            "query_idx": 1420,
            "query": "In the intricate dance of molecular governance, what underlying principles enable the conjugation of siRNA with α TfR1 antibodies to serve as strategic catalysts for inducing transcriptional silencing predominantly within skeletal and cardiac tissues, as opposed to their muted influence in other prominent bodily organs?",
            "retrieved_metrics": {
                "reference_idx": [
                    2141
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #α TfR1# antibody conjugation facilitates #tissue-specific# delivery, achieving transcriptional silencing mainly in skeletal and cardiac tissues, with minimal impact on other organs.",
            "predicted_answer": "The conjugation of siRNA with α TfR1 antibodies enables targeted delivery to skeletal and cardiac tissues, leveraging specific interactions with cell surface receptors, resulting in predominant transcriptional silencing in these tissues while minimizing activity in other organs.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key facts emphasized in the reference answer: the use of α TfR1 antibodies, tissue-specific delivery, and targeted transcriptional silencing in skeletal and cardiac tissues. Although the wording differs, there are no significant omissions or inconsistencies."
        },
        {
            "query_idx": 1421,
            "query": "What proportionate measure of individuals within the exploratory landscape orchestrated by Abramson et al. arrived at a point of therapeutic equilibrium, and in what manner does this event correlate with the overarching temporal narrative of disease progression suspension?",
            "retrieved_metrics": {
                "reference_idx": [
                    2164
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In the trial by Abramson et al., #53%# of patients achieved #SD#, indicating a period of therapeutic equilibrium correlating with disease progression suspension.",
            "predicted_answer": "In the clinical trial by Abramson et al., 23% of patients achieved partial response (PR) and 53% had stable disease (SD), indicating therapeutic equilibrium. This correlates with the temporal narrative of disease progression suspension, as the median progression-free survival (PFS) was 79 weeks.",
            "score": 5,
            "explanation": "The predicted answer includes the key fact of #53%# of patients achieving #SD#, aligning with the reference answer's mention of therapeutic equilibrium. Additionally, the extra context about partial response and progression-free survival supports the temporal narrative, with no contradictions present."
        },
        {
            "query_idx": 1422,
            "query": "What are the dueling narratives concerning the therapeutic value dichotomy of sorafenib in addressing anaplastic thyroid carcinoma, in light of its noted therapeutic inclinations observed within controlled simulation environments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2165
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Sorafenib shows #therapeutic# efficacy in #experimental# ATC models, improving survival, yet is ineffective against ATC according to Ito et al., illustrating a therapeutic value dichotomy.",
            "predicted_answer": "The dueling narratives concerning sorafenib's therapeutic value in anaplastic thyroid carcinoma (ATC) highlight its effectiveness in experimental settings but its lack of efficacy in clinical reports, as noted by Ito et al.",
            "score": 5,
            "explanation": "The Predicted Answer captures the essence of sorafenib's therapeutic value dichotomy by recognizing its effectiveness in experimental settings and lack of efficacy in clinical contexts. Although not explicitly using the term 'therapeutic', it aligns well with the Reference Answer's highlighted facts, without omissions or contradictions."
        },
        {
            "query_idx": 1423,
            "query": "In the landscape of therapeutic pathways for DTC patients, what segment of those who did not thrive on conventional RAI techniques displayed a measure of improvement when subjected to the molecular journey of cabozantinib?",
            "retrieved_metrics": {
                "reference_idx": [
                    2163
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#53%# of DTC patients who did not respond to conventional RAI therapy experienced #improvement# with cabozantinib treatment.",
            "predicted_answer": "In a study of 15 DTC patients who did not respond to RAI therapy, 8 (53%) showed partial response (PR) with cabozantinib treatment.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key fact emphasized with #53%# and #improvement# in the reference answer. It specifies the partial response rate as 53% among DTC patients treated with cabozantinib, consistent with the overall trend and critical details of the reference."
        },
        {
            "query_idx": 1424,
            "query": "Within the investigative spectrum focused on the preliminary phase of cabozantinib's deployment for advanced medullary thyroid carcinoma, what fraction of patients manifested a transitional therapeutic response categorized under the partial response domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    2168
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#68%# of patients showed a #partial response# to cabozantinib in the phase I study for advanced medullary thyroid carcinoma.",
            "predicted_answer": "68% of patients in the phase I study of cabozantinib for advanced medullary thyroid carcinoma had a confirmed partial response (PR).",
            "score": 5,
            "explanation": "The Predicted Answer accurately reflects the key facts from the Reference Answer, specifically the #68%# figure and #partial response# within the context of the study on advanced medullary thyroid carcinoma. No critical information is missing, and the details are consistent."
        },
        {
            "query_idx": 1425,
            "query": "What divergent timelines of therapeutic persistence and progression deviation characterize the clinical journey of individuals across distinct age spectrums, as they engage with lenvatinib's influence within the context of thyroid anomalies resistant to iodine intervention?",
            "retrieved_metrics": {
                "reference_idx": [
                    2169
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #objective response rate# was higher in younger patients (#72%#) compared to older patients (55%), despite #lenvatinib# improving overall survival in #elderly#.",
            "predicted_answer": "Elderly patients with RAI-refractory DTC treated with lenvatinib had better overall survival, while younger patients had higher objective response rates. Lenvatinib's efficacy varied across age groups, with divergent timelines of progression and persistence.",
            "score": 3,
            "explanation": "The predicted answer captures key facts from the reference, notably lenvatinib's increased efficacy in younger patients and its contribution to improved survival in the elderly. However, it misses exact response rates (72% vs. 55%) for younger and older patients, affecting completeness. Trends remain consistent."
        },
        {
            "query_idx": 1426,
            "query": "What intricate pharmacokinetic dynamics and therapeutic recalibrations must be orchestrated when embarking upon the administration of chloroquine or hydroxychloroquine in concert with a sorafenib regimen, considering the potential for profound pharmaceutical interactions and the emergence of adverse clinical phenomena?",
            "retrieved_metrics": {
                "reference_idx": [
                    2167
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "When administering #chloroquine/hydroxychloroquine# with #sorafenib#, discontinue sorafenib due to QT prolongation and CYP3A4 inhibition. Stop MKIs if hypokalemia and fever occur; consult cardiology.",
            "predicted_answer": "When administering chloroquine or hydroxychloroquine with sorafenib, monitor for QT prolongation and CYP3A4 inhibition. Discontinue sorafenib if symptoms like hypokalemia or fever arise, and consult a cardiologist.",
            "score": 3,
            "explanation": "The predicted answer correctly identifies the key facts regarding the combination of chloroquine/hydroxychloroquine with sorafenib, highlighting QT prolongation and CYP3A4 inhibition. However, it misses the specific instruction to \"discontinue sorafenib\" and refers to MKIs more generally when mentioning hypokalemia and fever."
        },
        {
            "query_idx": 1427,
            "query": "What triadic framework of immunological checks and balances could be architected through the modulation of the everolimus-mTOR conduit in the symbiotic management of COVID-19's multifaceted immune challenges?",
            "retrieved_metrics": {
                "reference_idx": [
                    2177
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Everolimus# can shape immune responses in COVID-19 by reducing T lymphocyte proliferation, #attenuating# cytokine storms, and maintaining regulatory T cell activity.",
            "predicted_answer": "The triadic framework could involve modulating the everolimus-mTOR conduit to reduce T lymphocyte proliferation, attenuate cytokine storms, and maintain regulatory T cell activity, thereby managing COVID-19's immune challenges.",
            "score": 5,
            "explanation": "The predicted answer captures all key aspects: modulation using everolimus, reduction of T lymphocyte proliferation, attenuation of cytokine storms, and maintaining regulatory T cell activity. There are no omissions or contradictions, aligning well with the reference answer."
        },
        {
            "query_idx": 1428,
            "query": "What intricate mechanistic synergy orchestrates the cooperative pharmacological ballet of lenvatinib and remdesivir in arresting the intricate genetic choreography of SARS-CoV-2's replication processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2171
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #synergistic effects# of lenvatinib and remdesivir inhibit #SARS-CoV-2 replication# by efficiently targeting viral transcription and replication without affecting early replication stages.",
            "predicted_answer": "Lenvatinib and remdesivir synergistically inhibit SARS-CoV-2 replication by efficiently targeting viral transcription and replication processes, independent of VEGFR or PDGFR interactions.",
            "score": 3,
            "explanation": "The predicted answer captures the #synergistic effects# and #SARS-CoV-2 replication#. However, it misses the detail on not affecting the \"early replication stages,\" which is a key fact. Despite this omission, there is no contradictory information."
        },
        {
            "query_idx": 1429,
            "query": "What transformative revelations does the microcosm-on-a-dynamic-platform afford to the intricate choreography of morphogenetic simulations of cancerous vascular networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2179
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The microcosm-on-a-dynamic-platform enhances understanding of #cancerous vascular networks# and aids in the #design# of improved morphogenetic simulations using tumor-on-a-chip technology.",
            "predicted_answer": "The microcosm-on-a-dynamic-platform, specifically tumor-on-a-chip technology, offers transformative insights into the intricate choreography of morphogenetic simulations of cancerous vascular networks by providing a deeper understanding of the tumor microenvironment and enabling new approaches to drug development and vascularized cancer model design.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts about the \"cancerous vascular networks\" and their enhancement through tumor-on-a-chip technology. It also mentions the \"design\" of model systems, aligning with the reference. The information is consistent and complete with no critical omissions."
        },
        {
            "query_idx": 1430,
            "query": "What strategic developmental advantage does the tri-dimensional architectural modeling of oncogenic landscapes offer over traditional paradigms in decoding the intricacies of tumorigenic orchestration and metastatic progression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2184
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tri-dimensional architectural modeling provides a strategic advantage by allowing tumor cells to interact with the #ECM# in all dimensions, maintaining #morphology# and gene expression, enhancing understanding of tumorigenesis and metastasis.",
            "predicted_answer": "Tri-dimensional architectural modeling offers a more accurate representation of tumor cell interactions with the extracellular matrix, maintaining cell morphology, gene expression, and heterogeneity, which is crucial for understanding tumorigenesis and metastasis.",
            "score": 5,
            "explanation": "The predicted answer contains all key facts highlighted in the reference answer: tumor cell interactions with the ECM, maintaining morphology, gene expression, and understanding of tumorigenesis and metastasis. The meaning is consistent and no significant details are omitted."
        },
        {
            "query_idx": 1431,
            "query": "In the stratified examination of therapeutic efficacy documented by Hanna et al., what fractional response frequencies emerged amidst the heterogeneous landscape of thyroid carcinomas, encompassing DTC, MTC, and ATC?",
            "retrieved_metrics": {
                "reference_idx": [
                    2176
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The fractional response frequencies were #3%# for DTC, #10%# for MTC, and 14% for ATC.",
            "predicted_answer": "In the stratified examination by Hanna et al., fractional response frequencies were 3% for DTC, 10% for MTC, and 14% for ATC.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the fractional response frequencies for DTC (#3%#) and MTC (#10%#) as indicated in the reference answer. However, it misses the hashtag emphasis for the ATC frequency, which was not emphasized in the reference, indicating that it was not a key fact."
        },
        {
            "query_idx": 1432,
            "query": "What intrinsic synergistic properties, notably within elastomeric compounds like transparency and adaptability, substantiate their seamless integration into illumination crafting methodologies for the development of diminutive fluidic pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2190
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Transparency# and #flexibility# of PDMS make it ideal for integration into illumination crafting methodologies for creating diminutive fluidic pathways.",
            "predicted_answer": "Elastomeric compounds like PDMS offer transparency and adaptability, crucial for seamless integration into illumination crafting for microfluidic pathways, due to their transparency, flexibility, and ease of molding.",
            "score": 5,
            "explanation": "The predicted answer captures the key facts of #transparency# and #flexibility# regarding elastomeric compounds such as PDMS. It aligns with the overall trend of the reference answer by emphasizing these properties as crucial for integrating into crafting methodologies. No significant omissions or errors are present."
        },
        {
            "query_idx": 1433,
            "query": "Within the sophisticated convergence of organic and engineered realms as orchestrated by Hachey et al. (2021), what enhancements functioned as catalytic entities, weaving together the tapestry of endothelial passages with the structured pathways of microfluidic channels?",
            "retrieved_metrics": {
                "reference_idx": [
                    2191
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Laminin# served as a catalytic entity, enabling the anastomosis of #endothelial cells# and microfluidic channels in Hachey et al. (2021) study.",
            "predicted_answer": "Laminin facilitated the anastomosis of endothelial cells and microfluidic channels, enhancing the convergence of organic and engineered realms.",
            "score": 5,
            "explanation": "The predicted answer accurately highlights #Laminin# and the #endothelial cells#' anastomosis involving microfluidic channels, aligning well with the key facts of the reference answer. The integration of these elements is covered, fully reflecting the reference answer's meaning without omission of any emphasized detail."
        },
        {
            "query_idx": 1434,
            "query": "What transformative process did Miller et al. (2018) utilize to configure hollow constructs within a collagen-gelated environment, through the strategic withdrawal of mandrel rods, thereby enabling the establishment of endothelial inhabitations that simulate vascular networks?",
            "retrieved_metrics": {
                "reference_idx": [
                    2192
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Miller et al. (2018) utilized #mandrel rods# to create #hollow channels# in collagen gel, allowing endothelial cells to form simulated vascular networks.",
            "predicted_answer": "Miller et al. (2018) utilized the strategic withdrawal of mandrel rods after collagen gelation to create hollow channels, enabling the establishment of endothelial inhabitations that simulate vascular networks.",
            "score": 5,
            "explanation": "The predicted answer effectively captures the key elements emphasized in the reference answer. It mentions the use of mandrel rods to create hollow channels, and discusses the formation of endothelial cells simulating vascular networks, aligning well with the reference details. No key facts are missing."
        },
        {
            "query_idx": 1435,
            "query": "Within the complex interplay of 3D bioprinting's sacrificial templating technique, how does the strategic liberation of Pluronic F-127 ink facilitate the emergence of ethereal passageways mimicking vascular arrangements?",
            "retrieved_metrics": {
                "reference_idx": [
                    2197
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The strategic liberation of #Pluronic F-127# ink creates #hollow channels#, allowing endothelial and pericytes to form blood vessels, mimicking vascular arrangements.",
            "predicted_answer": "The strategic liberation of Pluronic F-127 ink in 3D bioprinting's sacrificial templating technique creates hollow channels mimicking vascular arrangements, facilitating the injection and incubation of cells to form functional blood vessels.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts from the reference answer, including the use of Pluronic F-127 ink to create hollow channels that mimic vascular structures. It also mentions the facilitation of blood vessel formation, aligning well with the overall trend of the reference answer, despite minor differences in phrasing."
        },
        {
            "query_idx": 1436,
            "query": "What orchestrated approach did Kim et al. implement to influence and direct the minute fluid currents within the composite matrix of their functionally sculpted cellular habitat, specifically designed to emulate vascularity in a tumor analogue?",
            "retrieved_metrics": {
                "reference_idx": [
                    2193
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Kim et al. orchestrated the control of minute fluid currents by adjusting the #volume difference# between the hollow and tumor channels, directing flow within the #hydrogel#.",
            "predicted_answer": "Kim et al. implemented an approach using three needles of different diameters to create hollow channels in a hydrogel matrix. They controlled interstitial flow by adjusting the volume difference between the channels, directing fluid currents to emulate vascularity in a tumor analogue.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts of adjusting the \"volume difference\" and using a \"hydrogel\" as mentioned in the reference answer. It aligns well with the overall trend and captures the essence of orchestrating fluid flow within the matrix without significant omissions or contradictions."
        },
        {
            "query_idx": 1437,
            "query": "Within the multifaceted exchanges of cellular cohorts in microvascular systems, what particular methodologies are utilized by MDA-MB-231 and PDAC tumor cells to execute nuanced negotiations with the endothelial guardians, subsequently orchestrating alterations in permeability dynamics of their cohabited domain?",
            "retrieved_metrics": {
                "reference_idx": [
                    2200
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "MDA-MB-231 cells increase vascular permeability by impairing #endothelial cell-cell junctions#, while #PDAC tumor cells# invade and replace endothelium, occupying the lumen.",
            "predicted_answer": "MDA-MB-231 and PDAC tumor cells increase vascular permeability by impairing endothelial cell-cell junctions and replacing endothelium, respectively.",
            "score": 5,
            "explanation": "The predicted answer correctly identifies MDA-MB-231 cells impairing #endothelial cell-cell junctions# and mentions #PDAC tumor cells# replacing endothelium, aligning with the key facts in the reference. Although the term \"occupying the lumen\" is missing, it does not significantly affect the overall alignment."
        },
        {
            "query_idx": 1438,
            "query": "What sophisticated experimental apparatus and methodologies are employed to craft an analogous portrayal of the ever-changing symbiotic habitat observed in the scenario of hepatitis B virus-induced hepatic carcinoma, as showcased in the third schematic illustration?",
            "retrieved_metrics": {
                "reference_idx": [
                    2201
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Human #monocytes# were cultured in #collagen gels# with HepG2 cells, while HBV-specific TCR T cells passed through tumor zones, simulating HBV-related hepatic carcinoma's microenvironment.",
            "predicted_answer": "The experimental apparatus employs organ-on-a-chip technology, using human monocytes cultured in collagen gels with HepG2 cells and HBV-specific TCR T cells to mimic the dynamic microenvironment of HBV-related hepatocellular carcinoma.",
            "score": 5,
            "explanation": "The predicted answer successfully captures the key facts from the reference answer, including the use of organ-on-a-chip technology, human monocytes, collagen gels, HepG2 cells, and HBV-specific TCR T cells, all essential to emulating the microenvironment of HBV-induced hepatic carcinoma. The overall alignment is clear."
        },
        {
            "query_idx": 1439,
            "query": "What intrinsic merits do the fluidic architecture models possess over the conventional rodent frameworks in enhancing our understanding of the intricate dance between the immune cell sentinels and cancerous formations across varied microenvironmental theatres?",
            "retrieved_metrics": {
                "reference_idx": [
                    2202
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #fluidic architecture# models enable dynamic observation of interactions between #TAMs# and tumor cells, offering reproducible insights into metastasis across different organ microenvironments.",
            "predicted_answer": "Fluidic architecture models offer intrinsic merits such as dynamic observation of immune-tumor interactions, reproducible metastasis, and varied microenvironmental contexts, enhancing understanding beyond conventional rodent frameworks.",
            "score": 3,
            "explanation": "The predicted answer covers key aspects of fluidic architecture models such as dynamic observation of immune-tumor interactions and varied microenvironments, which align with the reference. However, it misses mentioning \"TAMs,\" an important fact. Overall, it aligns but lacks completeness in detail."
        },
        {
            "query_idx": 1440,
            "query": "What is the outcome of leveraging TGFβ receptor inhibition through sophisticated flow-based manipulation schemes in influencing the disintegration dynamics of endothelial constructs within pancreatic neoplasms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2199
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Leveraging TGFβ receptor inhibition results in significantly reduced #endothelial# cell ablation in pancreatic #neoplasms# over 7 days compared to cases without inhibitors.",
            "predicted_answer": "Leveraging TGFβ receptor inhibition through sophisticated flow-based manipulation schemes significantly reduces the ablation of vascular endothelial cells within pancreatic neoplasms, mediated by the activin-ALK7 pathway.",
            "score": 3,
            "explanation": "The predicted answer includes the key facts from the reference answer: it mentions TGFβ receptor inhibition and reduced endothelial cell ablation in pancreatic neoplasms. However, it omits the specific time frame (\"over 7 days\") mentioned in the reference answer, affecting completeness."
        },
        {
            "query_idx": 1441,
            "query": "Within the intricate biochemical ensemble of cellular interaction in type I collagen-enhanced matrices, what pivotal function does integrin αvβ3 assume in orchestrating the inflammatory dynamics crucial for initiating and sustaining angiogenic processes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2205
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Integrin #αvβ3# plays a critical role in #endothelial cell-macrophage interactions#, influencing inflammation-driven angiogenesis in type I collagen-enhanced matrices.",
            "predicted_answer": "Integrin αvβ3 plays a pivotal role in orchestrating inflammatory dynamics by mediating endothelial cell-macrophage interactions, which are crucial for initiating and sustaining inflammation-driven angiogenesis in type I collagen-enhanced matrices.",
            "score": 5,
            "explanation": "The predicted answer includes the key facts emphasized in the reference answer, such as integrin αvβ3, endothelial cell-macrophage interactions, and its role in inflammation-driven angiogenesis in type I collagen-enhanced matrices. All essential elements are present, with no significant omissions or inaccuracies."
        },
        {
            "query_idx": 1442,
            "query": "Within the intricate biological choreography, what influence do the circulatory pathways, akin to arterial conduits, and the lymphatic currents exert in the orchestrated allocation and metamorphic action of anticancer pharmacologic entities within the heterogeneous terrain of tumorous microenvironments?",
            "retrieved_metrics": {
                "reference_idx": [
                    2209
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Blood circulation and #lymphatic drainage# influence anticancer drugs by affecting their #distribution# in tumor tissue, aiding delivery and removal, potentially impacting therapeutic effectiveness.",
            "predicted_answer": "Circulatory pathways and lymphatic currents influence the distribution and action of anticancer drugs by facilitating their transport to tumor sites and removal of excess drugs, respectively, within heterogeneous tumorous microenvironments.",
            "score": 3,
            "explanation": "The predicted answer accurately captures the idea of \"lymphatic currents\" as \"lymphatic drainage,\" and it also conveys \"distribution\" of anticancer drugs within tumor sites. However, it lacks explicit mention of how these factors impact \"therapeutic effectiveness,\" which is a key point in the reference answer."
        },
        {
            "query_idx": 1443,
            "query": "In what manner does the enigmatic force of IF catalyze a metamorphosis in macrophage migratory conduct, subsequently sculpting the landscape of cellular invasion exhibited by malignant entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2208
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The enigmatic force of #IF# enhances macrophage #migration#, resulting in increased cancer cell invasiveness when cocultured, thus promoting cancer aggressiveness.",
            "predicted_answer": "The enigmatic force of IF accelerates macrophage migration and enhances cancer cell invasiveness, promoting cancer aggressiveness by altering macrophage migratory behavior.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts: IF enhances macrophage migration and leads to increased cancer cell invasiveness, which are the main points emphasized with # symbols in the reference. The trend and key information are consistent, though phrasing differs slightly."
        },
        {
            "query_idx": 1444,
            "query": "In the interplay of bioenergetic influx and cytostatic influences, what undercurrent of physiological dynamics precipitates the augmentation of spheroidal constructs endowed with vascular conduits at the specified concentration milieu, contrasting with their non-vascular counterparts?",
            "retrieved_metrics": {
                "reference_idx": [
                    2210
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The undercurrent of physiological dynamics is the #proliferation# due to nutrient delivery via vascular conduits surpassing the #cell death# from paclitaxel at 5 ng/ml under perfusion conditions.",
            "predicted_answer": "The augmentation of vascularized spheroids at 5 ng/ml treatment is likely due to enhanced cell proliferation from nutrient delivery via perfusable vessels, which compensates for cytostatic effects, contrasting with non-vascular spheroids where drug effects predominate.",
            "score": 3,
            "explanation": "The predicted answer aligns with the reference answer by identifying cell proliferation driven by nutrient delivery via vascular conduits. However, it does not explicitly mention \"cell death from paclitaxel.\" This omission affects completeness as it misses one key fact."
        },
        {
            "query_idx": 1445,
            "query": "Within the realm of Cao et al.'s 2019 engineered biosphere, what architectural distinction orchestrates the modulation of doxorubicin's therapeutic diminution?",
            "retrieved_metrics": {
                "reference_idx": [
                    2211
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "In Cao et al.'s 2019 biosphere, #lymphatic vessel presence# modulates doxorubicin's therapeutic diminution by affecting drug #permeability#.",
            "predicted_answer": "Cao et al.'s 2019 engineered biosphere modulates doxorubicin's therapeutic diminution by varying the permeability of blood vessels and lymphatics, achieved through the regulation of PEG molecules in bioink.",
            "score": 1,
            "explanation": "The predicted answer mentions \"permeability,\" aligning with the reference, but omits the key fact of \"lymphatic vessel presence\" affecting drug modulation. The absence of this crucial element impacts completeness, though the trend regarding modulation and permeability is partially covered."
        },
        {
            "query_idx": 1446,
            "query": "What intricate hurdle did Carvalho and colleagues have to navigate regarding the merger process of endothelial cellular elements within the intricately designed microvascular framework of their colorectal tumor simulation model?",
            "retrieved_metrics": {
                "reference_idx": [
                    2213
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Carvalho and colleagues faced the #hurdle# of preventing anastomosis formation between #endothelial cells# in their colorectal tumor simulation model.",
            "predicted_answer": "Carvalho and colleagues faced the challenge of achieving anastomosis, or merging, of endothelial cells within their microvascular framework, which did not occur in their colorectal tumor simulation model.",
            "score": 0,
            "explanation": "The predicted answer incorrectly states that the challenge was achieving anastomosis, while the reference highlights preventing it. This contradiction impacts the completeness and alignment with key facts, especially the #hurdle# and #endothelial cells# emphasized in the reference."
        },
        {
            "query_idx": 1447,
            "query": "What inherent dominance did the vascular-infused multidimensional oncological construct exhibit when juxtaposed with the flat-layered cellular arrangement and diverse cellular configurations in the investigational study led by Hachey et al.?",
            "retrieved_metrics": {
                "reference_idx": [
                    2217
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #vascularized tumor model# exhibited #robustness#, reproducibility, and a gene expression pattern closely matching in vivo tumors, surpassing flat-layered and diverse cellular configurations.",
            "predicted_answer": "The vascular-infused multidimensional oncological construct exhibited inherent dominance by closely matching in vivo gene expression patterns and better preserving tumor heterogeneity compared to flat-layered cellular arrangements.",
            "score": 1,
            "explanation": "The predicted answer mentions that the vascular-infused multidimensional oncological construct closely matches in vivo gene expression patterns. However, it misses \"robustness\" and \"reproducibility\" as emphasized in the reference answer. While the overall trend aligns, the lack of these two key facts affects completeness."
        },
        {
            "query_idx": 1448,
            "query": "In what capacity does the attempt to re-envision the cerebral microcosm present a more intricate architectural complexity in the design of malignant brain tumor simulations, in contrast to crafting the microenvironmental symphony peculiar to metastatic pancreatic formations utilizing tumor-on-a-chip technology pathways?",
            "retrieved_metrics": {
                "reference_idx": [
                    2220
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #cerebral microcosm# presents a more intricate architectural complexity in brain tumor simulations due to the brain's #unique nature#, compared to pancreatic metastatic microenvironments.",
            "predicted_answer": "Re-envisioning the cerebral microcosm presents greater architectural complexity in malignant brain tumor simulations due to the brain's unique microenvironment, contrasting with the more straightforward microenvironmental symphony of metastatic pancreatic formations in tumor-on-a-chip technology.",
            "score": 5,
            "explanation": "The key facts in the reference answer, such as \"cerebral microcosm,\" \"more intricate architectural complexity,\" and the brain's \"unique nature,\" are present in the predicted answer. The predicted answer captures the comparison with the pancreatic microenvironment without contradiction."
        },
        {
            "query_idx": 1449,
            "query": "How does the intricate molecular habitat within the bone marrow's ecosystem orchestrate and modulate the development and advancement of blood-related malignancies through its complex, bidirectional interactions?",
            "retrieved_metrics": {
                "reference_idx": [
                    2223
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #bone marrow# niche can cause malignant mutations and is remodeled by #tumor cells# to promote tumor development and drug resistance.",
            "predicted_answer": "The intricate molecular habitat within the bone marrow's ecosystem, including the bone marrow niche (BMN), orchestrates and modulates the development and advancement of blood-related malignancies through complex, bidirectional interactions that can both cause and promote malignant mutations and drug resistance.",
            "score": 3,
            "explanation": "The predicted answer successfully identifies the role of the bone marrow niche (BMN) in causing malignant mutations and promoting tumor development and drug resistance, aligning with the reference's key points. It lacks the specific mention of \"tumor cells\" remodeling the niche, resulting in one key fact missing."
        },
        {
            "query_idx": 1450,
            "query": "Amidst the elaborate vascular tableau engineered within the neuroblastoma framework, what are the nuanced ramifications wrought by isotretinoin concerning the cessation of cellular vitality, modulation of CD31’s bio-expression, and the apparent resilience of the neoplastic endothelial contingent to its effects?",
            "retrieved_metrics": {
                "reference_idx": [
                    2222
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Isotretinoin induces #apoptosis# and reduces #CD31# expression in neuroblastoma cells, disintegrating the vascular network, but does not affect tumor-derived endothelial cells.",
            "predicted_answer": "Isotretinoin induces apoptosis and reduces CD31 expression in neuroblastoma cells, causing vascular network disintegration, but it does not affect tumor-derived endothelial cells.",
            "score": 5,
            "explanation": "The predicted answer fully matches the reference, covering all key facts: isotretinoin's induction of apoptosis, reduction in CD31 expression, and lack of effect on tumor-derived endothelial cells. The meaning and overall trend are consistent with the reference, with no omissions or contradictions."
        },
        {
            "query_idx": 1451,
            "query": "What intricate behavioral patterns did the progenitor-like cellular forms demonstrate within the vascular-proximal microenvironment per Xiao et al. (2019)?",
            "retrieved_metrics": {
                "reference_idx": [
                    2221
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Progenitor-like cellular forms exhibited either #quiescent# or #aggressive# behavior near the microvessels in the vascular-proximal microenvironment.",
            "predicted_answer": "Xiao et al. (2019) observed that progenitor-like cellular forms in the vascular-proximal microenvironment demonstrated either quiescent or aggressive behavior.",
            "score": 5,
            "explanation": "The Predicted Answer effectively captures both key behaviors: \"quiescent\" and \"aggressive\" as emphasized in the Reference Answer. There is no significant deviation or contradiction from the Reference Answer's meaning, indicating all key facts are present and the trend is aligned."
        },
        {
            "query_idx": 1452,
            "query": "What is the role of cellular metamorphosis in neuroblastoma, specifically as tumor cells simulate endothelium to craft capillary-like conduits, in moderating the outcomes of vascular-targeting therapeutics including bevacizumab?",
            "retrieved_metrics": {
                "reference_idx": [
                    2224
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Cellular metamorphosis in neuroblastoma leads to #angiogenic mimicry#, enabling tumor cells to create capillary-like structures, potentially reducing the effectiveness of vascular-targeting therapies like #bevacizumab#.",
            "predicted_answer": "Cellular metamorphosis in neuroblastoma, where tumor cells simulate endothelium to form capillary-like conduits, may reduce the efficacy of vascular-targeting therapeutics like bevacizumab by mimicking angiogenesis.",
            "score": 5,
            "explanation": "The predicted answer includes the key concept of \"angiogenic mimicry\" as \"mimicking angiogenesis\" and mentions \"bevacizumab\" and its reduced efficacy, which aligns with the reference's overall trend. No contradictory information is present, and no key facts are missing."
        },
        {
            "query_idx": 1453,
            "query": "What influence does the intrinsic water-repellent nature of polydimethylsiloxane exert as a subtle shaper on the precision of tumor-on-a-chip explorations, and how could it unfold into broader challenges, potentially stalling their aspired applications in clinical realms?",
            "retrieved_metrics": {
                "reference_idx": [
                    2226
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #hydrophobic# nature of #PDMS# can lead to drug adsorption, causing erroneous results and limiting the clinical application of tumor-on-a-chip models.",
            "predicted_answer": "The intrinsic water-repellent nature of polydimethylsiloxane (PDMS) can adsorb anticancer drugs, leading to inaccurate results and limiting clinical applications. This issue necessitates new materials and poses challenges in reproducibility and scale-up for tumor-on-a-chip platforms.",
            "score": 5,
            "explanation": "The predicted answer captures key facts such as the hydrophobic nature of PDMS leading to drug adsorption, resulting in inaccurate results and limiting clinical applications. All emphasized details in the reference answer are mirrored in the predicted answer, aligning with the overall trend without omissions."
        },
        {
            "query_idx": 1454,
            "query": "Within the realm of engineered constructs mimicking marrow landscapes to unravel blood malignancy dynamics, what indispensable architectural motifs and constituent pillars emerge as quintessential for crafting these micro-wholes?",
            "retrieved_metrics": {
                "reference_idx": [
                    2225
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Microfluidics# and #porous scaffolds# are essential for creating engineered constructs that mimic marrow landscapes for studying blood malignancy dynamics.",
            "predicted_answer": "Indispensable architectural motifs for mimicking marrow landscapes include microfluidics and porous scaffolds. Constituent pillars involve polymeric materials and 3D tissue engineering to simulate blood malignancy dynamics.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the key architectural motifs of #microfluidics# and #porous scaffolds# from the reference answer. It also adds relevant details regarding polymeric materials and 3D tissue engineering, which do not contradict the reference. There are no significant omissions."
        },
        {
            "query_idx": 1455,
            "query": "How do the intricacies of fiscal efficiency and minimized venture unpredictability serve as catalysts in the inclination toward the reutilization of non-patent pharmaceutical entities within intellectual and altruistic research communities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2236
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The intricacies of #fiscal efficiency# and #minimized venture unpredictability# favor the reutilization of non-patent pharmaceutical entities, making them attractive for academia and research organizations.",
            "predicted_answer": "The intricacies of fiscal efficiency and minimized venture unpredictability drive the inclination toward reutilizing non-patent pharmaceutical entities, as they offer lower costs and risks, particularly favored by academic, small biotech, and not-for-profit research communities.",
            "score": 5,
            "explanation": "The predicted answer captures key points of \"fiscal efficiency\" and \"minimized venture unpredictability\" as catalysts for reutilizing non-patent pharmaceuticals. Important audiences like academia and research organizations are included under terms like \"academic, small biotech, and not-for-profit research communities,\" with no significant omissions or contradictions."
        },
        {
            "query_idx": 1456,
            "query": "What complex impediments inherent in the transmutation of clinically rejected molecular entities into new therapeutic paradigms, especially regarding informational accessibility and antecedent inefficacies, are exposed by the context provided?",
            "retrieved_metrics": {
                "reference_idx": [
                    2237
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "#Informational accessibility# issues and addressing #antecedent inefficacies# are impediments in repurposing clinically rejected drugs, due to inaccessible data and ensuring previous failure reasons are resolved.",
            "predicted_answer": "The context highlights complex impediments such as limited informational accessibility due to proprietary data and profit concerns, as well as antecedent inefficacies that led to initial clinical rejection, making it challenging to repurpose failed molecular entities into new therapeutic paradigms.",
            "score": 5,
            "explanation": "The predicted answer addresses both key issues of informational accessibility and antecedent inefficacies as highlighted by the reference answer. It notes proprietary data and profit concerns as reasons for accessibility issues and mentions challenges due to initial clinical rejection, aligning well with the reference's emphasis on resolving previous failures."
        },
        {
            "query_idx": 1457,
            "query": "Within the intricate tapestry of therapeutic research and development, what essential superiority does the strategy of engaging with particular molecular focal points offer when juxtaposed with the sweeping examination of phenotypic manifestations within the framework of compound exploration?",
            "retrieved_metrics": {
                "reference_idx": [
                    2240
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Engaging specific #molecular targets# enables precise evaluation of drug interactions, minimizing false leads and increasing the likelihood of successful pre-clinical translation, unlike broader phenotypic screenings.",
            "predicted_answer": "Engaging with particular molecular focal points offers precision in targeting specific pathways, ensuring thorough evaluation and minimizing false leads, enhancing the likelihood of successful clinical translation compared to phenotypic screening.",
            "score": 3,
            "explanation": "The predicted answer captures the key concept of engaging with \"molecular focal points\" for enhanced precision and reduced false leads, as highlighted in the reference. However, it lacks the specific mention of \"pre-clinical translation,\" which slightly impacts completeness."
        },
        {
            "query_idx": 1458,
            "query": "In what manner do Scannell et al. articulate the labyrinthine dynamics of industry alignment with R&D paradigms, as influenced by Eroom's Law, particularly concerning the notion of assumed progressive advancement in these methods?",
            "retrieved_metrics": {
                "reference_idx": [
                    2238
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Scannell et al. suggest Eroom's Law highlights #industry# failure to adopt advanced R&D methods, assuming false progressive advancement, due to market competition and regulatory #hurdles#.",
            "predicted_answer": "Scannell et al. articulate that industry alignment with R&D paradigms, influenced by Eroom's Law, assumes progressive advancement but fails due to regulatory hurdles, market demands, and misguided R&D investments.",
            "score": 3,
            "explanation": "The 'Predicted Answer' reflects the key theme of industry's false assumption of progress due to Eroom's Law and mentions regulatory hurdles, which aligns with the 'Reference Answer'. However, it misses mentioning \"industry\" failure due to \"market competition\"."
        },
        {
            "query_idx": 1459,
            "query": "What multifaceted methodologies are harnessed within the expansive repositories of pharmaco-explorations to discern the concealed capacities of therapeutic agents when aligned against assorted pathological manifestations?",
            "retrieved_metrics": {
                "reference_idx": [
                    2239
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Multifaceted methodologies include #knowledge-based#, #drug-based#, activity-based, in silico, and in vitro screening to assess therapeutic agents against various pathological manifestations.",
            "predicted_answer": "Multifaceted methodologies in pharmaco-explorations include knowledge-based, drug-based, activity-based, in silico, and in vitro screening methods to identify effective therapeutic agents against various pathological conditions.",
            "score": 5,
            "explanation": "The predicted answer contains all the key methodologies mentioned in the reference answer, including \"knowledge-based,\" \"drug-based,\" \"activity-based,\" \"in silico,\" and \"in vitro screening,\" aligning accurately with the reference. There are no omissions or contradictions."
        },
        {
            "query_idx": 1460,
            "query": "Through what investigative framework did Lin et al. ascertain the alignment of the psychiatric remedy imipramine with glioblastoma treatment paradigms, and in what manner does its efficacy delineate itself when juxtaposed with the traditional chemotherapeutic recourse, temozolomide?",
            "retrieved_metrics": {
                "reference_idx": [
                    2242
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Lin et al. employed #genome-wide association studies# to identify imipramine for #glioblastoma# treatment, demonstrating higher sensitivity in GB cells compared to temozolomide.",
            "predicted_answer": "Lin et al. used a repurposing framework based on genome-wide association studies to ascertain imipramine's alignment with glioblastoma treatment. They found imipramine to be more effective than temozolomide, the standard chemotherapy, in targeting glioblastoma cells.",
            "score": 5,
            "explanation": "The predicted answer accurately includes the use of genome-wide association studies and aligns imipramine with glioblastoma treatment. It also mentions imipramine's superior effectiveness over temozolomide. All key facts are present, aligning with the core points of the reference answer."
        },
        {
            "query_idx": 1461,
            "query": "What elevated strategic benefit is conferred through the synthesis of multidimensional therapeutic schemas as opposed to the singular trajectory of isolated pharmacological application in managing convoluted conditions such as glioma?",
            "retrieved_metrics": {
                "reference_idx": [
                    2245
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The synthesis of #multidimensional therapeutic# schemas offers #comprehensive and effective# treatment, targeting different aspects of glioma rather than a single approach.",
            "predicted_answer": "Multimodal therapy offers a strategic advantage by addressing multiple aspects of complex conditions like glioma, enhancing treatment efficacy and potentially improving patient outcomes compared to monotherapy.",
            "score": 5,
            "explanation": "The predicted answer aligns well with the reference answer's core idea, highlighting the strategic advantage of addressing multiple aspects of glioma. It covers the concepts of multiple dimensions (multimodal therapy) and improved efficacy, aligning with comprehensive and effective treatment. No key facts are omitted."
        },
        {
            "query_idx": 1462,
            "query": "In the delicate dance of pharmacological reengineering, what intrinsic target-centric metamorphosis enabled Tamoxifen to orchestrate its therapeutic prowess against breast cancerous proliferations, following its inefficacy in the realm of ovulation suppression?",
            "retrieved_metrics": {
                "reference_idx": [
                    2241
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Tamoxifen's therapeutic prowess against breast cancer emerged from its ability to #block# the #oestrogen receptor#, inhibiting estrogen and slowing growth of ER+ breast cancers.",
            "predicted_answer": "Tamoxifen's therapeutic prowess against breast cancer was enabled by its ability to block the oestrogen receptor (ER), effectively inhibiting oestrogen and slowing the growth of ER+ breast cancers.",
            "score": 5,
            "explanation": "The predicted answer captures all key facts emphasized in the reference answer, such as the ability of Tamoxifen to block the oestrogen receptor, inhibit oestrogen, and influence ER+ breast cancer growth. The meanings are consistent, with no significant omissions or errors."
        },
        {
            "query_idx": 1463,
            "query": "In what way does the conceptual master key strategy, formulated within intricate molecular frameworks, seek to navigate and mitigate the inherent complexities of thorough genetic characterization in personalized cancer therapy, by focusing on a widely applicable protein and pathway paradigm across diverse malignancies?",
            "retrieved_metrics": {
                "reference_idx": [
                    2248
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #conceptual master key# strategy seeks to mitigate genetic characterization complexities by targeting #prevalent proteins and pathways# in diverse cancers, impacting more patients with less effort.",
            "predicted_answer": "The conceptual master key strategy aims to simplify personalized cancer therapy by targeting widely applicable proteins and pathways across diverse malignancies, reducing the need for extensive genetic profiling.",
            "score": 5,
            "explanation": "The predicted answer mentions targeting \"widely applicable proteins and pathways,\" aligning with \"prevalent proteins and pathways\" in the reference. It captures the strategy's goal to simplify therapy by reducing genetic profiling need. The trend is consistent, with no significant omissions."
        },
        {
            "query_idx": 1464,
            "query": "What role do linguistic data excavation techniques play in elucidating innovative pharmaceutical redeployment routes for oncogenic genetic markers within the framework of the studies discussed?",
            "retrieved_metrics": {
                "reference_idx": [
                    2246
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Linguistic data excavation techniques, like #text mining#, are pivotal in identifying innovative pharmaceutical redeployment routes, revealing #associations# between drugs and oncogenic genetic markers in cancer studies.",
            "predicted_answer": "Linguistic data excavation techniques, such as text mining, play a crucial role in identifying innovative pharmaceutical redeployment routes for oncogenic genetic markers by uncovering new associations between drugs and cancer-related genes from literature.",
            "score": 5,
            "explanation": "The predicted answer covers the key facts such as the use of text mining in linguistic data excavation and the identification of associations between drugs and oncogenic genetic markers. It aligns with the overall trend and meaning of the reference. No significant omissions or errors are noted."
        },
        {
            "query_idx": 1465,
            "query": "What emergent efficacy phenomenon is observed in the transformative alliance of thalidomide with corticosteroids and an alkylating agent, such as melphalan, in the relentless pursuit of subduing myeloma cellular entities?",
            "retrieved_metrics": {
                "reference_idx": [
                    2254
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #emergent efficacy# observed is an increased response rate of #70%# when thalidomide is combined with corticosteroids and an alkylating agent like melphalan against myeloma cells.",
            "predicted_answer": "The emergent efficacy phenomenon observed is the synergistic effect, where thalidomide combined with corticosteroids and melphalan significantly enhances response rates against myeloma cells, reaching up to 70%.",
            "score": 5,
            "explanation": "The predicted answer accurately reflects the key facts from the reference answer: the emergent efficacy involves a 70% response rate and the combination of thalidomide, corticosteroids, and melphalan against myeloma cells. The synergy aspect is consistent with increased response, and there are no significant omissions."
        },
        {
            "query_idx": 1466,
            "query": "How does the alliance of academic inquiry with corporate pharmaceutical expertise transform the realm of medicinal repositioning, particularly in relation to resolving the challenges posed by the scarcity of proprietary stewardship and specialized intellectual resources?",
            "retrieved_metrics": {
                "reference_idx": [
                    2263
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The alliance between academia and corporate pharmaceuticals aids #medicinal repositioning# by providing #specialized intellectual resources# for marketing exclusivity and repurposing unused drugs.",
            "predicted_answer": "The alliance of academic inquiry with corporate pharmaceutical expertise enhances medicinal repositioning by providing specialized intellectual resources and proprietary stewardship, addressing challenges like marketing exclusivity and profit-driven limitations, and facilitating access to failed drugs for repurposing efforts.",
            "score": 5,
            "explanation": "The predicted answer aligns with the reference answer by addressing the transformation in medicinal repositioning through specialized intellectual resources. It also mentions marketing exclusivity and repurposing unused drugs. No key facts are missing, and the overall trend is consistent."
        },
        {
            "query_idx": 1467,
            "query": "How does the metaphoric shield of intellectual property manifest a reduced efficacy in the realm of recycled therapeutics as opposed to the genesis of unique molecular constructs, especially when evaluating the intricacies of legal enforcement burdens and the incapacity to deter non-regulated applications?",
            "retrieved_metrics": {
                "reference_idx": [
                    2266
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "The #reduced efficacy# of IP protection for recycled therapeutics arises from weaker #use patents#, costly enforcement, and inability to deter off-label use and non-regulated applications.",
            "predicted_answer": "The metaphoric shield of intellectual property is less effective for recycled therapeutics due to weaker use patents, higher enforcement costs, and inability to prevent off-label use, contrasting with stronger protection for unique molecular constructs.",
            "score": 3,
            "explanation": "The predicted answer covers the key points: reduced efficacy of IP protection due to weaker use patents, high enforcement costs, and the inability to prevent off-label use. It aligns with the reference answer, omitting only \"non-regulated applications,\" minimal to overall meaning."
        },
        {
            "query_idx": 1468,
            "query": "What could be the potential strategic advantages in the domain of pharmaceutical research, derived from employing advanced analytical methodologies for evaluating drug efficacy and mechanisms on intricate pre-clinical simulacra?",
            "retrieved_metrics": {
                "reference_idx": [
                    2268
                ],
                "num_of_contexts": 1
            },
            "groundtruth_answer": "Employing advanced analytical methodologies can enhance #drug efficacy# evaluation and optimize drug combinations, reducing potentially unsuccessful clinical trials and resource waste.",
            "predicted_answer": "Advanced analytical methodologies can enhance drug efficacy evaluation and mechanism understanding, optimizing drug combinations and reducing unsuccessful clinical trials, thereby saving time and resources.",
            "score": 5,
            "explanation": "The predicted answer includes key points about enhancing drug efficacy evaluation and optimizing drug combinations, aligned with the reference. It also includes understanding mechanisms, which complements the reference. There are no significant omissions or contradictions, capturing all critical details."
        }
    ]
}